Citrus Sinensis ID: 002732
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 887 | 2.2.26 [Sep-21-2011] | |||||||
| Q5RKH1 | 1007 | Serine/threonine-protein | yes | no | 0.382 | 0.336 | 0.578 | 1e-119 | |
| Q61136 | 1007 | Serine/threonine-protein | yes | no | 0.382 | 0.336 | 0.578 | 1e-119 | |
| Q08DZ2 | 1008 | Serine/threonine-protein | yes | no | 0.382 | 0.336 | 0.578 | 1e-119 | |
| Q13523 | 1007 | Serine/threonine-protein | yes | no | 0.382 | 0.336 | 0.578 | 1e-119 | |
| Q5R814 | 1007 | Serine/threonine-protein | yes | no | 0.382 | 0.336 | 0.572 | 1e-117 | |
| Q07538 | 477 | Serine/threonine-protein | yes | no | 0.509 | 0.947 | 0.454 | 1e-108 | |
| Q54WE5 | 811 | Serine/threonine-protein | yes | no | 0.376 | 0.411 | 0.531 | 1e-107 | |
| Q09815 | 836 | Serine/threonine-protein | no | no | 0.358 | 0.380 | 0.398 | 3e-55 | |
| Q8WQL7 | 882 | Dual specificity tyrosine | no | no | 0.379 | 0.382 | 0.342 | 7e-50 | |
| Q09690 | 1087 | Dual specificity protein | no | no | 0.358 | 0.292 | 0.345 | 7e-49 |
| >sp|Q5RKH1|PRP4B_RAT Serine/threonine-protein kinase PRP4 homolog OS=Rattus norvegicus GN=Prpf4b PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/346 (57%), Positives = 250/346 (72%), Gaps = 7/346 (2%)
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D N +EVA+KIIR
Sbjct: 664 LRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARAN---QEVAVKIIR 720
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
NNE M K G E++ LKKL ADP++K HC+R F ++ HLCLVFE L MNLREVLKK
Sbjct: 721 NNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKK 780
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVNE+K +LKLCDFG+A
Sbjct: 781 YGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASH 840
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+L
Sbjct: 841 VADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKL 900
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVT 844
M+LKG P KM+RKG F DQHFDQ+LNF E D VT++ ++ I P KD+ + +
Sbjct: 901 AMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLI 960
Query: 845 AS---PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
P + K + KDLLD+I +LDP KR+++ QAL H FI K
Sbjct: 961 GCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEK 1006
|
Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. Rattus norvegicus (taxid: 10116) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q61136|PRP4B_MOUSE Serine/threonine-protein kinase PRP4 homolog OS=Mus musculus GN=Prpf4b PE=1 SV=3 | Back alignment and function description |
|---|
Score = 430 bits (1106), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/346 (57%), Positives = 250/346 (72%), Gaps = 7/346 (2%)
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D N +EVA+KIIR
Sbjct: 664 LRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARAN---QEVAVKIIR 720
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
NNE M K G E++ LKKL ADP++K HC+R F ++ HLCLVFE L MNLREVLKK
Sbjct: 721 NNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKK 780
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVNE+K +LKLCDFG+A
Sbjct: 781 YGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASH 840
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+L
Sbjct: 841 VADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKL 900
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVT 844
M+LKG P KM+RKG F DQHFDQ+LNF E D VT++ ++ I P KD+ + +
Sbjct: 901 AMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLI 960
Query: 845 AS---PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
P + K + KDLLD+I +LDP KR+++ QAL H FI K
Sbjct: 961 GCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEK 1006
|
Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08DZ2|PRP4B_BOVIN Serine/threonine-protein kinase PRP4 homolog OS=Bos taurus GN=PRPF4B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/346 (57%), Positives = 250/346 (72%), Gaps = 7/346 (2%)
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D N +EVA+KIIR
Sbjct: 665 LRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARAN---QEVAVKIIR 721
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
NNE M K G E++ LKKL ADP++K HC+R F ++ HLCLVFE L MNLREVLKK
Sbjct: 722 NNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKK 781
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVNE+K +LKLCDFG+A
Sbjct: 782 YGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASH 841
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+L
Sbjct: 842 VADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKL 901
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVT 844
M+LKG P KM+RKG F DQHFDQ+LNF E D VT++ ++ I P KD+ + +
Sbjct: 902 AMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLI 961
Query: 845 AS---PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
P + K + KDLLD+I +LDP KR+++ QAL H FI K
Sbjct: 962 GCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEK 1007
|
Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q13523|PRP4B_HUMAN Serine/threonine-protein kinase PRP4 homolog OS=Homo sapiens GN=PRPF4B PE=1 SV=3 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 200/346 (57%), Positives = 250/346 (72%), Gaps = 7/346 (2%)
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D N +EVA+KIIR
Sbjct: 664 LRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARAN---QEVAVKIIR 720
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
NNE M K G E++ LKKL ADP++K HC+R F ++ HLCLVFE L MNLREVLKK
Sbjct: 721 NNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKK 780
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVNE+K +LKLCDFG+A
Sbjct: 781 YGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASH 840
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+L
Sbjct: 841 VADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKL 900
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVT 844
M+LKG P KM+RKG F DQHFDQ+LNF E D VT++ ++ I P KD+ + +
Sbjct: 901 AMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLI 960
Query: 845 AS---PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
P + K + KDLLD+I +LDP KR+++ QAL H FI K
Sbjct: 961 GCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEK 1006
|
Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R814|PRP4B_PONAB Serine/threonine-protein kinase PRP4 homolog OS=Pongo abelii GN=PRPF4B PE=2 SV=1 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-117, Method: Compositional matrix adjust.
Identities = 198/346 (57%), Positives = 249/346 (71%), Gaps = 7/346 (2%)
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D + +EVA+KIIR
Sbjct: 664 LRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDNARAS---QEVAVKIIR 720
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
NNE M K G E++ LKKL ADP++K HC+R F ++ HLCLVFE L MNLREVLKK
Sbjct: 721 NNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLKK 780
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVNE+K +LKLCDFG+A
Sbjct: 781 YGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVNESKTILKLCDFGSASH 840
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+L
Sbjct: 841 VADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLKL 900
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVT 844
M+LKG P KM+RKG F DQHFD +LNF E D VT++ ++ I P KD+ + +
Sbjct: 901 AMDLKGKMPNKMIRKGVFKDQHFDPNLNFMYIEVDKVTEREKVTVMSTINPTKDLLADLI 960
Query: 845 AS---PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
P + K + KDLLD+I +LDP KR+++ QAL H FI K
Sbjct: 961 GCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQEK 1006
|
Has a role in pre-mRNA splicing. Phosphorylates SF2/ASF. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q07538|PRP4_SCHPO Serine/threonine-protein kinase prp4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=prp4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 394 bits (1011), Expect = e-108, Method: Compositional matrix adjust.
Identities = 226/497 (45%), Positives = 291/497 (58%), Gaps = 45/497 (9%)
Query: 408 DRIMEESRKRRQAILEKYK---NQH----LQQQKDSNLVDVETDEKPSEHSSQSTDVNNK 460
D I+++ RKRR IL+KY+ N H + ++K VD + KP E + +K
Sbjct: 9 DEIIQQRRKRRLEILKKYQQTGNGHSDLSIPEKKLKEDVDQVSTTKPIEAVPKMKTNASK 68
Query: 461 LQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHI--P 518
++ + G N T LD V SP ++S I
Sbjct: 69 IEINKEG---------------------SNSNTKLD---VTNSTTSDSPSIKSSVQIEDT 104
Query: 519 CDDIFGETPV-GVRKTGKAEGLKIIR---SGLHDNWDDAEGYYSYRFGEILDGRYEVTAA 574
DD+F ++P V++ +G+ + + + DNWDD EGYY E LD RY V +
Sbjct: 105 EDDMFADSPSPSVKRQNTGKGISTLTRSFADMQDNWDDIEGYYKVVLMEELDSRYIVQSN 164
Query: 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH 634
GKG+FSTVV A D + AIKIIRNNE M K G EV IL++L AD E K+H
Sbjct: 165 LGKGMFSTVVSALD----RNRNQTFAIKIIRNNEVMYKEGLKEVSILERLQAADREGKQH 220
Query: 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
I + F ++NHLC+VFE L +NLR++LKKFGRN+GL + AVR YA Q+F+AL LK C
Sbjct: 221 IIHYERHFMHKNHLCMVFEMLSLNLRDILKKFGRNVGLSIKAVRLYAYQMFMALDLLKQC 280
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHP 754
V+H DIKPDNMLVNE +N+LK+CD G+A A +NEITPYLVSRFYRAPEIILG PY P
Sbjct: 281 NVIHSDIKPDNMLVNEKRNILKICDLGSASDASENEITPYLVSRFYRAPEIILGFPYSCP 340
Query: 755 LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 814
+D WSVGC LYELYTG++LFPG TNN MLR ME KG F KML++ F + HFD D NF
Sbjct: 341 IDTWSVGCSLYELYTGQILFPGRTNNQMLRYMMECKGKFSHKMLKRSQFLNDHFDADFNF 400
Query: 815 HATEEDPVTKKAIKKIIFNIKP-KDIGS---IVTASPGEDPKMLANFKDLLDKIFVLDPE 870
+ DP+T + +K + KP KDI S V S E+ + DLL+K L+PE
Sbjct: 401 IQIDHDPITNQETRKPVKFSKPTKDIRSRLKEVPTSTDEEFIIRQELMDLLEKCLELNPE 460
Query: 871 KRMTVAQALTHPFISGK 887
KR+ AL HPF K
Sbjct: 461 KRVPPEVALKHPFFIKK 477
|
Has a role in pre-mRNA splicing and is essential for growth. Phosphorylates srp1. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54WE5|PRP4B_DICDI Serine/threonine-protein kinase prpf4B OS=Dictyostelium discoideum GN=prpf4B PE=3 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 185/348 (53%), Positives = 249/348 (71%), Gaps = 14/348 (4%)
Query: 545 GLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII 604
L DNWDDA+GYY +R GEI+D +Y++ + G GVFSTVV AK+ K E+V IKII
Sbjct: 467 NLSDNWDDADGYYKFRVGEIMD-KYQIFSPIGSGVFSTVVSAKETKTN----EDVVIKII 521
Query: 605 RNNETMNKAGQTEVQILKKLAGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREV 662
RN +M+++G E++IL+K++ + K HCI+ F YRNHLC+VFE + M+L ++
Sbjct: 522 RNRPSMHRSGLKEIEILQKISNTPTSSNQKSHCIQMKDHFNYRNHLCIVFEPMSMSLHQL 581
Query: 663 LKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722
+KK+G++IGL L AVR YAKQLF+ALKH+KN +LH DIKPDN++VNEAKN +K+ DFG+
Sbjct: 582 IKKYGKDIGLSLNAVRVYAKQLFLALKHIKNSKILHADIKPDNIVVNEAKNTIKIVDFGS 641
Query: 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
A ++EITPYLVSRFYRAPEIILG YD+ +D+WSVGCCL E +TGK LFPG TNNDM
Sbjct: 642 AGEIHESEITPYLVSRFYRAPEIILGHKYDYSIDVWSVGCCLAEFFTGKFLFPGKTNNDM 701
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI-KP-KDIG 840
+RL ME +G F KKML+K F HF+++L F E D + +K ++K+ +I KP KDI
Sbjct: 702 IRLFMEYRGAFSKKMLKKSEFVSNHFNENLVFMKQEIDNI-EKTVRKVPHDITKPTKDIL 760
Query: 841 SIV----TASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ + P +D K L KDL++K +LDPEKR+T +AL H F+
Sbjct: 761 QFLLPKNVSIPDQDMKKLIQLKDLIEKCTILDPEKRITPFEALNHEFL 808
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09815|PPK5_SCHPO Serine/threonine-protein kinase ppk5 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 135/339 (39%), Positives = 188/339 (55%), Gaps = 21/339 (6%)
Query: 550 WDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET 609
+DD G Y G+ L RYE+ GKG F V++ D K G + VAIK+I+N +
Sbjct: 499 FDDDNGDYKAIQGDHLLYRYEIIDTVGKGSFGQVLKCIDHKRG----QVVAIKVIKNRQK 554
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
+ EV ILK+L ADP +K + IR+ S F +R HLC+V E L NL +V+++
Sbjct: 555 FHGQTLVEVGILKRLCEADPADKNNVIRYLSHFDFRGHLCIVTELLGSNLFDVIRENNYK 614
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA-KNVLKLCDFGNAMFAGK 728
GL L V+++A Q AL+ L+ ++HCD+KP+N+L++ K +KL DFG++ F +
Sbjct: 615 -GLPLIVVKSFALQGLQALRLLQGQNIIHCDLKPENLLLSHPLKARIKLIDFGSSCFYNE 673
Query: 729 NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
T YL SRFYRAPEIILGL Y +DIWS GC L EL+TG LFPG + L ME
Sbjct: 674 KVYT-YLQSRFYRAPEIILGLEYGKEIDIWSFGCILAELFTGVPLFPGGNETEQLGYIME 732
Query: 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPG 848
+ GP P ++R + +FD + H P+T + + + S T S
Sbjct: 733 VLGPPPMALIRNSTRSKAYFDSEGKPH-----PITDSHNRLL--------VPSTRTFSQL 779
Query: 849 EDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+ K A+F D L K DP+ R+TV AL H FI GK
Sbjct: 780 LNTKQ-ASFLDFLSKCLKWDPKDRITVDSALQHEFILGK 817
|
Has a role in meiosis. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 7e-50, Method: Compositional matrix adjust.
Identities = 124/362 (34%), Positives = 196/362 (54%), Gaps = 25/362 (6%)
Query: 543 RSGLHDNWDDAEGY-YSYRFGEILDGRYEVTA--AHGKGVFSTVVRAKDLKAGNGEPEEV 599
R G ++N D + Y Y + GEI D RY + + GKG F V +A D EEV
Sbjct: 299 RGGPYNNGYDDQNYDYILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTL----NKEEV 354
Query: 600 AIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL 659
AIKII+N +T Q E+ +L+ D +NK + + F +R HLCLVFE L NL
Sbjct: 355 AIKIIKNKKTFFDQAQIEIHLLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNL 414
Query: 660 REVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN--CGVLHCDIKPDN-MLVNEAKNVLK 716
++LK G+ L R +A+QL L L + ++HCD+KP+N +LVN ++ ++
Sbjct: 415 YDLLKNTSFR-GVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIR 473
Query: 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
+ DFG++ G + I Y+ SRFYR+PE++LG+ YD +D+WS+GC L E++TG+ LF G
Sbjct: 474 VIDFGSSCQTG-HRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAG 532
Query: 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLN-----------FHATEEDPVTKK 825
++ D + +E+ G PK+ML G T ++FD+ + + T + P +K
Sbjct: 533 SSEVDQMMKIVEVLGMPPKEMLDIGPKTHKYFDKTEDGIYYCKKTRDGYRHTYKAPGARK 592
Query: 826 AIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ I + G PG + + FKDL+ ++ DP++R++ + HPF+
Sbjct: 593 LHE--ILGVTSGGPGGRRLGEPGHSVEDYSKFKDLIKRMLQFDPKQRISPYYVVRHPFLK 650
Query: 886 GK 887
K
Sbjct: 651 QK 652
|
Possible role in the function of olfactory neurons. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q09690|POM1_SCHPO Dual specificity protein kinase pom1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=pom1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (498), Expect = 7e-49, Method: Compositional matrix adjust.
Identities = 117/339 (34%), Positives = 183/339 (53%), Gaps = 21/339 (6%)
Query: 550 WDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET 609
+DD G Y G+ + RYEV GKG F V+R D + G + VA+KIIRN +
Sbjct: 680 FDDERGDYKVVLGDHIAYRYEVVDFLGKGSFGQVLRCIDYETG----KLVALKIIRNKKR 735
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
+ E +IL+K+ DP ++ +++ F +R+HLC+ E L NL E++K G
Sbjct: 736 FHMQALVETKILQKIREWDPLDEYCMVQYTDHFYFRDHLCVATELLGKNLYELIKSNGFK 795
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV-NEAKNVLKLCDFGNAMFAGK 728
GL + +++ +QL L L V+HCD+KP+N+L+ + K+ +K+ DFG++ F G+
Sbjct: 796 -GLPIVVIKSITRQLIQCLTLLNEKHVIHCDLKPENILLCHPFKSQVKVIDFGSSCFEGE 854
Query: 729 NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
T Y+ SRFYR+PE+ILG+ Y P+D+WS+GC + E+YTG LFPG + L ME
Sbjct: 855 CVYT-YIQSRFYRSPEVILGMGYGTPIDVWSLGCIIAEMYTGFPLFPGENEQEQLACIME 913
Query: 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPG 848
+ GP ++ K + FD V+ K + + F+ K + ++
Sbjct: 914 IFGPPDHSLIDKCSRKKVFFDSS----GKPRPFVSSKGVSRRPFS---KSLHQVLQC--- 963
Query: 849 EDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+D L+ D L DP++RMT QA H F++GK
Sbjct: 964 KDVSFLSFISDCLK----WDPDERMTPQQAAQHDFLTGK 998
|
Involved in localization of polarized growth and cytokinesis. May interact with both the actin and microtubule cytoskeleton. Requires tea1 for localization to the cell ends but not to the cell center. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 887 | ||||||
| 297737836 | 998 | unnamed protein product [Vitis vinifera] | 0.977 | 0.868 | 0.616 | 0.0 | |
| 359472695 | 1119 | PREDICTED: uncharacterized protein LOC10 | 0.977 | 0.774 | 0.616 | 0.0 | |
| 147784275 | 1121 | hypothetical protein VITISV_004019 [Viti | 0.871 | 0.689 | 0.609 | 0.0 | |
| 255576469 | 1033 | prp4, putative [Ricinus communis] gi|223 | 0.937 | 0.805 | 0.574 | 0.0 | |
| 356574183 | 989 | PREDICTED: uncharacterized protein LOC10 | 0.864 | 0.775 | 0.596 | 0.0 | |
| 356498280 | 1460 | PREDICTED: uncharacterized protein LOC10 | 0.824 | 0.500 | 0.587 | 0.0 | |
| 449434626 | 1131 | PREDICTED: uncharacterized protein LOC10 | 0.913 | 0.716 | 0.542 | 0.0 | |
| 356534373 | 990 | PREDICTED: uncharacterized protein LOC10 | 0.848 | 0.760 | 0.602 | 0.0 | |
| 449493498 | 712 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.747 | 0.931 | 0.623 | 0.0 | |
| 22331335 | 935 | serine/threonine-protein kinase PRP4 [Ar | 0.863 | 0.819 | 0.530 | 0.0 |
| >gi|297737836|emb|CBI27037.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1024 bits (2648), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/913 (61%), Positives = 688/913 (75%), Gaps = 46/913 (5%)
Query: 12 VGEDAMKDNIGKQI-GDDVVSSSICDKVYNEQHG----NGELPRENGRENYKQWRES-KS 65
G+ + IG +I G+D +S K Y E +G++ R+ E++++ +S
Sbjct: 95 TGKSDYEAKIGNKIHGEDGLSRHPSAKHYEELFSIGSPDGDMNRDARHESHRKNNSGCES 154
Query: 66 PSRRSAKRNSYHDFDPMEDDQSYLHDRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRR 125
P + K SY+ E D+S L ++RKS+SSES+GDKY SP+ DR D+ H R
Sbjct: 155 PVKGYGKTESYY-----EVDKSELQNQRKSLSSESAGDKYKKLAHSPTHDRYRDKVHMR- 208
Query: 126 GRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDA----------NDSEDERLVRRGRNE 175
GRSRSHD +ERSRSQS++++ A K +++ E +A ND+++E +RR R+
Sbjct: 209 GRSRSHDHARERSRSQSILQDVALSKATHHQEWNASSYAGNRRTDNDTDEEMALRR-RDY 267
Query: 176 RHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREI----ERERRREWEREKSKHLEVDRE 231
RH SRDLVRD+ERE R+S +R R D+H SRE + R +WER++ + + RE
Sbjct: 268 RHPSRDLVRDEERE-RSSSHSRQTQRGDKHQSRETWDMAKAGREMDWERQREREQDRSRE 326
Query: 232 RRRD----------KNREQSRDRDIHRGRE-ERDRSRYEEVDRGRRREKERDRSRDRARV 280
R R+ K R++S DR++ R R+ E+DR E+DRGR++E+ERDRS DR R
Sbjct: 327 RERERNRERDRKREKERDRSMDREMDRNRKREKDRGTDREMDRGRKQERERDRSWDRDRA 386
Query: 281 NDRDMDRQR--DREKDRVRDNNLERERERRRDRSRDKGRDIESDR----EKGASPKDSYS 334
+RD +R R D E DR R + + ER RDRSRDK RD ESDR K + D Y
Sbjct: 387 RERDRNRNRDIDWENDRDRARDRKSERGSGRDRSRDKVRDSESDRVSRHHKYETLNDGYG 446
Query: 335 NRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEER 394
NRDRY S +L+HD+ + RTRK+D K SS + S+EG+GDK+ +DEDE +D++ER
Sbjct: 447 NRDRYGDSWYLRHDETEHQR-HRTRKNDEEKGLSSKNDSLEGNGDKLNRDEDEHEDYQER 505
Query: 395 VALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQS 454
V L+L E+EEE+ +RI EESR+RRQAILEKYK+QH QQQ S+ D D++ E S++
Sbjct: 506 VTLQLAEKEEEEFNRIKEESRRRRQAILEKYKSQHSQQQLASHTEDTGKDKESVEQPSET 565
Query: 455 TDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETS 514
+ +G+ DG + + AD SFSV KSPPQNG++A ++TS GGLG+G+PKSE
Sbjct: 566 IVAETMVPEVPDGKNDGTDTYDADPSFSVGKSPPQNGLSASERTSGAGGLGEGTPKSERP 625
Query: 515 NHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAA 574
+ + CDDIFGE+P GVRK+G+ +GL I RSGLHDNWDDAEGYYS+RFGEILDGRYE+TAA
Sbjct: 626 DDMFCDDIFGESPAGVRKSGRGDGLLIERSGLHDNWDDAEGYYSHRFGEILDGRYEITAA 685
Query: 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH 634
HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN+TM KAG E+ ILKKL GADP++KRH
Sbjct: 686 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNDTMYKAGLEELVILKKLVGADPDDKRH 745
Query: 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
C+RF SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL+NC
Sbjct: 746 CVRFLSSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLRNC 805
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHP 754
GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF+GKNEITPYLVSRFYRAPEIILGLPYDHP
Sbjct: 806 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFSGKNEITPYLVSRFYRAPEIILGLPYDHP 865
Query: 755 LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 814
+DIWSVGCCLYELYTGKVLFPG +NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF
Sbjct: 866 MDIWSVGCCLYELYTGKVLFPGPSNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 925
Query: 815 HATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874
HATEEDPVTKK IK++I NI+PKDIG+I+++SPGEDPKM NFKDLL+KIFVLDPEKRMT
Sbjct: 926 HATEEDPVTKKTIKRLIMNIRPKDIGTIISSSPGEDPKMAVNFKDLLEKIFVLDPEKRMT 985
Query: 875 VAQALTHPFISGK 887
V+QAL HPFI+GK
Sbjct: 986 VSQALCHPFITGK 998
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472695|ref|XP_002279073.2| PREDICTED: uncharacterized protein LOC100247382 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2645), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 563/913 (61%), Positives = 688/913 (75%), Gaps = 46/913 (5%)
Query: 12 VGEDAMKDNIGKQI-GDDVVSSSICDKVYNEQHG----NGELPRENGRENYKQWRES-KS 65
G+ + IG +I G+D +S K Y E +G++ R+ E++++ +S
Sbjct: 216 TGKSDYEAKIGNKIHGEDGLSRHPSAKHYEELFSIGSPDGDMNRDARHESHRKNNSGCES 275
Query: 66 PSRRSAKRNSYHDFDPMEDDQSYLHDRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRR 125
P + K SY+ E D+S L ++RKS+SSES+GDKY SP+ DR D+ H R
Sbjct: 276 PVKGYGKTESYY-----EVDKSELQNQRKSLSSESAGDKYKKLAHSPTHDRYRDKVHMR- 329
Query: 126 GRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDA----------NDSEDERLVRRGRNE 175
GRSRSHD +ERSRSQS++++ A K +++ E +A ND+++E +RR R+
Sbjct: 330 GRSRSHDHARERSRSQSILQDVALSKATHHQEWNASSYAGNRRTDNDTDEEMALRR-RDY 388
Query: 176 RHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREI----ERERRREWEREKSKHLEVDRE 231
RH SRDLVRD+ERE R+S +R R D+H SRE + R +WER++ + + RE
Sbjct: 389 RHPSRDLVRDEERE-RSSSHSRQTQRGDKHQSRETWDMAKAGREMDWERQREREQDRSRE 447
Query: 232 RRRD----------KNREQSRDRDIHRGRE-ERDRSRYEEVDRGRRREKERDRSRDRARV 280
R R+ K R++S DR++ R R+ E+DR E+DRGR++E+ERDRS DR R
Sbjct: 448 RERERNRERDRKREKERDRSMDREMDRNRKREKDRGTDREMDRGRKQERERDRSWDRDRA 507
Query: 281 NDRDMDRQR--DREKDRVRDNNLERERERRRDRSRDKGRDIESDR----EKGASPKDSYS 334
+RD +R R D E DR R + + ER RDRSRDK RD ESDR K + D Y
Sbjct: 508 RERDRNRNRDIDWENDRDRARDRKSERGSGRDRSRDKVRDSESDRVSRHHKYETLNDGYG 567
Query: 335 NRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEER 394
NRDRY S +L+HD+ + RTRK+D K SS + S+EG+GDK+ +DEDE +D++ER
Sbjct: 568 NRDRYGDSWYLRHDETEHQR-HRTRKNDEEKGLSSKNDSLEGNGDKLNRDEDEHEDYQER 626
Query: 395 VALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQS 454
V L+L E+EEE+ +RI EESR+RRQAILEKYK+QH QQQ S+ D D++ E S++
Sbjct: 627 VTLQLAEKEEEEFNRIKEESRRRRQAILEKYKSQHSQQQLASHTEDTGKDKESVEQPSET 686
Query: 455 TDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETS 514
+ +G+ DG + + AD SFSV KSPPQNG++A ++TS GGLG+G+PKSE
Sbjct: 687 IVAETMVPEVPDGKNDGTDTYDADPSFSVGKSPPQNGLSASERTSGAGGLGEGTPKSERP 746
Query: 515 NHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAA 574
+ + CDDIFGE+P GVRK+G+ +GL I RSGLHDNWDDAEGYYS+RFGEILDGRYE+TAA
Sbjct: 747 DDMFCDDIFGESPAGVRKSGRGDGLLIERSGLHDNWDDAEGYYSHRFGEILDGRYEITAA 806
Query: 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH 634
HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN+TM KAG E+ ILKKL GADP++KRH
Sbjct: 807 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNDTMYKAGLEELVILKKLVGADPDDKRH 866
Query: 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
C+RF SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL+NC
Sbjct: 867 CVRFLSSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLRNC 926
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHP 754
GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF+GKNEITPYLVSRFYRAPEIILGLPYDHP
Sbjct: 927 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFSGKNEITPYLVSRFYRAPEIILGLPYDHP 986
Query: 755 LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 814
+DIWSVGCCLYELYTGKVLFPG +NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF
Sbjct: 987 MDIWSVGCCLYELYTGKVLFPGPSNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 1046
Query: 815 HATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874
HATEEDPVTKK IK++I NI+PKDIG+I+++SPGEDPKM NFKDLL+KIFVLDPEKRMT
Sbjct: 1047 HATEEDPVTKKTIKRLIMNIRPKDIGTIISSSPGEDPKMAVNFKDLLEKIFVLDPEKRMT 1106
Query: 875 VAQALTHPFISGK 887
V+QAL HPFI+GK
Sbjct: 1107 VSQALCHPFITGK 1119
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147784275|emb|CAN68345.1| hypothetical protein VITISV_004019 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2452), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/857 (60%), Positives = 627/857 (73%), Gaps = 84/857 (9%)
Query: 111 SPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDA---------- 160
SP+ DR D+ H R GRSRSHD +ERSRSQS++++ A K +++ E +A
Sbjct: 269 SPTHDRYRDKVHMR-GRSRSHDHARERSRSQSILQDVALSKATHHQEWNASSYAGNRRTD 327
Query: 161 NDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREI----ERERRR 216
ND+++E +RR R+ RH SRDLVRD+ERE R+S +R R D+H SRE + R
Sbjct: 328 NDTDEEMALRR-RDYRHPSRDLVRDEERE-RSSSHSRQTQRGDKHQSRETWDMAKAGREM 385
Query: 217 EWEREKSKHLEVDRERRRD----------KNREQSRDRDIHRGRE-ERDRSRYEEVDRGR 265
+WER++ + + RER R+ K R++S DR++ R R+ E+DR E+DRGR
Sbjct: 386 DWERQREREQDRSRERERERNRERDRKREKERDRSMDREMDRNRKREKDRGTDREMDRGR 445
Query: 266 RREKERDRSRDRARVNDRDMDRQR--DREKDRVRDNNLERERERRRDRSRDKGRDIESDR 323
++E+ERDRS DR R +RD +R R D E DR R + + ER RDRSRDK RD ESDR
Sbjct: 446 KQERERDRSWDRDRARERDRNRNRDIDWENDRDRARDRKSERGSGRDRSRDKVRDSESDR 505
Query: 324 ----EKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGD 379
K + D Y NRDRY S +L+HD+ + RTRK+D K SS + S+EG+GD
Sbjct: 506 VSRHHKYXTLNDGYGNRDRYGDSWYLRHDETEHQR-HRTRKNDEEKGLSSKNDSLEGNGD 564
Query: 380 KITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLV 439
K+ +DEDE +D++ERV L+L E+EEE+ +RI EESR+RRQAILEKYK+QH QQQ S+
Sbjct: 565 KLNRDEDEHEDYQERVTLQLAEKEEEEFNRIKEESRRRRQAILEKYKSQHSQQQLASHTE 624
Query: 440 DVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTS 499
D D++ E S++ + +G+ DG + + AD SFSV KSPPQNG++A ++TS
Sbjct: 625 DTGKDKESVEQPSETIVAETMVPEVPDGKNDGTDTYDADPSFSVGKSPPQNGLSASERTS 684
Query: 500 VRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYY-- 557
GGLG+G+PKSE + + CDDIFGE+P GVRK+G+ +GL I RSGLHDNWDDAEGYY
Sbjct: 685 GAGGLGEGTPKSERPDDMFCDDIFGESPAGVRKSGRGDGLLIERSGLHDNWDDAEGYYRL 744
Query: 558 -----------------------------------SYRFGEILDGRYEVTAAHGKGVFST 582
+RFGEILDGRYE+TAAHGKGVFST
Sbjct: 745 NMMAALIWCLDGALYVGELSTSYLGSPLXAPNKHCGHRFGEILDGRYEITAAHGKGVFST 804
Query: 583 VVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642
VVRAKDLKAGNGEPEEVAIKIIRNN+TM KAG E+ ILKKL GADP++KRHC+RF SSF
Sbjct: 805 VVRAKDLKAGNGEPEEVAIKIIRNNDTMYKAGLEELVILKKLVGADPDDKRHCVRFLSSF 864
Query: 643 KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702
KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL+NCGVLHCDIK
Sbjct: 865 KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLRNCGVLHCDIK 924
Query: 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGC 762
PDNMLVNEAKNVLKLCDFGNAMF+GKNEITPYLVSRFYRAPEIILGLPYDHP+DIWSVGC
Sbjct: 925 PDNMLVNEAKNVLKLCDFGNAMFSGKNEITPYLVSRFYRAPEIILGLPYDHPMDIWSVGC 984
Query: 763 CLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK------------MLRKGAFTDQHFDQ 810
CLYELYTGKVLFPG +NNDMLRLHME +G F KK L GAFTDQHFDQ
Sbjct: 985 CLYELYTGKVLFPGPSNNDMLRLHMEFEGSFSKKDASKGKDSFSSLKLALGAFTDQHFDQ 1044
Query: 811 DLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870
DLNFHATEEDPVTKK IK++I NI+PKDIG+I+++SPGEDPKM NFKDLL+KIFVLDPE
Sbjct: 1045 DLNFHATEEDPVTKKTIKRLIMNIRPKDIGTIISSSPGEDPKMAVNFKDLLEKIFVLDPE 1104
Query: 871 KRMTVAQALTHPFISGK 887
KRMTV+QAL HPFI+GK
Sbjct: 1105 KRMTVSQALCHPFITGK 1121
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576469|ref|XP_002529126.1| prp4, putative [Ricinus communis] gi|223531405|gb|EEF33239.1| prp4, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/931 (57%), Positives = 637/931 (68%), Gaps = 99/931 (10%)
Query: 26 GDDVVSSSICDKVYNEQHGNGELPRE-NGRENYKQWRESKSPSRRSAKRNSYHDFDPMED 84
GDD +S H NG+L E + RE KQ ES+S SRRS KR SY + +
Sbjct: 133 GDDQIS-----------HANGDLGHEKHPREAKKQHGESRSSSRRSHKRKSYGGDETPDG 181
Query: 85 DQSYLHDRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVM 144
D++ L + S SS+S+ D+ S R +DE R G S S + +ERSRS+S++
Sbjct: 182 DETKLSNLGISSSSDSAADRLKTVTAYASHGRYHDEVVGRSG-SLSREFARERSRSRSIV 240
Query: 145 EEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDR 204
EE+ LKR ++E+ NDS DER+ + SRD+ ERE T+Y R G E+R
Sbjct: 241 EEDVLLKRRQHNEKAENDSADERMPGHDEDLWRSSRDV----ERECSTNYI-RSQGGEER 295
Query: 205 HHS-------REIERERRREWEREKSKHLEV----DRER------RRDKNREQSRDRDIH 247
H S RE+ E+RRE RE+S+ + DRER RRDK+RE+SRDRD+
Sbjct: 296 HGSWNTQGREREMNWEQRREQGRERSRERDQRRDKDRERSRERDQRRDKDRERSRDRDLR 355
Query: 248 RGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQ------------RDREKDR 295
R + R+ SR VDR RRREKE++RSRDR DRD+ RQ RD+ K+R
Sbjct: 356 REKG-REGSRDSSVDRYRRREKEQERSRDRE--VDRDLKRQKQQERSWDREVDRDQRKER 412
Query: 296 VRDNNLERE------RERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDD 349
+ +L+RE RER + RSR++ D + +EK S S S + +
Sbjct: 413 QWERSLDREMINDRRREREQGRSREEELDKKRQKEKDRSKDKSMSRANERDRDWERVKET 472
Query: 350 DKGSYGDRTR------------------------KDDLAKIHSSNSYSMEGSGDKITKDE 385
D+GSY +R R D AK ++ NS S+EG DK+ +DE
Sbjct: 473 DRGSYAERERARDRDWVTDRERRSDRSREKARETNGDSAKFYNFNSNSLEGDRDKLERDE 532
Query: 386 DEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKN---------QHLQQQKDS 436
D QDDFEER+ALKL EQEE DLDR+ EESRK RQAILEK++N Q +K++
Sbjct: 533 DAQDDFEERIALKLAEQEE-DLDRVKEESRKLRQAILEKFRNQQKQQQNETQSDNVEKET 591
Query: 437 NLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALD 496
V VE + S ++ K++ND + + +FSV KSP QNG+ +
Sbjct: 592 INVKVEPSASLPASNVASETIHVKMENDD---------FITEPAFSVGKSPLQNGIQDSE 642
Query: 497 KTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGY 556
+TS GLG+G+PKSE S+ CDDIFGETP +RK K +GL I R+ L+DNWDDA+GY
Sbjct: 643 RTSGVAGLGEGTPKSEGSDEKYCDDIFGETPARIRKPSKGDGLPITRTSLYDNWDDADGY 702
Query: 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT 616
Y YRFGE LDGRYE+ AA GKGVFSTVVRAKDLKAG GEPEEVAIKIIRN E M+KAGQ
Sbjct: 703 YGYRFGETLDGRYEIVAAQGKGVFSTVVRAKDLKAGVGEPEEVAIKIIRNKELMHKAGQN 762
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA 676
EVQI KLA ADPENKRHC+RF SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA
Sbjct: 763 EVQIFDKLAAADPENKRHCVRFLSSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA 822
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
V+AYAKQLFIALKHLKNC VLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV
Sbjct: 823 VKAYAKQLFIALKHLKNCEVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 882
Query: 737 SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
SRFYRAPEIILGLPYDHP+D+WSVGCCLYELY GKVLFPGATNNDMLRLHMELKGPFPKK
Sbjct: 883 SRFYRAPEIILGLPYDHPVDMWSVGCCLYELYAGKVLFPGATNNDMLRLHMELKGPFPKK 942
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
ML+KGAF DQHFDQDLNF++ EEDPVTKK IK+++ NIKPKDIGSI+ +SPGEDPKMLAN
Sbjct: 943 MLKKGAFVDQHFDQDLNFNSMEEDPVTKKIIKRMLLNIKPKDIGSIIMSSPGEDPKMLAN 1002
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
FKDLLDKIF+LDPEKR+TV QAL HPFI+GK
Sbjct: 1003 FKDLLDKIFMLDPEKRLTVNQALGHPFITGK 1033
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574183|ref|XP_003555231.1| PREDICTED: uncharacterized protein LOC100776908 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 496/832 (59%), Positives = 595/832 (71%), Gaps = 65/832 (7%)
Query: 78 DFD--PMEDDQSYLHDRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVK 135
DFD +E + H R S SSES G KY + SPS R R RSRS +
Sbjct: 201 DFDDETLEANVRKAHYNRNS-SSESGGGKYRMSGSSPSHGRY-------RSRSRSIGHTR 252
Query: 136 ERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYT 195
+RSRS+S+++E A KR R D ++ER+ RGR HGS V DD RE Y+
Sbjct: 253 DRSRSRSIIDEYAHSKR----RRSDYDHDEERVRVRGREHGHGS---VVDDRRE----YS 301
Query: 196 TRYVGRE--------DRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIH 247
TRY RE DR R++ RE+++E E S+ E++ E +R K RE+SR+R
Sbjct: 302 TRYHNREARDRDRSRDRDVDRDLHREKKQE---ETSRGKEIEWEHKRGKERERSRERYRR 358
Query: 248 RGREERDRSRYEEVDRGRRREKERDRSRDRA------------RVNDRDMDRQRDREKDR 295
E+DRSR E D RR+EKERDRS D R DR + +RDR+ +
Sbjct: 359 DA--EKDRSREREEDGDRRQEKERDRSWDTVFERDRRREKERDRSRDRTIGGKRDRDPEN 416
Query: 296 VRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYG 355
RD+ + RERR DR K RD + +++ +D N DRY+ +H +H++++ +
Sbjct: 417 ERDD---KNRERRDDRYGHKDRDTANGKDRHLRHEDGNDNGDRYR--KHSRHEENEYHWE 471
Query: 356 DRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESR 415
+ D+ K+++S + E K+T E E DD EE L+L EQEEEDL+RI EESR
Sbjct: 472 RKRNSDNPVKVYNSMGSTAEVDESKLTSSEVEPDDLEEDT-LQLPEQEEEDLNRIKEESR 530
Query: 416 KRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVH 475
+RR+AI+EKYK QH Q + +V E ++K D+ N + +G+ D +
Sbjct: 531 RRREAIMEKYKKQHQQVEA---VVGNEGNDK-------DADIPNDISEACDGKTD--DAD 578
Query: 476 LADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTGK 535
+ SF+V KSP +N A K S GGLG+G+PKSE S CDDIFGETP GVRK+GK
Sbjct: 579 YVEPSFAVGKSP-ENVNVASKKISPAGGLGEGTPKSERSEDKFCDDIFGETPTGVRKSGK 637
Query: 536 AEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGE 595
+GL I R GLHDNWDDAEGYYSYR GEILD RYEVTAAHG+GVFSTVVRAK+LK GNGE
Sbjct: 638 GDGLLIERVGLHDNWDDAEGYYSYRIGEILDSRYEVTAAHGRGVFSTVVRAKNLKMGNGE 697
Query: 596 PEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL 655
PEEVAIKIIR+N+TM KAG E+ ILKKL GADP++KRHC+RF SSF+YRNHLCLVFESL
Sbjct: 698 PEEVAIKIIRSNDTMYKAGMDELVILKKLVGADPDDKRHCVRFLSSFRYRNHLCLVFESL 757
Query: 656 HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715
+MNLREVLKKFGRNIGL+LTAVRAYAKQLFIALKHL+NCGVLHCDIKPDNMLVNEAKNVL
Sbjct: 758 NMNLREVLKKFGRNIGLRLTAVRAYAKQLFIALKHLRNCGVLHCDIKPDNMLVNEAKNVL 817
Query: 716 KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFP 775
KLCDFGNAMFAGKNE+TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY GKVLFP
Sbjct: 818 KLCDFGNAMFAGKNEVTPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYIGKVLFP 877
Query: 776 GATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIK 835
G TNNDMLRLHMELKGPFPKKMLRKGAFT+QHFDQDLNF ATEEDPVTK+ IK++I NIK
Sbjct: 878 GFTNNDMLRLHMELKGPFPKKMLRKGAFTEQHFDQDLNFLATEEDPVTKRTIKRLILNIK 937
Query: 836 PKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
PKDIG+++T SPGEDPKMLANFKDLL+K+FVLDP+KR+TV+QAL HPFI+GK
Sbjct: 938 PKDIGTLITGSPGEDPKMLANFKDLLEKVFVLDPDKRLTVSQALNHPFITGK 989
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356498280|ref|XP_003517981.1| PREDICTED: uncharacterized protein LOC100814081 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2211), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/783 (58%), Positives = 560/783 (71%), Gaps = 52/783 (6%)
Query: 136 ERSRSQSVMEEEAPLKRSNYHERDANDSEDERLV-------RRGRNERHGSRDLVRDDER 188
+RS S S++EE A KR + E+ +DS RL R R SRDLV D R
Sbjct: 681 DRSHSGSIVEEHARSKRKHSGEQ-GDDSYASRLKTDYDLDDERMMASRRESRDLVVDKRR 739
Query: 189 EHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHR 248
EHRTSY T+ R R+++R+ + E E+E+S++ EV+ RR+K RE+S +R HR
Sbjct: 740 EHRTSYHTQEAWGRARSSDRDVDRDLKMEKEQERSRNREVNWVHRREKERERSCER--HR 797
Query: 249 -----------------GREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDR 291
+E DR R +R RRR+KE+D+SRDR R ++R D++
Sbjct: 798 RDVEKDRREREDDRDRRREKESDRIRETVFERDRRRDKEKDQSRDRTRGDERVRDQETAE 857
Query: 292 EKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASP-----KDSYSNRDRYKHSRHLK 346
DR + +ERE+R D R K DR G D Y DRY+ R LK
Sbjct: 858 HNDRSWKRDKIKEREKRDDIKRHK------DRGNGMGKYLSHEDDYYDAHDRYR--RRLK 909
Query: 347 HDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEED 406
++ + + +R RK K+++S ++ +K+ + EDEQDD +E+V L+L +QEEED
Sbjct: 910 QEE-RECHQERKRKSSHVKVYNSMGSTLIDDANKLERGEDEQDDLDEKVTLQLPDQEEED 968
Query: 407 LDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSN 466
+R+ EESR+RR+AILEKYK QH Q +E + + Q+ ++ + + +
Sbjct: 969 FNRVKEESRRRREAILEKYKKQHQQ---------IELNTENEGKDRQAVEIPPSIPDALD 1019
Query: 467 GRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGET 526
G+ DGV+ + FSV+KSP +NG A DK S GGLG+GSPKSE S+ CDDIFGET
Sbjct: 1020 GKSDGVDDVEVETLFSVRKSPAENGNVASDKISSAGGLGEGSPKSERSDDKFCDDIFGET 1079
Query: 527 PVGVRKT--GKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVV 584
P GV+K+ GK EGL+I R GLHDNWDDAEGYYSY FGE+L GRYEV AAHG+GVFS VV
Sbjct: 1080 PTGVQKSVSGKGEGLRIERGGLHDNWDDAEGYYSYHFGEVLYGRYEVIAAHGRGVFSAVV 1139
Query: 585 RAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644
RAKDLK NGEP EVAIKIIR+N+TM KAG E+ ILKKL GADP++K HC+RF SSFKY
Sbjct: 1140 RAKDLKNSNGEPREVAIKIIRSNDTMYKAGMDELVILKKLVGADPDDKCHCVRFLSSFKY 1199
Query: 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704
+NHLCLVFESLHMNLREVLKKFGRNIGL+LTAVRAYAKQLFIALKHL+NCGVLHCDIKPD
Sbjct: 1200 KNHLCLVFESLHMNLREVLKKFGRNIGLRLTAVRAYAKQLFIALKHLRNCGVLHCDIKPD 1259
Query: 705 NMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCL 764
NMLV EAKN K CDFGNAMFAGKNE+TPYLVSRFYRAPEIILGLPYDHPLD+WSVGCCL
Sbjct: 1260 NMLVEEAKNTFKFCDFGNAMFAGKNEVTPYLVSRFYRAPEIILGLPYDHPLDMWSVGCCL 1319
Query: 765 YELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTK 824
YELYTGKVLFPG TNNDML LHMELKG FPKKMLRKGAF +QHFDQ LNF ATEEDPVTK
Sbjct: 1320 YELYTGKVLFPGFTNNDMLWLHMELKGIFPKKMLRKGAFIEQHFDQYLNFLATEEDPVTK 1379
Query: 825 KAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KAIK++I NIKPKDIG+I++ SPGEDPKML NFKDL++K+F+LDP+KR+TV+QAL HPFI
Sbjct: 1380 KAIKRMIVNIKPKDIGTIISGSPGEDPKMLTNFKDLMEKVFILDPDKRLTVSQALNHPFI 1439
Query: 885 SGK 887
+GK
Sbjct: 1440 TGK 1442
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434626|ref|XP_004135097.1| PREDICTED: uncharacterized protein LOC101220260 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/922 (54%), Positives = 611/922 (66%), Gaps = 112/922 (12%)
Query: 61 RESKSPSRRSAKRNSYHDFDPMEDDQSYLHD--RRKSVSSESSGDKYSPALRSPSRDRSY 118
++ SPS+ ++K+ S + + D + L + R + +E + ++P S S DR
Sbjct: 227 KQMASPSKGASKKISNNGNGKVATDGNTLGNGKRPQLERTEGKSEDFTP---STSHDRFI 283
Query: 119 DEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDA----------NDSEDERL 168
D R RSRS+ + +S+S+ +EEEA K +YH D ND +D+
Sbjct: 284 DASDCR-SRSRSNCHSRGQSQSRETVEEEAESKSRHYHGWDQPMFDDKIKIHNDLDDDYT 342
Query: 169 -VRRGRNERHGSRD----------LVRDDEREHRTSYTTRYVGREDRHHSREIER----E 213
RG RH SRD L R+ +E+ D+ E ER +
Sbjct: 343 ECVRGEG-RHRSRDTKDNGRSKMELDREWSKENEMGKNKDKDRGVDKQKYDERERGRSKD 401
Query: 214 RRREWEREKSKHLEVD----------------RERRRDKNREQSRDRDIHRGR------- 250
RR+E ER++S+ E++ +ER + RE RDR + R R
Sbjct: 402 RRKEMERKRSRERELERGDRRRERDVERDRRGKERGWSREREGQRDRRVERERGWSRERE 461
Query: 251 --------EERDRSRYEEVDRGRRREKERDRS---------------------------- 274
+ER S+ EVDR RR EKER RS
Sbjct: 462 AERDRRTEKERGWSKEREVDRDRRAEKERCRSTDREGNRDRRREREKDRSKDKEVDWDGR 521
Query: 275 ------RDRARVNDRDMDRQRDRE--KDRVRDNNLERERERRRDRSRDKGRDIESDREKG 326
D+A +DR+ DR+R RE KDR RD L+RER DR+++K D S ++K
Sbjct: 522 RDRDRNDDKAEYSDRNRDRERVREVQKDRFRDKELDRER--HNDRNKNKASDSLSSKDKY 579
Query: 327 ASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSG-DKITKDE 385
+ + Y K SRH +D++ G G R + + H S S G DK+
Sbjct: 580 GNLEHGYVKGS--KQSRH--YDNEFGLDGGRI---NAVEKHGSFKRSTREEGEDKLMSGH 632
Query: 386 DEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDE 445
DE+++ + ++ +L ++EEEDL+RI EESR+RRQAILEKYK Q L++Q ++++ + E D+
Sbjct: 633 DEEEEDGDGMSYQLADEEEEDLNRIKEESRRRRQAILEKYKCQQLEKQVEASMKESEKDK 692
Query: 446 KPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLG 505
+ SSQS + + +G +D +AD SF V+KSP QNG A DKT+ GLG
Sbjct: 693 DSGKDSSQSEAAAHAIPELVDGVVDD---SVADSSFVVEKSPQQNGAIASDKTAGTKGLG 749
Query: 506 DGSPKSETSNHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEIL 565
+G+PK+E S+ + CDDIFGETP VRK GK++GL+I RSGLHDNWDDA+GYY+YRFGE+L
Sbjct: 750 EGTPKAEGSDGLFCDDIFGETPAAVRKMGKSDGLQIERSGLHDNWDDADGYYNYRFGEVL 809
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLA 625
D RYE+ AAHGKGVFSTVVRAKDLKAG GEPEEVAIKI+R+NETM KAG E+ ILKKL
Sbjct: 810 DSRYEIAAAHGKGVFSTVVRAKDLKAGPGEPEEVAIKILRSNETMYKAGLEELVILKKLV 869
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
GADP++KRHC+RF SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF
Sbjct: 870 GADPDDKRHCVRFLSSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 929
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEI 745
IALKHL+NCGVLHCDIKPDNMLVNE KNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEI
Sbjct: 930 IALKHLRNCGVLHCDIKPDNMLVNEGKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEI 989
Query: 746 ILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805
ILGL YDHP+DIWSVGCCLYEL TGKVLFPG +NNDMLRLHMELKGPFPKKMLRKGAFTD
Sbjct: 990 ILGLSYDHPMDIWSVGCCLYELSTGKVLFPGPSNNDMLRLHMELKGPFPKKMLRKGAFTD 1049
Query: 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865
QHFDQDLNFHA+EEDPVTKK IK+II NIKPKDIGSI+ SP EDPKMLANFKDLLDKIF
Sbjct: 1050 QHFDQDLNFHASEEDPVTKKTIKRIIVNIKPKDIGSIIRGSPCEDPKMLANFKDLLDKIF 1109
Query: 866 VLDPEKRMTVAQALTHPFISGK 887
VLDPEKRMTV+QAL HPFI+GK
Sbjct: 1110 VLDPEKRMTVSQALNHPFITGK 1131
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356534373|ref|XP_003535730.1| PREDICTED: uncharacterized protein LOC100784523 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2201), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/815 (60%), Positives = 591/815 (72%), Gaps = 62/815 (7%)
Query: 94 KSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRS 153
++ SSES G+KY + SPS R R RSRS ++RSRS+S+++E KR
Sbjct: 217 RNSSSESGGEKYRMSGSSPSHGRY-------RSRSRSIGHTRDRSRSRSIIDEYPHSKRR 269
Query: 154 NYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGRE--DRHHSREIE 211
+ D ++ER+ RGR HGS V DD RE Y RY RE DR R++
Sbjct: 270 RFD----YDHDEERVRARGREHGHGS---VVDDRRE----YGIRYHNREARDRDVDRDLH 318
Query: 212 RERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKER 271
E+++E E S+ E++ E +R K RE+SRDR +R E+DRSR E DR RR+EKER
Sbjct: 319 GEKKQE---ETSRGKEIEWEHKRGKERERSRDR--YRRDIEKDRSREREEDRDRRQEKER 373
Query: 272 DRS------------------RDRARVNDRDMDRQRDRE-KDRVRDNNLERERERRRDRS 312
DRS RDR R RD D + +R+ K R RDN ++RER D+
Sbjct: 374 DRSWDTVMERDRRREKERDRSRDRIRGGKRDKDPENERDDKHRARDNI--KKRERHDDKY 431
Query: 313 RDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSY 372
R K RD + + + +D N DRY+ +H +H++++ + + D+ K++SS
Sbjct: 432 RHKDRDTANGKNRHLHHEDGDDNGDRYR--KHSRHEENEYRWERKRNSDNPVKVYSSMGS 489
Query: 373 SMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQ 432
+ E K+T E E DD EE L+L EQEEEDL+RI EESR+RR+AI+EKYK QH Q
Sbjct: 490 TAEVGESKLTSSEVEPDDLEEDT-LQLPEQEEEDLNRIKEESRRRREAIMEKYKKQH--Q 546
Query: 433 QKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGV 492
Q + + + D+K + + N + +G+ D + + SF+V KSP +N
Sbjct: 547 QVEEAVGNEGNDKKAA--------IPNDISEARDGKND--DADYLEPSFAVGKSP-ENVN 595
Query: 493 TALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDD 552
A K S GGLG+G+PKSE S CDDIFGETP GVRK+GK +GL I R+GLHDNWDD
Sbjct: 596 VASKKMSPAGGLGEGTPKSERSEDKFCDDIFGETPTGVRKSGKGDGLLIERAGLHDNWDD 655
Query: 553 AEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK 612
AEGYYSYR GEILDGRYEVTAAHG+GVFSTVVR K+LK GNGEPEEVAIKIIR+N+TM K
Sbjct: 656 AEGYYSYRIGEILDGRYEVTAAHGRGVFSTVVRGKNLKMGNGEPEEVAIKIIRSNDTMYK 715
Query: 613 AGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGL 672
AG E+ ILKKL GADP++KRHC+RF SSF+YRNHLCLVFESL+MNLREVLKKFGRNIGL
Sbjct: 716 AGMDELVILKKLVGADPDDKRHCVRFLSSFRYRNHLCLVFESLNMNLREVLKKFGRNIGL 775
Query: 673 KLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT 732
+LTAVRAYAKQLFIALKHL+NCGVLHCDIKPDNMLVNE+KNVLKLCDFGNAMFAGKNE+T
Sbjct: 776 RLTAVRAYAKQLFIALKHLRNCGVLHCDIKPDNMLVNESKNVLKLCDFGNAMFAGKNEVT 835
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY GKVLFPG TNNDMLRLHMELKGP
Sbjct: 836 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYIGKVLFPGLTNNDMLRLHMELKGP 895
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
FPKKMLRKGAFT+QHFDQDLNF ATEEDPVTKK IK++I NIKPKDIG+++T SPGEDPK
Sbjct: 896 FPKKMLRKGAFTEQHFDQDLNFLATEEDPVTKKTIKRLILNIKPKDIGTLITGSPGEDPK 955
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
MLANFKDLL+K+FVLDP+KR+TV+QAL HPFI+GK
Sbjct: 956 MLANFKDLLEKVFVLDPDKRLTVSQALNHPFITGK 990
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449493498|ref|XP_004159318.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase PRP4 homolog [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2152), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/723 (62%), Positives = 534/723 (73%), Gaps = 60/723 (8%)
Query: 209 EIERERR---REWEREKSKHLEVDRERRRDKNREQSRDRDIHRGR---EERDRSRYEEVD 262
++ER+RR R W RE+ E R+RR ++ R SR+R+ R R +ER S+ EVD
Sbjct: 6 DVERDRRGKERGWSRER----EGQRDRRVERERGWSREREAERDRRTEKERGWSKEREVD 61
Query: 263 RGRRREKERDRSRD----------------------------------RARVNDRDMDRQ 288
R RR EKER RS D +A +DR+ DR+
Sbjct: 62 RDRRAEKERCRSTDREGNRDRRREREKXRSKDKEVDWDGRRDRDRNDDKAEYSDRNRDRE 121
Query: 289 RDRE--KDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLK 346
R RE KDR RD L+RER DR+++K D S ++K + + Y K SRH
Sbjct: 122 RVREVQKDRFRDKELDRERHN--DRNKNKASDSLSSKDKYGNLEHGYVKGS--KQSRH-- 175
Query: 347 HDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSG-DKITKDEDEQDDFEERVALKLEEQEEE 405
+D++ G G R + + H S S G DK+ DE+++ + ++ +L ++EEE
Sbjct: 176 YDNEFGLDGGRI---NAVEKHGSFKRSTREEGEDKLMSGHDEEEEDGDGMSYQLADEEEE 232
Query: 406 DLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDS 465
DL+RI EESR+RRQAILEKYK Q L++Q ++++ + E D+ + SSQS + +
Sbjct: 233 DLNRIKEESRRRRQAILEKYKCQQLEKQVEASMKESEKDKDSGKDSSQSEAAAHAIPELV 292
Query: 466 NGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE 525
+G +D +AD SF V+KSP QNG A DKT+ GLG+G+PK+E S+ + CDDIFGE
Sbjct: 293 DGVVDD---SVADSSFVVEKSPQQNGAIASDKTAGTKGLGEGTPKAEGSDGLFCDDIFGE 349
Query: 526 TPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVR 585
TP VRK GK++GL+I RSGLHDNWDDA+GYY+YRFGE+LD RYE+ AAHGKGVFSTVVR
Sbjct: 350 TPAAVRKMGKSDGLQIERSGLHDNWDDADGYYNYRFGEVLDSRYEIAAAHGKGVFSTVVR 409
Query: 586 AKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645
AKDLKAG GEPEEVAIKI+R+NETM KAG E+ ILKKL GADP++KRHC+RF SSFKYR
Sbjct: 410 AKDLKAGPGEPEEVAIKILRSNETMYKAGLEELVILKKLVGADPDDKRHCVRFLSSFKYR 469
Query: 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705
NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL+NCGVLHCDIKPDN
Sbjct: 470 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLRNCGVLHCDIKPDN 529
Query: 706 MLV-NEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCL 764
MLV +NVLKLCDFGNAMFAGKNEITPYLVSR YRAPEIILGL YDHP+DIWSVGCCL
Sbjct: 530 MLVCXRGENVLKLCDFGNAMFAGKNEITPYLVSRXYRAPEIILGLSYDHPMDIWSVGCCL 589
Query: 765 YELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTK 824
YEL TGKVLFPG +NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHA+EEDPVTK
Sbjct: 590 YELSTGKVLFPGPSNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHASEEDPVTK 649
Query: 825 KAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
K IK+II NIKPKDIGSI+ SP EDPKMLANFKDLLDKIFVLDPEKRMTV+QAL HPFI
Sbjct: 650 KTIKRIIVNIKPKDIGSIIRGSPCEDPKMLANFKDLLDKIFVLDPEKRMTVSQALNHPFI 709
Query: 885 SGK 887
+GK
Sbjct: 710 TGK 712
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22331335|ref|NP_189213.2| serine/threonine-protein kinase PRP4 [Arabidopsis thaliana] gi|20260158|gb|AAM12977.1| protein kinase-like protein [Arabidopsis thaliana] gi|22136222|gb|AAM91189.1| protein kinase-like protein [Arabidopsis thaliana] gi|332643555|gb|AEE77076.1| serine/threonine-protein kinase PRP4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2005), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/886 (53%), Positives = 575/886 (64%), Gaps = 120/886 (13%)
Query: 41 EQHGNGELPRENGRENYKQWRESKSPSRRSAKRNSYHDFDPMEDDQSYLHDRRKSVSSES 100
E+ NG L RE+ RE+ + +E+ PS R +K SY + R
Sbjct: 131 EKSSNGVLTRESEREDKRWDKEAGGPSERVSK-------------LSYDNGRSSF----- 172
Query: 101 SGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDA 160
SPS R +E R RS+SHD +ER S+S E+ R +H+
Sbjct: 173 ----------SPSNSRQSNEGRAR-SRSKSHD--RERETSRSRFAEDEFSDRGRHHDS-- 217
Query: 161 NDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWER 220
R+ H D VR +ER HR RY DR +SRE+
Sbjct: 218 -----------SRDYHHDRVDSVRTEERYHRRG---RYE-ENDRQYSREV---------- 252
Query: 221 EKSKHLEVDRERRRDKNREQS-RDRD-------------------------IHRGREERD 254
LE DR + RD +RE S RDRD ++
Sbjct: 253 -----LERDRSKERDMDREGSIRDRDSEGSKRRDKDSDRRREREREKRREIESDRERRKE 307
Query: 255 RSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRD 314
+ R +DR RR+E+E D RDRA +R R +DR R N+ ER+RE+ R+ +D
Sbjct: 308 KERERSIDRDRRKEREGDYLRDRAN--------ERGRSRDRTRYNSRERKREKEREGEKD 359
Query: 315 --KGRDIESDREKGASPKDSYSNRDRYKHSRHLKHD--DDKGSYGDRTRKDDLAKIHSSN 370
+GR+ + DREK S Y R+K SR+ ++D DD RK + K H+S
Sbjct: 360 WERGRETQKDREKYISSDVDYGEM-RHKQSRNTRYDAVDDL-----EMRKPNSLKAHNSK 413
Query: 371 SYSME--GSGDKITKDEDEQDDFEERVALKLEEQEEEDL-DRIMEESRKRRQAILEKYKN 427
+E + D+ +++ED QDD +E + K E+EEE+L +RI EESRKR +AILEK+K
Sbjct: 414 GDKLEETWANDERSRNEDGQDDNDEGLTWKSPEEEEEELLNRIKEESRKRMEAILEKHKR 473
Query: 428 QHLQQQ----KDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSV 483
+ QQ +D+ V P S N Q +N D V A ++ +
Sbjct: 474 KPEQQNELLTQDNGKDIVPETGAPVSTSPAVVIAANVGQAKTNLDFDTV----AAKAPLI 529
Query: 484 KKSPP-QNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTG-KAEGLKI 541
PP +G++ +K + GLG+GSPKSE S + DDIFGE+P G+RK G K +G+ +
Sbjct: 530 AGGPPTMSGISDSEKNQAQAGLGEGSPKSERSADMFHDDIFGESPAGIRKVGGKGDGVPM 589
Query: 542 IRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAI 601
+RSGLHDNWDDAEGYYSY+FGE+LDGRYEV A HGKGVFSTVVRAKDLKAG EPEEVAI
Sbjct: 590 VRSGLHDNWDDAEGYYSYQFGELLDGRYEVIATHGKGVFSTVVRAKDLKAGPAEPEEVAI 649
Query: 602 KIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLRE 661
KIIRNNETM+KAG+ EVQILKKLAGAD E++RHC+RF SSFKYRNHLCLVFESLH+NLRE
Sbjct: 650 KIIRNNETMHKAGKIEVQILKKLAGADREDRRHCVRFLSSFKYRNHLCLVFESLHLNLRE 709
Query: 662 VLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721
VLKKFGRNIGL+L+AVRAY+KQLFIALKHLKNCGVLHCDIKPDNMLVNE KNVLKLCDFG
Sbjct: 710 VLKKFGRNIGLQLSAVRAYSKQLFIALKHLKNCGVLHCDIKPDNMLVNEGKNVLKLCDFG 769
Query: 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
NAMFAGKNE+TPYLVSRFYR+PEIILGL YDHPLDIWSVGCCLYELY+GKVLFPGATNND
Sbjct: 770 NAMFAGKNEVTPYLVSRFYRSPEIILGLTYDHPLDIWSVGCCLYELYSGKVLFPGATNND 829
Query: 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGS 841
MLRLHMELKGPFPKKMLRKGAF DQHFD DLNF+ATEED V+ K IK++I N+KPKD GS
Sbjct: 830 MLRLHMELKGPFPKKMLRKGAFIDQHFDHDLNFYATEEDTVSGKLIKRMIVNVKPKDFGS 889
Query: 842 IVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
I+ PGEDPK+LA+F+DLLDK+F+LDPE+R+TV+QAL HPFI+GK
Sbjct: 890 IIKGYPGEDPKILAHFRDLLDKMFILDPERRLTVSQALAHPFITGK 935
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 887 | ||||||
| TAIR|locus:2087347 | 935 | AT3G25840 [Arabidopsis thalian | 0.847 | 0.804 | 0.512 | 7e-193 | |
| TAIR|locus:2084086 | 642 | AT3G53640 [Arabidopsis thalian | 0.620 | 0.856 | 0.543 | 1.2e-159 | |
| ZFIN|ZDB-GENE-040426-2799 | 1010 | prpf4bb "PRP4 pre-mRNA process | 0.511 | 0.449 | 0.471 | 4e-116 | |
| ZFIN|ZDB-GENE-040426-947 | 986 | prpf4ba "PRP4 pre-mRNA process | 0.609 | 0.548 | 0.433 | 2.8e-115 | |
| UNIPROTKB|Q08DZ2 | 1008 | PRPF4B "Serine/threonine-prote | 0.512 | 0.451 | 0.474 | 2.6e-113 | |
| ASPGD|ASPL0000072111 | 780 | AN4936 [Emericella nidulans (t | 0.490 | 0.557 | 0.468 | 6.1e-113 | |
| UNIPROTKB|Q13523 | 1007 | PRPF4B "Serine/threonine-prote | 0.514 | 0.452 | 0.470 | 8.9e-113 | |
| UNIPROTKB|F5H2U2 | 993 | PRPF4B "Serine/threonine-prote | 0.514 | 0.459 | 0.470 | 8.9e-113 | |
| UNIPROTKB|E2RAT5 | 1042 | PRPF4B "Uncharacterized protei | 0.514 | 0.437 | 0.470 | 1.1e-112 | |
| MGI|MGI:109584 | 1007 | Prpf4b "PRP4 pre-mRNA processi | 0.512 | 0.451 | 0.474 | 1.4e-112 |
| TAIR|locus:2087347 AT3G25840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1833 (650.3 bits), Expect = 7.0e-193, Sum P(2) = 7.0e-193
Identities = 404/788 (51%), Positives = 492/788 (62%)
Query: 111 SPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVR 170
SPS R +E R RS+SHD +E SRS+ +E + R +H+ + D +R+
Sbjct: 173 SPSNSRQSNEGRAR-SRSKSHDRERETSRSRFAEDEFSD--RGRHHD-SSRDYHHDRVDS 228
Query: 171 RGRNERHGSRDLVRDDEREHRTSYTTRYVGXXXXXXXXXXXXXXXXXXXXXKSKHLEVDR 230
ER+ R +++R++ R + K + R
Sbjct: 229 VRTEERYHRRGRYEENDRQYSREVLERDRSKERDMDREGSIRDRDSEGSKRRDKDSDRRR 288
Query: 231 ERRRDKNREQSRDRDIHRGREERDRSRYXXXXXXXXXXXXXXXXXXXXXXXXXXMDRQRD 290
ER R+K RE DR+ R +ER+RS +R R
Sbjct: 289 EREREKRREIESDRE-RRKEKERERS----------IDRDRRKEREGDYLRDRANERGRS 337
Query: 291 REKXXXXXXXXXXXXXXXXXXXXXXXXXIESDREKGASPKDSYSNRDRYKHSRHLKHD-- 348
R++ + DREK S Y R+K SR+ ++D
Sbjct: 338 RDRTRYNSRERKREKEREGEKDWERGRETQKDREKYISSDVDYGEM-RHKQSRNTRYDAV 396
Query: 349 DDKGSYGDRTRKDDLAKIHSSNSYSMEGS--GDKITKDEDEQDDFXXXXXXXX-XXXXXX 405
DD RK + K H+S +E + D+ +++ED QDD
Sbjct: 397 DDL-----EMRKPNSLKAHNSKGDKLEETWANDERSRNEDGQDDNDEGLTWKSPEEEEEE 451
Query: 406 XXXXXXXXSRKRRQAILEKYKNQHLQQQK---DSNLVDVETDE-KPSEHSSQSTDVNNKL 461
SRKR +AILEK+K + QQ + N D+ + P S N
Sbjct: 452 LLNRIKEESRKRMEAILEKHKRKPEQQNELLTQDNGKDIVPETGAPVSTSPAVVIAANVG 511
Query: 462 QNDSNGRIDGVNVHLADQSFSVKKSPP-QNGVTALDKTSVRGGLGDGSPKSETSNHIPCD 520
Q +N D V A ++ + PP +G++ +K + GLG+GSPKSE S + D
Sbjct: 512 QAKTNLDFDTV----AAKAPLIAGGPPTMSGISDSEKNQAQAGLGEGSPKSERSADMFHD 567
Query: 521 DIFGETPVGVRKTG-KAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGV 579
DIFGE+P G+RK G K +G+ ++RSGLHDNWDDAEGYYSY+FGE+LDGRYEV A HGKGV
Sbjct: 568 DIFGESPAGIRKVGGKGDGVPMVRSGLHDNWDDAEGYYSYQFGELLDGRYEVIATHGKGV 627
Query: 580 FSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639
FSTVVRAKDLKAG EPEEVAIKIIRNNETM+KAG+ EVQILKKLAGAD E++RHC+RF
Sbjct: 628 FSTVVRAKDLKAGPAEPEEVAIKIIRNNETMHKAGKIEVQILKKLAGADREDRRHCVRFL 687
Query: 640 SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHC 699
SSFKYRNHLCLVFESLH+NLREVLKKFGRNIGL+L+AVRAY+KQLFIALKHLKNCGVLHC
Sbjct: 688 SSFKYRNHLCLVFESLHLNLREVLKKFGRNIGLQLSAVRAYSKQLFIALKHLKNCGVLHC 747
Query: 700 DIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWS 759
DIKPDNMLVNE KNVLKLCDFGNAMFAGKNE+TPYLVSRFYR+PEIILGL YDHPLDIWS
Sbjct: 748 DIKPDNMLVNEGKNVLKLCDFGNAMFAGKNEVTPYLVSRFYRSPEIILGLTYDHPLDIWS 807
Query: 760 VGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEE 819
VGCCLYELY+GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF DQHFD DLNF+ATEE
Sbjct: 808 VGCCLYELYSGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFIDQHFDHDLNFYATEE 867
Query: 820 DPVTXXXXXXXXXXXXXXXXGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879
D V+ GSI+ PGEDPK+LA+F+DLLDK+F+LDPE+R+TV+QAL
Sbjct: 868 DTVSGKLIKRMIVNVKPKDFGSIIKGYPGEDPKILAHFRDLLDKMFILDPERRLTVSQAL 927
Query: 880 THPFISGK 887
HPFI+GK
Sbjct: 928 AHPFITGK 935
|
|
| TAIR|locus:2084086 AT3G53640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1490 (529.6 bits), Expect = 1.2e-159, Sum P(3) = 1.2e-159
Identities = 314/578 (54%), Positives = 396/578 (68%)
Query: 320 ESDRE--KGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLA--KIHSSNSYSME 375
ES+R+ +G S +D + R + R + + K DR R++D + +I+ S +
Sbjct: 83 ESNRDNYRGRSSRDKARSSSR-ETGRENERERRKDQDRDRGRREDQSDQEIYKSGG---D 138
Query: 376 GSGDKITKDEDEQDDFXXXXXXXXXXXXXXXXXXXXXXSRKRRQAILEKYKNQHLQQQKD 435
G G+ ED+ D + +E+ + +++ ++
Sbjct: 139 GYGEVRHDAEDDLDSLKSHKPNGETQGNVERSEVDNDDDGEDVVWGVEEQEAAEMKRIEE 198
Query: 436 SNLVD---VETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGV 492
S + +E +K E SS DV K D+ +DG +A S +V ++P + +
Sbjct: 199 SKRITQAILEKYKKKLEQSSTVADVQAKAGLDTEA-VDG---EVAKLSSAVGETPARLVI 254
Query: 493 TALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPV--GVRKTGKAEGLKIIRSGLHDNW 550
+ D T G SPKS+ + DDIFGE+P+ G RK G A + +RSGL+DNW
Sbjct: 255 SDSDMTLASAG----SPKSDMFS----DDIFGESPLADGTRK-GNAL-VPFVRSGLNDNW 304
Query: 551 DDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM 610
DDAEGYYSY+ GE+LD RYE+ A HGKGVFSTVVRAKD K GEPEEVAIKIIR NETM
Sbjct: 305 DDAEGYYSYQLGELLDDRYEIMATHGKGVFSTVVRAKDTKPELGEPEEVAIKIIRKNETM 364
Query: 611 NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNI 670
+KAGQ E++ILKKL +DPENK HC+R S+F+YRNHLCLVFESLH+NLREV+KK G NI
Sbjct: 365 HKAGQAEIRILKKLVCSDPENKHHCVRLLSTFEYRNHLCLVFESLHLNLREVVKKIGVNI 424
Query: 671 GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
GLKL VR YA+QLFI+LKHLKNCGVLHCDIKPDN+L+NE +N+LKLCDFG+AMFAG+N+
Sbjct: 425 GLKLYDVRVYAEQLFISLKHLKNCGVLHCDIKPDNILMNEGRNMLKLCDFGSAMFAGENQ 484
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
+TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY+GK++FPG+TNNDMLRLHMELK
Sbjct: 485 VTPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYSGKIMFPGSTNNDMLRLHMELK 544
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXXXXXXXXXXXXGSIVTAS-PGE 849
GPFPKKMLRKGAF DQHFD+DL F+ATEED VT GS++ E
Sbjct: 545 GPFPKKMLRKGAFIDQHFDKDLCFYATEEDSVTGKTIRRIMVNVKPKDLGSVIRRRYEDE 604
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
DPK+L +F++LLDKIF LDP+KR+TV+QAL HPFI+GK
Sbjct: 605 DPKVLVHFRNLLDKIFTLDPQKRLTVSQALAHPFITGK 642
|
|
| ZFIN|ZDB-GENE-040426-2799 prpf4bb "PRP4 pre-mRNA processing factor 4 homolog Bb" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 4.0e-116, Sum P(3) = 4.0e-116
Identities = 228/484 (47%), Positives = 298/484 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQST-----DVNNKLQNDSNGRI 469
R++R AI++KYK + +DSNL + ++ + SS+S D+ ++ D
Sbjct: 545 RQQRLAIVQKYKAGN----EDSNLGSMASEPSSPQSSSRSRSPSPDDILERVAADVK-EY 599
Query: 470 DGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVG 529
+ NV+ + + K + + A +K G P S DD+F G
Sbjct: 600 ERENVNSFEANIKAK-----HNLIAQEKE----GNNPKKP-SAPDMFTESDDMFAADFDG 649
Query: 530 VRKTGKAEGLKIIRS-GLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKD 588
R G + L DNW DAEGYY GEILD RY+V G+GVFS VVRA+D
Sbjct: 650 ARLRAAGIGKDFKENPNLRDNWTDAEGYYRVNIGEILDKRYDVYGYTGQGVFSNVVRARD 709
Query: 589 L-KAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647
+AG +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ H
Sbjct: 710 TARAG----QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQH 765
Query: 648 LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML 707
LCLVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+L
Sbjct: 766 LCLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNIL 825
Query: 708 VNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYEL 767
VNE+K +LKLCDFG+A NEITPYLVSRFYRAPEI++G PYD+ +D+WSVGC LYEL
Sbjct: 826 VNESKTILKLCDFGSASHVADNEITPYLVSRFYRAPEIVIGKPYDYGIDMWSVGCTLYEL 885
Query: 768 YTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXX 827
YTGK+LFPG++NN ML+L M++KG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 886 YTGKILFPGSSNNHMLKLAMDVKGKMPNKMIRKGLFKDQHFDQNLNFLYIEVDKVTEREK 945
Query: 828 XXXXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+V P + K + KDLLD +LDP KR+++ QAL HPF
Sbjct: 946 VTVMSTINPTKDLLADMVGGQRLPEDQRKKVMQLKDLLDGTLMLDPAKRISINQALQHPF 1005
Query: 884 ISGK 887
I K
Sbjct: 1006 IQEK 1009
|
|
| ZFIN|ZDB-GENE-040426-947 prpf4ba "PRP4 pre-mRNA processing factor 4 homolog Ba" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1053 (375.7 bits), Expect = 2.8e-115, Sum P(3) = 2.8e-115
Identities = 253/584 (43%), Positives = 327/584 (55%)
Query: 319 IESDREKGASP--KDSYSNRDRYKHS--RHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSM 374
I S R SP + S S R R S RH + D R+R + + S M
Sbjct: 424 ISSRRRLNHSPLRRRSRSPRRRSSRSPLRHRERDRMDRRQPVRSRSQERRRRRSKEREDM 483
Query: 375 -EGSGDKITKDEDEQDDFXXXXXXXXXXXXXXXXXXXXXXSRKRRQAILEKYKNQHLQQQ 433
+GS + K E E D R +R AI++KYK +
Sbjct: 484 FKGSLSEGMKAEQEDSD---EEVLEDYDVDEEDEEALIEQRRLQRLAIMQKYKPVN---- 536
Query: 434 KDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVT 493
+DSN+ + S+H S + +++ + + ++ V AD VK +N T
Sbjct: 537 EDSNMSGL------SDHGSPQSSTHSRSPSPDD-ILERV---AAD----VKAYEQENLDT 582
Query: 494 ALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETP---------VGVRKTGKAEGLKIIRS 544
D + L S P D+F E+ +R G + K S
Sbjct: 583 FEDNVKAKYSLVSQEKNGANSKKPPAPDMFTESDDMFAAYFDSARLRAAGIGKDFKENPS 642
Query: 545 GLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII 604
L DNW DAEGYY GE+LD RY V G+GVFS V+RA+DL N +EVA+KII
Sbjct: 643 -LRDNWTDAEGYYRVNIGEVLDKRYAVYGYTGQGVFSNVIRARDLARAN---QEVAVKII 698
Query: 605 RNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLK 664
RNNE M K G E++ LKKL AD ++K HC+R F ++ HLCLVFE L MNLREVL+
Sbjct: 699 RNNEMMQKTGLKELEFLKKLNDADADDKFHCLRLFRHFYHKQHLCLVFEPLSMNLREVLR 758
Query: 665 KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724
K+G+++GL + AVR+Y++QLF+ALKHLK C +LH DIKPDN+LVNE K +LKLCDFG+A
Sbjct: 759 KYGKDVGLHIKAVRSYSQQLFLALKHLKRCNILHADIKPDNILVNEPKTILKLCDFGSAS 818
Query: 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYTGK+LFPG TNN ML+
Sbjct: 819 HVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYTGKILFPGKTNNHMLK 878
Query: 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXXXXXXXXXXXXGSIVT 844
L+M+LKG P KM+RKG F DQHFDQ+LNF TE D VT S+
Sbjct: 879 LNMDLKGKLPNKMIRKGLFKDQHFDQNLNFLYTEVDKVTEREKITVMSTINPTKDLSMDM 938
Query: 845 ----ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
A P + K + KDLLD+I +LDP KR+T+ QAL HPFI
Sbjct: 939 VGRQALPEDQRKKVGQLKDLLDQILMLDPAKRITINQALQHPFI 982
|
|
| UNIPROTKB|Q08DZ2 PRPF4B "Serine/threonine-protein kinase PRP4 homolog" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 2.6e-113, Sum P(2) = 2.6e-113
Identities = 229/483 (47%), Positives = 295/483 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNL-VDVETDEKPSEHSSQST---DVNNKLQNDSNGRID 470
R +RQAI++KYK +L DSNL V E S S+S D+ ++ D +
Sbjct: 543 RIQRQAIVQKYK--YLAD--DSNLSVPSEPSSPQSSTRSRSPSPDDILERVAADVK-EYE 597
Query: 471 GVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE--TPV 528
NV + S K + + A+++ + +P T + DD+F
Sbjct: 598 RENVDTFEASVKAK-----HNLMAVEQNNGSSQKKLLAPDMFTES----DDMFAAYFDSA 648
Query: 529 GVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKD 588
+R G + K L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D
Sbjct: 649 RLRAAGIGKDFKE-NPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARD 707
Query: 589 LKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648
N +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ HL
Sbjct: 708 NARAN---QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHL 764
Query: 649 CLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708
CLVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LV
Sbjct: 765 CLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILV 824
Query: 709 NEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY 768
NE+K +LKLCDFG+A N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELY
Sbjct: 825 NESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELY 884
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXX 828
TGK+LFPG TNN ML+L M+LKG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 885 TGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKV 944
Query: 829 XXXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
++ P + K + KDLLD+I +LDP KR+++ QAL H FI
Sbjct: 945 TVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFI 1004
Query: 885 SGK 887
K
Sbjct: 1005 QEK 1007
|
|
| ASPGD|ASPL0000072111 AN4936 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 6.1e-113, Sum P(4) = 6.1e-113
Identities = 218/465 (46%), Positives = 291/465 (62%)
Query: 434 KDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVT 493
KD + + DE PS T ++ K + + +G G + ++ S+ K+ Q+ V
Sbjct: 327 KDGAVDGADKDE-PSAADYDPT-IDMKAERERHG---GQSNDVSAASYDETKTTKQD-VL 380
Query: 494 ALDKTSVRGGLGDGSPKSETSNHIPC---DDIFGETPVGVRKTGKAEGLKIIRS-----G 545
D S + P+++ S I DD+F E K A + + ++
Sbjct: 381 LPDAPSQQ------EPEAKDSFDIFAEDDDDMFAEDTEETSKPAHASAIAVPQARELDVS 434
Query: 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR 605
+ DNWDD EGYY+ R GE++DGRY V GKG+FS+VVRAKD K GN VAIKIIR
Sbjct: 435 MMDNWDDPEGYYNLRIGELIDGRYHVQQNLGKGMFSSVVRAKDSKTGN----VVAIKIIR 490
Query: 606 NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
N+TM KAG E+ IL+KL ADPE+K+H I+F SF+++ HLC+VFE+L MNLREVLKK
Sbjct: 491 QNDTMKKAGLKEIGILEKLREADPEDKKHMIKFERSFEHKGHLCMVFENLSMNLREVLKK 550
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725
FGR++GL L A+RAYA+Q+F+ L ++ C +LH D+KPDNMLVNE +N+LK+CD G+A
Sbjct: 551 FGRDVGLNLRAIRAYAQQIFLGLSLMRKCNILHADLKPDNMLVNEQRNILKVCDLGSASL 610
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
A NEITPYLVSRFYRAPEIILG+PYD+ +D+WS+GC L+ELYTGK+LF G NN ML+
Sbjct: 611 ASDNEITPYLVSRFYRAPEIILGIPYDYAIDMWSIGCTLFELYTGKILFTGRNNNQMLKS 670
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXXX------XXXXXXXXX 839
ME +G +P K+LR+G+ HFD+ NFH+TEED +T
Sbjct: 671 IMECRGKYPPKLLRRGSLAHLHFDEMANFHSTEEDKITGRLTTRIMDFKKPTRDLKTRLM 730
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
G + K LA F DLLD+ L+PEKR T A+AL HPFI
Sbjct: 731 GKGTRGMTDSEAKELALFVDLLDRCLSLNPEKRCTPAEALKHPFI 775
|
|
| UNIPROTKB|Q13523 PRPF4B "Serine/threonine-protein kinase PRP4 homolog" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 227/482 (47%), Positives = 295/482 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDG-VN 473
R +RQAI++KYK +L + DSN+ +PS S ST + +D R+ V
Sbjct: 542 RIQRQAIVQKYK--YLAE--DSNM---SVPSEPSSPQS-STRTRSPSPDDILERVAADVK 593
Query: 474 VHLADQ--SFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE--TPVG 529
+ + +F N +T +++ + +P T + DD+F
Sbjct: 594 EYERENVDTFEASVKAKHNLMT-VEQNNGSSQKKLLAPDMFTES----DDMFAAYFDSAR 648
Query: 530 VRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDL 589
+R G + K L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D
Sbjct: 649 LRAAGIGKDFKE-NPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDN 707
Query: 590 KAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649
N +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ HLC
Sbjct: 708 ARAN---QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLC 764
Query: 650 LVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709
LVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVN
Sbjct: 765 LVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVN 824
Query: 710 EAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
E+K +LKLCDFG+A N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYT
Sbjct: 825 ESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYT 884
Query: 770 GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXX 829
GK+LFPG TNN ML+L M+LKG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 885 GKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVT 944
Query: 830 XXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
++ P + K + KDLLD+I +LDP KR+++ QAL H FI
Sbjct: 945 VMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQ 1004
Query: 886 GK 887
K
Sbjct: 1005 EK 1006
|
|
| UNIPROTKB|F5H2U2 PRPF4B "Serine/threonine-protein kinase PRP4 homolog" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1022 (364.8 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 227/482 (47%), Positives = 295/482 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDG-VN 473
R +RQAI++KYK +L + DSN+ +PS S ST + +D R+ V
Sbjct: 528 RIQRQAIVQKYK--YLAE--DSNM---SVPSEPSSPQS-STRTRSPSPDDILERVAADVK 579
Query: 474 VHLADQ--SFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE--TPVG 529
+ + +F N +T +++ + +P T + DD+F
Sbjct: 580 EYERENVDTFEASVKAKHNLMT-VEQNNGSSQKKLLAPDMFTES----DDMFAAYFDSAR 634
Query: 530 VRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDL 589
+R G + K L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D
Sbjct: 635 LRAAGIGKDFKE-NPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDN 693
Query: 590 KAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649
N +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ HLC
Sbjct: 694 ARAN---QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLC 750
Query: 650 LVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709
LVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVN
Sbjct: 751 LVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVN 810
Query: 710 EAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
E+K +LKLCDFG+A N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYT
Sbjct: 811 ESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYT 870
Query: 770 GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXX 829
GK+LFPG TNN ML+L M+LKG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 871 GKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVT 930
Query: 830 XXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
++ P + K + KDLLD+I +LDP KR+++ QAL H FI
Sbjct: 931 VMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQ 990
Query: 886 GK 887
K
Sbjct: 991 EK 992
|
|
| UNIPROTKB|E2RAT5 PRPF4B "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1021 (364.5 bits), Expect = 1.1e-112, Sum P(2) = 1.1e-112
Identities = 227/482 (47%), Positives = 295/482 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSNGRIDG-VN 473
R +RQAI++KYK +L + DSN+ +PS S ST + +D R+ V
Sbjct: 577 RIQRQAIVQKYK--YLAE--DSNM---SVPSEPSSPQS-STCTRSPSPDDILERVAADVK 628
Query: 474 VHLADQ--SFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE--TPVG 529
+ + +F N +T +++ + +P T + DD+F
Sbjct: 629 EYERENVDTFEASVKAKHNLMT-VEQNNGSSQKKLLAPDMFTES----DDMFAAYFDSAR 683
Query: 530 VRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDL 589
+R G + K L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D
Sbjct: 684 LRAAGIGKDFKE-NPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARDN 742
Query: 590 KAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649
N +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ HLC
Sbjct: 743 ARAN---QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHLC 799
Query: 650 LVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709
LVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LVN
Sbjct: 800 LVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILVN 859
Query: 710 EAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
E+K +LKLCDFG+A N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELYT
Sbjct: 860 ESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELYT 919
Query: 770 GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXXX 829
GK+LFPG TNN ML+L M+LKG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 920 GKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKVT 979
Query: 830 XXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
++ P + K + KDLLD+I +LDP KR+++ QAL H FI
Sbjct: 980 VMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFIQ 1039
Query: 886 GK 887
K
Sbjct: 1040 EK 1041
|
|
| MGI|MGI:109584 Prpf4b "PRP4 pre-mRNA processing factor 4 homolog B (yeast)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1025 (365.9 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
Identities = 229/483 (47%), Positives = 296/483 (61%)
Query: 415 RKRRQAILEKYKNQHLQQQKDSNL-VDVETDEKPSEHSSQST---DVNNKLQNDSNGRID 470
R +RQAI++KYK +L + DSN+ V E S S+S D+ ++ D +
Sbjct: 542 RIQRQAIVQKYK--YLAE--DSNISVPSEPSSPQSSTRSRSPSPDDILERVAADVK-EYE 596
Query: 471 GVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGE--TPV 528
NV + S K N +T +++ + +P T + DD+F
Sbjct: 597 RENVDTFEASVKAK----HNLMT-VEQNNGSSQKKILAPDMFTES----DDMFAAYFDSA 647
Query: 529 GVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKD 588
+R G + K L DNW DAEGYY GE+LD RY V G+GVFS VVRA+D
Sbjct: 648 RLRAAGIGKDFKE-NPNLRDNWTDAEGYYRVNIGEVLDKRYNVYGYTGQGVFSNVVRARD 706
Query: 589 LKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648
N +EVA+KIIRNNE M K G E++ LKKL ADP++K HC+R F ++ HL
Sbjct: 707 NARAN---QEVAVKIIRNNELMQKTGLKELEFLKKLNDADPDDKFHCLRLFRHFYHKQHL 763
Query: 649 CLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708
CLVFE L MNLREVLKK+G+++GL + AVR+Y++QLF+ALK LK C +LH DIKPDN+LV
Sbjct: 764 CLVFEPLSMNLREVLKKYGKDVGLHIKAVRSYSQQLFLALKLLKRCNILHADIKPDNILV 823
Query: 709 NEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY 768
NE+K +LKLCDFG+A N+ITPYLVSRFYRAPEII+G YD+ +D+WSVGC LYELY
Sbjct: 824 NESKTILKLCDFGSASHVADNDITPYLVSRFYRAPEIIIGKSYDYGIDMWSVGCTLYELY 883
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTXXXXX 828
TGK+LFPG TNN ML+L M+LKG P KM+RKG F DQHFDQ+LNF E D VT
Sbjct: 884 TGKILFPGKTNNHMLKLAMDLKGKMPNKMIRKGVFKDQHFDQNLNFMYIEVDKVTEREKV 943
Query: 829 XXXXXX--XXXXXGSIVTAS--PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
++ P + K + KDLLD+I +LDP KR+++ QAL H FI
Sbjct: 944 TVMSTINPTKDLLADLIGCQRLPEDQRKKVHQLKDLLDQILMLDPAKRISINQALQHAFI 1003
Query: 885 SGK 887
K
Sbjct: 1004 QEK 1006
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 887 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-53 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-50 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-48 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-46 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-41 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-40 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-38 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-38 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-36 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-36 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-34 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-33 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-33 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-33 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-33 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-32 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-32 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-31 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-31 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-30 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-30 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-29 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-29 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-29 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-28 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-27 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-27 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-24 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-23 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-23 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-20 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-16 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 7e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 5e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 2e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| TIGR01622 | 457 | TIGR01622, SF-CC1, splicing factor, CC1-like famil | 7e-08 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 8e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| TIGR01622 | 457 | TIGR01622, SF-CC1, splicing factor, CC1-like famil | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-07 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-07 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 9e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-06 | |
| pfam08648 | 158 | pfam08648, DUF1777, Protein of unknown function (D | 4e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-05 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 1e-05 | |
| pfam08648 | 158 | pfam08648, DUF1777, Protein of unknown function (D | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 2e-05 | |
| PRK12678 | 672 | PRK12678, PRK12678, transcription termination fact | 3e-05 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 3e-05 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 3e-05 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-04 | |
| TIGR00934 | 800 | TIGR00934, 2a38euk, potassium uptake protein, Trk | 2e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| pfam10243 | 506 | pfam10243, MIP-T3, Microtubule-binding protein MIP | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-04 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-04 | |
| pfam06495 | 182 | pfam06495, Transformer, Fruit fly transformer prot | 6e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-04 | |
| TIGR01642 | 509 | TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, la | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| TIGR01622 | 457 | TIGR01622, SF-CC1, splicing factor, CC1-like famil | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| TIGR02169 | 1164 | TIGR02169, SMC_prok_A, chromosome segregation prot | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| pfam03344 | 715 | pfam03344, Daxx, Daxx Family | 0.004 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-65
Identities = 101/330 (30%), Positives = 143/330 (43%), Gaps = 80/330 (24%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT-- 616
Y E L G+G F V A+D K G + VAIK+I+ + +
Sbjct: 1 YEILEKL----------GEGSFGKVYLARDKKTG----KLVAIKVIKKKKIKKDRERILR 46
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLT 675
E++ILKKL + +R F+ + L LV E +L ++LKK GR L
Sbjct: 47 EIKILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSED 97
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITPY 734
R Y +Q+ AL++L + G++H D+KP+N+L++E +KL DFG A E +T +
Sbjct: 98 EARFYLRQILSALEYLHSKGIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTF 156
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
+ + Y APE++LG Y +DIWS+G LYEL TGK FPG
Sbjct: 157 VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLE------------ 204
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
+ K I KP SP
Sbjct: 205 --------------------------------LFKKIGKPKPPFPPPEWDISP------- 225
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KDL+ K+ V DPEKR+T +AL HPF
Sbjct: 226 -EAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 86/334 (25%), Positives = 138/334 (41%), Gaps = 82/334 (24%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQ 615
Y L G G F TV +AK G + VA+KI++ ++ +
Sbjct: 1 YELLRKL----------GSGSFGTVYKAKHK----GTGKIVAVKILKKRSEKSKKDQTAR 46
Query: 616 TEVQILKKLAGADPENKRHC--IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLK 673
E++IL++L H +R +F+ ++HL LV E + ++ R L
Sbjct: 47 REIRILRRL--------SHPNIVRLIDAFEDKDHLYLVME--YCEGGDLFDYLSRGGPLS 96
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI- 731
+ A Q+ L++L + G++H D+KP+N+L++E V+K+ DFG A +
Sbjct: 97 EDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSL 155
Query: 732 TPYLVSRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
T ++ + +Y APE++L G Y +D+WS+G LYEL TGK F G D L+L +
Sbjct: 156 TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRIL 215
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
GP L F + ++
Sbjct: 216 GP------------------PLEFDEPKWSSGSE-------------------------- 231
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KDL+ K DP KR T + L HP+
Sbjct: 232 -----EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 103/318 (32%), Positives = 148/318 (46%), Gaps = 52/318 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENK 632
G+G + V +A+D K G E VA+K IR + T E+ +LK+L
Sbjct: 8 GEGTYGVVYKARDKKTG----EIVALKKIRLDNEEEGIPSTALREISLLKEL------KH 57
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ ++ L LVFE M+L++ L K + L +++ QL L +
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNL--IKSIMYQLLRGLAYCH 115
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILGLP 750
+ +LH D+KP N+L+N VLKL DFG A G T +V+ +YRAPEI+LG
Sbjct: 116 SHRILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 751 -YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFD 809
Y +DIWSVGC E+ TGK LFPG + D L ++ G P
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG-TP--------------- 218
Query: 810 QDLNFHATEEDP--VTKKAIKKIIF-NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
TEE VTK K F PKD+ ++ P DP+ + DLL K+
Sbjct: 219 -------TEESWPGVTKLPDYKPTFPKFPPKDLEKVL---PRLDPEGI----DLLSKMLQ 264
Query: 867 LDPEKRMTVAQALTHPFI 884
+P KR++ +AL HP+
Sbjct: 265 YNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 101/316 (31%), Positives = 157/316 (49%), Gaps = 47/316 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
G+G + V +A+D G E VAIK I+ +E + K E+++LK+L N
Sbjct: 8 GEGTYGVVYKARDKLTG----EIVAIKKIKLRFESEGIPKTALREIKLLKEL------NH 57
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ I+ F+++ L LVFE + +L +++K R GL + +++Y QL L
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNE-ITPYLVSRFYRAPEIILGLP 750
+ G+LH D+KP+N+L+N + VLKL DFG A F T Y+V+R+YRAPE++LG
Sbjct: 116 SHGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 751 -YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQHF 808
Y P+DIWSVGC EL + + LFPG + D L ++ L P P+ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW--PKFTSLARN 232
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868
F ++ + + K+ N P+ + DLL ++ D
Sbjct: 233 Y---KFSFPKKAGMP---LPKLFPNASPQAL-------------------DLLSQMLHYD 267
Query: 869 PEKRMTVAQALTHPFI 884
P KR+T QAL HP+
Sbjct: 268 PHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-46
Identities = 103/331 (31%), Positives = 155/331 (46%), Gaps = 51/331 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKL 624
RYE+ G G + V A D + G +VAIK I N + K E+++L+ L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTG----RKVAIKKISNVFDDLIDAKRILREIKLLRHL 56
Query: 625 AGADPENKRHCIRFASSFKYR--NHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAY 680
EN + N + +V E + +L +V+K LT ++ +
Sbjct: 57 ---RHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-----PQPLTDDHIQYF 108
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-----FAGKNEITPYL 735
Q+ LK+L + V+H D+KP N+LVN LK+CDFG A K +T Y+
Sbjct: 109 LYQILRGLKYLHSANVIHRDLKPSNILVNS-NCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 736 VSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
V+R+YRAPE++L Y +DIWSVGC EL T K LFPG D L L +E+ G
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
++DL F + +K + K + + PG P+ +
Sbjct: 228 --------------EEDLKF---ITSEKARNYLKSLPKK-PKKPLSKLF---PGASPEAI 266
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
DLL+K+ V DP+KR+T +AL HP+++
Sbjct: 267 ----DLLEKMLVFDPKKRITADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 98/326 (30%), Positives = 158/326 (48%), Gaps = 48/326 (14%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK---IIRNNETMNKAGQTEVQILKK 623
+YEV G+G + V++ ++ G E VAIK ++E + K EV++L++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATG----EIVAIKKFKESEDDEDVKKTALREVKVLRQ 56
Query: 624 LAGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
L RH + +F+ + L LVFE + L E+L+ GL AVR+Y
Sbjct: 57 L--------RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG--GLPPDAVRSYI 106
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF---AGKNEITPYLVSR 738
QL A+ + + ++H DIKP+N+LV+E+ VLKLCDFG A + +T Y+ +R
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATR 165
Query: 739 FYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+YRAPE+++G Y P+D+W++GC + EL G+ LFPG ++ D L L + GP P
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ F + F + S+ PG+ +F
Sbjct: 226 Q-------ELFSSNPRFAGV------------AFPEPSQPE--SLERRYPGKVSSPALDF 264
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
L +DP++R+T + L HP+
Sbjct: 265 ---LKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 89/319 (27%), Positives = 134/319 (42%), Gaps = 77/319 (24%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIK---IIRNNETMNKAGQTEVQILKKLAGADPENK 632
G+G F +V A D G E +A+K + ++E +A + E++IL L
Sbjct: 9 GRGSFGSVYLALDKDTG----ELMAVKSVELSGDSEEELEALEREIRILSSL------QH 58
Query: 633 RHCIRFASSF--KYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ +R+ S + +N L + E + +L +LKKFG+ L +R Y +Q+ L
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK---LPEPVIRKYTRQILEGLA 115
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR----FYRAPEI 745
+L + G++H DIK N+LV+ V KL DFG A G E S ++ APE+
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVV-KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 746 ILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805
I G Y DIWS+GC + E+ TGK + EL P
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWS------------ELGNPMA----------- 211
Query: 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865
A+ KI + +P +I P + KD L K
Sbjct: 212 --------------------ALYKIGSSGEPPEI-------PEHLSEEA---KDFLRKCL 241
Query: 866 VLDPEKRMTVAQALTHPFI 884
DP+KR T + L HPF+
Sbjct: 242 RRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 64/198 (32%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILKKLAGADPENKR 633
G+G F TV A+D K G ++VAIKII+ ++ + + E++ILKKL N
Sbjct: 2 GEGGFGTVYLARDKKTG----KKVAIKIIKKEDSSSLLEELLREIEILKKL------NHP 51
Query: 634 HCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ ++ F+ NHL LV E +L+++LK+ + + Q+ L++L
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDE--ILRILLQILEGLEYLH 109
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRFYRAPEIILGLP 750
+ G++H D+KP+N+L++ +KL DFG + + + K+ + + + Y APE++LG
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG 169
Query: 751 -YDHPLDIWSVGCCLYEL 767
Y DIWS+G LYEL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 98/331 (29%), Positives = 156/331 (47%), Gaps = 58/331 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAG--QT---EVQIL 621
RYE G+G ++ V +A+D + G VAIK I+ E K G T E+++L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETG----RIVAIKKIKLGERKEAKDGINFTALREIKLL 56
Query: 622 KKLAGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
++L +H I F +++++ LVFE + +L +V+K ++I L +++
Sbjct: 57 QEL--------KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKD--KSIVLTPADIKS 106
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVS 737
Y L++L + +LH D+KP+N+L+ + VLKL DFG A G ++T +V+
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVT 165
Query: 738 RFYRAPEIILGLPYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
R+YRAPE++ G + +D+WSVGC EL PG ++ D L E G
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP--- 222
Query: 797 MLRKGAFTDQHFDQDLNFHATEED-PVTKKAIKKIIFN-IKPKDIGSIVTASPGEDPKML 854
TEE+ P + F P + I A+ + L
Sbjct: 223 --------------------TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDD---AL 259
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
DLL ++ L+P KR+T QAL HP+ S
Sbjct: 260 ----DLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 2e-40
Identities = 94/330 (28%), Positives = 148/330 (44%), Gaps = 63/330 (19%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--------EVQI 620
Y+V G G F +V A++ + G E VAIK M K + EV+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETG----ELVAIK------KMKKKFYSWEECMNLREVKS 50
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
L+KL E+ + ++ F+ + L VFE + NL +++K + + +R+
Sbjct: 51 LRKL----NEH-PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-KGKPFSESVIRSI 104
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------TPY 734
Q+ L H+ G H D+KP+N+LV+ V+K+ DFG A EI T Y
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLA-----REIRSRPPYTDY 158
Query: 735 LVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
+ +R+YRAPEI+L Y P+DIW++GC + ELYT + LFPG++ D L + G
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP 218
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
K+ +G L F + P + ++ +
Sbjct: 219 TKQDWPEG----YKLASKLGFRFPQ---------------FAPTSLHQLIPNAS------ 253
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DL+ + DP+KR T +QAL HP+
Sbjct: 254 -PEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 1e-38
Identities = 103/329 (31%), Positives = 154/329 (46%), Gaps = 55/329 (16%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QT---EVQILKK 623
YE A G+G + V +A++ K G E VA+K IR K G T E+++L+K
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTG----ELVALKKIRM--ENEKEGFPITAIREIKLLQK 54
Query: 624 LAGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA--VRA 679
L N + I + K + + +VFE + +L +L + +K T ++
Sbjct: 55 L---RHPNIVRLKEIVTS---KGKGSIYMVFEYMDHDLTGLL----DSPEVKFTESQIKC 104
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY---LV 736
Y KQL L++L + G+LH DIK N+L+N VLKL DFG A K Y ++
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 737 SRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
+ +YR PE++LG Y +D+WSVGC L EL+ GK +F G+T + L EL G P
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-P- 221
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
TD+++ E + K K K +
Sbjct: 222 --------TDENWPGVSKLPWFEN--LKPKKPYKRRLREFFKHLID-------------P 258
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ DLLDK+ LDP+KR++ QAL H +
Sbjct: 259 SALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 102/338 (30%), Positives = 154/338 (45%), Gaps = 80/338 (23%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKL 624
Y++ G+G FS V++A+ K G AIK ++ + E +N E+Q L++L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGK----YYAIKCMKKHFKSLEQVNNL--REIQALRRL 54
Query: 625 AGA-----------DPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLK 673
+ D + R L LVFE + MNL E++K GR L
Sbjct: 55 SPHPNILRLIEVLFDRKTGR--------------LALVFELMDMNLYELIK--GRKRPLP 98
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-FAGKNEIT 732
V++Y QL +L H+ G+ H DIKP+N+L+ ++LKL DFG+ K T
Sbjct: 99 EKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYT 156
Query: 733 PYLVSRFYRAPEIIL--GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMEL 789
Y+ +R+YRAPE +L G Y +DIW+VGC +E+ + LFPG D + ++H L
Sbjct: 157 EYISTRWYRAPECLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVL 215
Query: 790 KGPFP--KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKA--IKKIIFNIKPKDIGSIVTA 845
P K RK + +F KK ++K++
Sbjct: 216 GTPDAEVLKKFRKSRHMNYNFPS-------------KKGTGLRKLL-------------- 248
Query: 846 SPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
P A DLL K+ DP++R+T QAL HP+
Sbjct: 249 -----PNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 93/322 (28%), Positives = 146/322 (45%), Gaps = 44/322 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGA 627
RY++ G+G V +AKD + G E VA+K + G Q L+++
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETG----ETVALKKVALR---RLEGGIPNQALREIKAL 53
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+ ++ F + + LV E + +L EVL+ R L V++Y + L
Sbjct: 54 QACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERP--LPEAQVKSYMRMLLKG 111
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY---LVSRFYRAPE 744
+ ++ G++H D+KP N+L++ A VLK+ DFG A + E Y + +R+YRAPE
Sbjct: 112 VAYMHANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 745 IILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGA 802
++ G YD +D+W+VGC EL G LFPG + + L + L P + +
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230
Query: 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIF-NIKPKDIGSIVTASPGEDPKMLANFKDLL 861
D + KI F KP + I P P+ L DLL
Sbjct: 231 LPDYN---------------------KITFPESKPIPLEEIF---PDASPEAL----DLL 262
Query: 862 DKIFVLDPEKRMTVAQALTHPF 883
+ V DP KR++ A+AL HP+
Sbjct: 263 KGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-36
Identities = 104/338 (30%), Positives = 162/338 (47%), Gaps = 62/338 (18%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKL 624
RYE+ G+G + V A++ + E VAIK I N + + K E+++L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEET--VAIKKITNVFSKKILAKRALRELKLLRHF 58
Query: 625 AG-------ADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA- 676
G D + I F +F N L L E + +L ++++ G LT
Sbjct: 59 RGHKNITCLYDMD-----IVFPGNF---NELYLYEELMEADLHQIIRS-----GQPLTDA 105
Query: 677 -VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA----MFAGKNE- 730
+++ Q+ LK++ + VLH D+KP N+LVN A LK+CDFG A G+N
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAG 164
Query: 731 -ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
+T Y+ +R+YRAPEI+L Y +D+WSVGC L EL K +F G D L ++
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 789 LKGPFPKKMLRK-GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ G ++ L + G+ Q++ + L NI K SI P
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLP-------------------NIPKKPFESIF---P 262
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+P L DLL+K+ DP KR++V +AL HP+++
Sbjct: 263 NANPLAL----DLLEKLLAFDPTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 104/344 (30%), Positives = 156/344 (45%), Gaps = 73/344 (21%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
RY+ G G V A D G VAIK + N T K E+ ++K +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQ----NVAIKKLSRPFQNVTHAKRAYRELVLMKLV 72
Query: 625 AGADPENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
N ++ I + F + + LV E + NL +V I + L R
Sbjct: 73 ------NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-------IQMDLDHER 119
Query: 679 -AY-AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYL 735
+Y Q+ +KHL + G++H D+KP N++V + LK+ DFG A AG + +TPY+
Sbjct: 120 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYV 178
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFP 794
V+R+YRAPE+ILG+ Y +DIWSVGC + E+ G VLFPG + D ++ +L P
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238
Query: 795 KKMLR-----------KGAFTDQHFDQ---DLNFHATEEDPVTKKAIKKIIFNIKPKDIG 840
+ M R + + F++ D+ F E KA
Sbjct: 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKA-------------- 284
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ +DLL K+ V+DPEKR++V AL HP+I
Sbjct: 285 --------------SQARDLLSKMLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 102/338 (30%), Positives = 158/338 (46%), Gaps = 66/338 (19%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQT--EVQILK 622
+YE+ GKG + V +A D + E VA+K I + N T A +T E+ L+
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTK----EVVALKKIFDAFRNAT--DAQRTFREIMFLQ 61
Query: 623 KLAGADPENKRHCIRFASSFKYRNH--LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+L + ++ + K N + LVFE + +L V++ NI L+ R
Sbjct: 62 ELGDHP-----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRA---NI-LEDVHKRYI 112
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNE------ITP 733
QL ALK++ + V+H D+KP N+L+N V KL DFG A + E +T
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV-KLADFGLARSLSELEENPENPVLTD 171
Query: 734 YLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
Y+ +R+YRAPEI+LG Y +D+WSVGC L E+ GK LFPG + + L +E+ GP
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK-----KIIFNIKPKDIGSIVTASP 847
+ ED +IK ++ ++ + + P
Sbjct: 232 -----------------------PSAEDIE---SIKSPFAATMLDSLPSRPRKPLDELLP 265
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
L DLL K+ V +P KR+T +AL HP+++
Sbjct: 266 KASDDAL----DLLKKLLVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 105/341 (30%), Positives = 163/341 (47%), Gaps = 77/341 (22%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQT--EVQILKKL 624
RY+ + G G + V A D K G +VAIK + R ++ A +T E+++LK +
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGR----KVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 625 AGADPENKRHCIRFASSFKYRNHLCL--VF---ESLHMNLREV----------LKKFGRN 669
+ N + L VF SL + ++V L +
Sbjct: 72 ------------------DHENVIGLLDVFTPASSL-EDFQDVYLVTHLMGADLNNIVKC 112
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729
L ++ Q+ LK++ + G++H D+KP N+ VNE LK+ DFG A
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARHTDD- 170
Query: 730 EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
E+T Y+ +R+YRAPEI+L + Y+ +DIWSVGC + EL TGK LFPG+ + D L+ M
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
Query: 789 LKG----PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT 844
L G +K+ + A +++ Q L P K K +F
Sbjct: 231 LVGTPDEELLQKISSESA---RNYIQSL--------PQMPKKDFKEVF------------ 267
Query: 845 ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
G +P + DLL+K+ VLDP+KR+T A+AL HP+++
Sbjct: 268 --SGANPLAI----DLLEKMLVLDPDKRITAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 98/318 (30%), Positives = 157/318 (49%), Gaps = 37/318 (11%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGA 627
++EV G+G + V++ + + E VAIK +++E + +T ++ LK L
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETK----EIVAIKKFKDSEENEEVKETTLRELKMLRTL 57
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
EN + +F+ R L LVFE + N+ E+L++ G+ VR+Y QL A
Sbjct: 58 KQEN---IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYIYQLIKA 112
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKN-EITPYLVSRFYRAPE 744
+ ++H DIKP+N+L++ +VLKLCDFG A + G N T Y+ +R+YR+PE
Sbjct: 113 IHWCHKNDIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804
++LG PY +D+WSVGC L EL G+ LFPG + D L ++ GP P + + K ++
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM-KLFYS 230
Query: 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKI 864
+ F L F A ++ I+ + +L DL+ +
Sbjct: 231 NPRF-HGLRFPAVNHPQSLERRYLGILSGV------------------LL----DLMKNL 267
Query: 865 FVLDPEKRMTVAQALTHP 882
L+P R Q L HP
Sbjct: 268 LKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 101/319 (31%), Positives = 157/319 (49%), Gaps = 46/319 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENK 632
G+G + V AK+ + E+VAIK I N N K E+++L+ L D EN
Sbjct: 14 GRGAYGIVCSAKNSETN----EKVAIKKIANAFDNRIDAKRTLREIKLLRHL---DHENV 66
Query: 633 ---RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ + + N + +V+E + +L ++++ + L + + QL LK
Sbjct: 67 IAIKDIMPPPHREAF-NDVYIVYELMDTDLHQIIRS---SQTLSDDHCQYFLYQLLRGLK 122
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIIL 747
++ + VLH D+KP N+L+N A LK+CDFG A + +T Y+V+R+YRAPE++L
Sbjct: 123 YIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 748 GLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
Y +D+WSVGC EL K LFPG L+L EL G P
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS-PS----------- 229
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
++DL F E KA ++ I ++ S P +P + DLL+K+ V
Sbjct: 230 --EEDLGFIRNE------KA-RRYIRSLPYTPRQSFARLFPHANPLAI----DLLEKMLV 276
Query: 867 LDPEKRMTVAQALTHPFIS 885
DP KR+TV +AL HP+++
Sbjct: 277 FDPSKRITVEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 6e-33
Identities = 82/333 (24%), Positives = 131/333 (39%), Gaps = 71/333 (21%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKKL 624
Y + G+G F V A+D K VA+K++ + + E+QIL L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRK-------LVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQ 683
+ + ++ F+ L LV E + +L ++LKK GR L + Q
Sbjct: 55 N-----HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN--------EITPYL 735
+ AL++L + G++H DIKP+N+L++ V+KL DFG A + +
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169
Query: 736 VSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
+ Y APE++LGL DIWS+G LYEL TG F G N+
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ------- 222
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
T K I ++ + SP
Sbjct: 223 ------------------------------TLKIILELPTPSLASPL------SPSNPEL 246
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ DLL K+ DP+ R++ + L+H ++
Sbjct: 247 ISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 92/326 (28%), Positives = 148/326 (45%), Gaps = 51/326 (15%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLA 625
YE A G+G + TV +A+DL G VA+K +R + E + + E+ +LK+L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGR----FVALKKVRVPLSEEGIPLSTLREIALLKQL- 55
Query: 626 GADPENKRHCIRFAS-SFKYRNH----LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+ + +R R L LVFE + +L L K + GL ++
Sbjct: 56 --ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKP-GLPPETIKDL 112
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYLVSRF 739
+QL + L + ++H D+KP N+LV V K+ DFG A +T +V+ +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV-KIADFGLARIYSFEMALTSVVVTLW 171
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
YRAPE++L Y P+D+WSVGC EL+ + LF G + D L ++ G P
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIG-LP----- 225
Query: 800 KGAFTDQHFDQDLNFHATEED-PVTKKAIKKIIF-NIKPKDIGSIVTASPGEDPKMLANF 857
+EE+ P ++ + F + P+ S V P++
Sbjct: 226 -----------------SEEEWPRN-VSLPRSSFPSYTPRSFKSFV-------PEICEEG 260
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
DLL K+ +P KR++ +AL HP+
Sbjct: 261 LDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 86/318 (27%), Positives = 132/318 (41%), Gaps = 83/318 (26%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLAGADPENKRH 634
GKG F V +A+ + G +EVAIK+I+ ++ + E+QILKK +H
Sbjct: 9 GKGGFGEVYKARHKRTG----KEVAIKVIKLESKEKKEKIINEIQILKKC--------KH 56
Query: 635 --CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+++ S+ ++ L +V E + L+++LK + L + + K+L L+
Sbjct: 57 PNIVKYYGSYLKKDELWIVME--FCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLE 112
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR----FYRAPEI 745
+L + G++H DIK N+L+ +KL DFG + + T + ++ APE+
Sbjct: 113 YLHSNGIIHRDIKAANILLTS-DGEVKLIDFG---LSAQLSDTKARNTMVGTPYWMAPEV 168
Query: 746 ILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805
I G PYD+ DIWS+G EL GK P+
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKP-------------------PYS----------- 198
Query: 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865
+L KA+ KI N P K FKD L K
Sbjct: 199 -----ELPPM---------KALFKIATNGPPGLR---------NPEKWSDEFKDFLKKCL 235
Query: 866 VLDPEKRMTVAQALTHPF 883
+PEKR T Q L HPF
Sbjct: 236 QKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 99/323 (30%), Positives = 150/323 (46%), Gaps = 40/323 (12%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLA 625
YE G+G + V +A+D G VA+K R + E + E+ +L+ L+
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGK----LVALKKTRLEMDEEGIPPTALREISLLQMLS 58
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL--TAVRAYAKQ 683
+ + + + L LVFE L +L++ + GR G L ++++ Q
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYR 741
L + H GV+H D+KP N+LV++ K +LK+ D G A T +V+ +YR
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 742 APEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800
APE++LG Y P+DIWSVGC E+ + LFPG + L LH+ F K+L
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL-LHI-----F--KLL-- 228
Query: 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
G T+Q + E P KP+D+ V P P+ L DL
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQW-----------KPQDLSRAV---PDLSPEGL----DL 270
Query: 861 LDKIFVLDPEKRMTVAQALTHPF 883
L K+ DP KR++ ALTHP+
Sbjct: 271 LQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 93/339 (27%), Positives = 152/339 (44%), Gaps = 57/339 (16%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQI 620
+ RY+ G G + V A D ++G ++VAIK I + T+ K E++I
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSG----KKVAIKKIPHAFDVPTLAKRTLRELKI 57
Query: 621 LKKLAGADPENKRH----CIR--FASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
L+ +H IR + +V + + +L ++ + L
Sbjct: 58 LRHF--------KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHS---DQPLTE 106
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--- 731
+R + QL LK++ + V+H D+KP N+LVNE L++ DFG A +
Sbjct: 107 EHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHK 165
Query: 732 ---TPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
T Y+ +R+YRAPE++L LP Y +D+WSVGC E+ + LFPG L+L +
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL 225
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ G +++L + + ++K I N+ K P
Sbjct: 226 SVLGSPSEEVLNR---------------------IGSDRVRKYIQNLPRKQPVPWSKIFP 264
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
P+ L DLL ++ DPE+R+TV QAL HPF++
Sbjct: 265 KASPEAL----DLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 102/323 (31%), Positives = 152/323 (47%), Gaps = 46/323 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
RY G G + +V A D + G E+VAIK + +E K E+ +LK +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTG----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAYAK 682
+ A S LV + +L++++ G L+ V+
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM-------GHPLSEDKVQYLVY 124
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
Q+ LK++ + G++H D+KP N+ VNE LK+ DFG A A E+T Y+V+R+YRA
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADA-EMTGYVVTRWYRA 182
Query: 743 PEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG-PFPKKMLRK 800
PE+IL + Y+ +DIWSVGC + E+ TGK LF G D L +++ G P P+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE----- 237
Query: 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
F Q L ED K IK + KD ++ PK DL
Sbjct: 238 -------FVQKL------EDKAAKSYIKSLP-KYPRKDFSTLF-------PKASPQAVDL 276
Query: 861 LDKIFVLDPEKRMTVAQALTHPF 883
L+K+ LD +KR+T +AL HP+
Sbjct: 277 LEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 89/323 (27%), Positives = 150/323 (46%), Gaps = 41/323 (12%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE A G G + TV +A+D +G VA+K +R N + + + EV +LK+L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVQTNEDGLPLSTVREVALLKRL 56
Query: 625 AGADPENKRHCIRFASSFK--YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
D N + ++ + + LVFE + +LR L K GL ++ +
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPP-GLPAETIKDLMR 115
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYR 741
Q L L ++H D+KP+N+LV V KL DFG A +++ + +TP +V+ +YR
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQV-KLADFGLARIYSCQMALTPVVVTLWYR 174
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
APE++L Y P+D+WSVGC E++ K LF G + D L +L G P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP------- 227
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
+ + +D+ P + ++ ++ P++ + LL
Sbjct: 228 ---EDDWPRDVTLPRGAFSPRGPRPVQSVV-------------------PEIEESGAQLL 265
Query: 862 DKIFVLDPEKRMTVAQALTHPFI 884
++ +P KR++ +AL HPF
Sbjct: 266 LEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 97/337 (28%), Positives = 158/337 (46%), Gaps = 58/337 (17%)
Query: 561 FGEILD--GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQT- 616
FG + + RY G G F V A+D G + VAIK I++ T A +T
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTG----QNVAIKKIMKPFSTPVLAKRTY 57
Query: 617 -EVQILKKLAGADPENKRH------CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
E+++LK L RH F S + + V E L +L +L +
Sbjct: 58 RELKLLKHL--------RHENIISLSDIFISPLE---DIYFVTELLGTDLHRLLT----S 102
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729
L+ ++ + Q+ LK++ + GV+H D+KP N+L+NE + LK+CDFG A
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD-LKICDFGLARIQ-DP 160
Query: 730 EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
++T Y+ +R+YRAPEI+L YD +DIWS GC E+ GK LFPG + + + +
Sbjct: 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
Query: 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPG 848
L G P ++ + + + + ++ ++
Sbjct: 221 LLGTPPDDVINT---------------------ICSENTLRFVQSLPKREPVPFSEKFKN 259
Query: 849 EDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
DP + DLL+K+ V DP+KR++ A+AL HP+++
Sbjct: 260 ADPSAI----DLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 88/335 (26%), Positives = 135/335 (40%), Gaps = 95/335 (28%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKK 623
+YE+ GKG F V + +G+ +K I + + A EV+ILKK
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKS--DGKL--YVLKEIDLSNMSEKEREDA-LNEVKILKK 55
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHM------NLREVLKKFGR-NIGLKLTA 676
L N + I++ SF+ + LC+V M +L + +KK +
Sbjct: 56 L------NHPNIIKYYESFEEKGKLCIV-----MEYADGGDLSQKIKKQKKEGKPFPEEQ 104
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------NAMFAGKNE 730
+ + QL +ALK+L + +LH DIKP N+ + + ++KL DFG + + K
Sbjct: 105 ILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTV 163
Query: 731 I-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
+ TPY Y +PE+ PY++ DIWS+GC LYEL T K F N L L L
Sbjct: 164 VGTPY-----YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELAL-KIL 216
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
KG +P + +L
Sbjct: 217 KGQYPP--------IPSQYSSELR------------------------------------ 232
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+L+ + DPE+R ++AQ L PFI
Sbjct: 233 ---------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-31
Identities = 104/330 (31%), Positives = 156/330 (47%), Gaps = 51/330 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILKKLA 625
RY+ + G+G + V A G +VAIK I E +T E++IL++
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTG----VKVAIKKISPFEHQTFCQRTLREIKILRRF- 60
Query: 626 GADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAYA 681
EN I SF+ N + +V E + +L +++K L+ ++ +
Sbjct: 61 --KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT------QHLSNDHIQYFL 112
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-----ITPYLV 736
Q+ LK++ + VLH D+KP N+L+N + LK+CDFG A A +T Y+
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEHDHTGFLTEYVA 171
Query: 737 SRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
+R+YRAPEI+L Y +DIWSVGC L E+ + + LFPG L L + + G P
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-PS 230
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
+ +DLN + IK + F KPK P DPK L
Sbjct: 231 Q-------------EDLN---CIISLRARNYIKSLPF--KPKV--PWNKLFPNADPKAL- 269
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
DLLDK+ +P KR+TV +AL HP++
Sbjct: 270 ---DLLDKMLTFNPHKRITVEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 88/315 (27%), Positives = 140/315 (44%), Gaps = 47/315 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G ++TV + ++ G E VA+K I E E+ ++K+L +
Sbjct: 9 GEGTYATVYKGRNRTTG----EIVALKEIHLDAEEGTPSTAIREISLMKEL--------K 56
Query: 634 H--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
H +R N L LVFE + +L++ + G L V+++ QL +
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILG- 748
VLH D+KP N+L+N+ + LKL DFG A G N + +V+ +YRAP+++LG
Sbjct: 117 HENRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 749 LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808
Y +DIWSVGC + E+ TG+ LFPG N D L + G
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT---------------- 219
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868
+ + + P K + P+D+ + P DLL ++ L+
Sbjct: 220 PTESTWPGISQLPEYKPTFPR----YPPQDLQQLF-------PHADPLGIDLLHRLLQLN 268
Query: 869 PEKRMTVAQALTHPF 883
PE R++ AL HP+
Sbjct: 269 PELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 95/315 (30%), Positives = 145/315 (46%), Gaps = 47/315 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENK 632
G+G + V +A++ G E VA+K IR + T E+ +LK+L N
Sbjct: 9 GEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKEL------NH 58
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ ++ N L LVFE LH +L++ + + G+ L +++Y QL L
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCH 117
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILGLP 750
+ VLH D+KP N+L+N +KL DFG A G T +V+ +YRAPEI+LG
Sbjct: 118 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 751 -YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQHF 808
Y +DIWS+GC E+ T + LFPG + D L R+ L P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP---------------- 220
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868
D+ + + P K + K +D +V P + + +DLL ++ D
Sbjct: 221 DEVV-WPGVTSLPDYKPSFPKWA----RQDFSKVV-------PPLDEDGRDLLSQMLHYD 268
Query: 869 PEKRMTVAQALTHPF 883
P KR++ AL HPF
Sbjct: 269 PNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 98/324 (30%), Positives = 162/324 (50%), Gaps = 43/324 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQT--EVQILKKL 624
RY+ + G G + +V A D K G VA+K + R +++ A +T E+++LK +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAYAK 682
+ A S + N + LV + +L ++K KLT V+
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK------CQKLTDDHVQFLIY 127
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
Q+ LK++ + ++H D+KP N+ VNE LK+ DFG A +E+T Y+ +R+YRA
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARHT-DDEMTGYVATRWYRA 185
Query: 743 PEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
PEI+L + Y+ +DIWSVGC + EL TG+ LFPG + D L+L + L G ++L+K
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK- 244
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
++ ++ + I ++ + G +P + DLL
Sbjct: 245 --------------------ISSESARNYIQSLTQMPKMNFANVFIGANPLAV----DLL 280
Query: 862 DKIFVLDPEKRMTVAQALTHPFIS 885
+K+ VLD +KR+T AQAL H + +
Sbjct: 281 EKMLVLDSDKRITAAQALAHAYFA 304
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 88/334 (26%), Positives = 131/334 (39%), Gaps = 96/334 (28%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQ----ILKKLAGADPEN 631
KG + V AK G + AIK+I+ + + K +V IL +
Sbjct: 2 SKGAYGRVFLAKKKSTG----DIYAIKVIKKADMIRKNQVDQVLTERDILSQA------Q 51
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ ++ SF+ + +L LV E L +L +L+ G L R Y ++ +AL++
Sbjct: 52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEY 108
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-------------NAMFAGKNEI--TPYL 735
L + G++H D+KPDN+L++ + LKL DFG N I TP
Sbjct: 109 LHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD- 166
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
Y APE+ILG + +D WS+GC LYE G F H E
Sbjct: 167 ----YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF-----------HGE------- 204
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
T E +I NI I ED ++
Sbjct: 205 ---------------------TPE---------EIFQNILNGKI------EWPEDVEVSD 228
Query: 856 NFKDLLDKIFVLDPEKRM---TVAQALTHPFISG 886
DL+ K+ V DPEKR+ ++ + HPF G
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 92/328 (28%), Positives = 154/328 (46%), Gaps = 56/328 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKL 624
+YE G+G + V++ K + G + VAIK +E + K E+++LK+L
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETG----QIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
RH + F+ + L LVFE + + + L+K+ GL + VR Y
Sbjct: 58 --------RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLF 107
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF-AGKNEI-TPYLVSRFY 740
Q+ ++ + ++H DIKP+N+LV+++ V+KLCDFG A A E+ T Y+ +R+Y
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWY 166
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK--- 796
RAPE+++G Y +DIW+VGC + E+ TG+ LFPG ++ D L ++ G +
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 797 -MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
+ F + E +P+ K+ PK+
Sbjct: 227 IFQKNPLFAGMRLPE-----VKEIEPLEKRF------------------------PKLSG 257
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DL + +DP+ R + +Q L H F
Sbjct: 258 LVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 98/328 (29%), Positives = 157/328 (47%), Gaps = 40/328 (12%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
RY+ G G V A D G VA+K + N+T K E+ +LK +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLG----INVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 625 AGADPENKRHCIRFASSFKYRNHL------CLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
N ++ I + F + L LV E + NL +V+ ++ L +
Sbjct: 78 ------NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-----HMELDHERMS 126
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYLVS 737
Q+ +KHL + G++H D+KP N++V ++ LK+ DFG A A N +TPY+V+
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTACTNFMMTPYVVT 185
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
R+YRAPE+ILG+ Y +DIWSVGC + EL G V+F G + D +E G +
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ + T +++ ++ + I F D I + D +
Sbjct: 246 MNRLQPTVRNYVEN------------RPQYPGISFEELFPDW--IFPSESERDKLKTSQA 291
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+DLL K+ V+DP+KR++V +AL HP+I+
Sbjct: 292 RDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 88/346 (25%), Positives = 143/346 (41%), Gaps = 72/346 (20%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAG-----QTEVQI 620
YE+ G+G F V +A+ +K G VA+K I+ +NE K G E++I
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTG----RVVALKKILMHNE---KDGFPITALREIKI 60
Query: 621 LKKLAGADPENKRHCIRFA------SSFKYRNHLC--LVFESLHMNLREVLKKFGRNIGL 672
LKKL + + R +V + +L +L+ ++ L
Sbjct: 61 LKKL------KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKL 112
Query: 673 KLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG----------- 721
+ ++ Y QL + +L +LH DIK N+L++ + +LK+ DFG
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPN 171
Query: 722 --NAMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGAT 778
G + T +V+R+YR PE++LG Y +DIW +GC E++T + + G +
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEED-PVTKKAIKKIIFNIKPK 837
+ D L L +L G TEE P + +
Sbjct: 232 DIDQLHLIFKLCGT-----------------------PTEETWPGWRSLPGCEGVHSFTN 268
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
++ P+ L DLL K+ LDP KR+T + AL HP+
Sbjct: 269 YPRTLEERFGKLGPEGL----DLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 98/325 (30%), Positives = 149/325 (45%), Gaps = 50/325 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE G+G + V +A+D + N E +A+K IR +E + E+ +LK++
Sbjct: 3 QYEKVEKIGEGTYGVVYKARD-RVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEM 58
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK---FGRNIGLKLTAVRAYA 681
+ +R L LVFE L ++L++ + F +N ++ Y
Sbjct: 59 ------QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN----PRLIKTYL 108
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRF 739
Q+ + + + VLH D+KP N+L++ N LKL DFG A G T +V+ +
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168
Query: 740 YRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
YRAPEI+LG Y P+DIWSVGC E+ K LFPG + D L + G P +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEET 227
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
G + + K A K PKD+ ++V P +P +
Sbjct: 228 WPGVTSLPDY---------------KSAFPK----WPPKDLATVV---PTLEPAGV---- 261
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPF 883
DLL K+ LDP KR+T AL H +
Sbjct: 262 DLLSKMLRLDPSKRITARAALEHEY 286
|
Length = 294 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 97/324 (29%), Positives = 154/324 (47%), Gaps = 43/324 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
RY G G + TV A D + G +VAIK + +E K E+++LK +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLK--KFGRNIGLKLTAVRAYAK 682
+ S + LV + +L +++K K + ++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSED------RIQFLVY 125
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
Q+ LK++ G++H D+KP N+ VNE LK+ DFG A +E+T Y+V+R+YRA
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQT-DSEMTGYVVTRWYRA 183
Query: 743 PEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
PE+IL + Y +DIWSVGC + E+ TGK LF G + D L M++ G K+ ++K
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
D K +KK+ + KD S++ P +P + ++L
Sbjct: 244 QSED-----------------AKNYVKKLP-RFRKKDFRSLL---PNANPLAV----NVL 278
Query: 862 DKIFVLDPEKRMTVAQALTHPFIS 885
+K+ VLD E R+T A+AL HP+
Sbjct: 279 EKMLVLDAESRITAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 98/329 (29%), Positives = 149/329 (45%), Gaps = 44/329 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN-ETMNKAGQT--EVQILKKL 624
RY++ GKG + V A D G E+VAIK I + E ++ A + E+++L+ L
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKINDVFEHVSDATRILREIKLLRLL 56
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
D +H I S + + +VFE + +L +V+K N L + + QL
Sbjct: 57 RHPDIVEIKH-IMLPPSRREFKDIYVVFELMESDLHQVIKA---NDDLTPEHHQFFLYQL 112
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA---GKNEI--TPYLVSRF 739
ALK++ V H D+KP N+L N A LK+CDFG A A I T Y+ +R+
Sbjct: 113 LRALKYIHTANVFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 740 YRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
YRAPE+ Y +DIWS+GC E+ TGK LFPG L L +L G +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ + V + ++ + +++ K P DP L
Sbjct: 232 ISR---------------------VRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL--- 267
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFISG 886
LL+++ DP+ R T +AL P+ G
Sbjct: 268 -RLLERLLAFDPKDRPTAEEALADPYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 85/362 (23%), Positives = 145/362 (40%), Gaps = 122/362 (33%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKI------IRNNETMNK 612
++FG+I+ G+G FSTVV AK+ + +E AIKI I+ K
Sbjct: 3 FKFGKII----------GEGSFSTVVLAKEKETN----KEYAIKILDKRQLIK----EKK 44
Query: 613 AGQ--TEVQILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFG 667
E ++L +L G H I+ +F+ +L V E + L + ++K+G
Sbjct: 45 VKYVKIEKEVLTRLNG-------HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG 97
Query: 668 RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727
L R YA ++ +AL++L + G++H D+KP+N+L+++ +K+ DFG A
Sbjct: 98 S---LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK-DMHIKITDFGTAKVLD 153
Query: 728 KNEIT--------------PYLVSRF--------YRAPEIILGLPYDHPLDIWSVGCCLY 765
N RF Y +PE++ P D+W++GC +Y
Sbjct: 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIY 213
Query: 766 ELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKK 825
++ TGK F G+ + +T +
Sbjct: 214 QMLTGKPPFRGSN-----------------------------------------EYLTFQ 232
Query: 826 AIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----AQALTH 881
I K+ ++ P + KDL++K+ VLDP+ R+ V + H
Sbjct: 233 KILKLEYSF---------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277
Query: 882 PF 883
PF
Sbjct: 278 PF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 82/238 (34%), Positives = 131/238 (55%), Gaps = 23/238 (9%)
Query: 650 LVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709
LV E + NL +V++ + L + Q+ +KHL + G++H D+KP N++V
Sbjct: 99 LVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV- 152
Query: 710 EAKNVLKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY 768
++ LK+ DFG A AG + +TPY+V+R+YRAPE+ILG+ Y +DIWSVGC + E+
Sbjct: 153 KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
K+LFPG D +E G + ++K T +++ ++ +A P K
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFP---KLFP 269
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLAN-FKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+F P D E K+ A+ +DLL K+ V+DP KR++V +AL HP+I+
Sbjct: 270 DSLF---PAD---------SEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 99/315 (31%), Positives = 146/315 (46%), Gaps = 47/315 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
G+G + V +A+D G E VA+K IR +E + E+ +LK+L N
Sbjct: 8 GEGTYGVVYKARDKLTG----EIVALKKIRLETEDEGVPSTAIREISLLKEL------NH 57
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ +R N L LVFE L ++L++ + GL +++Y QL + +
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILGLP 750
+ VLH D+KP N+L++ + LKL DFG A G T +V+ +YRAPEI+LG
Sbjct: 117 SHRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175
Query: 751 -YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQHF 808
Y P+DIWS+GC E+ + LFPG + D L R+ L P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP---------------- 219
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868
D+D + P K K +D+ +V P D L DLL K+ V D
Sbjct: 220 DED-VWPGVTSLPDYKPTFPK----WARQDLSKVV---PNLDEDGL----DLLSKMLVYD 267
Query: 869 PEKRMTVAQALTHPF 883
P KR++ AL HP+
Sbjct: 268 PAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 20/202 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENK 632
G+G F V + +L+ G + VAIK I + +A ++ E+ +LK L
Sbjct: 9 GRGAFGVVYKGLNLETG----DFVAIKQISLEKIKEEALKSIMQEIDLLKNL------KH 58
Query: 633 RHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+ +++ S + + L ++ E + + +LR+++KKFG L AV Y Q+ L +L
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAV--YVYQVLQGLAYL 115
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--SRFYRAPEIILGL 749
GV+H DIK N+L + V KL DFG A V + ++ APE+I
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVV-KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174
Query: 750 PYDHPLDIWSVGCCLYELYTGK 771
DIWS+GC + EL TG
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 74/205 (36%), Positives = 118/205 (57%), Gaps = 18/205 (8%)
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYLVSRFYR 741
Q+ +KHL + G++H D+KP N++V ++ LK+ DFG A AG + +TPY+V+R+YR
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV-KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 192
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
APE+ILG+ Y +DIWSVGC + E+ G VLFPG + D +E G + ++K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN-FKDL 860
T + + ++ +A +K ++F P D E K+ A+ +DL
Sbjct: 253 QPTVRTYVENRPKYAGYS---FEKLFPDVLF---PAD---------SEHNKLKASQARDL 297
Query: 861 LDKIFVLDPEKRMTVAQALTHPFIS 885
L K+ V+D KR++V +AL HP+I+
Sbjct: 298 LSKMLVIDASKRISVDEALQHPYIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 99/323 (30%), Positives = 164/323 (50%), Gaps = 41/323 (12%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQT--EVQILKKL 624
RY+ G G + +V A D + ++VA+K + R +++ A +T E+++LK +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRL----RQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ A+S + N + LV + +L ++K + L V+ QL
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-CQK---LSDEHVQFLIYQL 127
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPE 744
LK++ + G++H D+KP N+ VNE L++ DFG A A +E+T Y+ +R+YRAPE
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQA-DDEMTGYVATRWYRAPE 185
Query: 745 IILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG-PFPKKMLRKGA 802
I+L + Y+ +DIWSVGC + EL GK LFPG D L+ ME+ G P P+ + + +
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLD 862
+ + Q L + ++ +KKI P I DLL+
Sbjct: 246 EHARKYIQSL-------PHMPQQDLKKIFRGANPLAI-------------------DLLE 279
Query: 863 KIFVLDPEKRMTVAQALTHPFIS 885
K+ VLD +KR++ ++AL HP+ S
Sbjct: 280 KMLVLDSDKRISASEALAHPYFS 302
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 29/233 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
GKG F V+ + G A+K+++ + + + TE IL ++
Sbjct: 2 GKGSFGKVLLVRKKDTGK----LYAMKVLKKKKIIKRKEVEHTLTERNILSRI------- 50
Query: 632 KRH--CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFI 686
H ++ +F+ L LV E + L L K GR R YA ++ +
Sbjct: 51 -NHPFIVKLHYAFQTEEKLYLVLE--YAPGGELFSHLSKEGR---FSEERARFYAAEIVL 104
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRFYRAPE 744
AL++L + G+++ D+KP+N+L++ + +KL DFG A + + + + + Y APE
Sbjct: 105 ALEYLHSLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
++LG Y +D WS+G LYE+ TGK F ++ ++ FP+ +
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 96/318 (30%), Positives = 146/318 (45%), Gaps = 52/318 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
G+G + V + ++ K G + VA+K IR E + E+ +LK+L
Sbjct: 9 GEGTYGVVYKGRNKKTG----QIVAMKKIRLESEEEGVPSTAIREISLLKEL------QH 58
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ + + L L+FE L M+L++ L + + V++Y Q+ +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILGLP 750
+ VLH D+KP N+L++ K V+KL DFG A G T +V+ +YRAPE++LG P
Sbjct: 119 SRRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 751 -YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQHF 808
Y P+DIWS+G E+ T K LF G + D L R+ L P
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP---------------- 221
Query: 809 DQDLNFHATEED--PVTKKAIKKIIFNIKPK-DIGSIVTASPGEDPKMLANFKDLLDKIF 865
TE+ VT K F PK GS+ +A D L DLL+K+
Sbjct: 222 --------TEDVWPGVTSLPDYKNTF---PKWKKGSLRSAVKNLDEDGL----DLLEKML 266
Query: 866 VLDPEKRMTVAQALTHPF 883
+ DP KR++ +AL HP+
Sbjct: 267 IYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 88/326 (26%), Positives = 139/326 (42%), Gaps = 67/326 (20%)
Query: 578 GVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENKRH 634
G + V RA+D K G E VA+K ++ + T E+ IL KL +H
Sbjct: 16 GTYGVVYRARDKKTG----EIVALKKLKMEKEKEGFPITSLREINILLKL--------QH 63
Query: 635 ----CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
++ + + +V E + +L+ +++ + + V+ QL + H
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQP--FLQSEVKCLMLQLLSGVAH 121
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN--EITPYLVSRFYRAPEIILG 748
L + +LH D+K N+L+N + +LK+CDFG A G T +V+ +YRAPE++LG
Sbjct: 122 LHDNWILHRDLKTSNLLLNN-RGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG 180
Query: 749 LP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQ 806
Y +D+WSVGC EL T K LFPG + D L ++ L P
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP-------------- 226
Query: 807 HFDQDLNFHATEE---DPVTKKAIKKIIFNIKP-----KDIGSIVTASPGEDPKMLANFK 858
TE+ KK F P K ++ + G
Sbjct: 227 ----------TEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNG---------F 267
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFI 884
DLL+++ DP KR++ AL HP+
Sbjct: 268 DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 88/324 (27%), Positives = 137/324 (42%), Gaps = 63/324 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNET--MNKAGQTEVQILKKLAGADPENK 632
G+G + V RA+D +G E VA+K +R +NE + + E+ +L L +
Sbjct: 16 GEGTYGIVYRARDTTSG----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 633 RHCI---RFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ + S F LV E +L +L + V+ QL L+
Sbjct: 72 KEVVVGKHLDSIF-------LVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQ 122
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIIL 747
+L ++H D+K N+L+ + K LK+ DFG A G +TP +V+ +YRAPE++L
Sbjct: 123 YLHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 748 G-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG-------PFPKKMLR 799
G Y +D+W+VGC L EL K L PG + + L L ++L G P +
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
G FT Q N N+K K P +
Sbjct: 242 VGKFTLPK--QPYN-------------------NLKHK------------FPWLSEAGLR 268
Query: 860 LLDKIFVLDPEKRMTVAQALTHPF 883
LL+ + + DP+KR T +AL +
Sbjct: 269 LLNFLLMYDPKKRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 86/328 (26%), Positives = 150/328 (45%), Gaps = 56/328 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKL 624
+YE + G+G + V + ++ + G + VAIK +E + K E+++LK+L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETG----QIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+H + F+ + L LVFE + L+K R G+ ++
Sbjct: 58 --------KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIW 107
Query: 683 QLFIALK--HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF--AGKNEITPYLVSR 738
Q A+ H NC +H D+KP+N+L+ + +KLCDFG A ++ T Y+ +R
Sbjct: 108 QTLQAVNFCHKHNC--IHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 739 FYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF-PKK 796
+YRAPE+++G Y P+D+W++GC EL TG+ L+PG ++ D L L + G P+
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 797 MLRKGAFTDQHFDQDLNFHA-TEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
Q F + F + +P T++ ++ NI +
Sbjct: 225 Q--------QIFSTNQFFKGLSIPEPETREPLESKFPNISSPAL---------------- 260
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPF 883
L +DP +R++ + L HP+
Sbjct: 261 ---SFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 88/352 (25%), Positives = 142/352 (40%), Gaps = 79/352 (22%)
Query: 565 LDGRYEVTAAH-GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT------- 616
+ RY AH G+G + V +A D G + VAIK ++ E N +
Sbjct: 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTG----KIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 617 --------EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR 668
E++I+ ++ + + + + + LV + + +L++V R
Sbjct: 62 GIHFTTLRELKIMNEI------KHENIMGLVDVYVEGDFINLVMDIMASDLKKV---VDR 112
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------N 722
I L + V+ Q+ L L +H D+ P N+ +N K + K+ DFG
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS-KGICKIADFGLARRYGY 171
Query: 723 AMFAG----------KNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGK 771
++ + E+T +V+ +YRAPE+++G Y +D+WSVGC EL TGK
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
Query: 772 VLFPGATNNDMLRLHMELKG-PFPKKMLRKGAFTDQHFDQDLNFHA-TEEDPVTKKAIKK 829
LFPG D L EL G P + ++ Q TE P K +K
Sbjct: 232 PLFPGENEIDQLGRIFELLGTP-----------NEDNWPQAKKLPLYTEFTPRKPKDLKT 280
Query: 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881
I N I DLL + L+P +R++ +AL H
Sbjct: 281 IFPNASDDAI-------------------DLLQSLLKLNPLERISAKEALKH 313
|
Length = 335 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 91/317 (28%), Positives = 143/317 (45%), Gaps = 52/317 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G ++TV + + N VA+K IR + E EV +LK L A+
Sbjct: 15 GEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
I S L LVFE L +L++ L G +I + V+ + QL L +
Sbjct: 71 DIIHTEKS------LTLVFEYLDKDLKQYLDDCGNSINMH--NVKLFLFQLLRGLNYCHR 122
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG------KNEITPYLVSRFYRAPEIIL 747
VLH D+KP N+L+NE + LKL DFG A NE+ V+ +YR P+I+L
Sbjct: 123 RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEV----VTLWYRPPDILL 177
Query: 748 G-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
G Y +D+W VGC YE+ TG+ LFPG+T + L + G P + G +++
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT-PTEETWPGILSNE 236
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
F + N+ D + A P++ ++ +LL K+
Sbjct: 237 EF-KSYNYPKYRADCLHNHA------------------------PRLDSDGAELLSKLLQ 271
Query: 867 LDPEKRMTVAQALTHPF 883
+ KR++ +A+ HP+
Sbjct: 272 FEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 9e-24
Identities = 91/317 (28%), Positives = 142/317 (44%), Gaps = 52/317 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G ++TV + + N VA+K IR + E EV +LK L A+
Sbjct: 14 GEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
I L LVFE L +L++ L G N+ + + V+ + QL L +
Sbjct: 70 DIIHTERC------LTLVFEYLDSDLKQYLDNCG-NL-MSMHNVKIFMFQLLRGLSYCHK 121
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG------KNEITPYLVSRFYRAPEIIL 747
+LH D+KP N+L+NE K LKL DFG A NE+ V+ +YR P+++L
Sbjct: 122 RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEV----VTLWYRPPDVLL 176
Query: 748 G-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
G Y P+D+W VGC LYE+ TG+ +FPG+T + L L L G P + G +++
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGT-PTEETWPGITSNE 235
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
F + F P+ A P++ + DLL + +
Sbjct: 236 EF-RSYLFPQYRAQPLINHA------------------------PRLDTDGIDLLSSLLL 270
Query: 867 LDPEKRMTVAQALTHPF 883
+ + R++ AL H +
Sbjct: 271 YETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM---FAGKNEITP 733
V+ + Q+ LK+L + G+LH DIKP N+LVN + VLK+CDFG A +T
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQ 163
Query: 734 YLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
+V+++YRAPEI++G Y +DIWSVGC EL ++LF + L L +L G
Sbjct: 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI-KPKDIGSIVTASPGEDP 851
+ +R A E A I+ KP + + T S
Sbjct: 224 PSLEAMR---------------SACEG------ARAHILRGPHKPPSLPVLYTLSSQATH 262
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ + LL ++ V DP+KR++ A AL HP++
Sbjct: 263 EAV----HLLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 94/355 (26%), Positives = 163/355 (45%), Gaps = 50/355 (14%)
Query: 554 EGYYSYRFGEILD---GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM 610
EG++ GE +D R+++ + G+G F VV A D K E A+KI+RN
Sbjct: 113 EGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRK----RKEYCAVKIVRNVPKY 168
Query: 611 NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN-HLCLVFESLHMNLREVLKKFGRN 669
+ + E+Q ++K+ ADP ++ ++ F+ H+C+V L + + K G
Sbjct: 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGP- 227
Query: 670 IGLKLTAVRAYAKQLF---IALKHLKN-CGVLHCDIKPDNMLVNEAKNVL---------- 715
+ R A+ +F +AL + ++H D+KP+N+L+ + V+
Sbjct: 228 -----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282
Query: 716 -----KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG 770
++CD G ++ T + +R YR+PE++LGL + + D+WS+GC +YELYTG
Sbjct: 283 DPCRVRICDLGGCC-DERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 771 KVLFPGATNNDMLRLHMELKGPFPKK-MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKK 829
K+L+ N + L L + G P + R G TEE + + +
Sbjct: 342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCG---------------TEEARLLYNSAGQ 386
Query: 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ PK + I A P + DL+ + D +KR+ Q THP++
Sbjct: 387 LRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 96/324 (29%), Positives = 149/324 (45%), Gaps = 44/324 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE A G+G + V +A+DLK G VA+K +R E M + EV +L+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 625 AGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+ N + + S L LVFE + +L L K G+ ++
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMF 117
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYR 741
QL L L + V+H D+KP N+LV + + KL DFG A +++ + +T +V+ +YR
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYR 176
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
APE++L Y P+D+WSVGC E++ K LF G+++ D L +++ G P
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LP------- 228
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED--PKMLANFKD 859
EED A+ + F+ K A P E + KD
Sbjct: 229 ---------------GEEDWPRDVALPRQAFHSKS--------AQPIEKFVTDIDELGKD 265
Query: 860 LLDKIFVLDPEKRMTVAQALTHPF 883
LL K +P KR++ AL+HP+
Sbjct: 266 LLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 94/319 (29%), Positives = 143/319 (44%), Gaps = 53/319 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENK 632
G+G ++TV + + G VA+K IR A T E +LK L A+
Sbjct: 14 GEGSYATVYKGRSKLTGQ----LVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTL 68
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
I + L LVFE L +L++ + G GL + VR + QL L +
Sbjct: 69 HDIIHTKKT------LTLVFEYLDTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH 120
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG------KNEITPYLVSRFYRAPEII 746
VLH D+KP N+L++E + LKL DFG A NE+ V+ +YR P+++
Sbjct: 121 QRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSVPSKTYSNEV----VTLWYRPPDVL 175
Query: 747 LG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATN-NDMLRLHMELKGPFPKKMLRKGAFT 804
LG Y LD+W VGC YE+ TG+ LFPG+T+ D L + G P + G +
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT-PTEETWPGVSS 234
Query: 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKI 864
+ F + +F P + N P+ + GE +L K
Sbjct: 235 NPEF-KPYSFPFYPPRP---------LINHAPR----LDRIPHGE---------ELALKF 271
Query: 865 FVLDPEKRMTVAQALTHPF 883
+P+KR++ A+A+ HP+
Sbjct: 272 LQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 80/320 (25%), Positives = 130/320 (40%), Gaps = 81/320 (25%)
Query: 577 KGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCI 636
KG F +V AK G + AIK+++ ++ + K T V+ + + E +
Sbjct: 6 KGAFGSVYLAKKRSTG----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE-SPYVA 60
Query: 637 RFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
+ SF+ +++L LV E L+ + ++K G GL + Y ++ + ++ L G
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFG-------NAMFAGKNEITPYLVSRFYRAPEIILG 748
++H DIKP+N+L+++ + LKL DFG N F G TP Y APE ILG
Sbjct: 118 IIHRDIKPENLLIDQTGH-LKLTDFGLSRNGLENKKFVG----TPD-----YLAPETILG 167
Query: 749 LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808
+ D D WS+GC ++E G +P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG----------------------YPP------------- 192
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868
FHA D V NI + I P+ DL++++ +D
Sbjct: 193 -----FHAETPDAVFD--------NILSRRINWPEEVKEFCSPEA----VDLINRLLCMD 235
Query: 869 PEKRM---TVAQALTHPFIS 885
P KR+ + +HPF
Sbjct: 236 PAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 82/323 (25%), Positives = 126/323 (39%), Gaps = 81/323 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
G G F V A +L G E +A+K IR N+ K E+++L+ L N
Sbjct: 9 GGGTFGKVYTAVNLDTG----ELMAVKEIRIQDNDPKTIKEIADEMKVLELL---KHPN- 60
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+++ +R + + E E L + GR L +R Y QL L +L
Sbjct: 61 --LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI--LDEHVIRVYTLQLLEGLAYLH 116
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF--------YRAPE 744
+ G++H DIKP N+ ++ V+KL DFG A+ N T Y APE
Sbjct: 117 SHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTM--GEEVQSLAGTPAYMAPE 173
Query: 745 IILGLPYDHPL---DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
+I G DIWS+GC + E+ TGK P+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR-------------------PW-------- 206
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
+ D F +I+F++ G+ + ++ KD L
Sbjct: 207 SELDNEF--------------------QIMFHV-----GAGHKPPIPDSLQLSPEGKDFL 241
Query: 862 DKIFVLDPEKRMTVAQALTHPFI 884
D+ DP+KR T ++ L HPF+
Sbjct: 242 DRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 89/326 (27%), Positives = 144/326 (44%), Gaps = 53/326 (16%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE G+G + TV +AK+ + E VA+K +R ++E + + E+ +LK+L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL 56
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA--VRAYAK 682
++ +R L LVFE +L KK+ + + V+++
Sbjct: 57 ------KHKNIVRLYDVLHSDKKLTLVFEYCDQDL----KKYFDSCNGDIDPEIVKSFMF 106
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFY 740
QL L + VLH D+KP N+L+N+ LKL DFG A G + +V+ +Y
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWY 165
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798
R P+++ G Y +D+WS GC EL G+ LFPG +D L+ L G
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT------ 219
Query: 799 RKGAFTDQHFDQDLNFHATEED-PVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
TEE P K + + P T+ PK+ +
Sbjct: 220 -----------------PTEESWPGVSKLPDYKPYPMYPA-----TTSLVNVVPKLNSTG 257
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
+DLL + V +P +R++ +AL HP+
Sbjct: 258 RDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKK 623
+YE G+G F V L + + V IK I E M K A Q E Q+LK
Sbjct: 1 KYEKIRVVGRGAFGIV----HLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKL 55
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
L + + I + +F L +V E + L E ++K ++ L + +
Sbjct: 56 L------SHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFV 108
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEITPYLVSRFYR 741
Q+ +AL H+ +LH D+K N+L+++ K V+K+ DFG + + + K++ + + Y
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYI 168
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
+PE+ G PY+ DIW++GC LYEL + K F A
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 87/346 (25%), Positives = 149/346 (43%), Gaps = 69/346 (19%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQTEVQILKK 623
L RY G G V A D + VA+K I+ + K E++I+++
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCD----KRVAVKKIVLTDPQSVKHALREIKIIRR 58
Query: 624 LAGAD---------PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
L + P S + + + +V E + +L VL++ G L
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQ-GP---LSE 113
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-----FAGKN 729
R + QL LK++ + VLH D+KP N+ +N VLK+ DFG A ++ K
Sbjct: 114 EHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 730 EITPYLVSRFYRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
++ LV+++YR+P ++L P Y +D+W+ GC E+ TGK LF GA +++ ++ +
Sbjct: 174 YLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA--HELEQMQL 230
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIG------- 840
L E PV ++ + + N+ P +
Sbjct: 231 IL----------------------------ESVPVVREEDRNELLNVIPSFVRNDGGEPR 262
Query: 841 -SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ PG +P+ L D L++I +P R+T +AL HP++S
Sbjct: 263 RPLRDLLPGVNPEAL----DFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 92/336 (27%), Positives = 142/336 (42%), Gaps = 55/336 (16%)
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAG-----QTEVQ 619
+YE A G+G F V +A+ K + VA+K + NE K G E++
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTK----QIVALKKVLMENE---KEGFPITALREIK 63
Query: 620 ILKKLAGADPENKRHCIRFASSF-----KYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
IL+ L EN + I + +Y+ LVFE +L +L +N+ L
Sbjct: 64 ILQLL---KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN--KNVKFTL 118
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA------MFAGK 728
+ ++ K L L ++ +LH D+K N+L+ + +LKL DFG A +
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKP 177
Query: 729 NEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
N T +V+ +YR PE++LG Y P+D+W GC + E++T + G T L L
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+L G ++ L E P +K K KD ++
Sbjct: 238 QLCGSITPEVWPGV--------DKLELFKKMELPQGQKRKVKERLKPYVKDPHAL----- 284
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DL+DK+ VLDP KR+ AL H F
Sbjct: 285 -----------DLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 96/340 (28%), Positives = 141/340 (41%), Gaps = 70/340 (20%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLA 625
+++ G+G + V +A+D G E VA+K +R E E++IL++L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTG----ELVALKKVRLDNEKEGFPITAIREIKILRQL- 63
Query: 626 GADPENKRHCIRF---------ASSFKYRN-HLCLVFESLHMNLREVLKK----FGRNIG 671
N R+ + A FK LVFE + +L +L+ F +
Sbjct: 64 -----NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-- 116
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI 731
++++ KQL L + LH DIK N+L+N K +KL DFG A E
Sbjct: 117 ----HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEES 171
Query: 732 TPY---LVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
PY +++ +YR PE++LG Y +D+WS GC L EL+T K +F L L
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231
Query: 788 ELKG-PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN-IKPKDIGSIVTA 845
L G P P V IK FN +KPK
Sbjct: 232 RLCGSPCPA--------------------------VWPDVIKLPYFNTMKPK---KQYRR 262
Query: 846 SPGEDPKML-ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
E+ + DLLD + LDP KR T +AL P++
Sbjct: 263 RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-20
Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 36/242 (14%)
Query: 648 LCLVFESLHMNLREVLKKFGRN-IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNM 706
L +V E + + + +K + RN L L V+ Y+ QL AL ++ + + H D+KP N+
Sbjct: 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNL 201
Query: 707 LVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCC 763
L++ + LKLCDFG+A + AG+ ++ Y+ SRFYRAPE++LG Y +D+WS+GC
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRFYRAPELMLGATNYTTHIDLWSLGCI 260
Query: 764 LYELYTGKVLFPGATNNDML-RLHMELKGPFPKKM-LRKGAFTDQHFDQDLNFHATEEDP 821
+ E+ G +F G ++ D L R+ L P ++ + D F
Sbjct: 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFP------------ 308
Query: 822 VTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881
++KPKD+ + P P NF + + +P KR+ +AL
Sbjct: 309 -----------DVKPKDLKKVF---PKGTPDDAINF---ISQFLKYEPLKRLNPIEALAD 351
Query: 882 PF 883
PF
Sbjct: 352 PF 353
|
Length = 440 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 20/233 (8%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKK 623
++V GKG + +V + K L + A+K + + +M++ + E++IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDN----QFYALKEV-DLGSMSQKEREDAVNEIRILAS 55
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGL-KLTAVRAYA 681
+ N + I + +F N LC+V E +L + + K + L +
Sbjct: 56 V------NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR 741
QL L+ L +LH D+K N+L+ A +++K+ D G + KN + + Y
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYM 168
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
APE+ G PY + DIWS+GC LYE+ T F + D LR + +G +P
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LRYKV-QRGKYP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 33/216 (15%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQ---TEVQILK 622
G +++ GKG FS V +A L G VA+K ++ E M+ KA Q E+ +LK
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGR----VVALKKVQIFEMMDAKARQDCLKEIDLLK 57
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKF---GRNIGLKLTAVR 678
+L + + I++ +SF N L +V E +L ++K F R I + +
Sbjct: 58 QL------DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TIW 109
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-------NAMFAGKNEI 731
Y QL AL+H+ + ++H DIKP N+ + A V+KL D G A
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYEL 767
TPY Y +PE I Y+ DIWS+GC LYE+
Sbjct: 169 TPY-----YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 77/318 (24%), Positives = 124/318 (38%), Gaps = 82/318 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G + +V +A + G + VAIK++ E + E+ ILK+ + +
Sbjct: 12 GEGSYGSVYKAIHKETG----QVVAIKVVPVEED-LQEIIKEISILKQ------CDSPYI 60
Query: 636 IRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+++ S+ L +V E + +++K N L + A Q L++L +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEI--TPYLVSRFYRAPEIIL 747
+H DIK N+L+NE KL DFG A +N + TP+ + APE+I
Sbjct: 119 KKIHRDIKAGNILLNEEGQA-KLADFGVSGQLTDTMAKRNTVIGTPF-----WMAPEVIQ 172
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807
+ Y++ DIWS+G E+ E K P+
Sbjct: 173 EIGYNNKADIWSLGITAIEM-------------------AEGKPPY-------------- 199
Query: 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA-NFKDLLDKIFV 866
+ H +AI I P DP+ + F D + K V
Sbjct: 200 ----SDIHPM-------RAIFMIPNKPPPT----------LSDPEKWSPEFNDFVKKCLV 238
Query: 867 LDPEKRMTVAQALTHPFI 884
DPE+R + Q L HPFI
Sbjct: 239 KDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 635 CIRFASSFKYRNHLCLVFES-LHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
++ +FK + ++ ++ E L L +L+ G R Y + +A ++L N
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFEYLHN 111
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV-SRFYRAPEIILGLPYD 752
G+++ D+KP+N+L++ +KL DFG A + T + Y APEIIL YD
Sbjct: 112 RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 753 HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG----PFPKKMLRKG 801
+D WS+G LYEL TG+ F + M + LKG FP + +
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAA 223
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 87/313 (27%), Positives = 142/313 (45%), Gaps = 44/313 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G ++TV + + N VA+K IR + E EV +LK L A+
Sbjct: 15 GEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ S L LVFE L +L++ + G NI + + V+ + Q+ L +
Sbjct: 71 DIVHTDKS------LTLVFEYLDKDLKQYMDDCG-NI-MSMHNVKIFLYQILRGLAYCHR 122
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGLP- 750
VLH D+KP N+L+NE + LKL DFG A + +V+ +YR P+++LG
Sbjct: 123 RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 751 YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQ 810
Y +D+W VGC +E+ +G+ LFPG+T D L L L G P + G ++ F +
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT-PTEETWPGISSNDEF-K 239
Query: 811 DLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870
+ NF + P+ A P++ +LL K + +
Sbjct: 240 NYNFPKYKPQPLINHA------------------------PRLDTEGIELLTKFLQYESK 275
Query: 871 KRMTVAQALTHPF 883
KR++ +A+ H +
Sbjct: 276 KRISAEEAMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIK---IIRNNETMNKAGQT---EVQILKKLAGADP 629
G G F +V +L G + A+K + + +T +A + E+ +L KL
Sbjct: 9 GSGSFGSVYEGLNLDDG----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL----- 59
Query: 630 ENKRH--CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+H +++ + + ++L + E + +L ++LKK+G +R Y +Q+ +
Sbjct: 60 ---QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILL 113
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV-SRFYRAPEI 745
L++L + +H DIK N+LV + V+KL DFG A + S ++ APE+
Sbjct: 114 GLEYLHDRNTVHRDIKGANILV-DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
Query: 746 ILGL-PYDHPLDIWSVGCCLYELYTGK 771
I Y DIWS+GC + E+ TGK
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 77/235 (32%), Positives = 108/235 (45%), Gaps = 42/235 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN---KAGQTEVQILKKL 624
R E+ G+G + V R K + G VA+KII N +T + Q EV +L +L
Sbjct: 5 RLELI---GRGAYGAVYRGKHVPTGR----VVALKII-NLDTPDDDVSDIQREVALLSQL 56
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ P N ++ S+ L ++ E L K G I K +V +++
Sbjct: 57 RQSQPPN---ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISV--IIREV 110
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-----------MFAGKNEITP 733
+ALK++ GV+H DIK N+LV NV KLCDFG A F G TP
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNV-KLCDFGVAALLNQNSSKRSTFVG----TP 165
Query: 734 YLVSRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
Y + APE+I G YD DIWS+G +YE+ TG P ++ D R M
Sbjct: 166 Y-----WMAPEVITEGKYYDTKADIWSLGITIYEMATGN---PPYSDVDAFRAMM 212
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 42/208 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLAGADPENKRH 634
G+G V +A D G +EVAIK +R + E+ I+K +
Sbjct: 28 GEGASGEVYKATDRATG----KEVAIKKMRLRKQNKELIIN-EILIMKDC------KHPN 76
Query: 635 CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVR-AY-AKQLFIALK 689
+ + S+ + L +V E +M+ L +++ + +++ + AY +++ L+
Sbjct: 77 IVDYYDSYLVGDELWVVME--YMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLE 130
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--------KNEI--TPYLVSRF 739
+L + V+H DIK DN+L+++ +V KL DFG FA +N + TPY
Sbjct: 131 YLHSQNVIHRDIKSDNILLSKDGSV-KLADFG---FAAQLTKEKSKRNSVVGTPY----- 181
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYEL 767
+ APE+I Y +DIWS+G E+
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 77/333 (23%), Positives = 125/333 (37%), Gaps = 96/333 (28%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLA 625
+ + GKG F V +A D + + VAIK+I E ++ Q E+Q L +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTN----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC- 56
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAK 682
+ ++ SF + L ++ E + + ++LK L T + +
Sbjct: 57 -----RSPYITKYYGSFLKGSKLWIIME--YCGGGSCLDLLKP----GKLDETYIAFILR 105
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-----------MFAGKNEI 731
++ + L++L G +H DIK N+L++E +V KL DFG + F G
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDV-KLADFGVSGQLTSTMSKRNTFVG---- 160
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
TP F+ APE+I YD DIWS+G EL G
Sbjct: 161 TP-----FWMAPEVIKQSGYDEKADIWSLGITAIELAKG--------------------- 194
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
E P++ +++F I + S+ E
Sbjct: 195 ---------------------------EPPLSDLHPMRVLFLIPKNNPPSL------EGN 221
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
K FKD + DP++R + + L H FI
Sbjct: 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 29/221 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK---AGQTEVQILKKL 624
RYE+ G+G F + AK + E IK I + K A + EV +L K+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKA----KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM 56
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAYAK 682
+ + F +SF+ L +V E + + +++K+ R G+ + + ++
Sbjct: 57 KHPN------IVTFFASFQENGRLFIVME--YCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-------FAGKNEITPYL 735
Q+ + LKH+ + +LH DIK N+ +++ V KL DFG A A TPY
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY- 167
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
Y +PEI PY++ DIWS+GC LYEL T K F G
Sbjct: 168 ----YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 70/253 (27%), Positives = 103/253 (40%), Gaps = 53/253 (20%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKL 624
YEV GKG F TV + + G + + K I + M + + +EV IL++L
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDG----KILVWKEI-DYGNMTEKEKQQLVSEVNILREL 56
Query: 625 AGADPENKRHCIRFASSFKYR-NH-LCLVFE--------SLHMNLREVLKKFGRNIGLKL 674
+ +R+ R N L +V E L ++ K ++
Sbjct: 57 ------KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110
Query: 675 TAVRAYAKQLFIALKHLKNCG-----VLHCDIKPDNMLVNEAKNVLKLCDFG-------N 722
QL +AL N VLH D+KP N+ ++ NV KL DFG +
Sbjct: 111 LT------QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV-KLGDFGLAKILGHD 163
Query: 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
+ FA TPY Y +PE + + YD DIWS+GC +YEL F
Sbjct: 164 SSFAKTYVGTPY-----YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--- 215
Query: 783 LRLHMELK-GPFP 794
L+L ++K G F
Sbjct: 216 LQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKII---RNNETMNKAGQTEV--QILKKLAGADPE 630
G G FS+ +A+D+K G +A+K + RN + Q EV + K++
Sbjct: 9 GTGAFSSCYQARDVKTGT----LMAVKQVTYVRNT----SSEQEEVVEALRKEIRLMARL 60
Query: 631 NKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
N H IR + +H L E + ++ +L K+G K + Y +QL L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLS 117
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEITPYLVSRF-YRAP 743
+L ++H D+K N+L++ L++ DFG A G E L+ + AP
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYTGK 771
E++ G Y D+WSVGC + E+ T K
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 53/222 (23%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQILKKLAGADPENKR 633
G+G F V + K G + EVA+K ++ + + + E +I++KL +
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL------DHP 61
Query: 634 HCIRF---ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA-- 687
+ ++ + L +V E + +L L+K + L + ++A Q IA
Sbjct: 62 NVVKLLGVCTE---EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSD--LLSFALQ--IARG 114
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR--APE 744
+++L++ +H D+ N LV E V+K+ DFG + ++ + R APE
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ + D+WS G L+E++T G+ +PG +N ++L
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY 215
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 84/339 (24%), Positives = 127/339 (37%), Gaps = 90/339 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
G +E+ G+G + V +A+ K G + VAIKI+ E + + E IL+K +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTG----QLVAIKIMDIIEDEEEEIKEEYNILRKYS- 60
Query: 627 ADPENKRHCIRFASSFKYRNHLC------LVFE-SLHMNLREVLKKFGRNIGLKLT-AVR 678
N + F +F +N LV E ++ +++K R G +L
Sbjct: 61 ----NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-RKKGKRLKEEWI 115
Query: 679 AY-AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI----- 731
AY ++ L +L V+H DIK N+L+ + V KL DFG +A
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV-KLVDFGVSAQLDSTLGRRNTFI 174
Query: 732 -TPYLVSRFYRAPEII-----LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
TPY + APE+I YD D+WS+G EL GK P
Sbjct: 175 GTPYWM-----APEVIACDEQPDASYDARSDVWSLGITAIELADGK---P---------- 216
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845
D H P+ +A+ KI N P
Sbjct: 217 ----------------PLCDMH-------------PM--RALFKIPRNPPPT------LK 239
Query: 846 SPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
SP F D + + + + E+R + + L HPFI
Sbjct: 240 SPE---NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 85/324 (26%), Positives = 132/324 (40%), Gaps = 80/324 (24%)
Query: 576 GKGVFSTVVRAKDLKAG------NGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADP 629
G G F +V + +G E V+ +M A E+ +LK+L
Sbjct: 9 GSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL----- 63
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
+ +++ S +HL + E + ++ +L +G + T VR + +Q+ L
Sbjct: 64 -QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGL 119
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-------NAMFAGKNEITPYLV-SRFY 740
+L N G++H DIK N+LV+ K +K+ DFG N++ N P L S F+
Sbjct: 120 NYLHNRGIIHRDIKGANILVDN-KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800
APE++ Y DIWS+GC + E+ TGK H PFP
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK--------------H-----PFPD----- 214
Query: 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
Q +AI KI N P +I S +++ D
Sbjct: 215 -------CTQ-------------LQAIFKIGENASP-EIPSNISSEA----------IDF 243
Query: 861 LDKIFVLDPEKRMTVAQALTHPFI 884
L+K F +D KR T A+ L HPF+
Sbjct: 244 LEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 55/222 (24%), Positives = 106/222 (47%), Gaps = 25/222 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQILKKLAGADPENKR 633
G+G F V + G+G+ EVA+K ++ + + + E +I++KL +
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL------DHP 61
Query: 634 HCIRF---ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA-- 687
+ ++ + L +V E + +L + L+K R L L+ + ++A Q IA
Sbjct: 62 NIVKLLGVCTE---EEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQ--IARG 115
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR--APE 744
+++L++ +H D+ N LV E V+K+ DFG + ++ + R APE
Sbjct: 116 MEYLESKNFIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE 174
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ + D+WS G L+E++T G+ +PG +N ++L
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY 216
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-16
Identities = 44/205 (21%), Positives = 66/205 (32%), Gaps = 3/205 (1%)
Query: 123 TRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDL 182
R + + + + + + E AP R+ S E R R ER +
Sbjct: 80 AARAAAAARQAEQPAAEAAAAKAEAAPAARAAAAAAAEAASAPEAAQARERRERGEAARR 139
Query: 183 VRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSR 242
+ + + E ER+ RR + + E +R R +
Sbjct: 140 GAARKAGEGGEQPATEARADAAERTEEEERDERRRRGDREDRQAEAERGERGRREERGRD 199
Query: 243 DRDIHRGR---EERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDN 299
D R + R D G RR + R R R AR +D DR D
Sbjct: 200 GDDRDRRDRREQGDRREERGRRDGGDRRGRRRRRDRRDARGDDNREDRGDRDGDDGEGRG 259
Query: 300 NLERERERRRDRSRDKGRDIESDRE 324
R R RDR +G D ++RE
Sbjct: 260 GRRGRRFRDRDRRGRRGGDGGNERE 284
|
Length = 672 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 32/211 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G V + + G + A+K I +E K E++ L + P
Sbjct: 10 GQGSSGVVYKVRHKPTG----KIYALKKIHVDGDEEFRKQLLRELKTL--RSCESP---- 59
Query: 634 HCIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ ++ +F + +V E +M +L ++LKK G + + A+Q+ L +
Sbjct: 60 YVVKCYGAFYKEGEISIVLE--YMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDY 114
Query: 691 L-KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAPE 744
L ++H DIKP N+L+N V K+ DFG + E T + F Y +PE
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEV-KIADFG---ISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTGKVLFP 775
I G Y + DIWS+G L E GK FP
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK--FP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 569 YEVTAAHGKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
+E+ GKG F V V+ +D K K + N E +IL++L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL--NERRILQEL-- 57
Query: 627 ADPENKRH--CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQ 683
H + SF+ ++ LV + L +LR L + + V+ + +
Sbjct: 58 ------NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFSEEQVKFWICE 108
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYRA 742
+ +AL++L + G++H DIKPDN+L++E +V + DF A T + Y A
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHV-HITDFNIATKVTPDTLTTSTSGTPGYMA 167
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATN 779
PE++ Y +D WS+G YE GK + G +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 82/325 (25%), Positives = 141/325 (43%), Gaps = 47/325 (14%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK--AGQTEVQILKKLAG 626
YE G+G ++TV + K G + VA+K+IR E E +LK L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNG----KLVALKVIRLQEEEGTPFTAIREASLLKGLKH 62
Query: 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
A+ + + L LVFE +H +L + + K GL V+ + QL
Sbjct: 63 AN------IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPG--GLHPENVKLFLFQLLR 114
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPE 744
L ++ +LH D+KP N+L+++ LKL DFG A + + +V+ +YR P+
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGE-LKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173
Query: 745 IILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATN--NDMLRLHMELKGPFPKKMLRKG 801
++LG Y LD+W VGC E+ G FPG + + + R+ + L P + G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT--PNEDTWPG 231
Query: 802 AFTDQHFD-QDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
+ HF + ++ + ++A K+ + + + +DL
Sbjct: 232 VHSLPHFKPERFTLYSPKN---LRQAWNKLSY---------------------VNHAEDL 267
Query: 861 LDKIFVLDPEKRMTVAQALTHPFIS 885
K+ P+ R++ AL+H + S
Sbjct: 268 ASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 49/234 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G+G F V + G G +VA+K ++ + + E I+KKL
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKL-------- 58
Query: 633 RH---------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAY 680
H C + L +V E +M +L + L+K G + LK
Sbjct: 59 SHPNIVRLLGVCTQ-------GEPLYIVTE--YMPGGDLLDFLRKHGEKLTLKDLL--QM 107
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--------NAMFAGKNEIT 732
A Q+ +++L++ +H D+ N LV E V+K+ DFG +
Sbjct: 108 ALQIAKGMEYLESKNFVHRDLAARNCLVTE-NLVVKISDFGLSRDIYEDDYYRKRGGGKL 166
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
P + APE + + D+WS G L+E++T G+ +PG +N ++L L
Sbjct: 167 PI----KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEL 216
|
Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKR 633
G+G ++TV K + NG+ VA+K+I E + E +LK L A+
Sbjct: 14 GEGSYATVY--KGISRINGQ--LVALKVISMKTEEGVPFTAIREASLLKGLKHAN----- 64
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ + L VFE +H +L + + + GL VR + QL L ++
Sbjct: 65 -IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHG 121
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAPEIILG-LP 750
+LH D+KP N+L++ LKL DFG A + +V+ +YR P+++LG
Sbjct: 122 QHILHRDLKPQNLLISYLGE-LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 751 YDHPLDIWSVGCCLYELYTGKVLFPGATN 779
Y LDIW GC E+ G+ FPG ++
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 72/258 (27%), Positives = 102/258 (39%), Gaps = 56/258 (21%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G G V + G + +A+K IR NE + K E+ IL K
Sbjct: 10 GAGNSGVVSKVLHRPTG----KIMAVKTIRLEINEAIQKQILRELDILHKC--------- 56
Query: 634 HC---IRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + F +F + + E SL L+EV + I K+ A K
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA--VAVLK--- 111
Query: 686 IALKHLKNC-GVLHCDIKPDNMLVNEAKNVLKLCDFG------NAM---FAGKNEITPYL 735
L +L ++H D+KP N+LVN + KLCDFG N++ F G
Sbjct: 112 -GLTYLHEKHKIIHRDVKPSNILVNSRGQI-KLCDFGVSGQLVNSLAKTFVG-------- 161
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT---NNDMLRLHMELKGP 792
+ Y APE I G Y DIWS+G L EL TG+ +P + L + P
Sbjct: 162 -TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 793 FPKKMLRKGAFTD--QHF 808
P+ L G F+ Q F
Sbjct: 221 PPR--LPSGKFSPDFQDF 236
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
GKG + V A+DL +V I I E ++ Q E+ + L
Sbjct: 17 GKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLK------H 64
Query: 633 RHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
R+ +++ S + E SL LR K+G + + Y KQ+
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS---KWG-PLKDNEQTIIFYTKQILEG 120
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-FAGKNEITPYLVSRF-YRAPEI 745
LK+L + ++H DIK DN+LVN V+K+ DFG + AG N T Y APE+
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 746 ILGLP--YDHPLDIWSVGCCLYELYTGKVLF 774
I P Y P DIWS+GC + E+ TGK F
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/161 (34%), Positives = 77/161 (47%), Gaps = 32/161 (19%)
Query: 641 SFKYRNHLCLVFESLHMNLREVLKKFGRNIG-LKLTAVRAYAKQLFIALKHLKNCGVLHC 699
SF+ + HLC+V E + L K NIG L + R Y + +AL++L N G++H
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYGIVHR 125
Query: 700 DIKPDNMLVNEAKNVLKLCDFG----------NAMFAGKNEI------------TPYLVS 737
D+KPDN+L+ ++ KL DFG ++ G E TP
Sbjct: 126 DLKPDNLLITSMGHI-KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE--- 181
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
Y APE+IL Y P+D W++G LYE G V F G T
Sbjct: 182 --YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEP----EEVAIKIIRNNETMNKAGQTEVQILKK 623
RY + GKG F TV KD KA E +E+ + + NET+ E Q+L K
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQ--ANQEAQLLSK 58
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR 678
L + ++F +SF R+ C++ E L L E LK G+ + V
Sbjct: 59 L------DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEE-LKHTGKTLSE--NQVC 109
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI-TPYLV 736
+ QL + + ++ +LH D+K N+ + N+LK+ DFG + + G ++ T +
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 737 SRFYRAPEIILGLPYDHPLDIWSVGCCLYEL 767
+ +Y +PE + YD DIWS+GC LYE+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 86/349 (24%), Positives = 145/349 (41%), Gaps = 67/349 (19%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQT---EVQILKK 623
+YE+ G+G + V +AK +G+ E AIK + + E Q+ E+ +L++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGK--EYAIKKFKGDKEQYTGISQSACREIALLRE 58
Query: 624 LAGADPENKRHCIRFASSFKYRNHLC--LVFESLHMNLREVLKKFGRNIGLKLTA--VRA 679
L + + F L+F+ +L +++K + + + V++
Sbjct: 59 L------KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFG-----NAMFAGKNEI 731
Q+ + +L + VLH D+KP N+LV + V+K+ D G NA ++
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 732 TPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGA-----TNN----D 781
P +V+ +YRAPE++LG Y +DIW++GC EL T + +F G +N D
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232
Query: 782 MLRLHMELKG-------PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI 834
L E+ G P KKM +D K K +
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKM--------PEYDTL------------MKDFKTKTYPS 272
Query: 835 KPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+ + D + DLL K+ DP KR+T +AL HP+
Sbjct: 273 NS--LAKWMEKHKKPDSQGF----DLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 14/162 (8%)
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLK 673
E +IL+K+ + R + A +F+ ++ LCLV MN L+ + G G
Sbjct: 43 EKKILEKV------SSRFIVSLAYAFETKDDLCLVMTL--MNGGDLKYHIYNVGEP-GFP 93
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-FAGKNEIT 732
YA Q+ L+HL +++ D+KP+N+L+++ NV ++ D G A+ G +I
Sbjct: 94 EARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV-RISDLGLAVELKGGKKIK 152
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774
+ Y APE++ G YD +D +++GC LYE+ G+ F
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 19/235 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G + V AK G E VA+K + + K + +L +
Sbjct: 10 GQGGYGQVFLAKKKDTG----EIVALKRM-KKSLLFKLNEVR-HVLTERDILTTTKSEWL 63
Query: 636 IRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
++ +F+ +L L E + + R +L G L R Y ++F A+ L
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL 120
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV-SRFYRAPEIILGLPYDH 753
G +H D+KP+N L++ + ++ KL DFG + G +V S Y APE++ G YD
Sbjct: 121 GYIHRDLKPENFLIDASGHI-KLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 754 PLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808
+D WS+GC LYE G F G+T N+ LK + K+ L++ + D F
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLK--YWKETLQRPVYDDPRF 227
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/207 (31%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 587 KDLKAGNGEPEEVAIKIIRNNETMNK-----AGQTEV--QILKKLAGADPENKRHCIRFA 639
DL AGNG +K I M K ++ V QIL++L + + F
Sbjct: 11 SDLGAGNGGSVS-KVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 640 SSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC-GVL 697
+F N++C+ E + +L + KK G + + + A + L +L N ++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 698 HCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK--NEITPYLV-SRFYRAPEIILGLPYDHP 754
H DIKP N+LVN + KLCDFG +G+ N I V + Y +PE I G Y
Sbjct: 127 HRDIKPSNILVNSRGQI-KLCDFG---VSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 755 LDIWSVGCCLYELYTGKVLFPGATNND 781
D+WS+G + EL GK FP A +N
Sbjct: 183 SDVWSLGISIIELALGK--FPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 26/235 (11%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVA-IKIIRNNETMNKAGQTEVQILKKLAGA 627
+E+ GKG F V + ++ + + I + + N + E ++L KL
Sbjct: 2 FEILNKIGKGSFGVVFKV--VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL--- 56
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ + IR+ SF + L +V E + + +L ++LK R L V + Q+ +
Sbjct: 57 ---DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILL 112
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-------TPYLVSRF 739
L HL + +LH DIK N+ ++ NV K+ D G A N TPY
Sbjct: 113 GLAHLHSKKILHRDIKSLNLFLDAYDNV-KIGDLGVAKLLSDNTNFANTIVGTPY----- 166
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
Y +PE+ PY+ D+W++G LYE TGK P NN + ++G FP
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGK--HPFDANNQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 62/247 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKR 633
G+G F V + K LK +G+ EVA+K ++ + + K E +++KKL
Sbjct: 4 GEGAFGEVYKGK-LKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL--------G 54
Query: 634 H---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKK----FGRNIGLKLTAVR- 678
H C L LV E + +L + L+K F L+
Sbjct: 55 HPNVVRLLGVCTE-------EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 679 -AYAKQLFIA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
++A Q IA +++L + +H D+ N LV E V+K+ DFG ++ +
Sbjct: 108 LSFAIQ--IAKGMEYLASKKFVHRDLAARNCLVGE-DLVVKISDFG---------LSRDV 155
Query: 736 -VSRFYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNND 781
+YR APE + + D+WS G L+E++T G +PG +N +
Sbjct: 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
Query: 782 MLRLHME 788
+L +
Sbjct: 216 VLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 83/335 (24%), Positives = 122/335 (36%), Gaps = 89/335 (26%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKK----L 624
YE+ G G + V A L E+VAIK I + E QT V L+K +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNN----EKVAIKRI-DLEKC----QTSVDELRKEVQAM 53
Query: 625 AGADPEN--KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYA 681
+ + N K + SF + L LV L +L +++K GL +
Sbjct: 54 SQCNHPNVVKYYT-----SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI--------- 731
K++ L++L + G +H DIK N+L+ E +V K+ DFG +A A +
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV-KIADFGVSASLADGGDRTRKVRKTFV 167
Query: 732 -TPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
TP + APE++ + YD DIWS G EL TG P + M L + L
Sbjct: 168 GTPC-----WMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--PYSKYPPMKVLMLTL 220
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
+ P E KK K
Sbjct: 221 QNDPPS---------------------LETGADYKKYSK--------------------- 238
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+F+ ++ DP KR T + L H F
Sbjct: 239 ------SFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 50/281 (17%)
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLT 675
QI+++L N + + F +F + + E HM+ L +VLKK GR I +
Sbjct: 45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGR-IPENIL 101
Query: 676 AVRAYAKQLFIALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFG------NAM---F 725
+ A + L +L+ ++H D+KP N+LVN ++ +KLCDFG ++M F
Sbjct: 102 GKISIA--VLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSF 158
Query: 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
G +R Y +PE + G Y DIWS+G L E+ G+ P ++ +
Sbjct: 159 VG---------TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845
G + K + ++ H + IF + + IV
Sbjct: 210 F----GRPVSEGEAKESHR------PVSGHPPDSPRPMA------IFEL----LDYIVNE 249
Query: 846 SPGEDPKML--ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
P + P F+D +DK +P++R + + HPFI
Sbjct: 250 PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 21/218 (9%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILK 622
D +Y+ HG G TV +A L +A+K+I + T+ Q +E++IL
Sbjct: 1 QDIQYQEILGHGNG--GTVYKAYHLLTR----RILAVKVIPLDITVELQKQIMSELEILY 54
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
K + I F +F N + + E + +V +K ++ L AV A K
Sbjct: 55 KCDSP------YIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHV-LGRIAV-AVVK 106
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
L +L + +LH D+KP NMLVN V KLCDFG + + Y+ + Y A
Sbjct: 107 ----GLTYLWSLKILHRDVKPSNMLVNTRGQV-KLCDFGVSTQLVNSIAKTYVGTNAYMA 161
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
PE I G Y D+WS+G EL G+ +P N
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 88/360 (24%), Positives = 129/360 (35%), Gaps = 110/360 (30%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKK--L 624
+EV G+G F V +D G A+K++R M K Q ++ L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ----VYAMKVLRK-SDMIKRNQIAHVRAERDIL 55
Query: 625 AGADPE--NKRHCIRFASSFKYRNHLCLVFESLH----MNLREVLKKFGRNIGLKLTAVR 678
A AD K + SF+ HL LV E + MNL L + R
Sbjct: 56 ADADSPWIVKLYY-----SFQDEEHLYLVMEYMPGGDLMNL---LIRKDV---FPEETAR 104
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR 738
Y +L +AL + G +H DIKPDN+L++ A +KL DFG K + Y ++
Sbjct: 105 FYIAELVLALDSVHKLGFIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 739 F-------------------------------YRAPEIILGLPYDHPLDIWSVGCCLYEL 767
Y APE++ G PY D WS+G LYE+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 768 YTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAI 827
G FP PF L++ ++ + L F + PV+ +AI
Sbjct: 224 LYG---FP----------------PFYSDTLQETYNKIINWKESLRFPP--DPPVSPEAI 262
Query: 828 KKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA-QALTHPFISG 886
DL+ + + DPE R+ + +HPF G
Sbjct: 263 -------------------------------DLICR-LLCDPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMN--KAGQTEVQILKKLAGADP 629
G+G F V D+ G E+A+K + + ET A + E+Q+LK L
Sbjct: 11 GQGAFGRVYLCYDVDTG----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNL----- 61
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
+++R +++ + L + E + ++++ LK +G L T R Y +Q+ +
Sbjct: 62 QHER-IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGV 117
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEITPYLVSRFYRAP 743
++L + ++H DIK N+L + A NV KL DFG + + + + ++ +P
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYTGK 771
E+I G Y D+WSVGC + E+ T K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQ---TEVQILKKLAGADPEN 631
G+G FS V RA L + + VA+K ++ E M+ KA Q E+ +LK+L N
Sbjct: 11 GRGQFSEVYRATCLL----DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL------N 60
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGL-KLTAVRAYAKQLFIALK 689
+ I++ SF N L +V E +L +++K F + L V Y QL A++
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEITPYLV-SRFYRAPEIIL 747
H+ + V+H DIKP N+ + A V+KL D G F+ K LV + +Y +PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 748 GLPYDHPLDIWSVGCCLYEL 767
Y+ DIWS+GC LYE+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT----EVQILKKLAGADPEN 631
G+G FS V RA L G VA+K ++ + M+ + E+ +LK+L N
Sbjct: 11 GRGQFSEVYRATCLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQL------N 60
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGL-KLTAVRAYAKQLFIALK 689
+ I++ +SF N L +V E +L ++K F + L V Y QL AL+
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEITPYLV-SRFYRAPEIIL 747
H+ + V+H DIKP N+ + A V+KL D G F+ K LV + +Y +PE I
Sbjct: 121 HMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
Y+ DIWS+GC LYE+ + F G N
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 49/165 (29%), Positives = 88/165 (53%), Gaps = 10/165 (6%)
Query: 612 KAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNI 670
K E +IL+K+ N + A +F+ + HLCLV ++ +L+ + G
Sbjct: 38 KMALLEKEILEKV------NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-R 90
Query: 671 GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM-FAGKN 729
GL++ V Y+ Q+ + HL + +++ D+KP+N+L+++ N +L D G A+
Sbjct: 91 GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC-RLSDLGLAVELKDGK 149
Query: 730 EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774
IT + Y APEI+ PY +P+D +++GC +YE+ G+ F
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 3e-13
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 79/273 (28%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQ 619
+E G G F V+ + G+G+ A+K I++ + +N E +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHK--GSGKY--YALKILSKAKIVKLKQVEHVLN-----EKR 53
Query: 620 ILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFE--------SLHMNLREVLKKFGRN 669
IL+ + RH + SF+ ++L LV E S L+K GR
Sbjct: 54 ILQSI--------RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-------LRKSGR- 97
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729
R YA Q+ +AL++L + +++ D+KP+N+L+ ++ +K+ DFG FA +
Sbjct: 98 --FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL-DSDGYIKITDFG---FAKRV 151
Query: 730 EI-------TP-YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
+ TP YL APEIIL Y +D W++G +YE+ G F +N
Sbjct: 152 KGRTYTLCGTPEYL------APEIILSKGYGKAVDWWALGILIYEMLAGYPPF--FDDNP 203
Query: 782 MLRLHMELKG--PFPKKMLRKGAFTDQHFDQDL 812
+ L+G FP F D
Sbjct: 204 IQIYEKILEGKVRFPS-----------FFSPDA 225
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 23/233 (9%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT----EVQILKKLAGADP 629
GKG F V VR +D + A+K IR ++++ T E +L ++
Sbjct: 2 GKGSFGKVMQVRKRDTQ------RIYALKTIRKAHIVSRSEVTHTLAERTVLAQV----- 50
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
N + SF+ L LV +N E+ R L+ R Y +L AL+
Sbjct: 51 -NCPFIVPLKFSFQSPEKLYLVLA--FINGGELFHHLQREGRFDLSRARFYTAELLCALE 107
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP--YLVSRFYRAPEIIL 747
+L V++ D+KP+N+L++ ++ LCDFG K++ + + Y APE++L
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHI-ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800
G Y +D W++G LYE+ TG F N+M R ++ FP R
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRD 219
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-13
Identities = 36/116 (31%), Positives = 50/116 (43%), Gaps = 4/116 (3%)
Query: 211 ERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKE 270
+ E RE REKS+ + DR R + R + R R R R R+RS E+ R R R +
Sbjct: 2 DEEPDRE--REKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYRED-SRPRDRRRY 58
Query: 271 RDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKG 326
RS R + R R R + R + E+ R R RDRS + +
Sbjct: 59 DSRSPRSLRYSSVRRSRDRPRRRSRSVRSI-EQHRRRLRDRSPSNQWRKDDKKRSL 113
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-13
Identities = 64/229 (27%), Positives = 113/229 (49%), Gaps = 14/229 (6%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A+ G E AIKI++ + + + E +++K A P
Sbjct: 9 GKGSFGKVMLAER----KGTDELYAIKILKK-DVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 636 IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+ S F+ + L V E ++ +L +++ G+ K YA ++ I L L +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPYLVSRFYRAPEIILGLPY 751
G+++ D+K DN++++ A+ +K+ DFG +F GK T + + Y APEII PY
Sbjct: 121 GIIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIAYQPY 178
Query: 752 DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800
+D W+ G LYE+ G+ F G +++ + ME +PK + ++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKN 693
+ F SF+ HL +V E + + ++++K G + + Q+ + ++H+
Sbjct: 61 VAFKESFEADGHLYIVME--YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-------MFAGKNEITPYLVSRFYRAPEII 746
VLH DIK N+ + + V KL DFG+A +A TPY Y PEI
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKV-KLGDFGSARLLTSPGAYACTYVGTPY-----YVPPEIW 172
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLF-PGATNNDMLRLHMELKGPFP 794
+PY++ DIWS+GC LYEL T K F + N +L++ P P
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLP 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 64/234 (27%), Positives = 92/234 (39%), Gaps = 54/234 (23%)
Query: 654 SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713
SL ++V K+ GR IG K+ A+ + L +L + ++H DIKP N+L+ K
Sbjct: 87 SLDSIYKKVKKRGGR-IGEKVLG--KIAESVLKGLSYLHSRKIIHRDIKPSNILLTR-KG 142
Query: 714 VLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVL 773
+KLCDFG + + + + FY APE I G PY D+WS+G L E+ +
Sbjct: 143 QVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF- 201
Query: 774 FPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN 833
PFP E P+ + I N
Sbjct: 202 ------------------PFP---------------------PEGEPPLGPIELLSYIVN 222
Query: 834 IKP---KDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ KD PG K FKD + + DP +R T L HP+I
Sbjct: 223 MPNPELKD-------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 6/109 (5%)
Query: 683 QLFIALKHL-KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITPYLVSRFY 740
Q+ +AL++L K ++H D+ P+N+++ E V + DFG A +T + + Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT-ITDFGLAKQKQPESKLTSVVGTILY 179
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
PEI+ PY D+W+ GC LY++ T L P + +ML L ++
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT---LQPPFYSTNMLSLATKI 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 38/238 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A+ LK + E A+K+++ + + + E + +K A
Sbjct: 4 GKGSFGKVLLAE-LKGTD---ELYAVKVLKK-DVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 636 IRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ S F+ ++ L V E L +++ + R YA ++ + L+
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-------FDEPRARFYAAEIVLGLQF 111
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----------NAMFAGKNEITPYLVSRF 739
L G+++ D+K DN+L+ +++ +K+ DFG + F G TP
Sbjct: 112 LHERGIIYRDLKLDNVLL-DSEGHIKIADFGMCKEGILGGVTTSTFCG----TPD----- 161
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y APEI+ PY +D W++G LYE+ G+ F G +++ + +E + +P+ +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 14/230 (6%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A+ G E AIKI++ + + + E +++K A
Sbjct: 9 GKGSFGKVMLAER----KGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFL 63
Query: 636 IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+ S F+ + L V E ++ +L +++ GR K YA ++ I L L +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPYLVSRFYRAPEIILGLPY 751
G+++ D+K DN+++ +++ +K+ DFG M+ G T + + Y APEII PY
Sbjct: 121 GIIYRDLKLDNVML-DSEGHIKIADFGMCKENMWDGVTTKT-FCGTPDYIAPEIIAYQPY 178
Query: 752 DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
+D W+ G LYE+ G+ F G +++ + ME +PK M ++
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-12
Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 40/280 (14%)
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLT 675
QI+++L N + + F +F + + E HM+ L +VLKK GR L
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGRIPEQILG 106
Query: 676 AVR-AYAKQL-FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP 733
V A K L ++ KH ++H D+KP N+LVN ++ +KLCDFG + +
Sbjct: 107 KVSIAVIKGLTYLREKH----KIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANS 161
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM-LRLHMELKG- 791
++ +R Y +PE + G Y DIWS+G L E+ G+ P ++ L ++G
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221
Query: 792 -------PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT 844
P P+ R + ++ P+ + I N P + S V
Sbjct: 222 PAESETSPRPRPPGRPLS----------SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVF 271
Query: 845 ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
A F+D ++K + +P +R + Q + H FI
Sbjct: 272 G---------AEFQDFVNKCLIKNPAERADLKQLMVHAFI 302
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 43/232 (18%)
Query: 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQ 619
+FGE+ +G + T T V K LK G +P++ E Q
Sbjct: 18 QFGEVWEGLWNNT---------TPVAVKTLKPGTMDPKDFL---------------AEAQ 53
Query: 620 ILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFESL-HMNLREVLKKF-GRNIGLKLT 675
I+KKL RH I+ + + +V E + + +L E L+ GR LKL
Sbjct: 54 IMKKL--------RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLP 103
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
+ A Q+ + +L+ +H D+ N+LV E N+ K+ DFG A ++
Sbjct: 104 QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYEARE 162
Query: 736 VSRF---YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
++F + APE L + D+WS G L E+ T G++ +PG TN ++L
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-11
Identities = 35/205 (17%), Positives = 59/205 (28%), Gaps = 18/205 (8%)
Query: 92 RRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLK 151
++ ++ + S + +R+R R + E + +
Sbjct: 106 PAARAAAAAAAEAASAPEAAQARERRERG---EAARRGAARKAGEGGEQPATEARADAAE 162
Query: 152 RSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIE 211
R+ ERD +R R+ ER +
Sbjct: 163 RTEEEERDERRRRGDREDRQAEAERGERGRREERGRDGDD--------RDRRDRREQGDR 214
Query: 212 RERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKER 271
RE R + DR RR + + D +R E GRR + R
Sbjct: 215 REERGRRDGG-------DRRGRRRRRDRRDARGDDNREDRGDRDGDDGEGRGGRRGRRFR 267
Query: 272 DRSRDRARVNDRDMDRQRDREKDRV 296
DR R R D +R+ + +D V
Sbjct: 268 DRDRRGRRGGDGGNEREPELREDDV 292
|
Length = 672 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFG-----NA 723
L + V++ Q+ + +L VLH D+KP N+LV + +K+ D G N+
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 724 MFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
++ P +V+ +YRAPE++LG Y +DIW++GC EL T + +F +
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED-- 222
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFH---ATEEDPVTKKAIKKIIFNIKPKDI 839
++ PF L + F+ F D ++ E P +K ++ +
Sbjct: 223 ----IKTSNPFHHDQLDR-IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANS---- 273
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
S++ K + LL K+ +DP KR+T QAL P+
Sbjct: 274 -SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 78/336 (23%), Positives = 133/336 (39%), Gaps = 87/336 (25%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEV-AIKIIRNNETMNKAG-----QTEVQIL 621
R T A+GK VF +VR K G + ++ A+K+++ + KA +TE Q+L
Sbjct: 6 RVLGTGAYGK-VF--LVR----KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
+ + + +F+ L L+ + ++N E+ + + VR Y
Sbjct: 59 EAVRRCP-----FLVTLHYAFQTDTKLHLILD--YVNGGELFTHLYQREHFTESEVRVYI 111
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEITPYLVSRF- 739
++ +AL HL G+++ DIK +N+L++ +V L DFG + F + E Y F
Sbjct: 112 AEIVLALDHLHQLGIIYRDIKLENILLDSEGHV-VLTDFGLSKEFLAEEEERAY---SFC 167
Query: 740 ----YRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
Y APE+I G +D +D WS+G +EL TG PF
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG-------------------ASPF 208
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
+ + ++ I + I+ + P M
Sbjct: 209 ----------------------TVDGEQNSQSEISR-----------RILKSKPPFPKTM 235
Query: 854 LANFKDLLDKIFVLDPEKRM---TVAQALTHPFISG 886
A +D + K+ DP+KR+ + HPF G
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 44/123 (35%), Positives = 60/123 (48%), Gaps = 25/123 (20%)
Query: 687 ALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS-------- 737
AL +LK ++H D+KP N+L++ N+ KLCDFG I+ LV
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNI-KLCDFG---------ISGQLVDSIAKTRDA 168
Query: 738 --RFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
R Y APE I YD D+WS+G LYE+ TGK +P N+ +L +KG
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-WNSVFDQLTQVVKGD 227
Query: 793 FPK 795
P
Sbjct: 228 PPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 41/110 (37%), Positives = 58/110 (52%), Gaps = 14/110 (12%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----- 731
V Y Q+ A+ ++ G+LH DIK N+ + +A ++KL DFG + G
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAETV 161
Query: 732 --TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATN 779
TPY Y +PE+ G+ Y+ DIW++GC LYEL T K F ATN
Sbjct: 162 VGTPY-----YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 5e-11
Identities = 40/239 (16%), Positives = 65/239 (27%), Gaps = 14/239 (5%)
Query: 135 KERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSY 194
KE + P + R A + R + E ++ R +
Sbjct: 56 KEARGGGAAAAAATPAAPAAAARRAARAAAAARQAEQPAAEAAAAKAEAAPAARAAAAAA 115
Query: 195 TTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERD 254
E ER + ++ + R + R R
Sbjct: 116 AEAASAPEAAQARERRERGEAARRGAARKAGEGGEQPATEARADAAERTEEEERDERRRR 175
Query: 255 RSRYEEVDRGRRRE--------KE---RDRSRDRARVNDRDMDRQRDREKDRVRDNNLER 303
R + R E ++ RDR R + + R+ +RD R R +R
Sbjct: 176 GDREDRQAEAERGERGRREERGRDGDDRDRRDRREQGDRREERGRRDGGDRRGRRRRRDR 235
Query: 304 ERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDD 362
R D D+G D E + R R + R + D R+DD
Sbjct: 236 RDARGDDNREDRGDRDGDDGEGRGGRR---GRRFRDRDRRGRRGGDGGNEREPELREDD 291
|
Length = 672 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 42/218 (19%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQTEVQILKKLAG 626
YE+ G G + V +A+D+ G E VAIK+I+ + + Q E+ +LK+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATG----ELVAIKVIKLEPGDDFEIIQQEISMLKEC-- 57
Query: 627 ADPENKRHC--IRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRA 679
RH + + S+ R+ L +V E SL + L +
Sbjct: 58 ------RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT------RGPLSELQIAY 105
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEI--T 732
++ L +L G +H DIK N+L+ E +V KL DFG A A + T
Sbjct: 106 VCRETLKGLAYLHETGKIHRDIKGANILLTEDGDV-KLADFGVSAQLTATIAKRKSFIGT 164
Query: 733 PYLVSRFYRAPEII---LGLPYDHPLDIWSVGCCLYEL 767
PY + APE+ YD DIW++G EL
Sbjct: 165 PY-----WMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 38/242 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKL 624
+Y G+G F + K + G ++ IK I ++ K + EV +L +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDG----KQYVIKEINISKMSPKEREESRKEVAVLSNM 56
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFG--RNIGLKLTAVRAY 680
+H +++ SF+ +L +V + + ++ KK R + + +
Sbjct: 57 --------KHPNIVQYQESFEENGNLYIVMD--YCEGGDLYKKINAQRGVLFPEDQILDW 106
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------NAMFAGKNEI-TP 733
Q+ +ALKH+ + +LH DIK N+ + + +KL DFG + + + I TP
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTP 165
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF-PGATNNDMLRLHMELKGP 792
Y Y +PEI PY++ DIW++GC LYE+ T K F G N +L++ ++G
Sbjct: 166 Y-----YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---IRGS 217
Query: 793 FP 794
+P
Sbjct: 218 YP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 45/126 (35%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 649 CLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708
CLV +L L R +GL V A A+QL A+ ++ G++H DIK +N+LV
Sbjct: 236 CLVLPKYRSDLYTYLGARLRPLGL--AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
Query: 709 NEAKNVLKLCDFGNAMFAGKNEITPYLVSRFY--------RAPEIILGLPYDHPLDIWSV 760
N +++ L DFG A FA + TP+ Y APE++ G PY +DIWS
Sbjct: 294 NGPEDIC-LGDFGAACFARGSWSTPF----HYGIAGTVDTNAPEVLAGDPYTPSVDIWSA 348
Query: 761 GCCLYE 766
G ++E
Sbjct: 349 GLVIFE 354
|
Length = 461 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A +LK N E AIK ++ + + + +++ E+
Sbjct: 4 GKGSFGKVMLA-ELKGTN---EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 636 IRFASSFKYRNHLCLVFESLH----MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
F + F+ + HL V E L+ M + +F R YA ++ L+ L
Sbjct: 60 HLFCT-FQTKEHLFFVMEYLNGGDLMFHIQSSGRF------DEARARFYAAEIICGLQFL 112
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM--FAGKNEITPYLVSRFYRAPEIILGL 749
G+++ D+K DN+L+++ ++ K+ DFG G+ + + + + Y APEI+ G
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHI-KIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLFPG 776
Y+ +D WS G LYE+ G+ F G
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 648 LCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702
+ +V E L LRE K G L + + A+++L++ G +H D+
Sbjct: 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDM------CSDVCEAMEYLESNGFIHRDLA 127
Query: 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYDHPLDIWS 759
N LV E NV+K+ DFG A + ++ T ++F + PE+ + D+WS
Sbjct: 128 ARNCLVGE-DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWS 186
Query: 760 VGCCLYELYT-GKVLFPGATNNDML-RLHMELKGPFPK 795
G ++E+++ GK+ + +N++++ + + PK
Sbjct: 187 FGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 36/121 (29%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
V+ Y +L +AL HL + G+++ D+KP+N+L++E ++ KL DFG + + +E Y
Sbjct: 100 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKKAYSF 158
Query: 737 --SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
+ Y APE++ + D WS G ++E+ TG + F G + + + ++ K P
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
Query: 795 K 795
+
Sbjct: 219 Q 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 30/203 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQ----ILKKLAGADPEN 631
G G F V A+D++ E VAIK M+ +G+ + I+K++
Sbjct: 24 GHGSFGAVYFARDVRTN----EVVAIK------KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 632 KRHCIRFASSFKYRNHLC-LVFE---SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+ I + + R H LV E ++ EV KK L+ + A
Sbjct: 74 HPNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQG 127
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIIL 747
L +L + +H DIK N+L+ E V KL DFG+A + + ++ + ++ APE+IL
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTV-KLADFGSA--SLVSPANSFVGTPYWMAPEVIL 184
Query: 748 GL---PYDHPLDIWSVGCCLYEL 767
+ YD +D+WS+G EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 12/211 (5%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A +LK G+ E A+K ++ + + + K++ EN
Sbjct: 4 GKGSFGKVLLA-ELK---GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP-FL 58
Query: 636 IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+F+ + HL V E L+ +L ++ GR L YA ++ L+ L +
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSK 115
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGLPYD 752
G+++ D+K DN++++ ++ K+ DFG G N + + + Y APEI+ GL Y
Sbjct: 116 GIIYRDLKLDNVMLDRDGHI-KIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 753 HPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
+D WS G LYE+ G+ F G +++
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 12/229 (5%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ A + K G E AIKI++ + + + E +++K A +
Sbjct: 9 GKGSFGKVMLA-ERK---GTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFL 63
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
+ S F+ + L V E ++N +++ + K YA ++ + L L G
Sbjct: 64 TQLHSCFQTVDRLYFVME--YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPYLVSRFYRAPEIILGLPYD 752
+++ D+K DN++++ ++ K+ DFG M G T + + Y APEII PY
Sbjct: 122 IIYRDLKLDNVMLDSEGHI-KIADFGMCKEHMVDGVTTRT-FCGTPDYIAPEIIAYQPYG 179
Query: 753 HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
+D W+ G LYE+ G+ F G +++ + ME +PK + ++
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEA 228
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 45/139 (32%), Positives = 64/139 (46%), Gaps = 30/139 (21%)
Query: 687 ALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--------- 736
AL++L V+H D+KP N+L+N V KLCDFG I+ YLV
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQV-KLCDFG---------ISGYLVDSVAKTIDA 164
Query: 737 -SRFYRAPEIILG----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELK 790
+ Y APE I YD D+WS+G + EL TG+ FP + +L ++
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVE 222
Query: 791 GPFPKKMLRKGAFTDQHFD 809
P P+ L F+ + D
Sbjct: 223 EPSPQ--LPAEKFSPEFQD 239
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 37/116 (31%), Positives = 50/116 (43%), Gaps = 11/116 (9%)
Query: 251 EERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRD 310
EE DR R E RGR R++ +R R R+R R DR R + R+++ R+R R
Sbjct: 3 EEPDRER--EKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDS 60
Query: 311 RSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHL---------KHDDDKGSYGDR 357
RS R R + + S S R +H R L + DD K S D
Sbjct: 61 RSPRSLRYSSVRRSRDRPRRRSRSVRSIEQHRRRLRDRSPSNQWRKDDKKRSLWDI 116
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFG-----NAMFAGK 728
V++ Q+ + +L VLH D+KP N+LV + +K+ D G N+
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 729 NEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
++ P +V+ +YRAPE++LG Y +DIW++GC EL T + +F + +
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED------I 223
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ P+ L + F F D ++ ++ P +K N S++
Sbjct: 224 KTSNPYHHDQLDR-IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN--CSLIKYME 280
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
K + LL K+ +DP KR+T QA+ P+
Sbjct: 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 77/329 (23%), Positives = 134/329 (40%), Gaps = 81/329 (24%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-NETMNKAGQTEVQILKKLAGA 627
+E+ G G F V +AK+ + G A K+I +E + E++IL
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYMVEIEILATC--- 66
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAKQLFI 686
N + ++ +F + L ++ E + ++ + R GL ++ +Q+
Sbjct: 67 ---NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLE 121
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT-----PYLVSRFYR 741
AL++L + ++H D+K N+L+ ++ KL DFG + KN T ++ + ++
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDI-KLADFG---VSAKNVKTLQRRDSFIGTPYWM 177
Query: 742 APEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
APE+++ PYD+ DIWS+G L E+ ++ P H EL P +
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEM--AQIEPP----------HHELN---PMR 222
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
+L K A + +P T + P K
Sbjct: 223 VLLKIA---------------KSEPPT--------------------LSQPS---KWSME 244
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
F+D L PE R + AQ L HPF+S
Sbjct: 245 FRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 39/127 (30%), Positives = 62/127 (48%), Gaps = 22/127 (17%)
Query: 658 NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717
++ +L +FG L Y KQ+ + +L N V+H DIK +N+++ ++KL
Sbjct: 88 SISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML-MPNGIIKL 143
Query: 718 CDFGNA-------MFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCL 764
DFG A + + + TPY + APE+I Y DIWS+GC +
Sbjct: 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPY-----WMAPEVINESGYGRKSDIWSIGCTV 198
Query: 765 YELYTGK 771
+E+ TGK
Sbjct: 199 FEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 72/213 (33%)
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK--NEI-------- 731
+ AL L GV+H DIK D++L+ V KL DFG F + E+
Sbjct: 122 LAVLKALSFLHAQGVIHRDIKSDSILLTSDGRV-KLSDFG---FCAQVSKEVPRRKSLVG 177
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
TPY + APE+I LPY +DIWS+G + E+ G+ P
Sbjct: 178 TPY-----WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE---P---------------- 213
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
P+ F + +A+K+I N+ PK + ++ SP
Sbjct: 214 PY---------FNEPPL----------------QAMKRIRDNLPPK-LKNLHKVSP---- 243
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ LD++ V DP +R T A+ L HPF+
Sbjct: 244 ----RLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPEN 631
GKG F V+ A+ G E AIK+++ + + TE +IL A
Sbjct: 4 GKGSFGKVMLAEL----KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
HC F+ ++ L V E ++N +++ + R+ R YA ++ +AL L
Sbjct: 60 ALHC-----CFQTKDRLFFVME--YVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGL 749
GV++ D+K DN+L+ +A+ KL DFG T + + Y APEI+ L
Sbjct: 113 HRHGVIYRDLKLDNILL-DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
Y +D W++G +YE+ G+ F +D+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/243 (24%), Positives = 116/243 (47%), Gaps = 23/243 (9%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QTEVQILKK 623
+E+ G G + V + + +G+ + A+K+++ + KA +TE Q+L+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKV-SGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQ 683
+ + +F+ L L+ + ++N E+ + K V+ Y+ +
Sbjct: 61 I-----RQSPFLVTLHYAFQTDTKLHLILD--YINGGELFTHLSQRERFKEQEVQIYSGE 113
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRF-Y 740
+ +AL+HL G+++ DIK +N+L++ +V+ L DFG + E Y
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 741 RAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFP--GATNN--DMLRLHMELKGPFP 794
AP+I+ G +D +D WS+G +YEL TG F G N+ ++ R ++ + P+P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 232
Query: 795 KKM 797
++M
Sbjct: 233 QEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 42/164 (25%), Positives = 80/164 (48%), Gaps = 6/164 (3%)
Query: 641 SFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCD 700
+F+ + +L V E ++N +++ L YA ++ L+ L + G+++ D
Sbjct: 64 TFQTKENLFFVME--YLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 701 IKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIW 758
+K DN+L++ ++ K+ DFG G + + + Y APEI+LG Y+ +D W
Sbjct: 122 LKLDNILLDTDGHI-KIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWW 180
Query: 759 SVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802
S G LYE+ G+ F G ++ + + + P + L + A
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEELFQ-SIRMDNPCYPRWLTREA 223
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 4/117 (3%)
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLV-SRFY 740
Q+ +AL++L +LH D+K N+ + N++K+ D G A + + ++ L+ + +Y
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYY 168
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK-GPFPKK 796
+PE+ PY++ D+W++GCC+YE+ T K F N ++ +E K P PK
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 52/197 (26%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ AK G + A+K+++ +N+ Q + + + +N +H
Sbjct: 4 GKGSFGKVLLAKRKLDG----KCYAVKVLQKKIVLNRKEQKHIMAERNVL---LKNVKHP 56
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
+ ++ L F +N E+ R R YA ++ AL +L +
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGLPYDH 753
+++ D+KP+N+L++ +V+ L DFG A + T + + Y APE+I PYD+
Sbjct: 117 IVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 754 PLDIWSVGCCLYELYTG 770
+D W +G LYE+ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 25/105 (23%)
Query: 687 ALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV-----SR-- 738
AL +LK GV+H D+KP N+L++ + NV KLCDFG I+ LV +R
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILLDASGNV-KLCDFG---------ISGRLVDSKAKTRSA 175
Query: 739 ---FYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFPG 776
Y APE I YD D+WS+G L EL TG+ +
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 598 EVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFES 654
+VA+K ++ TM+ E QI+KKL RH ++ + + +V E
Sbjct: 32 KVAVKTLKPG-TMSPEAFLQEAQIMKKL--------RHDKLVQLYAVCSEEEPIYIVTEY 82
Query: 655 L-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713
+ +L + LK G L+L + A Q+ + +L++ +H D+ N+LV E
Sbjct: 83 MSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE-NL 140
Query: 714 VLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYDHPLDIWSVGCCLYELYT- 769
V K+ DFG A +E T ++F + APE + D+WS G L E+ T
Sbjct: 141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200
Query: 770 GKVLFPGATNNDMLR 784
G+V +PG TN ++L
Sbjct: 201 GRVPYPGMTNREVLE 215
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 18/168 (10%)
Query: 612 KAGQ-----TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKF 666
KAGQ TE IL+ + N I+ +F Y CL+ +L L
Sbjct: 123 KAGQRGGTATEAHILRAI------NHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK 176
Query: 667 GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726
+ + + A + + A+++L ++H DIK +N+ +N +V L DFG A F
Sbjct: 177 RN---IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC-LGDFGAACFP 232
Query: 727 ---GKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
N+ + + APE++ PY +DIWS G L+E+ T
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 68/284 (23%)
Query: 612 KAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLR-EVLKKFGRN 669
+ E +IL K+ + R + A +F+ + LCLV ++ +LR + N
Sbjct: 38 EGAMVEKRILAKV------HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN 91
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAG 727
G Y Q+ L+HL +++ D+KP+N+L++ NV ++ D G A + G
Sbjct: 92 PGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV-RISDLGLAVELKDG 150
Query: 728 KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
+++ Y + + APE++ G YD +D +++G LYE+ +
Sbjct: 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM-------------------I 191
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+GPF + V K +K+ I N VT
Sbjct: 192 AARGPF----------------------RARGEKVENKELKQRILN-------DSVTYP- 221
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALTHPFISG 886
K K + + DPEKR+ THP
Sbjct: 222 ---DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 29/203 (14%)
Query: 599 VAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE---- 653
VAIKI+++++ + + Q EVQ LK+L +H I + + ++ E
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRL------RHKHLISLFAVCSVGEPVYIITELMEK 86
Query: 654 -SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK 712
SL LR G+ L + ++ A Q+ + +L+ +H D+ N+LV E
Sbjct: 87 GSLLAFLRS---PEGQV--LPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE-D 140
Query: 713 NVLKLCDFGNA------MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYE 766
V K+ DFG A ++ ++ PY + APE + D+WS G LYE
Sbjct: 141 LVCKVADFGLARLIKEDVYLSSDKKIPYK----WTAPEAASHGTFSTKSDVWSFGILLYE 196
Query: 767 LYT-GKVLFPGATNNDMLRLHME 788
++T G+V +PG N+++
Sbjct: 197 MFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/233 (28%), Positives = 103/233 (44%), Gaps = 48/233 (20%)
Query: 558 SYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNK- 612
++R G++L G+G F V D G E+A+K ++ + ET +
Sbjct: 3 NWRLGKLL----------GQGAFGRVYLCYDADTG----RELAVKQVQFDPESPETSKEV 48
Query: 613 -AGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGR 668
A + E+Q+LK L C+R L + E HM ++++ LK +G
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPM----ERTLSIFME--HMPGGSIKDQLKSYG- 101
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM---- 724
L R Y +Q+ + +L + ++H DIK N+L + NV KL DFG +
Sbjct: 102 --ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNV-KLGDFGASKRLQT 158
Query: 725 --FAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
+G TPY +S PE+I G Y DIWSVGC + E+ T K
Sbjct: 159 ICLSGTGMKSVTGTPYWMS-----PEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 81/318 (25%), Positives = 129/318 (40%), Gaps = 82/318 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKR-H 634
G+G TV A D+ G +EVAIK MN Q + +++ ENK +
Sbjct: 28 GQGASGTVYTAIDVATG----QEVAIK------QMNLQQQPKKELIINEILVMRENKHPN 77
Query: 635 CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ + S+ + L +V E L +L +V+ + + G + A ++ AL+ L +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHS 133
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAPEII 746
V+H DIK DN+L+ +V KL DFG F +ITP R ++ APE++
Sbjct: 134 NQVIHRDIKSDNILLGMDGSV-KLTDFG---FCA--QITPEQSKRSTMVGTPYWMAPEVV 187
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
Y +DIWS+G E+ G+ P N + LR
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNENPLR---------------------- 222
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
A+ I N P+ + K+ A F+D L++
Sbjct: 223 -------------------ALYLIATNGTPE--------LQNPE-KLSAIFRDFLNRCLE 254
Query: 867 LDPEKRMTVAQALTHPFI 884
+D EKR + + L HPF+
Sbjct: 255 MDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 576 GKGVFSTV----VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPEN 631
GKG F V VRA E+ IK R E+M E QIL+K+ N
Sbjct: 9 GKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESM---ALNEKQILEKV------N 58
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ + A +++ ++ LCLV ++ +L+ + G N G + YA ++ L+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLED 117
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YRAPEIILGL 749
L ++ D+KP+N+L+++ ++ ++ D G A+ + E V Y APE++
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHI-RISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLFPG 776
Y D W +GC +YE+ G+ F G
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 14/183 (7%)
Query: 602 KIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLRE 661
K+I T K E+ ILK + + R I ++++++ +C+V +L
Sbjct: 121 KVIVKAVTGGKTPGREIDILKTI------SHRAIINLIHAYRWKSTVCMVMPKYKCDLFT 174
Query: 662 VLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721
+ + G L L ++L AL +L G++H D+K +N+ ++E +N + L DFG
Sbjct: 175 YVDRSG---PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFG 230
Query: 722 NAMFAGKNEITP----YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
A + TP + + +PE++ PY DIWS G L+E+ V G
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
Query: 778 TNN 780
Sbjct: 291 QVK 293
|
Length = 392 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 38/130 (29%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
+R YA ++ + L+H+ N V++ D+KP N+L++E +V ++ D G A K + +
Sbjct: 99 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVG 157
Query: 737 SRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND-------MLRLHME 788
+ Y APE++ G+ YD D +S+GC L++L G F D L + +E
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
Query: 789 LKGPFPKKML 798
L F ++
Sbjct: 218 LPDSFSPELR 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 34/101 (33%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG----NAMFAGKNEIT 732
VR + +Q+ L +L + G+LH D+K DN+LV +A + K+ DFG + ++
Sbjct: 110 VRFFTEQVLEGLAYLHSKGILHRDLKADNLLV-DADGICKISDFGISKKSDDIYDNDQNM 168
Query: 733 PYLVSRFYRAPEII--LGLPYDHPLDIWSVGCCLYELYTGK 771
S F+ APE+I Y +DIWS+GC + E++ G+
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G F V + G+ E+VA+K + E + E++IL+ L +
Sbjct: 13 GEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DHE 66
Query: 634 HCIRF--ASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ +++ L L+ E L +LR+ L++ I LK + ++ Q+ + +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR--LLLFSSQICKGMDY 124
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAP 743
L + +H D+ N+LV V K+ DFG A E Y + F+ AP
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLV-KISDFGLAKVL--PEDKDYYYVKEPGESPIFWYAP 181
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT 769
E + + D+WS G LYEL+T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG F V+ AK G+ A+K+++ + K Q + + + +N +H
Sbjct: 4 GKGSFGKVLLAKRKSDGSF----YAVKVLQKKTILKKKEQNHIMAERNVL---LKNLKHP 56
Query: 635 -CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ SF+ L V + ++N E+ R R YA ++ A+ +L +
Sbjct: 57 FLVGLHYSFQTAEKLYFVLD--YVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAPEIILG 748
+++ D+KP+N+L++ +V+ L DFG + E T S F Y APE++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVLRK 170
Query: 749 LPYDHPLDIWSVGCCLYELYTG 770
PYD +D W +G LYE+ G
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 23/202 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G G F V+ A K + P VAIK ++ + + V +K+ + N C
Sbjct: 39 GTGSFGRVILAT-YKNEDFPP--VAIKRFEKSKIIKQKQVDHVFSERKIL--NYINHPFC 93
Query: 636 IRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ SFK ++L LV E LR K+F ++G YA Q+ + ++
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGC------FYAAQIVLIFEY 146
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--SRFYRAPEIILG 748
L++ +++ D+KP+N+L+++ +K+ DFG FA + Y + + Y APEI+L
Sbjct: 147 LQSLNIVYRDLKPENLLLDK-DGFIKMTDFG---FAKVVDTRTYTLCGTPEYIAPEILLN 202
Query: 749 LPYDHPLDIWSVGCCLYELYTG 770
+ + D W++G +YE+ G
Sbjct: 203 VGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 28/210 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNK--AGQTEVQILKKLAGADP 629
G+G F V D+ G E+A K ++ + ET + A + E+Q+LK L
Sbjct: 11 GQGAFGRVYLCYDVDTG----RELAAKQVQFDPESPETSKEVSALECEIQLLKNL----- 61
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+++ + R L +M ++++ LK +G L + R Y +Q+
Sbjct: 62 -QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILE 117
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEITPYLVSRFYR 741
+ +L + ++H DIK N+L + A NV KL DFG + I + ++
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGK 771
+PE+I G Y D+WS+GC + E+ T K
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 62/207 (29%), Positives = 87/207 (42%), Gaps = 68/207 (32%)
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--------TPYLVSR 738
AL L GV+H DIK D++L+ V KL DFG K E+ TPY
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRV-KLSDFGFCAQVSK-EVPRRKSLVGTPY---- 181
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
+ APE+I LPY +DIWS+G + E+ G+ P N
Sbjct: 182 -WMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---PPYFN------------------- 218
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
E P+ KA+K I N+ PK + ++ SP + K
Sbjct: 219 --------------------EPPL--KAMKMIRDNLPPK-LKNLHKVSP--------SLK 247
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFIS 885
LD++ V DP +R T A+ L HPF++
Sbjct: 248 GFLDRLLVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 84/325 (25%), Positives = 130/325 (40%), Gaps = 83/325 (25%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGA 627
RYE G+G TV A D+ G +EVAIK I + K + E+ I + L
Sbjct: 23 RYEKI---GQGASGTVFTAIDVATG----QEVAIKQI----NLQKQPKKELIINEILVMK 71
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ +N + + F SF + L +V E L +L +V+ + + + A ++
Sbjct: 72 ELKNP-NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQ 126
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------F 739
AL+ L V+H DIK DN+L+ +V KL DFG +ITP R +
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMDGSV-KLTDFGFCA-----QITPEQSKRSTMVGTPY 180
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
+ APE++ Y +DIWS+G E+ G+ P N + LR
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNENPLRA-------------- 223
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
L AT P + P+ + I F+D
Sbjct: 224 ------------LYLIATNGTPELQ----------NPEKLSPI--------------FRD 247
Query: 860 LLDKIFVLDPEKRMTVAQALTHPFI 884
L++ +D EKR + + L HPF+
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 41/239 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA----GQTEVQILKKLAGADPEN 631
GKG F V+ ++ G + A+KI++ + K TE ++L+ N
Sbjct: 4 GKGTFGKVILVREKATG----KYYAMKILKKEVIIAKDEVAHTLTESRVLQ--------N 51
Query: 632 KRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
RH SF+ + LC V E + N E+ R R Y ++ AL
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVME--YANGGELFFHLSRERVFSEDRARFYGAEIVSALG 109
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----------NAMFAGKNEITPYLVSR 738
+L +C V++ D+K +N+++++ ++ K+ DFG F G E
Sbjct: 110 YLHSCDVVYRDLKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTPE-------- 160
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y APE++ Y +D W +G +YE+ G++ F + + L + + FP+ +
Sbjct: 161 -YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
GKG F V+ A+ E + A+K+++ + K + +E +L K N
Sbjct: 4 GKGSFGKVLLARH----KAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLK-------N 52
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+H F ++ L F ++N E+ R R YA ++ AL +L
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 112
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY-LVSRF-----YRAPEI 745
+ +++ D+KP+N+L++ +++ L DFG K I S F Y APE+
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIV-LTDFGLC----KENIEHNGTTSTFCGTPEYLAPEV 167
Query: 746 ILGLPYDHPLDIWSVGCCLYELYTG 770
+ PYD +D W +G LYE+ G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKII----RNNETMNK--AGQTEVQILKKLAGADP 629
G+G F V D G E+A+K + + ET + A + E+Q+LK L
Sbjct: 11 GRGAFGEVYLCYDADTG----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
C+R K L + E + ++++ LK +G L R Y +Q+ +
Sbjct: 67 VQYYGCLRDPEEKK----LSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGV 119
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEITPYLVSRFYRAP 743
+L + ++H DIK N+L + A NV KL DFG + I + ++ +P
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYTGK 771
E+I G Y D+WSV C + E+ T K
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGR------- 668
QI+++L N + + F +F + + E HM+ L +VLK+ R
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKEAKRIPEEILG 106
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728
+ + + AY ++ KH ++H D+KP N+LVN ++ +KLCDFG +
Sbjct: 107 KVSIAVLRGLAYLRE-----KH----QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLID 156
Query: 729 NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
+ ++ +R Y +PE + G Y DIWS+G L EL G+ P E
Sbjct: 157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-------E 209
Query: 789 LKGPFPKKMLRKGAFTDQHFD-------QDLNFHATEEDPVTKKAIKKIIFNIKPKDIGS 841
L+ F + ++ + ++ H + P IF + +
Sbjct: 210 LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMA------IFEL----LDY 259
Query: 842 IVTASPGEDPK--MLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
IV P + P +F++ ++K + +P +R + + H FI
Sbjct: 260 IVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 58/228 (25%), Positives = 85/228 (37%), Gaps = 73/228 (32%)
Query: 671 GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
GL +R +Q+ AL L + V+H D+K N+L+ +V KL DFG + K+
Sbjct: 99 GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDV-KLADFGVSA-KNKST 156
Query: 731 I--------TPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
+ TPY + APE++ PYD+ DIWS+G L EL + P
Sbjct: 157 LQKRDTFIGTPY-----WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHH 209
Query: 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837
N M L LK P + + ++ +F+
Sbjct: 210 ELNPMRVLLKILKSE-PPTLDQPSKWSS-------SFN---------------------- 239
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
D L V DP+ R T A+ L HPF+S
Sbjct: 240 ---------------------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 576 GKGVFSTV----VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPEN 631
GKG F V VRA + E+ IK R E M E QIL+K+ N
Sbjct: 9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAM---ALNEKQILEKV------N 58
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
R + A +++ ++ LCLV ++ +L+ + G N G YA ++ L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLED 117
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YRAPEIILGL 749
L +++ D+KP+N+L+++ ++ ++ D G A+ + E V Y APE++
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHI-RISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLF 774
Y D W +GC +YE+ GK F
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 12/190 (6%)
Query: 598 EVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM 657
+VAIK ++ M +A E QI+KKL + + +A + ++ F
Sbjct: 32 KVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKLVPLYAVVSEEPIYIVTEFMG-KG 85
Query: 658 NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717
+L + LK+ G LKL + A Q+ + +++ +H D++ N+LV + V K+
Sbjct: 86 SLLDFLKE-GDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD-NLVCKI 143
Query: 718 CDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVL 773
DFG A NE T ++F + APE L + D+WS G L EL T G+V
Sbjct: 144 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 774 FPGATNNDML 783
+PG N ++L
Sbjct: 204 YPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENKR 633
GKG F V + D N E VAIKII E ++ Q E+ +L + +
Sbjct: 13 GKGSFGEVYKGID----NRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSP 62
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ R+ S+ L ++ E L L K G L+ T + +++ L +L +
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHS 119
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--TPYLVSRFYRAPEIILGLPY 751
+H DIK N+L++E +V KL DFG A +I ++ + F+ APE+I Y
Sbjct: 120 ERKIHRDIKAANVLLSEQGDV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 752 DHPLDIWSVGCCLYELYTGK 771
D DIWS+G EL G+
Sbjct: 179 DFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 18/109 (16%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------ 731
R Y ++ +AL + + G +H D+KPDNML++++ + LKL DFG M N +
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMDANGMVRCDTA 203
Query: 732 --TPYLVSRFYRAPEIILGL----PYDHPLDIWSVGCCLYELYTGKVLF 774
TP +S PE++ Y D WSVG LYE+ G F
Sbjct: 204 VGTPDYIS-----PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 78/328 (23%), Positives = 130/328 (39%), Gaps = 79/328 (24%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGAD 628
+E+ G G F V KA N E +A + + ++ + V+I LA D
Sbjct: 7 WEIIGELGDGAFGKV-----YKAQNKETGVLAAAKVIDTKSEEELEDYMVEI-DILASCD 60
Query: 629 PENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+ ++ +F Y N+L ++ E + V+ + R L +R KQ A
Sbjct: 61 ---HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEA 115
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT-----PYLVSRFYRA 742
L +L ++H D+K N+L ++ KL DFG + KN T ++ + ++ A
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDI-KLADFG---VSAKNTRTIQRRDSFIGTPYWMA 171
Query: 743 PEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
PE+++ PYD+ D+WS+G L E+ ++ P H EL P ++
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEM--AQIEPP----------HHELN---PMRV 216
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
L K A + +P T A P + + F
Sbjct: 217 LLKIA---------------KSEPPT--------------------LAQPS---RWSSEF 238
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFIS 885
KD L K + + R T Q L HPF++
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 32/206 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
G G F V AK K E AIK ++ E + E IL +L +
Sbjct: 27 GTGSFGRVRIAK-HKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILMEL------S 76
Query: 632 KRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ SF+ N + + E L +LR+ +F ++ + Y +L +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVA------KFYHAELVL 129
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--SRFYRAPE 744
A ++L + +++ D+KP+N+L++ +V K+ DFG FA K + + + Y APE
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHV-KVTDFG---FAKKVPDRTFTLCGTPEYLAPE 185
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTG 770
+I + +D W++G LYE G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 53/230 (23%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADPEN 631
GKG F V+ ++ +G + A+KI++ + K TE ++LK N
Sbjct: 4 GKGTFGKVILVREKASG----KYYAMKILKKEVIIAKDEVAHTLTESRVLK--------N 51
Query: 632 KRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
RH SF+ ++ LC V E ++N E+ R R Y ++ AL
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVME--YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIIL 747
+L + +++ D+K +N+++++ ++ K+ DFG + + + Y APE++
Sbjct: 110 YLHSGKIVYRDLKLENLMLDKDGHI-KITDFGLCKEGITDAATMKTFCGTPEYLAPEVLE 168
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y +D W +G +YE+ G++ F + + L + FP+ +
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G G F V NG +VA+K ++ ++ E QI+KKL +
Sbjct: 15 GNGQFGEVWMG----TWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKL-------RHDK 62
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
+ + + +V E + K G LKL + A Q+ + +++
Sbjct: 63 LVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYD 752
+H D++ N+LV + V K+ DFG A NE T ++F + APE L +
Sbjct: 123 YIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 753 HPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
D+WS G L EL T G+V +PG N ++L
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G F V NG VAIK ++ +A E Q++KKL RH
Sbjct: 15 GQGCFGEVWMG----TWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL--------RH- 60
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIG--LKLTAVRAYAKQLFIALKHLKN 693
+ + + + + +M+ +L +G L+L + A Q+ + +++
Sbjct: 61 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLP 750
+H D++ N+LV E V K+ DFG A NE T ++F + APE L
Sbjct: 121 MNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 751 YDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ D+WS G L EL T G+V +PG N ++L
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 38/225 (16%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
+E+ GKG + V + + K G+ A+KI+ +++ + E IL+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGS----LAAVKILDPISDVDEEIEAEYNILQSLP- 76
Query: 627 ADPENKRHCIRFASSFKYRNH-----LCLVFESLH----MNLREVLKKFGRNIGLKLTAV 677
N + ++F F + L LV E + L + L G+ + + +
Sbjct: 77 ----NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
Y L L+HL N ++H D+K +N+L+ V KL DFG + ++T +
Sbjct: 133 ILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGV-KLVDFGVSA-----QLTSTRLR 184
Query: 738 R-------FYRAPEII-----LGLPYDHPLDIWSVGCCLYELYTG 770
R F+ APE+I YD D+WS+G EL G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 38/124 (30%), Positives = 61/124 (49%), Gaps = 4/124 (3%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYL 735
+ Y +L +AL+HL +++ D+KP+N+L+ +A + LCDFG A +
Sbjct: 99 KFYIAELVLALEHLHKYDIVYRDLKPENILL-DATGHIALCDFGLSKANLTDNKTTNTFC 157
Query: 736 VSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
+ Y APE++L Y +D WS+G ++E+ G F M R K FP
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP 217
Query: 795 KKML 798
K +L
Sbjct: 218 KNVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 45/115 (39%), Positives = 61/115 (53%), Gaps = 9/115 (7%)
Query: 659 LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718
L ++LKK G+ L V+ +QL AL L ++H DIK +N+L + AK+ + LC
Sbjct: 96 LFDLLKKEGK---LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152
Query: 719 DFGNAMFAGKNEITP--YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
D+G K TP Y + Y +PE I G YD D W+VG YEL TGK
Sbjct: 153 DYGLC----KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|233496 TIGR01622, SF-CC1, splicing factor, CC1-like family | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 37/100 (37%), Positives = 43/100 (43%), Gaps = 13/100 (13%)
Query: 214 RRREWEREKSKHLEVDRERRRDKNREQSRDR--DIHRGREERDRSRYEEVDRGRRREKER 271
R R+ ER + + + RR DK RE+SR R R R RDR Y RGRR R
Sbjct: 1 RYRDRERGRLR----NDTRRSDKGRERSRRRSRSRDRSRRRRDRDYY----RGRRG---R 49
Query: 272 DRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDR 311
RSR R DR R+ R N E E RD
Sbjct: 50 SRSRSPNRYYRPRGDRSYRRDDRRSGRNTKEPLTEAERDD 89
|
This model represents a subfamily of RNA splicing factors including the Pad-1 protein (N. crassa), CAPER (M. musculus) and CC1.3 (H.sapiens). These proteins are characterized by an N-terminal arginine-rich, low complexity domain followed by three (or in the case of 4 H. sapiens paralogs, two) RNA recognition domains (rrm: pfam00706). These splicing factors are closely related to the U2AF splicing factor family (TIGR01642). A homologous gene from Plasmodium falciparum was identified in the course of the analysis of that genome at TIGR and was included in the seed. Length = 457 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-08
Identities = 35/118 (29%), Positives = 43/118 (36%), Gaps = 4/118 (3%)
Query: 180 RDLVRDDEREH-RTSYTTRYVGRE-DRHHSREIERERRREWEREKSKHLEVDRERRRDKN 237
RD D ERE R R R R R R+R R + R+RRR +
Sbjct: 1 RDEEPDREREKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDS 60
Query: 238 REQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDR 295
R R R RDR R R E+ R R RDR+ N D ++ D
Sbjct: 61 RSPRSLRYSSVRR-SRDRPRRRSRSV-RSIEQHRRRLRDRSPSNQWRKDDKKRSLWDI 116
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 71/261 (27%), Positives = 114/261 (43%), Gaps = 62/261 (23%)
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA----GQTEVQIL 621
+Y ++ G G TV+ AK + +GEP A+K++ + E M++A Q EV L
Sbjct: 31 AKKYWISRVLGSGATGTVLCAK--RVSDGEP--FAVKVV-DMEGMSEADKNRAQAEVCCL 85
Query: 622 ------------KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
+ A DP N + + A Y N +LR+ +K +
Sbjct: 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANA---------GDLRQEIKSRAK- 135
Query: 670 IGLKLTAVRAYAK--------QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721
R + + Q+ +A+ H+ + ++H DIK N+L+ + ++KL DFG
Sbjct: 136 ------TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC-SNGLVKLGDFG 188
Query: 722 -NAMFA-------GKNEI-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772
+ M+A G+ TPY Y APEI PY D++S+G LYEL T K
Sbjct: 189 FSKMYAATVSDDVGRTFCGTPY-----YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
Query: 773 LFPGATNNDMLRLHMELKGPF 793
F G ++ +H L G +
Sbjct: 244 PFDGENMEEV--MHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 8e-08
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
GKG F V+ AK G + A+K+++ + K Q E +L K N
Sbjct: 4 GKGSFGKVLLAKHKADG----KFYAVKVLQKKAILKKKEQKHIMAERNVLLK-------N 52
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+H + ++ L F ++N E+ R R YA ++ AL +L
Sbjct: 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYL 112
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGL 749
+ +++ D+KP+N+L+ +++ + L DFG + + + Y APE++
Sbjct: 113 HSLNIIYRDLKPENILL-DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 750 PYDHPLDIWSVGCCLYELYTG 770
PYD +D W +G LYE+ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 46/168 (27%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
QTE + ++ A ++P + S F+ + L LV E ++N +++ R L
Sbjct: 43 QTEKHVFEQ-ASSNP----FLVGLHSCFQTTSRLFLVIE--YVNGGDLMFHMQRQRKLPE 95
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEIT 732
R YA ++ IAL L G+++ D+K DN+L++ ++ KL D+G + +
Sbjct: 96 EHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI-KLTDYGMCKEGLGPGDTTS 154
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
+ + Y APEI+ G Y +D W++G ++E+ G+ F T+N
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 27/232 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADPEN 631
GKG F V+ ++ G A+KI+R + K TE ++L +N
Sbjct: 4 GKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVL--------QN 51
Query: 632 KRHCIRFASSFKY----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
RH F ++ KY + LC V E + N E+ R R Y ++ A
Sbjct: 52 TRH--PFLTALKYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEIVSA 107
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT--PYLVSRFYRAPEI 745
L++L + V++ DIK +N+++++ ++ K+ DFG + T + + Y APE+
Sbjct: 108 LEYLHSRDVVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 746 ILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+ Y +D W +G +YE+ G++ F + + L + + FP+ +
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 576 GKGVFSTV----VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPEN 631
GKG F V VRA + E+ IK R E+M E QIL+K+ N
Sbjct: 9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESM---ALNEKQILEKV------N 58
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
R + A +++ ++ LCLV ++ +L+ + G G + YA ++ L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLED 117
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YRAPEIILGL 749
L +++ D+KP+N+L+++ ++ ++ D G A+ + + V Y APE++
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHI-RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLF 774
Y D W++GC LYE+ G+ F
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 65/275 (23%), Positives = 114/275 (41%), Gaps = 25/275 (9%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
G +E+ G G + V + + +K G + AIK++ + + E+ +LKK +
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGDEEEEIKQEINMLKKYS- 60
Query: 627 ADPENKRHCIRFASSFKYRN------HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+ R+ + +F +N L LV E L K + LK +
Sbjct: 61 ----HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN--EITPYLVSR 738
+++ L HL V+H DIK N+L+ E V KL DFG + + ++ +
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGRRNTFIGTP 175
Query: 739 FYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
++ APE+I YD D+WS+G E+ G P + M L + + P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCDMHPMRALFLIPRNPA 233
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
P+ +K + Q F + + P T++ +K
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 40/130 (30%), Positives = 69/130 (53%), Gaps = 9/130 (6%)
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA---MFAGKNEIT 732
VR Y+ ++ +AL+HL G+++ DIK +N+L++ +V+ L DFG + + K
Sbjct: 106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTY 164
Query: 733 PYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFP----GATNNDMLRLHM 787
+ + Y APEII G + +D WS+G ++EL TG F T +++ R +
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 788 ELKGPFPKKM 797
+ PFP +
Sbjct: 225 KCDPPFPSFI 234
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 36/268 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENKR 633
GKG F V + D N + VAIKII E ++ Q E+ +L + +
Sbjct: 13 GKGSFGEVFKGID----NRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSP 62
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ ++ S+ L ++ E L L + G ++ + K++ L +L +
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM---LKEILKGLDYLHS 119
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--TPYLVSRFYRAPEIILGLPY 751
+H DIK N+L++E +V KL DFG A +I ++ + F+ APE+I Y
Sbjct: 120 EKKIHRDIKAANVLLSEQGDV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 752 DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM----------ELKGPFPKKMLRKG 801
D DIWS+G EL G+ N+DM + + L G F K
Sbjct: 179 DSKADIWSLGITAIELAKGE-----PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPF---K 230
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKK 829
F D ++D +F T ++ + K I K
Sbjct: 231 EFIDACLNKDPSFRPTAKELLKHKFIVK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 26/200 (13%)
Query: 595 EPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFES 654
E +VAIK IR + E Q++ KL+ K ++ R+ +CLVFE
Sbjct: 27 EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS----HPK--LVQLYGVCTERSPICLVFEF 80
Query: 655 L-HMNLREVLK----KFGRN--IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML 707
+ H L + L+ KF + +G+ L A +L++ V+H D+ N L
Sbjct: 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA--------YLESSNVIHRDLAARNCL 132
Query: 708 VNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYDHPLDIWSVGCCL 764
V E + V+K+ DFG F ++ T ++F + +PE+ Y D+WS G +
Sbjct: 133 VGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLM 191
Query: 765 YELYT-GKVLFPGATNNDML 783
+E+++ GK + +N++++
Sbjct: 192 WEVFSEGKTPYENRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 2/99 (2%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
+R YA ++ + L+H+ N V++ D+KP N+L++E +V ++ D G A K + +
Sbjct: 99 MRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVG 157
Query: 737 SRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLF 774
+ Y APE++ G YD D +S+GC L++L G F
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/108 (31%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF 739
++ Q+ + +++ +H D++ N+LV+E+ + K+ DFG A NE T ++F
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKF 166
Query: 740 ---YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ APE I + D+WS G LYE+ T GK+ +PG +N+D++
Sbjct: 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 45/210 (21%), Positives = 88/210 (41%), Gaps = 34/210 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQILKKLAGADPENK 632
G G F VVR + G+ VA+K +++ + ++ E I+ L +
Sbjct: 4 GDGSFG-VVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSL------DH 55
Query: 633 RHCIRF-----ASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ IR +V E + +L + L+K ++ + YA Q+
Sbjct: 56 ENLIRLYGVVLTHPLM------MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIAN 108
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR----- 741
+++L++ +H D+ N+L+ + + +K+ DFG +NE + V +
Sbjct: 109 GMRYLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFA 165
Query: 742 --APEIILGLPYDHPLDIWSVGCCLYELYT 769
APE + + H D+W G L+E++T
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 641 SFKYRNHLCLVFESLHMNLREVLKKFGRNIG-LKLTAVRAYAKQLFIALKHLKNCGVLHC 699
+F+ +++L LV E + ++L R + Y +L +A+ + G +H
Sbjct: 69 AFQDKDNLYLVME--YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 700 DIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLV-SRFYRAPEIILGL------P 750
DIKP+N+L++ ++ KL DFG+A + A K + V + Y APE++ +
Sbjct: 127 DIKPENVLIDRTGHI-KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 751 YDHPLDIWSVGCCLYELYTGKVLF 774
Y D WS+G YE+ G+ F
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 11/110 (10%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY-LV 736
R Y+ ++ +AL L G+++ D+K DN+L+ +A+ +KL D+G K I P
Sbjct: 99 RFYSAEISLALNFLHERGIIYRDLKLDNVLL-DAEGHIKLTDYGMC----KEGIRPGDTT 153
Query: 737 SRF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
S F Y APEI+ G Y +D W++G ++E+ G+ F +D
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|233496 TIGR01622, SF-CC1, splicing factor, CC1-like family | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-07
Identities = 30/95 (31%), Positives = 42/95 (44%), Gaps = 9/95 (9%)
Query: 204 RHHSREIERERRREWEREKSKHLEVDRERRRDKNREQS---RDRDIHRGREERDRSRYEE 260
R+ RE R R +K + R RRR ++R++S RDRD +RGR R RSR
Sbjct: 1 RYRDRERGRLRNDTRRSDKGRE----RSRRRSRSRDRSRRRRDRDYYRGRRGRSRSR-SP 55
Query: 261 VDRGRRREKERDRSRDRARVNDRDMDRQRDREKDR 295
R R R DR + + + E+D
Sbjct: 56 NRYYRPRGDRSYRRDDRRSGRNTK-EPLTEAERDD 89
|
This model represents a subfamily of RNA splicing factors including the Pad-1 protein (N. crassa), CAPER (M. musculus) and CC1.3 (H.sapiens). These proteins are characterized by an N-terminal arginine-rich, low complexity domain followed by three (or in the case of 4 H. sapiens paralogs, two) RNA recognition domains (rrm: pfam00706). These splicing factors are closely related to the U2AF splicing factor family (TIGR01642). A homologous gene from Plasmodium falciparum was identified in the course of the analysis of that genome at TIGR and was included in the seed. Length = 457 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKR-H 634
G+G TV A D+ G +EVAIK MN Q + +++ ENK +
Sbjct: 28 GQGASGTVYTAIDIATG----QEVAIK------QMNLQQQPKKELIINEILVMRENKNPN 77
Query: 635 CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ + S+ + L +V E L +L +V+ + + G + A ++ AL L +
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALDFLHS 133
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAPEII 746
V+H DIK DN+L+ +V KL DFG +ITP R ++ APE++
Sbjct: 134 NQVIHRDIKSDNILLGMDGSV-KLTDFGFCA-----QITPEQSKRSTMVGTPYWMAPEVV 187
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
Y +DIWS+G E+ G+ P N + LR
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGE---PPYLNENPLR 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPY 734
R YA ++ AL L + G+++ D+K DN+L++ + KL DFG +F GK T +
Sbjct: 99 RFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTST-F 156
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
+ Y APEI+ + Y +D W++G LYE+ G F +D+
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 70/293 (23%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKL 624
E G G F V +D + A+K++ E + + E ++LK++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISE----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAV 677
H IR + + L ++ E L LR +F + G
Sbjct: 59 --------SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTG------ 103
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
YA ++ AL++L + +++ D+KP+N+L+++ + +KL DFG FA K L
Sbjct: 104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH-IKLTDFG---FAKK------LRD 153
Query: 738 RF--------YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
R Y APE+I ++ +D W++G +YE+ G F + +
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
K FP+ + D K IKK++ + + +G++
Sbjct: 214 KLEFPRHL----------------------DLYAKDLIKKLLVVDRTRRLGNM 244
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKR-H 634
G+G TV A D+ G +EVAI+ MN Q + +++ ENK +
Sbjct: 29 GQGASGTVYTAMDVATG----QEVAIR------QMNLQQQPKKELIINEILVMRENKNPN 78
Query: 635 CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ + S+ + L +V E L +L +V+ + + G + A ++ AL+ L +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEFLHS 134
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAPEII 746
V+H DIK DN+L+ +V KL DFG +ITP R ++ APE++
Sbjct: 135 NQVIHRDIKSDNILLGMDGSV-KLTDFGFCA-----QITPEQSKRSTMVGTPYWMAPEVV 188
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
Y +DIWS+G E+ G+ P N + LR
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGE---PPYLNENPLR 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 18/134 (13%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT---PY 734
R Y ++ +AL + + G +H D+KPDNML++++ + LKL DFG M K +
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTA 203
Query: 735 LVSRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
+ + Y +PE++ Y D WSVG LYE+ G F + L
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----------LV 253
Query: 791 GPFPKKMLRKGAFT 804
G + K M K + T
Sbjct: 254 GTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN--EITPYLVSRFYRAPE 744
AL +L N GV+H DIK D++L+ + +KL DFG K + + + ++ APE
Sbjct: 130 ALSYLHNQGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+I LPY +DIWS+G + E+ G+ P N L+ ++ P ++
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGE---PPYFNEPPLQAMRRIRDNLPPRV 238
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 29/108 (26%), Positives = 43/108 (39%)
Query: 283 RDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHS 342
RD + R+REK R RD + ER RRR R R + RD + + +DS R S
Sbjct: 1 RDEEPDREREKSRGRDRDRSSERPRRRSRDRSRFRDRHRRSRERSYREDSRPRDRRRYDS 60
Query: 343 RHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDD 390
R + R R ++ S D+ ++ +DD
Sbjct: 61 RSPRSLRYSSVRRSRDRPRRRSRSVRSIEQHRRRLRDRSPSNQWRKDD 108
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 77/328 (23%), Positives = 128/328 (39%), Gaps = 73/328 (22%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGAD 628
+E+ GKG + V + + K G + A+KI+ +++ + E ILK L+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNG----SKAAVKILDPIHDIDEEIEAEYNILKALSDHP 75
Query: 629 PENKRHCIRFASSFKYRNHLCLVFESLH----MNLREVLKKFGRNIGLKLTAVRAYAKQL 684
K + + + K + L LV E + +L + K G + + A + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH--EA 133
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRFYRA 742
+ L+HL +H D+K +N+L+ V KL DFG + + + + + + F+ A
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGV-KLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
Query: 743 PEII-----LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
PE+I L YD D+WS+G EL G + + LH
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL--------GDGDPPLADLH----------- 233
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN- 856
P+ +A+ KI N P P++ +N
Sbjct: 234 -----------------------PM--RALFKIPRNPPPTL----------HQPELWSNE 258
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPFI 884
F D + K D EKR TV+ L H FI
Sbjct: 259 FNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 54/244 (22%), Positives = 113/244 (46%), Gaps = 19/244 (7%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G ++ V+ + K +V K + N++ QTE + ++ + N
Sbjct: 4 GRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFL 58
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
+ S F+ + L V E ++N +++ R L R Y+ ++ +AL +L G
Sbjct: 59 VGLHSCFQTESRLFFVIE--YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRFYRAPEIILGLPYDH 753
+++ D+K DN+L++ ++ KL D+G + + + + Y APEI+ G Y
Sbjct: 117 IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 754 PLDIWSVGCCLYELYTGKVLFP--GATNND-------MLRLHMELKGPFPKKMLRKGAFT 804
+D W++G ++E+ G+ F G+++N + ++ +E + P+ + K A
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235
Query: 805 DQHF 808
+ F
Sbjct: 236 LKSF 239
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 21/108 (19%)
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----------NAMFAGK 728
Y ++ +AL+HL G+++ D+KP+N+L++ A+ +KL DFG F G
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGT 163
Query: 729 NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
E Y APEI++ + +D WS+G +Y++ TG F
Sbjct: 164 IE---------YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 28/219 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENKR 633
GKG F V + D N + VAIKII E ++ Q E+ +L + +
Sbjct: 13 GKGSFGEVFKGID----NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSP 62
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ ++ S+ L ++ E L L + G L T + +++ L +L +
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 119
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--TPYLVSRFYRAPEIILGLPY 751
+H DIK N+L++E V KL DFG A +I ++ + F+ APE+I Y
Sbjct: 120 EKKIHRDIKAANVLLSEHGEV-KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 752 DHPLDIWSVGCCLYELYTG----------KVLFPGATNN 780
D DIWS+G EL G KVLF NN
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN 217
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 66/252 (26%), Positives = 105/252 (41%), Gaps = 35/252 (13%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
G +E+ G G + V + + +K G + AIK++ E + + E+ +LKK +
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTEDEEEEIKLEINMLKKYS- 70
Query: 627 ADPENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+ R+ + +F + + L LV E L K + LK +
Sbjct: 71 ----HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEI--TP 733
+++ L HL V+H DIK N+L+ E V KL DFG + +N TP
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGRRNTFIGTP 185
Query: 734 YLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
Y + APE+I YD+ DIWS+G E+ G P + M L +
Sbjct: 186 Y-----WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP--PLCDMHPMRALFLI 238
Query: 789 LKGPFPKKMLRK 800
+ P PK +K
Sbjct: 239 PRNPPPKLKSKK 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 9e-07
Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 7/89 (7%)
Query: 267 REKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKG 326
R++E DR R+++R RD DR +R + R RD R R R R R + E R +
Sbjct: 1 RDEEPDREREKSR--GRDRDRSSERPRRRSRD----RSRFRDRHRRSRERSYREDSRPRD 54
Query: 327 ASPKDSYSNRD-RYKHSRHLKHDDDKGSY 354
DS S R RY R + + S
Sbjct: 55 RRRYDSRSPRSLRYSSVRRSRDRPRRRSR 83
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 569 YEVTAAHGKGVFS--TVVRAKDLKAGNGEPEEV-AIKIIRNNETMNKAGQT-----EVQI 620
+E+ G+G F VV+ K+ +V A+KI+ N M K +T E +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNT-------GQVYAMKIL-NKWEMLKRAETACFREERDV 54
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFES-LHMNLREVLKKFGRNIGLKLTAVRA 679
L ++R +F+ N+L LV + + +L +L KF + + R
Sbjct: 55 LVN------GDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA--RF 106
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--- 736
Y ++ +A+ + G +H DIKPDN+L+++ ++ +L DFG+ + + V
Sbjct: 107 YLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHI-RLADFGSCLRLLADGTVQSNVAVG 165
Query: 737 SRFYRAPEIILGLP-----YDHPLDIWSVGCCLYELYTGKVLF 774
+ Y +PEI+ + Y D WS+G C+YE+ G+ F
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQ---TEVQILKKLAGADPEN 631
G G F V A+D++ E VAIK + + + N+ Q EV+ L+KL +
Sbjct: 24 GHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
R C + CL S +L EV KK + + ++ AV A Q L +L
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSAS---DLLEVHKKPLQEV--EIAAVTHGALQ---GLAYL 131
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI--TPYLVSRFYRAPEIILG 748
+ ++H D+K N+L++E V KL DFG+A + A N TPY + APE+IL
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLV-KLGDFGSASIMAPANXFVGTPY-----WMAPEVILA 185
Query: 749 L---PYDHPLDIWSVGCCLYEL 767
+ YD +D+WS+G EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 46/195 (23%)
Query: 640 SSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+SF+ +LCLV + L L+ K L R YA ++ +AL++L
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEVARFYAAEVLLALEYLHLL 122
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDF---------GNAMFAGK---------NEITPYLV 736
G+++ D+KP+N+L++E+ +++ L DF + N I
Sbjct: 123 GIVYRDLKPENILLHESGHIM-LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 737 S--------RF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
S F Y APE+I G + +D W++G LYE+ G F G+ ++
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241
Query: 784 R--LHMELKGPFPKK 796
L E+ FP
Sbjct: 242 SNILKKEVT--FPGS 254
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/206 (26%), Positives = 78/206 (37%), Gaps = 68/206 (33%)
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-------TPYLVSRF 739
AL +L + GV+H DIK D++L+ V KL DFG K+ TPY
Sbjct: 129 ALCYLHSQGVIHRDIKSDSILLTLDGRV-KLSDFGFCAQISKDVPKRKSLVGTPY----- 182
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGK-VLFPGATNNDMLRLHMELKGPFPKKML 798
+ APE+I PY +DIWS+G + E+ G+ F + M RL P PK
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKLK- 238
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
N H PV +
Sbjct: 239 --------------NAHKIS--PV----------------------------------LR 248
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFI 884
D L+++ +P++R T + L HPF+
Sbjct: 249 DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 543 RSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK 602
R G+ + + A+ +Y EI G +E+ G G F V A + E VA+K
Sbjct: 1 RKGVVKDPEIADLFYKDDPEEIFVGLHEI----GHGSFGAVYFATNSHTN----EVVAVK 52
Query: 603 IIR-NNETMNKAGQ---TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN 658
+ + + N+ Q EV+ L++L + + C + CL S +
Sbjct: 53 KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS---D 109
Query: 659 LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718
L EV KK L+ + A L +L + ++H DIK N+L+ E V KL
Sbjct: 110 LLEVHKK-----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV-KLA 163
Query: 719 DFGNAMFAGKNEITPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYEL 767
DFG+A + + ++ + ++ APE+IL + YD +D+WS+G EL
Sbjct: 164 DFGSASKS--SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 59/239 (24%), Positives = 109/239 (45%), Gaps = 34/239 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE---VAIKIIRNNETMNKAGQ--TEVQILKKLAGADPE 630
G+G F VV A+ L +P+E VA+K+++++ T +E++++K +
Sbjct: 24 GEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----- 78
Query: 631 NKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLK-------KFGRNIG------LKLTA 676
++ I + L ++ E + NLRE L+ ++ +I +
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
+ + Q+ +++L + +H D+ N+LV E NV+K+ DFG A N I Y
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIADFGLAR--DVNNIDYYKK 195
Query: 737 SRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788
+ R APE + Y H D+WS G ++E++T G +PG ++ +L E
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGAD 628
+E+ G+G F V K LK + + A+KI+ E + +A +T ++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVK-LKNAD---KVFAMKILNKWEMLKRA-ETACFREERDVLVN 57
Query: 629 PENKRHCIRFASSFKYRNHLCLVFES-LHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+N+ +F+ N+L LV + + +L +L KF L R Y ++ IA
Sbjct: 58 GDNQ-WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIA 114
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA---MFAGKNEITPYLVSRFYRAPE 744
+ + +H DIKPDN+L++ ++ +L DFG+ M G + + + + Y +PE
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 745 IILGLP-----YDHPLDIWSVGCCLYELYTGKVLF 774
I+ + Y D WS+G C+YE+ G+ F
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 38/155 (24%)
Query: 640 SSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRA--YAKQLFIALKHLK 692
+ F+ +H+C V E L M++ F + RA YA + + L++L
Sbjct: 69 ACFQTEDHVCFVMEYAAGGDLMMHIHT--DVF--------SEPRAVFYAACVVLGLQYLH 118
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----------NAMFAGKNEITPYLVSRFYR 741
+++ D+K DN+L++ + +K+ DFG + F G E +
Sbjct: 119 ENKIVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPE---------FL 168
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
APE++ Y +D W +G +YE+ G+ FPG
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 576 GKGVFSTV----VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPEN 631
GKG F V VRA + E+ IK R E M E +IL+K+ N
Sbjct: 9 GKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAM---ALNEKRILEKV------N 58
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
R + A +++ ++ LCLV ++ +L+ + G N G YA +L L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLED 117
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YRAPEIILGL 749
L+ +++ D+KP+N+L+++ ++ ++ D G A+ + E V Y APE+I
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHI-RISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 750 PYDHPLDIWSVGCCLYELYTGKVLF 774
Y D W +GC +YE+ G+ F
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL- 735
V+ +A ++ +AL L G++ D+ P+N+L+++ ++ +L F +E+
Sbjct: 87 VKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI-QLTYFSRW-----SEVEDSCD 140
Query: 736 ---VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVL 773
V Y APE+ D WS+G L+EL TGK L
Sbjct: 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 49/218 (22%), Positives = 83/218 (38%), Gaps = 31/218 (14%)
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLA 625
+ E G G F TV + + G VAIK++R + + +IL +
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET----SPKANKEILDEAY 61
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHM---------NLREVLKKFGRNIGLKLTA 676
+ H +R L + S L + ++ NIG +
Sbjct: 62 VMASVDHPHVVRL---------LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY-- 110
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
+ + Q+ + +L+ ++H D+ N+LV + +K+ DFG A +E Y
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDE-KEYHA 168
Query: 737 SRF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
+ A E IL Y H D+WS G ++EL T
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 12/143 (8%)
Query: 641 SFKYRNHLCLVFES-LHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHC 699
+F+ N+L LV + + +L +L KF + + R Y ++ +A+ + +H
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA--RFYIAEMVLAIHSIHQLHYVHR 126
Query: 700 DIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV---SRFYRAPEIILGL-----PY 751
DIKPDN+L++ ++ +L DFG+ + ++ V + Y +PEI+ + Y
Sbjct: 127 DIKPDNVLLDMNGHI-RLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 752 DHPLDIWSVGCCLYELYTGKVLF 774
D WS+G C+YE+ G+ F
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|219953 pfam08648, DUF1777, Protein of unknown function (DUF1777) | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 8/109 (7%)
Query: 212 RERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKER 271
R R R R + + R+RR ++ RE+SR R+ R R R RS R + R
Sbjct: 3 RSRSRSPRRSRRRGRSRSRDRR-ERRRERSRSRERDRRRRSRSRSP-------HRSRRSR 54
Query: 272 DRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIE 320
R R+R R R RE+D+ +RER++ +G+ E
Sbjct: 55 SPRRHRSRSRSPSRRRDRKRERDKDAREPKKRERQKLIKEEDLEGKSDE 103
|
This is a family of eukaryotic proteins of unknown function. Some of the proteins in this family are putative nucleic acid binding proteins. Length = 158 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 24/231 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADPEN 631
GKG F V+ K+ G A+KI++ + K TE ++L +N
Sbjct: 4 GKGTFGKVILVKEKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVL--------QN 51
Query: 632 KRHCIRFASSFKYRNH--LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
RH A + ++ H LC V E + N E+ R R Y ++ AL
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVME--YANGGELFFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 690 HL-KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT--PYLVSRFYRAPEII 746
+L V++ D+K +N+++++ ++ K+ DFG K+ T + + Y APE++
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGHI-KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 168
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y +D W +G +YE+ G++ F + + L + + FP+ +
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 36/240 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE---VAIKIIRNNETMNKAGQ--TEVQILKKLAGADPE 630
G+G F VVRA+ P++ VA+K++++N T +E++++K +
Sbjct: 21 GEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI-----G 75
Query: 631 NKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLT-------------- 675
++ I L ++ E + NLRE L+ R G T
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRA-RRPPGPDYTFDITKVPEEQLSFK 134
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
+ + A Q+ +++L++ +H D+ N+LV E NV+K+ DFG A G ++I Y
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE-DNVMKIADFGLAR--GVHDIDYYK 191
Query: 736 VSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788
+ R APE + Y H D+WS G ++E++T G +PG ++ +L E
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 22/199 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQ---TEVQILKKLAGADPEN 631
G G F V A+D++ E VAIK + + + N+ Q EV+ L+++ +
Sbjct: 34 GHGSFGAVYFARDVRTN----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+ C + CL S +L EV KK + + ++ A+ A Q L +L
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSAS---DLLEVHKKPLQEV--EIAAITHGALQ---GLAYL 141
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGL-- 749
+ ++H DIK N+L+ E V KL DFG+A A + ++ + ++ APE+IL +
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQV-KLADFGSASIA--SPANSFVGTPYWMAPEVILAMDE 198
Query: 750 -PYDHPLDIWSVGCCLYEL 767
YD +D+WS+G EL
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF---AGKNEITPYLV 736
Y ++ +AL + + G++H D+KPDNML+++ + LKL DFG M G +
Sbjct: 147 YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVG 205
Query: 737 SRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLF 774
+ Y +PE++ Y D WSVG L+E+ G F
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 43/174 (24%), Positives = 66/174 (37%), Gaps = 50/174 (28%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---------NAMFAGK 728
R Y +L A++ + G +H DIKPDN+L++ ++ KL DFG ++ + K
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI-KLTDFGLCTGFRWTHDSKYYQK 162
Query: 729 N--------------------EITPYLVSRF----------------YRAPEIILGLPYD 752
+ P R Y APE++L Y
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222
Query: 753 HPLDIWSVGCCLYELYTGKVLF----PGATNNDMLRLHMELKGPFPKKMLRKGA 802
D WSVG LYE+ G+ F P T ++ L P K+ R+ +
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREAS 276
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 27/103 (26%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAP 743
+++L+ +H D+ N LV+ V+K+ DFG + +E T ++F + P
Sbjct: 112 GMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
E+ Y D+WS G ++E++T GK+ F +N +++ +
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 35/100 (35%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 688 LKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEITPYLVSRFYR 741
LK LK ++H D+KP N+LVN +KLCDFG A A N + + Y
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYM 168
Query: 742 APEIILGL-PYDHPL-----DIWSVGCCLYELYTGKVLFP 775
APE I P +P D+WS+G + E+ G+ +P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 44/281 (15%), Positives = 90/281 (32%), Gaps = 25/281 (8%)
Query: 201 REDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEE 260
+E +E+R E+EK K E E RD+ E+ R+R + R ++ +
Sbjct: 127 EPKDRKPKEEAKEKRPPKEKEKEK--EKKVEEPRDREEEKKRERVRAKSRPKKPPKKKPP 184
Query: 261 VDRGRRREKERDRSRDRARVNDRDMDRQRDREKDR------VRDNNLERERERRRDRSRD 314
+ E+E+ R R V + + + E+++ R+ E +S +
Sbjct: 185 NKKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEEDDGKDRETTTSPMEEDESRQSSE 244
Query: 315 KGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGD-----------RTRKDDL 363
R S +K S R R R ++ ++
Sbjct: 245 ISRRSSSSLKKPDPSPSMASPETRESSKRTETRPRTSLRPPSARPASARPAPPRVKRKEI 304
Query: 364 AKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRR----- 418
+ + + I + + +D+ +E ++ Q + + +E+
Sbjct: 305 VTVLQDAQGVGKIVSNVILEGKKSEDEDDENFVVEAAAQAPDIVAGGEDEAEDGEQQGGL 364
Query: 419 -QAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVN 458
Q ILE K S + E S + ++
Sbjct: 365 VQKILETKKEYETGSGSASPGETEASSAAKKERDSSAREIE 405
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|219953 pfam08648, DUF1777, Protein of unknown function (DUF1777) | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 230 RERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQR 289
R R R R + R R R R ER R R +R RRR + R RS R+R R R
Sbjct: 3 RSRSRSPRRSRRRGRSRSRDRRERRRERSRSRERDRRR-RSRSRSPHRSR-------RSR 54
Query: 290 DREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKD 331
+ R R + R R+R+R+R +D + +R+K +D
Sbjct: 55 SPRRHRSRSRSPSRRRDRKRERDKDAREPKKRERQKLIKEED 96
|
This is a family of eukaryotic proteins of unknown function. Some of the proteins in this family are putative nucleic acid binding proteins. Length = 158 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 29/182 (15%)
Query: 594 GEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE 653
G+P+ V +KI + T+ E +L+ + N IR + C+V
Sbjct: 89 GQPDPVVLKIGQKGTTL-----IEAMLLQNV------NHPSVIRMKDTLVSGAITCMVLP 137
Query: 654 SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713
+L L K R + + + KQ+ L++L ++H D+K +N+ +N+
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALI--IEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ 195
Query: 714 VLKLCDFGNAMFAGKNEITPYLVSRFY--------RAPEIILGLPYDHPLDIWSVGCCLY 765
V + D G A F P + F APE++ Y+ DIWS G L+
Sbjct: 196 VC-IGDLGAAQF-------PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
Query: 766 EL 767
E+
Sbjct: 248 EM 249
|
Length = 357 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-05
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 217 EWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRD 276
E K++ ++ RR + RDR+ R+ RD R R R E R+R +
Sbjct: 590 EQPAPKAEAKPERQQDRRKPRQNNRRDRN--ERRDTRDN-RTRREGRENREENRRNRRQA 646
Query: 277 RARVN-DRDMDRQRDREKDRVRDNNLERERERRRDRSR 313
+ + R+ + EK R +D E+++ RR+R R
Sbjct: 647 QQQTAETRESQQAEVTEKARTQD---EQQQAPRRERQR 681
|
Length = 1068 |
| >gnl|CDD|237171 PRK12678, PRK12678, transcription termination factor Rho; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 3e-05
Identities = 35/219 (15%), Positives = 56/219 (25%), Gaps = 26/219 (11%)
Query: 201 REDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEE 260
+ R+ + + E R + R R E
Sbjct: 77 ARRAARAAAAARQAEQPAAEAAAAKAEAAPAARAAAAAAAEAASAPEAAQARERRERGEA 136
Query: 261 VDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIE 320
RG R+ + +R + E+D R R R DR + R
Sbjct: 137 ARRGAARKAGEGGEQPATEARADAAERTEEEERDE------RRRRGDREDRQAEAERGER 190
Query: 321 SDR-EKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGD 379
R E+G D R + R + + + GDR G
Sbjct: 191 GRREERGRDGDDRDRRDRREQGDR--REERGRRDGGDR-----------------RGRRR 231
Query: 380 KITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRR 418
+ + + DD E + + E R R R
Sbjct: 232 RRDRRDARGDDNREDRGDRDGDDGEGRGGRRGRRFRDRD 270
|
Length = 672 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 31/145 (21%), Positives = 66/145 (45%), Gaps = 3/145 (2%)
Query: 200 GREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYE 259
E + E+++++E +E+ K +E ++K + ++++ + EE R R E
Sbjct: 105 EEEKEKEQVKEEKKKKKEKPKEEPK-DRKPKEEAKEKRPPKEKEKEKEKKVEE-PRDREE 162
Query: 260 EVDRGRRREKERDRSRDRARVNDRDMDR-QRDREKDRVRDNNLERERERRRDRSRDKGRD 318
E R R R K R + + + ++ + + ++++ R+ + E + R+K D
Sbjct: 163 EKKRERVRAKSRPKKPPKKKPPNKKKEPPEEEKQRQAAREAVKGKPEEPDVNEEREKEED 222
Query: 319 IESDREKGASPKDSYSNRDRYKHSR 343
DRE SP + +R + SR
Sbjct: 223 DGKDRETTTSPMEEDESRQSSEISR 247
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-05
Identities = 29/102 (28%), Positives = 51/102 (50%), Gaps = 19/102 (18%)
Query: 211 ERERRREWEREKSKHLEVDRERRRDKN-REQSRD-RDIHRGREERDRSRYEEVDRGRRR- 267
+ R++ +R K + + RRD+N R +RD R GRE R+ +R R RR+
Sbjct: 598 AKPERQQ-DRRKPR-----QNNRRDRNERRDTRDNRTRREGRENREENR-----RNRRQA 646
Query: 268 EKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRR 309
+++ +R+ + + R +D ++ R RER+RRR
Sbjct: 647 QQQTAETRESQQAEVTEKARTQDEQQQAPR-----RERQRRR 683
|
Length = 1068 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKII-RNNETMNKAG-QTEVQILKKLAGADPENKR 633
G+G F V A +G E VA+K + R N +G + E+ ILK L
Sbjct: 13 GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL------YHE 66
Query: 634 HCIRFAS--SFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ +++ S + L L+ E + + +LR+ L K + L + +A+Q+ + +
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNL--AQLLLFAQQICEGMAY 122
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPE 744
L + +H D+ N+L+ + ++K+ DFG A + Y V F+ A E
Sbjct: 123 LHSQHYIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVE 180
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT 769
+ + + D+WS G LYEL T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F D+ G+ +VA+K I+N+ T +A E ++ +L +
Sbjct: 15 GKGEFG------DVMLGDYRGNKVAVKCIKNDATA-QAFLAEASVMTQL-----RHSNLV 62
Query: 636 IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+ + L +V E + +L + L+ GR++ L + ++ + A+++L+
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN 121
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHP 754
+H D+ N+LV+E NV K+ DFG A + T L + + APE + +
Sbjct: 122 NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDTGKLPVK-WTAPEALREKKFSTK 179
Query: 755 LDIWSVGCCLYELYT-GKVLFP 775
D+WS G L+E+Y+ G+V +P
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 11/116 (9%)
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEA--KNVLKLCDFG-NAMFAGKNEI-------- 731
Q+ AL N G++H D+KP N++V++ + K+ DFG + G +
Sbjct: 87 QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
T L + Y APE + G P D+++ G E TG+ + GA+ ++L +
Sbjct: 147 TEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL 202
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 38/117 (32%), Positives = 52/117 (44%), Gaps = 38/117 (32%)
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF- 739
A+Q+ + +L ++H DIKP N+L+N AKNV K+ DFG VSR
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNV-KIADFG--------------VSRIL 218
Query: 740 ---------------YRAPEII-----LGLPYD-HPLDIWSVGCCLYELYTGKVLFP 775
Y +PE I G YD + DIWS+G + E Y G+ F
Sbjct: 219 AQTMDPCNSSVGTIAYMSPERINTDLNHGA-YDGYAGDIWSLGVSILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 576 GKGVFSTVVRAKDL---KAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPE 630
G+G F VV A+ + K +P VA+K+++++ T +E++++K +
Sbjct: 21 GEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG----- 75
Query: 631 NKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLK---------KFGR----NIGLKLTA 676
++ I + L ++ E + NLRE L+ F L
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK----NEIT 732
+ + A Q+ +++L + +H D+ N+LV E NV+K+ DFG A + T
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE-DNVMKIADFGLARDVHNIDYYKKTT 194
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788
+ + APE + Y H D+WS G L+E++T G +PG ++ +L E
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 25/99 (25%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAP 743
+ +L++ +H D+ N LV++ + +K+ DFG + + +E T + S+F + P
Sbjct: 112 GMAYLESKQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNND 781
E++L + D+W+ G ++E+Y+ GK+ + N++
Sbjct: 171 EVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 32/238 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE---EVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPE 630
G+G F VV A+ + +P +VA+K+++++ T +E++++K +
Sbjct: 27 GEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----- 81
Query: 631 NKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
++ I + L ++ E + NLRE L+ R G++ + ++ K
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYCYNPTQVPEEQLSFK 140
Query: 690 HLKNCG--------------VLHCDIKPDNMLVNEAKNVLKLCDFGNAM----FAGKNEI 731
L +C +H D+ N+LV E NV+K+ DFG A +
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKT 199
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788
T + + APE + Y H D+WS G L+E++T G +PG ++ +L E
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 39/129 (30%), Positives = 59/129 (45%), Gaps = 7/129 (5%)
Query: 659 LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718
LR L+ L L ++ Y+ QL AL +L++ +H DI N+LV+ V KL
Sbjct: 93 LRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCV-KLG 149
Query: 719 DFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYDHPLDIWSVGCCLYE-LYTGKVLF 774
DFG + + + + APE I + D+W G C++E L G F
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
Query: 775 PGATNNDML 783
G NND++
Sbjct: 210 QGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 67/336 (19%), Positives = 118/336 (35%), Gaps = 63/336 (18%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII---RNNETMNKAGQTEVQILKKLA 625
+ + + + K VA+K I ++ K Q E+ ++L
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTN------TLVAVKKINLDSCSKEDLKLLQQEIITSRQL- 56
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + + +SF + L +V + E L K GL A+ K +
Sbjct: 57 -----QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVL 111
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFA-GKNEITPYLVSRF--- 739
AL ++ + G +H +K ++L++ + L + M GK + + +
Sbjct: 112 NALDYIHSKGFIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 740 ---YRAPEI----ILGLPYDHPLDIWSVG--CCLYELYTGKVLFPGATNNDMLRLHM--- 787
+ +PE+ + G Y+ DI+SVG C EL G V F DM M
Sbjct: 171 NLPWLSPEVLQQNLQG--YNEKSDIYSVGITAC--ELANGHVPF-----KDMPATQMLLE 221
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+++G P +L K + ++ E P N D T S
Sbjct: 222 KVRGTVPC-LLDKSTYPLYEDSM-SQSRSSNEHPN----------NRDSVDHPYTRTFSE 269
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+F ++ DPE R + +Q L H F
Sbjct: 270 --------HFHQFVELCLQRDPESRPSASQLLNHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 35/135 (25%), Positives = 50/135 (37%), Gaps = 41/135 (30%)
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-------------- 721
R Y + +A+ + G +H DIKPDN+L+ +AK +KL DFG
Sbjct: 102 ETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL-DAKGHIKLSDFGLCTGLKKSHRTEFY 160
Query: 722 -----NAMFAGKNEI-TPYLVSRF--------------------YRAPEIILGLPYDHPL 755
+ I P R Y APE+ L Y+
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 756 DIWSVGCCLYELYTG 770
D WS+G +YE+ G
Sbjct: 221 DWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQTEVQILKKLAGADPENKRH 634
GKG F +V + + E VA+K ++++ + + + E++ILK L
Sbjct: 13 GKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL---------Q 63
Query: 635 CIRFASSFKY--------RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
KY R +L LV E L + +LR+ L+K + + + YA Q+
Sbjct: 64 HDNIV---KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL--YASQIC 118
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------- 738
+++L + +H D+ N+LV E++N +K+ DFG +++ Y R
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILV-ESENRVKIGDFGLTKVLPQDK--EYYKVREPGESPI 175
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
F+ APE + + D+WS G LYEL+T
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 38/133 (28%), Positives = 55/133 (41%), Gaps = 27/133 (20%)
Query: 656 HMNLREVLKKFGRNIGL----KLTAVRA-----YAKQLFIALKHLKNCGVLHCDIKPDNM 706
+MN LK F + L A+ A Q+ + +L GV+H DI N
Sbjct: 90 YMNWGN-LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNC 148
Query: 707 LVNEAKNVLKLCDFGNAM----FA------GKNEITPYLVSRFYRAPEIILGLPYDHPLD 756
+++E V K+ D NA+ F G NE P + A E ++ Y D
Sbjct: 149 VIDEELQV-KITD--NALSRDLFPMDYHCLGDNENRPVK----WMALESLVNKEYSSASD 201
Query: 757 IWSVGCCLYELYT 769
+WS G L+EL T
Sbjct: 202 VWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 34/96 (35%), Positives = 47/96 (48%), Gaps = 14/96 (14%)
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR-------APE 744
KNC +H D+ N LV E NVLK+ DFG + + E Y VS + APE
Sbjct: 112 KNC--IHRDLAARNCLVGE-NNVLKISDFG---MSREEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATN 779
+ Y D+WS G L+E ++ G +PG +N
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN 201
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|130009 TIGR00934, 2a38euk, potassium uptake protein, Trk family | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 48/263 (18%), Positives = 86/263 (32%), Gaps = 15/263 (5%)
Query: 161 NDSED--ERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREW 218
+ ED E V HGS ++ + R ++ + R E
Sbjct: 156 RELEDRPETGVAGRVTVPHGSAKRRDFQDKLFSGEFVKRDEPDQNSPDVKS--DTRADES 213
Query: 219 EREKSKHLEVDRERRRDKNREQS-RDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDR 277
+ R RD + E R + +G ER R + R R E + +
Sbjct: 214 ISDLEFEKFAKRRGSRDVDPEDLYRSIMMLQGIHERIREKSSANSRSDERSSESIQEQVE 273
Query: 278 ARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRD--KGRDIESDREKGASPKDSYSN 335
R + D++R R D + ++ RR ++ D + D+E +
Sbjct: 274 RRPSTSDIERNSQSLTRRYDDKSFDKAVRLRRSKTIDRAEACDLEELDR---AKDFEKMT 330
Query: 336 RDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERV 395
D +K K + + + RK S +Y E +G+ ++ E
Sbjct: 331 YDNWKAHHRKKKNFRPRGWNLKFRKASRFPKDSDRNY--EDNGNHLSASSSFGS---EEP 385
Query: 396 ALKLEEQEEEDLDRIMEESRKRR 418
+L EE ++ E+SR
Sbjct: 386 SLSSEENLYPTYNKKREDSRHTL 408
|
The proteins of the Trk family are derived from Gram-negative and Gram-positive bacteria, yeast and wheat. The proteins of E. coli K12 TrkH and TrkG as well as several yeast proteins have been functionally characterized.The E. coli TrkH and TrkG proteins are complexed to two peripheral membrane proteins, TrkA, an NAD-binding protein, and TrkE, an ATP-binding protein. This complex forms the potassium uptake system. This family is specific for the eukaryotic Trk system [Transport and binding proteins, Cations and iron carrying compounds]. Length = 800 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 16/34 (47%), Positives = 20/34 (58%)
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
K FKD L+K V DPEKR + + L HPF+
Sbjct: 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 52/223 (23%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV----QILKKLAGADPEN 631
G G F +VV+ +G+ EVA+K ++ AG+ E ++ +L +
Sbjct: 4 GHGNFGSVVKGV-YLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQL------D 54
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFG--RNIGLKLTAVRAYAKQLFIAL 688
+R K L LV E + L + LKK LK A Q+ + +
Sbjct: 55 HPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-----LAHQVAMGM 108
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLVSRF---YRAP 743
+L++ +H D+ N+L+ ++ K+ DFG A+ AG + R+ + AP
Sbjct: 109 AYLESKHFVHRDLAARNVLL-VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAP 167
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
E I + D+WS G L+E ++ G + +++ +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 54/263 (20%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKL 624
+E G+G F V + G+ A+KI+R + + K + E IL +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGH----IYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
GA ++ SF+ + +L L+ E L +++ + L A + Y +
Sbjct: 59 DGA------WVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAET 110
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL-------VS 737
+A+ + G +H DIKPDN+L+ +AK +KL DFG K T + S
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLL-DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 738 RF------------------------------YRAPEIILGLPYDHPLDIWSVGCCLYEL 767
F Y APE+ + Y+ D WS+G +YE+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 768 YTGKVLFPGATNNDMLRLHMELK 790
G F T + R M K
Sbjct: 230 LIGYPPFCSETPQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|220648 pfam10243, MIP-T3, Microtubule-binding protein MIP-T3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 24/154 (15%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 207 SREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRR 266
E + E EK K +V E+++ K + + +D E +++ +E ++ +
Sbjct: 93 KPAKEPKNESGKEEEKEKE-QVKEEKKKKKEKPKEEPKDRKPKEEAKEKRPPKEKEKEKE 151
Query: 267 REKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKG 326
++ E R DR+ +++++RVR + ++ +++ ++ K E ++++
Sbjct: 152 KKVEEPR------------DREEEKKRERVRAKSRPKKPPKKKPPNKKKEPP-EEEKQRQ 198
Query: 327 ASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRK 360
A+ + + + + ++D G + T
Sbjct: 199 AAREAVKGKPEEPDVNEEREKEEDDGKDRETTTS 232
|
This protein, which interacts with both microtubules and TRAF3 (tumour necrosis factor receptor-associated factor 3), is conserved from worms to humans. The N-terminal region is the microtubule binding domain and is well-conserved; the C-terminal 100 residues, also well-conserved, constitute the coiled-coil region which binds to TRAF3. The central region of the protein is rich in lysine and glutamic acid and carries KKE motifs which may also be necessary for tubulin-binding, but this region is the least well-conserved. Length = 506 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 35/113 (30%), Positives = 57/113 (50%), Gaps = 12/113 (10%)
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI 731
L L + Y+ Q+ ++ L + +H D+ N+L++E NV+K+CDFG A K+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKD-- 232
Query: 732 TPYLVSR-------FYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
P V + + APE I Y D+WS G L+E+++ G +PG
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G F V+ G ++VA+K I+ + T +A E ++ KL + ++
Sbjct: 15 GEGEFGAVL------QGEYTGQKVAVKNIKCDVTA-QAFLEETAVMTKL------HHKNL 61
Query: 636 IRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+R + N L +V E M NL L+ GR + + + + ++ + +++L+
Sbjct: 62 VRLLGVILH-NGLYIVME--LMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE 117
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYD 752
+ ++H D+ N+LV+E V K+ DFG A G + + + APE + +
Sbjct: 118 SKKLVHRDLAARNILVSE-DGVAKVSDFGLAR-VGSMGVDNSKLPVKWTAPEALKHKKFS 175
Query: 753 HPLDIWSVGCCLYELYT-GKVLFPGATNNDM 782
D+WS G L+E+++ G+ +P + ++
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 12/113 (10%)
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI 731
L L + +Y+ Q+ ++ L + +H D+ N+L++E NV+K+CDFG A K+
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKD-- 226
Query: 732 TPYLV----SRF---YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
P V +R + APE I Y D+WS G L+E+++ G +PG
Sbjct: 227 -PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQTEVQILKKLAGA 627
YE+ G G + V +A++L G E A+KII+ + Q E+ ++K+
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTG----ELAAVKIIKLEPGDDFSLIQQEIFMVKEC--- 63
Query: 628 DPENKRHC--IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQL 684
+HC + + S+ R L + E +L+++ G L++ V ++
Sbjct: 64 -----KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYV---CRET 115
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------ 738
L +L + G +H DIK N+L+ + +V KL DFG A +IT + R
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDV-KLADFGVAA-----KITATIAKRKSFIGT 169
Query: 739 -FYRAPEIIL---GLPYDHPLDIWSVGCCLYEL 767
++ APE+ Y+ DIW+VG EL
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 16/94 (17%)
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRFYR------AP 743
KNC +H D+ N+L+ K ++K+CDFG A + N Y+V R AP
Sbjct: 160 KNC--IHRDLAARNVLLTHGK-IVKICDFGLARDIMNDSN----YVVKGNARLPVKWMAP 212
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
E I Y D+WS G L+E+++ G +PG
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE----VAIKIIRN-NETMNKAGQTEVQILKKLAGADPE 630
G+G F V A+ N PE+ VA+K ++ +E+ + Q E ++L L
Sbjct: 14 GEGAFGKVFLAE---CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL------ 64
Query: 631 NKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIG------------LKLTAV 677
+H +RF L +VFE + H +L L+ G + L L +
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--------NAMFAGKN 729
A A Q+ + +L + +H D+ N LV + V+K+ DFG + G
Sbjct: 125 LAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGR 183
Query: 730 EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
+ P + PE IL + DIWS G L+E++T
Sbjct: 184 TMLPIR----WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|219061 pfam06495, Transformer, Fruit fly transformer protein | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 33/111 (29%), Positives = 45/111 (40%), Gaps = 16/111 (14%)
Query: 207 SREIERERRREWEREKSKHL-----EVDRERR-RDKNREQSRDRDIHRGREERDRSRYEE 260
SR RR ++EK + E DR R R + + +R HRGR R RSR +
Sbjct: 7 SRSPRDTRRDSRKKEKIPYFADEVRERDRVRNLRQRKTQSTRPTTSHRGRRTRSRSRSQS 66
Query: 261 VDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDR 311
+R + + R RSR R R + R + R R R R R
Sbjct: 67 AERNSCQRRHRSRSR----------SRNRSDSRHRSTSSTERRRRSRSRSR 107
|
This family consists of transformer proteins from several Drosophila species and also from Ceratitis capitata (Mediterranean fruit fly). The transformer locus (tra) produces an RNA processing protein that alternatively splices the doublesex pre-mRNA in the sex determination hierarchy of Drosophila melanogaster. Length = 182 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-04
Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 6/111 (5%)
Query: 671 GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGK 728
GL + ++ Q+ ++ L + +H D+ N+L+ + K ++K+CDFG A +
Sbjct: 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDS 291
Query: 729 NEIT--PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
N ++ + + APE I Y D+WS G L+E+++ G +PG
Sbjct: 292 NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 25/206 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG F V+ G+ ++VA+K ++++ T +A E ++ L RH
Sbjct: 15 GKGEFGDVML------GDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTL--------RHP 60
Query: 635 -CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
++ N L +V E +M +L + L+ GR + + L +A + +++
Sbjct: 61 NLVQLLGVVLQGNPLYIVTE--YMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEY 117
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLP 750
L+ +H D+ N+LV+E V K+ DFG A A + + + L + + APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEASQGQDSGKLPVK-WTAPEALREKK 175
Query: 751 YDHPLDIWSVGCCLYELYT-GKVLFP 775
+ D+WS G L+E+Y+ G+V +P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI---TPYLVSRFYR------A 742
KNC +H D+ N+L+ + V K+CDFG A +I + Y+V R A
Sbjct: 231 KNC--IHRDVAARNVLLTD-GRVAKICDFGLA-----RDIMNDSNYVVKGNARLPVKWMA 282
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
PE I Y D+WS G L+E+++ GK +PG
Sbjct: 283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 34/110 (30%), Positives = 56/110 (50%), Gaps = 12/110 (10%)
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR- 738
Y+ Q+ ++ L + +H D+ N+L++E NV+K+CDFG A K+ P V +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKD---PDYVRKG 234
Query: 739 ------FYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNND 781
+ APE I Y D+WS G L+E+++ G +PG N+
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|233503 TIGR01642, U2AF_lg, U2 snRNP auxilliary factor, large subunit, splicing factor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 34/150 (22%), Positives = 43/150 (28%), Gaps = 38/150 (25%)
Query: 91 DRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPL 150
D E S + R RS D R R R RSR +S E+ P
Sbjct: 2 DEEPDREREKSRGRDRDRSSERPRRRSRDRS---RFRDRHR-----RSRERSYREDSRPR 53
Query: 151 KRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREI 210
R Y R + R SRD R R R ++H R
Sbjct: 54 DRRRYDSRSPRSLRYSSVRR--------SRDRPRRRSRSVR---------SIEQHRRRLR 96
Query: 211 ERERRREWEREKSKHLEVDRERRRDKNREQ 240
+R +W R+ DK R
Sbjct: 97 DRSPSNQW-------------RKDDKKRSL 113
|
These splicing factors consist of an N-terminal arginine-rich low complexity domain followed by three tandem RNA recognition motifs (pfam00076). The well-characterized members of this family are auxilliary components of the U2 small nuclear ribonuclearprotein splicing factor (U2AF). These proteins are closely related to the CC1-like subfamily of splicing factors (TIGR01622). Members of this subfamily are found in plants, metazoa and fungi. Length = 509 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 59/260 (22%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKK-LAGA 627
+E G+G F V + G+ A+KI+R + + K ++ + L A
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGH----VYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
D ++ SF+ + +L L+ E L +++ + L + Y + +A
Sbjct: 59 D---SLWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLA 113
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY-------LVSRF- 739
+ + G +H DIKPDN+L+ ++K +KL DFG K T + L S F
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLL-DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 740 -----------------------------YRAPEIILGLPYDHPLDIWSVGCCLYELYTG 770
Y APE+ + Y+ D WS+G +YE+ G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 771 KVLFPGATNNDMLRLHMELK 790
F T + + M K
Sbjct: 233 YPPFCSETPQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 0.001
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 655 LHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG-------VLHCDIKPDNML 707
L N+++ K FG+ ++ A+ +QL AL + N VLH D+KP N+
Sbjct: 101 LSRNIQKCYKMFGK---IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157
Query: 708 VN-----------EAKN-----VLKLCDFGNAMFAGKNEITPYLV-SRFYRAPEIIL--G 748
++ +A N + K+ DFG + G + V + +Y +PE++L
Sbjct: 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHET 217
Query: 749 LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808
YD D+W++GC +YEL +GK F A N L ++ P K K +
Sbjct: 218 KSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIK--GKSKELNILI 275
Query: 809 DQDLNFHATEEDPVTKKAIKKIIFNIKP----KDIGSIVTASPG 848
LN A E + +II N+ P G+ V A+PG
Sbjct: 276 KNLLNLSAKERPSALQCLGYQIIKNVGPPVGAAGGGAGVAAAPG 319
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 34/124 (27%), Positives = 63/124 (50%), Gaps = 9/124 (7%)
Query: 600 AIKIIRNNETMNKAGQTEVQILKK-LAGADPENKRHCIRFASSFKYRNHLCLVFESL-HM 657
A+K+++ + +NK +VQ + LA + + S + N++ LV E L
Sbjct: 33 AVKVVKKADMINKNMVHQVQAERDALALS---KSPFIVHLYYSLQSANNVYLVMEYLIGG 89
Query: 658 NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717
+++ +L +G Y ++ +AL +L G++H D+KPDNML++ ++ KL
Sbjct: 90 DVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHI-KL 145
Query: 718 CDFG 721
DFG
Sbjct: 146 TDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEIT--PYLVSRFYRAPEIIL 747
KNC +H D+ N+L+ E K ++K+CDFG A + N I+ + + APE I
Sbjct: 258 KNC--VHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314
Query: 748 GLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
Y D+WS G L+E++T G +P N+
Sbjct: 315 NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|233496 TIGR01622, SF-CC1, splicing factor, CC1-like family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 22/76 (28%), Positives = 34/76 (44%), Gaps = 6/76 (7%)
Query: 287 RQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLK 346
R RDRE+ R+R+ RR D+ R++ R R++ +D R R SR
Sbjct: 1 RYRDRERGRLRN------DTRRSDKGRERSRRRSRSRDRSRRRRDRDYYRGRRGRSRSRS 54
Query: 347 HDDDKGSYGDRTRKDD 362
+ GDR+ + D
Sbjct: 55 PNRYYRPRGDRSYRRD 70
|
This model represents a subfamily of RNA splicing factors including the Pad-1 protein (N. crassa), CAPER (M. musculus) and CC1.3 (H.sapiens). These proteins are characterized by an N-terminal arginine-rich, low complexity domain followed by three (or in the case of 4 H. sapiens paralogs, two) RNA recognition domains (rrm: pfam00706). These splicing factors are closely related to the U2AF splicing factor family (TIGR01642). A homologous gene from Plasmodium falciparum was identified in the course of the analysis of that genome at TIGR and was included in the seed. Length = 457 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 30/117 (25%), Positives = 53/117 (45%), Gaps = 5/117 (4%)
Query: 220 REKSKHLEVDRERRRDKNREQSRDRDIHRGREER-DRSRYEEVDRGRRREKERDRSR--- 275
R H E R + + +R+ + + + R ER +R E ++R R ER+R
Sbjct: 429 RVDKDHAERARIEKENAHRKALEMKILEKKRIERLEREERERLERERMERIERERLERER 488
Query: 276 -DRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKD 331
+R R+ ++R R +R R + LER+R + R+ + +E+ G P D
Sbjct: 489 LERERLERDRLERDRLDRLERERVDRLERDRLEKARRNSYFLKGMENGLSAGGGPGD 545
|
Length = 1021 |
| >gnl|CDD|233758 TIGR02169, SMC_prok_A, chromosome segregation protein SMC, primarily archaeal type | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.002
Identities = 38/212 (17%), Positives = 73/212 (34%), Gaps = 19/212 (8%)
Query: 124 RRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDLV 183
R R E + Q + E LKR E + SE +RR N +
Sbjct: 660 RAPRGGILFSRSEPAELQRLRERLEGLKR----ELSSLQSE----LRRIENRLDELSQEL 711
Query: 184 RDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRD 243
D R+ ++ +E E + + + V E + + R + +
Sbjct: 712 SDASRKIGEIEKEIEQLEQEEEKLKERLEELEEDLSSLEQEIENVKSELKELEARIEELE 771
Query: 244 RDIHRGREE-------RDRSRYEEVDRGRRREKERDRSRDRARVNDRDM---DRQRDREK 293
D+H+ E SR E+ + E + SR AR+ + + ++E
Sbjct: 772 EDLHKLEEALNDLEARLSHSRIPEIQA-ELSKLEEEVSRIEARLREIEQKLNRLTLEKEY 830
Query: 294 DRVRDNNLERERERRRDRSRDKGRDIESDREK 325
L+ +R +++ + ++IE+ K
Sbjct: 831 LEKEIQELQEQRIDLKEQIKSIEKEIENLNGK 862
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. It is found in a single copy and is homodimeric in prokaryotes, but six paralogs (excluded from this family) are found in eukarotes, where SMC proteins are heterodimeric. This family represents the SMC protein of archaea and a few bacteria (Aquifex, Synechocystis, etc); the SMC of other bacteria is described by TIGR02168. The N- and C-terminal domains of this protein are well conserved, but the central hinge region is skewed in composition and highly divergent [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1164 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 21/95 (22%)
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE---------ITPYLVSRF------ 739
GVLH D+KPDN+L+ V+ L D+G A+F E S
Sbjct: 133 GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191
Query: 740 -----YRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
Y APE +LG+P DI+++G LY++ T
Sbjct: 192 VGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 32/220 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE-VAIKIIRNNET--MNKAGQTEVQILK--------KL 624
G+G F V +A+ EP VA+K+++ + M Q E ++ KL
Sbjct: 14 GQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKL 73
Query: 625 AGADPENKRHCIRFA-------SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAV 677
G K C+ F + F R+ SL + K + L T
Sbjct: 74 LGVCAVGKPMCLLFEYMAYGDLNEF-LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--------NAMFAGKN 729
AKQ+ + +L +H D+ N LV E V+K+ DFG + A +N
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKASEN 191
Query: 730 EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
+ P + PE I Y D+W+ G L+E+++
Sbjct: 192 DAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 15/127 (11%)
Query: 600 AIKIIRNNETMNKAGQTEVQILKK-LAGADPENKRHCIRFASSFKYRNHLCLVFESL--- 655
A+K +R + +N+ V+ + LA AD E ++ SF+ +++L V + +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNE---WVVKLYYSFQDKDNLYFVMDYIPGG 86
Query: 656 -HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714
M+L ++ F + R Y +L +A++ + G +H DIKPDN+L++ ++
Sbjct: 87 DMMSLLIRMEVFPEVLA------RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHI 140
Query: 715 LKLCDFG 721
KL DFG
Sbjct: 141 -KLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 658 NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717
+L+E L + I LK YA Q+ + +L + +H D+ N+LV E+++ +K+
Sbjct: 94 SLKEYLPRNKNKINLK--QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV-ESEHQVKI 150
Query: 718 CDFGNAMFAGKNEITPYLVSR------FYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769
DFG A + + Y V F+ APE ++ + D+WS G LYEL T
Sbjct: 151 GDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 46/232 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE--VAIKIIRNNETMNKAGQ--TEVQILKKLAGADPEN 631
G+G F VV+A + + E VA+K+++++ T +E++++K + ++
Sbjct: 21 GEGAFGQVVKA-EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KH 75
Query: 632 KRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKK-----------FGRNIGLKLT--AV 677
K + I L +V E + H NLR+ L+ R LT +
Sbjct: 76 K-NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
++A Q+ ++ L + +H D+ N+LV E +V+K+ DFG A +
Sbjct: 135 VSFAYQVARGMEFLASKKCIHRDLAARNVLVTE-DHVMKIADFGLARDIHHID------- 186
Query: 738 RFYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
+YR APE + Y H D+WS G L+E++T G +PG
Sbjct: 187 -YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 36/156 (23%), Positives = 57/156 (36%), Gaps = 50/156 (32%)
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---------------- 721
R Y + +A++ + G +H DIKPDN+L+ + +KL DFG
Sbjct: 104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILI-DRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
Query: 722 ----------------------NAMFAGKNEITPYLVSRF-----------YRAPEIILG 748
N + K++I + +R Y APEI L
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222
Query: 749 LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
Y D WS+G ++E G F +++ R
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYR 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 12/92 (13%)
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR------APEI 745
KNC +H D+ N+L+ + + K+CDFG A +N+ + Y+V R APE
Sbjct: 233 KNC--IHRDLAARNILLTHGR-ITKICDFGLARDI-RND-SNYVVKGNARLPVKWMAPES 287
Query: 746 ILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
I Y D+WS G L+E+++ G +PG
Sbjct: 288 IFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 34/165 (20%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 145 EEEAPLKRSNYHERDANDSEDERLVRRGRNERHGS-RDLVRDDEREHRTSYTTRYVGRED 203
EE P ++ + + +R R R + RD R++ R+ R
Sbjct: 584 EETKPQEQPAPKAEAKPERQQDR-----RKPRQNNRRD--RNERRDTR--------DNRT 628
Query: 204 RHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDR 263
R RE RE R R+ + RE ++ + E++R +D + R+R R
Sbjct: 629 RREGRE-NREENRRNRRQAQQQTAETRESQQAEVTEKARTQDEQQQAPRRERQR------ 681
Query: 264 GRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERR 308
RR E+ +++ A+ + + ++ E++ R R++R
Sbjct: 682 --RRNDEKRQAQQEAKALNVEEQSVQETEQEERVQQVQPR-RKQR 723
|
Length = 1068 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 24/126 (19%)
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-------------NAMFAGKN 729
Q+ +AL + + ++H D+K N+ + ++KL DFG + F G
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCG-- 233
Query: 730 EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
TPY Y APE+ Y D+WS+G LYEL T F G + ++++ +
Sbjct: 234 --TPY-----YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286
Query: 790 K-GPFP 794
K PFP
Sbjct: 287 KYDPFP 292
|
Length = 478 |
| >gnl|CDD|217503 pfam03344, Daxx, Daxx Family | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.004
Identities = 26/164 (15%), Positives = 61/164 (37%), Gaps = 9/164 (5%)
Query: 297 RDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGD 356
+D+ E ER +R++R R SD K +S S + + +
Sbjct: 395 QDDTEEEERRKRQERERQGTSSRSSDPSKASSTSGE---------SPSMASQESEEEESV 445
Query: 357 RTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRK 416
+++ + S E G+ ++E+ + D ++ + + D + E++ +
Sbjct: 446 EEEEEEEEEEEEEEQESEEEEGEDEEEEEEVEADNGSEEEMEGSSEGDGDGEEPEEDAER 505
Query: 417 RRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNK 460
R + + QQ + S++ E+P + S + +
Sbjct: 506 RNSEMAGISRMSEGQQPRGSSVQPESPQEEPLQPESMDAESVGE 549
|
The Daxx protein (also known as the Fas-binding protein) is thought to play a role in apoptosis, but precise role played by Daxx remains to be determined. Daxx forms a complex with Axin. Length = 715 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 41/234 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE----VAIKIIRN-NETMNKAGQTEVQILKKLAGADPE 630
G+G F V A+ N PE+ VA+K +++ ++ K E ++L L
Sbjct: 14 GEGAFGKVFLAE---CYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL------ 64
Query: 631 NKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGL--------KLTAVRAY- 680
H ++F + L +VFE + H +L + L+ G + L +LT +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 681 -AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL-KLCDFG--------NAMFAGKNE 730
A+Q+ + +L + +H D+ N LV E N+L K+ DFG + G +
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGE--NLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ P + PE I+ + D+WS+G L+E++T GK + +NN+++
Sbjct: 183 MLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 887 | |||
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.21 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.13 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.0 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| KOG4676 | 479 | consensus Splicing factor, arginine/serine-rich [R | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| KOG4676 | 479 | consensus Splicing factor, arginine/serine-rich [R | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.54 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.49 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.15 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.13 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.08 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.84 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.79 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.28 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.25 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 96.17 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.01 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.95 | |
| KOG3263 | 196 | consensus Nucleic acid binding protein [General fu | 95.77 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.72 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.58 | |
| PF08648 | 180 | DUF1777: Protein of unknown function (DUF1777); In | 95.26 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.09 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.43 |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-85 Score=713.60 Aligned_cols=493 Identities=57% Similarity=0.914 Sum_probs=425.1
Q ss_pred ccchHHHHHHHhhHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCCCCCCCCCCCCccccccccccCcc
Q 002732 387 EQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEKPSEHSSQSTDVNNKLQNDSN 466 (887)
Q Consensus 387 ~~~d~ee~~~~~~~~~e~~e~~k~~e~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~se~~~~~~~~~~~~~~~~~ 466 (887)
.+++..+++.|+.++.++.+++-++|+.+++.++||+||++...||+...+.- ..|.. +-.+.+.....+.-..++.
T Consensus 255 ~~dd~~~~~~~~s~ee~~~~~~~ieed~~~~~~~il~k~~~~~~qq~~~~q~~-~~p~~--~~~~~~~~~~~~~~q~~~~ 331 (752)
T KOG0670|consen 255 RSDDIGEKLTWESEEEEEAESEIIEEDRRKREEEILEKYKQKGEQQGSGAQTS-SDPHT--SVSVESSKLSADVDQVKTT 331 (752)
T ss_pred ccccccccccccchhhhhhhhhhhhHHHHHHHHHHHHHHHhhhhhcccccccc-CCCCC--CCccccccccCChhhhhhc
Confidence 44666777888888755455666666799999999999999999988864442 22111 1011111222222233344
Q ss_pred CccCCcccccCCCCCccCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCCCCccccccccc-ccccceeeccC
Q 002732 467 GRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTG-KAEGLKIIRSG 545 (887)
Q Consensus 467 ~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~s~~s~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 545 (887)
..+..|.--++..+..+...|..........+.+.++ ..+++++....+++.+++|+..|.+....+ ++..+..+.++
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~a~-~~~s~k~~~e~d~~~dd~f~~s~~~~~~~~~~g~~~~~~~~~ 410 (752)
T KOG0670|consen 332 LPIEAVEKERENASTIEGEKPKRNEIMDSDKTNATAS-DEGSPKSSVESDDFEDDMFADSPSPSGKRQNKGSTVPRVNPG 410 (752)
T ss_pred ccccCCcccccCcchhhcCCccccccchhhhhhhhhc-ccCCccccchhhhhhhhhhccCCCcccccccCCccccccCCc
Confidence 4444444334444444555555555444443333333 678999999999999999999976655443 44477888999
Q ss_pred CCCCCcCCCCceecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhh
Q 002732 546 LHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLA 625 (887)
Q Consensus 546 ~~~~~~~~~g~~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~ 625 (887)
+.+||++++|||.|++||+|..+|.|...+|+|.|++|+.|.+...+ ..||||||.++..+.+..+.|+.||++|.
T Consensus 411 L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~----~~vAiKIIRnNE~M~KtGl~EleiLkKL~ 486 (752)
T KOG0670|consen 411 LQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARG----QEVAIKIIRNNEVMHKTGLKELEILKKLN 486 (752)
T ss_pred cccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCC----CeeEEEEeecchHHhhhhhHHHHHHHHhh
Confidence 99999999999999999999999999999999999999999998877 69999999999999999999999999999
Q ss_pred CCCCCCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCC
Q 002732 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705 (887)
Q Consensus 626 ~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~N 705 (887)
.+.+....||+.|+-.|.+.+|+|||||.+..+|.++|++++.+.+|....++.|+.||+.||..|..|||+|+||||.|
T Consensus 487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDN 566 (752)
T KOG0670|consen 487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDN 566 (752)
T ss_pred ccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002732 706 MLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785 (887)
Q Consensus 706 ILl~~~~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~ 785 (887)
|||+++.+++||||||.|.+.+.+.+++|+.+.+|.|||+|+|.+|+++.|+||+||+||||+||+++|+|.++++||..
T Consensus 567 iLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 567 ILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCC-CCccccccC---CCCCChhhHHHHHHHH
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP-KDIGSIVTA---SPGEDPKMLANFKDLL 861 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~s~~~~dLL 861 (887)
+|++.|+||..|++++.|..++|+.+++|.+.+.+.++...+..++.+++| .++.+.+.. ++..++.+..+|.+||
T Consensus 647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL 726 (752)
T KOG0670|consen 647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL 726 (752)
T ss_pred HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999988888888888 688877765 7888899999999999
Q ss_pred HHhcccCCCCCcCHHHHHhCCCCCCC
Q 002732 862 DKIFVLDPEKRMTVAQALTHPFISGK 887 (887)
Q Consensus 862 ~kmL~~DP~~RpTa~elL~Hpwf~~~ 887 (887)
.+||.+||.+|+|+.|||+||||++|
T Consensus 727 dkml~LdP~KRit~nqAL~HpFi~~k 752 (752)
T KOG0670|consen 727 DKMLILDPEKRITVNQALKHPFITEK 752 (752)
T ss_pred HHHhccChhhcCCHHHHhcCCcccCC
Confidence 99999999999999999999999986
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-56 Score=506.63 Aligned_cols=328 Identities=41% Similarity=0.687 Sum_probs=280.5
Q ss_pred CcCCCCceecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCC
Q 002732 550 WDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADP 629 (887)
Q Consensus 550 ~~~~~g~~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~ 629 (887)
+++.++.|.+.+++++..+|.|+++||+|+||.|.+|.+..++ +.||||++++......+...|+.||..|....+
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~----e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~ 244 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTG----EIVAIKIIKNKKRFLRQAQIEIRILELLNKHDP 244 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCC----cEEEEEeeccChHHHHHHHHHHHHHHHHhccCC
Confidence 6778899999999999999999999999999999999999988 999999999999999999999999999987777
Q ss_pred CCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc
Q 002732 630 ENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709 (887)
Q Consensus 630 ~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 709 (887)
.+..|||+++++|.+.+|+|||||.+..+|+++|+.... .+|++..++.|+.|||.||.+||..|||||||||+||||.
T Consensus 245 ~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~ 323 (586)
T KOG0667|consen 245 DDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLK 323 (586)
T ss_pred CCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeec
Confidence 778899999999999999999999999999999998544 5699999999999999999999999999999999999996
Q ss_pred C-CCCeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 002732 710 E-AKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 710 ~-~~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~ 788 (887)
. ....|||||||+|++.....+ +++.+.+|.|||+|+|.+|+.++|||||||||+||++|.++|+|.+..++++.|++
T Consensus 324 ~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 324 DPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred cCCcCceeEEecccccccCCcce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 4 345799999999999887655 89999999999999999999999999999999999999999999999999999999
Q ss_pred hhCCCChhhhhccccccccccc-ccccccCcC-C-------hhhHHHHHHHHhhcCCC-CccccccCCCCCChhhHHHHH
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQ-DLNFHATEE-D-------PVTKKAIKKIIFNIKPK-DIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~-~l~~~~~~~-~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~ 858 (887)
.+|.+|..||..+..+..+|+. ...+....+ . +.....+.......... ...++...... ..-..|+
T Consensus 403 ~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~---~~~~~F~ 479 (586)
T KOG0667|consen 403 VLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPK---ADDKLFI 479 (586)
T ss_pred HhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccc---ccHHHHH
Confidence 9999999999999999988888 332221111 1 11111112222222222 22222222222 2236789
Q ss_pred HHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 859 DLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
+||.+||.+||..|+|+.|+|+||||++
T Consensus 480 dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 480 DFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred HHHHHHhccCchhcCCHHHHhcCccccc
Confidence 9999999999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=422.97 Aligned_cols=282 Identities=31% Similarity=0.596 Sum_probs=238.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|+.+.++|+|+||+||+|+++.+| +.||||.+..+ +...+..++||.+|++| .|+|+|.|+.+|-
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tg----qIVAIKkF~Esedd~~VkKIAlREIrmLKqL------kH~NLVnLiEVFr 71 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTG----QIVAIKKFVESEDDPVVKKIALREIRMLKQL------KHENLVNLIEVFR 71 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcc----cEEEEEeeccCCccHHHHHHHHHHHHHHHhc------ccchHHHHHHHHH
Confidence 35889999999999999999999998 99999999753 44567788999999999 9999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
-...++||||||..++.+.|+.+.. +++...+..|+.||+.|+.|+|+++||||||||+||||+. .+++||||||+|
T Consensus 72 rkrklhLVFE~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~-~gvvKLCDFGFA 148 (396)
T KOG0593|consen 72 RKRKLHLVFEYCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ-NGVVKLCDFGFA 148 (396)
T ss_pred hcceeEEEeeecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec-CCcEEeccchhh
Confidence 9999999999999999999988654 5999999999999999999999999999999999999995 899999999999
Q ss_pred eecC--CCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAG--KNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~--~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+.+. ...+|.++.|.||.|||.+.| .+|+.++|||++|||+.||++|.++|+|.++.+++..|...+|.++....
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq-- 226 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ-- 226 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH--
Confidence 8765 334788999999999999998 68999999999999999999999999999999999999999999876542
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..|....-|+..... .+... ...+...+.++.-+++|+.+||..||.+|++++|+|.
T Consensus 227 -----~iF~~N~~F~Gv~lP--------------~~~~~----epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 227 -----SIFSSNPFFHGVRLP--------------EPEHP----EPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred -----HHhccCCceeeeecC--------------CCCCc----cchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 122222222211100 00000 0112223566678899999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 284 H~yFd~ 289 (396)
T KOG0593|consen 284 HPYFDG 289 (396)
T ss_pred ChHHHH
Confidence 999953
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-50 Score=433.63 Aligned_cols=316 Identities=33% Similarity=0.580 Sum_probs=273.2
Q ss_pred CcCCCCceecccCceec-CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCC
Q 002732 550 WDDAEGYYSYRFGEILD-GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 550 ~~~~~g~~~~~~~eil~-~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~ 628 (887)
-+..+||+++.+|++|+ ++|.++.+||||.|+|||+|.|.... ..|||||++....+.+....||.+|+++....
T Consensus 60 dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~----r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D 135 (590)
T KOG1290|consen 60 DYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNK----RYVALKVVKSAQHYTEAALDEIKLLQQVREGD 135 (590)
T ss_pred hhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCC----eEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence 46788999999999999 99999999999999999999998877 89999999999899999999999999998766
Q ss_pred --CCCCcceeEecceeeec----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhh-ccceeccCC
Q 002732 629 --PENKRHCIRFASSFKYR----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK-NCGVLHCDI 701 (887)
Q Consensus 629 --~~~h~~Iv~l~~~~~~~----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLH-s~gIvHrDL 701 (887)
.....+||+|+++|.+. .|+|||||+++.+|..+|+.+.. .+|++..++.|++|||.||.||| .|||||.||
T Consensus 136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDl 214 (590)
T KOG1290|consen 136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDL 214 (590)
T ss_pred CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCC
Confidence 45667999999999874 69999999999999999998765 45999999999999999999999 589999999
Q ss_pred CCCCccccCC----------------------------------------------------------------------
Q 002732 702 KPDNMLVNEA---------------------------------------------------------------------- 711 (887)
Q Consensus 702 KP~NILl~~~---------------------------------------------------------------------- 711 (887)
||+||||...
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 9999997110
Q ss_pred -------------------------------------------C------------------------------------
Q 002732 712 -------------------------------------------K------------------------------------ 712 (887)
Q Consensus 712 -------------------------------------------~------------------------------------ 712 (887)
.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 0
Q ss_pred ----------------CeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 713 ----------------NVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 713 ----------------~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
-.|||+|||.|||... .++.-+.|..|.|||||+|..|++.+||||++||+|||+||.++|.-
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHK-HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhh-hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 0368899999988765 46666889999999999999999999999999999999999999963
Q ss_pred ------CChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCC
Q 002732 777 ------ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850 (887)
Q Consensus 777 ------~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (887)
.-++++++.|++++|.+|..++..+.+...||+....+... -.++++.+..++.....-.
T Consensus 454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI--------------~~LK~WpL~~VL~eKY~~s 519 (590)
T KOG1290|consen 454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHI--------------RRLKPWPLYEVLIEKYEWS 519 (590)
T ss_pred CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecc--------------cccCCCcHHHHHHHHhCCC
Confidence 23568999999999999999999999999999976554322 2344455554444434444
Q ss_pred hhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 851 ~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
..-..+|-+||.-||+++|.+||||.++|+||||+
T Consensus 520 ~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 520 EEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred HHHHHHHHHHHHHHHhcCccccccHHHHhcCcccc
Confidence 55668999999999999999999999999999997
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-51 Score=435.95 Aligned_cols=257 Identities=29% Similarity=0.467 Sum_probs=217.6
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--------hHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--------NKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--------~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
.+++.|.+.+.||+|+||.|-+|....++ +.||||++++.... .....+|++||++| +||+|
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tg----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL------~HP~I 238 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTG----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL------SHPNI 238 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccC----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhc------CCCCE
Confidence 36678999999999999999999999998 89999999864222 12346999999999 99999
Q ss_pred eEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC--C
Q 002732 636 IRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA--K 712 (887)
Q Consensus 636 v~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~ 712 (887)
|+++++|......||||||+ +|.|.+.+-... .+.+..-+.|++|||.||.|||+.||+||||||+||||... .
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcc
Confidence 99999999999999999999 789999887644 48999999999999999999999999999999999999742 2
Q ss_pred CeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHH
Q 002732 713 NVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLP---YDHPLDIWSVGCCLYELYTGKVLFPGATNND-MLRLHM 787 (887)
Q Consensus 713 ~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~---~s~~sDIwSLG~iL~elltG~~PF~~~~~~~-~l~~i~ 787 (887)
-.+||+|||+|.+.+... +.++|||+.|.|||++.+.. |..++||||||||||-+|+|.+||....... ....|.
T Consensus 316 ~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~ 395 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL 395 (475)
T ss_pred eEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence 579999999999987543 67899999999999998764 3458899999999999999999997654443 333332
Q ss_pred HhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhccc
Q 002732 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL 867 (887)
Q Consensus 788 ~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~ 867 (887)
..... ..+..|..++.++++||.+||..
T Consensus 396 ~G~y~----------------------------------------------------f~p~~w~~Iseea~dlI~~mL~V 423 (475)
T KOG0615|consen 396 KGRYA----------------------------------------------------FGPLQWDRISEEALDLINWMLVV 423 (475)
T ss_pred cCccc----------------------------------------------------ccChhhhhhhHHHHHHHHHhhEe
Confidence 22111 12344667889999999999999
Q ss_pred CCCCCcCHHHHHhCCCCC
Q 002732 868 DPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 868 DP~~RpTa~elL~Hpwf~ 885 (887)
||+.|||+.|||+||||.
T Consensus 424 dP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 424 DPENRPSADEALNHPWFK 441 (475)
T ss_pred CcccCcCHHHHhcChhhh
Confidence 999999999999999997
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=445.34 Aligned_cols=249 Identities=29% Similarity=0.450 Sum_probs=225.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc----cchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN----NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~----~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.+|...++||+|+|+.||.+.+..++ +.||+|++.+ .....+...+||+|.+.| +|||||+|+++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tg----e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L------~HpnIV~f~~~F 87 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTG----EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL------KHPNIVQFYHFF 87 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCC----cEEEEEEeehHHhcCcchHHHHHHHHHHHHhc------CCCcEEeeeeEe
Confidence 36999999999999999999999988 8999999987 455567888999999999 999999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++.+++|||+|+| .++|..+++.. ..|++.++++|++||+.||.|||+++|||||||..||||+. +..|||+|||
T Consensus 88 EDs~nVYivLELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~-~~~VKIgDFG 163 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE-NMNVKIGDFG 163 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC-cCcEEecccc
Confidence 9999999999999 68999999853 34999999999999999999999999999999999999995 7789999999
Q ss_pred cceecCC--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAGK--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|+.+.. ....+.|||+.|+|||++....+++.+||||||||||-||+|++||...+-.+++..|......+|.
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~---- 239 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS---- 239 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----
Confidence 9987663 3467789999999999999999999999999999999999999999988888888888655544442
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.++.++++||.+||..||..|||+.+||
T Consensus 240 ----------------------------------------------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 240 ----------------------------------------------------HLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred ----------------------------------------------------ccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 3457889999999999999999999999
Q ss_pred hCCCCC
Q 002732 880 THPFIS 885 (887)
Q Consensus 880 ~Hpwf~ 885 (887)
.|+||+
T Consensus 268 ~h~Ff~ 273 (592)
T KOG0575|consen 268 DHPFFK 273 (592)
T ss_pred cCHhhh
Confidence 999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=442.75 Aligned_cols=284 Identities=33% Similarity=0.565 Sum_probs=238.1
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+-.+|.++++||.|.||.||+|..+.++ +.||||.+++.-.. .-.-.+|+..|++|. .|||||+|.+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~----~~VAIK~MK~Kf~s~ee~~nLREvksL~kln-----~hpniikL~Evi 78 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETG----ELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----PHPNIIKLKEVI 78 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCC----ceeeHHHHHhhhccHHHHHHHHHHHHHHhcC-----CCCcchhhHHHh
Confidence 4568999999999999999999998888 78999999764222 233367999999992 499999999999
Q ss_pred eecC-eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRN-HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~-~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.+.+ .+|||||||.++|+++|+.. +..|++..++.||.||+.||.|||.+|++||||||+||||.. ...|||+|||
T Consensus 79 ~d~~~~L~fVfE~Md~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~-~~~iKiaDFG 155 (538)
T KOG0661|consen 79 RDNDRILYFVFEFMDCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG-NDVIKIADFG 155 (538)
T ss_pred hccCceEeeeHHhhhhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc-cceeEecccc
Confidence 9887 99999999999999999985 456999999999999999999999999999999999999984 7899999999
Q ss_pred cceecC-CCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAG-KNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~-~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|+-+. .+.+|.++.|.||+|||+|+.. -|+.++|||++||||+||++-+++|+|.+..+++..|.+.+|.+.+.-|.
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 997654 5678999999999999999865 58999999999999999999999999999999999999999988654432
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+ ......++|. +..+.+..+..++ +..+.++.+||..||.|||.+||||.|+|
T Consensus 236 eg----~~La~~mnf~---------------~P~~~~~~l~~L~-------p~~s~~~~~li~~ll~WDP~kRpTA~~al 289 (538)
T KOG0661|consen 236 EG----YNLASAMNFR---------------FPQVKPSPLKDLL-------PNASSEAASLIERLLAWDPDKRPTASQAL 289 (538)
T ss_pred hH----HHHHHHhccC---------------CCcCCCCChHHhC-------cccCHHHHHHHHHHhcCCCccCccHHHHh
Confidence 21 0000111111 2234444444444 23568899999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||+.
T Consensus 290 ~~pffq~ 296 (538)
T KOG0661|consen 290 QHPFFQV 296 (538)
T ss_pred cCccccc
Confidence 9999973
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=435.30 Aligned_cols=283 Identities=31% Similarity=0.521 Sum_probs=237.2
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
.....|+.+++||+|.||.||+|++..++ .+||||.+..+. .......+||.||++| +||||++|.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tg----kivALKKvr~d~~~~~~~~t~~REI~ILr~l------~HpNIikL~e 183 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETG----KIVALKKVRFDNEKEGFPITAIREIKILRRL------DHPNIIKLEE 183 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccC----cEEEEEEeecccCCCcchHHHHHHHHHHHhc------CCCcccceee
Confidence 34456999999999999999999999998 899999997543 3345668999999999 9999999999
Q ss_pred eeeec--CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 641 SFKYR--NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 641 ~~~~~--~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
..... ..+|||||||..+|.-++...+ ..|++.++..||+||+.||+|||..||+|||||.+||||+ +++.+||+
T Consensus 184 ivt~~~~~siYlVFeYMdhDL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid-n~G~LKia 260 (560)
T KOG0600|consen 184 IVTSKLSGSIYLVFEYMDHDLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID-NNGVLKIA 260 (560)
T ss_pred EEEecCCceEEEEEecccchhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc-CCCCEEec
Confidence 98886 7899999999999999887633 4599999999999999999999999999999999999999 58999999
Q ss_pred ecCcceecCCC---CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 719 DFGNAMFAGKN---EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 719 DFG~a~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
|||+|.++... .+|..+.|+||.|||+|+|. .|+.++||||+||||.||++|++.|+|.+..+++..|+.++|.+.
T Consensus 261 DFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred cccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 99999976644 37888999999999999997 599999999999999999999999999999999999999999988
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
+..|.. ....+|. .|...... ...+... ...++..+++||..||.+||.+|.|
T Consensus 341 e~~W~~--~kLP~~~---~~kp~~~y---~r~l~E~-------------------~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 341 EDYWPV--SKLPHAT---IFKPQQPY---KRRLRET-------------------FKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred hhcccc--ccCCccc---ccCCCCcc---cchHHHH-------------------hccCCHHHHHHHHHHhccCcccccc
Confidence 777541 1111111 11111110 1111111 1244578899999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
|.++|+|+||+.
T Consensus 394 A~~aL~seyF~t 405 (560)
T KOG0600|consen 394 ASSALQSEYFTT 405 (560)
T ss_pred HHHHhcCccccc
Confidence 999999999953
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=399.55 Aligned_cols=279 Identities=31% Similarity=0.529 Sum_probs=236.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh---hHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM---NKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~---~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.+|..+++||+|.||+||+|.+..++ +.||||.++..... .....+||.+|+.| +|+||+.|+++|.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~----~~VAIKKIkl~~~kdGi~~talREIK~Lqel------~h~nIi~LiD~F~ 71 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETG----KRVAIKKIKLGNAKDGINRTALREIKLLQEL------KHPNIIELIDVFP 71 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCC----cEEEEEEeeccccccCccHHHHHHHHHHHHc------cCcchhhhhhhcc
Confidence 36888999999999999999999988 89999999864332 56778999999999 8999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+...+.||+|||..+|..+|+.. ...|+...+..|+.+++.||+|||.+.|+||||||.|+||+. ++.+||+|||+|
T Consensus 72 ~~~~l~lVfEfm~tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~-~g~lKiADFGLA 148 (318)
T KOG0659|consen 72 HKSNLSLVFEFMPTDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS-DGQLKIADFGLA 148 (318)
T ss_pred CCCceEEEEEeccccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC-CCcEEeecccch
Confidence 99999999999999999999874 446999999999999999999999999999999999999994 899999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+.++... .+..+.|.||.|||.+.|. .|+..+||||+|||+.||+.+.+.|+|.++.+++..|+..+|.+...-|..
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc
Confidence 9887543 3444789999999999987 599999999999999999999999999999999999999999875554322
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...-..|. -+..+.+..+..+| +..+..+++||.+||.+||.+|+||.|+|+
T Consensus 229 ~~~lpdY~---------------------~~~~~P~~~~~~lf-------~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 229 MTSLPDYV---------------------KIQQFPKPPLNNLF-------PAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccccHH---------------------HHhcCCCCcccccc-------ccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 21111110 01122233333333 344567799999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||+.
T Consensus 281 ~~yf~~ 286 (318)
T KOG0659|consen 281 HPYFKS 286 (318)
T ss_pred chhhhc
Confidence 999974
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=426.94 Aligned_cols=251 Identities=29% Similarity=0.538 Sum_probs=226.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.+|.+++.||.|+|++||+|.++.++ ..|||||+.+.... .+.+..|-.+|.+|. +||.|++|+..|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~-----~hPgivkLy~TF 143 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATG----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS-----GHPGIVKLYFTF 143 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCC----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh-----CCCCeEEEEEEe
Confidence 45999999999999999999999988 89999999864332 355677888999996 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++...+|+|+||+ +|.|.++|.+++. |++..+++|+.||+.||+|||++|||||||||+||||+. ++.++|+|||
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~-dmhikITDFG 219 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK-DGHIKITDFG 219 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC-CCcEEEeecc
Confidence 9999999999999 8999999999986 999999999999999999999999999999999999995 8999999999
Q ss_pred cceecCCCC---------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 002732 722 NAMFAGKNE---------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH 786 (887)
Q Consensus 722 ~a~~~~~~~---------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i 786 (887)
.|.++.... ...++||..|++||+|.....++.+|||+||||||+||.|.+||.+.+...+++.|
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI 299 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI 299 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 997654211 14589999999999999999999999999999999999999999999999999999
Q ss_pred HHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcc
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
+.+...||+.+ ++.+.+||.++|.
T Consensus 300 ~~l~y~fp~~f--------------------------------------------------------p~~a~dLv~KLLv 323 (604)
T KOG0592|consen 300 QALDYEFPEGF--------------------------------------------------------PEDARDLIKKLLV 323 (604)
T ss_pred HHhcccCCCCC--------------------------------------------------------CHHHHHHHHHHHc
Confidence 99887776433 3567899999999
Q ss_pred cCCCCCcCHHHHHhCCCCCC
Q 002732 867 LDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 867 ~DP~~RpTa~elL~Hpwf~~ 886 (887)
.||.+|+|++||.+||||.+
T Consensus 324 ~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 324 RDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred cCccccccHHHHhhCccccc
Confidence 99999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=419.19 Aligned_cols=320 Identities=34% Similarity=0.640 Sum_probs=266.2
Q ss_pred cCCCCceecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCC
Q 002732 551 DDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPE 630 (887)
Q Consensus 551 ~~~~g~~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~ 630 (887)
++..|.|.|++|+++.++|.++..||+|.||.|..|.+..++ ..|||||++.-..+.++..-|+.+|.+|....+.
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~----~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~ 148 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETK----EHVALKIIKNVDKYREAALIEIEVLQKINESDPN 148 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCC----ceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCC
Confidence 678899999999999999999999999999999999998886 8999999998888889999999999999888877
Q ss_pred CCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 631 NKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
.-.-||++.++|...+++|||||.++.++.++|...+ ..+|+...++.|+.||+.++.|||+.+|+|.||||+|||+..
T Consensus 149 g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 149 GKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVS 227 (415)
T ss_pred CceEEEeeehhhhccCceEEEEeccChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEec
Confidence 7788999999999999999999999999999998744 356999999999999999999999999999999999999842
Q ss_pred C-------------------CCeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCC
Q 002732 711 A-------------------KNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771 (887)
Q Consensus 711 ~-------------------~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~ 771 (887)
+ ...|+|+|||.|++..... .+.+.|..|.|||++++.+++.++||||+||||+||++|.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 1 1258999999998876543 6678899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCCh
Q 002732 772 VLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851 (887)
Q Consensus 772 ~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (887)
.+|++..+.++|++|..++|++|..|+.+......+....++|.......- .+..+..++| +..++. ...
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~----~k~v~~~ckp--l~~~~~----~~d 376 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK----SKYVFEPCKP--LKKYML----QDD 376 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc----chhhhcCCcc--HHHHhc----cCc
Confidence 999999999999999999999999998776433322223344332222111 1111111221 111111 111
Q ss_pred hhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 852 ~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
..-..|.+||++||.+||.+|+|+.|||.||||+.
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 22356899999999999999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=411.10 Aligned_cols=251 Identities=30% Similarity=0.511 Sum_probs=222.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..|+++++||+|+||+||++....++ +.||+|++++.... ......|..||..+ +||+||.++-.|
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~----kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v------~hPFiv~l~ysF 94 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTG----KIYAMKVLKKKKIVEKKEVRHTKAERNILSKI------KHPFIVKLIYSF 94 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccC----ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC------CCCcEeeeEEec
Confidence 56999999999999999999999887 89999999875332 35567899999998 999999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++...+|||++|+ +|.|...|++.+. |++..++.|+.+|+.||.|||++|||||||||+||||+. .++|+|+|||
T Consensus 95 Qt~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~-~GHi~LtDFg 170 (357)
T KOG0598|consen 95 QTEEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE-QGHIKLTDFG 170 (357)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC-CCcEEEeccc
Confidence 9999999999999 6799999987665 999999999999999999999999999999999999995 8999999999
Q ss_pred cceecC-C-CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAG-K-NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~-~-~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
++...- . ....++|||+.|||||++.+.+|+.++|||||||+||+||+|.+||.+.+...++..|.......+.
T Consensus 171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---- 246 (357)
T KOG0598|consen 171 LCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---- 246 (357)
T ss_pred cchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC----
Confidence 997432 2 2455689999999999999999999999999999999999999999999888888887665533321
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc----CH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM----TV 875 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp----Ta 875 (887)
..++.++.+||.++|..||.+|+ .+
T Consensus 247 ---------------------------------------------------~~ls~~ardll~~LL~rdp~~RLg~~~d~ 275 (357)
T KOG0598|consen 247 ---------------------------------------------------GYLSEEARDLLKKLLKRDPRQRLGGPGDA 275 (357)
T ss_pred ---------------------------------------------------ccCCHHHHHHHHHHhccCHHHhcCCCCCh
Confidence 22457889999999999999996 68
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.+|-.||||.+
T Consensus 276 ~~ik~HpfF~~ 286 (357)
T KOG0598|consen 276 EEIKRHPFFKG 286 (357)
T ss_pred HHhhcCccccc
Confidence 99999999975
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=408.72 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=220.0
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEec--ccchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~--~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.....+.+..||+|..|+||+|.++.++ ..+|+|++. .++....++..|+.||+.+ +||+||.+|+.|
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~----~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~------~spyIV~~ygaF 146 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTG----KIYALKVILLNIDPALQKQILRELEILRSC------QSPYIVGFYGAF 146 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCC----eEEEEEeecccCCHHHHHHHHHHHHHHhhC------CCCCeeeEeEEE
Confidence 3446788899999999999999999988 899999994 3566678899999999999 999999999999
Q ss_pred eecC-eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEe
Q 002732 643 KYRN-HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 643 ~~~~-~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
...+ .++|+|||| +|+|..++...+. +++..+..|+.+|+.||.|||. .+||||||||+||||+. .+.|||||
T Consensus 147 ~~~~~~isI~mEYMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicD 222 (364)
T KOG0581|consen 147 YSNGEEISICMEYMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICD 222 (364)
T ss_pred EeCCceEEeehhhcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEecc
Confidence 9998 599999999 7899999998765 9999999999999999999995 99999999999999995 89999999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--ChHHHHHHHHHhhCCCChhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA--TNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~--~~~~~l~~i~~~~g~~p~~~ 797 (887)
||.+..+-+....+++||..|||||.+.+..|+.++||||||++|+||++|..||... +....+..+.....
T Consensus 223 FGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~------ 296 (364)
T KOG0581|consen 223 FGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD------ 296 (364)
T ss_pred ccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc------
Confidence 9999877766778899999999999999999999999999999999999999999653 11122222221111
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCCh-hhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP-KMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+.. |..+. .++++|.+||..||+.||..|||+.
T Consensus 297 -----------------------------------~pp-----------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 297 -----------------------------------EPP-----------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred -----------------------------------CCC-----------CCCCcccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 111 12222 3779999999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
|+|+||||.+
T Consensus 331 qLl~Hpfi~~ 340 (364)
T KOG0581|consen 331 QLLQHPFIKK 340 (364)
T ss_pred HHhcCHHHhh
Confidence 9999999974
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=406.89 Aligned_cols=280 Identities=35% Similarity=0.596 Sum_probs=237.5
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+...|..++.||.|+||.|+.|.+..++ +.||||.+.. +....+...+|+.+|+.+ .|+||+.+++.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~----~~VAIKKi~~~F~~~~~akRtlRElklLr~~------~HeNIi~l~di 89 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTG----EKVAIKKILNPFENQIDAKRTLRELKLLRHL------RHENIIGLLDI 89 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCC----CEeehhhhhhhhhchHHHHHHHHHHHHHHHh------cCCCcceEEee
Confidence 4566888899999999999999999988 8999999872 455567778999999999 89999999998
Q ss_pred eee-----cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 642 FKY-----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 642 ~~~-----~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
+.. -+-+|||+|+|+.+|..+|+... .|+...+..+++|||.||.|+|+.||+||||||.|||++. +..+|
T Consensus 90 ~~p~~~~~f~DvYiV~elMetDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~-~c~lK 165 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELMETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA-DCDLK 165 (359)
T ss_pred cccccccccceeEEehhHHhhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc-CCCEE
Confidence 876 35799999999999999998743 3999999999999999999999999999999999999995 78889
Q ss_pred EEecCcceecC----CCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 717 LCDFGNAMFAG----KNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 717 L~DFG~a~~~~----~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||||+|+... ...+|.++.|.||.|||+++.. .|+.++||||+||||.|||+|++.|+|.+..+++..|++.+|
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999999885 4456889999999999998755 799999999999999999999999999999999999999999
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCC---CccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK---DIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
.+++..+... .......++.+.... ++..+| +..++.+++||.+||.+|
T Consensus 246 tP~~e~l~~i---------------------~s~~ar~yi~slp~~p~~~f~~~f-------p~a~p~AidLlekmL~fd 297 (359)
T KOG0660|consen 246 TPSEEDLQKI---------------------RSEKARPYIKSLPQIPKQPFSSIF-------PNANPLAIDLLEKMLVFD 297 (359)
T ss_pred CCCHHHHHHh---------------------ccHHHHHHHHhCCCCCCCCHHHHc-------CCCCHHHHHHHHHHhccC
Confidence 9987765321 111122233333222 222222 355678999999999999
Q ss_pred CCCCcCHHHHHhCCCCCC
Q 002732 869 PEKRMTVAQALTHPFISG 886 (887)
Q Consensus 869 P~~RpTa~elL~Hpwf~~ 886 (887)
|.+|+||+|||+||||..
T Consensus 298 P~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 298 PKKRITAEEALAHPYLAP 315 (359)
T ss_pred ccccCCHHHHhcChhhhh
Confidence 999999999999999963
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.45 Aligned_cols=282 Identities=29% Similarity=0.486 Sum_probs=233.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|+.+..|+.|+||.||.|+++.++ ++||+|.++.+.. ..-...+||.||.++ .|||||.+-.+...
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~----eIVALKr~kmekek~GFPItsLREIniLl~~------~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTD----EIVALKRLKMEKEKEGFPITSLREINILLKA------RHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcc----eeEEeeecccccccCCCcchhHHHHHHHHhc------CCCCeeeeEEEEec
Confidence 4899999999999999999999988 9999999985432 234457899999999 89999999887765
Q ss_pred --cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 --RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 --~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.+.+|||||||..+|..+|.... ..|...+++.++.|||.||.|||.+.|+||||||+|+|++ ..+.+||+|||+
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~-~~G~lKiaDFGL 223 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS-HKGILKIADFGL 223 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec-cCCcEEecccch
Confidence 35799999999999999999876 4599999999999999999999999999999999999999 489999999999
Q ss_pred ceecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 723 AMFAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 723 a~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
|+.++.. .+|+.+.|+||.|||+|+|. .|++++|+||+||||.|||++++.|+|.+..+++..|+.++|.+.+..|.
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 9988765 47889999999999999997 49999999999999999999999999999999999999999998776642
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
- +....+....+|. ..++. .+ ...|. ...++....+||..+|.+||.+|+||.|+|
T Consensus 304 g--~~~lp~~k~~~f~---~~pyn--~l------------r~kF~-----~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 304 G--YSELPAVKKMTFS---EHPYN--NL------------RKKFG-----ALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred C--ccccchhhccccC---CCCch--hh------------hhhcc-----ccccchhHHHHHHHHhccCccccccHHHhh
Confidence 1 1100000111111 11111 01 11111 011567889999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+|+||.+
T Consensus 360 ~h~~F~e 366 (419)
T KOG0663|consen 360 KHEYFRE 366 (419)
T ss_pred ccccccc
Confidence 9999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=387.17 Aligned_cols=249 Identities=27% Similarity=0.452 Sum_probs=226.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|++++.||.|+||.|.+++.+.++ ..||+|++.+.... .+...+|..||+.+ .||+++.+++.|
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g----~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v------~~PFlv~l~~t~ 113 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSG----NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV------SHPFLVKLYGTF 113 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCC----ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc------cCceeEEEEEee
Confidence 45999999999999999999999887 79999999875332 24557899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.+...+||||||+ +|.|..+|.+.++ |++..++.|+.||+.||+|||+++||+|||||+||||+. .+.+||+|||
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~-~G~iKitDFG 189 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ-NGHIKITDFG 189 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc-CCcEEEEecc
Confidence 9999999999999 7899999999877 999999999999999999999999999999999999995 8999999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+|...... ..+.|||+.|+|||++...+|+.++|+|+|||++|||+.|.+||...+...++.+|++....||.-
T Consensus 190 FAK~v~~r-T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~----- 263 (355)
T KOG0616|consen 190 FAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY----- 263 (355)
T ss_pred ceEEecCc-EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc-----
Confidence 99887765 566899999999999999999999999999999999999999999999999999998887777632
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVA 876 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~ 876 (887)
++.++++||.++|+.|-.+|. .+.
T Consensus 264 ---------------------------------------------------fs~~~kdLl~~LL~vD~t~R~gnlknG~~ 292 (355)
T KOG0616|consen 264 ---------------------------------------------------FSSDAKDLLKKLLQVDLTKRFGNLKNGVE 292 (355)
T ss_pred ---------------------------------------------------cCHHHHHHHHHHHhhhhHhhhcCcCCCcc
Confidence 346789999999999999994 677
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+|..||||.+
T Consensus 293 dIk~H~wF~~ 302 (355)
T KOG0616|consen 293 DIKNHPWFKG 302 (355)
T ss_pred ccccCccccc
Confidence 9999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=403.48 Aligned_cols=331 Identities=24% Similarity=0.384 Sum_probs=263.1
Q ss_pred CCCCCCCccccccccccCccCccCCcccccCCCCCccCCCCCCCCCccccccccCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 002732 447 PSEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKSPPQNGVTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGET 526 (887)
Q Consensus 447 ~se~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~sp~~~~~~~~~~~~~~~~~~~~s~~s~~~~~~~~~~~~~~~ 526 (887)
-||+++.++.+|++|++|.+++||+|||+.++. .+...+..+......++++... ....++.+..+.
T Consensus 272 isEl~K~p~~GWyKlLsqeEGEyyNvp~~~~~~----------e~~~~lr~k~~~~~~~~~~s~p-~~~~~~~~~~~~-- 338 (683)
T KOG0696|consen 272 ISELQKAPVDGWYKLLSQEEGEYYNVPVPDEDS----------EDNEELRQKFERARIGPGSSKP-EKKTMPTDSKFH-- 338 (683)
T ss_pred HHHHhhcchhhHHHHhhhhcCceeccCCCCchh----------hHHHHHHHHHhhcccCCCcCCC-CCCCCCCcccCC--
Confidence 467999999999999999999999999976541 1112222222222222222110 001111110000
Q ss_pred ccccccccccccceeeccCCCCCCcCCCCceecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc
Q 002732 527 PVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN 606 (887)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~ 606 (887)
..++. .-+-...|.++.+||+|+||.|.+|..+.+. +.||||++++
T Consensus 339 -----~~~~~-------------------------d~i~~tDFnFl~VlGKGSFGKVlLaerkgtd----ELyAiKiLkK 384 (683)
T KOG0696|consen 339 -----NSSKR-------------------------DRIKATDFNFLMVLGKGSFGKVLLAERKGTD----ELYAIKILKK 384 (683)
T ss_pred -----CCCcc-------------------------cceeecccceEEEeccCccceeeeecccCcc----hhhhhhhhcc
Confidence 00000 0112245999999999999999999988877 8999999999
Q ss_pred cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHH
Q 002732 607 NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685 (887)
Q Consensus 607 ~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl 685 (887)
+...++.......+.+++..+. ...|.+++|+.+|++.+.+|+||||+ +|+|.-.|+..++ |.+..+..|+..|+
T Consensus 385 DViiQdDDvectm~EKrvLAL~-~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEia 460 (683)
T KOG0696|consen 385 DVIIQDDDVECTMVEKRVLALP-GKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIA 460 (683)
T ss_pred ceeeecCcccceehhhhheecC-CCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHH
Confidence 8777766666666666664443 36789999999999999999999999 7899999999887 99999999999999
Q ss_pred HHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee--cCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHH
Q 002732 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF--AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCC 763 (887)
Q Consensus 686 ~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~i 763 (887)
.||.|||+.|||+||||.+||||+ ..++|||+|||++.- .......++|||+.|+|||++...+|+.++||||+||+
T Consensus 461 igLFFLh~kgIiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVL 539 (683)
T KOG0696|consen 461 IGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 539 (683)
T ss_pred HHhhhhhcCCeeeeeccccceEec-cCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHH
Confidence 999999999999999999999999 589999999999853 44455678999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccc
Q 002732 764 LYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIV 843 (887)
Q Consensus 764 L~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (887)
|||||.|++||.|.+..+.++.|++....+|+.+
T Consensus 540 LyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKsl---------------------------------------------- 573 (683)
T KOG0696|consen 540 LYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSL---------------------------------------------- 573 (683)
T ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccc----------------------------------------------
Confidence 9999999999999999999999999888887655
Q ss_pred cCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-----HHHHhCCCCC
Q 002732 844 TASPGEDPKMLANFKDLLDKIFVLDPEKRMTV-----AQALTHPFIS 885 (887)
Q Consensus 844 ~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa-----~elL~Hpwf~ 885 (887)
+.++.+++..+|...|.+|+.+ .+|-.||||.
T Consensus 574 ----------SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR 610 (683)
T KOG0696|consen 574 ----------SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR 610 (683)
T ss_pred ----------cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence 3677899999999999999854 5799999995
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=421.33 Aligned_cols=310 Identities=27% Similarity=0.481 Sum_probs=241.1
Q ss_pred CCCceecccCcee---cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCC
Q 002732 553 AEGYYSYRFGEIL---DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADP 629 (887)
Q Consensus 553 ~~g~~~~~~~eil---~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~ 629 (887)
..+.+.+.+++.+ .++|.++++||+|+||+||+|.+..++ ..||||++.........+..|+.++..+.....
T Consensus 112 ~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~----~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~ 187 (467)
T PTZ00284 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRK----EYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187 (467)
T ss_pred CCCceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCC----eEEEEEEEecchhhHHHHHHHHHHHHHHhhcCc
Confidence 3455666666654 578999999999999999999998776 799999997654445566789999999987777
Q ss_pred CCCcceeEecceeeec-CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCcc
Q 002732 630 ENKRHCIRFASSFKYR-NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNML 707 (887)
Q Consensus 630 ~~h~~Iv~l~~~~~~~-~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NIL 707 (887)
..|++|+.++++|... .++||||++++++|.++|...+ .|++..++.|+.||+.||.|||. +||||+||||+|||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 7888899999998764 6899999999999999887654 49999999999999999999997 69999999999999
Q ss_pred ccCCCC---------------eEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 002732 708 VNEAKN---------------VLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772 (887)
Q Consensus 708 l~~~~~---------------~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~ 772 (887)
|+..+. .+||+|||++..... ..+..++|+.|+|||++.+..|+.++||||||||||+|++|.+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~ 343 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKL 343 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCcc-ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 975332 489999998865432 3455789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChhhhhccccc--ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCC
Q 002732 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFT--DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850 (887)
Q Consensus 773 PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~--~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (887)
||.+.+..+++..+...++.+|..|....... ..+|.....+... .....+..+. .......
T Consensus 344 pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~------------~~~~~~~ 407 (467)
T PTZ00284 344 LYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPC----TDPKHLARIA------------RARPVRE 407 (467)
T ss_pred CCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhccccccc----CCHHHHHhhh------------cccchhh
Confidence 99999999999999999999998886432211 1112111111000 0000111110 0000000
Q ss_pred hhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 851 ~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
......|.+||.+||++||.+||||.|||+||||..
T Consensus 408 ~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 408 VIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred hhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 112367889999999999999999999999999975
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=409.00 Aligned_cols=253 Identities=29% Similarity=0.522 Sum_probs=214.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh----HHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~----~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|+++.+||+|+||.||+|.-+.+| .+||+|++++..... .-...|-.||... ..+.||+|+-.|
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg----~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~------ds~~vVKLyYsF 210 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTG----EIYAMKILKKSEMLKKNQVEHVRAERDILAEV------DSPWVVKLYYSF 210 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCC----cEEeeecccHHHHHhhhhHHHHHHHHHHhhhc------CCCcEEEEEEEe
Confidence 45999999999999999999999998 899999999865443 2334566666654 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++..++||||||+ ||++.++|...+. |++.++++|+.+++.||+.||+.||||+||||+|+||+. .|+|||+|||
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~-~GHiKLSDFG 286 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA-KGHIKLSDFG 286 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC-CCCEeecccc
Confidence 9999999999999 7899999998765 999999999999999999999999999999999999995 8999999999
Q ss_pred cceecCC----------------------CCc---------------------------cCcccCCcccchhhhcCCCCC
Q 002732 722 NAMFAGK----------------------NEI---------------------------TPYLVSRFYRAPEIILGLPYD 752 (887)
Q Consensus 722 ~a~~~~~----------------------~~~---------------------------~~~~gt~~Y~aPE~l~~~~~s 752 (887)
|+.-+.. ..+ ...+|||.|||||+|.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 9831100 000 124789999999999999999
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHh
Q 002732 753 HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF 832 (887)
Q Consensus 753 ~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~ 832 (887)
..+|||||||||||||.|.+||.+.+..+++.+|+.....+ .|+
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------------~fP----------------- 410 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------------KFP----------------- 410 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------------cCC-----------------
Confidence 99999999999999999999999999999999887543221 111
Q ss_pred hcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 002732 833 NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---VAQALTHPFISG 886 (887)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---a~elL~Hpwf~~ 886 (887)
....++.+++|||.+||. ||.+|+. ++||-+||||.+
T Consensus 411 ----------------~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 411 ----------------EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred ----------------CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 112234788999999999 9999985 999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=394.35 Aligned_cols=279 Identities=34% Similarity=0.579 Sum_probs=230.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec--
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR-- 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~-- 645 (887)
.|.-.+++|.|+||+||.|....+. +.||||.+..+.. .-..|+.||..+ .|||||+|+-+|...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~----~~vAIKKv~~d~r---~knrEl~im~~l------~HpNIV~L~~~f~~~~~ 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE----EEVAIKKVLQDKR---YKNRELQIMRKL------DHPNIVRLLYFFSSSTE 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC----ceeEEEEecCCCC---cCcHHHHHHHhc------CCcCeeeEEEEEEecCC
Confidence 4999999999999999999998876 8999999876543 335799999988 999999999888763
Q ss_pred C---eEEEEEecchhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 646 N---HLCLVFESLHMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 646 ~---~~~lV~E~~~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
. +++||||||+.+|..++..+.. +..++...++-|+.||+.||.|||+.||+||||||.||||+...+.+||||||
T Consensus 92 ~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 92 SDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred CchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 2 5789999999999999987522 34589999999999999999999999999999999999999988999999999
Q ss_pred cceecCCC-CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAGKN-EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
.|.....+ ...++..|.+|+|||.++|. .|+.++||||+||||.||+.|++.|+|.+..+++..|+.++|.+..+-+.
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 99876543 45678889999999999987 59999999999999999999999999999999999999999999887654
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
..+..-. ...|+ .+++.....+ ....+++++.+||.++|+++|.+|++|.|||
T Consensus 252 ~mn~~y~----~~~~p-----------------~ik~~~~~~~------~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 252 SMNPNYT----EFKFP-----------------QIKAHPWHKV------FFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred hcCcccc----cccCc-----------------ccccccceee------cccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 3221100 00000 0111111111 1234557889999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||..
T Consensus 305 ~h~fFde 311 (364)
T KOG0658|consen 305 AHPFFDE 311 (364)
T ss_pred cchhhHH
Confidence 9999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=393.85 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=217.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.|.+...||.|+||+||+|.+..++ ..||||.+.+. ....+.+..||.||+.| +|||||.|++++.
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel------~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSG----TEVAIKCIAKKKLNKKLVELLLSEIKILKEL------KHPNIVRLLDCIE 79 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCC----ceEEeeeehhhccCHHHHHHHHHHHHHHHhc------CCcceeeEEEEEe
Confidence 56999999999999999999999887 89999999764 33456778999999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC--C---CeEEE
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA--K---NVLKL 717 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~---~~vKL 717 (887)
..+++||||||| +|+|..+|+..+. +++.+++.++.||+.||++||+++||||||||.||||+.. . -.+||
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 999999999999 6899999999765 9999999999999999999999999999999999999853 1 46999
Q ss_pred EecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 718 CDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 718 ~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+|||+|++..... ..+.||++.|||||++....|+.++|+||+|+|||+|++|.+||...+..+.+..+......+|
T Consensus 157 ADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~-- 234 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVP-- 234 (429)
T ss_pred cccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccC--
Confidence 9999999887654 5678999999999999999999999999999999999999999998888777664422211111
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
..+..++..+.+|+...|+.+|..|.+..
T Consensus 235 ---------------------------------------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 235 ---------------------------------------------------VLPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred ---------------------------------------------------chhhhccCchhhhhhHHHhcCccccCchH
Confidence 11122334456888888899999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+.+.|+|+..
T Consensus 264 ~~~~~~~l~~ 273 (429)
T KOG0595|consen 264 DFFDHPFLAA 273 (429)
T ss_pred Hhhhhhhccc
Confidence 9988888764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=410.01 Aligned_cols=250 Identities=29% Similarity=0.476 Sum_probs=218.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+-|.+.+.||.|+.|.|-+|++..|| +.+|||+|.+. ......+..||.||+.| .||||++||++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TG----qlaaiKii~k~~~~s~s~~~~IerEIviMkLi------~HpnVl~LydVw 81 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETG----QLAAIKIIPKRSELSSSQPAGIEREIVIMKLI------EHPNVLRLYDVW 81 (786)
T ss_pred cceeccccccCCCCceehhhhccccc----ceeEEEeeccccccccccccchhhhhHHHHHh------cCCCeeeeeeee
Confidence 45999999999999999999999998 99999999764 22345678999999999 999999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
+...++|||+||+ +|.|+++|-..+. |++..+..++.||+.||.|||..+|+|+||||+|+||+..++ |||+|||
T Consensus 82 e~~~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFG 157 (786)
T KOG0588|consen 82 ENKQHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFG 157 (786)
T ss_pred ccCceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-Eeeeccc
Confidence 9999999999999 7899999988765 999999999999999999999999999999999999997444 9999999
Q ss_pred cceecCC-CCccCcccCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAGK-NEITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~-s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|.+... ..+.+.||++.|.|||++.|.+| +.++||||+|||||.||+|.+||.+.+-...+.++......+
T Consensus 158 MAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~M------ 231 (786)
T KOG0588|consen 158 MASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEM------ 231 (786)
T ss_pred eeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccC------
Confidence 9977544 45788999999999999999998 689999999999999999999998655555544443222222
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
+-.++.++.+||.+||..||.+|+|++||+
T Consensus 232 --------------------------------------------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 232 --------------------------------------------------PSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred --------------------------------------------------CCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 234568899999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+|||+.+
T Consensus 262 kHP~l~g 268 (786)
T KOG0588|consen 262 KHPFLSG 268 (786)
T ss_pred hCchhhc
Confidence 9999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=386.75 Aligned_cols=282 Identities=34% Similarity=0.555 Sum_probs=233.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcc-eeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRH-CIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~-Iv~l~~~~~ 643 (887)
.|..+++||.|+||+||+|..+.++ ..||||.+..... .......|+.+|+.| .|+| |+.|++++.
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g----~~VALKkirl~~~~EG~P~taiREisllk~L------~~~~~iv~L~dv~~ 81 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTG----KFVALKKIRLEFEEEGVPSTAIREISLLKRL------SHANHIVRLHDVIH 81 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCC----CEEEEEEEeccccccCCCchhhHHHHHHHHh------CCCcceEEEEeeee
Confidence 4778889999999999999999988 8999999976433 456678999999999 6666 999999999
Q ss_pred ecC------eEEEEEecchhhHHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 644 YRN------HLCLVFESLHMNLREVLKKFGRN-IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 644 ~~~------~~~lV~E~~~gsL~~~L~~~~~~-~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
..+ .++|||||+..+|..+|...... .+++...++.|+.||+.||.|||+++|+||||||.||||+. .+.+|
T Consensus 82 ~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~-~G~lK 160 (323)
T KOG0594|consen 82 TSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS-SGVLK 160 (323)
T ss_pred ecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC-CCcEe
Confidence 877 89999999999999999987643 46888999999999999999999999999999999999996 89999
Q ss_pred EEecCcceecC--CCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 717 LCDFGNAMFAG--KNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 717 L~DFG~a~~~~--~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|+|||+|.... ...+++.++|++|.|||+++|. .|+..+||||+|||++||+++.+.|++....+++..|...+|.+
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 99999997654 3347888999999999999998 69999999999999999999999999999999999999999998
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
....|........+- ..|.... .+..+.. ..+.......+||.+||+++|.+|+
T Consensus 241 ~e~~Wp~v~~~~~~k---~~f~~~~----------------~~~~l~~-------~~~~~~~~~~dll~~~L~y~p~~R~ 294 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYK---APFPKWP----------------GPKDLSS-------ILPKLDPDGIELLSKLLQYDPAKRI 294 (323)
T ss_pred CccCCCCcccccccc---ccCcCCC----------------CccchHH-------hccccCccHHHHHHHHhccCcccCc
Confidence 776653211111110 0111000 0111111 1122235778999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
||..+|.||||..
T Consensus 295 Sa~~al~h~yf~~ 307 (323)
T KOG0594|consen 295 SAKGALTHPYFSE 307 (323)
T ss_pred CHHHHhcChhhcc
Confidence 9999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=404.18 Aligned_cols=251 Identities=33% Similarity=0.522 Sum_probs=220.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|-+.+.||+|+||.||+|+.+.+. +.||||++.+.. .....+.+|+.|+..| +|||||.++++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~----~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l------kHpniv~m~esfE 71 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTI----QVVAIKFIDKSGRNEKELKNLRQEVRILRSL------KHPNIVEMLESFE 71 (808)
T ss_pred cchhHHHHhcCCccceeeecccccce----eEEEEEEehhcCCchHHHHHHHHHHHHHHhc------CCcchhhHHHhhc
Confidence 35888899999999999999998887 899999998643 2335678899999999 9999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...++|+|+||+.|+|..+|...+. |++..+..|+.+++.||.|||+++|+|+|+||.||||. .++++||||||+|
T Consensus 72 t~~~~~vVte~a~g~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~-~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 72 TSAHLWVVTEYAVGDLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE-KGGTLKLCDFGLA 147 (808)
T ss_pred ccceEEEEehhhhhhHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec-CCCceeechhhhh
Confidence 9999999999998899999998654 99999999999999999999999999999999999998 4899999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+.+..+. .+.+.||+.|||||++.+.+|+..+|+||||||||||++|++||....-.+.+..|+.--..+
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~-------- 219 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP-------- 219 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC--------
Confidence 8877654 577889999999999999999999999999999999999999997654444444332221111
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+..++..|.+||+.+|..||.+|+|..++|.|
T Consensus 220 ------------------------------------------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 ------------------------------------------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------------------------------------------------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 23566889999999999999999999999999
Q ss_pred CCCCCC
Q 002732 882 PFISGK 887 (887)
Q Consensus 882 pwf~~~ 887 (887)
||+.++
T Consensus 252 pF~k~~ 257 (808)
T KOG0597|consen 252 PFWKGK 257 (808)
T ss_pred hHHhhh
Confidence 999764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=401.22 Aligned_cols=255 Identities=30% Similarity=0.519 Sum_probs=220.7
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----c--hhhHHHHHHHHHHHHhhCCCCCC-Ccce
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----E--TMNKAGQTEVQILKKLAGADPEN-KRHC 635 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~--~~~~~~~~Ei~iL~~L~~~~~~~-h~~I 635 (887)
....+.|.+...||.|+||+|++|.+..++ ..||||++... . .....+..|+.+|+.+ . ||||
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~------~~HpnI 82 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTG----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRL------RSHPNI 82 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCC----CeEEEEEechhcccccccccchhhHHHHHHHHHh------ccCCCE
Confidence 345678999999999999999999998887 89999988753 1 2345566899999999 5 9999
Q ss_pred eEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCe
Q 002732 636 IRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 636 v~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 714 (887)
++++.++.....+||||||+ +|.|.++|...+. |.+..++.|+.||+.||.|||++||+||||||+|||++...+.
T Consensus 83 ~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 83 IRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred eEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC
Confidence 99999999999999999999 5699999988554 9999999999999999999999999999999999999964388
Q ss_pred EEEEecCcceec--CCCCccCcccCCcccchhhhcCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 715 LKLCDFGNAMFA--GKNEITPYLVSRFYRAPEIILGLP-YD-HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 715 vKL~DFG~a~~~--~~~~~~~~~gt~~Y~aPE~l~~~~-~s-~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+||+|||++... ......+.|||+.|+|||++.+.. |+ .++||||||||||.|++|..||...+...++..|....
T Consensus 160 ~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 160 LKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred EEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 999999999887 344678899999999999999987 85 89999999999999999999998866666665554333
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhh-HHHHHHHHHHhcccCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM-LANFKDLLDKIFVLDP 869 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~dLL~kmL~~DP 869 (887)
..+|. .+ +..+..||.+||..||
T Consensus 240 ~~~p~--------------------------------------------------------~~~S~~~~~Li~~mL~~~P 263 (370)
T KOG0583|consen 240 FKIPS--------------------------------------------------------YLLSPEARSLIEKMLVPDP 263 (370)
T ss_pred ccCCC--------------------------------------------------------CcCCHHHHHHHHHHcCCCc
Confidence 33321 22 5788999999999999
Q ss_pred CCCcCHHHHHhCCCCCC
Q 002732 870 EKRMTVAQALTHPFISG 886 (887)
Q Consensus 870 ~~RpTa~elL~Hpwf~~ 886 (887)
.+|+|+.+|+.||||+.
T Consensus 264 ~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 264 STRITLLEILEHPWFQK 280 (370)
T ss_pred ccCCCHHHHhhChhhcc
Confidence 99999999999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=409.75 Aligned_cols=251 Identities=22% Similarity=0.415 Sum_probs=216.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhH----HHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~----~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
-.+|.++++||+|+||+|++|..+.++ ++||||++++.....+ ..+.|..|+..+. .||.++.|+.+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~----e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-----~HPFL~~L~~~ 437 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTN----EYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-----RHPFLVNLFSC 437 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCC----cEEEEEEeeccceeccccHHHHHHHHHHHHHhc-----cCCeEeecccc
Confidence 356999999999999999999999888 8999999998766554 3455666665553 79999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
|++..++|+||||+ +|+|..+ +. ...|++..++.|+..|+.||.|||++||||||||.+||||+. .|+|||+||
T Consensus 438 fQT~~~l~fvmey~~Ggdm~~~-~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~-eGh~kiADF 512 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLMHH-IH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT-EGHVKIADF 512 (694)
T ss_pred cccCCeEEEEEEecCCCcEEEE-Ee---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc-cCcEEeccc
Confidence 99999999999999 4553322 22 234999999999999999999999999999999999999995 899999999
Q ss_pred Ccceec--CCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 721 GNAMFA--GKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|+++-. ......++|||+.|||||+|.+..|+.++|||+|||+|||||.|..||+|.+.++++..|+..-..+|
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP---- 588 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP---- 588 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----
Confidence 999642 33457789999999999999999999999999999999999999999999999999988865544444
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC----
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---- 874 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---- 874 (887)
..++.++++||++||..+|.+|+.
T Consensus 589 ----------------------------------------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~ 616 (694)
T KOG0694|consen 589 ----------------------------------------------------RFLSKEAIAIMRRLLRKNPEKRLGSGER 616 (694)
T ss_pred ----------------------------------------------------CcccHHHHHHHHHHhccCcccccCCCCC
Confidence 345678999999999999999995
Q ss_pred -HHHHHhCCCCCC
Q 002732 875 -VAQALTHPFISG 886 (887)
Q Consensus 875 -a~elL~Hpwf~~ 886 (887)
+.+|.+||||..
T Consensus 617 d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 617 DAEDIKKHPFFRS 629 (694)
T ss_pred CchhhhhCCcccc
Confidence 578999999964
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=369.37 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=222.7
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
.|.+.|.+.++||+|.|+.||.|.+..++ +.+|+|++... ....+.+..|+.|-..| +||||++|.+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg----~~fa~kiin~~k~~~~~~e~l~rEarIC~~L------qHP~IvrL~~ 77 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKL------QHPNIVRLHD 77 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccch----HHHHHHHhhhhhhccccHHHHHHHHHHHHhc------CCCcEeehhh
Confidence 45677999999999999999999998888 89999998743 23346678899999999 9999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHH-HHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC--CCeEE
Q 002732 641 SFKYRNHLCLVFESL-HMNLREV-LKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA--KNVLK 716 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~-L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~~vK 716 (887)
.+......|||||+| ++.|..- .+.+ -+++..+-.+++|||.||.|+|.+|||||||||+|+||-.. ..-||
T Consensus 78 ti~~~~~~ylvFe~m~G~dl~~eIV~R~----~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 78 SIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred hhcccceeEEEEecccchHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCcee
Confidence 999999999999999 5677644 4442 28999999999999999999999999999999999999532 34699
Q ss_pred EEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 717 LCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 717 L~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|+|||+|...+... ....+||+.|||||++...+|+.++|||+.|||||-||.|.+||.+.+....+..|++....+|.
T Consensus 154 L~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 154 LADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred ecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC
Confidence 99999998776433 34578999999999999999999999999999999999999999998888888888776555532
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
..|+.+++.+++||.+||..||.+|+||
T Consensus 234 ----------------------------------------------------~~w~~is~~Ak~LvrrML~~dP~kRIta 261 (355)
T KOG0033|consen 234 ----------------------------------------------------PEWDTVTPEAKSLIRRMLTVNPKKRITA 261 (355)
T ss_pred ----------------------------------------------------cccCcCCHHHHHHHHHHhccChhhhccH
Confidence 2345677899999999999999999999
Q ss_pred HHHHhCCCCCCC
Q 002732 876 AQALTHPFISGK 887 (887)
Q Consensus 876 ~elL~Hpwf~~~ 887 (887)
.|+|+||||.++
T Consensus 262 ~EAL~HpWi~~r 273 (355)
T KOG0033|consen 262 DEALKHPWICNR 273 (355)
T ss_pred HHHhCCchhcch
Confidence 999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=382.64 Aligned_cols=279 Identities=29% Similarity=0.499 Sum_probs=225.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.++++||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| .|+||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 74 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKNL------KHANIVTLHDIIHT 74 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCC----CEEEEEEecccccCCcchhHHHHHHHHHhC------CCCCEeeEEEEEcC
Confidence 35999999999999999999998777 799999987532 2234567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+||||||+.++|.+++...+. .+++..+..++.||+.||.|||++||||+||||+|||++. .+.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~ 151 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE-KGELKLADFGLAR 151 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEECcCccee
Confidence 999999999998899998876442 4789999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCC--CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... ......+++.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+..+.+..+....+.++...+...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 152 AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred eccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcc
Confidence 64432 2344567899999999976 46899999999999999999999999999999999999999888877765332
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.....++... +.. .... .. ....+.++.++++||.+||++||.+||||.|||+|
T Consensus 232 ~~~~~~~~~~--~~~-----------------~~~~---~~----~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 232 TSNEEFRSYL--FPQ-----------------YRAQ---PL----INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred ccchhhhccc--cCc-----------------cCCC---ch----HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111000 000 0000 00 01123456788999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 286 p~f 288 (288)
T cd07871 286 SYF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=388.40 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=230.7
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.+-|.+.+.||.|.|++|-+|++.-+| ++||||+|.+.. .....+..|+.+|+.+ +|||||+||.+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTG----ekVAVKviDKTKlD~~st~hlfqEVRCMKLV------QHpNiVRLYEV 85 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV------QHPNIVRLYEV 85 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhccc----ceeEEEEecccccchhhhhHHHHHHHHHHHh------cCcCeeeeeeh
Confidence 4566999999999999999999999888 899999998753 3345667899999999 99999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
......+|||+|+- +|+|+++|-+.. .+|.+..+..|+.||+.|+.|+|+..+||+||||+||++.+..+.|||+||
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeec
Confidence 99999999999988 679999998754 469999999999999999999999999999999999999888899999999
Q ss_pred CcceecCC-CCccCcccCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 721 GNAMFAGK-NEITPYLVSRFYRAPEIILGLPYD-HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~s-~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|++..+.. ..+++.||++.|.|||+|+|..|+ +++||||||||||.|++|++||...++.++|.+||.|+..+|.
T Consensus 164 GFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs--- 240 (864)
T KOG4717|consen 164 GFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS--- 240 (864)
T ss_pred cccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch---
Confidence 99965554 458899999999999999999986 7899999999999999999999999999999999999877764
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.++.++.+||..||+.||.+|.++++|
T Consensus 241 -----------------------------------------------------hvS~eCrdLI~sMLvRdPkkRAslEeI 267 (864)
T KOG4717|consen 241 -----------------------------------------------------HVSKECRDLIQSMLVRDPKKRASLEEI 267 (864)
T ss_pred -----------------------------------------------------hhhHHHHHHHHHHHhcCchhhccHHHH
Confidence 345789999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
..|+|++.
T Consensus 268 ~s~~Wlq~ 275 (864)
T KOG4717|consen 268 VSTSWLQA 275 (864)
T ss_pred hccccccC
Confidence 99999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=370.72 Aligned_cols=244 Identities=29% Similarity=0.472 Sum_probs=210.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecc-ee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFAS-SF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~-~~ 642 (887)
..|.|+++||.|.||.||+|.++.++ ..||+|.+.- +.........|+.+|++| +|||||++++ .|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL------~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDG----KLVALKKIQFGMMDAKARQDCVKEISLLKQL------NHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCc----chhhhhhcchhhccHHHHHHHHHHHHHHHhc------CCchHHHHHHHhh
Confidence 35999999999999999999999988 8999999874 334456778999999999 9999999998 56
Q ss_pred eecCe-EEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhc--cc--eeccCCCCCCccccCCCCeE
Q 002732 643 KYRNH-LCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKN--CG--VLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 643 ~~~~~-~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs--~g--IvHrDLKP~NILl~~~~~~v 715 (887)
...+. ++||||+| .|+|..+|+.+.. ..-|++..+|.|+.||+.||.+||+ .. |+||||||.||||+ +.++|
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvv 167 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVV 167 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCce
Confidence 66665 99999999 7899999988654 3459999999999999999999999 45 99999999999999 58899
Q ss_pred EEEecCcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCC-
Q 002732 716 KLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP- 792 (887)
Q Consensus 716 KL~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~- 792 (887)
||+|||+++++.... ..+++|||+||+||.+.+.+|++++|||||||+||||+.-++||.|.+......+|.++..+
T Consensus 168 KLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred eeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 999999999887654 46689999999999999999999999999999999999999999998776666666554221
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
+| ...+|..+..||.-||..||.+|
T Consensus 248 ~p-------------------------------------------------------~~~YS~~l~~li~~ci~vd~~~R 272 (375)
T KOG0591|consen 248 LP-------------------------------------------------------DEHYSTDLRELINMCIAVDPEQR 272 (375)
T ss_pred Cc-------------------------------------------------------HHHhhhHHHHHHHHHccCCcccC
Confidence 22 13467888999999999999999
Q ss_pred cCHH
Q 002732 873 MTVA 876 (887)
Q Consensus 873 pTa~ 876 (887)
|++-
T Consensus 273 P~t~ 276 (375)
T KOG0591|consen 273 PDTV 276 (375)
T ss_pred CCcc
Confidence 9853
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=379.77 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=219.5
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
-..|.+++.||.|.-|+||+|....++ ..+|||++.+.... ...+..|-.||..| +||.|+.||..
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l------DHPFlPTLYa~ 145 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTN----CLFAMKVMDKESLASRKKLKRAQTEREILSLL------DHPFLPTLYAS 145 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCC----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc------CCCccchhhhe
Confidence 356999999999999999999998877 79999999875443 24456788999999 99999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
|+...++||||||| +|+|..++++. ....|++..+++|+.+|+.||+|||.+|||+|||||+||||-+ +++|.|+||
T Consensus 146 fet~~~~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvre-dGHIMLsDF 223 (459)
T KOG0610|consen 146 FETDKYSCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRE-DGHIMLSDF 223 (459)
T ss_pred eeccceeEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEec-CCcEEeeec
Confidence 99999999999999 78998888774 4556999999999999999999999999999999999999985 899999999
Q ss_pred Ccceec-------CC----------------------------C-----------------------CccCcccCCcccc
Q 002732 721 GNAMFA-------GK----------------------------N-----------------------EITPYLVSRFYRA 742 (887)
Q Consensus 721 G~a~~~-------~~----------------------------~-----------------------~~~~~~gt~~Y~a 742 (887)
.++... .. . ....++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 987211 00 0 0122567778999
Q ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChh
Q 002732 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPV 822 (887)
Q Consensus 743 PE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~ 822 (887)
||+|.|...+.++|||+|||+|||||.|..||.|.+..+++.+|+..-..||..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-------------------------- 357 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-------------------------- 357 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------------------------
Confidence 999999999999999999999999999999999999999998886544333321
Q ss_pred hHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC----HHHHHhCCCCCC
Q 002732 823 TKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT----VAQALTHPFISG 886 (887)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT----a~elL~Hpwf~~ 886 (887)
+.++.+++|||+++|..||.+|+. |.||-+||||.|
T Consensus 358 ----------------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g 397 (459)
T KOG0610|consen 358 ----------------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG 397 (459)
T ss_pred ----------------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence 245678999999999999999998 999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=394.50 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=218.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
..|....+||+|+.|.||.|....++ +.||||.+..... ....+.+|+.||+.+ .|+|||.+++.|...
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~------~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTK----QEVAIKRMDLRKQPKKELLLNEILVMRDL------HHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCC----ceEEEEEEEeccCCchhhhHHHHHHHHhc------cchHHHHHHHHhccc
Confidence 35999999999999999999998887 7899999976544 357778999999999 999999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+++||||| +|+|-+++..+. |++.++..|++++|.||.|||..||||+|||.+|||++. ++.|||+|||++.
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~-~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM-DGSVKLTDFGFCA 417 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc-CCcEEEeeeeeee
Confidence 9999999999 779999988754 899999999999999999999999999999999999995 7779999999987
Q ss_pred ecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
.+... ...+.+||++|||||++....|++++||||||+|++||+-|.+||...+...-+..|... |.+
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P--------- 487 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP--------- 487 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCC---------
Confidence 66543 357789999999999999999999999999999999999999999765555444443211 111
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+..++..|.+||.+||+.||.+|++|.|||+||
T Consensus 488 -------------------------------------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 488 -------------------------------------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred -------------------------------------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence 1123467889999999999999999999999999999
Q ss_pred CCC
Q 002732 883 FIS 885 (887)
Q Consensus 883 wf~ 885 (887)
||.
T Consensus 525 Fl~ 527 (550)
T KOG0578|consen 525 FLK 527 (550)
T ss_pred hhh
Confidence 995
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.61 Aligned_cols=281 Identities=32% Similarity=0.587 Sum_probs=223.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||++++++|.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 70 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETK----EIVAIKKFKDSEENEEVKETTLRELKMLRTL------KQENIVELKEAFR 70 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCC----cEEEEEEEecccccccchhhHHHHHHHHHhC------CCccccchhhhEe
Confidence 36999999999999999999998777 789999987542 2335667899999999 8999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
....+||||||+.+++...+.... ..+++..++.++.||+.||.|||+.||+|+||||+||||+. ++.+||+|||++
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~ 147 (287)
T cd07848 71 RRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH-NDVLKLCDFGFA 147 (287)
T ss_pred cCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEEeeccCc
Confidence 999999999999776666665432 35999999999999999999999999999999999999984 788999999999
Q ss_pred eecCCC---CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKN---EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... ......+++.|+|||++.+..++.++||||||||||+|++|.+||.+.+..+.+..+....+++|...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 765432 23345789999999999999999999999999999999999999999888888888888888888766432
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.. .+..++.... +. ...... ........++..+.+||.+||.+||.+|||+.+||+
T Consensus 228 ~~-------~~~~~~~~~~-~~-------------~~~~~~---~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FY-------SNPRFHGLRF-PA-------------VNHPQS---LERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hh-------ccchhccccc-Cc-------------ccCccc---HHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 1111100000 00 000000 000011235678999999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 284 hp~f 287 (287)
T cd07848 284 HPAF 287 (287)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=374.38 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=219.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
...|++..+||.|..++||+|....++ ++||||++..+ ....+.+..|+..|..+ +||||+.++.+|.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~----e~VAIK~inLEkc~~~ld~l~kE~~~msl~------~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTN----EVVAIKIINLEKCNNDLDALRKEVQTMSLI------DHPNIVTYHCSFV 94 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccC----CEEEEEEeehhhhhhhHHHHHHHHHHhhhc------CCCCcceEEEEEE
Confidence 356999999999999999999999988 89999999753 23357788999999999 9999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+|+||+|| +|++.++|..+-. .+|.+..+..|++++|.||.|||.+|.||||||+.||||+ .+|.|||+|||.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~-~dG~VkLadFgv 172 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID-SDGTVKLADFGV 172 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc-CCCcEEEcCcee
Confidence 999999999999 7899999998654 4599999999999999999999999999999999999999 589999999998
Q ss_pred ceecCCCC------ccCcccCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 723 AMFAGKNE------ITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 723 a~~~~~~~------~~~~~gt~~Y~aPE~l~~--~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+-.+.... +.+++||++|||||++.. ..|+.++|||||||+..||.+|..||.......+|. +.+.+.+|
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp 250 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPP 250 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCC
Confidence 75433221 367789999999999643 369999999999999999999999997766655543 34444443
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
.... ..........++..|..||..||+.||.+|||
T Consensus 251 ~~~t--------------------------------------------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt 286 (516)
T KOG0582|consen 251 TLLT--------------------------------------------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPT 286 (516)
T ss_pred Cccc--------------------------------------------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCC
Confidence 2110 00011223456679999999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
|.++|+|+||+.
T Consensus 287 AskLlkh~FFk~ 298 (516)
T KOG0582|consen 287 ASKLLKHAFFKK 298 (516)
T ss_pred HHHHhccHHHhh
Confidence 999999999974
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=390.01 Aligned_cols=259 Identities=30% Similarity=0.478 Sum_probs=227.7
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
+-+...|.+...||.|.||+||+|....++ ..||+|++.+.... .....+|+.||++|. .|||||+|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~-----~hpniv~l 101 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTG----KEVACKVIPKRKLRGKEDREDVRREVAILQQLS-----GHPNIVQL 101 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCC----ceeEEEEeehhhccccccHHHHHHHHHHHHhcc-----CCCCEEEE
Confidence 445567999999999999999999999987 89999999875442 357889999999993 39999999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC---Ce
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK---NV 714 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~~ 714 (887)
+++|+....++||||+| +|.|.+.|... .+++..+..++.||+.|+.|||++||||+||||+|||+.... ..
T Consensus 102 ~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 102 KDAFEDPDSVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred EEEEEcCCeEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCc
Confidence 99999999999999999 68999998876 299999999999999999999999999999999999997532 37
Q ss_pred EEEEecCcceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 715 LKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 715 vKL~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
+||+|||+|.+.... .+...+||+.|+|||++...+|+..+||||+|||+|.|++|.+||.+.+....+..|......|
T Consensus 178 ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f 257 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF 257 (382)
T ss_pred EEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC
Confidence 999999999887763 4678899999999999999999999999999999999999999999998887777665443322
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+ ...|+.++..+.+||..||..||..|+
T Consensus 258 ~----------------------------------------------------~~~w~~is~~akd~i~~ll~~dp~~R~ 285 (382)
T KOG0032|consen 258 T----------------------------------------------------SEPWDDISESAKDFIRKLLEFDPRKRL 285 (382)
T ss_pred C----------------------------------------------------CCCccccCHHHHHHHHHhcccCcccCC
Confidence 2 234566778999999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
||.++|+||||++
T Consensus 286 ta~~~L~HpWi~~ 298 (382)
T KOG0032|consen 286 TAAQALQHPWIKS 298 (382)
T ss_pred CHHHHhcCccccC
Confidence 9999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=399.13 Aligned_cols=283 Identities=29% Similarity=0.505 Sum_probs=222.9
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.....|.++++||.|+||+||+|.+..++ ..||||++.... .....|+.+|..| .|+||++++++|.
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~---~~~~~Ei~il~~l------~h~niv~l~~~~~ 129 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTS----EKVAIKKVLQDP---QYKNRELLIMKNL------NHINIIFLKDYYY 129 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCC----CEEEEEEEecCc---chHHHHHHHHHhc------CCCCCcceeeeEe
Confidence 34567999999999999999999998777 789999886543 2345799999999 8999999988775
Q ss_pred ec--------CeEEEEEecchhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCe
Q 002732 644 YR--------NHLCLVFESLHMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 644 ~~--------~~~~lV~E~~~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 714 (887)
.. .+++|||||+.++|.+++.... ....+++..++.|+.||+.||.|||+.|||||||||+||||+..++.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred ecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence 42 3578999999999988876543 23459999999999999999999999999999999999999865668
Q ss_pred EEEEecCcceecCC-CCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCC
Q 002732 715 LKLCDFGNAMFAGK-NEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 715 vKL~DFG~a~~~~~-~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
+||+|||+|..+.. .....+++|+.|+|||++.+. .|+.++||||||||||+|++|.+||.+.+..+.+..++..++.
T Consensus 210 vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 210 LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999999976543 234456789999999999875 6999999999999999999999999999999999999988887
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
++...+.... ..| ..+.|.. +.+..+..+ .+..++.++++||.+||++||.+|
T Consensus 290 p~~~~~~~~~---~~~-~~~~~~~-----------------~~~~~l~~~------~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 290 PTEDQLKEMN---PNY-ADIKFPD-----------------VKPKDLKKV------FPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred CCHHHHHHhc---hhh-hcccCCc-----------------cCchhHHHH------hccCCCHHHHHHHHHHCCCChhHC
Confidence 7665543210 000 0001100 000001000 012345789999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
|||.|||+||||.+
T Consensus 343 ~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 343 LNPIEALADPFFDD 356 (440)
T ss_pred cCHHHHhCChhHHh
Confidence 99999999999963
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=379.50 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=207.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
+|...+.||+|+||+||++.+..++ ..+|||.+.... ...+.+..|+.||.+| .||+||++++......
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g----~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l------~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTG----ELMAVKSVELEDSPTSESLEREIRILSRL------NHPNIVQYYGSSSSRE 87 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCC----cceeeeeeecccchhHHHHHHHHHHHHhC------CCCCEEeeCCcccccc
Confidence 4888899999999999999998876 789999987542 1146688999999999 7999999999855544
Q ss_pred --eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 647 --HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 647 --~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.++|+|||+ +|+|.+++..++. .|++..++.|+.||+.||.|||++|||||||||+||||+..++.+||+|||++
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence 699999999 7899999999774 49999999999999999999999999999999999999954689999999999
Q ss_pred eecCC-----CCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 724 MFAGK-----NEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~-----~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
..... .......||+.|||||++... ...+++|||||||++.||+||.+||... .+....++...
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig------- 236 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIG------- 236 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHh-------
Confidence 76552 224567899999999999963 3345999999999999999999999653 11111110000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
... ..|..+..++..+.+||.+||..+|..||||.+
T Consensus 237 ---------------------------------~~~-----------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e 272 (313)
T KOG0198|consen 237 ---------------------------------RED-----------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEE 272 (313)
T ss_pred ---------------------------------ccC-----------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 000 012234457789999999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
+|.|||+..
T Consensus 273 LL~hpf~~~ 281 (313)
T KOG0198|consen 273 LLEHPFLKQ 281 (313)
T ss_pred HhhChhhhc
Confidence 999999865
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=375.92 Aligned_cols=282 Identities=28% Similarity=0.472 Sum_probs=217.0
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
++|.+++.||.|+||+||+|.+..++ ..||||++..... ....+.+|+.+|+.| .|+||++++++|..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 74 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNG----KLVALKVIRLQEEEGTPFTAIREASLLKGL------KHANIVLLHDIIHT 74 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCC----CEEEEEEeccccccccchhHHHHHHHHhhC------CCCCcCeEEEEEec
Confidence 56999999999999999999998777 7899999875322 234567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+||||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||||+||||+||||+. .+.+||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 151 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD-TGELKLADFGLAR 151 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECCCCcce
Confidence 99999999999999998887642 34899999999999999999999999999999999999985 7789999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATN-NDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~-~~~l~~i~~~~g~~p~~~l~~ 800 (887)
..... .....++++.|+|||++.+. .++.++||||||||||+|++|.+||.+... .+.+..+....+.++...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 152 AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred eccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 54322 23445778999999998764 589999999999999999999999987544 355666666655554433221
Q ss_pred cccccccccc-ccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 801 GAFTDQHFDQ-DLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 801 ~~~~~~~f~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.... ..+.. .+.. ..+..+...+. ...++..+.+||.+||++||.+|||+.|||
T Consensus 232 ~~~~-~~~~~~~~~~-------------------~~~~~~~~~~~-----~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 232 VHSL-PHFKPERFTL-------------------YSPKNLRQAWN-----KLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred hhhc-cccccccccc-------------------cCCccHHHHhh-----ccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 1111 00100 0000 00000000000 011346788999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||.+
T Consensus 287 ~h~~f~~ 293 (303)
T cd07869 287 SHEYFSD 293 (303)
T ss_pred cCccccc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=383.88 Aligned_cols=301 Identities=32% Similarity=0.543 Sum_probs=230.8
Q ss_pred CCceecccCc---eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCC
Q 002732 554 EGYYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGA 627 (887)
Q Consensus 554 ~g~~~~~~~e---il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~ 627 (887)
.++|++.+++ .+.++|.+++.||.|+||+||+|.+..++ ..||||++... ......+..|+.++..+
T Consensus 5 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--- 77 (359)
T cd07876 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG----INVAVKKLSRPFQNQTHAKRAYRELVLLKCV--- 77 (359)
T ss_pred CCcceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCC----ceeEEEEecccccchhHHHHHHHHHHHHHhC---
Confidence 4577777777 45688999999999999999999998877 79999998643 22345567899999988
Q ss_pred CCCCCcceeEecceeeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCC
Q 002732 628 DPENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI 701 (887)
Q Consensus 628 ~~~~h~~Iv~l~~~~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDL 701 (887)
.|+||++++++|... ..+||||||+.++|..++.. .+++..+..++.||+.||.|||++||||+||
T Consensus 78 ---~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDl 149 (359)
T cd07876 78 ---NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 149 (359)
T ss_pred ---CCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 899999999998654 35799999998888887743 3889999999999999999999999999999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~ 780 (887)
||+||||+. ++.+||+|||++...... ......+|+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..
T Consensus 150 kp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 150 KPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred CHHHEEECC-CCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999985 788999999999764332 345567899999999999999999999999999999999999999998888
Q ss_pred HHHHHHHHhhCCCChhhhhccccccc-ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQ-HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~-~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 859 (887)
+.+..++...+.++..++........ ++.....+.. . .+..++... ++..........+..+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPG-----I---SFEELFPDW-------IFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCC-----c---chhhhcccc-------ccccccccccccchhHHH
Confidence 88888888887776655432111000 0000000000 0 000000000 000011122334578899
Q ss_pred HHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 860 LLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
||.+||.+||.+|||+.|||+||||.
T Consensus 294 li~~mL~~dP~~R~t~~e~l~hp~~~ 319 (359)
T cd07876 294 LLSKMLVIDPDKRISVDEALRHPYIT 319 (359)
T ss_pred HHHHHhccCcccCCCHHHHhcCchhh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.06 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=222.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh----HHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~----~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|++.+.||+|.||.||+|....+. -.||||++.+..... .++..|++|-..| .||||++++++|
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~----~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L------~hpnilrlY~~f 91 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSL----FIVALKVLFKSQILKTQVEHQLRREIEIQSHL------RHPNILRLYGYF 91 (281)
T ss_pred hhccccccccCCccccEeEeeeccCC----cEEEEeeeeHHHHHHhcchhhhhheeEeeccc------CCccHHhhhhhe
Confidence 45999999999999999999998887 799999998764322 3444555555555 999999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.+...+||++||. .|.|+..|... ....|++..+..|+.|++.||.|||.++||||||||+|+|++ ..+.+||+|||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg-~~~~lkiAdfG 169 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG-SAGELKIADFG 169 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC-CCCCeeccCCC
Confidence 9999999999999 78999999842 234599999999999999999999999999999999999999 48889999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
.+.....+...+.|||..|.|||++.+..++..+|+|+||++.||+|.|.+||...+..++++.|..+...+|.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~------ 243 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS------ 243 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc------
Confidence 99998888888999999999999999999999999999999999999999999998888888888776555542
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.++..+.|||.+||..+|..|++..|++.|
T Consensus 244 --------------------------------------------------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 244 --------------------------------------------------TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --------------------------------------------------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 344678999999999999999999999999
Q ss_pred CCCC
Q 002732 882 PFIS 885 (887)
Q Consensus 882 pwf~ 885 (887)
|||.
T Consensus 274 pwI~ 277 (281)
T KOG0580|consen 274 PWIV 277 (281)
T ss_pred HHHH
Confidence 9985
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=379.09 Aligned_cols=280 Identities=30% Similarity=0.489 Sum_probs=221.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+.++||.|+||.||+|.+..++ ..||||++... ......+..|+.+|..| .||||+++++++..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~ 70 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG----EKVAIKKINDVFEHVSDATRILREIKLLRLL------RHPDIVEIKHIMLP 70 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC----CEEEEEEechhhccchhHHHHHHHHHHHHhC------CCCCEeeecceEec
Confidence 5999999999999999999998877 79999998642 12234567899999999 89999999998864
Q ss_pred c-----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 645 R-----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 ~-----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
. ..+|||||||+++|.+++.... .+++..+..|+.||+.||.|||++||||+||||+|||++. ++.+||+|
T Consensus 71 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kL~D 146 (338)
T cd07859 71 PSRREFKDIYVVFELMESDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA-DCKLKICD 146 (338)
T ss_pred cCCCCCceEEEEEecCCCCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCcEEEcc
Confidence 3 3589999999999999887643 4999999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCC-----CccCcccCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCC
Q 002732 720 FGNAMFAGKN-----EITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 720 FG~a~~~~~~-----~~~~~~gt~~Y~aPE~l~~--~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
||++...... .....++++.|+|||++.+ ..++.++||||||||||+|++|.+||.+.+...++..+..+.+.
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~ 226 (338)
T cd07859 147 FGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226 (338)
T ss_pred CccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9998754321 1234678999999999876 57899999999999999999999999998888888888888887
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
++..++...... ....++..+....... .....+.++..+.+||.+||..||.+|
T Consensus 227 ~~~~~~~~i~~~---------------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R 281 (338)
T cd07859 227 PSPETISRVRNE---------------------KARRYLSSMRKKQPVP----FSQKFPNADPLALRLLERLLAFDPKDR 281 (338)
T ss_pred CCHHHHHHhhhh---------------------hHHHHHHhhcccCCCc----hHHhcCCCChHHHHHHHHHcCcCcccC
Confidence 776654221100 0011111111100000 011122345678999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
||+.+||+||||++
T Consensus 282 pt~~e~l~hp~f~~ 295 (338)
T cd07859 282 PTAEEALADPYFKG 295 (338)
T ss_pred CCHHHHhcCchhhh
Confidence 99999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=388.99 Aligned_cols=282 Identities=20% Similarity=0.299 Sum_probs=219.1
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..+.|.+++.||.|+||.||+|.+..++ ..||||+... ..+..|+.+|..| .||||++++++|..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~----~~vaiK~~~~-----~~~~~E~~il~~l------~HpnIv~~~~~~~~ 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTC----EHVVIKAGQR-----GGTATEAHILRAI------NHPSIIQLKGTFTY 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCC----CEEEEechhh-----hhhHHHHHHHHhC------CCCCCCCEeEEEEE
Confidence 3457999999999999999999998887 8999997543 3467899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+|||||++.++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. .+.+||+|||+|.
T Consensus 155 ~~~~~lv~e~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~ 230 (391)
T PHA03212 155 NKFTCLILPRYKTDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH-PGDVCLGDFGAAC 230 (391)
T ss_pred CCeeEEEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC-CCCEEEEeCCccc
Confidence 99999999999999998887643 4899999999999999999999999999999999999985 7789999999996
Q ss_pred ecCC---CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-------ChHHHHHHHHHhhCCCC
Q 002732 725 FAGK---NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA-------TNNDMLRLHMELKGPFP 794 (887)
Q Consensus 725 ~~~~---~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~-------~~~~~l~~i~~~~g~~p 794 (887)
.... ......+||+.|+|||++.+..|+.++||||||||||+|++|..||... ....++..++...+.+|
T Consensus 231 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p 310 (391)
T PHA03212 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP 310 (391)
T ss_pred ccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh
Confidence 5322 2344568999999999999999999999999999999999999887543 23456777777778776
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..+.... .......+..+.......... .........++.++.+||.+||++||.+|||
T Consensus 311 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt 369 (391)
T PHA03212 311 NEFPIDA------------------QANLDEIYIGLAKKSSRKPGS---RPLWTNLYELPIDLEYLICKMLAFDAHHRPS 369 (391)
T ss_pred hhcCcch------------------hHHHHHHHHHHHhccCCCCCC---CCCHHHHhhhhhhHHHHHHHHhcCChhhCCC
Confidence 5442100 000000000111000000000 0000011235678899999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
|.|||+||||..
T Consensus 370 a~elL~hp~f~~ 381 (391)
T PHA03212 370 AEALLDFAAFQD 381 (391)
T ss_pred HHHHhcChhhcc
Confidence 999999999974
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=358.90 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=218.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---------hhhHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---------TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
.|.-.+.||.|..++|..|.+..++ ..+|+|++.... ...++...|+.||+++. .||+|++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~----~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~-----GHP~II~l 88 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETG----KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM-----GHPYIIDL 88 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccc----cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc-----CCCcEEEe
Confidence 4777788999999999999998888 788999886321 12355578999999996 89999999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
.++|+....+++||+.| .|.|.++|...- .+++..++.||+||+.|+.|||..+|||+||||+|||++. +..|+|
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd-n~~i~i 164 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD-NMNIKI 164 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc-ccceEE
Confidence 99999999999999999 689999998754 4999999999999999999999999999999999999994 778899
Q ss_pred EecCcceecCCC-CccCcccCCcccchhhhcC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 718 CDFGNAMFAGKN-EITPYLVSRFYRAPEIILG------LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 718 ~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~------~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|||+|+.+... .+...|||+.|+|||.+.. ..|+..+|+|++|||||-||.|.+||......-++.+|++..
T Consensus 165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 999999887655 4778999999999999853 358999999999999999999999997766666666666554
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..| ...+|..++.+.++||.+||+.||.
T Consensus 245 yqF----------------------------------------------------~speWadis~~~KdLIsrlLqVdp~ 272 (411)
T KOG0599|consen 245 YQF----------------------------------------------------RSPEWADISATVKDLISRLLQVDPT 272 (411)
T ss_pred ccc----------------------------------------------------CCcchhhccccHHHHHHHHHeeCch
Confidence 333 1234567778899999999999999
Q ss_pred CCcCHHHHHhCCCCC
Q 002732 871 KRMTVAQALTHPFIS 885 (887)
Q Consensus 871 ~RpTa~elL~Hpwf~ 885 (887)
+|+|+.|+|+||||.
T Consensus 273 ~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 273 KRITAKEALAHPFFI 287 (411)
T ss_pred hcccHHHHhcChHHH
Confidence 999999999999994
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=372.07 Aligned_cols=280 Identities=30% Similarity=0.493 Sum_probs=218.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||+||+|.+...+ +..||||++.... .....+..|+.++..|... .||||++++++|..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~hpniv~~~~~~~~ 75 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVCTV 75 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCC---CeEEEEEEEecccCCCCchHHHHHHHHHHHhhccc---CCCCcceEEEEEec
Confidence 6999999999999999999986542 2689999987532 2234556788888877443 79999999998853
Q ss_pred -----cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 645 -----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 -----~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
...++|||||+.++|.+++..... ..+++..++.|+.||+.||.|||+.||+|+||||+||||+. ++.+||+|
T Consensus 76 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~-~~~~kl~D 153 (290)
T cd07862 76 SRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLAD 153 (290)
T ss_pred ccCCCCCcEEEEEccCCCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC-CCCEEEcc
Confidence 456999999999999999876432 34899999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 720 FGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 720 FG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
||++....... .....+++.|+|||++.+..++.++||||||||||+|++|.+||.+.+..+.+..++...+.++...+
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 154 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99997655432 34567899999999999999999999999999999999999999999988999888887765433322
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
... +.+... .+.......+.. ..+.++..+.+||.+||++||.+|||+.+|
T Consensus 234 ~~~----------~~~~~~------------~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 234 PRD----------VALPRQ------------AFHSKSAQPIEK-------FVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred hhh----------hcccch------------hccCCCCCCHHH-------HccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 110 000000 000000000000 112355778999999999999999999999
Q ss_pred HhCCCC
Q 002732 879 LTHPFI 884 (887)
Q Consensus 879 L~Hpwf 884 (887)
|+||||
T Consensus 285 l~hp~f 290 (290)
T cd07862 285 LSHPYF 290 (290)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=374.61 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=211.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| .||||+++++++.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~ 71 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISE----HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV------SHPFIIRLFWTEH 71 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCC----CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC------CCCcHhhhHhhhc
Confidence 5999999999999999999998777 799999986532 2234567899999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.+++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~-~~~~kl~Dfg~ 147 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK-EGHIKLTDFGF 147 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEEEecCc
Confidence 999999999999 679999997654 4899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
+...... ....+|++.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 148 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------- 217 (291)
T cd05612 148 AKKLRDR-TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF--------- 217 (291)
T ss_pred chhccCC-cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC---------
Confidence 9765443 334578999999999999999999999999999999999999998876665555443322111
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHH
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQ 877 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~e 877 (887)
+..++..+.+||.+||+.||.+||+ +++
T Consensus 218 -----------------------------------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~ 250 (291)
T cd05612 218 -----------------------------------------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADD 250 (291)
T ss_pred -----------------------------------------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHH
Confidence 1123467899999999999999995 999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||.||||..
T Consensus 251 ~l~h~~~~~ 259 (291)
T cd05612 251 VKNHRWFKS 259 (291)
T ss_pred HhcCccccC
Confidence 999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=377.48 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=209.0
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh---------------hHHHHHHHHHHHHhhCCCCC
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM---------------NKAGQTEVQILKKLAGADPE 630 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~---------------~~~~~~Ei~iL~~L~~~~~~ 630 (887)
-++|+++..||+|.||.|-+|.+..++ +.||||++.+.... .+....||.||++|
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~----~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl------ 165 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDG----KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL------ 165 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCC----cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc------
Confidence 356999999999999999999998888 89999999753221 13567899999999
Q ss_pred CCcceeEecceeee--cCeEEEEEecch-hhHHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCc
Q 002732 631 NKRHCIRFASSFKY--RNHLCLVFESLH-MNLREVLKKFGRNIG-LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNM 706 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~--~~~~~lV~E~~~-gsL~~~L~~~~~~~~-ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NI 706 (887)
.|+|||+|+.+..+ .+.+|||+|||. |.+.+ +..... |++.+++.|+.+++.||+|||.+|||||||||+|+
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL 241 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL 241 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 99999999999876 468999999994 44332 223334 99999999999999999999999999999999999
Q ss_pred cccCCCCeEEEEecCcceecCC-------CCccCcccCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCC
Q 002732 707 LVNEAKNVLKLCDFGNAMFAGK-------NEITPYLVSRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFP 775 (887)
Q Consensus 707 Ll~~~~~~vKL~DFG~a~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~----~s~~sDIwSLG~iL~elltG~~PF~ 775 (887)
||+. .++|||+|||.+..... ..+...+||+.|+|||++.+.. .+.+.|||||||+||+|+.|+.||.
T Consensus 242 Ll~~-~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 242 LLSS-DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred EEcC-CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9995 79999999999976521 1234468999999999998743 4688999999999999999999998
Q ss_pred CCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHH
Q 002732 776 GATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855 (887)
Q Consensus 776 ~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 855 (887)
+....+++..|+..-..||. .+.+..
T Consensus 321 ~~~~~~l~~KIvn~pL~fP~------------------------------------------------------~pe~~e 346 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFPE------------------------------------------------------NPEINE 346 (576)
T ss_pred cchHHHHHHHHhcCcccCCC------------------------------------------------------cccccH
Confidence 88777777766544333321 123447
Q ss_pred HHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 856 ~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
.+.+||.+||..||.+|+++.+|..|||.+.
T Consensus 347 ~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 347 DLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHHHHHhhcChhheeehhhheecceecc
Confidence 8899999999999999999999999999874
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=381.16 Aligned_cols=300 Identities=32% Similarity=0.545 Sum_probs=228.7
Q ss_pred CceecccCc---eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCC
Q 002732 555 GYYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 555 g~~~~~~~e---il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~ 628 (887)
++|++.+++ .+.++|.+++.||.|+||.||+|.+..++ ..||||++... ......+..|+.+++.+
T Consensus 2 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---- 73 (355)
T cd07874 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCV---- 73 (355)
T ss_pred cceeeccCchhhhhhhceeEEEEeeecCCEEEEEEEecCCC----ceEEEEEeCCcccChHHHHHHHHHHHHHHHh----
Confidence 456667666 35678999999999999999999987776 78999998753 22335667899999999
Q ss_pred CCCCcceeEecceeeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 629 PENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 629 ~~~h~~Iv~l~~~~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
.|+||++++++|... ..+||||||+.++|.+++.. .+++..+..++.||+.||.|||+.||||+|||
T Consensus 74 --~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDik 146 (355)
T cd07874 74 --NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146 (355)
T ss_pred --CCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 899999999988653 35799999998888887754 28899999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~ 781 (887)
|+||||+. ++.+||+|||++....... .....+|+.|+|||++.+..|+.++||||||||||+|++|..||.+....+
T Consensus 147 p~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 225 (355)
T cd07874 147 PSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_pred hHHEEECC-CCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999985 7889999999997655432 345678999999999999999999999999999999999999999988888
Q ss_pred HHHHHHHhhCCCChhhhhcccccccccc-cccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFD-QDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~f~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
.+..++...+.....++.........+. ....+... .+...+ ...++..........+..+.+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL--------TFPKLF-------PDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccc--------cchhhc-------cccccccccccccccchHHHHH
Confidence 8888877776655444322111110000 00000000 000000 0001111112223345788999
Q ss_pred HHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 861 LDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
|.+||.+||.+|||+.|||+||||.
T Consensus 291 i~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcCcchh
Confidence 9999999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=380.80 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=211.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|.+.+.||.|+||.||+|.+..++ +.||||++.... .....+..|+.+|..| .||||++++++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~ 87 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTG----EYYAIKCLKKREILKMKQVQHVAQEKSILMEL------SHPFIVNMMCSF 87 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCcEEEEE
Confidence 45999999999999999999998877 799999997542 2234567899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+.+||||||+ +++|.++|.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||
T Consensus 88 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kl~Dfg 163 (329)
T PTZ00263 88 QDENRVYFLLEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN-KGHVKVTDFG 163 (329)
T ss_pred EcCCEEEEEEcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC-CCCEEEeecc
Confidence 9999999999999 679999988644 4899999999999999999999999999999999999985 7889999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
++....... ...+|++.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 164 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~-------- 234 (329)
T PTZ00263 164 FAKKVPDRT-FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF-------- 234 (329)
T ss_pred CceEcCCCc-ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC--------
Confidence 998765433 34678999999999999999999999999999999999999998766555444433221111
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VA 876 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~ 876 (887)
+..++..+.+||.+||+.||.+||+ +.
T Consensus 235 ------------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 266 (329)
T PTZ00263 235 ------------------------------------------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVA 266 (329)
T ss_pred ------------------------------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHH
Confidence 1123467889999999999999997 79
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+||.||||.+
T Consensus 267 ~ll~hp~f~~ 276 (329)
T PTZ00263 267 DVKNHPYFHG 276 (329)
T ss_pred HHhcCCccCC
Confidence 9999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=380.96 Aligned_cols=289 Identities=21% Similarity=0.347 Sum_probs=221.9
Q ss_pred ccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 560 ~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
....++..+|.++..||.|+||.||+|...... ....||||++... .....|+.+|..| .|+||++++
T Consensus 85 ~~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~--~~~~v~vK~~~~~----~~~~~E~~il~~l------~h~~iv~~~ 152 (392)
T PHA03207 85 DPASVVRMQYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGG----KTPGREIDILKTI------SHRAIINLI 152 (392)
T ss_pred CcchhccCceEEEEeecCCCCeEEEEEEEcCCc--cceeEEEEecccc----ccHHHHHHHHHhc------CCCCcccee
Confidence 344566778999999999999999999764422 3468999988653 3446799999999 899999999
Q ss_pred ceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 640 SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
++|.....+|||||++.++|.+++... ..|++..++.|+.||+.||.|||++||||+||||+||||+. .+.++|+|
T Consensus 153 ~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~-~~~~~l~D 228 (392)
T PHA03207 153 HAYRWKSTVCMVMPKYKCDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE-PENAVLGD 228 (392)
T ss_pred eeEeeCCEEEEEehhcCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-CCCEEEcc
Confidence 999999999999999999999988543 34999999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHHHhhCC
Q 002732 720 FGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT---NNDMLRLHMELKGP 792 (887)
Q Consensus 720 FG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~---~~~~l~~i~~~~g~ 792 (887)
||++....... .....+|+.|+|||++.+..|+.++||||||||||+|++|..||.+.. ....+..++.+++.
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~ 308 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQV 308 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhcc
Confidence 99997654322 234578999999999999999999999999999999999999997654 34566777777666
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCC-ccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKD-IGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.|..+..... ......+..+.....+.. +..++ ....++..+.+||.+||.+||.+
T Consensus 309 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 309 HPLEFPQNGS------------------TNLCKHFKQYAIVLRPPYTIPPVI-----RKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CccccCCccc------------------hhHHHHHHhhcccccCCccccchh-----hccCcchhHHHHHHHHhccChhh
Confidence 5543211100 000011111111111110 00110 01134567899999999999999
Q ss_pred CcCHHHHHhCCCCCCC
Q 002732 872 RMTVAQALTHPFISGK 887 (887)
Q Consensus 872 RpTa~elL~Hpwf~~~ 887 (887)
||||.+||.||||..+
T Consensus 366 Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 366 RPSAQDILSLPLFTKE 381 (392)
T ss_pred CCCHHHHhhCchhhcc
Confidence 9999999999999753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=380.23 Aligned_cols=290 Identities=32% Similarity=0.538 Sum_probs=223.3
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.++|.+++.||.|+||.||+|.+..++ ..||||++... ......+..|+.+++.+ .|+||+.++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~ii~~~~~ 91 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCV------NHKNIIGLLNV 91 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCC----cEEEEEEeCccccCchhHHHHHHHHHHHHhc------CCCCcccccee
Confidence 4578999999999999999999998777 78999998753 22335567899999888 89999999988
Q ss_pred eeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 642 FKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 642 ~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
|... ..+||||||+.++|..++.. .+++..+..++.||+.||.|||++||||+||||+||||+. ++.+
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~ 165 (364)
T cd07875 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTL 165 (364)
T ss_pred ecccccccccCeEEEEEeCCCCCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC-CCcE
Confidence 7643 46799999999898888753 2889999999999999999999999999999999999985 7889
Q ss_pred EEEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 716 KLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
||+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..++...+.++
T Consensus 166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999997765433 3456789999999999999999999999999999999999999999999888888888877765
Q ss_pred hhhhhccccccccc-ccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 795 KKMLRKGAFTDQHF-DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 795 ~~~l~~~~~~~~~f-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
..++.........+ .....+... .+..++. ..++..........+..+.+||.+||++||.+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~-------~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGY--------SFEKLFP-------DVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCC--------ChHhhCc-------cccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 55433211110000 000000000 0000000 0001111112223456789999999999999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||+||||.
T Consensus 311 t~~e~L~hp~~~ 322 (364)
T cd07875 311 SVDEALQHPYIN 322 (364)
T ss_pred CHHHHhcCcccc
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=370.69 Aligned_cols=281 Identities=28% Similarity=0.503 Sum_probs=225.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||.|+||+||+|.+..++ ..||||++..... ....+..|+.++..| .|+||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 75 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIVHT 75 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCC----CeEEEEEeeccccCCcchhHHHHHHHHHhC------CCCCcceEEEEEee
Confidence 45999999999999999999988776 7899999875322 234567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.+.+||||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+||||+. .+.+||+|||++.
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~ 152 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE-RGELKLADFGLAR 152 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECccccce
Confidence 99999999999889998887643 24899999999999999999999999999999999999985 7889999999997
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... ......+++.|+|||++.+. .++.++||||||||||+|++|.+||.+.+..+.+..++...+.++..++...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 153 AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 64432 23345678899999998764 6899999999999999999999999999988999999998888777665332
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.....+.. .++.. ..+ ..++ ...+.++..+.+||.+||.+||.+|||+.|||.|
T Consensus 233 ~~~~~~~~--~~~~~-----------------~~~---~~~~----~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 233 SSNDEFKN--YNFPK-----------------YKP---QPLI----NHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cchhhhhh--hhcCc-----------------cCC---Cchh----hhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 21111110 00000 000 0000 1123456788999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 287 ~~~~~ 291 (309)
T cd07872 287 AYFRS 291 (309)
T ss_pred hhhhh
Confidence 99974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=364.75 Aligned_cols=279 Identities=31% Similarity=0.535 Sum_probs=219.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+++.||.|+||+||+|.+..++ ..||||++..... .......|+.++..|... .|+||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~ni~~~~~~~~~ 73 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF---DHPNIVRLMDVCAT 73 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhc---CCCCeeeeeeeecc
Confidence 4899999999999999999998877 8999999875321 223456788888887543 69999999998864
Q ss_pred -----cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 645 -----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 -----~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
...+++||||+.++|.+++..... ..+++..++.++.||+.||.|||+.||||+||||+|||++. ++.+||+|
T Consensus 74 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-~~~~kl~d 151 (288)
T cd07863 74 SRTDRETKVTLVFEHVDQDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGQVKLAD 151 (288)
T ss_pred ccCCCCceEEEEEcccccCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECc
Confidence 356899999998899998876432 34899999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 720 FGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 720 FG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
||++...... ......++..|+|||++.+..++.++||||||||||+|++|.+||.+....+.+..+....+.++...+
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 152 FGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9999766533 234567789999999999999999999999999999999999999988888888888877665543332
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
... .........+ ..+.. .....+.++..+.+||.+||++||.+|||+.+|
T Consensus 232 ~~~----------~~~~~~~~~~------------~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 232 PRD----------VTLPRGAFSP------------RGPRP-------VQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred ccc----------ccccccccCC------------CCCCc-------hHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 110 0000000000 00000 001123455788999999999999999999999
Q ss_pred HhCCCC
Q 002732 879 LTHPFI 884 (887)
Q Consensus 879 L~Hpwf 884 (887)
|.||||
T Consensus 283 l~hp~f 288 (288)
T cd07863 283 LQHPFF 288 (288)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=377.79 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=203.9
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||+|+||.||+|.+..++ ..||||++.+... ....+..|+.+|..+ .||||+.++++|...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~~ 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG----KYYAMKILKKEVIIAKDEVAHTLTESRVLQNT------RHPFLTALKYSFQTHDRL 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCCEEEEEEcCCEE
Confidence 36899999999999998877 8999999975422 224456788899888 899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||++....
T Consensus 71 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 71 CFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccc
Confidence 9999999 678988887643 4899999999999999999999999999999999999985 7889999999986532
Q ss_pred C--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 K--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 ~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
. ......+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~------------ 214 (323)
T cd05571 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------------ 214 (323)
T ss_pred cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 2 22345678999999999999999999999999999999999999998766554444332111111
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~ 880 (887)
+..++..+.+||.+||..||.+|| ++.+||+
T Consensus 215 --------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 --------------------------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --------------------------------------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 123457789999999999999999 8999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 251 h~~f~~ 256 (323)
T cd05571 251 HRFFAS 256 (323)
T ss_pred CCCcCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=376.97 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=214.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|.+++.||.|+||.||+|.+..++ +.||||++.+... ....+..|+.+|..+ .|+||++++++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~ 70 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG----EIVALKRMKKSLLFKLNEVRHVLTERDILTTT------KSEWLVKLLYAF 70 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC------CCCCCccEEEEE
Confidence 35999999999999999999998877 7999999975422 234567788898888 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+++||||||+ +++|.+++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. .+.+||+|||
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kL~Dfg 146 (333)
T cd05600 71 QDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA-SGHIKLTDFG 146 (333)
T ss_pred EcCCEEEEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCCEEEEeCc
Confidence 9999999999999 679999997644 3899999999999999999999999999999999999985 7889999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
++..... .....++++.|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..+......+..
T Consensus 147 ~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 219 (333)
T cd05600 147 LSKGIVT-YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR------ 219 (333)
T ss_pred CCccccc-ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC------
Confidence 9976544 344567899999999999999999999999999999999999999887776665544322111100
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+. .......++..+.+||.+||..+|.+|||+.+||.|
T Consensus 220 ----------------------------------~~--------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 ----------------------------------PV--------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----------------------------------CC--------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 000012356788999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 258 ~~~~~ 262 (333)
T cd05600 258 PFFKE 262 (333)
T ss_pred cccCC
Confidence 99974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=379.39 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=207.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|++++.||+|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..+ +|++|++++++|.
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~------~~~~iv~~~~~~~ 71 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTG----HVYAMKILRKADMLEKEQVGHIRAERDILVEA------DSLWVVKMFYSFQ 71 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC------CCCCcceEEEEEe
Confidence 5999999999999999999998877 7999999975322 224566788898888 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+||||||+ +++|.++|.... .+++..++.|+.||+.||.|||++||||+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~-~~~vkL~DFGl 147 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS-KGHVKLSDFGL 147 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-CCCEEEeeccC
Confidence 999999999999 679999987644 4999999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCC-------------------------------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHH
Q 002732 723 AMFAGKNE-------------------------------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLY 765 (887)
Q Consensus 723 a~~~~~~~-------------------------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ 765 (887)
+....... ....+||+.|+|||++.+..|+.++||||||||||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 86432110 12457899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccC
Q 002732 766 ELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845 (887)
Q Consensus 766 elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (887)
+|++|.+||.+.+..+.+..++.....++
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------------- 256 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLI--------------------------------------------------- 256 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCccc---------------------------------------------------
Confidence 99999999988777666655543221110
Q ss_pred CCCCChhhHHHHHHHHHHhcccCCCC---CcCHHHHHhCCCCCC
Q 002732 846 SPGEDPKMLANFKDLLDKIFVLDPEK---RMTVAQALTHPFISG 886 (887)
Q Consensus 846 ~~~~~~~~s~~~~dLL~kmL~~DP~~---RpTa~elL~Hpwf~~ 886 (887)
.+ ....++..+.+||.+||. +|.. ||++.|||+||||.+
T Consensus 257 ~p-~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 257 FP-PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CC-CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 00 011245678899999875 5554 589999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=326.83 Aligned_cols=279 Identities=30% Similarity=0.520 Sum_probs=232.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.-+++||+|.||+||+|....+. +.||+|.+..+ .........||-+|+.| .|.|||++++....
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~----eivalkrvrlddddegvpssalreicllkel------khknivrl~dvlhs 72 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLHDVLHS 72 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCcc----ceEEEEEEeccCCCCCCcHHHHHHHHHHHHh------hhcceeehhhhhcc
Confidence 4677889999999999999998887 89999999753 33346778999999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.+.+.||||||...|..++...+ +.+....++.++.|++.||.|+|+++++|+||||.|+||+. ++.+||+|||++.
T Consensus 73 dkkltlvfe~cdqdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~-ngelkladfglar 149 (292)
T KOG0662|consen 73 DKKLTLVFEFCDQDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR-NGELKLADFGLAR 149 (292)
T ss_pred CceeEEeHHHhhHHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc-CCcEEecccchhh
Confidence 99999999999999999988764 45999999999999999999999999999999999999995 8899999999998
Q ss_pred ecCCC--CccCcccCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
.++.. .+..-+.|+||.+|.++.|.. |++.+|+||.|||+.||.. |.++|+|.+..+++..|+.++|.+.+.-|..
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 77754 356667899999999999985 8999999999999999998 9999999999999999999999886654321
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.. +...+......+.+ ..+.+ .-|+++....+||+++|..+|.+|++|+++|+
T Consensus 230 ~t-------~lpdyk~yp~ypat-tswsq-------------------ivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 230 MT-------KLPDYKPYPIYPAT-TSWSQ-------------------IVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cc-------cCCCCcccCCcccc-chHHH-------------------HhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 10000000000000 00111 12456677889999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||++
T Consensus 283 hpyf~d 288 (292)
T KOG0662|consen 283 HPYFSD 288 (292)
T ss_pred Cccccc
Confidence 999975
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=380.96 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=208.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ +|+||++++++|.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~~~~~~~ 71 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTG----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEA------DNPWVVKLYYSFQ 71 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceEEEEE
Confidence 5999999999999999999998877 799999997532 2234456799999998 7999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|...+ .|++..++.|+.||+.||.|||++||||+||||+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~ 147 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA-KGHIKLSDFGL 147 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEeeccc
Confidence 999999999999 679999987644 4999999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCC----------------------------------------ccCcccCCcccchhhhcCCCCCchhhHHHHHH
Q 002732 723 AMFAGKNE----------------------------------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGC 762 (887)
Q Consensus 723 a~~~~~~~----------------------------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~ 762 (887)
+..+.... ....+||+.|+|||++.+..|+.++|||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 86432111 11346899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCcccc
Q 002732 763 CLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842 (887)
Q Consensus 763 iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (887)
|||+|++|.+||.+.+..+.+..++.....++
T Consensus 228 il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------------------ 259 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETYRKIINWKETLQ------------------------------------------------ 259 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC------------------------------------------------
Confidence 99999999999987766555544432111100
Q ss_pred ccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 002732 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---VAQALTHPFISG 886 (887)
Q Consensus 843 ~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---a~elL~Hpwf~~ 886 (887)
.+ ....++..+.+||.+||. +|.+|++ +.+||.||||.+
T Consensus 260 ---~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 260 ---FP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred ---CC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 00 011345788999999997 9999998 999999999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=366.11 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=207.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
|.+++.||.|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..| .|++|+.++++|..
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~iv~~~~~~~~ 71 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKRILEKV------NSRFVVSLAYAYET 71 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCC----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc------CCCcEEEEEEEEcc
Confidence 889999999999999999998887 7999999875322 123467899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+|+||||+ +++|..++.... ...+++..++.++.||+.||.|||+.||||+||||+||||+. .+.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~-~~~~kl~Dfg~~ 149 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD-RGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC-CCCEEEeeCCCc
Confidence 99999999999 578888776533 235899999999999999999999999999999999999984 788999999999
Q ss_pred eecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 724 MFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 724 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....++++.|+|||++.+..|+.++||||||||||+|++|..||.+.........+......
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~---------- 219 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE---------- 219 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc----------
Confidence 775432 234567899999999999999999999999999999999999999765432222111110000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHH
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQ 877 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~e 877 (887)
.....+..++..+.+||.+||..||.+||| +.+
T Consensus 220 ------------------------------------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05631 220 ------------------------------------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAG 257 (285)
T ss_pred ------------------------------------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence 000112335678899999999999999997 899
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||+||||.+
T Consensus 258 ~~~h~~~~~ 266 (285)
T cd05631 258 VKQHPIFKN 266 (285)
T ss_pred HhcCHhhcC
Confidence 999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=376.67 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=211.2
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
..+.|.++..||.|+||.||+|.+..++ ...||||++.... .....+..|+.+|..| .||||+++++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~ 98 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNED---FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI------NHPFCVNLYG 98 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCC---CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCCcceEE
Confidence 3456999999999999999999876543 2579999986532 2234567899999998 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
+|...+.+||||||+ +++|.++|.... .+++..+..|+.||+.||.|||++||||+||||+||||+. ++.+||+|
T Consensus 99 ~~~~~~~~~lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~-~~~ikL~D 174 (340)
T PTZ00426 99 SFKDESYLYLVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK-DGFIKMTD 174 (340)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC-CCCEEEec
Confidence 999999999999999 679999987644 4999999999999999999999999999999999999984 78899999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
||++...... ....+||+.|+|||++.+..++.++||||||||||+|++|.+||.+.+....+..+......+
T Consensus 175 FG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------ 247 (340)
T PTZ00426 175 FGFAKVVDTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF------ 247 (340)
T ss_pred CCCCeecCCC-cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC------
Confidence 9999876543 345678999999999999999999999999999999999999998776655544443221111
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----C
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----T 874 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----T 874 (887)
+..++..+.+||.+||+.||.+|+ |
T Consensus 248 --------------------------------------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 277 (340)
T PTZ00426 248 --------------------------------------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKG 277 (340)
T ss_pred --------------------------------------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCC
Confidence 122346788999999999999995 8
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+++|++||||.+
T Consensus 278 ~~~~~~hp~f~~ 289 (340)
T PTZ00426 278 AQNVKEHPWFGN 289 (340)
T ss_pred HHHHHcCCCcCC
Confidence 999999999975
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=353.53 Aligned_cols=293 Identities=26% Similarity=0.419 Sum_probs=226.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|+++..||.|.||.||+|....++......+|||.++.. ........+|+.+++.| .|+||+.|..+|..
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl------~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL------KHPNVISLVKVFLS 98 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh------cCCcchhHHHHHhc
Confidence 3999999999999999999877766445568999999754 23346778999999999 99999999999987
Q ss_pred -cCeEEEEEecchhhHHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC---CCeEEEE
Q 002732 645 -RNHLCLVFESLHMNLREVLKKFGR--NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA---KNVLKLC 718 (887)
Q Consensus 645 -~~~~~lV~E~~~gsL~~~L~~~~~--~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~vKL~ 718 (887)
...++|||+|...+|..+|+.... ...++...+..|+.||+.|+.|||++-|+||||||.||||... .+.|||+
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 789999999999999999986543 3459999999999999999999999999999999999999731 3789999
Q ss_pred ecCcceecCCCC-----ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCC---------hHHHH
Q 002732 719 DFGNAMFAGKNE-----ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGAT---------NNDML 783 (887)
Q Consensus 719 DFG~a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~---------~~~~l 783 (887)
|||+++++.+.. ....+.|.||.|||.|+|. .||.++|||++|||+.|||+-.+.|.+.. ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998876542 3456779999999999998 49999999999999999999999997632 34789
Q ss_pred HHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhh-cCCCCccccccCCCCCChhhHHHHHHHHH
Q 002732 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN-IKPKDIGSIVTASPGEDPKMLANFKDLLD 862 (887)
Q Consensus 784 ~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLL~ 862 (887)
..|++++|.+.+.-|..-. ..|.....+..+-.. .....+...+.... .-++...+||.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lk----------------k~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k----~k~~~a~~LL~ 318 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLK----------------KMPEYQTLLSDFRRHYYDNVSLHKYYHKHK----VKDPSALDLLQ 318 (438)
T ss_pred HHHHHHcCCCccccchhhh----------------hCcchHHHHHHhHHhhcCcchHHHHHHHhc----CCCchHHHHHH
Confidence 9999999987655432111 111111111111100 00000111111011 11234689999
Q ss_pred HhcccCCCCCcCHHHHHhCCCCCC
Q 002732 863 KIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 863 kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
+||++||.+|+||+++|+|+||+.
T Consensus 319 klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 319 KLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHhccCchhhccHHHHhccccccc
Confidence 999999999999999999999975
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=368.27 Aligned_cols=301 Identities=21% Similarity=0.299 Sum_probs=218.4
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+..++|.++..||.|+||.||+|.+..++ ..||+|++... ......+..|+.+|..| +|+||++++++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 71 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSG----LIMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGA 71 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHHC------CCCCCCeEEEE
Confidence 34567999999999999999999998877 78999998754 23345678899999999 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhcc-ceeccCCCCCCccccCCCCeEEEEe
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC-GVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
|...+.++|||||+ +++|.+++.... .+++..+..++.||+.||.|||+. +|||+||||+||||+. .+.++|+|
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~D 147 (331)
T cd06649 72 FYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCD 147 (331)
T ss_pred EEECCEEEEEeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEcc
Confidence 99999999999999 579999987643 389999999999999999999985 6999999999999985 78899999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
||++............+++.|+|||++.+..++.++||||||||||+|++|..||......+....+.............
T Consensus 148 fg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 148 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred CcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 99997665555556678999999999999999999999999999999999999998766544332211100000000000
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.......... ...............+..++..+..... .......++..+.+||.+||++||.+|||+.+||
T Consensus 228 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 228 SISPRPRPPG--RPVSGHGMDSRPAMAIFELLDYIVNEPP------PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccCccccccc--ccccccccccccchhHHHHHHHHHhCCC------cCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0000000000 0000000001111111111111111000 0011224668899999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||..
T Consensus 300 ~h~~~~~ 306 (331)
T cd06649 300 NHTFIKR 306 (331)
T ss_pred cChHHhh
Confidence 9999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.00 Aligned_cols=278 Identities=30% Similarity=0.500 Sum_probs=221.3
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.++++||.|+||+||+|.+..++ ..||||++... ......+..|+.+|..| .|+||+.+++++...
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~ 71 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDG----KRVALKKMPNVFQNLVSCKRVFRELKMLCFF------KHDNVLSALDILQPP 71 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCC----CEEEEEeccccccchHHHHHHHHHHHHHHhC------CCCCcCCHhheecCC
Confidence 788999999999999999988777 78999998642 22335667899999998 899999999999887
Q ss_pred C-----eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 646 N-----HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 646 ~-----~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
+ ++||||||+.++|.+++... ..|++..++.|+.||+.||.|||+.||+|+||||+||||+. ++.+||+||
T Consensus 72 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~-~~~~kL~Df 147 (372)
T cd07853 72 HIDPFEEIYVVTELMQSDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS-NCVLKICDF 147 (372)
T ss_pred CccccceEEEEeeccccCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC-CCCEEeccc
Confidence 6 89999999988888887653 34999999999999999999999999999999999999995 788999999
Q ss_pred CcceecCCC---CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 721 GNAMFAGKN---EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 721 G~a~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
|++...... ......+++.|+|||++.+. .|+.++||||||||||+|++|.+||.+.+...++..|...++..+..
T Consensus 148 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 148 GLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred cceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 999765432 23445678899999999875 48999999999999999999999999999999999999888876654
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhh-c-CCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN-I-KPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
.+.... ......+.. . .+.....++ .....++..+.+||.+||++||.+|||
T Consensus 228 ~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~mL~~dP~~R~t 281 (372)
T cd07853 228 AMRSAC----------------------EGARAHILRGPHKPPSLPVLY----TLSSQATHEAVHLLCRMLVFDPDKRIS 281 (372)
T ss_pred HHHHhh----------------------HHHHHHHHhCCCCCCchHHhc----ccCCCCCHHHHHHHHHhCCCChhhCcC
Confidence 432110 001111111 0 001111110 112234678899999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+.|||.||||.+
T Consensus 282 ~~e~l~hp~~~~ 293 (372)
T cd07853 282 AADALAHPYLDE 293 (372)
T ss_pred HHHHhcCHhhCC
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=380.01 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=205.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.+|..+ .|+||++++++|.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~l~~~~~ 71 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTH----ALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEWVVKLYYSFQ 71 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc------CCCCeeeeEEEEe
Confidence 4899999999999999999998877 899999997542 2234567899999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|.... .+++..++.++.||+.||.|||+.||||+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~-~~~~kL~DFGl 147 (381)
T cd05626 72 DKDNLYFVMDYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL-DGHIKLTDFGL 147 (381)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC-CCCEEEeeCcC
Confidence 999999999999 679999987754 3899999999999999999999999999999999999985 78899999998
Q ss_pred ceecCCC-------------------------------------------------CccCcccCCcccchhhhcCCCCCc
Q 002732 723 AMFAGKN-------------------------------------------------EITPYLVSRFYRAPEIILGLPYDH 753 (887)
Q Consensus 723 a~~~~~~-------------------------------------------------~~~~~~gt~~Y~aPE~l~~~~~s~ 753 (887)
+...... .....+||+.|+|||++.+..|+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 7432100 012357899999999999999999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhh
Q 002732 754 PLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN 833 (887)
Q Consensus 754 ~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~ 833 (887)
++||||||||||+|++|.+||...+..+....++.....+.
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------- 268 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH--------------------------------------- 268 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC---------------------------------------
Confidence 99999999999999999999987665544433322111100
Q ss_pred cCCCCccccccCCCCCChhhHHHHHHHHHHhccc--CCCCCcCHHHHHhCCCCCC
Q 002732 834 IKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL--DPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~--DP~~RpTa~elL~Hpwf~~ 886 (887)
......++.++.+||.+||.. +|..|+|+.+||.||||++
T Consensus 269 -------------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 269 -------------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 001123557889999997655 4445999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=376.94 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=211.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ .|+||++++++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~ 70 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTG----QVYAMKVLRKSDMIKRNQIAHVRAERDILADA------DSPWIVKLYYSF 70 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCC----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc------CCCCccchhhhe
Confidence 36999999999999999999998777 899999997542 2234567888999888 799999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+++||||||+ +++|.+++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~-~~~~kL~Dfg 146 (350)
T cd05573 71 QDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA-DGHIKLADFG 146 (350)
T ss_pred ecCCeEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEeecCC
Confidence 9999999999999 679999998753 4999999999999999999999999999999999999985 7889999999
Q ss_pred cceecCCCC-------------------------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcC
Q 002732 722 NAMFAGKNE-------------------------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG 770 (887)
Q Consensus 722 ~a~~~~~~~-------------------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG 770 (887)
++....... ....+||+.|+|||++.+..++.++||||||||||+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 997654332 2345789999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCC
Q 002732 771 KVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850 (887)
Q Consensus 771 ~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (887)
..||.+.+....+..++.....+. .+ ..
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------------------------------~p-~~ 254 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESLR---------------------------------------------------FP-PD 254 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCccc---------------------------------------------------CC-CC
Confidence 999988776555544433111100 00 01
Q ss_pred hhhHHHHHHHHHHhcccCCCCCcC-HHHHHhCCCCCC
Q 002732 851 PKMLANFKDLLDKIFVLDPEKRMT-VAQALTHPFISG 886 (887)
Q Consensus 851 ~~~s~~~~dLL~kmL~~DP~~RpT-a~elL~Hpwf~~ 886 (887)
..++..+.+||..||. ||.+||+ +.+||+||||.+
T Consensus 255 ~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 255 PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 1245788999999997 9999999 999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=380.25 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=205.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||.|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..+ .||||++++++|.
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~ 71 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTG----KIYAMKTLLKSEMFKKDQLAHVKAERDVLAES------DSPWVVSLYYSFQ 71 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC------CCCCcceEEEEEE
Confidence 5999999999999999999998877 8999999865422 234567789998888 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|.... .|++..++.|+.||+.||.|||++||||+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~-~~~~kl~DfGl 147 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR-GGHIKLSDFGL 147 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC-CCCEEEeeccc
Confidence 999999999999 679999987644 4899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCC-------------C------------------------------------ccCcccCCcccchhhhcCCCCCc
Q 002732 723 AMFAGKN-------------E------------------------------------ITPYLVSRFYRAPEIILGLPYDH 753 (887)
Q Consensus 723 a~~~~~~-------------~------------------------------------~~~~~gt~~Y~aPE~l~~~~~s~ 753 (887)
+..+... . ....+||+.|+|||++.+..|+.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 8532110 0 01246899999999999999999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhh
Q 002732 754 PLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN 833 (887)
Q Consensus 754 ~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~ 833 (887)
++||||||||||+|++|.+||.+.+..+.+..+......++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------- 268 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY--------------------------------------- 268 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC---------------------------------------
Confidence 99999999999999999999987766555554432111000
Q ss_pred cCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC---cCHHHHHhCCCCCC
Q 002732 834 IKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR---MTVAQALTHPFISG 886 (887)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R---pTa~elL~Hpwf~~ 886 (887)
.+ ....++..+.+||.+||. +|..| +|+.+||.||||.+
T Consensus 269 ------------~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 269 ------------FP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred ------------CC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 00 011245778999999998 77765 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=363.28 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=219.6
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh----HHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~----~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
..+..+|+|.+.||+|.||.|-+|.....+ ..||||.|.++.... -.+..||.||..| +||||+++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sg----R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL------NHPhII~I 118 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSG----REVAIKSIRKDKIKDEQDLVHIRREIEIMSSL------NHPHIIQI 118 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCC----cEeehhhhhhhhcccHHHHHHHHHHHHHHhhc------CCCceeeh
Confidence 345678999999999999999999987777 899999998765443 3346899999999 99999999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
+.+|+..+.+.|||||. +|.|++||-..+. |++.+++.|++||+.|+.|+|.+++||+|||.+||||+. ++.+||
T Consensus 119 yEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~-N~NiKI 194 (668)
T KOG0611|consen 119 YEVFENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ-NNNIKI 194 (668)
T ss_pred hhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC-CCCeee
Confidence 99999999999999999 7899999998776 999999999999999999999999999999999999995 778899
Q ss_pred EecCcceecCCC-CccCcccCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 718 CDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 718 ~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~-s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
+|||++.++... .++++||++.|.+||++.|.+| ++.+|.|||||+||.|+.|.+||+|.+...++..|......
T Consensus 195 ADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr--- 271 (668)
T KOG0611|consen 195 ADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR--- 271 (668)
T ss_pred eccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc---
Confidence 999999776544 5789999999999999999998 58899999999999999999999999887777666322111
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.|.-+..+.-||+.||..||.+|.|+
T Consensus 272 ------------------------------------------------------EP~~PSdA~gLIRwmLmVNP~RRATi 297 (668)
T KOG0611|consen 272 ------------------------------------------------------EPETPSDASGLIRWMLMVNPERRATI 297 (668)
T ss_pred ------------------------------------------------------CCCCCchHHHHHHHHHhcCcccchhH
Confidence 01112456689999999999999999
Q ss_pred HHHHhCCCCC
Q 002732 876 AQALTHPFIS 885 (887)
Q Consensus 876 ~elL~Hpwf~ 885 (887)
++|..|=|++
T Consensus 298 eDiAsHWWvN 307 (668)
T KOG0611|consen 298 EDIASHWWVN 307 (668)
T ss_pred HHHhhhheee
Confidence 9999998875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.83 Aligned_cols=286 Identities=26% Similarity=0.419 Sum_probs=208.4
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee--cCeEE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY--RNHLC 649 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~--~~~~~ 649 (887)
..+||+|+||+||+|.+.... ....||||++.... ....+..|+.+|..| .||||++++++|.. ...+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~--~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTG-ISMSACREIALLREL------KHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEccCC--CCceEEEEEECCCC-CcHHHHHHHHHHHhc------CCCCCcceeeeEecCCCcEEE
Confidence 358999999999999875422 23689999987543 234567899999999 89999999998864 46789
Q ss_pred EEEecchhhHHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc---CCCCeEEEEec
Q 002732 650 LVFESLHMNLREVLKKFG------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN---EAKNVLKLCDF 720 (887)
Q Consensus 650 lV~E~~~gsL~~~L~~~~------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~~vKL~DF 720 (887)
|||||++++|..++.... ....+++..++.|+.||+.||.|||+.||||+||||+||||. ...+.+||+||
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 77 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 999999999998886532 123489999999999999999999999999999999999994 23568999999
Q ss_pred CcceecCCC-----CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHH
Q 002732 721 GNAMFAGKN-----EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATN---------NDMLRL 785 (887)
Q Consensus 721 G~a~~~~~~-----~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~---------~~~l~~ 785 (887)
|++...... .....++|+.|+|||++.+. .|+.++||||||||||+|++|.+||.+... ..++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 23456789999999999875 589999999999999999999999975432 356667
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+...++.++...+......... ...+..+...... ...+...........+..+++||.+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dli~~mL 298 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEH----------------STLMKDFRRNTYT--NCSLIKYMEKHKVKPDSKAFHLLQKLL 298 (317)
T ss_pred HHHhcCCCChHHhHHHhhccch----------------hhhhhhhhccccC--cccccchHHhcCCCCChHHHHHHHHHh
Confidence 7777776554443221100000 0000000000000 000000001111223456889999999
Q ss_pred ccCCCCCcCHHHHHhCCCC
Q 002732 866 VLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 866 ~~DP~~RpTa~elL~Hpwf 884 (887)
++||.+||||+|||+||||
T Consensus 299 ~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 299 TMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=379.64 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=206.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.++++||+|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..+ .|+||++++++|.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~------~h~~iv~~~~~~~ 71 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTK----ALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEWVVRLYYSFQ 71 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCC----CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC------CCCcCCeEEEEEE
Confidence 5999999999999999999998877 8999999975422 234567899999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||| +++|.++|...+ .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~-~g~~kL~DFGl 147 (382)
T cd05625 72 DKDNLYFVMDYIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGL 147 (382)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEEeECCC
Confidence 999999999999 679999987643 3899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCC-------------------------------------------------CCccCcccCCcccchhhhcCCCCCc
Q 002732 723 AMFAGK-------------------------------------------------NEITPYLVSRFYRAPEIILGLPYDH 753 (887)
Q Consensus 723 a~~~~~-------------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~ 753 (887)
+..+.. ......+||+.|+|||++.+..|+.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 742210 0012346899999999999999999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhh
Q 002732 754 PLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN 833 (887)
Q Consensus 754 ~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~ 833 (887)
++||||||||||+|++|.+||.+.+..+....+......++
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------- 268 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH--------------------------------------- 268 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC---------------------------------------
Confidence 99999999999999999999987766555444332111100
Q ss_pred cCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 002732 834 IKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---VAQALTHPFISG 886 (887)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---a~elL~Hpwf~~ 886 (887)
......++.++.+||.+|+ .+|.+|++ +.+||.||||.+
T Consensus 269 -------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 269 -------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred -------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 0011235578899999987 59999997 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=368.69 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=202.6
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||+|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ +||||++++++|...+.+||
T Consensus 1 lg~G~~g~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~l 70 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ----RIYALKTIRKAHIVSRSEVTHTLAERTVLAQV------NCPFIVPLKFSFQSPEKLYL 70 (312)
T ss_pred CCcCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCcEeceeeEEecCCeEEE
Confidence 799999999999998777 789999997532 2234556788999888 89999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC-
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK- 728 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~- 728 (887)
||||+ +++|.++|...+ .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||++.....
T Consensus 71 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 71 VLAFINGGELFHHLQREG---RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EEcCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC-CCcEEEEECcccccCccC
Confidence 99999 679999887643 4999999999999999999999999999999999999985 78899999999875332
Q ss_pred -CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 729 -NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 729 -~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
......+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+....+..++.....
T Consensus 147 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~--------------- 211 (312)
T cd05585 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--------------- 211 (312)
T ss_pred CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC---------------
Confidence 2234567899999999999999999999999999999999999999876655554433221111
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc---CHHHHHhCCCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM---TVAQALTHPFI 884 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp---Ta~elL~Hpwf 884 (887)
.+..++..+.+||.+||..||.+|| +|.++|.||||
T Consensus 212 -----------------------------------------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 212 -----------------------------------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred -----------------------------------------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCc
Confidence 1123456789999999999999997 58999999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
..
T Consensus 251 ~~ 252 (312)
T cd05585 251 SQ 252 (312)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.57 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=207.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..+. .|++|+.++++|.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC-----CCCceeeeEEEEE
Confidence 4899999999999999999988776 789999997542 22345567777777772 3457889999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~ 147 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA-EGHIKIADFGM 147 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC-CCCEEEeecCc
Confidence 999999999999 679998887644 3899999999999999999999999999999999999985 78899999999
Q ss_pred ceecC--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAG--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+.... .......+||+.|+|||++.+..++.++||||||||||+|++|.+||.+.+..+.+..+......+|
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~------ 221 (324)
T cd05587 148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP------ 221 (324)
T ss_pred ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 86432 2233456789999999999999999999999999999999999999988776666655533222211
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-----
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----- 875 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa----- 875 (887)
..++..+.+||.+||..||.+|+++
T Consensus 222 --------------------------------------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 251 (324)
T cd05587 222 --------------------------------------------------KSLSKEAVSICKGLLTKHPAKRLGCGPTGE 251 (324)
T ss_pred --------------------------------------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence 1234678899999999999999986
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.+|+.||||.+
T Consensus 252 ~~~~~hp~~~~ 262 (324)
T cd05587 252 RDIREHAFFRR 262 (324)
T ss_pred HHHhcCCCcCC
Confidence 89999999974
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=370.42 Aligned_cols=277 Identities=34% Similarity=0.544 Sum_probs=220.3
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.++..||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|+.| .|+||++++++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~ 83 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLR----QKVAVKKLSRPFQSLIHARRTYRELRLLKHM------KHENVIGLLDVF 83 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCC----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhc------CCCchhhhhhhh
Confidence 467999999999999999999998777 799999987532 2234566899999999 899999999988
Q ss_pred eec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 643 KYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 643 ~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
... ..+|+|+++++++|.+++.. ..+++..+..|+.||+.||.|||+.||+|+||||+||||+. ++.+|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~-~~~~k 158 (343)
T cd07878 84 TPATSIENFNEVYLVTNLMGADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE-DCELR 158 (343)
T ss_pred cccccccccCcEEEEeecCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC-CCCEE
Confidence 643 46799999999999888753 24999999999999999999999999999999999999984 78899
Q ss_pred EEecCcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 717 L~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|+|||++..... ....+++++.|+|||++.+ ..++.++||||||||||+|++|.+||.+.+..+.+..+....+..+.
T Consensus 159 l~Dfg~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 159 ILDFGLARQADD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred EcCCccceecCC-CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999999977654 3455678999999999987 46899999999999999999999999998888888888888777666
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhc---CCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI---KPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
.++..... .....++..+ ....+..+ ...++..+.+||.+||.+||.+|
T Consensus 238 ~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 238 EVLKKISS---------------------EHARKYIQSLPHMPQQDLKKI-------FRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHHHhcch---------------------hhHHHHhhccccccchhHHHh-------ccCCCHHHHHHHHHHcCCChhhC
Confidence 55422110 0001111110 00000001 11234568899999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
||+.|||.||||..
T Consensus 290 ~s~~ell~hp~~~~ 303 (343)
T cd07878 290 ISASEALAHPYFSQ 303 (343)
T ss_pred CCHHHHhcCcchhc
Confidence 99999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=371.42 Aligned_cols=244 Identities=23% Similarity=0.405 Sum_probs=203.0
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||+|+||.||+|.+..++ ..||||++.+.. .....+..|+.+|..+ .||||+.++++|...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~iv~~~~~~~~~~~~ 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG----KYYAMKILKKEVIIAKDEVAHTLTESRVLKNT------RHPFLTSLKYSFQTKDRL 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceEEEEEcCCEE
Confidence 36899999999999998877 899999997542 2234556788888888 899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||++....
T Consensus 71 ~lv~Ey~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 71 CFVMEYVNGGELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGI 146 (328)
T ss_pred EEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC-CCcEEEecCcCCccCC
Confidence 9999999 678888876543 4999999999999999999999999999999999999984 7889999999986532
Q ss_pred C--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 K--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 ~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
. ......++|+.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~------------- 213 (328)
T cd05593 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK------------- 213 (328)
T ss_pred CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc-------------
Confidence 2 2234567899999999999999999999999999999999999999776555444333211111
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~ 880 (887)
.+..++..+.+||.+||..||.+|+ ++.+||+
T Consensus 214 -------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 214 -------------------------------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -------------------------------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1123457789999999999999997 8999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 251 h~~~~~ 256 (328)
T cd05593 251 HSFFTG 256 (328)
T ss_pred CCCcCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=360.15 Aligned_cols=281 Identities=28% Similarity=0.507 Sum_probs=222.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+++.||.|+||.||+|.+..++ ..||||.+.... .....+..|+.+|..| .|+||+.++++|..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~nI~~~~~~~~~ 75 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHANIVTLHDIIHT 75 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCC----cEEEEEEEecccccCchhHHHHHHHHHHhc------CCCCcceEEEEEec
Confidence 45999999999999999999988776 789999987432 2234567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.+.+||||||+.++|..++.... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++.
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~ 152 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE-RGELKLADFGLAR 152 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC-CCcEEECcCcchh
Confidence 99999999999989999887643 34899999999999999999999999999999999999985 7889999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... ......+++.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..+.+..+....+.++...+...
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 153 AKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred ccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 54322 23344568899999998764 5889999999999999999999999998888888888888777665554321
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.... .|.. ..++. .... ......+.++..+.+||.+||.+||.+|||+.|||+|
T Consensus 233 ~~~~-~~~~-~~~~~-----------------~~~~-------~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNE-EFKS-YNYPK-----------------YRAD-------CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccc-cccc-cccCc-----------------cccc-------cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110 0000 00000 0000 0011123456788999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||..
T Consensus 287 ~~f~~ 291 (301)
T cd07873 287 PYFHC 291 (301)
T ss_pred ccccc
Confidence 99964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=378.43 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=206.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||+|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..| .|+||++++++|.
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~h~~iv~~~~~~~ 71 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTN----ALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DNEWVVKLYYSFQ 71 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCC----CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC------CCCCcceEEEEEE
Confidence 5999999999999999999998877 8999999975322 234567899999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|...+ .+++..++.|+.||+.||.|||++||||+||||+||||+. .+.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~-~~~ikL~DFG~ 147 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGL 147 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC-CCCEEEEeCCC
Confidence 999999999999 679999997754 3899999999999999999999999999999999999984 78899999999
Q ss_pred ceecCC---------------------------------------------CCccCcccCCcccchhhhcCCCCCchhhH
Q 002732 723 AMFAGK---------------------------------------------NEITPYLVSRFYRAPEIILGLPYDHPLDI 757 (887)
Q Consensus 723 a~~~~~---------------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~~sDI 757 (887)
|..+.. ......+||+.|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 742210 00123578999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCC
Q 002732 758 WSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837 (887)
Q Consensus 758 wSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (887)
||||||||+|++|.+||.+....+.+..+......++
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------------------- 264 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLH------------------------------------------- 264 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHHHHhccCcccc-------------------------------------------
Confidence 9999999999999999987766554433321110000
Q ss_pred CccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 002732 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM---TVAQALTHPFISG 886 (887)
Q Consensus 838 ~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp---Ta~elL~Hpwf~~ 886 (887)
......++..+.+||.+|+ .+|.+|+ |+.+||+||||.+
T Consensus 265 ---------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 265 ---------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ---------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 0011234577889999976 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.91 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=203.2
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||+|+||.||+|.+..++ ..||||++..... ....+..|+.+|..+ .||||++++++|...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~i~~~~~~~~~~~~~ 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAFQTHDRL 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCcceeeEEecCCEE
Confidence 36899999999999998777 7999999975321 223456788888888 899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||++....
T Consensus 71 ~lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 71 CFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC-CCCEEecccHHhcccc
Confidence 9999999 678988886643 4899999999999999999999999999999999999985 7889999999986532
Q ss_pred C--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 K--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 ~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
. ......++++.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 147 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~------------ 214 (323)
T cd05595 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF------------ 214 (323)
T ss_pred CCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------
Confidence 2 22345678999999999999999999999999999999999999997766555444332211111
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~ 880 (887)
+..++..+.+||.+||..||.+|| ++.+||+
T Consensus 215 --------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 --------------------------------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --------------------------------------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 123457789999999999999998 9999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 251 h~~~~~ 256 (323)
T cd05595 251 HRFFLS 256 (323)
T ss_pred CCCcCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=367.31 Aligned_cols=301 Identities=33% Similarity=0.559 Sum_probs=233.0
Q ss_pred CceecccCc---eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCC
Q 002732 555 GYYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 555 g~~~~~~~e---il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~ 628 (887)
|||++.+|+ .+.++|.+++.||.|+||+||+|.+..++ ..||||++... ......+..|+.++..+
T Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l---- 72 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTG----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLV---- 72 (353)
T ss_pred CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCC----CEEEEEecCccccChhHHHHHHHHHHHHHhc----
Confidence 688899988 45788999999999999999999998877 78999998642 22234566799999998
Q ss_pred CCCCcceeEecceeeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 629 PENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 629 ~~~h~~Iv~l~~~~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
.|+||++++++|... .++||||||+.++|.+++... +++..+..++.||+.||.|||.+||+|+|||
T Consensus 73 --~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk 145 (353)
T cd07850 73 --NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 145 (353)
T ss_pred --CCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 899999999988643 357999999998998887642 8999999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~ 781 (887)
|+|||++. ++.++|+|||++....... .....++..|+|||++.+..++.++|||||||+||+|++|..||.+.+...
T Consensus 146 p~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~ 224 (353)
T cd07850 146 PSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID 224 (353)
T ss_pred HHHEEECC-CCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999985 7789999999998765443 234567889999999999999999999999999999999999999988888
Q ss_pred HHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCcccccc-CCCCCChhhHHHHHHH
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT-ASPGEDPKMLANFKDL 860 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dL 860 (887)
.+..++..++.++..++.........+.... ......+ +..++ +. .++. .....+...+..+.+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~----~~---~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 225 QWNKIIEQLGTPSDEFMSRLQPTVRNYVENR--PKYAGYS-----FEELF----PD---VLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHHHHHHhcCCCCHHHHHHhhhhhhHHhhcC--CCCCCcc-----hhhhC----cc---cccCcccccccccchhHHHHH
Confidence 8888888888877766433221111110000 0000000 00000 00 0000 0011123456788999
Q ss_pred HHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 861 LDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
|.+||++||.+|||+.|||.||||.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHh
Confidence 9999999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=367.02 Aligned_cols=250 Identities=21% Similarity=0.390 Sum_probs=206.1
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
|.+++.||+|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..+.. ..||||++++++|..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~---l~hp~i~~~~~~~~~ 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG----ELYAIKALKKGDIIARDEVESLMCEKRIFETANS---ERHPFLVNLFACFQT 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc---cCCCChhceeeEEEc
Confidence 788999999999999999998777 799999997542 122445667666665533 279999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+++||||||+ +++|..++.. ..|++..++.|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~ 148 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT-EGFVKIADFGLC 148 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence 99999999999 5688777653 24999999999999999999999999999999999999995 788999999998
Q ss_pred eecC--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAG--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
.... .......++++.|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..+......+
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~-------- 220 (324)
T cd05589 149 KEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY-------- 220 (324)
T ss_pred ccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 6432 222345678999999999999999999999999999999999999998876665554443221111
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVA 876 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~ 876 (887)
+..++..+.+||.+||..||.+|| ++.
T Consensus 221 ------------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 252 (324)
T cd05589 221 ------------------------------------------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAE 252 (324)
T ss_pred ------------------------------------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHH
Confidence 123456788999999999999999 799
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+||+||||.+
T Consensus 253 ~l~~~~~f~~ 262 (324)
T cd05589 253 DVKKQPFFRD 262 (324)
T ss_pred HHhhCCCcCC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=367.46 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=203.1
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
+||+|+||+||+|.+..++ ..||||++.+.. .....+..|+.++..+. .||||++++++|...+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~~~~~~~~~~~ 72 (320)
T cd05590 2 VLGKGSFGKVMLARLKESG----RLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHPFLTQLYCCFQTPDRLF 72 (320)
T ss_pred eeeeCCCeEEEEEEEcCCC----CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcc-----CCCchhceeeEEEcCCEEE
Confidence 6899999999999998777 799999997532 22344566777776652 6999999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC-
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG- 727 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~- 727 (887)
|||||+ +++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.++|+|||++....
T Consensus 73 iv~Ey~~~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEEcCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCc
Confidence 999999 679988887644 3999999999999999999999999999999999999985 7889999999986532
Q ss_pred -CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 728 -KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 728 -~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
.......+||+.|+|||++.+..++.++||||||||||+|++|..||.+.+..+++..+......+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 215 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY------------- 215 (320)
T ss_pred CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-------------
Confidence 223345678999999999999999999999999999999999999998877666555443221111
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH------HHHHh
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV------AQALT 880 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa------~elL~ 880 (887)
+..++..+.+||.+||+.||.+||++ .+||.
T Consensus 216 -------------------------------------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 216 -------------------------------------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred -------------------------------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 11244678999999999999999998 99999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 253 h~~f~~ 258 (320)
T cd05590 253 HPFFKE 258 (320)
T ss_pred CCCcCC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=374.58 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=210.1
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
...|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.+|..+ +||||+.++++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~------~h~~iv~~~~~ 111 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSK----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA------NSEWIVQLHYA 111 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCcceEEEE
Confidence 457999999999999999999998877 799999997532 1223456788999888 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
|...+++||||||+ +++|.+++... .+++..+..++.||+.||.|||+.||||+||||+||||+. ++.+||+||
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~-~~~~kL~Df 186 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADF 186 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC-CCCEEEEec
Confidence 99999999999999 67999988653 3899999999999999999999999999999999999985 788999999
Q ss_pred CcceecCCCC---ccCcccCCcccchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 721 GNAMFAGKNE---ITPYLVSRFYRAPEIILGL----PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 721 G~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~----~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|++....... ....+||+.|+|||++.+. .++.++||||||||||+|++|.+||.+.+....+..|+.....+
T Consensus 187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05596 187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC
Confidence 9997654332 2346789999999999764 38899999999999999999999998776655554443211110
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC--
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK-- 871 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~-- 871 (887)
. ......++..+.+||.+||..+|.+
T Consensus 267 ~----------------------------------------------------~~~~~~~s~~~~~li~~~L~~~p~r~~ 294 (370)
T cd05596 267 T----------------------------------------------------FPDDIEISKQAKDLICAFLTDREVRLG 294 (370)
T ss_pred C----------------------------------------------------CCCcCCCCHHHHHHHHHHccChhhccC
Confidence 0 0011235678999999999999988
Q ss_pred CcCHHHHHhCCCCCC
Q 002732 872 RMTVAQALTHPFISG 886 (887)
Q Consensus 872 RpTa~elL~Hpwf~~ 886 (887)
|+|+.+||+||||.+
T Consensus 295 R~s~~ell~h~~~~~ 309 (370)
T cd05596 295 RNGVDEIKSHPFFKN 309 (370)
T ss_pred CCCHHHHhcCcccCC
Confidence 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=373.69 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=209.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
+..++|.+++.||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..+ .||||++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~~ 109 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQ----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQLF 109 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC------CCCCEeeEE
Confidence 34567999999999999999999998877 799999986532 1224466788888888 899999999
Q ss_pred ceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
++|...+++||||||+ +++|.+++... .+++..+..|+.||+.||.|||++||+|+||||+||||+. .+.+||+
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~-~~~~kL~ 184 (370)
T cd05621 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK-HGHLKLA 184 (370)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC-CCCEEEE
Confidence 9999999999999999 67999988653 3899999999999999999999999999999999999984 7889999
Q ss_pred ecCcceecCCCC---ccCcccCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 719 DFGNAMFAGKNE---ITPYLVSRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 719 DFG~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~~----~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||++....... ....+||+.|+|||++.+.. ++.++||||||||||+|++|.+||.+.+....+..++....
T Consensus 185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05621 185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 999997754332 24567999999999997643 78999999999999999999999987766555554433221
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.++ ......++..+.+||..||..+|.+
T Consensus 265 ~~~----------------------------------------------------~p~~~~~s~~~~~li~~~L~~~~~r 292 (370)
T cd05621 265 SLN----------------------------------------------------FPEDVEISKHAKNLICAFLTDREVR 292 (370)
T ss_pred ccC----------------------------------------------------CCCcccCCHHHHHHHHHHccCchhc
Confidence 110 0011234577899999999866654
Q ss_pred --CcCHHHHHhCCCCCC
Q 002732 872 --RMTVAQALTHPFISG 886 (887)
Q Consensus 872 --RpTa~elL~Hpwf~~ 886 (887)
|+|+.+||+||||.+
T Consensus 293 ~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 293 LGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cCCCCHHHHhcCcccCC
Confidence 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.61 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=209.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.++..||.|+||+||+|.+..++ ..||||++..... ....+..|+.++..+ +|++|+.++++|.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~------~~~~i~~~~~~~~ 71 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATG----DIYAMKVMKKSVLLAQETVSFFEEERDILSIS------NSPWIPQLQYAFQ 71 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCcceeeEEe
Confidence 5999999999999999999998877 7999999986432 334567788888877 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.+++.... ..+++..+..|+.||+.||.|||+.||+|+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~ 148 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR-TGHIKLADFGS 148 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC-CCCEEeccCCC
Confidence 999999999999 779999998752 24999999999999999999999999999999999999984 78899999999
Q ss_pred ceecCCCC---ccCcccCCcccchhhhc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 723 AMFAGKNE---ITPYLVSRFYRAPEIIL------GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 723 a~~~~~~~---~~~~~gt~~Y~aPE~l~------~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
+....... .....+|+.|+|||++. +..++.++||||||||||+|++|..||...+....+..++.....+
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred CeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc
Confidence 97765432 22346899999999997 4568899999999999999999999998776655554443221000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
.. ...+.++..+.+||.+||. +|.+||
T Consensus 229 ---------------------------------------------------~~-~~~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 229 ---------------------------------------------------KF-PEDPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred ---------------------------------------------------CC-CCCCCCCHHHHHHHHHHcc-ChhhCC
Confidence 00 0122456788999999998 999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
|+.+||.||||.+
T Consensus 256 t~~~l~~h~~~~~ 268 (330)
T cd05601 256 GYEGLCCHPFFSK 268 (330)
T ss_pred CHHHHhCCCCcCC
Confidence 9999999999974
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=365.04 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=207.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.++..||+|+||.||+|.+..++ ..||||++.+.... ......|..++..+. .|++|+.++++|.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-----KPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCeEeeEEEEEe
Confidence 3889999999999999999998776 79999999764321 223455666665552 6789999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||+
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~kL~DfG~ 147 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS-EGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC-CCcEEEccCCC
Confidence 999999999999 679998887654 3899999999999999999999999999999999999995 78899999999
Q ss_pred ceecCC--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGK--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+..... ......+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+....+..+......+|
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p------ 221 (323)
T cd05616 148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------ 221 (323)
T ss_pred ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 875432 223456789999999999999999999999999999999999999988777666655543322221
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----H
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----V 875 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a 875 (887)
..++..+.+||.+||+.||.+|++ .
T Consensus 222 --------------------------------------------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~ 251 (323)
T cd05616 222 --------------------------------------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGE 251 (323)
T ss_pred --------------------------------------------------CcCCHHHHHHHHHHcccCHHhcCCCCCCCH
Confidence 123467899999999999999998 4
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.+|++||||..
T Consensus 252 ~~i~~h~~~~~ 262 (323)
T cd05616 252 RDIKEHAFFRY 262 (323)
T ss_pred HHHhcCCCcCC
Confidence 89999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=372.78 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=206.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||+|+||+||+|.+..++ ..||||++..... ....+..|+.+|..+ .|++|++++++|.
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~~~~~ 71 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTG----HIYAMKILRKADMLEKEQVAHIRAERDILVEA------DGAWVVKMFYSFQ 71 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCEeeEEEEEE
Confidence 5999999999999999999998877 7999999975321 234556788888888 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|.... .+++..++.|+.||+.||.|||++||||+||||+||||+. .+.++|+|||+
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~-~~~vkL~DfG~ 147 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA-KGHVKLSDFGL 147 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC-CCCEEEeeccC
Confidence 999999999999 679999987644 4999999999999999999999999999999999999984 78899999999
Q ss_pred ceecCCC-------------------------------------CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHH
Q 002732 723 AMFAGKN-------------------------------------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLY 765 (887)
Q Consensus 723 a~~~~~~-------------------------------------~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ 765 (887)
+...... .....+||+.|+|||++.+..|+.++||||||||||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 8543211 012357899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccC
Q 002732 766 ELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845 (887)
Q Consensus 766 elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (887)
+|++|.+||.+.+....+..++.....++
T Consensus 228 el~tG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------------------------------- 256 (360)
T cd05627 228 EMLIGYPPFCSETPQETYRKVMNWKETLV--------------------------------------------------- 256 (360)
T ss_pred ecccCCCCCCCCCHHHHHHHHHcCCCcee---------------------------------------------------
Confidence 99999999988776665554432111100
Q ss_pred CCCCChhhHHHHHHHHHHhcccCCCCCc---CHHHHHhCCCCCC
Q 002732 846 SPGEDPKMLANFKDLLDKIFVLDPEKRM---TVAQALTHPFISG 886 (887)
Q Consensus 846 ~~~~~~~~s~~~~dLL~kmL~~DP~~Rp---Ta~elL~Hpwf~~ 886 (887)
.+ ....++..+.+||.+|+. ||..|+ ++.+|+.||||.+
T Consensus 257 ~p-~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 257 FP-PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred cC-CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence 00 011245778999999875 999998 5899999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=365.56 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=203.3
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
+||.|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..+. .||+|+.++++|...+.+|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~i~~~~~~~~~~~~~~ 72 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTD----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KHPFLTALHCCFQTKDRLF 72 (321)
T ss_pred ccccCCCeEEEEEEECCCC----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCeEE
Confidence 6899999999999998776 7999999976422 2234556777777653 7999999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||++.....
T Consensus 73 lv~E~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEeecccceeccc
Confidence 999999 679988887644 3899999999999999999999999999999999999985 78899999999865322
Q ss_pred --CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 729 --NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 729 --~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
......+|++.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..+......+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~------------- 215 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY------------- 215 (321)
T ss_pred CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 22345678999999999999999999999999999999999999998877666655443221111
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-------CHHHHH
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-------TVAQAL 879 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-------Ta~elL 879 (887)
+..++.++.+||.+||..||.+|| ++.+||
T Consensus 216 -------------------------------------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 216 -------------------------------------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred -------------------------------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 112346789999999999999999 999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||.+
T Consensus 253 ~hp~~~~ 259 (321)
T cd05591 253 QHPFFKE 259 (321)
T ss_pred cCCccCC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.05 Aligned_cols=279 Identities=29% Similarity=0.477 Sum_probs=220.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.++..| .|+||++++++|..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 70 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG----QIVAMKKIRLESEEEGVPSTAIREISLLKEL------QHPNIVCLQDVLMQ 70 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC----cEEEEEEeccccccCCchHHHHHHHHHHHhc------CCCCEeeeEEEEee
Confidence 3899999999999999999988776 789999986532 2235677899999999 79999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.+.+|+||||+.++|.+++........+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++.
T Consensus 71 ~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~ 149 (285)
T cd07861 71 ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN-KGVIKLADFGLAR 149 (285)
T ss_pred CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC-CCcEEECccccee
Confidence 999999999998899999877554456999999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...... .....+++.|+|||++.+. .++.++||||||||||+|++|.+||.+.+..+.+..+....+.++...+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 150 AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 654322 2334567889999998764 5799999999999999999999999988877777777777766655443211
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
..... ....+....... .......++.++.+||.+||..||.+|||+.+||.|
T Consensus 230 ~~~~~--------------------~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPD--------------------YKNTFPKWKKGS-------LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHH--------------------HHhhccccCcch-------hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 10000 000000000000 001122356788999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 283 ~~~ 285 (285)
T cd07861 283 PYF 285 (285)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=362.08 Aligned_cols=297 Identities=23% Similarity=0.364 Sum_probs=216.3
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+..++|++++.||.|+||.||+|.+..++ ..||+|++... ......+..|+.+|..| .|+||++++++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 71 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSG----LIMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYGA 71 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHHC------CCCcccceeEE
Confidence 45578999999999999999999998777 78999988753 22345678999999999 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEe
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
|...+++||||||+ +++|.++|.... .+++..+..++.||+.||.|||+ .+|+|+||||+||||+. .+.+||+|
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~D 147 (333)
T cd06650 72 FYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCD 147 (333)
T ss_pred EEECCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEee
Confidence 99999999999999 679999997643 38999999999999999999997 47999999999999985 77899999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-hhCCCChhhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME-LKGPFPKKML 798 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~-~~g~~p~~~l 798 (887)
||++...........+++..|+|||++.+..++.++||||||||||+|++|..||......+....+.. ..+.++....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 148 FGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred CCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 999976554444556789999999999998999999999999999999999999976654333222111 0111110000
Q ss_pred hcccccccccccccccccCcCChh-hHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPV-TKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
. .........+....+...+. ....+...+....+..+ ....++.++.+||.+||++||.+|||+.|
T Consensus 228 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rpt~~e 295 (333)
T cd06650 228 S---PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL---------PSGVFGAEFQDFVNKCLIKNPAERADLKQ 295 (333)
T ss_pred C---cccCCccchhhhhcccccccccHHHHHHHHhcCCCccC---------CCCCcCHHHHHHHHHhccCCcccCcCHHH
Confidence 0 00000000000000000000 00011111111111100 01134678999999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||.||||..
T Consensus 296 ll~h~~~~~ 304 (333)
T cd06650 296 LMVHAFIKR 304 (333)
T ss_pred HhhCHHHhc
Confidence 999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=367.50 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=201.7
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||.|+||+||+|.+..++ ..||||++.+... ....+..|+.++..+ .|+||+.++++|...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~------~hp~i~~~~~~~~~~~~~ 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG----RYYAMKILKKEVIVAKDEVAHTLTENRVLQNS------RHPFLTALKYSFQTHDRL 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCCCceEEEEEcCCEE
Confidence 36899999999999998877 7999999975321 223446677888877 899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||+ .||||+||||+||||+. ++.+||+|||++...
T Consensus 71 ~lv~E~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 71 CFVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEG 146 (325)
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeec
Confidence 9999999 678888876543 48999999999999999999997 89999999999999984 788999999998653
Q ss_pred C--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 G--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
. .......++|+.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~----------- 215 (325)
T cd05594 147 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----------- 215 (325)
T ss_pred CCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCC-----------
Confidence 3 223345678999999999999999999999999999999999999998766554444332111111
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHH
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQAL 879 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL 879 (887)
+..++..+.+||.+||..||.+|+ ++.+||
T Consensus 216 ---------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 216 ---------------------------------------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred ---------------------------------------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 122446789999999999999997 999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||.+
T Consensus 251 ~h~~~~~ 257 (325)
T cd05594 251 QHKFFAG 257 (325)
T ss_pred cCCCcCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=365.58 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=202.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+|.+++.||.|+||+||+|.+.... ..+..||||++.+... ....+..|+.+|..+. +|++|+.++++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH-DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR-----QSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCcccEEEEE
Confidence 4899999999999999999874321 2337899999975321 2344567888888884 589999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+.+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~-~~~~kl~DfG 150 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS-EGHVVLTDFG 150 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC-CCCEEEeeCc
Confidence 9999999999999 679999887643 4999999999999999999999999999999999999985 7789999999
Q ss_pred cceecCCC---CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKN---EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++...... .....+||+.|+|||++.+. .++.++||||||||||+|++|..||...........+.
T Consensus 151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~---------- 220 (332)
T cd05614 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS---------- 220 (332)
T ss_pred CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH----------
Confidence 99754322 23346789999999999875 48899999999999999999999996432211111000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc----
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM---- 873 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp---- 873 (887)
..++ .. .+..+..++..+.+||.+||..||.+||
T Consensus 221 ------------------------------~~~~-~~-----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 258 (332)
T cd05614 221 ------------------------------RRIL-KC-----------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP 258 (332)
T ss_pred ------------------------------HHHh-cC-----------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 0000 00 0111233557889999999999999999
Q ss_pred -CHHHHHhCCCCCC
Q 002732 874 -TVAQALTHPFISG 886 (887)
Q Consensus 874 -Ta~elL~Hpwf~~ 886 (887)
++++||+||||.+
T Consensus 259 ~~~~~~l~h~~~~~ 272 (332)
T cd05614 259 QGASEIKEHPFFKG 272 (332)
T ss_pred CCHHHHHcCCCcCC
Confidence 8999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=368.33 Aligned_cols=280 Identities=20% Similarity=0.275 Sum_probs=208.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..|.+++.||.|+||.||+|.+..++ ..||||+.... ....|+.+|..| .|+||++++++|....
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~valK~~~~~-----~~~~E~~~l~~l------~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQP----DPVVLKIGQKG-----TTLIEAMLLQNV------NHPSVIRMKDTLVSGA 130 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCC----ceEEEEeCCcc-----ccHHHHHHHHhC------CCCCCcChhheEEeCC
Confidence 46999999999999999999988776 78999986443 335689999998 8999999999999999
Q ss_pred eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 647 HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 647 ~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
..|||||++.++|..++.... ..+++..++.|+.||+.||.|||++||||+||||+||||+. .+.++|+|||++.+.
T Consensus 131 ~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 131 ITCMVLPHYSSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND-VDQVCIGDLGAAQFP 207 (357)
T ss_pred eeEEEEEccCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEecCcccccc
Confidence 999999999999999887643 35899999999999999999999999999999999999985 778999999999754
Q ss_pred CCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCh---------HHHHHHHHHhhCCCCh
Q 002732 727 GKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK-VLFPGATN---------NDMLRLHMELKGPFPK 795 (887)
Q Consensus 727 ~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~-~PF~~~~~---------~~~l~~i~~~~g~~p~ 795 (887)
... ......+|+.|+|||++.+..|+.++||||||||||+|+++. ++|..... ...+..++..++..|.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 287 (357)
T PHA03209 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287 (357)
T ss_pred ccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence 332 334567899999999999999999999999999999999854 44443221 2234444444444443
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.+... +.. .....++. ...................++..+.+||.+||++||.+||||
T Consensus 288 ~~~~~--------------------~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta 345 (357)
T PHA03209 288 EFPRD--------------------PGS-RLVRGFIE-YASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA 345 (357)
T ss_pred hcCCC--------------------Ccc-HHHHHHHh-hcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH
Confidence 33100 000 00001110 000000000000000112345677899999999999999999
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.|||+||||+.
T Consensus 346 ~e~l~hp~f~~ 356 (357)
T PHA03209 346 EEILNYPMFAQ 356 (357)
T ss_pred HHHhcCchhcc
Confidence 99999999974
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=360.18 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=201.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..|+++++||.||.+.||++...+.+ .||+|.+.. +......+.+||.+|.+|. .|.+||+|++|-.
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-----iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk-----g~~~IIqL~DYEv 430 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ-----IYALKKVVLLEADNQTLDGYRNEIALLNKLK-----GHDKIIQLYDYEV 430 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc-----chhhhHHHHhhcCHHHHHHHHHHHHHHHHhc-----CCceEEEEeeeec
Confidence 45999999999999999999865543 577776542 4455678899999999996 6679999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..+++||||||-..+|..+|...... ++...++.|++|||.|+.++|..||||.||||.|+||- .|.+||||||+|
T Consensus 431 ~d~~lYmvmE~Gd~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV--kG~LKLIDFGIA 506 (677)
T KOG0596|consen 431 TDGYLYMVMECGDIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV--KGRLKLIDFGIA 506 (677)
T ss_pred cCceEEEEeecccccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE--eeeEEeeeechh
Confidence 99999999999889999999986542 44458999999999999999999999999999999996 689999999999
Q ss_pred eecCCCCc----cCcccCCcccchhhhcCCC-----------CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 002732 724 MFAGKNEI----TPYLVSRFYRAPEIILGLP-----------YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 724 ~~~~~~~~----~~~~gt~~Y~aPE~l~~~~-----------~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~ 788 (887)
..+..... ...+||+.||+||++.... .+.++||||||||||+|+.|++||.... ..++.+..
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~a 584 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHA 584 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHh
Confidence 87776542 3468999999999996432 5689999999999999999999994321 11111111
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
+.. |. ....++..++. .++++++..||.+|
T Consensus 585 I~~--------------------------------------------P~----~~Iefp~~~~~--~~li~~mK~CL~rd 614 (677)
T KOG0596|consen 585 ITD--------------------------------------------PN----HEIEFPDIPEN--DELIDVMKCCLARD 614 (677)
T ss_pred hcC--------------------------------------------CC----ccccccCCCCc--hHHHHHHHHHHhcC
Confidence 100 00 00011222222 23889999999999
Q ss_pred CCCCcCHHHHHhCCCCCC
Q 002732 869 PEKRMTVAQALTHPFISG 886 (887)
Q Consensus 869 P~~RpTa~elL~Hpwf~~ 886 (887)
|.+|||+.+||+|||++.
T Consensus 615 PkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 615 PKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cccCCCcHHHhcCccccc
Confidence 999999999999999874
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=362.83 Aligned_cols=245 Identities=27% Similarity=0.432 Sum_probs=200.5
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
++||.|+||.||+|.+..++ ..||||++.+... .......|+.++..+. .|++|++++++|...+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-----ENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhcc-----CCCCccCeeEEEEeCCEE
Confidence 36899999999999998877 7999999976422 2234456666665442 789999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec-
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA- 726 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~- 726 (887)
||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~ 147 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENV 147 (316)
T ss_pred EEEECCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEeCccCCCeecc
Confidence 9999999 679988887643 4899999999999999999999999999999999999985 778999999998642
Q ss_pred -CCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 727 -GKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 727 -~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
........+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+....+..+......
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~------------- 214 (316)
T cd05620 148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH------------- 214 (316)
T ss_pred cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence 233345567899999999999999999999999999999999999999876655444333211100
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-HHHHhCCCC
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV-AQALTHPFI 884 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa-~elL~Hpwf 884 (887)
.+..++..+.+||.+||..||.+||++ .+|++||||
T Consensus 215 -------------------------------------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 215 -------------------------------------------YPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred -------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 111245678999999999999999998 588899999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 252 ~~ 253 (316)
T cd05620 252 KT 253 (316)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=356.75 Aligned_cols=286 Identities=26% Similarity=0.416 Sum_probs=206.7
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee--cCeEE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY--RNHLC 649 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~--~~~~~ 649 (887)
..+||+|+||+||+|.+.... ....||||.+..... ...+..|+.+|..| .|+||++++++|.. ...+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~--~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGI-SMSACREIALLREL------KHPNVIALQKVFLSHSDRKVW 76 (317)
T ss_pred ceEeccCCCeeEEEEEecCCC--ccceEEEEEecCCCC-cHHHHHHHHHHHhC------CCCCeeeEEEEEeccCCCeEE
Confidence 358999999999999875422 236899999875432 34567899999999 89999999998854 56889
Q ss_pred EEEecchhhHHHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc---CCCCeEEEEec
Q 002732 650 LVFESLHMNLREVLKKFG------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN---EAKNVLKLCDF 720 (887)
Q Consensus 650 lV~E~~~gsL~~~L~~~~------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~~vKL~DF 720 (887)
|||||++++|.+++.... ....+++..++.|+.||+.||.|||+.||||+||||+||||. ...+.+||+||
T Consensus 77 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 77 LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 999999999988886432 123488999999999999999999999999999999999994 23568999999
Q ss_pred CcceecCCC-----CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCh---------HHHHHH
Q 002732 721 GNAMFAGKN-----EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATN---------NDMLRL 785 (887)
Q Consensus 721 G~a~~~~~~-----~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~---------~~~l~~ 785 (887)
|++...... ......+|+.|+|||++.+. .++.++||||||||||+|++|.+||..... ...+..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 999765432 23445778999999999874 589999999999999999999999975432 244555
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+...++......+........+......+.... + ....+...........+..+.+||.+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~~~~~~~~~~~~ll~~~l 298 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTT---------------Y---ANSSLIKYMEKHKVKPDSKVFLLLQKLL 298 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccc---------------c---CCchhhhhhhcccCCCChHHHHHHHHHh
Confidence 666666554443322111111111000000000 0 0000000011112223467889999999
Q ss_pred ccCCCCCcCHHHHHhCCCC
Q 002732 866 VLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 866 ~~DP~~RpTa~elL~Hpwf 884 (887)
+.||.+||||.|||+||||
T Consensus 299 ~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 299 TMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ccCcccccCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=362.55 Aligned_cols=248 Identities=23% Similarity=0.394 Sum_probs=203.2
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
++.||+|+||.||+|.+.... ..+..||||++..... ....+..|+.+|..| .||||++++++|...+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~iv~~~~~~~~~~ 73 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV------KHPFIVDLIYAFQTGG 73 (323)
T ss_pred CceeeecCCeEEEEEEEcccC-CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC------CCCchhceeeEEecCC
Confidence 357999999999999874321 2347899999975322 223456799999998 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+||||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++..
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~ 149 (323)
T cd05584 74 KLYLILEYLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKE 149 (323)
T ss_pred eEEEEEeCCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence 999999999 679999887644 3899999999999999999999999999999999999985 78899999999864
Q ss_pred cCC--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGK--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
... ......++++.|+|||++.+..++.++||||||||||+|++|.+||.+.+....+..+......
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~----------- 218 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN----------- 218 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 322 2234467899999999999999999999999999999999999999876655544433221111
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHH
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQA 878 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~el 878 (887)
.++.++..+.+||.+||..||.+|| ++.++
T Consensus 219 ---------------------------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 219 ---------------------------------------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred ---------------------------------------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 1123456789999999999999999 89999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
+.||||..
T Consensus 254 ~~h~~~~~ 261 (323)
T cd05584 254 QSHPFFRH 261 (323)
T ss_pred hcCCCcCC
Confidence 99999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=393.83 Aligned_cols=262 Identities=26% Similarity=0.385 Sum_probs=210.5
Q ss_pred cccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 559 ~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
|..++++.+.|.++..||.|+||+||+|.+..++ ..||+|++... ......+..|+.+|..| .||||
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg----~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L------~HPNI 74 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ----EFFCWKAISYRGLKEREKSQLVIEVNVMREL------KHKNI 74 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCC----eEEEEEEEeccccCHHHHHHHHHHHHHHHHc------CCCCc
Confidence 4556777889999999999999999999998877 89999998753 23345678899999999 89999
Q ss_pred eEecceeee--cCeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhcc-------ceeccCCCCC
Q 002732 636 IRFASSFKY--RNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNC-------GVLHCDIKPD 704 (887)
Q Consensus 636 v~l~~~~~~--~~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~-------gIvHrDLKP~ 704 (887)
|+++++|.. ...+||||||+ +++|.++|.... ....|++..++.|+.|||.||.|||.. +|||+||||+
T Consensus 75 Vrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPe 154 (1021)
T PTZ00266 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQ 154 (1021)
T ss_pred CeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHH
Confidence 999999865 46799999999 579999987642 234599999999999999999999985 4999999999
Q ss_pred CccccCC----------------CCeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHH
Q 002732 705 NMLVNEA----------------KNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLY 765 (887)
Q Consensus 705 NILl~~~----------------~~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~ 765 (887)
||||+.. ...+||+|||++..+.... ....++|+.|+|||++.+. .|+.++||||||||||
T Consensus 155 NILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 155 NIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred HeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 9999631 2358999999997665432 3456789999999999754 5899999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccC
Q 002732 766 ELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845 (887)
Q Consensus 766 elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (887)
+||+|.+||........+..++.....+
T Consensus 235 ELLTGk~PF~~~~~~~qli~~lk~~p~l---------------------------------------------------- 262 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQLISELKRGPDL---------------------------------------------------- 262 (1021)
T ss_pred HHHHCCCCCCcCCcHHHHHHHHhcCCCC----------------------------------------------------
Confidence 9999999997655443332221110000
Q ss_pred CCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 846 SPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 846 ~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
....++..+.+||..||.++|.+|||+.|||.||||.
T Consensus 263 ---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 263 ---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred ---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 0012346789999999999999999999999999996
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.27 Aligned_cols=253 Identities=31% Similarity=0.525 Sum_probs=208.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHH---HHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---QTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~---~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|++++.||+|+||+||+|.+..++ +.||+|++.......... ..|+.++..| .|++|+++++++...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~ 70 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG----QKVAVKIIDKSEIEEEEREENIREIKILRRL------RHPNIVQILDVFQDD 70 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT----EEEEEEEEESTTHHHHHHHHHHHHHHHHHHH------TBTTBCHEEEEEEES
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC----eEEEEEEeccccccccccchhhhhhhccccc------ccccccccccccccc
Confidence 889999999999999999998887 899999998765443332 4599999999 899999999999999
Q ss_pred CeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+|+|||++.+ +|.++|.... .+++..++.++.||+.||.+||+.||+|+||+|+|||++ .++.++|+|||++.
T Consensus 71 ~~~~~v~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 71 NYLYIVMEYCPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD-ENGEVKLIDFGSSV 146 (260)
T ss_dssp SEEEEEEEEETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES-TTSEEEESSGTTTE
T ss_pred ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc-cccccccccccccc
Confidence 999999999965 9999998433 389999999999999999999999999999999999999 58889999999997
Q ss_pred ec--CCCCccCcccCCcccchhhhc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FA--GKNEITPYLVSRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~--~~~~~~~~~gt~~Y~aPE~l~-~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
.. .........++..|+|||++. +..++.++|||||||+||+|++|..||...........+...........
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 222 (260)
T PF00069_consen 147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---- 222 (260)
T ss_dssp ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc----
Confidence 63 233455677899999999998 78899999999999999999999999987744444433332221110000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.. ........+.+||.+||..||.+|||+.+||+|
T Consensus 223 --------------------------------~~-------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 --------------------------------SQ-------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --------------------------------TT-------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --------------------------------cc-------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000112678999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 258 ~~~ 260 (260)
T PF00069_consen 258 PWF 260 (260)
T ss_dssp GGG
T ss_pred CCC
Confidence 998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=373.67 Aligned_cols=283 Identities=21% Similarity=0.253 Sum_probs=208.4
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...|.+...||.|+||.||+|.+..++ ..||||.... ..+.+|+.+|..| +|+|||++++++...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~----~~vavK~~~~-----~~~~~E~~iL~~L------~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP----QRVVVKAGWY-----ASSVHEARLLRRL------SHPAVLALLDVRVVG 232 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC----CEEEEecccc-----cCHHHHHHHHHHC------CCCCCCcEEEEEEEC
Confidence 457999999999999999999998876 7899996432 3456899999999 899999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
...||||+++.++|..+|.... ..|++..++.|+.||+.||.|||+.||||+||||+||||+. .+.++|+|||++..
T Consensus 233 ~~~~lv~e~~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~ 309 (461)
T PHA03211 233 GLTCLVLPKYRSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG-PEDICLGDFGAACF 309 (461)
T ss_pred CEEEEEEEccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC-CCCEEEcccCCcee
Confidence 9999999999889999887632 25999999999999999999999999999999999999985 67899999999976
Q ss_pred cCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------hHHHHHHHHHhhCCCC
Q 002732 726 AGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT-------NNDMLRLHMELKGPFP 794 (887)
Q Consensus 726 ~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~-------~~~~l~~i~~~~g~~p 794 (887)
..... ....+||+.|+|||++.+..++.++||||||||||+|++|..|+.... ...++..++...+...
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 54322 223568999999999999999999999999999999999876553321 1233333333222111
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..+ .....................+.... ........++..+.+||.+||++||.+|||
T Consensus 390 ~~~-----------------~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~dli~~mL~~DP~~RPs 448 (461)
T PHA03211 390 DEF-----------------PQHAGSRLVSQYRHRAARNRRPAYTR----PAWTRYYKLDLDVEYLVCRALTFDGARRPS 448 (461)
T ss_pred ccC-----------------CCCcchHHHHHHHhhhhcccCCccCC----cchhhhccccchHHHHHHHHcccChhhCcC
Confidence 110 00000000000000000000000000 000001134467899999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 002732 875 VAQALTHPFISGK 887 (887)
Q Consensus 875 a~elL~Hpwf~~~ 887 (887)
+.|||+||||+.|
T Consensus 449 a~elL~hp~f~~~ 461 (461)
T PHA03211 449 AAELLRLPLFQSK 461 (461)
T ss_pred HHHHhhCcccCCC
Confidence 9999999999876
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.89 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=200.1
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
++||+|+||+||+|.+..++ ..||||++..... .......|..++..+ ..||||++++++|....++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN----EFFAIKALKKDVVLEDDDVECTMVERRVLALA-----WEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc-----cCCCCccceeeEEEcCCEE
Confidence 36899999999999998777 7899999975422 123344555565543 2799999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..+..|+.||+.||.|||+.||+|+||||+||||+. ++.+||+|||++....
T Consensus 72 ~lv~e~~~gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC-CCCEEEccCcCCeECC
Confidence 9999999 679988887644 4999999999999999999999999999999999999985 7889999999997543
Q ss_pred C--CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 K--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 ~--~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
. ......+||+.|+|||++.+..++.++||||||||||+|++|..||.+.+..+++..+......
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~------------- 214 (316)
T cd05592 148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPH------------- 214 (316)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 2 2334567899999999999999999999999999999999999999887665555443221111
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-HHHHhCCCC
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV-AQALTHPFI 884 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa-~elL~Hpwf 884 (887)
.+..++..+.+||.+||..||.+||++ .+++.||||
T Consensus 215 -------------------------------------------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 215 -------------------------------------------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred -------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence 112244678899999999999999986 588899999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 252 ~~ 253 (316)
T cd05592 252 RG 253 (316)
T ss_pred CC
Confidence 74
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=361.68 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=204.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh---hHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM---NKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~---~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
...+...||.|+||+||++.+..+. .||||++...... ...+..|+.+|.+| .|||||+|+++|..
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~-----~vavK~~~~~~~~~~~~~~f~~E~~il~~l------~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTD-----VVAVKIISDPDFDDESRKAFRREASLLSRL------RHPNIVQFYGACTS 110 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCce-----eEEEEEecchhcChHHHHHHHHHHHHHHhC------CCCCeeeEEEEEcC
Confidence 3555666999999999999987653 4999999864322 45889999999999 99999999999999
Q ss_pred cC-eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccc-eeccCCCCCCccccCCCCeEEEEecC
Q 002732 645 RN-HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG-VLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 645 ~~-~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g-IvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.. .++|||||+ +|+|..+|... ....|++..++.|+.||+.||.|||+++ |||+||||.||||+....++||+|||
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCc
Confidence 87 799999999 78999999885 3445999999999999999999999999 99999999999999633499999999
Q ss_pred cceecCC--CCccCcccCCcccchhhhc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGK--NEITPYLVSRFYRAPEIIL--GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~--~~~~~~~gt~~Y~aPE~l~--~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++..... ...+...||+.|||||++. ...|+.++||||||||||||+||..||.+.........+. ..+..|
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~-~~~~Rp--- 265 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV-VGGLRP--- 265 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-hcCCCC---
Confidence 9987665 3455578999999999999 5589999999999999999999999998877633333222 111111
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..+..++..+..||..||..||..||+..+
T Consensus 266 --------------------------------------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~e 295 (362)
T KOG0192|consen 266 --------------------------------------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLE 295 (362)
T ss_pred --------------------------------------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHH
Confidence 111224577889999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
|+.
T Consensus 296 i~~ 298 (362)
T KOG0192|consen 296 IVS 298 (362)
T ss_pred HHH
Confidence 864
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.97 Aligned_cols=245 Identities=24% Similarity=0.414 Sum_probs=202.8
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.++..+. .|+||++++++|...+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-----~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc-----CCCCccceeeEEEcCCEE
Confidence 36899999999999998776 789999997642 22344567777877763 799999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 147 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGI 147 (318)
T ss_pred EEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC-CCcEEecccCCCeecC
Confidence 9999999 679988887654 4999999999999999999999999999999999999985 7789999999986532
Q ss_pred --CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 --KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 --~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.......++++.|+|||++.+..++.++||||||||||+|++|..||.+.+....+..+......+
T Consensus 148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~------------ 215 (318)
T cd05570 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY------------ 215 (318)
T ss_pred cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 222344578999999999999999999999999999999999999998766555444332111111
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-----HHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV-----AQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa-----~elL~ 880 (887)
+..++..+.+||.+||..||.+|||+ .+||.
T Consensus 216 --------------------------------------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 --------------------------------------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --------------------------------------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 12245678999999999999999999 99999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||..
T Consensus 252 ~~~~~~ 257 (318)
T cd05570 252 HPFFRE 257 (318)
T ss_pred CCCcCC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=364.77 Aligned_cols=250 Identities=27% Similarity=0.361 Sum_probs=211.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|..+.+||.|.||.||+|.+..++ +.||||++..... .-..++.|+.+|.++ .++||.++|+.|...
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~----k~vAiKii~Le~~~deIediqqei~~Ls~~------~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTK----KVVAIKIIDLEEAEDEIEDIQQEISVLSQC------DSPNITEYYGSYLKG 83 (467)
T ss_pred ccccchhccccccceeeeeeecccc----ceEEEEEechhhcchhhHHHHHHHHHHHhc------CcchHHhhhhheeec
Confidence 4888899999999999999998888 8999999986433 236778899999999 789999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..++|+|||| +|++.++|+.... +.+..+..|+++++.||.|||..+.+|+|||+.||||.. .+.|||+|||.+.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~-~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE-SGDVKLADFGVAG 159 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcceecccccccceeEec-cCcEEEEecceee
Confidence 9999999999 6799999887443 589999999999999999999999999999999999996 5889999999997
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... ..+++||++|||||++.+..|+.++||||||+++|||++|.+||....+. ..+..+|+.
T Consensus 160 ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------rvlflIpk~------ 226 (467)
T KOG0201|consen 160 QLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------RVLFLIPKS------ 226 (467)
T ss_pred eeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------eEEEeccCC------
Confidence 765443 36789999999999999889999999999999999999999999654331 111111110
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
. .|..+..++..|++||..||..||..||+|.+||+|+
T Consensus 227 --------------------------------~----------PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 227 --------------------------------A----------PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred --------------------------------C----------CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 1 1222335678899999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||+.
T Consensus 265 FIk~ 268 (467)
T KOG0201|consen 265 FIKR 268 (467)
T ss_pred HHHh
Confidence 9863
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.95 Aligned_cols=277 Identities=28% Similarity=0.483 Sum_probs=216.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+++.||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||++++++|..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l------~h~~i~~~~~~~~~ 70 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLYDVLHS 70 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC----cEEEEEEeecccccccCccchhHHHHHHHhc------CCCCeeeHHHHhcc
Confidence 4899999999999999999998877 789999986532 2234567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+|||+||+.++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|+|||++. .+.++|+|||++.
T Consensus 71 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~ 147 (284)
T cd07839 71 DKKLTLVFEYCDQDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK-NGELKLADFGLAR 147 (284)
T ss_pred CCceEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC-CCcEEECccchhh
Confidence 99999999999989988887643 34899999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCC-CCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVL-FPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~P-F~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
..... ......+++.|+|||++.+. .++.++||||||||||+|++|..| |.+.+..+.+..+....+..+...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHH
Confidence 65432 23345678899999999875 479999999999999999998877 566666777777777766655443211
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...... +..... ... ........+.++.++.+||.+||..||.+|||+.+||.
T Consensus 228 ~~~~~~-------~~~~~~-------------------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPD-------YKPYPM-------------------YPA-TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhccc-------ccccCC-------------------CCC-cchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 000000 000 00001122356788999999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 281 h~~f 284 (284)
T cd07839 281 HPYF 284 (284)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=360.35 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=205.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.++..+ +|++|+.++++|.
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 71 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTG----QVYAMKILNKWEMLKRAETACFREERDVLVNG------DRRWITNLHYAFQ 71 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC------CCCCCCceEEEEe
Confidence 5999999999999999999998877 799999997532 1234467788888887 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|.... ..+++..+..|+.||+.||.|||++||+|+||||+||||+. .+.+||+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~ 148 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK-NGHIRLADFGS 148 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC-CCCEEEEECCc
Confidence 999999999999 779999997643 24899999999999999999999999999999999999984 78899999999
Q ss_pred ceecCCCC---ccCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 723 AMFAGKNE---ITPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 723 a~~~~~~~---~~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+....... ....++|+.|+|||++.+ ..++.++||||||||||+|++|..||.+.+..+.+..++.....+
T Consensus 149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~- 227 (331)
T cd05597 149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF- 227 (331)
T ss_pred eeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-
Confidence 86654322 223468999999999973 357889999999999999999999998766555544442211100
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC--C
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK--R 872 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~--R 872 (887)
..+...+.++..+.+||.+||..++.. |
T Consensus 228 --------------------------------------------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r 257 (331)
T cd05597 228 --------------------------------------------------QFPPDVTDVSEEAKDLIRRLICSPETRLGR 257 (331)
T ss_pred --------------------------------------------------cCCCccCCCCHHHHHHHHHHccCcccccCC
Confidence 011112235678899999999765554 7
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
+++.+||+||||.+
T Consensus 258 ~~~~~~l~hp~~~~ 271 (331)
T cd05597 258 NGLQDFKDHPFFEG 271 (331)
T ss_pred CCHHHHhcCCCCCC
Confidence 89999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.38 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=207.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.++..||.|+||+||+|.+..++ ..||||++.+... ....+..|+.++..+. +|++|+.++++|.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTD----ELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-----KPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCchhheeeEEe
Confidence 3789999999999999999998877 7999999975422 2234566777777662 5678889999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.+++...+ .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~-~~~ikL~Dfg~ 147 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS-EGHIKIADFGM 147 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEecccc
Confidence 999999999999 679998887654 3999999999999999999999999999999999999995 78899999999
Q ss_pred ceecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+...... .....+||+.|+|||++.+..++.++||||||||||+|++|.+||.+.+....+..++.....+|
T Consensus 148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p------ 221 (323)
T cd05615 148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP------ 221 (323)
T ss_pred ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence 8654322 23345689999999999999999999999999999999999999988776665555543222211
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----H
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----V 875 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a 875 (887)
..++..+.+||.+||..+|.+|++ +
T Consensus 222 --------------------------------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 251 (323)
T cd05615 222 --------------------------------------------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251 (323)
T ss_pred --------------------------------------------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCH
Confidence 123467889999999999999997 5
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.++++||||.+
T Consensus 252 ~~i~~h~~f~~ 262 (323)
T cd05615 252 RDIREHAFFRR 262 (323)
T ss_pred HHHhcCcccCC
Confidence 79999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=359.56 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=200.4
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||.|+||+||+|.+..++ ..||||++..... .......|..++..+ ..||||++++++|...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-----WEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc-----cCCCcCcceEEEEEeCCEE
Confidence 36899999999999998876 7899999976421 223445566666654 2899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..+..|+.||+.||.|||+.||||+||||+||||+. ++.++|+|||++....
T Consensus 72 ~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~ 147 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT-DGHIKIADFGMCKENM 147 (316)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-CCCEEEccCCcceECC
Confidence 9999999 679999887643 3899999999999999999999999999999999999985 7789999999986532
Q ss_pred --CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 --KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 --~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.......++|+.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..+......
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~------------- 214 (316)
T cd05619 148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC------------- 214 (316)
T ss_pred CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------------
Confidence 22334567899999999999999999999999999999999999999876655444433111000
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH-HHHhCCCC
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA-QALTHPFI 884 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~-elL~Hpwf 884 (887)
.+..++..+.+||.+||..||.+||++. +|++||||
T Consensus 215 -------------------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05619 215 -------------------------------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251 (316)
T ss_pred -------------------------------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence 0112446788999999999999999996 99999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 252 ~~ 253 (316)
T cd05619 252 RE 253 (316)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=361.58 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=198.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||.|+||+||+|.+..++ +.||||++.... .....+..|+.+|..| .|+||++++++|..
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 143 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTG----RLYALKVIYGNHEDTVRRQICREIEILRDV------NHPNVVKCHDMFDH 143 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCC----CEEEEEEEecCCcHHHHHHHHHHHHHHHhC------CCCCcceeeeEecc
Confidence 35888999999999999999998777 799999986532 2345678899999998 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|... ..+.+..+..|+.||+.||.|||++||||+||||+||||+. ++.+||+|||++
T Consensus 144 ~~~~~lv~e~~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kL~DfG~~ 215 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS-AKNVKIADFGVS 215 (353)
T ss_pred CCeEEEEEecCCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCEEEcccccc
Confidence 99999999999 4566432 12577888999999999999999999999999999999985 788999999999
Q ss_pred eecCCC--CccCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
..+... .....+|+..|+|||++.. ..++.++||||||||||+|++|..||......+....+...
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------- 288 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI------- 288 (353)
T ss_pred eecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------
Confidence 765432 2345678999999999843 23457899999999999999999999633222111111000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
... ..+.....++..+.+||.+||..||.+|||+.
T Consensus 289 ----------------------------------~~~-----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ 323 (353)
T PLN00034 289 ----------------------------------CMS-----------QPPEAPATASREFRHFISCCLQREPAKRWSAM 323 (353)
T ss_pred ----------------------------------hcc-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence 000 01112234567899999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
|||+||||.+
T Consensus 324 ell~hp~~~~ 333 (353)
T PLN00034 324 QLLQHPFILR 333 (353)
T ss_pred HHhcCccccc
Confidence 9999999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.21 Aligned_cols=249 Identities=24% Similarity=0.388 Sum_probs=200.9
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||+||+|.+..++ ..||||++...... ...+..|+.+|..| +|++|+.++++|....++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~i~~~~~~~~~~~~~~l 70 (280)
T cd05608 1 LGKGGFGEVSACQMRATG----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKV------HSRFIVSLAYAFQTKTDLCL 70 (280)
T ss_pred CCCCCceeEEEEEEccCC----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC------CCCcEeeeeEEEcCCCeEEE
Confidence 699999999999998877 79999998754221 24456789999999 89999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 651 VFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
||||+ +++|..++.... ....+++..++.|+.||+.||.|||++||+|+||||+||||+. .+.++|+|||++.....
T Consensus 71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKD 149 (280)
T ss_pred EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEeeCccceecCC
Confidence 99999 678988875433 2345999999999999999999999999999999999999985 77899999999976543
Q ss_pred CC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 729 NE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 729 ~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
.. .....+++.|+|||++.+..++.++||||||||||+|++|..||...........+...
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----------------- 212 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----------------- 212 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh-----------------
Confidence 22 33457889999999999999999999999999999999999999654322111111000
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHhC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALTH 881 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~H 881 (887)
++ ......+..++..+.+||.+||..||.+|| |+.+||+|
T Consensus 213 -----------------------~~------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 213 -----------------------IL------------NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred -----------------------hc------------ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00 000111234567899999999999999999 89999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||++
T Consensus 258 ~~~~~ 262 (280)
T cd05608 258 PLFRD 262 (280)
T ss_pred hhhhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.16 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=199.5
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
++||.|+||.||+|.+..++ ..||||++.+... ....+..|+.++..+. +||||+.++++|...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~-----~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc-----CCCCCCceEEEEEcCCEE
Confidence 36899999999999998877 7999999975322 2244567888888773 699999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. .+.+||+|||++....
T Consensus 72 ~lv~e~~~~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~ 147 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGI 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEECcCccccccc
Confidence 9999999 678988886643 4999999999999999999999999999999999999985 7889999999986422
Q ss_pred --CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 --KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 --~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.......+||+.|+|||++.+..++.++|||||||+||+|++|..||......+. |..
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----------~~~--------- 207 (329)
T cd05588 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN-----------PDQ--------- 207 (329)
T ss_pred cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc-----------ccc---------
Confidence 2234456889999999999999999999999999999999999999953221100 000
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC------HHHHH
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT------VAQAL 879 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT------a~elL 879 (887)
.....+...+... ....+..++..+.+||.+||+.||.+||| +.+||
T Consensus 208 ----------------~~~~~~~~~~~~~-----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 208 ----------------NTEDYLFQVILEK-----------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred ----------------cchHHHHHHHHcC-----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 0000001111100 01112345678899999999999999997 78999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||..
T Consensus 261 ~hp~~~~ 267 (329)
T cd05588 261 SHPFFRN 267 (329)
T ss_pred cCCCCCC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.99 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=222.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.|.+++++|.|+||.++++.++... ..||||.+... .........|+.++.+| .|||||.+.+.|.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~------~hP~iv~y~ds~~ 73 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDD----KLYVLKKINLEKLTEPERRSAIQEMDLLSKL------LHPNIVEYKDSFE 73 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCC----ceEEEEEEeccccCchhhHHHHHHHHHHHhc------cCCCeeeeccchh
Confidence 45999999999999999999998877 79999999753 33345778999999999 9999999999999
Q ss_pred ecCe-EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 644 YRNH-LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 644 ~~~~-~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
..+. +||||+|| +|+|.+.|.... ...|++..++.|+.||+.||.|||+..|+|||||+.|||++. ++.|+|+|||
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk-~~~VkLgDfG 151 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK-DKKVKLGDFG 151 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc-cCceeecchh
Confidence 9887 99999999 779999988754 355999999999999999999999999999999999999996 6666999999
Q ss_pred cceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|...+... ..+++||+.||+||++.+.+|+.++|||||||+||||++-+++|.+.+....+..|+.....+
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P------ 225 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP------ 225 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC------
Confidence 999988763 567899999999999999999999999999999999999999999988888777776554211
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+..++.++..||..||..+|..||+|.+||
T Consensus 226 -------------------------------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 226 -------------------------------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred -------------------------------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence 2334668899999999999999999999999
Q ss_pred hCCCCC
Q 002732 880 THPFIS 885 (887)
Q Consensus 880 ~Hpwf~ 885 (887)
.+|.+.
T Consensus 257 ~~P~l~ 262 (426)
T KOG0589|consen 257 RRPHLL 262 (426)
T ss_pred hChhhh
Confidence 999764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=350.69 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=207.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|+++++||.|+||+||+|.+..++ ..||||++...... ...+.+|+.+|..| +|++|+.++++|.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 70 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGEAMALNEKQILEKV------NSRFVVSLAYAYE 70 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCC----ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc------CCCCEeeeeeeec
Confidence 3899999999999999999988776 79999998753221 23456799999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|..++.... ...+++..+..++.||+.||.|||+.||||+||+|+|||++. .+.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~ 148 (285)
T cd05605 71 TKDALCLVLTLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD-YGHIRISDLGL 148 (285)
T ss_pred CCCeEEEEEeccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC-CCCEEEeeCCC
Confidence 999999999999 578888876532 235999999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 723 AMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 723 a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+....... ....++++.|+|||++.+..++.++|||||||+||+|++|..||.+.........+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 220 (285)
T cd05605 149 AVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED-------- 220 (285)
T ss_pred ceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--------
Confidence 97654322 234578899999999999899999999999999999999999997654433222221110000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVA 876 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~ 876 (887)
....+..++..+.+||.+||..||.+|| ++.
T Consensus 221 --------------------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05605 221 --------------------------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAE 256 (285)
T ss_pred --------------------------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHH
Confidence 0011233567889999999999999999 999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+||+||||..
T Consensus 257 ~l~~~~~~~~ 266 (285)
T cd05605 257 EVKAHPFFRT 266 (285)
T ss_pred HHhcCcCccC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=365.89 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=209.1
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
.+..+.|.+++.||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..+ .||||+++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~------~hp~iv~~ 108 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTR----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA------NSPWVVQL 108 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCC----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC------CCCCCCeE
Confidence 344578999999999999999999998877 899999986532 1223456788888888 89999999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
+++|....++||||||+ +++|.+++... .+++..+..++.||+.||.|||++||||+||||+||||+. .+.+||
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~-~~~ikL 183 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKL 183 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC-CCCEEE
Confidence 99999999999999999 67999988653 3899999999999999999999999999999999999985 788999
Q ss_pred EecCcceecCCCC---ccCcccCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 718 CDFGNAMFAGKNE---ITPYLVSRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 718 ~DFG~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~~----~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|||++....... ....+||+.|+|||++.+.. ++.++||||||||||+|++|.+||.+.+....+..|+...
T Consensus 184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999997664332 23567899999999997643 8899999999999999999999998776655555443321
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..++ ......++..+.+||.+||..+|.
T Consensus 264 ~~~~----------------------------------------------------~~~~~~~s~~~~~li~~~L~~~~~ 291 (371)
T cd05622 264 NSLT----------------------------------------------------FPDDNDISKEAKNLICAFLTDREV 291 (371)
T ss_pred Cccc----------------------------------------------------CCCcCCCCHHHHHHHHHHcCChhh
Confidence 1110 001124567889999999984444
Q ss_pred C--CcCHHHHHhCCCCCC
Q 002732 871 K--RMTVAQALTHPFISG 886 (887)
Q Consensus 871 ~--RpTa~elL~Hpwf~~ 886 (887)
+ |+++.+|++||||.+
T Consensus 292 r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 292 RLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred hcCCCCHHHHhcCcccCC
Confidence 3 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=376.78 Aligned_cols=297 Identities=18% Similarity=0.245 Sum_probs=207.5
Q ss_pred cccCceecCcEEEEEEeccCCceEEEEEEEcCCCCC---------------CCcEEEEEEecccchhhHHHHHHHHHHHH
Q 002732 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNG---------------EPEEVAIKIIRNNETMNKAGQTEVQILKK 623 (887)
Q Consensus 559 ~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~---------------~~~~vAIKii~~~~~~~~~~~~Ei~iL~~ 623 (887)
+..+..+.++|.++..||+|+||+||+|........ ....+++|.+.........+.+|+.+|..
T Consensus 140 ~~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~ 219 (501)
T PHA03210 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGR 219 (501)
T ss_pred cccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHh
Confidence 344555667899999999999999999875432200 00111222222233334567789999999
Q ss_pred hhCCCCCCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHhhhccceeccCC
Q 002732 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR--NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI 701 (887)
Q Consensus 624 L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~--~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDL 701 (887)
| +|+||++++++|...+..|||++++.++|..++..... ...+....++.|+.||+.||.|||++||||+||
T Consensus 220 l------~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDL 293 (501)
T PHA03210 220 L------NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293 (501)
T ss_pred C------CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9 89999999999999999999999998888888764321 122456678899999999999999999999999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCCCC---ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC-CCCCC
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV-LFPGA 777 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~-PF~~~ 777 (887)
||+||||+. ++.+||+|||++..+.... ....+||+.|+|||++.+..|+.++||||||||||+|++|.. ||...
T Consensus 294 KP~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 294 KLENIFLNC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred CHHHEEECC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 999999985 7889999999997765332 234678999999999999999999999999999999999875 44332
Q ss_pred --ChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHH
Q 002732 778 --TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855 (887)
Q Consensus 778 --~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 855 (887)
.....+..++...+..+..+..... ..| ..+....+...+..+..++. ...++.
T Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~----------------~~i~~~~~~~~~~~~~~~~~-----~~~~~~ 428 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSVCDEEFPDPPC---KLF----------------DYIDSAEIDHAGHSVPPLIR-----NLGLPA 428 (501)
T ss_pred CCCHHHHHHHHHHhcccChhhcCCcHH---HHH----------------HHhhhhhcccCccchhhHHH-----hcCCCh
Confidence 2334444444444333222110000 000 00000000001111111111 112346
Q ss_pred HHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 856 ~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
.|.+||.+||++||.+||||.|||.||||.+
T Consensus 429 ~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 429 DFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 7889999999999999999999999999975
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=358.99 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=198.3
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHH-HHHhhCCCCCCCcceeEecceeeecCe
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQI-LKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~i-L~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
+.||.|+||+||+|.+..++ ..||||++.+.... ...+..|..+ +..+ .||||++++++|...+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l------~hp~iv~~~~~~~~~~~ 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV------KHPFLVGLHYSFQTADK 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC------CCCCCCCeeEEEEeCCE
Confidence 36899999999999998877 89999999753221 1223334333 3445 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++...
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS-QGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-CCcEEEeccCCCccc
Confidence 99999999 679988887643 4899999999999999999999999999999999999985 788999999998653
Q ss_pred C--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 G--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
. .......+||+.|+|||++.+..++.++||||||||||+|++|.+||.+.+..+.+..++...
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------- 212 (323)
T cd05575 147 IEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-------------- 212 (323)
T ss_pred ccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence 2 223445678999999999999999999999999999999999999998766555544332110
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH----HHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----AQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa----~elL~ 880 (887)
....+.++..+.+||.+||+.||.+||++ .+||.
T Consensus 213 ------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 213 ------------------------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred ------------------------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 00112345778999999999999999998 69999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||..
T Consensus 251 ~~~~~~ 256 (323)
T cd05575 251 HVFFSS 256 (323)
T ss_pred CCCcCC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=358.81 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=197.7
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||+|+||+||+|.+..++ ..||||++.+.. .....+..|+.++..+. .||||++++++|...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcC-----CCCcCCceeeEEEeCCEE
Confidence 36899999999999998877 799999997532 22234567777777663 799999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++....
T Consensus 72 ~lv~E~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~ 147 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGL 147 (329)
T ss_pred EEEEeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC-CCCEEEeeCCcccccc
Confidence 9999999 678888776543 4999999999999999999999999999999999999985 7889999999986532
Q ss_pred --CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 --KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 --~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.......+||+.|+|||++.+..++.++||||||||||+|++|..||........ +.
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----------~~---------- 206 (329)
T cd05618 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN-----------PD---------- 206 (329)
T ss_pred CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC-----------cc----------
Confidence 2223456789999999999999999999999999999999999999953211000 00
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC------HHHHH
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT------VAQAL 879 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT------a~elL 879 (887)
......+...+... ....+..++..+.+||.+||..||.+||| +.+|+
T Consensus 207 ---------------~~~~~~~~~~i~~~-----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05618 207 ---------------QNTEDYLFQVILEK-----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 260 (329)
T ss_pred ---------------cccHHHHHHHHhcC-----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence 00000000111000 01122345678899999999999999998 58999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||.+
T Consensus 261 ~hp~f~~ 267 (329)
T cd05618 261 GHPFFRN 267 (329)
T ss_pred cCCCCCC
Confidence 9999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=357.07 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.++++||+|+||+||++.+..++ ..||||++.+.. .....+..|+.++..+ .|++|+.++++|.
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 71 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNAD----KVFAMKILNKWEMLKRAETACFREERDVLVNG------DNQWITTLHYAFQ 71 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCC----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC------CCCCEeeEEEEEe
Confidence 5999999999999999999988776 789999996532 1223456777777777 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.++|.... ..+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~-~~~~kL~DfG~ 148 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGS 148 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC-CCCEEEeecch
Confidence 999999999999 789999997643 24899999999999999999999999999999999999984 78899999999
Q ss_pred ceecCCCC---ccCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 723 AMFAGKNE---ITPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 723 a~~~~~~~---~~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+....... ....+||+.|+|||++.+ ..++.++||||||||||+|++|..||.+.+..+.+..++.....++
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 228 (332)
T ss_pred heecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc
Confidence 86543221 233578999999999973 4689999999999999999999999987766665554432211110
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC--C
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK--R 872 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~--R 872 (887)
.+.....++..+.+||.+||..+|.+ |
T Consensus 229 ---------------------------------------------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 229 ---------------------------------------------------FPAQVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred ---------------------------------------------------CCCccccCCHHHHHHHHHHccChhhhcCC
Confidence 01111234578899999999776555 6
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
+++.++|+||||.+
T Consensus 258 ~~~~~~~~h~~f~~ 271 (332)
T cd05623 258 NGIEDFKQHPFFTG 271 (332)
T ss_pred CCHHHHhCCCCcCC
Confidence 89999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.56 Aligned_cols=259 Identities=24% Similarity=0.398 Sum_probs=211.6
Q ss_pred cCcEEEEE-EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTA-AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~-~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.+.|.+.. +||-|-.|.|..|.++.++ +.+|+|++... ....+|+++.-... .|+|||.++++|+.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~----ekfALKvL~Ds----~KARrEVeLHw~~s-----~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQ----EKFALKVLLDS----PKARREVELHWMAS-----GHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccch----hhhHHHHHhcC----HHHHhHhhhhhhhc-----CCCceEEeehhhhh
Confidence 34466654 7899999999999999988 89999998654 44567887766654 89999999999875
Q ss_pred ----cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC--CCCeEEE
Q 002732 645 ----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE--AKNVLKL 717 (887)
Q Consensus 645 ----~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~~vKL 717 (887)
...+.||||.| +|.|+.-|+..+. ..|++.++..|+.||+.||.|||+.+|.||||||+|+|+.. .+..+||
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 46789999999 7899999988664 56999999999999999999999999999999999999963 3457999
Q ss_pred EecCcceecC-CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 718 CDFGNAMFAG-KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 718 ~DFG~a~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+|||+|.... ...+.+.|.|++|+|||++-...|+...|+||||||||-||+|.+||...... .++..
T Consensus 206 tDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----------aispg 274 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----------AISPG 274 (400)
T ss_pred cccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----------cCChh
Confidence 9999998765 45577789999999999999999999999999999999999999999654221 12222
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
|-. +|.. + ...+...+|..+|+.+++||++||..+|.+|+|++
T Consensus 275 Mk~-----------------------------rI~~-------g-qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~ 317 (400)
T KOG0604|consen 275 MKR-----------------------------RIRT-------G-QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIE 317 (400)
T ss_pred HHh-----------------------------Hhhc-------c-CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHH
Confidence 211 0100 0 01112345778899999999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+++.|||+++
T Consensus 318 ~~m~hpwi~~ 327 (400)
T KOG0604|consen 318 EVMDHPWINQ 327 (400)
T ss_pred HhhcCchhcc
Confidence 9999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=337.53 Aligned_cols=287 Identities=30% Similarity=0.505 Sum_probs=229.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.+.|.-+.+||+|.||.||+|....++ +.||+|++.- ..........|+.||..| .|+|++.|+..|
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~----kkvalkkvlmeneKeGfpitalreikiL~~l------kHenv~nliEic 85 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTG----KKVALKKVLMENEKEGFPITALREIKILQLL------KHENVVNLIEIC 85 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCcc----chhHHHHHHHhccccCCcHHHHHHHHHHHHh------cchhHHHHHHHH
Confidence 356888999999999999999998887 7899987653 233446678899999999 899999988887
Q ss_pred eec--------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCe
Q 002732 643 KYR--------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 643 ~~~--------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 714 (887)
... ..+||||.+|..+|.-+|-. ....|++.++..++.+|+.||.|||...|+|||+||.||||+. +++
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~-dgi 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEHDLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK-DGI 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhhhHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC-Cce
Confidence 642 35999999999999988865 3345999999999999999999999999999999999999994 899
Q ss_pred EEEEecCcceecC------CCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002732 715 LKLCDFGNAMFAG------KNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787 (887)
Q Consensus 715 vKL~DFG~a~~~~------~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~ 787 (887)
+||+|||+|..+. .+.++..+.|++|++||.++|. .|++++|||..||||.+|+++.+.|.+.+...++..|.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9999999995432 3346777889999999999987 69999999999999999999999999999999999999
Q ss_pred HhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhccc
Q 002732 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL 867 (887)
Q Consensus 788 ~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~ 867 (887)
.++|.+.+..|.+- +....+...+..|.......++-...+| +.. ..++.+||.+||.+
T Consensus 243 ~LcGs~tkevWP~~-------d~lpL~~sie~ePl~~~~~rkv~n~~kp---------~~k-----d~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 243 QLCGSITKEVWPNV-------DNLPLYQSIELEPLPKGQKRKVKNRLKP---------YVK-----DDEALDLLEKLLKL 301 (376)
T ss_pred HHhccCCcccCCCc-------ccchHHHhccCCCCCcchhhhhhhhccc---------ccC-----ChhHHHHHHHHhcc
Confidence 99999876664321 1111122222222222222222222221 111 25678999999999
Q ss_pred CCCCCcCHHHHHhCCCCCC
Q 002732 868 DPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 868 DP~~RpTa~elL~Hpwf~~ 886 (887)
||.+||++.++|+|.||-.
T Consensus 302 DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCcchHhhhchhhhhc
Confidence 9999999999999999964
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=343.75 Aligned_cols=252 Identities=24% Similarity=0.408 Sum_probs=218.7
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHH----HHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~----~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
.-+.|.++++||+|.||.|.+|+.+.++ ..|||||+++.......- ..|-.+|+.. .||.+..|.-
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~----k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~------~HPFLt~LKY 235 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATG----KLYAIKILKKEVIIAKDEVAHTLTENRVLQNC------RHPFLTSLKY 235 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccC----ceeehhhhhhhheeehHHhhhhhhHHHHHHhc------cCcHHHHhhh
Confidence 3356999999999999999999999988 899999999865443222 3466777777 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
.|+..+++|+||||. +|.|.-.|... ..|++..++.|...|+.||.|||+.+||++|||.+|+||+. +++|||+|
T Consensus 236 sFQt~drlCFVMeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk-DGHIKitD 311 (516)
T KOG0690|consen 236 SFQTQDRLCFVMEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK-DGHIKITD 311 (516)
T ss_pred hhccCceEEEEEEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc-CCceEeee
Confidence 999999999999999 67888777663 34999999999999999999999999999999999999995 89999999
Q ss_pred cCccee--cCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 720 FGNAMF--AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 720 FG~a~~--~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
||++.- .......++|||+.|+|||+|....|+.++|||.+||+||||++|.+||.+......+..|+..-..||.
T Consensus 312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr-- 389 (516)
T KOG0690|consen 312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR-- 389 (516)
T ss_pred cccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc--
Confidence 999853 3334567899999999999999999999999999999999999999999998888888777665555543
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc----
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM---- 873 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp---- 873 (887)
.++++++.||..+|..||.+|+
T Consensus 390 ------------------------------------------------------~ls~eAktLLsGLL~kdP~kRLGgGp 415 (516)
T KOG0690|consen 390 ------------------------------------------------------TLSPEAKTLLSGLLKKDPKKRLGGGP 415 (516)
T ss_pred ------------------------------------------------------cCCHHHHHHHHHHhhcChHhhcCCCc
Confidence 3457889999999999999998
Q ss_pred -CHHHHHhCCCCCC
Q 002732 874 -TVAQALTHPFISG 886 (887)
Q Consensus 874 -Ta~elL~Hpwf~~ 886 (887)
.|.||.+|+||.+
T Consensus 416 dDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 416 DDAKEIMRHRFFAS 429 (516)
T ss_pred hhHHHHHhhhhhcc
Confidence 5889999999975
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.11 Aligned_cols=247 Identities=24% Similarity=0.407 Sum_probs=203.5
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
+.||+|+||.||++.+.... ..+..||||++..... ....+..|+.+|.+| .|+||++++++|...+.+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred ceeeeCCCEEEEEEEEeccC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC------CCCCcccEEEEEEcCCEEE
Confidence 57999999999999874221 2337899999975432 223456788999988 8999999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||||+ +++|.+++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.++|+|||++.....
T Consensus 75 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 75 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE-EGHIKLTDFGLSKESID 150 (318)
T ss_pred EEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC-CCcEEEeeccCCcccCC
Confidence 999999 679998886643 4899999999999999999999999999999999999985 77899999999876543
Q ss_pred C--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 729 N--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 729 ~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
. .....++++.|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..+......+
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~------------- 217 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM------------- 217 (318)
T ss_pred CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC-------------
Confidence 3 2345678999999999999899999999999999999999999998776655554443221111
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHHHHhC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQALTH 881 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~elL~H 881 (887)
+..++..+.+||.+||+.||.+||| +.++|.|
T Consensus 218 -------------------------------------------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 218 -------------------------------------------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred -------------------------------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1224467889999999999999999 7889999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||..
T Consensus 255 ~~~~~ 259 (318)
T cd05582 255 PFFST 259 (318)
T ss_pred CCcCC
Confidence 99964
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.64 Aligned_cols=279 Identities=29% Similarity=0.527 Sum_probs=221.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.+++.+ .|+||+.++++|..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~ 70 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG----ETVALKKVALRRLEGGIPNQALREIKALQAC------QHPYVVKLLDVFPH 70 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC----ceEEEEEEEcccccchhhHHHHHHHHHHHhC------CCCCCcceeeEEec
Confidence 4899999999999999999988776 789999987543 2235678899999999 79999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+|+||||++++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++.
T Consensus 71 ~~~~~~v~e~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~ 147 (286)
T cd07832 71 GSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA-DGVLKIADFGLAR 147 (286)
T ss_pred CCeeEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC-CCcEEEeeeeecc
Confidence 99999999999889999987644 35999999999999999999999999999999999999995 7889999999987
Q ss_pred ecCCCC---ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKNE---ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~---~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... .....++..|+|||++.+. .++.++|||||||+||+|++|.+||.+.+....+..++...+.+....+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 665433 4455788899999998765 468999999999999999999999988888888888877776654433221
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
......+ ....+... ....+ ....+.++..+.+||.+||..+|.+|||+.+||.
T Consensus 228 ~~~~~~~--~~~~~~~~-----------------~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDY--NKITFPES-----------------KPIPL-------EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchh--hcccCCCC-----------------CcchH-------HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1000000 00000000 00000 0111234578899999999999999999999999
Q ss_pred CCCCC
Q 002732 881 HPFIS 885 (887)
Q Consensus 881 Hpwf~ 885 (887)
||||+
T Consensus 282 h~~~~ 286 (286)
T cd07832 282 HPYFT 286 (286)
T ss_pred CcCcC
Confidence 99995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.78 Aligned_cols=281 Identities=27% Similarity=0.436 Sum_probs=220.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..|.++..||.|+||.||+|.+..++ ..||||++..... .......|+.+|.+| .|+||+++++++.
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 76 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSG----EIVALKKVRMDNERDGIPISSLREITLLLNL------RHPNIVELKEVVV 76 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCC----cEEEEEEEEeccCCCCCcchhhHHHHHHHhC------CCCCCcceEEEEe
Confidence 45999999999999999999998777 7999999874322 123456799999999 8999999999987
Q ss_pred ec--CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 644 YR--NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 644 ~~--~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.. +.+||||||+.++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~kL~dfg 153 (309)
T cd07845 77 GKHLDSIFLVMEYCEQDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD-KGCLKIADFG 153 (309)
T ss_pred cCCCCeEEEEEecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECccc
Confidence 64 5789999999889999887643 35899999999999999999999999999999999999984 7889999999
Q ss_pred cceecCCC--CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 722 NAMFAGKN--EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 722 ~a~~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
++...... ..+...+++.|+|||++.+ ..++.++||||||||||+|++|.+||.+.+..+.+..+...++..+..++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 99766543 2334456788999999876 45899999999999999999999999999999999989888877655543
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
........ .....+ ...... ........++..+.+||.+||++||.+|||+.+|
T Consensus 234 ~~~~~~~~--~~~~~~--------------------~~~~~~----~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 234 PGFSDLPL--VGKFTL--------------------PKQPYN----NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred hhhhcccc--cccccc--------------------cCCCCC----chHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 21110000 000000 000000 0000112245788999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
|.||||.+
T Consensus 288 l~h~~f~~ 295 (309)
T cd07845 288 LESSYFKE 295 (309)
T ss_pred hcChhhcc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=365.00 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=211.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc-cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+-|.|+..||-|+||.||+|..+.++ -..|.|+|.. .......++-||.||..+ .||+||+|++.|...
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~----~lAAaKvIetkseEELEDylVEIeILa~C------dHP~ivkLl~ayy~e 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETK----LLAAAKVIETKSEEELEDYLVEIEILAEC------DHPVIVKLLSAYYFE 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccch----hhhhhhhhcccchhHHhhhhhhhhhhhcC------CChHHHHHHHHHhcc
Confidence 34889999999999999999988776 6778888864 344457788899999999 899999999999999
Q ss_pred CeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.++|++|||+ |-...+|...+. .|++.++..+++|+|.||.|||+++|||+|||..|||++. +|.|+|+|||.+.
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl-dGdirLADFGVSA 178 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL-DGDIRLADFGVSA 178 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe-cCcEeeecccccc
Confidence 99999999995 566667777665 5999999999999999999999999999999999999995 8899999999885
Q ss_pred ecCC--CCccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 725 FAGK--NEITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 725 ~~~~--~~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
.... ....+++||++|||||++. ..+|++++|||||||+|++|..+.+|....+..-++..|... .+| .+
T Consensus 179 Kn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePP-TL 255 (1187)
T KOG0579|consen 179 KNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-TL 255 (1187)
T ss_pred cchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCC-cc
Confidence 4332 2356789999999999985 447999999999999999999999998665554444333211 111 11
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+ .+..++..|.|||.+||..||.-||++.+
T Consensus 256 l--------------------------------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq 285 (1187)
T KOG0579|consen 256 L--------------------------------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQ 285 (1187)
T ss_pred c--------------------------------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence 0 12345678999999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||+||||++
T Consensus 286 ll~Hpfv~~ 294 (1187)
T KOG0579|consen 286 LLKHPFVQN 294 (1187)
T ss_pred HhhCccccc
Confidence 999999984
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.53 Aligned_cols=255 Identities=23% Similarity=0.395 Sum_probs=205.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+.++||+|+||+||+|.+..++ ..||||.+..... ....+..|+.+|..| .|++|+.+++.|.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~i~~~~~~~~ 70 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATG----KMYACKKLEKKRIKKRKGESMALNEKQILEKV------NSRFVVSLAYAYE 70 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCC----ceEEEEEEehhhccchHHHHHHHHHHHHHHhC------CCCCeeeeeEEEe
Confidence 3788999999999999999998887 8999999865322 123456799999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.+++..... ..+++..+..|+.||+.||.|||++||+|+||||+|||++. .+.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~-~~~~~l~Dfg~ 148 (285)
T cd05630 71 TKDALCLVLTLMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD-HGHIRISDLGL 148 (285)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC-CCCEEEeeccc
Confidence 999999999999 6789988865432 35899999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 723 AMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 723 a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+...... ......+++.|+|||++.+..++.++|||||||++|+|++|.+||...........+.......
T Consensus 149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-------- 220 (285)
T cd05630 149 AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-------- 220 (285)
T ss_pred eeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--------
Confidence 8765432 2234578899999999999999999999999999999999999997543211111010000000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VA 876 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~ 876 (887)
. ......++..+.+||.+||+.||.+||| +.
T Consensus 221 ---------------------------------~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 256 (285)
T cd05630 221 ---------------------------------Q-----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAR 256 (285)
T ss_pred ---------------------------------h-----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchH
Confidence 0 0001224467899999999999999999 99
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
|||+||||.+
T Consensus 257 ~~~~h~~~~~ 266 (285)
T cd05630 257 EVKEHPLFKQ 266 (285)
T ss_pred HHHcChhhhc
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.07 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=206.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||+|+||+||+|.+..++ ..||||++.+.. .....+..|+.++..+ .|++|+.++++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~l~~~~ 70 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE----RIYAMKILNKWEMLKRAETACFREERNVLVNG------DCQWITTLHYAF 70 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC----CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 36999999999999999999998777 789999987532 1223456778888777 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+++||||||+ +++|.++|.... ..+++..+..|+.||+.||.|||++||+|+||||+||||+. .+.+||+|||
T Consensus 71 ~~~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfG 147 (331)
T cd05624 71 QDENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM-NGHIRLADFG 147 (331)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC-CCCEEEEecc
Confidence 9999999999999 789999998643 24899999999999999999999999999999999999984 7789999999
Q ss_pred cceecCCCCc---cCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 722 NAMFAGKNEI---TPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 722 ~a~~~~~~~~---~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
++........ ...+|++.|+|||++.+ ..++.++||||||||||+|++|..||.+.+..+.+..++.....+
T Consensus 148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05624 148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227 (331)
T ss_pred ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc
Confidence 9976543321 23568999999999976 468899999999999999999999998766655554443211111
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC--
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK-- 871 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~-- 871 (887)
+ .+.....++..+.+||.+||...|.+
T Consensus 228 ~---------------------------------------------------~p~~~~~~~~~~~~li~~ll~~~~~~~~ 256 (331)
T cd05624 228 Q---------------------------------------------------FPSHITDVSEEAKDLIQRLICSRERRLG 256 (331)
T ss_pred c---------------------------------------------------CCCccccCCHHHHHHHHHHccCchhhcC
Confidence 0 01111234578899999999976655
Q ss_pred CcCHHHHHhCCCCCC
Q 002732 872 RMTVAQALTHPFISG 886 (887)
Q Consensus 872 RpTa~elL~Hpwf~~ 886 (887)
|++++++++||||.+
T Consensus 257 ~~~~~~~~~h~~f~~ 271 (331)
T cd05624 257 QNGIEDFKKHAFFEG 271 (331)
T ss_pred CCCHHHHhcCCCcCC
Confidence 569999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=343.53 Aligned_cols=281 Identities=30% Similarity=0.514 Sum_probs=215.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.++..||.|+||+||+|.+..++ ..||||.+..... ....+..|+.+++.| +|+||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 74 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTG----QLVALKEIRLEHEEGAPFTAIREASLLKDL------KHANIVTLHDIIHT 74 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCC----cEEEEEEEecccccCCchhHHHHHHHHhhC------CCcceeeEEEEEec
Confidence 46999999999999999999987766 7899999865322 224456899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..++||||||+.++|.+++..... .+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~ 151 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE-RGELKLADFGLAR 151 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC-CCCEEECcccccc
Confidence 999999999998899998876432 5899999999999999999999999999999999999985 7789999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~-~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
..... ......++..|+|||++.+ ..++.++||||||||||+|++|.+||.+.. ..+.+..+....+.++..++..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07844 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231 (291)
T ss_pred ccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhh
Confidence 54322 1222346778999999876 458999999999999999999999998765 4566666777666655554432
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
......+......+. .+..+... .+.. .....+.+||.+||.++|..|||+.++|.
T Consensus 232 ~~~~~~~~~~~~~~~-------------------~~~~~~~~---~~~~--~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 232 VSSNPEFKPYSFPFY-------------------PPRPLINH---APRL--DRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhcccccccccccc-------------------CChhHHHh---CcCC--CCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 221111111111100 00000000 0000 11257789999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 288 ~~~f 291 (291)
T cd07844 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=343.67 Aligned_cols=282 Identities=31% Similarity=0.525 Sum_probs=217.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+...||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+. +|+||+++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTG----KLVALKKTRLEMDEEGIPPTALREISLLQMLS-----ESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCC----cEEEEEeehhhccccCCchHHHHHHHHHHHcc-----CCCCccceeeeEe
Confidence 35999999999999999999998777 7999999865422 2356678999999983 5689999999998
Q ss_pred ecCe-----EEEEEecchhhHHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 644 YRNH-----LCLVFESLHMNLREVLKKFGR--NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 644 ~~~~-----~~lV~E~~~gsL~~~L~~~~~--~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
.... +||||||+.++|.+++..... ...+++..++.++.||+.||.|||..||+|+||+|+|||++..++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred ecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEE
Confidence 7665 899999998899998876432 245899999999999999999999999999999999999996578999
Q ss_pred EEecCcceecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 717 LCDFGNAMFAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 717 L~DFG~a~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|+|||++...... ..+...+++.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+....+..++...+..
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 152 IADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred EeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998754332 22334567889999998764 57999999999999999999999999988887777777766655
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+...+........+.. + ....+..+ ....+.++..+.+||.+||..||.+||
T Consensus 232 ~~~~~~~~~~~~~~~~----~-----------------~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~R~ 283 (295)
T cd07837 232 TEQVWPGVSKLRDWHE----F-----------------PQWKPQDL-------SRAVPDLSPEGLDLLQKMLRYDPAKRI 283 (295)
T ss_pred ChhhCcchhhccchhh----c-----------------CcccchhH-------HHhccccCHHHHHHHHHHccCChhhcC
Confidence 4433211100000000 0 00000000 001123567889999999999999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||.||||.
T Consensus 284 ~~~eil~~~~~~ 295 (295)
T cd07837 284 SAKAALTHPYFD 295 (295)
T ss_pred CHHHHhcCCCcC
Confidence 999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.22 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=199.0
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
++||+|+||+||+|.+..++ ..||||++.+... ....+..|+.++..+. .|++|+.++++|...+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND----QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc-----CCCCEeeEEEEEEeCCEE
Confidence 36899999999999998877 7999999986422 2244567888887773 689999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..++.|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~ 147 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGL 147 (327)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC-CCCEEEeccccceecc
Confidence 9999999 679988887643 4999999999999999999999999999999999999985 7789999999986532
Q ss_pred --CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 --KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 --~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.......+||+.|+|||++.+..|+.++||||||||||+|++|..||..........
T Consensus 148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--------------------- 206 (327)
T cd05617 148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--------------------- 206 (327)
T ss_pred CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---------------------
Confidence 223445678999999999999999999999999999999999999995432110000
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC------HHHHH
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT------VAQAL 879 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT------a~elL 879 (887)
....+...+... ....+..++..+.+||.+||..||.+|++ +.+|+
T Consensus 207 -----------------~~~~~~~~~~~~-----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 258 (327)
T cd05617 207 -----------------TEDYLFQVILEK-----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258 (327)
T ss_pred -----------------cHHHHHHHHHhC-----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHH
Confidence 000000011000 00112335577899999999999999998 56999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||.+
T Consensus 259 ~h~~f~~ 265 (327)
T cd05617 259 SHTFFRS 265 (327)
T ss_pred cCCCCCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=338.86 Aligned_cols=280 Identities=28% Similarity=0.525 Sum_probs=213.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|+++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||+.++++|.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~ 70 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG----QIVAIKKFVESEDDPVIKKIALREIRMLKQL------KHPNLVNLIEVFR 70 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC----cEEEEEEEeecccCccccHHHHHHHHHHHhC------CCCCEeeeeeEEe
Confidence 36999999999999999999998776 789999886432 2235567899999999 8999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
....++|||||+.+.+...+... ...+++..++.++.||+.||.|||+.||+|+||+|.||||+. .+.++|+|||++
T Consensus 71 ~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~ 147 (286)
T cd07847 71 RKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK-QGQIKLCDFGFA 147 (286)
T ss_pred eCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC-CCcEEECccccc
Confidence 99999999999965444433322 224899999999999999999999999999999999999985 778999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
....... .....++..|+|||++.+ ..++.++||||||||+|+|++|.+||.+....+.+..+....+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 7654432 334567889999999876 4589999999999999999999999998888777777766665543322100
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
. ....++ ..+....... ... .....+.++..+.+||.+||..+|.+|||+.|||.
T Consensus 228 ~-~~~~~~-~~~~~~~~~~-------------------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 228 F-STNQFF-KGLSIPEPET-------------------REP----LESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred c-cccccc-ccccCCCccc-------------------ccC----HHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000000 0000000000 000 00011234678899999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 283 ~~~f 286 (286)
T cd07847 283 HPYF 286 (286)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.55 Aligned_cols=245 Identities=26% Similarity=0.350 Sum_probs=214.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..+.+++.||.|.||.||+|.+.... .||+|.++........+..|+.||++| .|++||+|+++|....
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~-----~vavk~ik~~~m~~~~f~~Ea~iMk~L------~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGST-----KVAVKTIKEGSMSPEAFLREAQIMKKL------RHEKLVKLYGVCTKQE 274 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCC-----cccceEEeccccChhHHHHHHHHHHhC------cccCeEEEEEEEecCC
Confidence 34778889999999999999987763 699999988766778899999999999 9999999999999988
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+||||||| .|+|.++|... ....+....++.|+.|||.|++||+++++|||||.+.||||+. +..|||+|||+|+.
T Consensus 275 piyIVtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE-DLVVKISDFGLARL 352 (468)
T ss_pred ceEEEEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc-CceEEEcccccccc
Confidence 999999999 79999999982 3345999999999999999999999999999999999999995 88999999999997
Q ss_pred cCCCCccCccc---CCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEITPYLV---SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~~~~g---t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...+.++...+ ...|.|||++....|+.++|||||||+||||+| |+.||+++++.+.+..+.....-
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--------- 423 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--------- 423 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC---------
Confidence 77666655444 456999999999999999999999999999999 99999999999998877543221
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
..++.++.++.+|+..||..+|++|||.+.++
T Consensus 424 ----------------------------------------------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 424 ----------------------------------------------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------------------------------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 12345668889999999999999999998654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=358.89 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=197.2
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||+|+||+||+|.+..++ ..||||++.+.... ......|..++..+. ...||+|+.++.+|...+++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~~p~i~~~~~~~~~~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL---LDESPFIVGLKFSFQTDSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCC----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc---cCCCCcCcceEEEEecCCeEEE
Confidence 799999999999998877 79999999653221 122334555655542 1269999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC--
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG-- 727 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~-- 727 (887)
||||+ +++|..++.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.++|+|||++....
T Consensus 74 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD 149 (330)
T ss_pred EEcCCCCChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence 99999 679988887643 4999999999999999999999999999999999999985 7789999999986532
Q ss_pred CCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 728 KNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 728 ~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
.......+||+.|+|||++.+. .++.++||||||||||+|++|..||.+.+..+.+..+......+|
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------ 217 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP------------ 217 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 2233456789999999999865 489999999999999999999999987666555444322111111
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc----CHHHHHhCC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM----TVAQALTHP 882 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp----Ta~elL~Hp 882 (887)
...++..+.+||.+||..||.+|| ++.+||.||
T Consensus 218 -------------------------------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 218 -------------------------------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred -------------------------------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 012346788999999999999998 799999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||.+
T Consensus 255 ~~~~ 258 (330)
T cd05586 255 FFAD 258 (330)
T ss_pred cccC
Confidence 9964
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=356.69 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=197.6
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHH-HHHhhCCCCCCCcceeEecceeeecCe
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQI-LKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~i-L~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
+.||.|+||+||+|.+..++ ..||||++.+... ....+..|..+ ++.+ .||||++++++|...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~hp~iv~~~~~~~~~~~ 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG----KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV------KHPFLVGLHYSFQTTEK 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC------CCCCCccEEEEEecCCE
Confidence 36899999999999998877 7999999975322 12233444443 4445 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++...
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~ 146 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS-QGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEEeecCCcccC
Confidence 99999999 678888876543 4999999999999999999999999999999999999985 778999999998643
Q ss_pred C--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 G--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
. .......+|++.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..+++..++....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~------------- 213 (325)
T cd05604 147 IAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL------------- 213 (325)
T ss_pred CCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 2 2234556789999999999999999999999999999999999999987665555443321100
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH----HHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----AQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa----~elL~ 880 (887)
...+.++..+.+||.+||..+|.+||++ .+||.
T Consensus 214 -------------------------------------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 214 -------------------------------------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred -------------------------------------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 0012344678899999999999999976 59999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 251 h~~f~~ 256 (325)
T cd05604 251 HPFFES 256 (325)
T ss_pred CCCcCC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=385.92 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=218.0
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
...|.|+++||.|+||.|.++..+.++ ++||+|++.+-. .....|..|-.||..- +.+=|++|+-.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~------ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTE----KVYAMKILNKWEMLKRAETACFREERDIMVFG------NSEWIVQLHYA 143 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccc----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcC------CcHHHHHHHHH
Confidence 357999999999999999999999988 899999998732 2235667777887766 67789999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
|++..++||||+|| ||+|..+|-+++. |++.++++|+..|+.||.-||++|+|||||||+||||+. .|+|||+||
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~---~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~-~GHikLADF 219 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDR---LPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK-SGHIKLADF 219 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCC---ChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc-cCcEeeccc
Confidence 99999999999999 8899999999874 999999999999999999999999999999999999995 899999999
Q ss_pred CcceecCCCC---ccCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCC
Q 002732 721 GNAMFAGKNE---ITPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 721 G~a~~~~~~~---~~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
|.+..+..+. ....+|||.|++||+|.. +.|+..+|||||||+|||||.|..||...+..+++..|+.....
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 9998777544 355789999999999963 46999999999999999999999999988888888877654211
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
| . +| ....+|.++.+||+++|. +|..|
T Consensus 300 l-------------------~--------------------------------FP-~~~~VSeeakdLI~~ll~-~~e~R 326 (1317)
T KOG0612|consen 300 L-------------------S--------------------------------FP-DETDVSEEAKDLIEALLC-DREVR 326 (1317)
T ss_pred c-------------------C--------------------------------CC-cccccCHHHHHHHHHHhc-Chhhh
Confidence 1 1 12 223477899999999865 88999
Q ss_pred cC---HHHHHhCCCCCC
Q 002732 873 MT---VAQALTHPFISG 886 (887)
Q Consensus 873 pT---a~elL~Hpwf~~ 886 (887)
+. +++|-.||||.|
T Consensus 327 Lgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 327 LGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred cccccHHHHHhCccccC
Confidence 98 999999999986
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=343.64 Aligned_cols=278 Identities=32% Similarity=0.528 Sum_probs=218.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh------hHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM------NKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~------~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+|.++..||.|+||.||+|.+..++ ..||||.+...... ...+..|+.++..+ .|+||++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~ 70 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG----RIVAIKKIKLGERKEAKDGINFTALREIKLLQEL------KHPNIIGLLDV 70 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC----cEEEEEEEeccccccccchhhHHHHHHHHHHhhc------CCCCChhhhhe
Confidence 4889999999999999999988776 79999999764322 34456788999888 89999999999
Q ss_pred eeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 642 FKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 642 ~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
|...+.+||||||++++|.++|.... ..+++..++.|+.||+.||.|||.+||+|+||+|+||||+. ++.++|+|||
T Consensus 71 ~~~~~~~~lv~e~~~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~-~~~~~l~dfg 147 (298)
T cd07841 71 FGHKSNINLVFEFMETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS-DGVLKLADFG 147 (298)
T ss_pred eecCCEEEEEEcccCCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC-CCCEEEccce
Confidence 99999999999999889999987643 24999999999999999999999999999999999999995 7889999999
Q ss_pred cceecCCC--CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 722 NAMFAGKN--EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 722 ~a~~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
++...... ......+++.|+|||++.+ ..++.++||||||||||+|++|.+||.+.+..+.+..+....+.++..++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 148 LARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred eeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 99776543 2333456788999999865 46799999999999999999999999888877777777666555544433
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
........+. .+. . ..+..+. ......+..+.+||.+||.++|.+|||+.+|
T Consensus 228 ~~~~~~~~~~----~~~---~--------------~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~ 279 (298)
T cd07841 228 PGVTSLPDYV----EFK---P--------------FPPTPLK-------QIFPAASDDALDLLQRLLTLNPNKRITARQA 279 (298)
T ss_pred hhcccccccc----ccc---c--------------cCCcchh-------hhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence 2111110000 000 0 0000000 0112345788999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
|.||||.+
T Consensus 280 l~~~~~~~ 287 (298)
T cd07841 280 LEHPYFSN 287 (298)
T ss_pred hhCccccC
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.69 Aligned_cols=282 Identities=31% Similarity=0.497 Sum_probs=222.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+...||.|+||+||+|.+..++ +.||||++.... .....+..|+.+++.| .|+||+++++++.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 71 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN----ETIALKKIRLEQEDEGVPSTAIREISLLKEM------QHGNIVRLQDVVH 71 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC----cEEEEEehhhccccccchHHHHHHHHHHHhc------cCCCEeeEEEEEe
Confidence 45999999999999999999988776 789999986532 2235677899999999 8999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...++|+||||+.++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++..++.+||+|||++
T Consensus 72 ~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 72 SEKRLYLVFEYLDLDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred cCCeEEEEEecccccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9999999999998888888765432 346889999999999999999999999999999999999865678999999999
Q ss_pred eecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... ..+...+++.|+|||++.+. .++.++||||||||+|+|++|.+||...+..+.+..++...+..+..+|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 765432 23344668899999998764 589999999999999999999999998888888887877777666555432
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
......+... .....+..+ ....+.++..+.+||.+||..+|.+||++.++|.
T Consensus 231 ~~~~~~~~~~--------------------~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 231 VTSLPDYKSA--------------------FPKWPPKDL-------ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccchhhhhh--------------------cccCCCCCH-------HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111000 000000000 0012345577899999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||.+
T Consensus 284 ~~~~~~ 289 (294)
T PLN00009 284 HEYFKD 289 (294)
T ss_pred CchHhH
Confidence 999974
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=354.74 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=197.4
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHH-HHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQ-ILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~-iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
+.||.|+||+||+|.+..++ ..||||++.+.... ...+..|.. ++..+ .|+||++++++|...+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~h~~Iv~~~~~~~~~~~ 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV------KHPFLVGLHFSFQTADK 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC------CCCCCCceeEEEEcCCe
Confidence 36899999999999998776 78999999754221 122233333 34445 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+||||||+ +++|..++.... .+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++...
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~ 146 (325)
T cd05602 71 LYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS-QGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEEccCCCCccc
Confidence 99999999 668988887643 4899999999999999999999999999999999999985 778999999998653
Q ss_pred C--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 G--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
. .......+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..+.+..+.....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------- 213 (325)
T cd05602 147 IEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL------------- 213 (325)
T ss_pred ccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc-------------
Confidence 2 2234456789999999999999999999999999999999999999987766555444322100
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH----HHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA----QALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~----elL~ 880 (887)
...+.++..+.+||.+||+.||.+||++. +|++
T Consensus 214 -------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 214 -------------------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred -------------------------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 01123457789999999999999999876 8999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
|+||..
T Consensus 251 ~~~~~~ 256 (325)
T cd05602 251 HIFFSP 256 (325)
T ss_pred CcccCC
Confidence 999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=369.20 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=208.0
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
..++|.+...||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ .|++|++++..
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~------~h~~iv~~~~~ 99 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDG----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNC------DFFSIVKCHED 99 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCC----CEEEEEEEecccCCHHHHHHHHHHHHHHhcC------CCCcEEEeecc
Confidence 3468999999999999999999998877 799999987532 2234566788888777 89999999887
Q ss_pred eeecC--------eEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC
Q 002732 642 FKYRN--------HLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 642 ~~~~~--------~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 711 (887)
|.... .++|||||+ +|+|.++|.... ....|++..+..|+.||+.||.|||+.||||+||||+||||+.
T Consensus 100 ~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~- 178 (496)
T PTZ00283 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS- 178 (496)
T ss_pred eecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC-
Confidence 75432 478999999 679999987533 2345999999999999999999999999999999999999985
Q ss_pred CCeEEEEecCcceecCCC----CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 002732 712 KNVLKLCDFGNAMFAGKN----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787 (887)
Q Consensus 712 ~~~vKL~DFG~a~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~ 787 (887)
++.+||+|||++..+... .....+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..++
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 788999999998765422 2345678999999999999999999999999999999999999998766555444332
Q ss_pred HhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhccc
Q 002732 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL 867 (887)
Q Consensus 788 ~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~ 867 (887)
... + ...++.++..+.+||.+||..
T Consensus 259 ~~~--~-----------------------------------------------------~~~~~~~~~~l~~li~~~L~~ 283 (496)
T PTZ00283 259 AGR--Y-----------------------------------------------------DPLPPSISPEMQEIVTALLSS 283 (496)
T ss_pred cCC--C-----------------------------------------------------CCCCCCCCHHHHHHHHHHccc
Confidence 110 0 001233457889999999999
Q ss_pred CCCCCcCHHHHHhCCCCC
Q 002732 868 DPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 868 DP~~RpTa~elL~Hpwf~ 885 (887)
||.+|||+.+||.|||+.
T Consensus 284 dP~~RPs~~ell~~p~~~ 301 (496)
T PTZ00283 284 DPKRRPSSSKLLNMPICK 301 (496)
T ss_pred ChhhCcCHHHHHhCHHHH
Confidence 999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.80 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=205.9
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
++||.|+|+.|--|....++ ..||||||.+.+. ....+..|++++.+.. .|+||++|+++|++...+|||
T Consensus 84 e~LGeGAyasVqtcv~i~t~----~EYAVKiidKq~gHsR~RvfREVe~f~~Cq-----gh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTG----KEYAVKIIDKQPGHSRSRVFREVETFYQCQ-----GHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeeccc----hhhhhhhhhcCCchHHHHHHHHHHHHHHhc-----CCccHHHHHHHhcccceEEEE
Confidence 36899999999999999988 8999999987543 3567789999999985 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC--eEEEEecCcceec--
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN--VLKLCDFGNAMFA-- 726 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--~vKL~DFG~a~~~-- 726 (887)
||-| +|.|...|++.. .|++.++..++++|+.||.|||.+||.||||||+|||....+. -||||||.++.-+
T Consensus 155 fEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 9999 778888887644 4999999999999999999999999999999999999975444 3899999987322
Q ss_pred -------CCCCccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 727 -------GKNEITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 727 -------~~~~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
..+.+.+.+|+..|||||++. ...|+...|+||||||||.||+|.+||.|....+-
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------------ 299 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------------ 299 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC------------
Confidence 122345567888899999874 23589999999999999999999999987543210
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
-|---+.... +-..++..+.- -...+....|..++.+.++||..+|..||.+|++
T Consensus 300 ------------------GWdrGe~Cr~---CQ~~LFesIQE----GkYeFPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 300 ------------------GWDRGEVCRV---CQNKLFESIQE----GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred ------------------CccCCCccHH---HHHHHHHHHhc----cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 0000000001 11111111100 0011123346778899999999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
|.++|+|||++.
T Consensus 355 a~~vlnhPw~~~ 366 (463)
T KOG0607|consen 355 AAQVLNHPWVQR 366 (463)
T ss_pred hhhccCCccccc
Confidence 999999999974
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=343.39 Aligned_cols=288 Identities=27% Similarity=0.483 Sum_probs=219.9
Q ss_pred cccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 559 ~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
+.+++.+. +|.++..||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..| .||||
T Consensus 5 ~~~~~~~~-~y~~~~~lg~g~~~~v~~~~~~~~~----~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i 73 (310)
T cd07865 5 FPFCDEVS-KYEKLAKIGQGTFGEVFKARHKKTK----QIVALKKVLMENEKEGFPITALREIKILQLL------KHENV 73 (310)
T ss_pred Ccccchhh-heEEEEEeecCCCEEEEEEEECCCC----cEEEEEEEeccCCcCCchhHHHHHHHHHHhC------CCCCc
Confidence 33444554 5999999999999999999988777 8999998864321 223456799999999 89999
Q ss_pred eEecceeeecC--------eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcc
Q 002732 636 IRFASSFKYRN--------HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML 707 (887)
Q Consensus 636 v~l~~~~~~~~--------~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NIL 707 (887)
++++++|.... .+||||||+.++|..++.... ..+++..++.++.||+.||.|||+.||+|+||+|+|||
T Consensus 74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999876643 469999999889988886532 34899999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEecCcceecCCCC------ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 002732 708 VNEAKNVLKLCDFGNAMFAGKNE------ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 708 l~~~~~~vKL~DFG~a~~~~~~~------~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~ 780 (887)
|+. .+.++|+|||++....... .....++..|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..
T Consensus 152 ~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 152 ITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred ECC-CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 985 7889999999996553321 2234567889999998775 4789999999999999999999999998888
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
..+..+..+.+.+|..++..... ...+.. +.+..... ..+.. . + .....+..+.+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~-----~~~~~---~-----l---------~~~~~~~~~~dl 286 (310)
T cd07865 231 HQLTLISQLCGSITPEVWPGVDK-LELFKK-MELPQGQK-----RKVKE---R-----L---------KPYVKDPHALDL 286 (310)
T ss_pred HHHHHHHHHhCCCChhhcccccc-hhhhhh-ccCCCccc-----hhhHH---h-----c---------ccccCCHHHHHH
Confidence 88888888888888776533211 011110 00000000 00000 0 0 000123567899
Q ss_pred HHHhcccCCCCCcCHHHHHhCCCC
Q 002732 861 LDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
|.+||..||.+|||+.+||+||||
T Consensus 287 i~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 287 IDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHHHhcCChhhccCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=340.98 Aligned_cols=278 Identities=31% Similarity=0.506 Sum_probs=217.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||.||+|.+..++ ..||||++..... ....+..|+.+|..| .|+||++++++|..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 70 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKEL------NHPNIVKLLDVIHT 70 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCC----CEEEEEEccccccccccchHHHHHHHHHHhc------CCCCCcchhhhccc
Confidence 3899999999999999999998777 7899998875322 224677899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.+.+|+||||+.++|..++.... ...+++..++.++.||+.||.|||..||+|+||+|+|||++. ++.++|+|||++.
T Consensus 71 ~~~~~~v~e~~~~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~-~~~~~l~dfg~~~ 148 (284)
T cd07860 71 ENKLYLVFEFLHQDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLAR 148 (284)
T ss_pred CCcEEEEeeccccCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEeeccchh
Confidence 99999999999888988887643 345899999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCC--CccCcccCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... ......+++.|+|||++.+.. ++.++|||||||+||+|++|..||.+.+....+..+....+..+..++...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07860 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228 (284)
T ss_pred hcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 65432 223345678899999987754 688999999999999999999999988877777777777766554432110
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.. +......+.......+ ....+.++..+.+||.+||..||.+|||+.+||.|
T Consensus 229 ~~-----------------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 229 TS-----------------------LPDYKPSFPKWARQDF----SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hH-----------------------HHHHHhhcccccccCH----HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 0000000000000000 00112355778999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 282 ~~f 284 (284)
T cd07860 282 PFF 284 (284)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=366.44 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=209.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
.|.+...||.|+||.||+|....+. ...||+|.+..... ....+..|+.+|..| .||||++++++|...+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~---~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~~~~~~~~~~ 138 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDP---KEKVVAKFVMLNDERQAAYARSELHCLAAC------DHFGIVKHFDDFKSDD 138 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCC---CeEEEEEEcccCCHHHHHHHHHHHHHHHhC------CCCCEeEEEEEEEECC
Confidence 3999999999999999999987662 26788897754332 234567799999998 9999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 647 HLCLVFESL-HMNLREVLKKF-GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~-~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
++||||||+ +++|.++|... .....|++..+..|+.||+.||.|||+.||||+||||+||||+. .+.+||+|||++.
T Consensus 139 ~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~~~kL~DFgla~ 217 (478)
T PTZ00267 139 KLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSK 217 (478)
T ss_pred EEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC-CCcEEEEeCcCce
Confidence 999999999 67999888653 23345899999999999999999999999999999999999995 7889999999997
Q ss_pred ecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... ....+||+.|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..++.....
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------- 289 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------- 289 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 654321 34467899999999999999999999999999999999999999876665554443221100
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..+..++..+.+||.+||..||..|||+.++|.
T Consensus 290 -----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----------------------------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----------------------------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 011234467899999999999999999999999
Q ss_pred CCCCC
Q 002732 881 HPFIS 885 (887)
Q Consensus 881 Hpwf~ 885 (887)
|||+.
T Consensus 323 ~~~~~ 327 (478)
T PTZ00267 323 TEFLK 327 (478)
T ss_pred CHHHH
Confidence 99974
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=341.19 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=207.5
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
|.+.+.||.|+||+||+|.+..++ +.||||++..... ....+..|+.+|..| .|++|+.++++|..
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l------~~~~i~~~~~~~~~ 71 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATG----KMYACKRLEKKRIKKRKGESMALNEKQILEKV------NSQFVVNLAYAYET 71 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCC----cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc------CCcCceeEEEEEec
Confidence 788899999999999999998877 7999999865432 123457799999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+|+||||+ +++|..++.... ...+++..+..++.||+.||.|||+.||||+||+|.|||++. .+.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~-~~~~kl~Dfg~~ 149 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD-YGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC-CCCEEEecCCcc
Confidence 99999999999 568888876543 235999999999999999999999999999999999999985 678999999998
Q ss_pred eecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 724 MFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 724 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... ......+++.|+|||++.+..++.++|||||||+||+|++|..||.+.........+.......+
T Consensus 150 ~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------- 221 (285)
T cd05632 150 VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------- 221 (285)
T ss_pred eecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--------
Confidence 665432 23456789999999999998999999999999999999999999976654433332221110000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHH
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQ 877 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~e 877 (887)
......++..+.+||..||+.||.+||| +.+
T Consensus 222 --------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~ 257 (285)
T cd05632 222 --------------------------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE 257 (285)
T ss_pred --------------------------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence 0011234567889999999999999999 899
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
+|.||||..
T Consensus 258 l~~~~~~~~ 266 (285)
T cd05632 258 VKRHPFFRN 266 (285)
T ss_pred HHcChhhhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.12 Aligned_cols=279 Identities=29% Similarity=0.519 Sum_probs=220.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+|.+++.||.|+||+||+|.+..++ ..||||++..... ....+..|+.++..| .|+||++++++|...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~ 70 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG----EIVALKEIHLDAEEGTPSTAIREISLMKEL------KHENIVRLHDVIHTE 70 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC----eEEEEEEecccccccchHHHHHHHHHHHhh------cCCCEeeeeeeEeeC
Confidence 4899999999999999999998777 7899999875432 235667899999999 899999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+.+||||||+.++|.+++........+++..+..++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++..
T Consensus 71 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~ 149 (284)
T cd07836 71 NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK-RGELKLADFGLARA 149 (284)
T ss_pred CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC-CCcEEEeecchhhh
Confidence 99999999998899999887654456999999999999999999999999999999999999984 77899999999865
Q ss_pred cCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 726 AGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 726 ~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
.... ......++..|+|||++.+. .++.++||||||||||+|++|.+||.+.+..+.+..++.....+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 4332 22344568889999998764 57899999999999999999999999888888888887776655444432221
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
.... +... ++.. ....+ ....+.++..+.+||.+||+.||.+|||+.+||+||
T Consensus 230 ~~~~-~~~~--~~~~-----~~~~~-------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 282 (284)
T cd07836 230 QLPE-YKPT--FPRY-----PPQDL-------------------QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHP 282 (284)
T ss_pred cCch-hccc--ccCC-----ChHHH-------------------HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCC
Confidence 1100 0000 0000 00000 001123457789999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 283 ~f 284 (284)
T cd07836 283 WF 284 (284)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=340.10 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=198.2
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||+||+|.+..++ ..||+|++..... ....+..|+.+|..| +||||++++++|....++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~i~~~~~~~~~~~~~~l 70 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG----KMYACKKLDKKRLKKKSGEKMALLEKEILEKV------NSPFIVNLAYAFESKTHLCL 70 (277)
T ss_pred CCCCCceEEEEEEEccCC----cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc------CCCcEEEEEEEEecCCeEEE
Confidence 799999999999998877 7999999864322 223445689999998 89999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|..++.... ...+++..+..++.||+.||.|||+.||+|+||||+||||+. .+.++|+|||++......
T Consensus 71 v~e~~~g~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 71 VMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EEecCCCCCHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCC
Confidence 99999 678988876543 234899999999999999999999999999999999999985 778999999998765543
Q ss_pred C-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccc
Q 002732 730 E-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808 (887)
Q Consensus 730 ~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f 808 (887)
. .....++..|+|||++.+..++.++|||||||+||+|++|..||...........+..
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~-------------------- 208 (277)
T cd05607 149 KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR-------------------- 208 (277)
T ss_pred ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH--------------------
Confidence 2 3345688999999999999999999999999999999999999965432211111100
Q ss_pred ccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH----HHHHhCCCC
Q 002732 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----AQALTHPFI 884 (887)
Q Consensus 809 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa----~elL~Hpwf 884 (887)
..+... .......++.++.+||.+||+.||.+|||+ +++|.||||
T Consensus 209 --------------------~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 209 --------------------RTLEDE-----------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred --------------------Hhhccc-----------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 000000 000012345788999999999999999999 778899999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 258 ~~ 259 (277)
T cd05607 258 KT 259 (277)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.78 Aligned_cols=244 Identities=24% Similarity=0.329 Sum_probs=195.9
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHH-HHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQ-ILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~-iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
++||.|+||+||+|.+..++ ..||||++.+.... ...+..|+. ++..+ .|+||++++++|...+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~------~h~~iv~~~~~~~~~~~ 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG----SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL------KHPFLVGLHYSFQTAEK 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC----CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC------CCCCccceeeEEEcCCE
Confidence 36899999999999998777 89999999753221 223334443 45555 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+||||||+ +++|...+... ..+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++...
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS-QGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEccCCCCccC
Confidence 99999999 56888877653 34899999999999999999999999999999999999985 788999999998653
Q ss_pred C--CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 G--KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~--~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
. .......++++.|+|||++.+..++.++||||||||||+|++|.+||.+.+....+..+.....
T Consensus 147 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------- 213 (321)
T cd05603 147 VEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL------------- 213 (321)
T ss_pred CCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC-------------
Confidence 2 2223456789999999999999999999999999999999999999987655444433321100
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH----HHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV----AQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa----~elL~ 880 (887)
..++..+..+.+||.+||+.||.+||++ .++++
T Consensus 214 -------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 214 -------------------------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred -------------------------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 0112334678899999999999999875 59999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||..
T Consensus 251 ~~~~~~ 256 (321)
T cd05603 251 HVFFSP 256 (321)
T ss_pred CCCcCC
Confidence 999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.81 Aligned_cols=276 Identities=33% Similarity=0.551 Sum_probs=216.6
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec-
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR- 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~- 645 (887)
|.++..||.|+||.||+|.+..++ ..||||++.... ........|+.++..+. .|+||++++++|...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~----~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG----KYYAIKCMKKHFKSLEQVNNLREIQALRRLS-----PHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC----cEEEEEEehhccCCchhhhHHHHHHHHhhcC-----CCCCccceEEEEecCC
Confidence 678999999999999999988776 789999987532 22223346777777772 599999999999987
Q ss_pred -CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 -NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 -~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.++|||||+.++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|.|||++. +.++|+|||++.
T Consensus 72 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~ 147 (282)
T cd07831 72 TGRLALVFELMDMNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCR 147 (282)
T ss_pred CCcEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEeccccc
Confidence 8999999999889988887532 34899999999999999999999999999999999999995 889999999997
Q ss_pred ecCCC-CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKN-EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~-~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
..... ......++..|+|||++.. ..++.++|||||||+||+|++|.+||.+.+..+.+..+....+..+..+.....
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 65432 3344567889999998754 457899999999999999999999999988888888888888887776632111
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
... ...+.+. ...+ ..+ ....+.++..+.+||.+||..+|.+|||+.+||.||
T Consensus 228 ~~~---~~~~~~~--~~~~---------------~~~-------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~ 280 (282)
T cd07831 228 KSR---HMNYNFP--SKKG---------------TGL-------RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280 (282)
T ss_pred ccc---cccccCc--cccc---------------ccH-------HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCC
Confidence 000 0000000 0000 000 001124568899999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 281 ~~ 282 (282)
T cd07831 281 YF 282 (282)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.72 Aligned_cols=281 Identities=25% Similarity=0.408 Sum_probs=213.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+++.||.|+||.||+|.+..++ ..||||++...... ...+..|+.+|..| .|+||+++++++..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~ 74 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRING----QLVALKVISMKTEEGVPFTAIREASLLKGL------KHANIVLLHDIIHT 74 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCC----cEEEEEEecccCcCCCcHHHHHHHHHHHhc------CCCCEeEEEEEEec
Confidence 46999999999999999999988777 78999998754322 23567899999999 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+|+||||+.++|.+++.... ..+++..+..++.||+.||.|||..||+|+||||+|||++. .+.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~ 151 (291)
T cd07870 75 KETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY-LGELKLADFGLAR 151 (291)
T ss_pred CCeEEEEEecccCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC-CCcEEEecccccc
Confidence 99999999999888888776532 34788999999999999999999999999999999999985 7789999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATN-NDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~-~~~l~~i~~~~g~~p~~~l~~ 800 (887)
..... ......+++.|+|||++.+. .++.++|||||||+||+|++|..||.+... .+.+..++...+.++..++..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 152 AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred ccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 54332 12334568889999998764 588999999999999999999999976543 456666666666655544322
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
......+....+.. ..+..+..+.... ..+..+.+||.+||..||.+|||+.++|.
T Consensus 232 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~-----~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLP-------------------CKPQQLRVVWKRL-----SRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccc-------------------cCCcchhhhcccc-----CCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 21111111100000 0000000000000 11367889999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 288 h~~~ 291 (291)
T cd07870 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.57 Aligned_cols=281 Identities=33% Similarity=0.610 Sum_probs=222.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.++..||.|+||.||+|.+..++ +.||||++... ......+..|+.+|+.| .|+||++++++|.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~ 70 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG----EIVAIKKFKESEDDEDVKKTALREVKVLRQL------RHENIVNLKEAFR 70 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC----cEEEEehhhhhcccccchhHHHHHHHHHHhc------CCCCeeehhheEE
Confidence 36999999999999999999988776 79999988753 23346778999999999 7999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..+.+||||||+.+++...+... ...+++..++.++.||+.||.|||..||+|+||+|+||+++. ++.++|+|||++
T Consensus 71 ~~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~ 147 (288)
T cd07833 71 RKGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE-SGVLKLCDFGFA 147 (288)
T ss_pred ECCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCEEEEeeecc
Confidence 99999999999977666555442 234899999999999999999999999999999999999995 788999999998
Q ss_pred eecCCC---CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 724 MFAGKN---EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 724 ~~~~~~---~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
...... ....+.++..|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..+.+..+....+.++..+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 765543 23446678899999999988 88999999999999999999999999888888888888888887776543
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
....... +.. ..+... .....+. ...+..++..+.+||.+||..+|.+|||+.+||
T Consensus 228 ~~~~~~~-~~~-~~~~~~----~~~~~~~------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 228 LFSSNPR-FAG-VAFPEP----SQPESLE------------------RRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred hcccCcc-ccc-cccCCC----CCcHHHH------------------HhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 2211110 000 000000 0000000 001123467899999999999999999999999
Q ss_pred hCCCC
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~Hpwf 884 (887)
.||||
T Consensus 284 ~~~~f 288 (288)
T cd07833 284 QHPYF 288 (288)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=342.18 Aligned_cols=285 Identities=24% Similarity=0.380 Sum_probs=212.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.+++.||.|+||.||+|.+..++ ..||+|++... ......+..|+.+|..| .||||++++++|...
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 71 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSG----LIMARKLIHLEIKPAIRNQIIRELKVLHEC------NSPYIVGFYGAFYSD 71 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCC----eEEEEEEeccccCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEeeC
Confidence 5999999999999999999988877 78999998753 22335577899999999 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+++||||||+ +++|.+++.... .+++..+..++.||+.||.|||+ ++|+|+||+|.|||++. ++.++|+|||++
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~ 147 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS 147 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCc
Confidence 9999999999 579999998753 48999999999999999999997 69999999999999985 778999999998
Q ss_pred eecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
...........+++..|+|||++.+..++.++||||||||||+|++|..||...+.......+ ...+.........
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~ 223 (308)
T cd06615 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF----GRPVSEGEAKESH 223 (308)
T ss_pred ccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh----cCccccccccCCc
Confidence 765544445567889999999999888999999999999999999999999766533322211 1111111000000
Q ss_pred cccccccccccc-cCcCChhhHHH-HHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 804 TDQHFDQDLNFH-ATEEDPVTKKA-IKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 804 ~~~~f~~~l~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
...... ........... ...++....+ . . ....++.++.+||.+||..+|.+|||+.+||+|
T Consensus 224 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 ------RPVSGHPPDSPRPMAIFELLDYIVNEPPP-K-------L--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ------ccccCCCCCccchhhHHHHHHHHhcCCCc-c-------C--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000000011 1111111100 0 0 111256789999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 288 ~~~~~ 292 (308)
T cd06615 288 PFIKR 292 (308)
T ss_pred hhhhh
Confidence 99964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.96 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=209.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+++.||.|+||.||+|.+..++ +.||||++.... .....+..|+.+|+.| .|+||+.+++++.
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 71 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSG----KYYALKILSKAKIVKLKQVEHVLNEKRILQSI------RHPFLVNLYGSFQ 71 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCC----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC------CCCCccceeeEEE
Confidence 5999999999999999999998776 799999987532 2235567899999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.+++.... .|++..+..++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~-~~~~kl~dfg~ 147 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS-DGYIKITDFGF 147 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC-CCCEEEeeCCC
Confidence 999999999999 789999988753 4999999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
+...... ....++++.|+|||++.+..++.++||||||||||+|++|..||...........+......+
T Consensus 148 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 217 (290)
T cd05580 148 AKRVKGR-TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF--------- 217 (290)
T ss_pred ccccCCC-CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC---------
Confidence 9776544 344578889999999998889999999999999999999999997766444443332111111
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHH
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQ 877 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~e 877 (887)
+..++..+.+||.+||..||.+|+ ++.+
T Consensus 218 -----------------------------------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~ 250 (290)
T cd05580 218 -----------------------------------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVND 250 (290)
T ss_pred -----------------------------------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHH
Confidence 112346788999999999999999 9999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||+||||..
T Consensus 251 l~~~~~~~~ 259 (290)
T cd05580 251 IKNHPWFAG 259 (290)
T ss_pred HHcCccccc
Confidence 999999963
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=341.60 Aligned_cols=288 Identities=27% Similarity=0.457 Sum_probs=213.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcC--CCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLK--AGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~--~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+|.++.+||.|+||.||+|.+.. .+ ..||||++.... .....+..|+.++..| +||||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~----~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 70 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDG----KEYAIKKFKGDKEQYTGISQSACREIALLREL------KHENVVSLVEV 70 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCC----CeEEEEEeccccccccCccHHHHHHHHHHHhc------CCCCccceEEE
Confidence 48999999999999999999877 44 799999998632 2235667899999999 89999999999
Q ss_pred eeec--CeEEEEEecchhhHHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC---CCCe
Q 002732 642 FKYR--NHLCLVFESLHMNLREVLKKFGRN--IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE---AKNV 714 (887)
Q Consensus 642 ~~~~--~~~~lV~E~~~gsL~~~L~~~~~~--~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~~ 714 (887)
|... ..+||||||++++|.+++...... ..+++..++.|+.||+.||.|||+.+|+|+||+|+||||+. ..+.
T Consensus 71 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 71 FLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred EeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce
Confidence 9988 889999999988888887654322 35899999999999999999999999999999999999984 2678
Q ss_pred EEEEecCcceecCCCC-----ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChH--------
Q 002732 715 LKLCDFGNAMFAGKNE-----ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNN-------- 780 (887)
Q Consensus 715 vKL~DFG~a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~-------- 780 (887)
+||+|||++....... ....+++..|+|||++.+. .++.++|||||||+||+|++|.+||.+....
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 9999999987654322 2234678889999998774 5899999999999999999999999765432
Q ss_pred -HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHH
Q 002732 781 -DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 781 -~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 859 (887)
..+..++..++..+...+........+... . ... .........+... .......+..+.+
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~----------------~-~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~ 291 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTL----------------M-KDF-KTKTYPSNSLAKW-MEKHKKPDSQGFD 291 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhh----------------h-hhc-cCCCCCCccHHHH-HHhccCCCHHHHH
Confidence 345555666655544433211100000000 0 000 0000000000000 0001134568899
Q ss_pred HHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 860 LLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
||.+||.+||.+|||+.|||.||||
T Consensus 292 ~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 292 LLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHhcCCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=349.31 Aligned_cols=280 Identities=30% Similarity=0.488 Sum_probs=220.0
Q ss_pred ecCcEEE-EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh---------------HHHHHHHHHHHHhhCCC
Q 002732 565 LDGRYEV-TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN---------------KAGQTEVQILKKLAGAD 628 (887)
Q Consensus 565 l~~~Y~i-~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~---------------~~~~~Ei~iL~~L~~~~ 628 (887)
+.++|.. ...||.|+||+||+|.+..++ ..||||++....... ..+..|+.+|..|
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---- 77 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTG----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI---- 77 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCC----CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC----
Confidence 4466765 467999999999999988776 799999987543221 2467899999999
Q ss_pred CCCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccc
Q 002732 629 PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708 (887)
Q Consensus 629 ~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl 708 (887)
.|+||+.++++|...+++||||||+.++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||||
T Consensus 78 --~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 78 --KHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred --CCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 8999999999999999999999999999999987633 48999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEecCcceecCC----------------CCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCC
Q 002732 709 NEAKNVLKLCDFGNAMFAGK----------------NEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGK 771 (887)
Q Consensus 709 ~~~~~~vKL~DFG~a~~~~~----------------~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~ 771 (887)
+. .+.++|+|||++..... .......+++.|+|||++.+. .++.++|||||||+||+|++|.
T Consensus 153 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 153 NS-KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred CC-CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 84 77899999999876541 112234567789999999865 4799999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCCh
Q 002732 772 VLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851 (887)
Q Consensus 772 ~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (887)
+||.+.+..+.+..++..++.++..+|........+.. +... .+..+. ...+
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~-----------------~~~~~~-------~~~~ 283 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE----FTPR-----------------KPKDLK-------TIFP 283 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc----cCcC-----------------CcccHH-------HhCc
Confidence 99999988888888888887766554322111110000 0000 000000 0112
Q ss_pred hhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 852 ~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
.++..+.+||.+||..+|.+|||+.++|.||||.+
T Consensus 284 ~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 284 NASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred CCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 34577899999999999999999999999999975
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.79 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=207.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+|++++.||.|+||+||+|.+..++ ..||||.+... ......+..|+.+|..+ .|+||++++++|...
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~ 71 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTG----VTMAMKEIRLELDESKFNQIIMELDILHKA------VSPYIVDFYGAFFIE 71 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCC----cEEEEEEeecccCHHHHHHHHHHHHHHHhc------CCCcHHhhhhheecC
Confidence 5899999999999999999988776 78999988653 23345678899999998 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+.+||||||+ +++|..++........+++..+..++.||+.||.|||. +||+|+||+|+|||++. .+.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~ 150 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVS 150 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCc
Confidence 9999999999 56888888764323359999999999999999999996 69999999999999995 788999999999
Q ss_pred eecCCCCccCcccCCcccchhhhcCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILGL------PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~~------~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
............+++.|+|||++.+. .++.++|||||||+||+|++|..||........+..+.......
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---- 226 (286)
T cd06622 151 GNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---- 226 (286)
T ss_pred ccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC----
Confidence 76655445556778899999998654 35889999999999999999999997544333222221111000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
.+..++.++..+.+||.+||+.+|.+||++.+
T Consensus 227 ------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 227 ------------------------------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred ------------------------------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 01112335678899999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
+|.||||..
T Consensus 259 l~~~~~~~~ 267 (286)
T cd06622 259 LLEHPWLVK 267 (286)
T ss_pred HhcChhhhh
Confidence 999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=339.61 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=202.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.++++||.|+||.||+|.+..++ ..||||++... ......+..|+.+|.+| .|+||++++++|...
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 71 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTR----RILAVKVIPLDITVELQKQIMSELEILYKC------DSPYIIGFYGAFFVE 71 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCC----cEEEEEEEecCCChHHHHHHHHHHHHHHhC------CCCCeeeEEEEEEEC
Confidence 4889999999999999999998777 78999998754 22345677899999998 899999999999999
Q ss_pred CeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.++|||||+. ++|..+. .+++..+..++.||+.||.|||+.||+|+||+|.|||++. ++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~ 143 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT-RGQVKLCDFGVST 143 (279)
T ss_pred CEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC-CCCEEEeeCCcce
Confidence 99999999994 4554331 2789999999999999999999999999999999999995 7889999999997
Q ss_pred ecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 725 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
..........+++..|+|||++.+..++.++|||||||++|+|++|..||.......... .+..
T Consensus 144 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~--------~~~~-------- 207 (279)
T cd06619 144 QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--------MPLQ-------- 207 (279)
T ss_pred ecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc--------chHH--------
Confidence 766555566788999999999999899999999999999999999999996422110000 0000
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
.+. .+....+..+ ....++..+.+||.+||..+|.+||++.+||.||||
T Consensus 208 ---------------------~~~-~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 208 ---------------------LLQ-CIVDEDPPVL---------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred ---------------------HHH-HHhccCCCCC---------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 000 0000000000 112345788999999999999999999999999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
..
T Consensus 257 ~~ 258 (279)
T cd06619 257 VQ 258 (279)
T ss_pred cc
Confidence 74
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=337.08 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=204.0
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.+.|.+...||.|+||.||+|.+..++ ..||||++.........+..|+.++..+. .|+||++++++|...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~aik~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~ 75 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKK 75 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCC----cEEEEEEEEcCCccHHHHHHHHHHHHHhc-----CCCCeeeEeeEEeec
Confidence 466899999999999999999988777 89999999766555567788999998873 689999999998753
Q ss_pred ------CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 646 ------NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 646 ------~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
..+||||||+ +++|.+++.... ...+++..+..++.||+.||.|||+++|+|+||+|.||||+. .+.++|+
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~-~~~~~l~ 153 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE-NAEVKLV 153 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC-CCCEEEc
Confidence 4689999999 569999887632 235899999999999999999999999999999999999995 7789999
Q ss_pred ecCcceecCCC--CccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 719 DFGNAMFAGKN--EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 719 DFG~a~~~~~~--~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||++...... ......+++.|+|||++. +..|+.++|||||||+||+|++|..||...........+...
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-- 231 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-- 231 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--
Confidence 99998765322 234467888999999986 346889999999999999999999999654332221111000
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.. .......++..+.+||.+||..+|.+
T Consensus 232 -------------------------------------------~~---------~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (272)
T cd06637 232 -------------------------------------------PA---------PRLKSKKWSKKFQSFIESCLVKNHSQ 259 (272)
T ss_pred -------------------------------------------CC---------CCCCCCCcCHHHHHHHHHHcCCChhh
Confidence 00 00011234567899999999999999
Q ss_pred CcCHHHHHhCCCC
Q 002732 872 RMTVAQALTHPFI 884 (887)
Q Consensus 872 RpTa~elL~Hpwf 884 (887)
|||+.+||.||||
T Consensus 260 Rpt~~~il~~~~~ 272 (272)
T cd06637 260 RPTTEQLMKHPFI 272 (272)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.74 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=204.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch------hhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET------MNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+.|.+.+.||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..| .|+||+++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~ 71 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNL------QHERIVQYYG 71 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC------CCCCeeeeEE
Confidence 35899999999999999999987776 7899999864321 124567788999988 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
++.....+|+||||+ +++|.+++.... .+++..+..|+.||+.||.|||..||+|+||+|.|||++. ++.++|+|
T Consensus 72 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~-~~~~~l~d 147 (263)
T cd06625 72 CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS-AGNVKLGD 147 (263)
T ss_pred EEccCCeEEEEEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEee
Confidence 999999999999999 679999887654 3899999999999999999999999999999999999984 78899999
Q ss_pred cCcceecCCCC-----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 720 FGNAMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 720 FG~a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
||++....... .....++..|+|||++.+..++.++||||||||||+|++|..||........+..+.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--- 224 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--- 224 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC---
Confidence 99986543321 1335677889999999999999999999999999999999999965443322221110000
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
.+..+..++..+.+||.+||..+|.+|||
T Consensus 225 ---------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 253 (263)
T cd06625 225 ---------------------------------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPS 253 (263)
T ss_pred ---------------------------------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCC
Confidence 00112234567899999999999999999
Q ss_pred HHHHHhCCCC
Q 002732 875 VAQALTHPFI 884 (887)
Q Consensus 875 a~elL~Hpwf 884 (887)
+.+||+||||
T Consensus 254 ~~~ll~~~~~ 263 (263)
T cd06625 254 AEELLRHFFV 263 (263)
T ss_pred HHHHhhCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=350.31 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=205.3
Q ss_pred ccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCccee
Q 002732 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCI 636 (887)
Q Consensus 560 ~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv 636 (887)
...+|..+.+.+...||.|.||+||+|.+..+ ||||++... +...++|++|+.+|++. .|.||+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT------RH~NIl 451 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-------VAVKLLNVDDPTPEQLQAFKNEVAVLKKT------RHENIL 451 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc-------eEEEEEecCCCCHHHHHHHHHHHHHHhhc------chhhhe
Confidence 34466667788999999999999999998753 999999853 44568899999999999 899999
Q ss_pred EecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 637 RFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 637 ~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
-|+|+|....+ .||+-||.| +|+.+|+-.. ..|.+..++.|++||++|+.|||.++|||+|||..||||.+ ++.|
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~-~~kV 527 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE-DLKV 527 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc-CCcE
Confidence 99999998876 999999955 8999987643 45999999999999999999999999999999999999985 6999
Q ss_pred EEEecCcce----ecCCCCccCcccCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 002732 716 KLCDFGNAM----FAGKNEITPYLVSRFYRAPEIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 716 KL~DFG~a~----~~~~~~~~~~~gt~~Y~aPE~l~~---~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~ 788 (887)
||+|||++. +.+...+....+.+.|||||++.. .+|++.+||||||||+|||++|..||...+.+.++-++
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-- 605 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-- 605 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe--
Confidence 999999984 455666677778899999999974 47999999999999999999999999843333222111
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
..|-+. .++ .......+.+++.||..||.++
T Consensus 606 GrG~l~---------------pd~----------------------------------s~~~s~~pk~mk~Ll~~C~~~~ 636 (678)
T KOG0193|consen 606 GRGYLM---------------PDL----------------------------------SKIRSNCPKAMKRLLSDCWKFD 636 (678)
T ss_pred cccccC---------------ccc----------------------------------hhhhccCHHHHHHHHHHHHhcC
Confidence 011000 000 0011234578999999999999
Q ss_pred CCCCcCHHHHHh
Q 002732 869 PEKRMTVAQALT 880 (887)
Q Consensus 869 P~~RpTa~elL~ 880 (887)
|+.||...+||.
T Consensus 637 ~~eRP~F~~il~ 648 (678)
T KOG0193|consen 637 REERPLFPQLLS 648 (678)
T ss_pred cccCccHHHHHH
Confidence 999999999886
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.39 Aligned_cols=283 Identities=32% Similarity=0.528 Sum_probs=221.6
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+..+|.++..||.|+||+||+|.+..++ ..||||.+... ......+..|+.+|..+ .|+||++++++
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~ni~~~~~~ 72 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETN----EKVAIKKIANAFDNRIDAKRTLREIKLLRHL------DHENVIAIKDI 72 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCC----CeEEEEEecccccccchhHHHHHHHHHHHhc------CCCCccchHHh
Confidence 3457999999999999999999998777 89999998642 22234566799999998 89999999998
Q ss_pred eeec-----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 642 FKYR-----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 642 ~~~~-----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
|... ..+||||||++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||+|+|||++. .+.++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~-~~~~k 148 (337)
T cd07858 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLK 148 (337)
T ss_pred eecccccccCcEEEEEeCCCCCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEE
Confidence 8754 3589999999999998887643 4999999999999999999999999999999999999985 77899
Q ss_pred EEecCcceecCCC--CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 717 LCDFGNAMFAGKN--EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 717 L~DFG~a~~~~~~--~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|+|||++...... ......++..|+|||++.+ ..++.++||||||||||+|++|.+||.+.+....+..+....+..
T Consensus 149 L~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (337)
T cd07858 149 ICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228 (337)
T ss_pred ECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999999765432 2344567889999999875 468999999999999999999999999988888888888888877
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+...+... . .+.. ..++......... ......+.++..+.+||.+||+.+|.+||
T Consensus 229 ~~~~~~~~--~---------------~~~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 283 (337)
T cd07858 229 SEEDLGFI--R---------------NEKA----RRYIRSLPYTPRQ----SFARLFPHANPLAIDLLEKMLVFDPSKRI 283 (337)
T ss_pred ChHHhhhc--C---------------chhh----hHHHHhcCccccc----CHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence 66543100 0 0000 0011000000000 00111234567899999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
|+.+||+||||..
T Consensus 284 s~~ell~h~~~~~ 296 (337)
T cd07858 284 TVEEALAHPYLAS 296 (337)
T ss_pred CHHHHHcCcchhh
Confidence 9999999999963
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=349.50 Aligned_cols=282 Identities=31% Similarity=0.534 Sum_probs=222.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..+|.+...||.|+||.||+|.+..++ ..||||++.... .....+..|+.+|..| .|+||++++++|
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~ 73 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSG----KKVAIKKIPHAFDVPTLAKRTLRELKILRHF------KHDNIIAIRDIL 73 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCC----CEEEEEEeccccccccchHHHHHHHHHHHhc------CCCCccCHHHhc
Confidence 367999999999999999999998877 799999987532 2335567899999999 899999999988
Q ss_pred ee----cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 643 KY----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 643 ~~----~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
.. ...+||||||+.++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~ 149 (334)
T cd07855 74 RPPGADFKDVYVVMDLMESDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE-DCELRIG 149 (334)
T ss_pred cccCCCCceEEEEEehhhhhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEec
Confidence 64 35789999999889988886533 3999999999999999999999999999999999999995 7889999
Q ss_pred ecCcceecCCCC------ccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 719 DFGNAMFAGKNE------ITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 719 DFG~a~~~~~~~------~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||++....... ....+++..|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+...++..+....+
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g 229 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence 999986543221 134577889999999876 4589999999999999999999999999988888888888888
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.+|..++.... ...+...+..+..... + ......+.++..+.+||.+||+.+|.+
T Consensus 230 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~li~~~l~~~P~~ 284 (334)
T cd07855 230 SPSEEVLNRIG---------------------SDRVRKYIQNLPRKQP--V--PWSKIFPKASPEALDLLSQMLQFDPEE 284 (334)
T ss_pred CChhHhhhhhc---------------------hhhHHHHHhhcccCCC--C--CHHHHcccCCHHHHHHHHHHccCChhh
Confidence 88777643211 0001111111000000 0 000011335688999999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 002732 872 RMTVAQALTHPFISG 886 (887)
Q Consensus 872 RpTa~elL~Hpwf~~ 886 (887)
|||+.+||.||||.+
T Consensus 285 Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 285 RITVEQALQHPFLAQ 299 (334)
T ss_pred CcCHHHHHhChhhhh
Confidence 999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.70 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=212.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.-+..||.|+||.||.|.+..+. +.||||.+.-+ ...-..+..|+.+|.+| .|||+|.+-++|.
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l------~HPntieYkgCyL 96 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL------RHPNTIEYKGCYL 96 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCcc----ceeeeeeccccccccHHHHHHHHHHHHHHHhc------cCCCcccccceee
Confidence 3777889999999999999998887 89999998643 22346778999999999 9999999999999
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
-....|||||||-|+-.++|.-.. .+|-+..+..|+.+.|.||.|||+++.||+|||..||||+. .+.|||+|||.|
T Consensus 97 re~TaWLVMEYClGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse-~g~VKLaDFGSA 173 (948)
T KOG0577|consen 97 REHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE-PGLVKLADFGSA 173 (948)
T ss_pred ccchHHHHHHHHhccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC-CCeeeeccccch
Confidence 999999999999887777776643 35999999999999999999999999999999999999995 899999999999
Q ss_pred eecCCCCccCcccCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
.+..+ ..+++|||+|||||||+. +.|+-++|||||||+.+||.-.++|+.+++..-.+.-|...
T Consensus 174 si~~P--AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN----------- 240 (948)
T KOG0577|consen 174 SIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN----------- 240 (948)
T ss_pred hhcCc--hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-----------
Confidence 77654 367899999999999974 47999999999999999999999999776655444433221
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
-.| .+. .+.++..|.+||..||+.-|..|||.++||.
T Consensus 241 ---------------------------------esP-tLq---------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ---------------------------------ESP-TLQ---------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---------------------------------CCC-CCC---------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 110 2456789999999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
|+|+..
T Consensus 278 H~fv~R 283 (948)
T KOG0577|consen 278 HRFVLR 283 (948)
T ss_pred cchhcc
Confidence 999863
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.66 Aligned_cols=282 Identities=31% Similarity=0.499 Sum_probs=216.4
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.++|.++++||+|+||+||+|.+..++ ..||||++... ......+..|+.+|..| .|+||+++++++
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~ 72 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTG----VKVAIKKISPFEHQTFCQRTLREIKILRRF------KHENIIGILDII 72 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCC----CeEEEEEecccccchhHHHHHHHHHHHHhC------CCCCcCchhhee
Confidence 3467999999999999999999998877 78999998642 22345567899999999 799999999876
Q ss_pred eec-----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 643 KYR-----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 643 ~~~-----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
... .++|+|+||+.++|..++.. ..|++..++.++.||+.||.|||+.||||+||||+||||+. .+.++|
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~-~~~~kl 147 (336)
T cd07849 73 RPPSFESFNDVYIVQELMETDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-NCDLKI 147 (336)
T ss_pred ecccccccceEEEEehhcccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC-CCCEEE
Confidence 653 46899999998888888754 24999999999999999999999999999999999999985 788999
Q ss_pred EecCcceecCCCC-----ccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 718 CDFGNAMFAGKNE-----ITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 718 ~DFG~a~~~~~~~-----~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
+|||++....... ....+++..|+|||++.+ ..++.++||||||||||+|++|.+||.+.....++..+...++
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~ 227 (336)
T cd07849 148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG 227 (336)
T ss_pred CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999987644321 233567889999999765 4689999999999999999999999998888788887777777
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
..+...+..... .....++..+....... .....+.++..+.+||.+||+.+|.+
T Consensus 228 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~ 282 (336)
T cd07849 228 TPSQEDLNCIIS---------------------LRARNYIKSLPFKPKVP----WNKLFPNADPKALDLLDKMLTFNPHK 282 (336)
T ss_pred CCCHHHHHHhhc---------------------hhhhhHHhhcCcCCccc----HHHHhcccCcHHHHHHHHHcCCChhh
Confidence 654443211000 00000000000000000 00011234678899999999999999
Q ss_pred CcCHHHHHhCCCCCC
Q 002732 872 RMTVAQALTHPFISG 886 (887)
Q Consensus 872 RpTa~elL~Hpwf~~ 886 (887)
|||+.+||.||||..
T Consensus 283 Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 283 RITVEEALAHPYLEQ 297 (336)
T ss_pred CcCHHHHhcCccccc
Confidence 999999999999963
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.67 Aligned_cols=281 Identities=30% Similarity=0.503 Sum_probs=218.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.|.++..||.|+||.||+|.+..++ ..||||.+..... ....+..|+.+|..| .||||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~ 74 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTG----EIVALKKLKMEKEKEGFPITSLREINILLKL------QHPNIVTVKEVVV 74 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCC----cEEEEEEEeeccccccchhhHHHHHHHHHhc------CCCCEEEEEEEEE
Confidence 35999999999999999999998776 7899999875322 223456799999999 8999999999998
Q ss_pred ec--CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 644 YR--NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 644 ~~--~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.. +.+||||||+.++|.+++..... .+++..++.++.||+.||.|||++||+|+||+|+||||+. ++.++|+|||
T Consensus 75 ~~~~~~~~lv~e~~~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~-~~~~~l~d~g 151 (293)
T cd07843 75 GSNLDKIYMVMEYVEHDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN-RGILKICDFG 151 (293)
T ss_pred ecCCCcEEEEehhcCcCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC-CCcEEEeecC
Confidence 87 89999999998899998876432 5899999999999999999999999999999999999995 7889999999
Q ss_pred cceecCCC--CccCcccCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 722 NAMFAGKN--EITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 722 ~a~~~~~~--~~~~~~gt~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
++...... ......+++.|+|||++.+.. ++.++|||||||+||+|++|.+||......+.+..+....+.++...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 152 LAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred ceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 98765543 234456788899999997654 689999999999999999999999998888888888777776555443
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
........... ..+.. .....+.. ..+. ..++..+.+||.+||+.+|.+|||+.||
T Consensus 232 ~~~~~~~~~~~--~~~~~-----------------~~~~~~~~---~~~~--~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 232 PGFSELPGAKK--KTFTK-----------------YPYNQLRK---KFPA--LSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred HHhhccchhcc--ccccc-----------------ccchhhhc---cccc--cCCChHHHHHHHHHhccCccccCCHHHH
Confidence 22111000000 00000 00000000 0110 0146788999999999999999999999
Q ss_pred HhCCCC
Q 002732 879 LTHPFI 884 (887)
Q Consensus 879 L~Hpwf 884 (887)
|.||||
T Consensus 288 l~~~~f 293 (293)
T cd07843 288 LKHPYF 293 (293)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.57 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=215.2
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
++||.|.||+||-+++..+| +.||||+|.+- ......+.+|+.||+.| .||.||.|...|++.+.++
T Consensus 570 evLGSGQFG~VYgg~hRktG----rdVAvKvIdKlrFp~kqesqlR~EVaILq~l------~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTG----RDVAVKVIDKLRFPTKQESQLRNEVAILQNL------HHPGIVNLECMFETPERVF 639 (888)
T ss_pred hhccCCcceeeecceecccC----ceeeeeeeecccCCCchHHHHHHHHHHHHhc------CCCCeeEEEEeecCCceEE
Confidence 58999999999999999998 89999999763 33347788999999999 9999999999999999999
Q ss_pred EEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC--CeEEEEecCcceecC
Q 002732 650 LVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK--NVLKLCDFGNAMFAG 727 (887)
Q Consensus 650 lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~~vKL~DFG~a~~~~ 727 (887)
+|||-+.|++.+.|.... ...|++....+++.|||.||.|||-+|||||||||+||||.... ..+||||||+|++++
T Consensus 640 VVMEKl~GDMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred EEehhhcchHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 999999999888887643 34599999999999999999999999999999999999997543 379999999999998
Q ss_pred CCCc-cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 728 KNEI-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 728 ~~~~-~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
...+ ...+||+.|+|||+|....|....|+||+|||+|--|.|..||... +++-..|..
T Consensus 719 EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQN------------------ 778 (888)
T KOG4236|consen 719 EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQN------------------ 778 (888)
T ss_pred hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhc------------------
Confidence 7654 5678999999999999999999999999999999999999999432 222211211
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
..|+..+..|..++..+++||..+|+..=.+|.|+...|.|||+++
T Consensus 779 ----------------------------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 779 ----------------------------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred ----------------------------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 1233345567788899999999999999999999999999999986
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.87 Aligned_cols=279 Identities=31% Similarity=0.547 Sum_probs=214.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+++.||.|+||.||+|.+..++ ..||||++..... ....+..|+.+|..+ .|+||++++++|.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 70 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETG----QIVAIKKFLESEDDKMVKKIAMREIRMLKQL------RHENLVNLIEVFR 70 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCC----CEEEEEeHhhccCcchhhHHHHHHHHHHHhc------CCcchhhHHHhcc
Confidence 35999999999999999999987766 7899998865322 235667899999998 8999999999999
Q ss_pred ecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+||||||+.+ .|..++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~-~~~~~l~dfg~ 146 (286)
T cd07846 71 RKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGF 146 (286)
T ss_pred cCCeEEEEEecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCcEEEEeeee
Confidence 99999999999965 555544332 24899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 723 AMFAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 723 a~~~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+...... ......++..|+|||++.+. .++.++|||||||+||+|++|.+||.+....+.+..+....+.++.....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 147 ARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 8765432 23445678899999999764 47899999999999999999999998887777777777776665433210
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+.... ++........... .......+.++..+.+||.+||..+|.+|||+.+||
T Consensus 227 -------~~~~~~-----------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 227 -------IFQKNP-----------------LFAGMRLPEVKEI-EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred -------Hhccch-----------------HhhccccccccCc-chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 000000 0000000000000 000111235668899999999999999999999999
Q ss_pred hCCCC
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~Hpwf 884 (887)
+||||
T Consensus 282 ~~~~~ 286 (286)
T cd07846 282 HHEFF 286 (286)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.05 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=208.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+.+.||.|+||+||+|.+..++ ..||||.+..... ....+..|+.+|..+ .|++|+++++++.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~ 71 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTG----KLFALKVLDKKEMIKRNKVKRVLTEQEILATL------DHPFLPTLYASFQ 71 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCC----cEEEEEEEeccccchHHHHHHHHHHHHHHHhC------CCCCchhheeeee
Confidence 5999999999999999999998766 7999999976432 234567888999988 7999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+||||||+ +++|.+++... ....|++..++.++.||+.||.|||+.||+|+||||+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~dfg~ 149 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE-SGHIMLSDFDL 149 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC-CCCEEEeecch
Confidence 999999999999 67999988753 2345999999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCC-------------------------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCC
Q 002732 723 AMFAGKNE-------------------------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771 (887)
Q Consensus 723 a~~~~~~~-------------------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~ 771 (887)
+....... ...+.++..|+|||++.+..++.++||||||||||+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 85432211 11235778899999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCCh
Q 002732 772 VLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851 (887)
Q Consensus 772 ~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (887)
.||.+.+....+..+......+| ...
T Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~------------------------------------------------------~~~ 255 (316)
T cd05574 230 TPFKGSNRDETFSNILKKEVTFP------------------------------------------------------GSP 255 (316)
T ss_pred CCCCCCchHHHHHHHhcCCccCC------------------------------------------------------Ccc
Confidence 99987766555544321111110 001
Q ss_pred hhHHHHHHHHHHhcccCCCCCcC----HHHHHhCCCCCC
Q 002732 852 KMLANFKDLLDKIFVLDPEKRMT----VAQALTHPFISG 886 (887)
Q Consensus 852 ~~s~~~~dLL~kmL~~DP~~RpT----a~elL~Hpwf~~ 886 (887)
.++..+.+||.+||..||..||| +.+||.||||.+
T Consensus 256 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 256 PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 14578899999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.11 Aligned_cols=280 Identities=34% Similarity=0.532 Sum_probs=225.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||.|+||.||+|.+..++ ..||||++... ......+..|+.+|+.| +|+||+.+++++..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG----RKVAIKKISNVFDDLIDAKRILREIKLLRHL------RHENIIGLLDILRP 70 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC----cEEEEEeeccccccchhhhhHHHHHHHHHhc------CCcchhhhhhhhcc
Confidence 5899999999999999999987766 78999998753 22346678899999999 79999999999887
Q ss_pred cC-----eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 645 RN-----HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 ~~-----~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
.. .+||||+|++++|..++.... .+++..++.|+.||+.||.|||+.||+|+||+|.||||+. ++.++|+|
T Consensus 71 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~-~~~~~L~d 146 (330)
T cd07834 71 PSPEDFNDVYIVTELMETDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS-NCDLKICD 146 (330)
T ss_pred cCcccccceEEEecchhhhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEcc
Confidence 75 899999999888988887543 5999999999999999999999999999999999999995 68899999
Q ss_pred cCcceecCCCC-----ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 720 FGNAMFAGKNE-----ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 720 FG~a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
||++....... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+++..++...+.+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 226 (330)
T cd07834 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226 (330)
T ss_pred cCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCC
Confidence 99997765432 3455678899999999988 79999999999999999999999999999999999998888877
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+...+...... . ...++.......... .....+.++..+.+||..||+++|.+||
T Consensus 227 ~~~~~~~~~~~-----------------~----~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rp 281 (330)
T cd07834 227 SEEDLKFITSE-----------------K----ARNYLKSLPKKPKKP----LSKLFPGASPEAIDLLEKMLVFDPKKRI 281 (330)
T ss_pred ChhHhhhcccc-----------------c----hhhHHhhcccCCcch----hHHhcccCCHHHHHHHHHHccCChhhCC
Confidence 76554311000 0 000010000000000 0011223567899999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
|+.+||.||||.+
T Consensus 282 t~~~ll~~~~~~~ 294 (330)
T cd07834 282 TADEALAHPYLAQ 294 (330)
T ss_pred CHHHHHhCccHHh
Confidence 9999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=325.92 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=204.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|.+++.||.|+||.||+|.+..++ ..||||.+.... .....+..|+.++..+ .|++|+.+++.|..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG----KQYVIKKLNLRNASRRERKAAEQEAQLLSQL------KHPNIVAYRESWEG 70 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhC------CCCCeeeeeeeecC
Confidence 3899999999999999999998776 789999986532 2234567888899888 89999999988864
Q ss_pred -cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 -RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 -~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...+||||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~-~~~~~l~df~~ 148 (257)
T cd08223 71 EDGLLYIVMGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR-TNIIKVGDLGI 148 (257)
T ss_pred CCCEEEEEecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec-CCcEEEecccc
Confidence 45789999999 578988887632 235899999999999999999999999999999999999984 78899999999
Q ss_pred ceecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+...... ......+++.|+|||++.+..++.++||||||||+|+|++|..||...+...+...+.... +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~------- 219 (257)
T cd08223 149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L------- 219 (257)
T ss_pred eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C-------
Confidence 8765432 2334567889999999999999999999999999999999999997665444433222111 0
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..+..++..+.+||.+||+.+|..|||+.+||+
T Consensus 220 ----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ----------------------------------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----------------------------------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0011234578899999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 254 ~~~~ 257 (257)
T cd08223 254 QPYI 257 (257)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=335.21 Aligned_cols=277 Identities=32% Similarity=0.510 Sum_probs=217.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.+++.||.|++|+||+|.+..++ ..||||++.... .....+.+|+.++..+ .|++|+++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l------~~~~iv~~~~~~~~~ 70 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG----EIVALKKIRLETEDEGVPSTAIREISLLKEL------NHPNIVRLLDVVHSE 70 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC----CEEEEEEeecccccccchhHHHHHHHHHHhc------CCCCccCHhheeccC
Confidence 678899999999999999988777 789999987542 2234567899999999 899999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+.+|+||||+.++|.+++..... ..+++..++.++.||+.||.|||+.+|+|+||+|.|||++. ++.++|+|||++..
T Consensus 71 ~~~~iv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~ 148 (283)
T cd07835 71 NKLYLVFEFLDLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR-EGALKLADFGLARA 148 (283)
T ss_pred CeEEEEEeccCcCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC-CCcEEEeecccccc
Confidence 99999999998899998876442 34899999999999999999999999999999999999996 78899999999865
Q ss_pred cCCCC--ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 726 AGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 726 ~~~~~--~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
..... .....++..|+|||++.+. .++.++|||||||+||+|++|.+||.+.+....+..++...+.+...++....
T Consensus 149 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT 228 (283)
T ss_pred cCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence 44322 2333557889999988765 57899999999999999999999999888877777777776666554432111
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+. ..+....... .....+.++..+.+||.+||+.+|.+|||+.+||.||
T Consensus 229 ~~~~~~--------------------~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 281 (283)
T cd07835 229 SLPDYK--------------------PTFPKWARQD-------LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHP 281 (283)
T ss_pred hchhhh--------------------hhcccccccc-------hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCC
Confidence 100000 0000000000 0111234567899999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 282 ~~ 283 (283)
T cd07835 282 YF 283 (283)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.99 Aligned_cols=294 Identities=18% Similarity=0.258 Sum_probs=203.7
Q ss_pred EEEEeccC--CceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 571 VTAAHGKG--VFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 571 i~~~LG~G--~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
++.+||.| +|++||+|.+..++ +.||||++.... .....+..|+.+++.| +||||++++++|...
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~hpniv~~~~~~~~~ 71 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG----EYVTVRRINLEACTNEMVTFLQGELHVSKLF------NHPNIVPYRATFIAD 71 (327)
T ss_pred hhhhccccccceEEEEEEeecccC----cEEEEEEechhhccHHHHHHHHHHHHHHHhc------CCCCeeeEEEEEEEC
Confidence 56789999 78999999998887 899999997532 2335667899999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+||||||+ +++|.+++..... ..+++..++.|+.||+.||.|||++||||+||||+||||+. ++.++|+||+.+.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~ 149 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNL 149 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec-CCcEEEcccchhh
Confidence 9999999999 5799999875422 34899999999999999999999999999999999999985 6788999998653
Q ss_pred ecCCC---------CccCcccCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 725 FAGKN---------EITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 725 ~~~~~---------~~~~~~gt~~Y~aPE~l~~--~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
..... ......++..|+|||++.+ ..|+.++||||||||||+|++|..||........+.... .+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCc
Confidence 22110 0112345677999999986 468999999999999999999999998765544433332 2222
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
|..+ .........+..... ............ ......+. ............++..|.+||.+||++||.+||
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 228 PCLL-DTTTIPAEELTMKPS-RSGANSGLGEST---TVSTPRPS---NGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred cccc-cccchhhhhcccCCc-ccCCcCCCCccc---ccCCcCcc---ccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 2111 000000000000000 000000000000 00000000 000001112334567899999999999999999
Q ss_pred CHHHHHhCCCCCC
Q 002732 874 TVAQALTHPFISG 886 (887)
Q Consensus 874 Ta~elL~Hpwf~~ 886 (887)
|+.+||+||||..
T Consensus 300 t~~ell~~p~f~~ 312 (327)
T cd08227 300 SASTLLNHSFFKQ 312 (327)
T ss_pred CHHHHhcChhhhh
Confidence 9999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.25 Aligned_cols=248 Identities=31% Similarity=0.487 Sum_probs=203.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----------hhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----------MNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
+|.+...||.|+||.||+|.+..++ ..||||.+..... ....+..|+.++..| .|+||++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~ 70 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSG----ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL------QHENIVQ 70 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCC----cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc------CCCCeee
Confidence 4788899999999999999987766 7899998864321 124567889999999 8999999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
+++++....++++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||||+. .+.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~-~~~~~ 146 (267)
T cd06628 71 YLGSSLDADHLNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN-KGGIK 146 (267)
T ss_pred EEEEEEeCCccEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC-CCCEE
Confidence 999999999999999999 669999997654 3899999999999999999999999999999999999984 78899
Q ss_pred EEecCcceecCCCC--------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Q 002732 717 LCDFGNAMFAGKNE--------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 717 L~DFG~a~~~~~~~--------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~ 788 (887)
|+|||++....... .....++..|+|||++.+..++.++||||||||||+|++|..||...+....+..+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 99999986554211 1234577889999999998999999999999999999999999976544332221111
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
. . .+..+..++..+.+||.+||+.|
T Consensus 227 ~--~-----------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~ 251 (267)
T cd06628 227 N--A-----------------------------------------------------SPEIPSNISSEAIDFLEKTFEID 251 (267)
T ss_pred c--C-----------------------------------------------------CCcCCcccCHHHHHHHHHHccCC
Confidence 0 0 01112234578899999999999
Q ss_pred CCCCcCHHHHHhCCCC
Q 002732 869 PEKRMTVAQALTHPFI 884 (887)
Q Consensus 869 P~~RpTa~elL~Hpwf 884 (887)
|.+|||+.+||+||||
T Consensus 252 p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 252 HNKRPTAAELLKHPFL 267 (267)
T ss_pred chhCcCHHHHhhCCCC
Confidence 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.05 Aligned_cols=277 Identities=36% Similarity=0.586 Sum_probs=220.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.++..||.|++|.||+|.+..++ +.||||.+..... ....+..|+.+|+.+ .|++|+++++++...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 70 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG----EIVAIKKIKLRFESEGIPKTALREIKLLKEL------NHPNIIKLLDVFRHK 70 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC----cEEEEEEeccccccchhHHHHHHHHHHHHHh------cCCCcchHHHhhccC
Confidence 677889999999999999987766 7899999875422 245677899999999 799999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
..+|+||||+.++|..++.... ..+++..+..++.||+.||.|||..||+|+||+|.|||++. ++.++|+|||++..
T Consensus 71 ~~~~~v~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~df~~~~~ 147 (283)
T cd05118 71 GDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT-EGVLKLADFGLARS 147 (283)
T ss_pred CCEEEEEeccCCCHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC-CCcEEEeeeeeeEe
Confidence 9999999999889998887743 35899999999999999999999999999999999999984 78899999999977
Q ss_pred cCCCC--ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 726 AGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 726 ~~~~~--~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
..... .....++..|+|||++.+. .++.++|||||||+||+|++|+.||.+.+..+.+..+....+.....++....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 65442 3345677889999999887 78999999999999999999999999988888887777766665444332211
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....... ..+ ... .........+.++..+.+||.+||.+||.+||++.+||.||
T Consensus 228 ~~~~~~~--~~~--------------------~~~----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~ 281 (283)
T cd05118 228 SLARNYK--FSF--------------------PKK----AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281 (283)
T ss_pred hhhhhhh--hhh--------------------ccc----cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence 1000000 000 000 00001112345678999999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 282 ~~ 283 (283)
T cd05118 282 YF 283 (283)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=325.74 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=208.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|.+...||.|+||.||+|.+..++ ..||+|.+... ......+..|+.++..+ .|+||++++++|..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 70 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK----RVYAMKQIDLSKMNRREREEAIDEARVLAKL------DSSYIIRYYESFLD 70 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhc------CCCCeehheeeecc
Confidence 3889999999999999999998777 78999998643 23456677899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|.+++.... ...++...++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~-~~~~~l~df~~~ 148 (256)
T cd08529 71 KGKLNIVMEYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA-YDNVKIGDLGVA 148 (256)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC-CCCEEEcccccc
Confidence 99999999999 679999988742 245899999999999999999999999999999999999995 788999999998
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... .....+++.|+|||++.+..++.++||||||||||+|++|..||...+....+..+... .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------- 218 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--VF-------- 218 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC--------
Confidence 7655432 23456788999999999999999999999999999999999999776654443332111 00
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+.....++..+.+||.+||+.+|.+||++.++|.|
T Consensus 219 ---------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 ---------------------------------------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---------------------------------------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00011344678999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
||+
T Consensus 254 ~~~ 256 (256)
T cd08529 254 PSL 256 (256)
T ss_pred CCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=330.34 Aligned_cols=254 Identities=26% Similarity=0.458 Sum_probs=205.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-------hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-------TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+|.....||+|+||.||+|.+..++ ..||||++.... .....+..|+.+|+.| .|+||+++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~ 70 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL------NHPHIIRMLG 70 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc------CCCceehhhc
Confidence 3788899999999999999987777 789999987432 1235678899999999 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
+|...+++++||||+ +++|.++|.... .+++..++.++.||+.||.|||++||+|+||+|.|||++..+..++|+|
T Consensus 71 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 71 ATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eeccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999 579999987644 4899999999999999999999999999999999999986556799999
Q ss_pred cCcceecCCCC------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 720 FGNAMFAGKNE------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 720 FG~a~~~~~~~------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
||++....... .....++..|+|||++.+..++.++||||||||+|+|++|..||...........+.....
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 225 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-- 225 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--
Confidence 99986654321 1234578889999999988899999999999999999999999964332211111111000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
....+..+..++..+.+||.+||..+|..||
T Consensus 226 -------------------------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 256 (268)
T cd06630 226 -------------------------------------------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256 (268)
T ss_pred -------------------------------------------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCc
Confidence 0001222345667899999999999999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||+||||.
T Consensus 257 ~~~~ll~~~~~~ 268 (268)
T cd06630 257 PSRELLKHPVFR 268 (268)
T ss_pred CHHHHhcCcccC
Confidence 999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=352.53 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=209.7
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecc-cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVF 652 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~ 652 (887)
+||+|.||+||-|+|..+. ..+|||-|.. +.....-++.||.+...| .|.|||+++++|...+++-|.|
T Consensus 582 VLGKGTYG~VYA~RD~~tq----vrIaIKEIpekdsr~~QPLhEEIaLH~~L------rHkNIVrYLGs~senGf~kIFM 651 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQ----VRIAIKEIPEKDSREVQPLHEEIALHSTL------RHKNIVRYLGSVSENGFFKIFM 651 (1226)
T ss_pred EeecCceeEEEeeccccce----eEEEeeecccccchhhccHHHHHHHHHHH------hhHhHHHHhhccCCCCeEEEEe
Confidence 7999999999999999887 7889998864 344456678899999999 8999999999999999999999
Q ss_pred ecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee-cCCC-
Q 002732 653 ESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF-AGKN- 729 (887)
Q Consensus 653 E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~-~~~~- 729 (887)
|-+ +|+|..+|...=....=++.++-+|.+|||.||.|||.+.|||||||-+||||+.-.+++||+|||.+.. .+.+
T Consensus 652 EqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP 731 (1226)
T KOG4279|consen 652 EQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP 731 (1226)
T ss_pred ecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc
Confidence 999 7899999987432222388999999999999999999999999999999999998889999999999854 3433
Q ss_pred CccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 730 EITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 730 ~~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
...++.||+.|||||+|-.+ .|+.++|||||||++.||.||++||....... ..||+-++
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------------AAMFkVGm----- 793 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------------AAMFKVGM----- 793 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------------Hhhhhhcc-----
Confidence 45678899999999999876 49999999999999999999999995433221 11221111
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
+.-.|..+..++++++.||.+||.+||.+||+|.++|..||+.-
T Consensus 794 -----------------------------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 794 -----------------------------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred -----------------------------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 11245567788999999999999999999999999999999974
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.63 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=210.8
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
|.++.+||.|+||.||+|.+..+| ..||||.+..+.. ...+..||.||+++ ..++||++|+.|....-+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG----~v~AIK~VPV~sD-LQEIIKEISIMQQC------~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESG----HVLAIKKVPVDTD-LQEIIKEISIMQQC------KSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccC----cEEEEEecCccch-HHHHHHHHHHHHHc------CCchhhhhhhhhccCCce
Confidence 778999999999999999999988 8999999876543 46778999999999 889999999999888889
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
+|||||| .|++.+++... +.+|++.++..+++..|.||+|||...-||||||..||||+. .++.||+|||.|-.+.
T Consensus 104 WIVMEYCGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT-DGIAKLADFGVAGQLT 180 (502)
T ss_pred EeehhhcCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc-cchhhhhhccccchhh
Confidence 9999999 57999999874 456999999999999999999999999999999999999995 8899999999985543
Q ss_pred CC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 728 KN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 728 ~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.. ...+.+||++|||||++....|...+||||||++..||.-|++||...-.. ..|+-.--.+|
T Consensus 181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---RAIFMIPT~PP----------- 246 (502)
T KOG0574|consen 181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---RAIFMIPTKPP----------- 246 (502)
T ss_pred hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---ceeEeccCCCC-----------
Confidence 22 245678999999999999999999999999999999999999999542211 11100000000
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
.. -..+..++.+|.+||.+||...|.+|.||.+||+|||+.
T Consensus 247 -------------------------------PT--------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 247 -------------------------------PT--------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred -------------------------------CC--------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhc
Confidence 00 012345678999999999999999999999999999997
Q ss_pred C
Q 002732 886 G 886 (887)
Q Consensus 886 ~ 886 (887)
+
T Consensus 288 n 288 (502)
T KOG0574|consen 288 N 288 (502)
T ss_pred C
Confidence 5
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.48 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=203.3
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee-
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY- 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~- 644 (887)
.+.|.++..||.|+||.||+|.+..++ ..||+|++.........+..|+.++..+. +|+||++++++|..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~a~K~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTEDEEEEIKLEINMLKKYS-----HHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCC----cEEEEEEEecChHHHHHHHHHHHHHHHhc-----CCCcEEEEeeehhcc
Confidence 356999999999999999999998776 79999999776555567788888888884 68999999999853
Q ss_pred -----cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 645 -----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 645 -----~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
..++||||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|.||||+. .+.++|+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~-~~~~~l~ 163 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE-NAEVKLV 163 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEe
Confidence 46899999999 568999887633 234889999999999999999999999999999999999985 7789999
Q ss_pred ecCcceecCC--CCccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 719 DFGNAMFAGK--NEITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 719 DFG~a~~~~~--~~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||++..... .......+++.|+|||++. ...++.++||||||||+|+|++|.+||........+..+..
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--- 240 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--- 240 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---
Confidence 9999865432 1234456888999999986 34688899999999999999999999965433222211100
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.. +. ......++..+.+||.+||..||.+
T Consensus 241 ~~------------------------------------------~~---------~~~~~~~~~~~~~li~~cl~~~p~~ 269 (282)
T cd06636 241 NP------------------------------------------PP---------KLKSKKWSKKFIDFIEGCLVKNYLS 269 (282)
T ss_pred CC------------------------------------------CC---------CCcccccCHHHHHHHHHHhCCChhh
Confidence 00 00 0001234578999999999999999
Q ss_pred CcCHHHHHhCCCC
Q 002732 872 RMTVAQALTHPFI 884 (887)
Q Consensus 872 RpTa~elL~Hpwf 884 (887)
|||+.+||.||||
T Consensus 270 Rp~~~ell~~~~~ 282 (282)
T cd06636 270 RPSTEQLLKHPFI 282 (282)
T ss_pred CcCHHHHhcCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=329.77 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=206.1
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.++|.+++.||.|+||.||+|.+..++ ..||+|++.........+..|+.++..+. .|+||++++++|...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTG----QLVAIKIMDIIEDEEEEIKEEYNILRKYS-----NHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCC----cEEEEEEEecCchhHHHHHHHHHHHHHhc-----CCCChheEEEEEEec
Confidence 467999999999999999999987766 78999999876666677889999999983 689999999999764
Q ss_pred C------eEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 646 N------HLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 646 ~------~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
. .+||||||+ +++|.+++.... ....+++..++.++.||+.||.|||+.||+|+||+|+||+|+. ++.++|
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~-~~~~~l 154 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK-NAEVKL 154 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc-CCeEEE
Confidence 4 589999999 568998887643 2345899999999999999999999999999999999999985 788999
Q ss_pred EecCcceecCCC--CccCcccCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 718 CDFGNAMFAGKN--EITPYLVSRFYRAPEIILGL-----PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 718 ~DFG~a~~~~~~--~~~~~~gt~~Y~aPE~l~~~-----~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|||++...... ......++..|+|||++... .++.++||||||||||+|++|.+||........+..+...
T Consensus 155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 233 (275)
T cd06608 155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN- 233 (275)
T ss_pred CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc-
Confidence 999998765432 23345678899999998643 4788999999999999999999999754433332222110
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..+ . ......++..+.+||.+||..||.
T Consensus 234 -~~~-~--------------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~ 261 (275)
T cd06608 234 -PPP-T--------------------------------------------------LKSPENWSKKFNDFISECLIKNYE 261 (275)
T ss_pred -CCC-C--------------------------------------------------CCchhhcCHHHHHHHHHHhhcChh
Confidence 000 0 001123457889999999999999
Q ss_pred CCcCHHHHHhCCCC
Q 002732 871 KRMTVAQALTHPFI 884 (887)
Q Consensus 871 ~RpTa~elL~Hpwf 884 (887)
+|||+.+||+|||+
T Consensus 262 ~Rpt~~~ll~~~~~ 275 (275)
T cd06608 262 QRPFMEELLEHPFI 275 (275)
T ss_pred hCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=344.19 Aligned_cols=279 Identities=28% Similarity=0.443 Sum_probs=210.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.++|.+++.||.|+||.||+|.+..++ ..||||++..... ....+..|+.+|+.+ .|+||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~----~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l------~h~~i~~~~~~~~~ 73 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCD----KRVAVKKIVLTDPQSVKHALREIKIIRRL------DHDNIVKVYEVLGP 73 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCC----cEEEEEEEecCCCchHHHHHHHHHHHHhc------CCCcchhhHhhhcc
Confidence 478999999999999999999998877 7999998865432 235677899999999 89999999877665
Q ss_pred c--------------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 645 R--------------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~--------------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
. ..+|+||||+.++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||||+||||+.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 74 SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred cccccccccccccccceEEEEeecccccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 3 36899999998888888754 24899999999999999999999999999999999999986
Q ss_pred CCCeEEEEecCcceecCCC-----CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKN-----EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~-----~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~ 784 (887)
.+..++|+|||++...... ......++..|+|||++.. ..++.++|||||||+||+|++|..||.+.+..+.+.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6778999999999765322 1223456888999998765 468899999999999999999999998887766665
Q ss_pred HHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHh-hcCCCCccccccCCCCCChhhHHHHHHHHHH
Q 002732 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF-NIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863 (887)
Q Consensus 785 ~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~k 863 (887)
.+.............. .++ .+...+. ..... ........+.++..+.+||.+
T Consensus 230 ~~~~~~~~~~~~~~~~----------~~~------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 282 (342)
T cd07854 230 LILESVPVVREEDRNE----------LLN------------VIPSFVRNDGGEP-----RRPLRDLLPGVNPEALDFLEQ 282 (342)
T ss_pred HHHHhcCCCChHHhhh----------hhh------------hhhhhhhhccccc-----CCCHHHHccCCCHHHHHHHHH
Confidence 5544332221111000 000 0000000 00000 000000112356788999999
Q ss_pred hcccCCCCCcCHHHHHhCCCCC
Q 002732 864 IFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 864 mL~~DP~~RpTa~elL~Hpwf~ 885 (887)
||+.||.+|||+.+||.||||+
T Consensus 283 ~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 283 ILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred HhCCCchhccCHHHHhCCCccc
Confidence 9999999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=335.30 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=204.6
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.+.|.++++||.|+||.||+|.+..++ ..||+|++.... .....+..|+.++..+ .|+||++++++|..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 80 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYMVEIEILATC------NHPYIVKLLGAFYW 80 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCC----ceEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCcEeeeEEEEEe
Confidence 356999999999999999999998777 789999987543 2345677899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|..++.... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~kl~dfg~~ 157 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL-DGDIKLADFGVS 157 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC-CCCEEEccCccc
Confidence 99999999999 567777765533 34899999999999999999999999999999999999984 788999999998
Q ss_pred eecCCC--CccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
...... ......+++.|+|||++. ...++.++||||||||||+|++|.+||...+....+..+... ..|
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~-- 233 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-- 233 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc--
Confidence 654322 223456788999999985 345788999999999999999999999765543332222110 000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
....+..++..+.+||.+||..+|.+||++.
T Consensus 234 -------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 264 (292)
T cd06644 234 -------------------------------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAA 264 (292)
T ss_pred -------------------------------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHH
Confidence 0001123456789999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
++|+||||..
T Consensus 265 ~il~~~~~~~ 274 (292)
T cd06644 265 QLLEHPFVSS 274 (292)
T ss_pred HHhcCccccc
Confidence 9999999973
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=344.31 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=198.0
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+-.++|.++++||.|+||.||+|.+.... ......||||++.... .....+..|+.+|..|. +||||+.+++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~ 78 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG-----NHLNVVNLLG 78 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc-----cCcceeeEEe
Confidence 33467999999999999999999864321 1223579999987532 22356788999999884 6899999999
Q ss_pred eeeec-CeEEEEEecc-hhhHHHHHHHhcc--------------------------------------------------
Q 002732 641 SFKYR-NHLCLVFESL-HMNLREVLKKFGR-------------------------------------------------- 668 (887)
Q Consensus 641 ~~~~~-~~~~lV~E~~-~gsL~~~L~~~~~-------------------------------------------------- 668 (887)
+|... ..+||||||+ +|+|.++|.....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 88764 4689999999 6899999875321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC----ccCcc
Q 002732 669 ---------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYL 735 (887)
Q Consensus 669 ---------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~ 735 (887)
...|++..+..|+.||+.||.|||+.||||+||||+||||+. ++.+||+|||++....... .....
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCC
Confidence 124788899999999999999999999999999999999985 7789999999997643221 11233
Q ss_pred cCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccccccccc
Q 002732 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNF 814 (887)
Q Consensus 736 gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~ 814 (887)
+++.|+|||++.+..|+.++||||||||||+|++ |.+||.+....+.+...+.. +..
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~--------------------- 295 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR--------------------- 295 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC---------------------
Confidence 4578999999999999999999999999999997 99999775443322211110 000
Q ss_pred ccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 815 HATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..+..++..+.+||.+||..||.+|||+.+||+
T Consensus 296 --------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 --------------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred --------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011234467899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=336.52 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=200.5
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC------------CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCC
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG------------NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPE 630 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~------------~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~ 630 (887)
..++|.+.++||.|+||.||+|.+.... ......||||++.... .....+..|+.+|..|
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------ 76 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL------ 76 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc------
Confidence 3467999999999999999999864321 1233579999987642 2335678899999998
Q ss_pred CCcceeEecceeeecCeEEEEEecc-hhhHHHHHHHhcc----------------CCCCCHHHHHHHHHHHHHHHHhhhc
Q 002732 631 NKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGR----------------NIGLKLTAVRAYAKQLFIALKHLKN 693 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~----------------~~~ls~~~~~~i~~qIl~aL~yLHs 693 (887)
.|+||++++++|...+.+||||||+ +++|.++|..... ...+++..++.|+.||+.||.|||+
T Consensus 77 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 156 (304)
T cd05096 77 KDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS 156 (304)
T ss_pred CCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 8999999999999999999999999 6799998865321 1247888999999999999999999
Q ss_pred cceeccCCCCCCccccCCCCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc
Q 002732 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769 (887)
Q Consensus 694 ~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt 769 (887)
+||+|+||||+||||+. .+.+||+|||++........ ....++..|+|||++.+..++.++|||||||+||+|++
T Consensus 157 ~~ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 157 LNFVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred CCccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999995 78899999999976543221 12344678999999999899999999999999999987
Q ss_pred --CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCC
Q 002732 770 --GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847 (887)
Q Consensus 770 --G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (887)
+..||...+..+.+..+......... .+ ..
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~---~~ 267 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQGR---------------------------------------------QV---YL 267 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhccc---------------------------------------------cc---cc
Confidence 66788776655544433221110000 00 00
Q ss_pred CCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 848 ~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
..++.++..+.+||.+||..||.+|||+.+|+
T Consensus 268 ~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 268 FRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred cCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 11223456789999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.33 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=207.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
+.|.+...||.|+||.||+|.+..++ ..||+|.+..... ...+..|+.++..+ +|+||++++++|....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~-~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETG----QVVAIKVVPVEED-LQEIIKEISILKQC------DSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCC----cEEEEEEeecHHH-HHHHHHHHHHHHhC------CCCcEeeeeeeeecCC
Confidence 46999999999999999999987765 7899999876543 57788999999999 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
++|+|+||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||+|.|||++. ++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE-EGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC-CCcEEEcccccchh
Confidence 999999999 569999987643 34899999999999999999999999999999999999985 77899999999876
Q ss_pred cCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
..... .....++..|+|||++.+..++.++||||||||||+|++|..||...........+.. ..
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---------- 215 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP---------- 215 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC----------
Confidence 54432 2334578889999999999999999999999999999999999976443322111100 00
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
. .....+..++..+.+||.+||+.+|.+|||+.+||.|||
T Consensus 216 --------------------------------~--------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 216 --------------------------------P--------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred --------------------------------C--------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 0 000112335578899999999999999999999999999
Q ss_pred C
Q 002732 884 I 884 (887)
Q Consensus 884 f 884 (887)
|
T Consensus 256 ~ 256 (256)
T cd06612 256 I 256 (256)
T ss_pred C
Confidence 8
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=350.94 Aligned_cols=250 Identities=31% Similarity=0.452 Sum_probs=214.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh---HHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN---KAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~---~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.|.++..||+|.|++|.+|.+..++ ..||||++.++.... ..+..|+.||+.| +|||||+++.+.+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~----~~VaiK~idkt~ln~~~~~k~~rev~imk~l------~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTG----TEVAIKIIDKTQLNPSKRQKLGREVDIMKSL------NHPNIVKLFSVIE 125 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCC----ceEEEEEehhcccChHHHHHHHHHHHHHHhc------CCcceeeeeeeee
Confidence 55999999999999999999999887 799999998754332 3367899999999 9999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+|+||||+ +|.|.++|.+.+. +.+..+..++.||+.|++|||+.+|||+|||++||||+. +..|||+|||+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~-~mnikIaDfgf 201 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE-NMNIKIADFGF 201 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc-ccceeeecccc
Confidence 999999999999 8899999999876 788999999999999999999999999999999999995 66689999999
Q ss_pred ceecCCC-CccCcccCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGKN-EITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~-s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+.++... ...++||++.|.|||++.+..| ++.+|+||||+|||-|+.|.+||.+.+..+.-...+..+.
T Consensus 202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--------- 272 (596)
T KOG0586|consen 202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--------- 272 (596)
T ss_pred ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee---------
Confidence 9877654 4688999999999999999987 6889999999999999999999987644322111111111
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..+..++.++.+||++||.++|.+|+++++|+.
T Consensus 273 -----------------------------------------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 -----------------------------------------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -----------------------------------------------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 112234567899999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
|.|++.
T Consensus 306 ~~W~n~ 311 (596)
T KOG0586|consen 306 DRWRND 311 (596)
T ss_pred hcccch
Confidence 999874
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.10 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=200.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+|.++..||.|+||.||+|.+..++ ..||||++..... ....+..|+.++.++ ..|+||++++++|...
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~iv~~~~~~~~~ 72 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTG----TIMAVKRIRATVNSQEQKRLLMDLDISMRS-----VDCPYTVTFYGALFRE 72 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCC----cEEEEEEEecCCCcHHHHHHHHHHHHHHHH-----cCCCCeeeeeEEEecC
Confidence 5999999999999999999998877 8999999875422 223444566553333 2899999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHhhhcc-ceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 NHLCLVFESLHMNLREVLKKF-GRNIGLKLTAVRAYAKQLFIALKHLKNC-GVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~-~~~~~ls~~~~~~i~~qIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+.+|+||||+.++|.+++... .....+++..++.++.||+.||.|||+. +|+|+||+|+|||++. .+.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~ 151 (283)
T cd06617 73 GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGIS 151 (283)
T ss_pred CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-CCCEEEeecccc
Confidence 999999999999998888753 2335699999999999999999999986 9999999999999985 788999999999
Q ss_pred eecCCCC-ccCcccCCcccchhhhcC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHhhCCCChhh
Q 002732 724 MFAGKNE-ITPYLVSRFYRAPEIILG----LPYDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~~~-~~~~~gt~~Y~aPE~l~~----~~~s~~sDIwSLG~iL~elltG~~PF~~~~-~~~~l~~i~~~~g~~p~~~ 797 (887)
....... .+...++..|+|||++.+ ..++.++|||||||+||+|++|..||.... ..+.+..+.. +..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---- 225 (283)
T cd06617 152 GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPS---- 225 (283)
T ss_pred cccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCC----
Confidence 7654332 233567888999999865 457899999999999999999999995421 1121111110 000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+ ......++..+.+||.+||..+|.+|||+.+
T Consensus 226 --------------------------------------~----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 226 --------------------------------------P----------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred --------------------------------------C----------CCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0 0001135578899999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||.||||..
T Consensus 258 il~~~~~~~ 266 (283)
T cd06617 258 LLQHPFFEL 266 (283)
T ss_pred HhcCchhhh
Confidence 999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=344.83 Aligned_cols=281 Identities=33% Similarity=0.532 Sum_probs=222.9
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.++|.++..||.|+||+||+|.+..++ ..||||++... ......+..|+.+++.+ .|+||+.++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 82 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTG----RKVAIKKLSRPFQSAIHAKRTYRELRLLKHM------DHENVIGLLDV 82 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCC----cEEEEEecccccchhhHHHHHHHHHHHHHhc------cCCCHHHHHHH
Confidence 3567999999999999999999998776 78999998642 22234566799999999 89999999988
Q ss_pred eeecCe------EEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 642 FKYRNH------LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 642 ~~~~~~------~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
+..... +|||+||++++|.+++.. ..|++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~-~~~~ 157 (343)
T cd07851 83 FTPASSLEDFQDVYLVTHLMGADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCEL 157 (343)
T ss_pred hhccccccccccEEEEEecCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCE
Confidence 876554 999999999999998875 24999999999999999999999999999999999999985 7789
Q ss_pred EEEecCcceecCCCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 716 KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+|+|||++...... .....++..|+|||++.+. .++.++|||||||+||+|++|.+||.+......+..++...+.++
T Consensus 158 kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 158 KILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred EEcccccccccccc-ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 99999999766443 4455778899999998763 688999999999999999999999999888888888888888777
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..++.+..... ...++........ .. .......++..+.+||.+||..+|.+|||
T Consensus 237 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~-~~---~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 237 EELLQKISSES---------------------ARNYIQSLPQMPK-KD---FKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred HHHHhhccchh---------------------HHHHHHhccccCC-CC---HHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 77653322100 0011111000000 00 00111234678999999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+.+||.||||..
T Consensus 292 ~~ell~h~~~~~ 303 (343)
T cd07851 292 AAEALAHPYLAE 303 (343)
T ss_pred HHHHhcCCCccc
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.99 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=206.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.+|.++..||.|+||.||+|.+..++ ..||||.+..... ....+..|+.++..+ .|+||+.++++|...
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~v~~~~~~~~~~ 89 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVG 89 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCC----cEEEEEEEecCCcchHHHHHHHHHHHHhC------CCCCEeeEEEEEEeC
Confidence 57999999999999999999987776 7899998875432 245677899999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.++||||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++.
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~ 164 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 164 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCEEECccccch
Confidence 9999999999 67999988642 3899999999999999999999999999999999999985 7789999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
..... ......+++.|+|||++.+..++.++||||||||||+|++|.+||........+..+... ..|
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~--~~~-------- 234 (296)
T cd06654 165 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN--GTP-------- 234 (296)
T ss_pred hccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC--CCC--------
Confidence 54332 233457788999999999988999999999999999999999999765543332211100 000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+..++..+.+||.+||..+|..|||+.+||.||
T Consensus 235 -------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~ 271 (296)
T cd06654 235 -------------------------------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ 271 (296)
T ss_pred -------------------------------------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence 0001123456788999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 272 ~~~~ 275 (296)
T cd06654 272 FLKI 275 (296)
T ss_pred hhhc
Confidence 9963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.25 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=202.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
++|.+.+.||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+ .|+||+++++++...
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~e~~~~~~l------~h~~ii~~~~~~~~~ 78 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTG----ELAAIKVIKLEPGEDFAVVQQEIIMMKDC------KHSNIVAYFGSYLRR 78 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCC----cEEEEEEEecCchhHHHHHHHHHHHHHhC------CCCCeeeEEEEEEeC
Confidence 46889999999999999999988777 7899999875432 234567889999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~-~~~~~l~dfg~~~ 154 (267)
T cd06645 79 DKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD-NGHVKLADFGVSA 154 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECcceeee
Confidence 9999999999 569999987654 4999999999999999999999999999999999999984 7789999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
..... ......++..|+|||++. ...++.++||||||||||+|++|.+||........+..+... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~------ 226 (267)
T cd06645 155 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NF------ 226 (267)
T ss_pred EccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CC------
Confidence 55432 223457889999999985 456889999999999999999999999654432222111100 00
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+.. ......++..+.+||.+||..+|.+|||+.+||
T Consensus 227 -----------------------------------~~~~--------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 227 -----------------------------------QPPK--------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred -----------------------------------CCCc--------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 0000 000112446788999999999999999999999
Q ss_pred hCCC
Q 002732 880 THPF 883 (887)
Q Consensus 880 ~Hpw 883 (887)
+|||
T Consensus 264 ~~~~ 267 (267)
T cd06645 264 QHPF 267 (267)
T ss_pred cCCC
Confidence 9999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=329.01 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=202.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-------hhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-------MNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+|.+...||.|+||+||+|.+. ++ ..||||++..... ....+..|+.+|..+ .|+||+++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~ 69 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL------KHVNIVQYLG 69 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CC----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc------CCCCEeeEee
Confidence 3788999999999999999863 34 6899998864321 124567899999988 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
+|...+.+|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||+|.|||++. .+.++|+|
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~l~d 145 (265)
T cd06631 70 TCLDDNTISIFMEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP-NGIIKLID 145 (265)
T ss_pred EeecCCeEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC-CCeEEecc
Confidence 999999999999999 679999987643 3899999999999999999999999999999999999984 78899999
Q ss_pred cCcceecCC--------CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 720 FGNAMFAGK--------NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 720 FG~a~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
||++..... .......++..|+|||++.+..++.++|||||||+||+|++|..||........+..+....+
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG 225 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC
Confidence 999865421 112345678899999999998999999999999999999999999976544332222211111
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
.+ +..+..++..+.+||.+||..+|..
T Consensus 226 ~~-----------------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~ 252 (265)
T cd06631 226 LM-----------------------------------------------------PRLPDSFSAAAIDFVTSCLTRDQHE 252 (265)
T ss_pred CC-----------------------------------------------------CCCCCCCCHHHHHHHHHHhcCCccc
Confidence 11 1112235578899999999999999
Q ss_pred CcCHHHHHhCCCC
Q 002732 872 RMTVAQALTHPFI 884 (887)
Q Consensus 872 RpTa~elL~Hpwf 884 (887)
|||+.++|.||||
T Consensus 253 Rp~~~~~l~~~~~ 265 (265)
T cd06631 253 RPSALQLLRHDFL 265 (265)
T ss_pred CCCHHHHhcCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=334.40 Aligned_cols=284 Identities=29% Similarity=0.442 Sum_probs=218.9
Q ss_pred CceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 562 ~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
|++..+.|.+...||.|+||+||+|.+..++ ..||||++.... .....+..|+.++..| .||||+++
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~~i~~~ 71 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTG----ELVALKKVRLDNEKEGFPITAIREIKILRQL------NHRNIVNL 71 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCC----cEEEEEEEeecccccCchHHHHHHHHHHHhC------CCCCeeee
Confidence 4556678999999999999999999998776 789999997532 2234567899999999 89999999
Q ss_pred cceeeecC----------eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccc
Q 002732 639 ASSFKYRN----------HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708 (887)
Q Consensus 639 ~~~~~~~~----------~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl 708 (887)
++++.... .+||||||+.++|..++... ...+++..++.|+.||+.||.|||+.||+|+||+|.|||+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred eheecCcchhhhccccCCcEEEEEcccCccHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99887654 89999999988888887653 2358999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEecCcceecCCCC---ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 002732 709 NEAKNVLKLCDFGNAMFAGKNE---ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784 (887)
Q Consensus 709 ~~~~~~vKL~DFG~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~ 784 (887)
+. .+.+||+|||++....... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||...+....+.
T Consensus 150 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 150 NN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred CC-CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 84 7889999999987654322 2223457789999998754 57899999999999999999999999888888888
Q ss_pred HHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHh
Q 002732 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKI 864 (887)
Q Consensus 785 ~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~km 864 (887)
.+....+..+..++........+...+.. . ............++..+.+||..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-------------------~~~~~~~~~~~~~~~~~~~li~~~ 282 (302)
T cd07864 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPK-------K-------------------QYRRRLREEFSFIPTPALDLLDHM 282 (302)
T ss_pred HHHHHhCCCChhhcccccccccccccccc-------c-------------------ccccchhhhcCCCCHHHHHHHHHH
Confidence 88777666554443221111100000000 0 000000011123457789999999
Q ss_pred cccCCCCCcCHHHHHhCCCC
Q 002732 865 FVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 865 L~~DP~~RpTa~elL~Hpwf 884 (887)
|..+|.+|||+.+||.||||
T Consensus 283 l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 283 LTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=331.35 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=207.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
++|.++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.+++.+ .|+||+.++++|..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 70 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTN----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC------RSPYITKYYGSFLK 70 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCC----eEEEEEEeeccccchHHHHHHHHHHHHHHc------CCCCeeeeeEEEEE
Confidence 36889999999999999999988776 899999987543 2235667899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+|+|+||+ +++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++. ++.++|+|||++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~ 145 (274)
T cd06609 71 GSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE-EGDVKLADFGVS 145 (274)
T ss_pred CCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEcccccc
Confidence 99999999999 56899888763 4899999999999999999999999999999999999995 788999999999
Q ss_pred eecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...... ......++..|+|||++.+..++.++||||||||||+|++|.+||...+....+..+.....
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---------- 215 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP---------- 215 (274)
T ss_pred eeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC----------
Confidence 776543 23445678889999999998999999999999999999999999976543332222211100
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.. .+ ...++..+.+||.+||..+|.+|||+.++|.|
T Consensus 216 -----------------------------------~~-------~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 -----------------------------------PS-------LE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----------------------------------CC-------Cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 00 01145678999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 252 ~~~~~ 256 (274)
T cd06609 252 KFIKK 256 (274)
T ss_pred hhhcC
Confidence 99975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.00 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=207.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+|.++..||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ .|++|+++++.+...
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 71 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNN----EKVAIKRIDLEKCQTSVDELRKEVQAMSQC------NHPNVVKYYTSFVVG 71 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCC----cEEEEEEeccCCcchHHHHHHHHHHHHHhc------CCCCEEEEEEEEeeC
Confidence 5999999999999999999987766 789999987532 2346678899999888 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+|||||++ +++|.+++........+++..+..++.||+.||.|||+.||+|+||+|.||+++. ++.++|+|||++.
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~ 150 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE-DGSVKIADFGVSA 150 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC-CCCEEEcccchHH
Confidence 9999999999 6799999876433345899999999999999999999999999999999999995 6789999999986
Q ss_pred ecCCCC------ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 725 FAGKNE------ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 725 ~~~~~~------~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
...... ....+++..|+|||++... .++.++||||||||||+|++|..||...+....+..+... .+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 227 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL 227 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc
Confidence 544321 1334678899999999877 7899999999999999999999999765443333222111 00000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
........++..+.+||.+||..||..|||+.+
T Consensus 228 -----------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 228 -----------------------------------------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred -----------------------------------------------CCccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 000012345678899999999999999999999
Q ss_pred HHhCCCC
Q 002732 878 ALTHPFI 884 (887)
Q Consensus 878 lL~Hpwf 884 (887)
||.||||
T Consensus 261 ll~~p~~ 267 (267)
T cd06610 261 LLKHKFF 267 (267)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.06 Aligned_cols=278 Identities=33% Similarity=0.538 Sum_probs=218.2
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..| .|+||+.+++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 70 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG----ELVALKKIRMENEKEGFPITAIREIKLLQKL------RHPNIVRLKEIVTSK 70 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC----eEEEEEEEecccccccchHHHHHHHHHHHhc------cCCCeeeheeeEecC
Confidence 678999999999999999998776 789999998652 2335677899999999 799999999999988
Q ss_pred --CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 --NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 --~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..+||||||+.++|.+++.... ..+++..++.++.||+.||.|||..||+|+||+|.||||+. ++.++|+|||++
T Consensus 71 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~-~~~~~l~d~g~~ 147 (287)
T cd07840 71 GKGSIYMVFEYMDHDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN-DGVLKLADFGLA 147 (287)
T ss_pred CCCcEEEEeccccccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC-CCCEEEccccce
Confidence 8999999999889988887642 35999999999999999999999999999999999999995 788999999999
Q ss_pred eecCCCC---ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 724 MFAGKNE---ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 724 ~~~~~~~---~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
....... .+...++..|+|||++.+. .++.++|||||||++|+|++|..||...+....+..+....+.++...+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 148 RPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 7765442 3344567889999988754 58999999999999999999999999888888888887776665544332
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
..... ..+............+...+ ...++..+.+||.+||..+|.+|||+.+||
T Consensus 228 ~~~~~-------~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 228 GVSKL-------PWFENLKPKKPYKRRLREFF------------------KHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccccc-------hhhhhccccccchhHHHHHh------------------cccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 11111 00000000000000000000 001357889999999999999999999999
Q ss_pred hCCCC
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~Hpwf 884 (887)
.||||
T Consensus 283 ~~~~~ 287 (287)
T cd07840 283 QHEYF 287 (287)
T ss_pred hCcCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.94 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=207.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||.||+|.+..++ ..||||.+.... .....+..|+.+|+.+ .|++|+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~ 70 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ----KLVIIKQIPVEQMTKDERLAAQNECQVLKLL------SHPNIIEYYENFLE 70 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC----cEEEEEEEeccccccHHHHHHHHHHHHHhhC------CCCchhheeeeEec
Confidence 4899999999999999999988766 899999986532 2345677899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.++|||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+|+||+|.|||++..+..++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 71 DKALMIVMEYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 99999999999 569999997643 2348999999999999999999999999999999999999866678899999999
Q ss_pred eecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 724 MFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 724 ~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
....... .....++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... .+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~--~~--------- 218 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG--TF--------- 218 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc--CC---------
Confidence 7765432 23456788999999999888999999999999999999999999766544333222110 00
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
...+..++..+.+||..||..+|..|||+.+||+||
T Consensus 219 --------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 219 --------------------------------------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred --------------------------------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 001112456789999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 255 ~~ 256 (256)
T cd08220 255 IC 256 (256)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.71 Aligned_cols=280 Identities=29% Similarity=0.483 Sum_probs=215.6
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.++.+||.|+||.||+|.+..++ ..||||++..... ....+.+|+.+|..| .|+||+++++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 76 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG----RVVALKKILMHNEKDGFPITALREIKILKKL------KHPNVVPLIDMA 76 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC----cEEEEEEEEeccCCCCcchhHHHHHHHHHhc------CCCCccchhhhe
Confidence 367999999999999999999988777 7899998864322 224567899999999 899999999887
Q ss_pred eec--------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCe
Q 002732 643 KYR--------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 643 ~~~--------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~ 714 (887)
... ..+|+||+|+.++|..++... ...+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.
T Consensus 77 ~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~-~~~ 153 (311)
T cd07866 77 VERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN-QGI 153 (311)
T ss_pred ecccccccccCceEEEEEecCCcCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCC
Confidence 543 357999999988888877653 235999999999999999999999999999999999999985 788
Q ss_pred EEEEecCcceecCCCC-------------ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 002732 715 LKLCDFGNAMFAGKNE-------------ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 715 vKL~DFG~a~~~~~~~-------------~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~ 780 (887)
++|+|||++....... .+...+++.|+|||++.+. .++.++||||||||||+|++|.+||.+.+..
T Consensus 154 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 154 LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999986543221 2234567889999998764 5899999999999999999999999998888
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
..+..+....+.++...+..+........ .......+ ..+.. ....++..+.+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------------~~~~~-------~~~~~~~~~~~~ 287 (311)
T cd07866 234 DQLHLIFKLCGTPTEETWPGWRSLPGCEG----VHSFTNYP---------------RTLEE-------RFGKLGPEGLDL 287 (311)
T ss_pred HHHHHHHHHhCCCChhhchhhhhcccccc----cccCCCCC---------------ccHHH-------HcccCChhHHHH
Confidence 88888888777665544332221111000 00000000 00000 011233678999
Q ss_pred HHHhcccCCCCCcCHHHHHhCCCC
Q 002732 861 LDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
|.+||..||.+|||+.+||.||||
T Consensus 288 i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 288 LSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=330.21 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=201.4
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
...|.++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||++++++|..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~----~~~aik~~~~~~~~~~~~~~~e~~~l~~~------~h~~ii~~~~~~~~ 77 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG----ELAAVKIIKLEPGDDFSLIQQEIFMVKEC------KHCNIVAYFGSYLS 77 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC----eEEEEEEEecCccchHHHHHHHHHHHHhc------CCCCeeeeeEEEEe
Confidence 346999999999999999999988777 789999987532 2234567899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+||||||+ +++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|.|||++. .+.++|+|||++
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~-~~~~~l~dfg~~ 153 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD-NGDVKLADFGVA 153 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCCEEECcCccc
Confidence 99999999999 568998887543 4899999999999999999999999999999999999984 677999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
....... .....++..|+|||++. ...++.++|||||||+||+|++|.+||...........+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~-------- 225 (267)
T cd06646 154 AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN-------- 225 (267)
T ss_pred eeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC--------
Confidence 7654321 23456788999999985 3457889999999999999999999995443222111110000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
+ .+. .......++..+.+||.+||..+|.+|||+.+|
T Consensus 226 ---------------~--------------------~~~--------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 262 (267)
T cd06646 226 ---------------F--------------------QPP--------KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262 (267)
T ss_pred ---------------C--------------------CCC--------CCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 0 000 000112345788999999999999999999999
Q ss_pred HhCCC
Q 002732 879 LTHPF 883 (887)
Q Consensus 879 L~Hpw 883 (887)
|+|+|
T Consensus 263 l~~l~ 267 (267)
T cd06646 263 LTHLF 267 (267)
T ss_pred hcCCC
Confidence 99998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.13 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=206.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
++|.++..||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| .|+||++++++|...
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETG----LFAAAKIIQIESEEELEDFMVEIDILSEC------KHPNIVGLYEAYFYE 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCC----cEEEEEEEeeCCHHHHHHHHHHHHHHHhC------CCCceeEEEEEEecC
Confidence 45999999999999999999987766 789999987543 2345677899999999 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+||||||+ +++|..++..... .|++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~-~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL-DGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC-CCCEEEccCccch
Confidence 9999999999 5689888876432 4999999999999999999999999999999999999985 7889999999886
Q ss_pred ecCCC--CccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
..... ......++..|+|||++. +..++.++|||||||++|+|++|.+||........+..+... ..|
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~--- 226 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPP--- 226 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCC---
Confidence 54322 223456788999999985 345788999999999999999999999766544333222110 000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
....+..++..+.+||.+||..+|.+|||+.+
T Consensus 227 ------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (280)
T cd06611 227 ------------------------------------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258 (280)
T ss_pred ------------------------------------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 00012234567899999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||+||||.+
T Consensus 259 il~~~~~~~ 267 (280)
T cd06611 259 LLKHPFVSD 267 (280)
T ss_pred HhcChhhcc
Confidence 999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.56 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=205.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.|.+++.||.|+||.||+|.+..++ ..||||.+..... ....+..|+.++..+ .|+||+++++.|.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 71 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETR----QRFAMKKINKQNLILRNQIQQVFVERDILTFA------ENPFVVSMFCSFE 71 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCC----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC------CCCCeeeeEEEEe
Confidence 5999999999999999999998877 7899999875432 234556788888888 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.++|.... .+++..+..++.||+.||.|||+.||+|+||+|.||||+. .+.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~-~~~~~l~dfg~ 147 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS-MGHIKLTDFGL 147 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC-CCCEEEeeCCC
Confidence 999999999999 569999997654 4899999999999999999999999999999999999984 78899999998
Q ss_pred ceecCCCC-----------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 002732 723 AMFAGKNE-----------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785 (887)
Q Consensus 723 a~~~~~~~-----------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~ 785 (887)
+....... .....++..|+|||++.+..++.++||||||||||+|++|..||.+.+..+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 85321110 1123567789999999988999999999999999999999999987665544443
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+......+| .....++..+.+||.+||
T Consensus 228 ~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~li~~~l 254 (305)
T cd05609 228 VISDDIEWP-----------------------------------------------------EGDEALPADAQDLISRLL 254 (305)
T ss_pred HHhcccCCC-----------------------------------------------------CccccCCHHHHHHHHHHh
Confidence 322111111 011134577899999999
Q ss_pred ccCCCCCcC---HHHHHhCCCCCC
Q 002732 866 VLDPEKRMT---VAQALTHPFISG 886 (887)
Q Consensus 866 ~~DP~~RpT---a~elL~Hpwf~~ 886 (887)
+.+|.+||| +.++|.||||.+
T Consensus 255 ~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 255 RQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccChhhccCccCHHHHHhCccccC
Confidence 999999998 899999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.77 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=207.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
++|.++..||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+ +|+||+++++++...
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~ 72 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATG----ELVAIKVIKLEPGDDFEIIQQEISMLKEC------RHPNIVAYFGSYLRR 72 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCC----CEEEEEEEEcCchhhHHHHHHHHHHHHhC------CCCChhceEEEEEeC
Confidence 46999999999999999999987766 7899999875432 346778899999999 899999999999999
Q ss_pred CeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+||||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|+||||+. ++.++|+|||++.
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~ 149 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE-DGDVKLADFGVSA 149 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC-CCCEEECccccch
Confidence 99999999994 68888887642 34999999999999999999999999999999999999994 7889999999987
Q ss_pred ecCCC--CccCcccCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~~~---~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
..... ......++..|+|||++.+. .++.++||||||||||+|++|.+||...........+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~------ 223 (262)
T cd06613 150 QLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP------ 223 (262)
T ss_pred hhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC------
Confidence 65432 23445678889999999877 89999999999999999999999997765444333221110000
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
. .......++..+.+||.+||..+|..|||+.+||
T Consensus 224 -------------------------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 224 -------------------------------------P--------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred -------------------------------------c--------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0 0011234567889999999999999999999999
Q ss_pred hCCC
Q 002732 880 THPF 883 (887)
Q Consensus 880 ~Hpw 883 (887)
.|||
T Consensus 259 ~~~~ 262 (262)
T cd06613 259 QHPF 262 (262)
T ss_pred cCCC
Confidence 9999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.18 Aligned_cols=281 Identities=32% Similarity=0.512 Sum_probs=220.7
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.++|.++..||.|+||+||+|.+..++ ..||||++... ......+..|+.+|+.| .|+||++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~ 82 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHM------KHENVIGLLDV 82 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCC----cEEEEEEecccccchHHHHHHHHHHHHHHhc------CCCCccceeee
Confidence 4578999999999999999999988777 78999998643 22234567899999999 89999999998
Q ss_pred eeecC------eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 642 FKYRN------HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 642 ~~~~~------~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
|.... .+||||+|++++|..++.. ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~-~~~~ 157 (343)
T cd07880 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE-DCEL 157 (343)
T ss_pred ecCCccccccceEEEEEecCCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCE
Confidence 87643 4699999998899888764 24899999999999999999999999999999999999985 7789
Q ss_pred EEEecCcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 716 KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+|+|||++...... .....+++.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..++...+..|
T Consensus 158 kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 158 KILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred EEeecccccccccC-ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999999765432 334567889999999986 4589999999999999999999999998888888888888777777
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..+........ ...++..+....... .....+.++..+.+||.+||..||.+|||
T Consensus 237 ~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 237 KEFVQKLQSED---------------------AKNYVKKLPRFRKKD----FRSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred HHHHHhhcchh---------------------HHHHHHhccccCcch----HHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 66543211100 001111100000000 00112345578899999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+.++|.||||..
T Consensus 292 ~~~~l~~~~~~~ 303 (343)
T cd07880 292 AAEALAHPYFEE 303 (343)
T ss_pred HHHHhcCccHhh
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=331.94 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=203.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
|++++.||.|+||.||+|.+..++ ..||+|.+.... .....+..|+.++..+ .|+||+.++++|...+.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETG----VLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVKLLDAFYYENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCC----eEEEEEEeCCCCHHHHHHHHHHHHHHHHC------CCCCeeeEEEEEeeCCE
Confidence 678899999999999999988776 789999986532 3345677899999998 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+|+||||+ +++|..++.... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~ 153 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL-DGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc-CCCEEEccccccccc
Confidence 99999999 567777765422 35899999999999999999999999999999999999985 788999999998654
Q ss_pred CCC--CccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 727 GKN--EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 727 ~~~--~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
... ......+++.|+|||++. +..++.++||||||||||+|++|.+||...+....+..+.....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 227 (282)
T cd06643 154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------ 227 (282)
T ss_pred cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC------
Confidence 322 223456788999999984 3457889999999999999999999997765544433332111000
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
...+..++..+.+||.+||..+|.+|||+.+||
T Consensus 228 -----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 228 -----------------------------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred -----------------------------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 001123457889999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
+||||..
T Consensus 261 ~~~~~~~ 267 (282)
T cd06643 261 QHPFVTV 267 (282)
T ss_pred cCCCEec
Confidence 9999973
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.67 Aligned_cols=276 Identities=34% Similarity=0.537 Sum_probs=222.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.+...||.|+||.||+|....++ +.||||++... ......+..|+.++..+ .|++|+++++++...
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~ 70 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG----EIVALKKIRLDNEEEGIPSTALREISLLKEL------KHPNIVKLLDVIHTE 70 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC----cEEEEEEeccccccccccHHHHHHHHHHHhc------CCCCHHHHHhhhhcC
Confidence 677889999999999999988776 79999999864 22345667899999998 799999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
..+++||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++..
T Consensus 71 ~~~~~v~e~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~ 147 (282)
T cd07829 71 RKLYLVFEYCDMDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR-DGVLKLADFGLARA 147 (282)
T ss_pred CceEEEecCcCcCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC-CCCEEEecCCcccc
Confidence 9999999999889999998753 24999999999999999999999999999999999999985 78899999999876
Q ss_pred cCCC--CccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 726 AGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 726 ~~~~--~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
.... .......+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+....+.....++....
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc
Confidence 5433 23344567789999999877 78999999999999999999999999988888888888887777666543322
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
... .+...+... ..... ....+.++..+.+||.+||..||.+||++.+||.||
T Consensus 228 ~~~-~~~~~~~~~-------------------~~~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p 280 (282)
T cd07829 228 KLP-DYKPTFPKF-------------------PPKDL-------EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP 280 (282)
T ss_pred ccc-ccccccccc-------------------Cccch-------HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence 221 111111000 00000 001122357899999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 281 ~~ 282 (282)
T cd07829 281 YF 282 (282)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.42 Aligned_cols=250 Identities=24% Similarity=0.463 Sum_probs=207.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||.||++.+..++ ..||||.+... ......+..|+.+++.| .|+||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG----KQYVIKEINISKMSPKEREESRKEVAVLSNM------KHPNIVQYQESFEE 70 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC----CEEEEEEEEhHhCChHHHHHHHHHHHHHHhC------CCCCeeeeEeeecC
Confidence 4899999999999999999988776 78999998643 23345678899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+++||||||+ +++|.+++.... ...+++..+..|+.||+.||.|||++||+|+||+|+||||+. .+.++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~-~~~~~l~d~~~~ 148 (256)
T cd08218 71 NGNLYIVMDYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK-DGTIKLGDFGIA 148 (256)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEEEeeccce
Confidence 99999999999 679998887532 234899999999999999999999999999999999999985 778999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... .....+++.|+|||++.+..++.++|||||||++|+|++|..||......+.+..+.. +.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~-------- 218 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSY-------- 218 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCC--------
Confidence 7654432 2234578889999999998999999999999999999999999976555444333211 111
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+..+..++..+.+||.+||..+|.+||++.+||+|
T Consensus 219 ---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 ---------------------------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---------------------------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00112345678999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 254 ~~~ 256 (256)
T cd08218 254 NFI 256 (256)
T ss_pred cCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=335.34 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=205.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.+|.+++.||.|+||.||+|.+..++ ..||||.+.... .....+..|+.++..+ .|+||+.++++|...
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~ 88 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATG----QEVAIKQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLVG 88 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCC----CEEEEEEEecCccchHHHHHHHHHHHHhC------CCCCEeeEEEEEecC
Confidence 57999999999999999999987776 789999987533 2345667889999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.++|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~ 163 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 163 (297)
T ss_pred CEEEEeecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEECcCccce
Confidence 9999999999 67999888652 3899999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....+++.|+|||++.+..++.++|||||||+||+|++|..||.+.+....+..+.. ...|
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~--~~~~-------- 233 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTP-------- 233 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc--CCCC--------
Confidence 654332 2345678899999999998899999999999999999999999965443222110000 0000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+..++..+.+||.+||..+|..|||+.+||.||
T Consensus 234 -------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 234 -------------------------------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred -------------------------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 0001123456788999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 271 ~~~~ 274 (297)
T cd06656 271 FLKL 274 (297)
T ss_pred hhcc
Confidence 9963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.30 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=203.2
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee-
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK- 643 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~- 643 (887)
..++|.++..||.|+||+||+|.+..++ ..||||++.........+..|+.++..|. .|+||++++++|.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNG----SKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCC----ceeEEEeeccccchHHHHHHHHHHHHHHh-----cCCCeeeeeeeeee
Confidence 4567999999999999999999998776 78999998764444466788999999884 5999999999874
Q ss_pred ----ecCeEEEEEecc-hhhHHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 644 ----YRNHLCLVFESL-HMNLREVLKKF-GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 644 ----~~~~~~lV~E~~-~gsL~~~L~~~-~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
..+.+||||||+ +++|.+++... .....+++..++.++.||+.||.|||+.+|+|+||+|+|||++. .+.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~-~~~~kl 165 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT-EGGVKL 165 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC-CCCEEE
Confidence 346799999999 67999887643 22345899999999999999999999999999999999999985 677999
Q ss_pred EecCcceecCCCC--ccCcccCCcccchhhhcC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 718 CDFGNAMFAGKNE--ITPYLVSRFYRAPEIILG-----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 718 ~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~-----~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|||++....... .....+++.|+|||++.. ..++.++|||||||++|+|++|..||........+..+..
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-- 243 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR-- 243 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc--
Confidence 9999987654322 234568889999999853 4588999999999999999999999965543222211100
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..+ + . ...+..++..+.+||.+||+.||.
T Consensus 244 -~~~-----------------------------------------~-~--------~~~~~~~~~~~~~li~~~l~~~p~ 272 (286)
T cd06638 244 -NPP-----------------------------------------P-T--------LHQPELWSNEFNDFIRKCLTKDYE 272 (286)
T ss_pred -cCC-----------------------------------------C-c--------ccCCCCcCHHHHHHHHHHccCCcc
Confidence 000 0 0 000112346789999999999999
Q ss_pred CCcCHHHHHhCCCC
Q 002732 871 KRMTVAQALTHPFI 884 (887)
Q Consensus 871 ~RpTa~elL~Hpwf 884 (887)
+|||+.+||+||||
T Consensus 273 ~Rps~~ell~~~~~ 286 (286)
T cd06638 273 KRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCHHHHhhcccC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.17 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=204.6
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..++|.++..||.|+||.||+|.+..++ ..||||++.........+..|+.++..|. .|+||++++++|..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~----~~~aik~~~~~~~~~~~~~~e~~~l~~l~-----~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDG----SLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCC----CEEEEEEecccccHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEEe
Confidence 3567999999999999999999988777 78999999765444566778899988884 68999999999875
Q ss_pred c-----CeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 645 R-----NHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 645 ~-----~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
. ..+|+||||+ +++|.+++.... ....+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~-~~~~kl 169 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-EGGVKL 169 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC-CCCEEE
Confidence 3 4689999999 679999886432 2345899999999999999999999999999999999999985 777899
Q ss_pred EecCcceecCCCC--ccCcccCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 718 CDFGNAMFAGKNE--ITPYLVSRFYRAPEIILGL-----PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 718 ~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~-----~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|||++....... .....++..|+|||++... .++.++||||||||+|+|++|.+||........+..+..
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~-- 247 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR-- 247 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc--
Confidence 9999987654322 2334678889999998653 368999999999999999999999976544333322210
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..+..+ .....++..+.+||.+||+.+|.
T Consensus 248 -~~~~~~--------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~ 276 (291)
T cd06639 248 -NPPPTL--------------------------------------------------LHPEKWCRSFNHFISQCLIKDFE 276 (291)
T ss_pred -CCCCCC--------------------------------------------------CcccccCHHHHHHHHHHhhcChh
Confidence 000000 00112345789999999999999
Q ss_pred CCcCHHHHHhCCCCC
Q 002732 871 KRMTVAQALTHPFIS 885 (887)
Q Consensus 871 ~RpTa~elL~Hpwf~ 885 (887)
.||++.+||+||||.
T Consensus 277 ~Rps~~~il~~~~~~ 291 (291)
T cd06639 277 ARPSVTHLLEHPFIK 291 (291)
T ss_pred hCcCHHHHhcCcccC
Confidence 999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.62 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=194.6
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
.||+|+||.||+|.+..++ ..||||++.+.... ......|..++..+.. ..|++|+.++++|...+.+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMTYAFHTPDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCC----cEEEEEEEEccccccchHHHHHHHHHHHHHHHhh---CCCCcEeEEEEEEecCCeEE
Confidence 4899999999999998776 79999998754221 1233445444444422 27899999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||||+ +++|..++...+ .|++..+..|+.||+.||.|||+.||+|+||||+|||++. ++.++|+|||++.....
T Consensus 74 lv~e~~~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~ 149 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (279)
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence 999999 678988887643 4999999999999999999999999999999999999985 77899999999876554
Q ss_pred CCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 729 NEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 729 ~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
.......++..|+|||++.+ ..++.++|||||||+||+|++|..||.......... +......
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~--------------- 213 (279)
T cd05633 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--------------- 213 (279)
T ss_pred cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc---------------
Confidence 44445578999999999874 568999999999999999999999996543211110 0000000
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHhCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALTHP 882 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~Hp 882 (887)
.....++.++..+.+||.+||..||.+|| |++++|+||
T Consensus 214 -------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 214 -------------------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -------------------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 00111234567889999999999999999 699999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||.+
T Consensus 257 ~~~~ 260 (279)
T cd05633 257 FFKG 260 (279)
T ss_pred cccC
Confidence 9986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=327.98 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=206.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.++..||.|+||.||+|.+..++ ..||+|++..... ....+.+|+.+|..| .|+||+.++++|..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 70 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTG----MIFALKTITTDPNPDLQKQILRELEINKSC------KSPYIVKYYGAFLD 70 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCC----eEEEEEEEecCCchHHHHHHHHHHHHHHhC------CCCCeeeeeeEEEc
Confidence 35999999999999999999998766 8999999875432 346678899999998 89999999998865
Q ss_pred --cCeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 645 --RNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 645 --~~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
.+.+||||||+ +++|.+++.... ....+++..+..|+.||+.||.|||+.||+|+||+|.|||++. .+.++|+||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~-~~~~~l~df 149 (287)
T cd06621 71 ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR-KGQVKLCDF 149 (287)
T ss_pred cCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec-CCeEEEeec
Confidence 35799999999 669988876432 2345899999999999999999999999999999999999985 778999999
Q ss_pred CcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHhhCCCChhhh
Q 002732 721 GNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATN--NDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~--~~~l~~i~~~~g~~p~~~l 798 (887)
|++............++..|+|||++.+..++.++||||||||+|+|++|..||..... ....... ..
T Consensus 150 g~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~--------- 219 (287)
T cd06621 150 GVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SY--------- 219 (287)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HH---------
Confidence 99876554444455678889999999999999999999999999999999999975422 0000000 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
+....... +...+.....++..+.+||.+||..+|.+|||+.||
T Consensus 220 --------------------------------~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ei 263 (287)
T cd06621 220 --------------------------------IVNMPNPE----LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263 (287)
T ss_pred --------------------------------HhcCCchh----hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHH
Confidence 00000000 000111112356789999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
|.||||..
T Consensus 264 l~~~~~~~ 271 (287)
T cd06621 264 LEHPWIKA 271 (287)
T ss_pred HhCccccc
Confidence 99999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.35 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=207.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.+|.++..||.|+||+||+|.+..++ +.||||.+.... .....+.+|+.++..| .|+||+.++++|...
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATG----QEVAIKQINLQKQPKKELIINEILVMKEL------KNPNIVNFLDSFLVG 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCC----cEEEEEEEecccCchHHHHHHHHHHHHhc------CCCceeeeeeeEecC
Confidence 45999999999999999999988777 789999886532 2345677899999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+|+||||+ +++|..++... .+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~ 163 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCA 163 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEccCccch
Confidence 9999999999 67888887642 3899999999999999999999999999999999999985 7889999999986
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....++..|+|||++.+..++.++||||||||+|+|++|..||.+......+..+... ..+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~--~~~-------- 233 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN--GTP-------- 233 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCc--------
Confidence 544322 23456788999999999988999999999999999999999999776554433222110 000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+..++..+.+||.+||..||.+|||+.+||.||
T Consensus 234 -------------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~ 270 (296)
T cd06655 234 -------------------------------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (296)
T ss_pred -------------------------------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 0001123456788999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 271 ~~~~ 274 (296)
T cd06655 271 FLKL 274 (296)
T ss_pred Hhhh
Confidence 9963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.88 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=206.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+.+.||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..| +||||+.++++|.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 70 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK----KMFAMKYMNKQKCVEKGSVRNVLNERRILQEL------NHPFLVNLWYSFQ 70 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhC------CCCChHHHHHhhc
Confidence 4899999999999999999988776 789999997532 2346678899999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+|+||||+ +++|.+++... ..+++..+..|+.||+.||.|||.+||+|+||+|.|||++. ++.++|+|||+
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~l~d~~~ 146 (258)
T cd05578 71 DEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE-QGHVHITDFNI 146 (258)
T ss_pred CCCeEEEEEeCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC-CCCEEEeeccc
Confidence 999999999999 67999988764 34999999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 723 AMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 723 a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+...... ......++..|+|||++.+..++.++|||||||++|+|++|..||......... .+......
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~--------- 216 (258)
T cd05578 147 ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-QIRAKQET--------- 216 (258)
T ss_pred ccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-HHHHHhcc---------
Confidence 8765543 234456788899999999888999999999999999999999999765532110 00000000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH--HHHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV--AQAL 879 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa--~elL 879 (887)
..+..++.++..+.+||.+||..||.+||++ .+++
T Consensus 217 -------------------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -------------------------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------------------------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0011122345788999999999999999999 9999
Q ss_pred hCCCC
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~Hpwf 884 (887)
.||||
T Consensus 254 ~~~~~ 258 (258)
T cd05578 254 NHPYF 258 (258)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.83 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=209.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|+++++||.|+||.||++.+..++ ..||+|.+... ......+..|+.+|+++ +|+||++++++|..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~ 70 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD----SLVVWKEVNLTRLSEKERRDALNEIVILSLL------QHPNIIAYYNHFMD 70 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC----cEEEEEEEeecccchhHHHHHHHHHHHHHhC------CCCCeeEEEeEEec
Confidence 4999999999999999999988777 78999987643 33345678899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.+||+|||++
T Consensus 71 ~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~ 148 (256)
T cd08221 71 DNTLLIEMEYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK-AGLIKLGDFGIS 148 (256)
T ss_pred CCeEEEEEEecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC-CCCEEECcCcce
Confidence 99999999999 679999987642 235899999999999999999999999999999999999985 778999999999
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... .....+++.|+|||++.+..++.++||||||||+|+|++|..||...+..+.+..+... .++
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~------- 219 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT------- 219 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC-------
Confidence 7654432 33456789999999999988999999999999999999999999776555544433211 110
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.....++..+.+||.+||..+|.+|||+.+||+|
T Consensus 220 ----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ----------------------------------------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----------------------------------------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0012345678999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 254 ~~l 256 (256)
T cd08221 254 PLL 256 (256)
T ss_pred cCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=337.67 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=214.9
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
.+-.+.|.+..+||+|+||.||-|....+| ..||+|.+.+.-.. .....+|-.||.++ +.+.||.|
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTG----KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV------~s~FiVsl 250 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATG----KMYACKKLDKKRIKKRKGETMALNEKQILEKV------SSPFIVSL 250 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecch----hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh------ccCcEEEE
Confidence 344567999999999999999999999988 89999998754322 24557899999999 77799999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
.-.|++.+.+||||..| +|+|.-.|...+. .+|++..+++|+.+|+.||++||..+||+|||||+||||+. .++|.|
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd-~GhvRI 328 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD-HGHVRI 328 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc-CCCeEe
Confidence 99999999999999999 6788877777664 56999999999999999999999999999999999999994 899999
Q ss_pred EecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 718 CDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 718 ~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+|+|+|+-+.... ....+||..|||||++.+..|++..|||+|||+||+||.|+.||........
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-------------- 394 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-------------- 394 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------------
Confidence 9999998776654 4555999999999999999999999999999999999999999953211110
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc---
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM--- 873 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp--- 873 (887)
...+.+.+ +......+.++++++++|+..+|..||.+|+
T Consensus 395 ---------------------------~eEvdrr~-----------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 395 ---------------------------REEVDRRT-----------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---------------------------HHHHHHHH-----------hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 01111111 0111222356779999999999999999998
Q ss_pred --CHHHHHhCCCCCC
Q 002732 874 --TVAQALTHPFISG 886 (887)
Q Consensus 874 --Ta~elL~Hpwf~~ 886 (887)
+++++-+||||.+
T Consensus 437 g~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 437 GEGAQEVKEHPFFKD 451 (591)
T ss_pred CcCcchhhhCccccc
Confidence 5679999999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=335.11 Aligned_cols=282 Identities=31% Similarity=0.495 Sum_probs=217.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+.+.||.|+||.||+|.+.... ....||||++... ......+..|+.++..+. +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~ 73 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETS--EEETVAIKKITNVFSKKILAKRALRELKLLRHFR-----GHKNITCLYDMDIV 73 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCC--cCceEEEEEeccccccchhHHHHHHHHHHHHHhc-----CCCChheeeeeeee
Confidence 4899999999999999999987761 1278999998642 222355678999998883 58999999987543
Q ss_pred c----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 645 R----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 645 ~----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
. ..+|++++|++++|..++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|+||
T Consensus 74 ~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~-~~~~kl~Df 149 (332)
T cd07857 74 FPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA-DCELKICDF 149 (332)
T ss_pred ccccCCcEEEEEecccCCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC-CCCEEeCcC
Confidence 2 568999999998999888653 34999999999999999999999999999999999999985 778999999
Q ss_pred CcceecCCCC------ccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 721 GNAMFAGKNE------ITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 721 G~a~~~~~~~------~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|++....... .....+++.|+|||++.+ ..++.++|||||||+||+|++|.+||.+.+....+..++..++.+
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 9997543221 233568889999998876 468999999999999999999999999988888999999998888
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+..++....... ...++.......... .....+.++..+.+||.+||++||.+||
T Consensus 230 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~ 284 (332)
T cd07857 230 DEETLSRIGSPK---------------------AQNYIRSLPNIPKKP----FESIFPNANPLALDLLEKLLAFDPTKRI 284 (332)
T ss_pred CHHHHHhhhhhh---------------------HHHHHHhccccCCcc----hHhhCCCCCHHHHHHHHHHccCCcccCC
Confidence 776643221100 000000000000000 0111223457899999999999999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||.||||.
T Consensus 285 t~~~ll~~~~~~ 296 (332)
T cd07857 285 SVEEALEHPYLA 296 (332)
T ss_pred CHHHHhcChhhh
Confidence 999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.66 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=206.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.++..||.|+||.||+|.+..++ ..||+|++.... .....+..|+.+|..+ .|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG----KILVWKEIDYGNMTEKEKQQLVSEVNILREL------KHPNIVRYYDRIID 70 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC----CEEEEEEEecccCCHHHHHHHHHHHHHHHhc------CCCccceeeeeeec
Confidence 4899999999999999999988777 789999986432 2345667899999999 89999999998764
Q ss_pred --cCeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhh-----ccceeccCCCCCCccccCCCCeE
Q 002732 645 --RNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLK-----NCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 645 --~~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLH-----s~gIvHrDLKP~NILl~~~~~~v 715 (887)
...+|+||||+ +++|.+++.... ....+++..++.++.||+.||.||| +.+|+|+||+|+||||+. .+.+
T Consensus 71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~-~~~~ 149 (265)
T cd08217 71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA-NNNV 149 (265)
T ss_pred CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec-CCCE
Confidence 45789999999 679999987642 2345899999999999999999999 899999999999999994 7899
Q ss_pred EEEecCcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 716 KLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 716 KL~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
+|+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++|..||...........+... .+
T Consensus 150 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~ 227 (265)
T cd08217 150 KLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KF 227 (265)
T ss_pred EEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--CC
Confidence 999999997765443 34457888999999999988999999999999999999999999776543333222110 00
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+..+..++..+.+||.+||..+|.+||
T Consensus 228 -----------------------------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp 254 (265)
T cd08217 228 -----------------------------------------------------RRIPYRYSSELNEVIKSMLNVDPDKRP 254 (265)
T ss_pred -----------------------------------------------------CCCccccCHHHHHHHHHHccCCcccCC
Confidence 011123457789999999999999999
Q ss_pred CHHHHHhCCCC
Q 002732 874 TVAQALTHPFI 884 (887)
Q Consensus 874 Ta~elL~Hpwf 884 (887)
|+.+||+|||+
T Consensus 255 ~~~~il~~~~~ 265 (265)
T cd08217 255 STEELLQLPLI 265 (265)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=339.64 Aligned_cols=279 Identities=34% Similarity=0.552 Sum_probs=215.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..+|.+...||.|+||.||+|.+..++ ..||||++... ......+..|+.++..+ .|+||++++++|
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~ 83 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTG----EKVAIKKLSRPFQSEIFAKRAYRELTLLKHM------QHENVIGLLDVF 83 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCC----cEEEEEEecCccccccchhHHHHHHHHHHhc------CCCCccchhhee
Confidence 467999999999999999999988777 79999998753 22234567899999998 899999999998
Q ss_pred eec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 643 KYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 643 ~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
... ..+|+|+||+..+|..++. ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~-~~~~k 157 (342)
T cd07879 84 TSAVSGDEFQDFYLVMPYMQTDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE-DCELK 157 (342)
T ss_pred cccccCCCCceEEEEecccccCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEE
Confidence 754 3569999999877766642 24899999999999999999999999999999999999995 78899
Q ss_pred EEecCcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 717 L~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|+|||++..... ......++..|+|||++.+ ..++.++||||||||||+|++|+.||.+.+....+..++...+..+.
T Consensus 158 L~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 158 ILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred EeeCCCCcCCCC-CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999999876533 2344567888999999876 46899999999999999999999999988877788888777776655
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.++....... ....+. .+..+....+ ....+.++..+.+||.+||+.||.+|||+
T Consensus 237 ~~~~~~~~~~-----------------~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dP~~R~~~ 291 (342)
T cd07879 237 EFVQKLEDKA-----------------AKSYIK-SLPKYPRKDF-------STLFPKASPQAVDLLEKMLELDVDKRLTA 291 (342)
T ss_pred HHHHHhcccc-----------------hHHHHh-hcCCcccchH-------HHHhcCCCHHHHHHHHHHcCCChhhCcCH
Confidence 5432111100 000000 0000000000 00112345678999999999999999999
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.+||.||||.+
T Consensus 292 ~e~l~h~~f~~ 302 (342)
T cd07879 292 TEALEHPYFDS 302 (342)
T ss_pred HHHhcCcchhh
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=310.88 Aligned_cols=268 Identities=25% Similarity=0.369 Sum_probs=213.0
Q ss_pred CCCceecccCceec---CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCC
Q 002732 553 AEGYYSYRFGEILD---GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGA 627 (887)
Q Consensus 553 ~~g~~~~~~~eil~---~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~ 627 (887)
..||.+..-|+... +...++..||.|..|+||++....++ ...|||.+..+.. ..+.+...+.|+..-
T Consensus 75 ~tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~----~iiAVK~M~rt~Nkee~kRILmDldvv~~s--- 147 (391)
T KOG0983|consen 75 QTGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTG----HIIAVKQMRRTGNKEENKRILMDLDVVLKS--- 147 (391)
T ss_pred CceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccc----eEEEEEeecccCCHHHHHHHHHhhhHHhhc---
Confidence 45666665444432 34677889999999999999999888 7999999976432 234444444444433
Q ss_pred CCCCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhh-ccceeccCCCCCCc
Q 002732 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK-NCGVLHCDIKPDNM 706 (887)
Q Consensus 628 ~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLH-s~gIvHrDLKP~NI 706 (887)
..+|+||+++++|.....++|.||.|...+..+|..... ++++..+-.+...|+.||.||. .++||||||||+||
T Consensus 148 --~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI 223 (391)
T KOG0983|consen 148 --HDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 223 (391)
T ss_pred --cCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence 268999999999999999999999998888888877543 5999999999999999999998 57999999999999
Q ss_pred cccCCCCeEEEEecCccee-cCCCCccCcccCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCC-ChHH
Q 002732 707 LVNEAKNVLKLCDFGNAMF-AGKNEITPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGA-TNND 781 (887)
Q Consensus 707 Ll~~~~~~vKL~DFG~a~~-~~~~~~~~~~gt~~Y~aPE~l~~~---~~s~~sDIwSLG~iL~elltG~~PF~~~-~~~~ 781 (887)
||+. .+.|||||||++-. ......+-..|.+.|||||-|.-. .|+..+||||||+.|+||.||+.||.+. +..+
T Consensus 224 LlDe-~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe 302 (391)
T KOG0983|consen 224 LLDE-RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE 302 (391)
T ss_pred EEcc-CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence 9996 78899999999854 344445667889999999998643 5999999999999999999999999874 4556
Q ss_pred HHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHH
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL 861 (887)
++..++.... | .+ .....++..|.+|+
T Consensus 303 ~ltkvln~eP--P-~L--------------------------------------------------~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 303 VLTKVLNEEP--P-LL--------------------------------------------------PGHMGFSPDFQSFV 329 (391)
T ss_pred HHHHHHhcCC--C-CC--------------------------------------------------CcccCcCHHHHHHH
Confidence 6666644211 1 00 01123678999999
Q ss_pred HHhcccCCCCCcCHHHHHhCCCCC
Q 002732 862 DKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 862 ~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
..||..|+.+||...+||+|||+.
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~ 353 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIK 353 (391)
T ss_pred HHHhhcCcccCcchHHHhcCccee
Confidence 999999999999999999999985
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=324.66 Aligned_cols=278 Identities=29% Similarity=0.524 Sum_probs=214.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.++..||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+... .|++|++++++|...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~h~~i~~~~~~~~~~ 73 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG----RFVALKKVRVPLSEEGIPLSTLREIALLKQLESF---EHPNIVRLLDVCHGP 73 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC----CEEEEEEeccccccchhhhhHHHHHHHHHHhhcc---CCCCcceEEEEEeec
Confidence 678999999999999999987766 7899999974322 234556788888888543 699999999999887
Q ss_pred Ce-----EEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 646 NH-----LCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 646 ~~-----~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
.. +++||||+.++|.+++..... ..+++..++.++.||+.||.|||+.+|+|+||+|+|||++. ++.++|+||
T Consensus 74 ~~~~~~~~~l~~e~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~-~~~~~l~df 151 (287)
T cd07838 74 RTDRELKLTLVFEHVDQDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS-DGQVKIADF 151 (287)
T ss_pred cCCCCceeEEEehhcccCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc-CCCEEEecc
Confidence 76 999999998899998876432 35899999999999999999999999999999999999995 688999999
Q ss_pred CcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 721 GNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 721 G~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
|++....... .....++..|+|||++.+..++.++|||||||+||+|++|.+||.+.+..+.+..++.........-+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 152 GLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred CcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 9987654332 234457888999999999999999999999999999999999999888888877776654432211100
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
. ..... . ..+....+.. .....+.++..+.+||.+||+.||.+||++.++|
T Consensus 232 ~----------~~~~~--------~----~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 232 R----------NVSLP--------R----SSFPSYTPRS-------FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred C----------Ccccc--------h----hhcccccccc-------hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 00000 0 0000000000 0111234567889999999999999999999999
Q ss_pred hCCCC
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~Hpwf 884 (887)
.||||
T Consensus 283 ~~~~~ 287 (287)
T cd07838 283 QHPYF 287 (287)
T ss_pred cCcCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=326.78 Aligned_cols=249 Identities=25% Similarity=0.361 Sum_probs=196.5
Q ss_pred CcEEEEEEe--ccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAH--GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~L--G~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+.+.+ |.|+||.||+|.+..++ ..+|+|++...... ..|+.++..+. +|+||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~k~~~~~~~~----~~e~~~~~~~~-----~h~~iv~~~~~~~~ 80 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQ----KLFVQKIIKAKNFN----AIEPMVHQLMK-----DNPNFIKLYYSVTT 80 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCC----cEEEEEEEehhhcc----hhhHHHHHHhh-----cCCCEEEEEEEEec
Confidence 456776666 99999999999988877 78999998754221 12333333231 68999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.||+|+||+|+|||++..+..++|+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999 679999997643 59999999999999999999999999999999999999964448999999998
Q ss_pred eecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHhhCCCChhhhhccc
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l-~~i~~~~g~~p~~~l~~~~ 802 (887)
...... ....++..|+|||++.+..++.++|||||||++|+|++|..||........- ..+.... .
T Consensus 158 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~---------- 224 (267)
T PHA03390 158 KIIGTP--SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q---------- 224 (267)
T ss_pred eecCCC--ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c----------
Confidence 776533 2346788999999999999999999999999999999999999754332210 0000000 0
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-HHHHHhC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-VAQALTH 881 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-a~elL~H 881 (887)
......+.++..+.+||.+||+++|.+||+ +++||+|
T Consensus 225 ------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 225 ------------------------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ------------------------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 000111245678999999999999999996 5999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 263 ~~~~~ 267 (267)
T PHA03390 263 PFLKI 267 (267)
T ss_pred CcccC
Confidence 99974
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.48 Aligned_cols=290 Identities=33% Similarity=0.536 Sum_probs=233.4
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+..+|.-+..+|.|.- .|..|.|.-.+ ..||||.+.. +.........|+.++..+ +|+||+.++.+
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~----~~v~ikk~~~pf~n~~~akra~rel~l~~~v------~~~nii~l~n~ 83 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLG----RPVAIKKLSRPFQNQTHAKRAYRELKLMKCV------NHKNIISLLNV 83 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhcc----CceehhhhcCccccCccchhhhhhhhhhhhh------cccceeeeeec
Confidence 3467999999999998 88888887776 7899998753 233346678899999999 99999999999
Q ss_pred eeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 642 FKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 642 ~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
|... ..+|+|||+|..+|.+++.. .+....+.+|+.|++.|+.|||+.||+||||||+||+|+. ..++
T Consensus 84 ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~-~~~l 157 (369)
T KOG0665|consen 84 FTPQKTLEEFQEVYLVMELMDANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS-DCTL 157 (369)
T ss_pred cCccccHHHHHhHHHHHHhhhhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc-hhhe
Confidence 9864 45899999999999999883 2899999999999999999999999999999999999984 8899
Q ss_pred EEEecCcceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 716 KLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
||.|||+|...+.. ..++++.+.+|.|||++.+..|...+||||+|||+.||++|...|+|...-+++.++.+.+|.+.
T Consensus 158 Ki~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 158 KILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred eeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 99999999887776 67899999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..++..-..+...|...... +....+..++ + ..++....+..+.-...+.+||.+||..||++|++
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~-------y~~~~f~~~f---p----D~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris 303 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQ-------YQAISFSELF---P----DSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS 303 (369)
T ss_pred HHHHHHhhHHHHHHhhcChH-------hhccchhhhC---C----cccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence 77765433333222221110 0000111111 0 01111111222334467899999999999999999
Q ss_pred HHHHHhCCCCC
Q 002732 875 VAQALTHPFIS 885 (887)
Q Consensus 875 a~elL~Hpwf~ 885 (887)
+++||.||||+
T Consensus 304 v~daL~HPY~~ 314 (369)
T KOG0665|consen 304 VDDALRHPYIK 314 (369)
T ss_pred HHHHhcCCeee
Confidence 99999999995
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=335.78 Aligned_cols=281 Identities=33% Similarity=0.522 Sum_probs=219.4
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.++|.++..||+|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~~iv~~~~~ 84 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHM------KHENVIGLLDV 84 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCC----eEEEEEEecCcchhhHHHHHHHHHHHHHHHc------CCCcccceeee
Confidence 4577999999999999999999988776 799999987532 2235567899999999 89999999998
Q ss_pred eeec------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 642 FKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 642 ~~~~------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
|... +.+|+|+++++++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~ 159 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCEL 159 (345)
T ss_pred eeecccccccccEEEEehhcccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC-CCCE
Confidence 8643 457899999999998887642 3899999999999999999999999999999999999985 7789
Q ss_pred EEEecCcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 716 KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
+|+|||++..... ......++..|+|||++.+ ..++.++|||||||+||+|++|.+||.+......+..+....+..+
T Consensus 160 kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 160 KILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred EEecccccccccc-cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999876543 3344577889999999877 4689999999999999999999999998888888888888777776
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..++...... .....+. .+......... ......+..+.+||..||+.||.+|||
T Consensus 239 ~~~~~~~~~~-----------------~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dp~~R~t 293 (345)
T cd07877 239 AELLKKISSE-----------------SARNYIQ-SLTQMPKMNFA-------NVFIGANPLAVDLLEKMLVLDSDKRIT 293 (345)
T ss_pred HHHHhhcccH-----------------hHHHHHH-HhcccCCcchh-------hhcCCCCHHHHHHHHHHcCCChhhcCC
Confidence 6654221100 0000000 00011111100 001124567899999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+.++|.||||.+
T Consensus 294 ~~e~l~h~~f~~ 305 (345)
T cd07877 294 AAQALAHAYFAQ 305 (345)
T ss_pred HHHHhcChhhhh
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=355.43 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=199.5
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc-cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee-
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK- 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~-~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~- 643 (887)
..++.|.++|.+|||+.||+|.+...+ ..||||.+-. +......+.+||.+|+.|. .|+|||.|++...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~-----gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGG----KKYALKRMYVNDEEALNAVKREIDIMKLLS-----GHKNIVSYIDSSAI 106 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCC----ceeeeeeeecCCHHHHHHHHHHHHHHHHhc-----CCCceeeEeccccc
Confidence 346999999999999999999998875 6899997754 4555688899999999995 7999999999422
Q ss_pred e------cCeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccc--eeccCCCCCCccccCCCCe
Q 002732 644 Y------RNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG--VLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 644 ~------~~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~ 714 (887)
. ...++|+||||. |+|.++|...... .|++.+++.|+.+++.|+.+||.+. |||||||-+||||. +++.
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~ 184 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGN 184 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCC
Confidence 2 135789999995 7999999865443 3999999999999999999999988 99999999999999 4888
Q ss_pred EEEEecCcceecCCCCcc-----------CcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 002732 715 LKLCDFGNAMFAGKNEIT-----------PYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 715 vKL~DFG~a~~~~~~~~~-----------~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~ 780 (887)
+||||||.|+-......+ ....|+.|+|||+|. +.+.+.++|||+||||||-||....||......
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 999999998643221101 123488899999984 678999999999999999999999999654332
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
.++ ++.|. +| ..+.++..|.+|
T Consensus 265 aIl----------------ng~Y~-----------------------------------------~P-~~p~ys~~l~~L 286 (738)
T KOG1989|consen 265 AIL----------------NGNYS-----------------------------------------FP-PFPNYSDRLKDL 286 (738)
T ss_pred eEE----------------ecccc-----------------------------------------CC-CCccHHHHHHHH
Confidence 111 00000 11 125788999999
Q ss_pred HHHhcccCCCCCcCHHHHHhC
Q 002732 861 LDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~H 881 (887)
|..||+.||.+||++-|+|.+
T Consensus 287 I~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 287 IRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHhccCcccCCCHHHHHHH
Confidence 999999999999999999864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=327.07 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=206.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|++.+.||.|+||.||+|.+..++ ..||||++.... .....+..|+.+++.+ .|+||+.++++|...
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~ 71 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTG----KIMAVKTIRLEINEAIQKQILRELDILHKC------NSPYIVGFYGAFYNN 71 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCC----cEEEEEEEecccChHHHHHHHHHHHHHHHC------CCCchhhhheeeecC
Confidence 5888999999999999999998776 789999987642 3345677899999988 799999999999999
Q ss_pred CeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 NHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+.+||||||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+|+||+|+|||++. .+.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~ 148 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS 148 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccc
Confidence 99999999995 79999988642 358999999999999999999999 99999999999999995 778999999998
Q ss_pred eecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATN--NDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~--~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
............++..|+|||++.+..++.++|||||||+||+|++|..||..... ...+..
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------- 212 (265)
T cd06605 149 GQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL---------------- 212 (265)
T ss_pred hhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH----------------
Confidence 66543333336778899999999999999999999999999999999999965421 000000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChh-hHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK-MLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..++.... +..... ++..+.+||.+||..||.+|||+.+||.
T Consensus 213 -------------------------~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 213 -------------------------LQYIVNEPP-----------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------------------------HHHHhcCCC-----------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011110000 001111 5678899999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||+.
T Consensus 257 ~~~~~~ 262 (265)
T cd06605 257 HPFIKK 262 (265)
T ss_pred Cchhhc
Confidence 999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.03 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=198.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc------hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE------TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
.|.+.+.||+|+||.||+|.+..++ ..||||++.... .....+..|+.+|..| .|+||+.++++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 72 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTG----RELAAKQVQFDPESPETSKEVSALECEIQLLKNL------QHERIVQYYGC 72 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCC----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc------CCCCeeeEEEE
Confidence 4899999999999999999988777 789999886431 1234567899999999 89999999998
Q ss_pred eee--cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 642 FKY--RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 642 ~~~--~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
+.. ...++|||||+ +++|.+++.... .+++..++.++.||+.||.|||+++|+|+||+|+|||++. ++.++|+
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~-~~~~~l~ 148 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS-AGNVKLG 148 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC-CCCEEEc
Confidence 875 36789999999 568999887643 3899999999999999999999999999999999999984 7789999
Q ss_pred ecCcceecCCC-----CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 719 DFGNAMFAGKN-----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 719 DFG~a~~~~~~-----~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|||++...... ......++..|+|||++.+..++.++||||||||+|+|++|..||........+..+.. ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~ 225 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP 225 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC
Confidence 99998654321 12234578889999999998899999999999999999999999965433222211100 00
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
..+..+..++..+.+|| .||..+|.+||
T Consensus 226 ---------------------------------------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp 253 (266)
T cd06651 226 ---------------------------------------------------TNPQLPSHISEHARDFL-GCIFVEARHRP 253 (266)
T ss_pred ---------------------------------------------------CCCCCchhcCHHHHHHH-HHhcCChhhCc
Confidence 00111223456778888 57778999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||.||||+
T Consensus 254 ~~~eil~hp~~~ 265 (266)
T cd06651 254 SAEELLRHPFAQ 265 (266)
T ss_pred CHHHHhcCcccc
Confidence 999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=334.45 Aligned_cols=280 Identities=32% Similarity=0.561 Sum_probs=222.5
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.++|.++..||.|+||.||+|.+..++ ..||||++.+. ......+..|+.+|..| .||||++++++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~ 77 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTG----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHL------RHENIISLSDI 77 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCC----CEEEEEEecccccccchhHHHHHHHHHHHhc------CCCCeeeEeee
Confidence 4678999999999999999999998877 79999988642 22235667899999999 89999999999
Q ss_pred eee-cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKY-RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~-~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
|.. ...+||||||++++|..++.. ..+++..+..++.||+.||.|||+.||+|+||+|.|||++. .+.++|+||
T Consensus 78 ~~~~~~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~-~~~~~l~df 152 (328)
T cd07856 78 FISPLEDIYFVTELLGTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE-NCDLKICDF 152 (328)
T ss_pred EecCCCcEEEEeehhccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC-CCCEEeCcc
Confidence 876 568999999998899888764 23889999999999999999999999999999999999985 778999999
Q ss_pred CcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 721 GNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 721 G~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
|++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+......+..+.+.++.+|..+..
T Consensus 153 g~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 153 GLARIQDP-QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccccccCC-CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 99876543 2344567888999999876 568999999999999999999999999988888888888889988887754
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
...... .+ .++......... ......+.++..+.+||.+||+.+|.+|||+.++|
T Consensus 232 ~~~~~~-----~~----------------~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 232 TICSEN-----TL----------------RFVQSLPKREPV----PFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred hccchh-----hH----------------HHHhhccccCCC----cHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 221110 00 000000000000 00011123567899999999999999999999999
Q ss_pred hCCCCC
Q 002732 880 THPFIS 885 (887)
Q Consensus 880 ~Hpwf~ 885 (887)
.||||.
T Consensus 287 ~~~~~~ 292 (328)
T cd07856 287 AHPYLA 292 (328)
T ss_pred cCCccc
Confidence 999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.52 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=201.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc------hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE------TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
.|.+...||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..| .|+||++++++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~ 72 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTG----RELAVKQVQFDPESPETSKEVNALECEIQLLKNL------LHERIVQYYGC 72 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCC----cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc------CCCCeeeEEeE
Confidence 5999999999999999999988777 789999885321 1234667899999999 89999999998
Q ss_pred eee--cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 642 FKY--RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 642 ~~~--~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
|.. ...+++||||+ +++|.+++..... +++..+..++.||+.||.|||+++|+|+||+|.|||++. ++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~l~ 148 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS-VGNVKLG 148 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC-CCCEEEC
Confidence 876 35789999999 5799999876543 899999999999999999999999999999999999984 7889999
Q ss_pred ecCcceecCC-----CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 719 DFGNAMFAGK-----NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 719 DFG~a~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|||++..... .......++..|+|||++.+..++.++||||||||||+|++|..||........+..+ ....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~ 225 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQP 225 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCC
Confidence 9999865432 1233456788999999999888999999999999999999999999654333222111 0000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
..+..++.++..+.+||.+||. +|..||
T Consensus 226 ---------------------------------------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp 253 (265)
T cd06652 226 ---------------------------------------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRP 253 (265)
T ss_pred ---------------------------------------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCC
Confidence 0011233456788999999994 999999
Q ss_pred CHHHHHhCCCCC
Q 002732 874 TVAQALTHPFIS 885 (887)
Q Consensus 874 Ta~elL~Hpwf~ 885 (887)
|+.+||+|||+.
T Consensus 254 ~~~~il~~~~~~ 265 (265)
T cd06652 254 SADELLRHTFVH 265 (265)
T ss_pred CHHHHhcCcccC
Confidence 999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=321.13 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=206.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+.+.||.|+||.||+|.+..++ ..||||.+... ......+..|+.+++.+ .|+||++++++|..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~------~h~~i~~~~~~~~~ 70 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS----EHCVIKEIDLTKMPVKEKEASKKEVILLAKM------KHPNIVTFFASFQE 70 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC----ceEEEEEeeHhhccchhhHHHHHHHHHHHhC------CCCChhhhhheecc
Confidence 4899999999999999999998776 78999998653 12345677899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+||||||+ +++|.+++.... ...+++..+..|+.||+.||.|||+.+|+|+||+|.|||++..+..++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 71 NGRLFIVMEYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred CCeEEEEEecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 99999999999 679999887633 2348999999999999999999999999999999999999865567899999998
Q ss_pred eecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... .....+++.|+|||++.+..++.++||||||||+|+|++|..||...+....+..+... .+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~-------- 219 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--YF-------- 219 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--cC--------
Confidence 7655432 23346788899999999889999999999999999999999999765544333222110 00
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
....+.++..+.+||.+||..+|.+|||+.+||.|
T Consensus 220 ---------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ---------------------------------------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---------------------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00112344678999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 255 ~~~ 257 (257)
T cd08225 255 PFL 257 (257)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.92 Aligned_cols=278 Identities=32% Similarity=0.544 Sum_probs=217.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCC-CcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPEN-KRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~-h~~Iv~l~~~~~~~ 645 (887)
|.+.+.||.|+||+||+|.+..++ ..||||.+..... .......|+.++..+ . |++|+.++++|...
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~------~~h~~i~~~~~~~~~~ 70 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG----ELVAIKKMKKKFYSWEECMNLREVKSLRKL------NEHPNIVKLKEVFREN 70 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC----cEEEEEEehhhccchhHHHHHHHHHHHHhc------cCCCCchhHHHHhhcC
Confidence 678899999999999999987766 7899999865422 122335677788777 5 99999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+.+|+||||++++|.+++.... ...+++..+..++.||+.+|.|||++||+|+||+|.||||+. .+.++|+|||++..
T Consensus 71 ~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~ 148 (283)
T cd07830 71 DELYFVFEYMEGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG-PEVVKIADFGLARE 148 (283)
T ss_pred CcEEEEEecCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC-CCCEEEeeccccee
Confidence 9999999999999999887643 235899999999999999999999999999999999999995 78899999999976
Q ss_pred cCCC-CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGKN-EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~~-~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.... ......++..|+|||++.. ..++.++|||||||+||+|++|.+||......+.+..+...++.++...+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 149 IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 6543 2345667889999998854 4589999999999999999999999999988888888888888776554432211
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
....+...+. ...+..+..+ .+..+..+.+||.+||+.+|.+|||+.|||.|||
T Consensus 229 ~~~~~~~~~~-------------------~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 229 LASKLGFRFP-------------------QFAPTSLHQL-------IPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred hhcccccccc-------------------ccccccHHHH-------cccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 1110100000 0000000000 0112467899999999999999999999999999
Q ss_pred C
Q 002732 884 I 884 (887)
Q Consensus 884 f 884 (887)
|
T Consensus 283 ~ 283 (283)
T cd07830 283 F 283 (283)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.25 Aligned_cols=248 Identities=31% Similarity=0.574 Sum_probs=206.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+|.+...||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..+. .|+||++++++|.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~~ 72 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETN----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GHPGIIKLYYTFQ 72 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCC----CEEEEEEechHhccchHHHHHHHHHHHHHHhcc-----cCCCchhHHHHhc
Confidence 5999999999999999999998776 799999997632 22356677888888882 3999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+||||||+ +++|.+++.... .+++..++.|+.||+.||.|||++||+|+||+|+||||+. ++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~-~~~~~l~df~~ 148 (280)
T cd05581 73 DEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK-DMHIKITDFGT 148 (280)
T ss_pred CCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEecCCcc
Confidence 999999999999 789999998754 4999999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCC----------------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH
Q 002732 723 AMFAGKNE----------------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 723 a~~~~~~~----------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~ 780 (887)
+....... .....++..|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 87654322 12345678899999999888999999999999999999999999876654
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
..+..+......+ +..++..+.+|
T Consensus 229 ~~~~~~~~~~~~~--------------------------------------------------------~~~~~~~~~~l 252 (280)
T cd05581 229 LTFQKILKLEYSF--------------------------------------------------------PPNFPPDAKDL 252 (280)
T ss_pred HHHHHHHhcCCCC--------------------------------------------------------CCccCHHHHHH
Confidence 4443332211111 11234678899
Q ss_pred HHHhcccCCCCCcCH----HHHHhCCCC
Q 002732 861 LDKIFVLDPEKRMTV----AQALTHPFI 884 (887)
Q Consensus 861 L~kmL~~DP~~RpTa----~elL~Hpwf 884 (887)
|..||..+|.+|||+ .+||+||||
T Consensus 253 i~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 253 IEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=324.04 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=202.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----------hhHHHHHHHHHHHHhhCCCCCCCccee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----------MNKAGQTEVQILKKLAGADPENKRHCI 636 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv 636 (887)
+|.+.+.||.|+||.||+|.+..++ ..||||.+..... ..+.+..|+.++..+ .|+||+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~ 71 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG----EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL------DHLNIV 71 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC----ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc------CCCCcc
Confidence 4889999999999999999987776 7899998863211 123466788888888 899999
Q ss_pred EecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 637 RFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 637 ~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
++++++...+.+++||||+ +++|.+++...+ .+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~-~~~~ 147 (272)
T cd06629 72 QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA-DGIC 147 (272)
T ss_pred eEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC-CCeE
Confidence 9999999999999999999 679999987753 4899999999999999999999999999999999999985 7889
Q ss_pred EEEecCcceecCCC----CccCcccCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHh
Q 002732 716 KLCDFGNAMFAGKN----EITPYLVSRFYRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789 (887)
Q Consensus 716 KL~DFG~a~~~~~~----~~~~~~gt~~Y~aPE~l~~~~--~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~ 789 (887)
+|+|||++...... ......++..|+|||++.... ++.++||||||||+|+|++|..||........+..+...
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK 227 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc
Confidence 99999998654321 123346788899999998755 899999999999999999999999654433222211100
Q ss_pred hCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCC
Q 002732 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDP 869 (887)
Q Consensus 790 ~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP 869 (887)
.... . ......+.++..+.+||.+||..+|
T Consensus 228 ~~~~--------------------------------------------~------~~~~~~~~~~~~~~~li~~~l~~~p 257 (272)
T cd06629 228 RSAP--------------------------------------------P------IPPDVSMNLSPVALDFLNACFTINP 257 (272)
T ss_pred ccCC--------------------------------------------c------CCccccccCCHHHHHHHHHHhcCCh
Confidence 0000 0 0001123356789999999999999
Q ss_pred CCCcCHHHHHhCCCC
Q 002732 870 EKRMTVAQALTHPFI 884 (887)
Q Consensus 870 ~~RpTa~elL~Hpwf 884 (887)
..|||+.+||+||||
T Consensus 258 ~~Rps~~~il~~~~~ 272 (272)
T cd06629 258 DNRPTARELLQHPFI 272 (272)
T ss_pred hhCCCHHHHhhCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=320.11 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=204.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc------hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE------TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+|.+.+.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..+ .|++|++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~ 70 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL------QHPNIVQYLGT 70 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhc------CCCCchheeee
Confidence 4778899999999999999987666 789999986532 1335677899999988 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
+.....+||||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++. .+.+||+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~-~~~~kl~d~ 146 (258)
T cd06632 71 EREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT-NGVVKLADF 146 (258)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEccC
Confidence 99999999999999 569999987643 3899999999999999999999999999999999999985 788999999
Q ss_pred CcceecCCCC-ccCcccCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 721 GNAMFAGKNE-ITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|++....... .....++..|+|||.+.... ++.++||||||||||+|++|..||........+..+... ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~------ 219 (258)
T cd06632 147 GMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS-KE------ 219 (258)
T ss_pred ccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc-cc------
Confidence 9987654433 34566788999999998776 899999999999999999999999655432222111100 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.+..+..++..+.+||.+||..+|..|||+.++
T Consensus 220 -----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 220 -----------------------------------------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred -----------------------------------------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 011122345778999999999999999999999
Q ss_pred HhCCCC
Q 002732 879 LTHPFI 884 (887)
Q Consensus 879 L~Hpwf 884 (887)
|.||||
T Consensus 253 l~~~~~ 258 (258)
T cd06632 253 LEHPFV 258 (258)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=321.33 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=199.3
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
+.....||+|+||.||+|.+..++ ..||||.+.... .....+..|+.++..+ .|+||+++++++...+.
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~----~~v~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQ----VRIAIKEIPERDSRYVQPLHEEIALHSYL------KHRNIVQYLGSDSENGF 79 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCC----cEEEEEEecCCCHHHHHHHHHHHHHHHhc------CCCCeeeeeeeeccCCE
Confidence 334458999999999999987766 789999887543 2345678899999998 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
++|||||+ +++|.+++.........+...+..++.||+.||.|||+.||+|+||+|.||||+...+.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999 57999998764222112888899999999999999999999999999999999865678999999998765
Q ss_pred CCC--CccCcccCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 727 GKN--EITPYLVSRFYRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 727 ~~~--~~~~~~gt~~Y~aPE~l~~~~--~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
... ......+++.|+|||++.+.. ++.++||||||||||+|++|.+||..............
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-------------- 225 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-------------- 225 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh--------------
Confidence 432 223345788999999987654 88999999999999999999999964322111100000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
+. ...+..+..++..+.+||.+||..+|.+|||+.++|.||
T Consensus 226 ----------------------------~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 266 (268)
T cd06624 226 ----------------------------MF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266 (268)
T ss_pred ----------------------------hh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence 00 001111233557889999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
||
T Consensus 267 ~~ 268 (268)
T cd06624 267 FL 268 (268)
T ss_pred CC
Confidence 98
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.81 Aligned_cols=247 Identities=27% Similarity=0.465 Sum_probs=195.6
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh----HHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~----~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.||.|+||.||+|.+..++ ..||||++.+..... .....|..++... ..|+||++++++|...+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-----GESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhc-----CCCCCeeeeeeeEEcCCeE
Confidence 57899999999999987776 789999987543211 1222333332222 2799999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
||||||+ +++|..++.... .+++..+..|+.||+.||.|||+.||+|+||+|.|||++. .+.++|+|||++....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGL 148 (260)
T ss_pred EEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCcEEEeecccceecc
Confidence 9999999 679999987654 4899999999999999999999999999999999999985 7789999999986644
Q ss_pred CCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 728 KNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 728 ~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
. .....++..|+|||++.+..++.++||||||||||+|++|.+||...+....+..+......++
T Consensus 149 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 213 (260)
T cd05611 149 E--NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP------------- 213 (260)
T ss_pred c--cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC-------------
Confidence 3 2334678889999999988899999999999999999999999987665554443322111110
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---HHHHHhCCCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---VAQALTHPFI 884 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---a~elL~Hpwf 884 (887)
......++..+.+||.+||+.+|..||| ++|||.||||
T Consensus 214 ---------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 214 ---------------------------------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred ---------------------------------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 0011234577899999999999999994 5799999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 255 ~~ 256 (260)
T cd05611 255 KS 256 (260)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=322.96 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=200.8
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.++..| .|+||+++++++.....+||
T Consensus 1 lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~l 70 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN----RTFALKCVKKRHIVETGQQEHIFSEKEILEEC------NHPFIVKLYRTFKDKKYIYM 70 (262)
T ss_pred CCCCCceEEEEEEECCCC----cEEEEEEEehhcchhhhHHHHHHHHHHHHHhC------CCCCEeeeeeeEEcCCccEE
Confidence 699999999999997766 789999997543 2335678899999988 89999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.++|.... .+++..+..++.||+.||.|||++||+|+||+|.||||+. ++.++|+|||++......
T Consensus 71 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 71 LMEYCLGGELWTILRDRG---LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EEecCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCcc
Confidence 99998 679999997643 3899999999999999999999999999999999999985 788999999999766543
Q ss_pred -CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 730 -EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT--NNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 730 -~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~--~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
......++..|+|||++.+..++.++||||||||||+|++|.+||.... ....+..+.....
T Consensus 147 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 211 (262)
T cd05572 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG--------------- 211 (262)
T ss_pred cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC---------------
Confidence 2234567889999999988889999999999999999999999997655 2222222210000
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHHHHhC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQALTH 881 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~elL~H 881 (887)
....+..++..+.+||.+||..+|.+||| +.|+|+|
T Consensus 212 ---------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 212 ---------------------------------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ---------------------------------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 00011122467899999999999999999 9999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||++
T Consensus 253 ~~~~~ 257 (262)
T cd05572 253 KWFNG 257 (262)
T ss_pred hhhhC
Confidence 99974
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.67 Aligned_cols=244 Identities=33% Similarity=0.532 Sum_probs=201.8
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+ .|+||+++++++.....+||
T Consensus 1 lg~g~~~~vy~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~~l 70 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG----DIYAIKVIKKADMIRKNQVDQVLTERDILSQA------QSPYVVKLYYSFQGKKNLYL 70 (265)
T ss_pred CCCCCceEEEEEEECCCC----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhC------CCcchhHHHHheecCcEEEE
Confidence 689999999999988766 7999999976432 345667888888888 89999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.+++.... .+++..+..|+.||+.||.|||..||+|+||+|.|||++. ++.++|+|||++......
T Consensus 71 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 71 VMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC-CCCEEEEecccchhcccC
Confidence 99999 569999998754 4899999999999999999999999999999999999995 788999999998654332
Q ss_pred ----------CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 730 ----------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 730 ----------~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
......++..|+|||++.+..++.++|||||||++|+|++|..||........+..+......+|.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 222 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE---- 222 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc----
Confidence 223345678899999999888999999999999999999999999876655544433221111100
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH---H
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV---A 876 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa---~ 876 (887)
...++..+.+||.+||+.+|.+|||+ .
T Consensus 223 --------------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~ 252 (265)
T cd05579 223 --------------------------------------------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIE 252 (265)
T ss_pred --------------------------------------------------cccCCHHHHHHHHHHhcCCHhhcCCCccHH
Confidence 00134778999999999999999999 9
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
++|.||||++
T Consensus 253 ~~l~~~~~~~ 262 (265)
T cd05579 253 EIKNHPFFKG 262 (265)
T ss_pred HHhcCccccC
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=326.38 Aligned_cols=249 Identities=21% Similarity=0.380 Sum_probs=194.7
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
+||+|+||.||+|.+..++ +.||||++.+.... ...+..|..++..+.. ..|++|+.++++|.....+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~~~~~~~ 73 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVST---GDCPFIVCMSYAFHTPDKLS 73 (278)
T ss_pred CcccCCCeEEEEEEEecCC----CEEEEEEeeccccccchhHHHHHHHHHHHHHHHh---CCCCcEeeeeeeeecCCEEE
Confidence 4799999999999988776 79999998754221 1223445555544433 27899999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
+||||+ +++|..++.... .+++..++.|+.||+.||.|||+.+|+|+||+|.|||++. ++.++|+|||++.....
T Consensus 74 ~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~ 149 (278)
T cd05606 74 FILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 149 (278)
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence 999999 678888876533 4999999999999999999999999999999999999985 78899999999876554
Q ss_pred CCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 729 NEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 729 ~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
......+++..|+|||++.+. .++.++||||||||||+|++|..||............ ..
T Consensus 150 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~------------------ 210 (278)
T cd05606 150 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RM------------------ 210 (278)
T ss_pred cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HH------------------
Confidence 444456789999999999854 6899999999999999999999999654221111000 00
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHhCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALTHP 882 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~Hp 882 (887)
... ..+..+..++..+.+||.+||..+|..|| ++.++|+||
T Consensus 211 -----------------------~~~-----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 211 -----------------------TLT-----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred -----------------------hhc-----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 000 00011223457899999999999999999 999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||.+
T Consensus 257 ~~~~ 260 (278)
T cd05606 257 FFRS 260 (278)
T ss_pred cccC
Confidence 9975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.94 Aligned_cols=249 Identities=27% Similarity=0.362 Sum_probs=205.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.+++.||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|++|+.++++|...
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQ----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKG 74 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCC----EEEEEEEEeccccHHHHHHHHHHHHHHHhC------CCCCEeeEEEEEEEC
Confidence 4888899999999999999988776 789999987543 2345677888999888 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+|+|+||+|+|||++. .+.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~ 149 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE-QGDVKLADFGVAG 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC-CCCEEEcccccce
Confidence 9999999999 6699888864 24899999999999999999999999999999999999985 7789999999996
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....++..|+|||++.+..++.++|||||||+||+|++|.+||........+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------- 216 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN------------- 216 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-------------
Confidence 654322 23345788899999999989999999999999999999999999765443222111000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
. .+.....++..+.+||.+||..+|.+|||+.++|.||
T Consensus 217 --------------------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 217 --------------------------------N----------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred --------------------------------C----------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 0 0111223557789999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 255 ~~~~ 258 (277)
T cd06640 255 FIVK 258 (277)
T ss_pred Hhhh
Confidence 9964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.94 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=201.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.++..||.|+||.||++.+..++ ..||||.+.... .....+..|+.++.++. .|+||+++++++...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~~iv~~~~~~~~~ 75 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSG----TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-----DCPYIVKFYGALFRE 75 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCC----CEEEEEEehhccChHHHHHHHHHHHHHHHhc-----CCCCEeeeeeEEecC
Confidence 3667788999999999999998877 899999987532 23456678888888882 489999999999999
Q ss_pred CeEEEEEecchhhHHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 646 NHLCLVFESLHMNLREVLKKF--GRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~--~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...++||||+.++|.++.... .....+++..+..++.||+.||.|||+ .+|+|+||+|+|||++. .+.++|+|||+
T Consensus 76 ~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~ 154 (288)
T cd06616 76 GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGI 154 (288)
T ss_pred CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecch
Confidence 999999999987766654321 122459999999999999999999997 59999999999999985 77899999999
Q ss_pred ceecCCC-CccCcccCCcccchhhhcCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKN-EITPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~-~~~~~~gt~~Y~aPE~l~~~---~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+...... ......+++.|+|||++.+. .++.++||||||||+|+|++|.+||.... .....+.......+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~- 231 (288)
T cd06616 155 SGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL- 231 (288)
T ss_pred hHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-
Confidence 8654332 22344678899999999876 68999999999999999999999996543 11111111111000000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.......++..+.+||.+||+.+|.+|||+.+|
T Consensus 232 -----------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 264 (288)
T cd06616 232 -----------------------------------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264 (288)
T ss_pred -----------------------------------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 001112356789999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
|.||||..
T Consensus 265 ~~~~~~~~ 272 (288)
T cd06616 265 LEHPFIKD 272 (288)
T ss_pred hcChhhhc
Confidence 99999964
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=326.19 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=198.1
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||+||+|.+..++ ..||||++..... ....+..|+.+|..| +||||+.++++|...+.+||
T Consensus 1 lg~g~~g~vy~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~l 70 (277)
T cd05577 1 LGKGGFGEVCACQVKATG----KMYACKKLDKKRLKKRKGEQMALNEKKILEKV------SSRFIVSLAYAFETKDDLCL 70 (277)
T ss_pred CCCCCceeEEEEEEcCCC----cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC------CCCCEeeeeeEEecCCeEEE
Confidence 699999999999988777 7899999865321 223446789999888 79999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.++|..... ..+++..++.++.||+.||.|||++||+|+||+|.|||++. ++.++|+|||++......
T Consensus 71 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 71 VMTLMNGGDLKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGG 148 (277)
T ss_pred EEecCCCCcHHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEccCcchhhhccC
Confidence 99999 5799998876542 35899999999999999999999999999999999999985 778999999998765432
Q ss_pred -CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccc
Q 002732 730 -EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808 (887)
Q Consensus 730 -~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f 808 (887)
......++..|+|||++.+..++.++||||||||||+|++|..||...........+.....
T Consensus 149 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 211 (277)
T cd05577 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL----------------- 211 (277)
T ss_pred CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----------------
Confidence 22344567889999999988899999999999999999999999965433111111100000
Q ss_pred ccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc-----CHHHHHhCCC
Q 002732 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVAQALTHPF 883 (887)
Q Consensus 809 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~elL~Hpw 883 (887)
......+..++..+.+||.+||+.+|.+|| ++.+||.|||
T Consensus 212 -----------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 212 -----------------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred -----------------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence 000011223457889999999999999999 9999999999
Q ss_pred CCC
Q 002732 884 ISG 886 (887)
Q Consensus 884 f~~ 886 (887)
|..
T Consensus 257 ~~~ 259 (277)
T cd05577 257 FKD 259 (277)
T ss_pred hhc
Confidence 963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=329.77 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=206.2
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
.....|.++..||.|+||+||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||++++
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~~~ 81 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTN----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL------RHPNTIEYK 81 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCC----cEEEEEEEeccccCcHHHHHHHHHHHHHHHhC------CCCCEEEEE
Confidence 34456999999999999999999987766 789999886421 2224567899999998 899999999
Q ss_pred ceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 640 SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
++|...+..||||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|.|||++. ++.++|+|
T Consensus 82 ~~~~~~~~~~lv~e~~~g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~-~~~~kL~d 158 (307)
T cd06607 82 GCYLREHTAWLVMEYCLGSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE-PGTVKLAD 158 (307)
T ss_pred EEEEeCCeEEEEHHhhCCCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC-CCCEEEee
Confidence 9999999999999999999888886533 24899999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
||++...... ....++..|+|||++. ...++.++||||||||||+|++|.+||.+.+....+..+... ..|
T Consensus 159 fg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~-- 232 (307)
T cd06607 159 FGSASLVSPA--NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP-- 232 (307)
T ss_pred cCcceecCCC--CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCC--
Confidence 9998765433 3456788899999985 346889999999999999999999999766544332221100 000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
. .....++..+.+||.+||..+|.+|||+.
T Consensus 233 -----------------------------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 262 (307)
T cd06607 233 -----------------------------------------T---------LSSNDWSDYFRNFVDSCLQKIPQDRPSSE 262 (307)
T ss_pred -----------------------------------------C---------CCchhhCHHHHHHHHHHhcCChhhCcCHH
Confidence 0 00112456789999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
+||.||||..
T Consensus 263 ~il~~~~~~~ 272 (307)
T cd06607 263 ELLKHRFVLR 272 (307)
T ss_pred HHhcChhhcc
Confidence 9999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=336.99 Aligned_cols=284 Identities=32% Similarity=0.502 Sum_probs=218.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
.+.++|.+.+.||.|+||.||+|.+..++ ..||||.+... ......+..|+.++.+|. +|+||+++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~ni~~~~~ 74 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTK----EVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLN 74 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCC----eEEEEEeeccccCcchhhhhhhHHHHHHHHhc-----CCCCccceee
Confidence 45677999999999999999999987766 78999988542 222345567888888883 6899999999
Q ss_pred eeeec--CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 641 SFKYR--NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 641 ~~~~~--~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
+|... ..+||||||+.++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|.||||+. ++.++|+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~-~~~~kl~ 149 (337)
T cd07852 75 VIKAENDKDIYLVFEYMETDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS-DCRVKLA 149 (337)
T ss_pred eeccCCCceEEEEecccccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEEe
Confidence 88653 468999999998998888653 4889999999999999999999999999999999999985 7889999
Q ss_pred ecCcceecCCC-------CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 719 DFGNAMFAGKN-------EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 719 DFG~a~~~~~~-------~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
|||++...... ....+.++..|+|||++.+ ..++.++||||||||||+|++|.+||.+....+.+..+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99998654322 2234567889999998865 457899999999999999999999999988888888888777
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
+.++...+.... ......++..+....... .....+.++.++.+||.+||+.||.
T Consensus 230 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~P~ 284 (337)
T cd07852 230 GPPSAEDIESIK---------------------SPFAATMLDSLPSRPRKP----LDELLPKASDDALDLLKKLLVFNPN 284 (337)
T ss_pred CCCCHHHHHHHH---------------------hhhHHHhhhhcccccccc----hhhhccCCCHHHHHHHHHhccCCcc
Confidence 766554321100 000001111000000000 0111223568899999999999999
Q ss_pred CCcCHHHHHhCCCCCC
Q 002732 871 KRMTVAQALTHPFISG 886 (887)
Q Consensus 871 ~RpTa~elL~Hpwf~~ 886 (887)
.|||+.++|+||||.+
T Consensus 285 ~Rps~~~il~~~~~~~ 300 (337)
T cd07852 285 KRLTAEEALEHPYVAQ 300 (337)
T ss_pred cccCHHHHhhChhhhh
Confidence 9999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=319.44 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=208.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.+.+.||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|++|++++++|...
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~----~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 71 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTG----KIYALKKIHVDGDEEFRKQLLRELKTLRSC------ESPYVVKCYGAFYKE 71 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCC----cEEEEEEeccCcchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEccC
Confidence 5899999999999999999998877 799999987653 2356778899999999 799999999999999
Q ss_pred CeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 NHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+.++|||||+. ++|.+++... ..+++..++.++.||+.||.|||+ .||+|+||+|+||+++. ++.++|+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~-~~~~~l~df~~~ 147 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS-KGEVKIADFGIS 147 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC-CCCEEEccCccc
Confidence 99999999995 7999999875 349999999999999999999999 99999999999999985 788999999999
Q ss_pred eecCCCCc--cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNEI--TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
........ ....++..|+|||++.+..++.++||||||||||+|++|..||...........+......
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------- 218 (264)
T cd06623 148 KVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG--------- 218 (264)
T ss_pred eecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---------
Confidence 77654332 2456788899999999989999999999999999999999999665321111111000000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChh-hHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK-MLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
. .+..... ++..+.+||.+||..+|..|||+.+||+
T Consensus 219 --------------------------------~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 --------------------------------P-----------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --------------------------------C-----------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 0001112 5578899999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||..
T Consensus 256 ~~~~~~ 261 (264)
T cd06623 256 HPFIKK 261 (264)
T ss_pred CHHHHh
Confidence 999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=343.61 Aligned_cols=236 Identities=25% Similarity=0.390 Sum_probs=195.9
Q ss_pred EEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 571 i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
-++-||.|+.|.||++.... +.||||.++ +....+|+-|++| .|+||+.|.++|.....+||
T Consensus 128 ELeWlGSGaQGAVF~Grl~n------etVAVKKV~------elkETdIKHLRkL------kH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHN------ETVAVKKVR------ELKETDIKHLRKL------KHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hhhhhccCcccceeeeeccC------ceehhHHHh------hhhhhhHHHHHhc------cCcceeeEeeeecCCceeEE
Confidence 35668999999999998755 579999874 3334577888888 99999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC-C
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG-K 728 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~-~ 728 (887)
||||| .|.|+++|+.-.. ++...+..|.++|+.|++|||.+.|||||||.-||||.. +.+|||+|||.+.-.. .
T Consensus 190 iMEfCa~GqL~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeeccccccHHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec-cceEEeccccchHhhhhh
Confidence 99999 7899999987543 999999999999999999999999999999999999995 8899999999986443 3
Q ss_pred CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccc
Q 002732 729 NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHF 808 (887)
Q Consensus 729 ~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f 808 (887)
...-.++||..|||||+|.+.+++.++|||||||||||||||..||.......+
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------------------------- 319 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------------------------- 319 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee--------------------------
Confidence 345678999999999999999999999999999999999999999965332211
Q ss_pred ccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 809 DQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 809 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
|+.+-...+ ....+..++.-|+-||.+||+-.|..||++.+||.|=
T Consensus 320 ----------------------IwGVGsNsL------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 320 ----------------------IWGVGSNSL------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ----------------------EEeccCCcc------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 111111110 0112334557899999999999999999999999984
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.53 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=206.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||+|+||+||+|.+..++ ..||+|++... ......+..|+.++..+ .|+||++++++|..
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~ 74 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTG----TVMAKKVVHIGAKSSVRKQILRELQIMHEC------RSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCC----cEEEEEEEEecCcchHHHHHHHHHHHHHHc------CCCCcceEeeeEec
Confidence 46899999999999999999998777 78999988753 23346778899999998 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.+.+||||||+ +++|..++...+ .+++..+..++.+|+.||.|||+ .+|+|+||+|+|||++. .+.++|+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl 150 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGV 150 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCc
Confidence 99999999999 568888887643 48999999999999999999996 69999999999999984 77899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
+...........+++..|+|||++.+..++.++|||||||+||+|++|..||........... .+..+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-------~~~~~----- 218 (284)
T cd06620 151 SGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-------DPMGI----- 218 (284)
T ss_pred ccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-------hhhHH-----
Confidence 865543333456788999999999988999999999999999999999999976543211000 00000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
...+..++.... ..+ ....++..+.+||.+||..||..|||+.|||+||
T Consensus 219 ---------------------~~~~~~~~~~~~-~~~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 219 ---------------------LDLLQQIVQEPP-PRL---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---------------------HHHHHHHhhccC-CCC---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000111111000 000 0112456789999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 268 ~~~~ 271 (284)
T cd06620 268 PFIQ 271 (284)
T ss_pred cccc
Confidence 9853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.24 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
.|.....||.|+||.||++.+..++ ..||||.+.... .....+..|+.++..+ .|+||+++++.|...+
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTG----KQVAVKKMDLRKQQRRELLFNEVVIMRDY------HHENVVDMYNSYLVGD 92 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCC----CEEEEEEEecchHHHHHHHHHHHHHHHhC------CCCcHHHHHHheecCC
Confidence 3566678999999999999987766 789999986532 2345677899999888 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++..
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~ 167 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQ 167 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCEEEccCcchhh
Confidence 999999999 5678887753 23899999999999999999999999999999999999985 68899999999865
Q ss_pred cCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.... ......++..|+|||++.+..++.++||||||||||+|++|..||.+......+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 237 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR---------- 237 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc----------
Confidence 4322 1234567889999999999899999999999999999999999997655443332221110000
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
......++..+.+||.+||..||.+|||+.+||+|||
T Consensus 238 -------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 274 (292)
T cd06658 238 -------------------------------------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF 274 (292)
T ss_pred -------------------------------------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 0001124567889999999999999999999999999
Q ss_pred CCC
Q 002732 884 ISG 886 (887)
Q Consensus 884 f~~ 886 (887)
|..
T Consensus 275 ~~~ 277 (292)
T cd06658 275 LKL 277 (292)
T ss_pred hhc
Confidence 974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.74 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=204.9
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...|.+.+.||.|+||.||+|.+...+ ..||+|++..+......+..|+.+|..+ .|++|++++++|...
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTRE 74 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCC----ceEEEEEecCCchHHHHHHHHHHHHHhC------CCCChhheEEEEcCC
Confidence 345999999999999999999988766 7899999987655556778899999999 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~df~~~~ 152 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSR 152 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC-CCcEEeCCCcccc
Confidence 9999999999 679999987643 234899999999999999999999999999999999999984 7889999999997
Q ss_pred ecCCCCccC---cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKNEITP---YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~~~~---~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
......... ...+..|+|||++.+..++.++|||||||+||+|++ |..||.+....+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 222 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY---------- 222 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence 765443222 223457999999999999999999999999999998 999998765544433321100
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+..+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 223 ---------------------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------------------------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------------------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00111234578899999999999999999999986
Q ss_pred C
Q 002732 881 H 881 (887)
Q Consensus 881 H 881 (887)
.
T Consensus 258 ~ 258 (263)
T cd05052 258 A 258 (263)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=321.20 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=199.8
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
...|.+...||+|+||.||+|.+.... .....||||++.... .....+..|+.+|..+ .||||++++++|.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~ 76 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPS-KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF------DHSNIVRLEGVIT 76 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCC-CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEe
Confidence 356999999999999999999865322 234689999987642 2235677889888888 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+++||||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||.||||+. ++.++|+|||.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~-~~~~~l~dfg~ 153 (266)
T cd05064 77 RGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS-DLVCKISGFRR 153 (266)
T ss_pred cCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC-CCcEEECCCcc
Confidence 999999999999 568888887642 34899999999999999999999999999999999999985 78899999998
Q ss_pred ceecCCCCc---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+........ ....++..|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+..... +
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~----- 227 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-L----- 227 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-C-----
Confidence 755432211 12234567999999999999999999999999999875 9999987766555443321100 0
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..+..++..+.+||..||+.+|..|||+.+|
T Consensus 228 -------------------------------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 228 -------------------------------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 0112244678899999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
++
T Consensus 259 ~~ 260 (266)
T cd05064 259 HS 260 (266)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=344.18 Aligned_cols=249 Identities=26% Similarity=0.435 Sum_probs=208.2
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEec-----ccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-----NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~-----~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.+..+||+|+|-+||+|.|..+| ..||=--++ +.+.....+..|+.+|+.| +|+||++||++|..
T Consensus 43 k~~evLGrGafKtVYka~De~~g----iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL------~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEG----IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL------KHPNIIRFYDSWVD 112 (632)
T ss_pred ehhhhcccccceeeeeccccccc----hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC------CCCceeeeeeheec
Confidence 34458999999999999998887 455532222 2334447888999999999 99999999999998
Q ss_pred cC--eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccc--eeccCCCCCCccccCCCCeEEEEe
Q 002732 645 RN--HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG--VLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 ~~--~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~vKL~D 719 (887)
.. .+.||+|.+ .|+|..|++++.. ++...++.|++|||.||.|||++. |||||||-+||||+.+.|.|||+|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 64 588999999 8999999999876 899999999999999999999874 999999999999998889999999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|+|...........+|||.|||||+.. ..|+..+||||||+||+||+|+..||.-..+..++.
T Consensus 190 LGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--------------- 253 (632)
T KOG0584|consen 190 LGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--------------- 253 (632)
T ss_pred hhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH---------------
Confidence 9999998888888899999999999988 689999999999999999999999996555544433
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
++++..++|..+..+- .++++.||.+||.. ...||||.|||
T Consensus 254 ----------------------------KKV~SGiKP~sl~kV~----------dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 254 ----------------------------KKVTSGIKPAALSKVK----------DPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred ----------------------------HHHHcCCCHHHhhccC----------CHHHHHHHHHHhcC-chhccCHHHHh
Confidence 2333333333222211 25789999999999 99999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||..
T Consensus 295 ~d~Ff~~ 301 (632)
T KOG0584|consen 295 KDPFFDE 301 (632)
T ss_pred hChhhcc
Confidence 9999975
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.68 Aligned_cols=251 Identities=31% Similarity=0.469 Sum_probs=204.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+ .|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~ 70 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG----ELMAVKEIRIQDNDPKTIKEIADEMKVLELL------KHPNLVKYYGVEVH 70 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC----cEEEEEEEECcccchHHHHHHHHHHHHHHhC------CCCChhheeeeEec
Confidence 5899999999999999999987766 7899999986543 456778899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+++|+||+ +++|.+++.... .+++..+..|+.||+.||.|||+.||+|+||+|.|||++. .+.++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~kl~d~g~~ 146 (264)
T cd06626 71 REKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH-NGVIKLGDFGCA 146 (264)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEcccccc
Confidence 99999999999 579999887633 3889999999999999999999999999999999999995 788999999998
Q ss_pred eecCCCCc------cCcccCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 724 MFAGKNEI------TPYLVSRFYRAPEIILGLP---YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 724 ~~~~~~~~------~~~~gt~~Y~aPE~l~~~~---~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
........ ....++..|+|||++.+.. ++.++||||||||||+|++|..||........+...... +..|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~ 225 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP 225 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC
Confidence 76543221 1345678899999998776 899999999999999999999999755332222111111 0000
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
. . .....++..+.+||.+||+.+|.+|||
T Consensus 226 ~--------------------------------------------------~-~~~~~~~~~~~~li~~~l~~~p~~R~~ 254 (264)
T cd06626 226 P--------------------------------------------------I-PDSLQLSPEGKDFLDRCLESDPKKRPT 254 (264)
T ss_pred C--------------------------------------------------C-CcccccCHHHHHHHHHHccCCcccCCC
Confidence 0 0 001123567889999999999999999
Q ss_pred HHHHHhCCCC
Q 002732 875 VAQALTHPFI 884 (887)
Q Consensus 875 a~elL~Hpwf 884 (887)
+.++|.|||+
T Consensus 255 ~~~i~~~~~~ 264 (264)
T cd06626 255 ASELLQHPFV 264 (264)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.95 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=205.0
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++..++|.++++||.|+||.||+|.+.... ......||||++..... ....+..|+.+++.+ .|+||++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~ 75 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF------TCHHVVRLL 75 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC------CCCCeeeEE
Confidence 345678999999999999999999765321 11235799998865432 223566788888888 899999999
Q ss_pred ceeeecCeEEEEEecc-hhhHHHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR-------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 711 (887)
+++...+..||||||+ +++|.++|..... ...++...+..++.||+.||.|||+++|+|+||||+||||+.
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~- 154 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH- 154 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC-
Confidence 9999999999999999 6899999976432 123567788999999999999999999999999999999995
Q ss_pred CCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002732 712 KNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLH 786 (887)
Q Consensus 712 ~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i 786 (887)
++.++|+|||++........ ....++..|+|||++.+..++.++|||||||+||+|++ |.+||.+....+.+..+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 78899999999875433221 12234567999999999899999999999999999998 78999776655544332
Q ss_pred HHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcc
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
... .++ ..+..++..+.+||.+||+
T Consensus 235 ~~~--~~~-----------------------------------------------------~~~~~~~~~~~~li~~~l~ 259 (288)
T cd05061 235 MDG--GYL-----------------------------------------------------DQPDNCPERVTDLMRMCWQ 259 (288)
T ss_pred HcC--CCC-----------------------------------------------------CCCCCCCHHHHHHHHHHcC
Confidence 210 000 0011223678999999999
Q ss_pred cCCCCCcCHHHHHh------CCCCCC
Q 002732 867 LDPEKRMTVAQALT------HPFISG 886 (887)
Q Consensus 867 ~DP~~RpTa~elL~------Hpwf~~ 886 (887)
.||.+|||+.++|+ ||||.+
T Consensus 260 ~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 260 FNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 99999999999988 999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.52 Aligned_cols=246 Identities=19% Similarity=0.303 Sum_probs=201.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..|.+++.||.|+||+||+|.+... ..||||.+.........+..|+.++..| .||||++++++|....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~aik~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQ-----YDVAIKMIKEGSMSEDEFIEEAKVMMKL------SHEKLVQLYGVCTKQR 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCC-----CcEEEEEcCCCcccHHHHHHHHHHHhcC------CCCCeeeEEEEEccCC
Confidence 3599999999999999999987543 3599999876555556788899999998 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+||||||+ +++|.+++..... .+++..++.|+.||+.||.|||+.||+|+||+|.||||+. ++.+||+|||++..
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~ 149 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QGCVKVSDFGLSRY 149 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC-CCCEEECCCcccee
Confidence 999999999 6789998876432 4899999999999999999999999999999999999984 78899999999876
Q ss_pred cCCCCccC---cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEITP---YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~~---~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
........ ..++..|+|||++.+..++.++|||||||+||+|++ |..||...+..+....+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 221 (256)
T cd05113 150 VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------- 221 (256)
T ss_pred cCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC--------
Confidence 54433222 233567999999998889999999999999999998 999997666554443332211100
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.+...+..+.+||.+||..+|.+|||+.+||.+
T Consensus 222 -----------------------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 -----------------------------------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 001134678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.93 Aligned_cols=282 Identities=27% Similarity=0.462 Sum_probs=218.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec-
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR- 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~- 645 (887)
++|+++.++|.|.|+.||.|....+. +.++||+++. ...+.+..|+.||..|. .+|||+.|++...+.
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~----eK~ViKiLKP--VkkkKIkREikIL~nL~-----gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNN----EKCVIKILKP--VKKKKIKREIKILQNLR-----GGPNIIKLLDIVKDPE 106 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCC----ceEEEeeech--HHHHHHHHHHHHHHhcc-----CCCCeeehhhhhcCcc
Confidence 56999999999999999999987776 8999999975 44578899999999995 689999999998874
Q ss_pred -CeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 646 -NHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 646 -~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
....|||||+.. +...+... |+...++.++.+||.||.|+|++||+|||+||.||||+.....++|+|||+|
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchH
Confidence 568899999954 44444333 8889999999999999999999999999999999999987888999999999
Q ss_pred eecCCCC-ccCcccCCcccchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHhhCCCChh-hhh
Q 002732 724 MFAGKNE-ITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLF-PGATNNDMLRLHMELKGPFPKK-MLR 799 (887)
Q Consensus 724 ~~~~~~~-~~~~~gt~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~elltG~~PF-~~~~~~~~l~~i~~~~g~~p~~-~l~ 799 (887)
.++.... +...+.+..|--||.+...+ |+...|+|||||+|..|++.+-|| .|.++.+++-.|...+|.-.-. .+.
T Consensus 181 EFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 181 EFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 8876553 55567788999999998764 899999999999999999988766 5788889999999888753111 011
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
+ .....+|... .++...........+ ..+..-.++++++|||.++|.+|-..||||.|++
T Consensus 261 K--------------Y~i~Ldp~~~----~i~~~~~rk~w~~Fi--~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 261 K--------------YQIDLDPQFE----DILGRHSRKPWSRFI--NSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred H--------------HccCCChhHh----hHhhccccccHHHhC--CccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 1 0001111111 111111111111111 1112223458899999999999999999999999
Q ss_pred hCCCCC
Q 002732 880 THPFIS 885 (887)
Q Consensus 880 ~Hpwf~ 885 (887)
.||||.
T Consensus 321 ~HpyF~ 326 (338)
T KOG0668|consen 321 AHPYFA 326 (338)
T ss_pred cCchHH
Confidence 999995
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=329.54 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=202.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
|.....||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..| .||||++++++|...+.
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~~~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSG----RQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHQNVVEMYKSYLVGEE 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCC----CEEEEEEEEecccchHHHHHHHHHHHHhC------CCCchhhhhhheeeCCe
Confidence 444557999999999999987766 789999986432 2345677888888888 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++...
T Consensus 93 ~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~ 167 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEEecCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc-CCcEEEeechhHhhc
Confidence 99999999 5688877654 23899999999999999999999999999999999999985 788999999998654
Q ss_pred CCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 GKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
... .....+++..|+|||++.+..++.++||||||||||+|++|..||........+..+... .+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~--------- 235 (297)
T cd06659 168 SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP--------- 235 (297)
T ss_pred ccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC---------
Confidence 332 223456888999999999989999999999999999999999999766554443322110 000
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
.......++..+.+||.+||+.+|.+|||+.+||+||||
T Consensus 236 -----------------------------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 236 -----------------------------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred -----------------------------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhh
Confidence 000112344678899999999999999999999999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
.+
T Consensus 275 ~~ 276 (297)
T cd06659 275 LQ 276 (297)
T ss_pred cc
Confidence 64
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.96 Aligned_cols=250 Identities=32% Similarity=0.497 Sum_probs=208.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||.|+||.||+|.+..++ ..|+||++.... .....+..|+.++..| .|++|+++++++..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG----ELMAVKSVELSGDSEEELEALEREIRILSSL------QHPNIVRYYGSERD 70 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC----cEEEEEEeeccccchHHHHHHHHHHHHHHHc------CCCCEeeEEEEEec
Confidence 4888999999999999999988766 789999987654 3456778899999999 79999999999998
Q ss_pred c--CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 645 R--NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 645 ~--~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
. ..+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+|+. ++.++|+|||
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~-~~~~~l~d~~ 146 (260)
T cd06606 71 EEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS-DGVVKLADFG 146 (260)
T ss_pred CCCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-CCCEEEcccc
Confidence 8 8999999999 789999998754 5999999999999999999999999999999999999995 7889999999
Q ss_pred cceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
.+....... .....++..|+|||++.+..++.++||||||||||+|++|..||...... ...+......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~----- 219 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSS----- 219 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhcccc-----
Confidence 997766543 34456788999999999888999999999999999999999999765421 1111111000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
...+..+..++..+.+||.+||..+|.+|||+.+
T Consensus 220 ----------------------------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 220 ----------------------------------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred ----------------------------------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 0001112233578899999999999999999999
Q ss_pred HHhCCCC
Q 002732 878 ALTHPFI 884 (887)
Q Consensus 878 lL~Hpwf 884 (887)
+|.||||
T Consensus 254 ll~~~~~ 260 (260)
T cd06606 254 LLQHPFL 260 (260)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=338.64 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=199.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~-~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.+++.||.|+||.||+|.+...+. .....||||++.... .....+..|+.+|..|. .|+||++++++|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-----~h~nIv~~~~~~ 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG-----QHKNIVNLLGAC 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc-----cCCceeeEeeEe
Confidence 3569999999999999999998755432 233579999997532 22356778999998883 699999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-----------------------------------------------------
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR----------------------------------------------------- 668 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~----------------------------------------------------- 668 (887)
.....+||||||+ +|+|.++|.....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999 6799998865321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCCcc--
Q 002732 669 --------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT-- 732 (887)
Q Consensus 669 --------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~-- 732 (887)
...+++..++.|+.||+.||.|||++||+|+||||+|||++. ++.++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCcceee
Confidence 124788899999999999999999999999999999999984 788999999999765432211
Q ss_pred --CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccc
Q 002732 733 --PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFD 809 (887)
Q Consensus 733 --~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~ 809 (887)
...+++.|+|||++.+..|+.++||||||||||+|++ |..||........+..++.....+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~---------------- 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------- 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc----------------
Confidence 1223567999999999899999999999999999997 999997654333222221110000
Q ss_pred cccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 810 QDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 810 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 335 --------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 --------------------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred --------------------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001123467899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.38 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=204.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
.|.....||.|+||.||+|.+..++ ..||||++.... .....+.+|+.++..+ .|+||++++++|...+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~e~~~l~~~------~h~~vv~~~~~~~~~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTG----RQVAVKKMDLRKQQRRELLFNEVVIMRDY------QHPNIVEMYSSYLVGD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCC----CEEEEEEEeccchhHHHHHHHHHHHHHHc------CCCChheEEEEEEcCC
Confidence 3666779999999999999987766 789999886432 2235577899999998 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+.|+|+||+ +++|.+++.. . .+++..+..|+.||+.||.|||++||+|+||+|.|||++. ++.++|+|||++..
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~-~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~ 164 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH-T---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQ 164 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh-C---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC-CCcEEEcccccchh
Confidence 999999999 6799998876 2 3899999999999999999999999999999999999985 78899999998765
Q ss_pred cCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.... ......++..|+|||++.+..++.++||||||||||+|++|..||...+....+..+.... .+
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~--------- 233 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PP--------- 233 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CC---------
Confidence 4332 1233467889999999999899999999999999999999999997655444433222110 00
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
.......++..+.+||.+||..+|.+|||+.+||.|||
T Consensus 234 ------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (285)
T cd06648 234 ------------------------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPF 271 (285)
T ss_pred ------------------------------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcc
Confidence 00011224567899999999999999999999999999
Q ss_pred CCC
Q 002732 884 ISG 886 (887)
Q Consensus 884 f~~ 886 (887)
|..
T Consensus 272 ~~~ 274 (285)
T cd06648 272 LAK 274 (285)
T ss_pred ccc
Confidence 964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.28 Aligned_cols=249 Identities=25% Similarity=0.284 Sum_probs=204.1
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+..+.|.+.+.||.|+||.||+|.+... ..||||.+.........+..|+.++..+ .|+||++++++|.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 71 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNT-----TPVAVKTLKPGTMDPKDFLAEAQIMKKL------RHPKLIQLYAVCT 71 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCC-----eEEEEEeeCCCcccHHHHHHHHHHHHHC------CCCCccceeEEEe
Confidence 3456799999999999999999986443 5799999987655567788999999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..+.+|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~dfg~ 149 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE-NNICKVADFGL 149 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC-CCCEEECCcce
Confidence 999999999999 789999987643 235899999999999999999999999999999999999995 77899999999
Q ss_pred ceecCCCCccCccc---CCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKNEITPYLV---SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~~~~~~g---t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+............+ +..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+....+..+.... .+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----- 223 (261)
T cd05068 150 ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY-RM----- 223 (261)
T ss_pred EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence 98765433222222 346999999999899999999999999999999 999998766554443332110 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..+..++..+.+||.+||..+|.+|||+.+|
T Consensus 224 -------------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 224 -------------------------------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred -------------------------------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 0011234678999999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
+.
T Consensus 255 ~~ 256 (261)
T cd05068 255 QW 256 (261)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.84 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=204.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..|.+++.||.|+||.||+|.+...+ ......||||.+.... .....+..|+.+|..+ .|+||+++++++.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l------~h~~i~~~~~~~~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL------QHPNIVCLLGVCT 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc------CCcccceEEEEEc
Confidence 45899999999999999999876543 2234579999986432 2345678899999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 709 (887)
....+|+||||+ +++|.++|..... ...+++..++.++.||+.||.|||+.||+|+||||+||||+
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 999999999999 6799999976422 13488999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 002732 710 EAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784 (887)
Q Consensus 710 ~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~ 784 (887)
. ++.++|+|||++....... .....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+....+...
T Consensus 159 ~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 E-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred C-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 5 7789999999987643321 223455788999999998899999999999999999998 999998776655443
Q ss_pred HHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHh
Q 002732 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKI 864 (887)
Q Consensus 785 ~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~km 864 (887)
.+... .+ +..+..++..+.+||.+|
T Consensus 238 ~i~~~--~~-----------------------------------------------------~~~~~~~~~~~~~l~~~c 262 (283)
T cd05048 238 MIRSR--QL-----------------------------------------------------LPCPEDCPARVYALMIEC 262 (283)
T ss_pred HHHcC--Cc-----------------------------------------------------CCCcccCCHHHHHHHHHH
Confidence 33211 00 011234557899999999
Q ss_pred cccCCCCCcCHHHHHhC
Q 002732 865 FVLDPEKRMTVAQALTH 881 (887)
Q Consensus 865 L~~DP~~RpTa~elL~H 881 (887)
|+.||.+|||+.+|+++
T Consensus 263 ~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 263 WNEIPARRPRFKDIHTR 279 (283)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=322.78 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=203.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.|.+++.||.|+||.||+|.+.... ......||||++..... ....+..|+.+|..| .|+||++++++|.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF------QHENIVKFYGVCT 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc------CCCCchheeeEEe
Confidence 45899999999999999999875431 12336899999876432 246788999999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGR-----------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~-----------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 711 (887)
....+||||||+ +++|.++|...+. ...+++..+..++.||+.||.|||++||+|+||+|+||||+.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~- 157 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY- 157 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC-
Confidence 999999999999 6799999976432 234889999999999999999999999999999999999985
Q ss_pred CCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002732 712 KNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLH 786 (887)
Q Consensus 712 ~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i 786 (887)
.+.++|+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++ |..||........+..+
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 7899999999997543322 122344678999999999999999999999999999998 99999776655544433
Q ss_pred HHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcc
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
...... ..+..++..+.+||.+||.
T Consensus 238 ~~~~~~-------------------------------------------------------~~~~~~~~~~~~li~~~l~ 262 (280)
T cd05049 238 TQGRLL-------------------------------------------------------QRPRTCPSEVYDIMLGCWK 262 (280)
T ss_pred HcCCcC-------------------------------------------------------CCCCCCCHHHHHHHHHHcC
Confidence 211000 0112345778999999999
Q ss_pred cCCCCCcCHHHHHh
Q 002732 867 LDPEKRMTVAQALT 880 (887)
Q Consensus 867 ~DP~~RpTa~elL~ 880 (887)
.||..|||+.|+|.
T Consensus 263 ~~p~~Rp~~~eil~ 276 (280)
T cd05049 263 RDPQQRINIKDIHE 276 (280)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.12 Aligned_cols=237 Identities=18% Similarity=0.199 Sum_probs=194.3
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCCCCcceeEecceeee----
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPENKRHCIRFASSFKY---- 644 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~---- 644 (887)
..||.|+++.||+|... + ..||||++...... ...+.+|+.+|.+| .||||++++++|..
T Consensus 26 ~~i~~g~~~~v~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--N----KEVIIRTFKKFHKGHKVLIDITENEIKNLRRI------DSNNILKIYGFIIDIVDD 93 (283)
T ss_pred eEEeeCCceEEEEEEEC--C----EEEEEEeccccccccHHHHHHHHHHHHHHHhc------CCCCEEEEeeeEEecccC
Confidence 46899999999999873 3 68999999764332 25567999999999 89999999999877
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...++|||||+ +|+|.++|.... .+++..+..++.||+.||.|||. .+++|+||||+|||++. ++.+||+|||+
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~ 169 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGL 169 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccch
Confidence 45789999999 678999997643 48999999999999999999998 59999999999999995 78899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+....... ...+++..|+|||++.+ ..|+.++||||||||+|+|++|..||.+.+..+.+..+......++
T Consensus 170 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 242 (283)
T PHA02988 170 EKILSSPP-FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------ 242 (283)
T ss_pred Hhhhcccc-ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence 87654432 34567889999999976 6899999999999999999999999987766555544432211110
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+..++..+.+||.+||+.||..|||+.+||+
T Consensus 243 ------------------------------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ------------------------------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ------------------------------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01124567899999999999999999999986
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.20 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=200.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..|.+++.||.|+||.||+|..... ..||||.+.........+..|+.+|..| .||||++++++|....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~a~K~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQ-----IKVAIKAINEGAMSEEDFIEEAKVMMKL------SHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccC-----ceEEEEecccCCccHHHHHHHHHHHHHC------CCCCceeEEEEEccCC
Confidence 3589999999999999999987543 4799999876555556788899999999 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++..
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~ 149 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS-TGVVKVSDFGMTRY 149 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC-CCeEEECCCCCccc
Confidence 999999999 679999887532 24899999999999999999999999999999999999984 78899999999876
Q ss_pred cCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... ...++..|+|||++.+..++.++|||||||+||+|++ |.+||...+..+.+..+.......
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------- 221 (256)
T cd05114 150 VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-------- 221 (256)
T ss_pred cCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC--------
Confidence 5433221 2234567999999998899999999999999999999 999997766555554442211000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+...+..+.+||.+||..+|.+|||+.+||+
T Consensus 222 -----------------------------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 -----------------------------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00112356889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.25 Aligned_cols=248 Identities=26% Similarity=0.354 Sum_probs=202.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
|.++..||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||+.++++|....
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~ 75 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQ----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYVTKYYGSYLKDT 75 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCC----cEEEEEEeccccchHHHHHHHHHHHHHHhc------CCCCEeEEEEEEEeCC
Confidence 788999999999999999987766 789999986432 2235667888899888 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+||||||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+|+||+|.|||++. ++.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~ 150 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE-HGEVKLADFGVAGQ 150 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC-CCCEEEeeccccee
Confidence 999999999 5688888764 24899999999999999999999999999999999999984 78899999999866
Q ss_pred cCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 726 AGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 726 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
..... .....++..|+|||++.+..++.++|||||||+||+|++|..||...........+... ..
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------- 218 (277)
T cd06641 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP---------- 218 (277)
T ss_pred cccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC----------
Confidence 54332 23346788899999999888999999999999999999999999654433322221100 00
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
+.....++..+.+||.+||..+|.+||++.+||+|||
T Consensus 219 -------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 255 (277)
T cd06641 219 -------------------------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255 (277)
T ss_pred -------------------------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence 0011234467889999999999999999999999999
Q ss_pred CCC
Q 002732 884 ISG 886 (887)
Q Consensus 884 f~~ 886 (887)
|..
T Consensus 256 ~~~ 258 (277)
T cd06641 256 IVR 258 (277)
T ss_pred Hhh
Confidence 964
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.01 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=200.3
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.+|.|.+.||.|||+-||++....++ ..||+|.+.-.. ...+..+.|+...+++ +||||++++++...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~----~~YAlKkI~c~~~~~~e~~~rEid~~rkf------~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTG----HLYALKKILCHSQEDIEEALREIDNHRKF------NSPNVLRLVDHQLR 89 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcc----cchhhheeeccchHHHHHHHHHHHHHHhh------CCcchHHHHHHHHH
Confidence 468999999999999999999988877 899999887543 4457778999999999 89999999988765
Q ss_pred c-----CeEEEEEecc-hhhHHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHhhhccc--eeccCCCCCCccccCCCCeE
Q 002732 645 R-----NHLCLVFESL-HMNLREVLKKFGRNI-GLKLTAVRAYAKQLFIALKHLKNCG--VLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 645 ~-----~~~~lV~E~~-~gsL~~~L~~~~~~~-~ls~~~~~~i~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~v 715 (887)
. ...|||++|+ .|+|.+.|.....++ .+++..++.|+.+|+.||.+||... +.|+||||.|||+.. .+.+
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~ 168 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLP 168 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCce
Confidence 4 3599999998 789999998765443 6999999999999999999999998 999999999999985 7888
Q ss_pred EEEecCcceecCCCCc-----------cCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 002732 716 KLCDFGNAMFAGKNEI-----------TPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~-----------~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~ 781 (887)
+|+|||.++....... ..-..|..|.|||.+. +...+.++|||||||+||.|+.|..||.-
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~----- 243 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER----- 243 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH-----
Confidence 9999999865442211 1123478899999885 44678999999999999999999999931
Q ss_pred HHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHH
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL 861 (887)
+.+.-+.+ .+ + +.......|...+ ++..+..||
T Consensus 244 ----~~~~GgSl-------------------aL------A-----------------v~n~q~s~P~~~~-yse~l~~li 276 (302)
T KOG2345|consen 244 ----IYQQGGSL-------------------AL------A-----------------VQNAQISIPNSSR-YSEALHQLI 276 (302)
T ss_pred ----HhhcCCeE-------------------EE------e-----------------eeccccccCCCCC-ccHHHHHHH
Confidence 11111110 00 0 0000011222333 889999999
Q ss_pred HHhcccCCCCCcCHHHHHhC
Q 002732 862 DKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 862 ~kmL~~DP~~RpTa~elL~H 881 (887)
..||+.||.+||++.++|.+
T Consensus 277 k~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 277 KSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHhcCCcccCCCHHHHHHH
Confidence 99999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=339.00 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=201.8
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...|.+...||.|+|+.|-.|.+..+. +.+++|++.+. .....+|+.++.... +|+||+.+.+.|...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~----~~~~vkii~~~---~~~~~~e~~~~~~~~-----~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTD----QEPAVKIISKR---ADDNQDEIPISLLVR-----DHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeeccccc----cchhheecccc---ccccccccchhhhhc-----CCCcceeecceecCC
Confidence 456889999999999999999998887 88999999765 234456777777664 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.++|+|||.+ ++-|.+-+.... .....+..|+.+|+.||.|||.+|||||||||+|||+..+.+.|+|+|||.+.
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999999 445555544422 23377888999999999999999999999999999995357889999999998
Q ss_pred ecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 725 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
..... +.+.+.|..|.|||++....|+.++||||||+|||+||+|..||........ |+...+..
T Consensus 465 ~~~~~-~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~----------- 529 (612)
T KOG0603|consen 465 ELERS-CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMP----------- 529 (612)
T ss_pred hCchh-hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCC-----------
Confidence 77665 3344678899999999999999999999999999999999999977655511 11111111
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
.....+|.++++||.+||++||.+||++.+|+.||||
T Consensus 530 -------------------------------------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 -------------------------------------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------------------------------ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 0113567899999999999999999999999999999
Q ss_pred C
Q 002732 885 S 885 (887)
Q Consensus 885 ~ 885 (887)
.
T Consensus 567 ~ 567 (612)
T KOG0603|consen 567 L 567 (612)
T ss_pred h
Confidence 3
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.82 Aligned_cols=247 Identities=21% Similarity=0.290 Sum_probs=202.5
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...|.++++||.|+||.||+|.+... ..||||.+.........+..|+.++..+ .|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 73 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNS-----TKVAVKTLKPGTMSVQAFLEEANLMKTL------QHDKLVRLYAVVTKE 73 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCC-----ceEEEEEccCCchhHHHHHHHHHHHHhC------CCCCeeeEEEEEcCC
Confidence 45699999999999999999986543 4799999876655567788999999999 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.++|||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+|+|+||+|+|||++. .+.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 151 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE-SLMCKIADFGLAR 151 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC-CCcEEECCCccce
Confidence 9999999999 679999987642 234899999999999999999999999999999999999985 7889999999997
Q ss_pred ecCCCCc---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
....... ....++..|+|||++.+..++.++|||||||+||+|++ |..||.+.........+.... .+
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~------- 223 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-RM------- 223 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC-------
Confidence 7654322 22334567999999998899999999999999999998 999998765554443332110 00
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.....++.++.+||.+||..+|.+|||+++|+.
T Consensus 224 -----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -----------------------------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011234467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.36 Aligned_cols=251 Identities=31% Similarity=0.506 Sum_probs=208.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+.+.||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+|++.+++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~~~~~~~~~~~ 70 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG----KLYVLKEIDLSNMSEKEREDALNEVKILKKL------NHPNIIKYYESFEE 70 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC----cEEEEEEeecccCChHHHHHHHHHHHHHHhc------CCCChhheEEEEec
Confidence 4899999999999999999998766 789999997542 3345677899999999 79999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...++|||||+ +++|.+++.... ....+++..+..++.+|+.||.|||+.||+|+||+|+|||++. ++.++|+|||+
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~-~~~~~l~d~~~ 149 (258)
T cd08215 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS-NGLVKLGDFGI 149 (258)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC-CCcEEECCccc
Confidence 99999999999 569999887642 1245999999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 723 AMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 723 a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+....... .....+++.|+|||++.+..++.++||||||+|+|+|++|..||...........+.... +
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~------- 220 (258)
T cd08215 150 SKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--Y------- 220 (258)
T ss_pred eeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--C-------
Confidence 97655432 233567888999999999899999999999999999999999997655443333221110 0
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..+..++..+.+||.+||..+|.+|||+.+||.
T Consensus 221 ----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 ----------------------------------------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----------------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011134477899999999999999999999999
Q ss_pred CCCC
Q 002732 881 HPFI 884 (887)
Q Consensus 881 Hpwf 884 (887)
||||
T Consensus 255 ~~~~ 258 (258)
T cd08215 255 SPFI 258 (258)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.89 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=202.1
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++..++|.+...||+|+||+||+|.+.... ......||||++..... ....+..|+.+++.+ .|+||++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~iv~~~ 75 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 75 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeeeEE
Confidence 345678999999999999999999875321 12336799999865322 234567889998888 899999999
Q ss_pred ceeeecCeEEEEEecc-hhhHHHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR-------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 711 (887)
++|.....+++||||+ +++|.+++..... ...+++..+..++.||+.||.|||+.||+|+||||.||||+.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~- 154 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 154 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-
Confidence 9999999999999999 6799999876432 123678889999999999999999999999999999999995
Q ss_pred CCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 002732 712 KNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLH 786 (887)
Q Consensus 712 ~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i 786 (887)
.+.++|+|||++........ ....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+.+....+..+
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 78899999999865433221 12244677999999999899999999999999999999 78999876655444333
Q ss_pred HHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcc
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
.... ++ ..+..++..+.+||.+||+
T Consensus 235 ~~~~--~~-----------------------------------------------------~~~~~~~~~~~~li~~~l~ 259 (277)
T cd05062 235 MEGG--LL-----------------------------------------------------DKPDNCPDMLFELMRMCWQ 259 (277)
T ss_pred HcCC--cC-----------------------------------------------------CCCCCCCHHHHHHHHHHcC
Confidence 2110 00 0011234678999999999
Q ss_pred cCCCCCcCHHHHHhC
Q 002732 867 LDPEKRMTVAQALTH 881 (887)
Q Consensus 867 ~DP~~RpTa~elL~H 881 (887)
.||.+|||+.++|.+
T Consensus 260 ~~p~~Rps~~e~l~~ 274 (277)
T cd05062 260 YNPKMRPSFLEIISS 274 (277)
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.90 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=201.2
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
..+.|.+++.||.|+||.||+|.+.... ......||||.+.... .....+..|+.++..+ .|+||++++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~ 77 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF------NHQNIVRLIGV 77 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCCCEeeEEEE
Confidence 3456999999999999999999987511 1123689999886432 2235577899999988 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC--Ce
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGR----NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK--NV 714 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~----~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~~ 714 (887)
+......||||||+ +++|.++|..... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++..+ ..
T Consensus 78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence 99999999999999 6799999977532 12489999999999999999999999999999999999997432 36
Q ss_pred EEEEecCcceecCCCCcc----CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHh
Q 002732 715 LKLCDFGNAMFAGKNEIT----PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMEL 789 (887)
Q Consensus 715 vKL~DFG~a~~~~~~~~~----~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~ 789 (887)
+||+|||++......... ....+..|+|||++.+..++.++||||||||||+|++ |.+||.+.+....+..+...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 899999999765332211 2223457999999999899999999999999999997 99999876655443322110
Q ss_pred hCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCC
Q 002732 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDP 869 (887)
Q Consensus 790 ~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP 869 (887)
.. ...+..++..+.+||.+||+.+|
T Consensus 238 -~~------------------------------------------------------~~~~~~~~~~~~~~i~~cl~~~p 262 (277)
T cd05036 238 -GR------------------------------------------------------LDPPKGCPGPVYRIMTDCWQHTP 262 (277)
T ss_pred -Cc------------------------------------------------------CCCCCCCCHHHHHHHHHHcCCCc
Confidence 00 00112334678899999999999
Q ss_pred CCCcCHHHHHhC
Q 002732 870 EKRMTVAQALTH 881 (887)
Q Consensus 870 ~~RpTa~elL~H 881 (887)
..|||+.+||+|
T Consensus 263 ~~Rps~~~vl~~ 274 (277)
T cd05036 263 EDRPNFATILER 274 (277)
T ss_pred ccCcCHHHHHHH
Confidence 999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.32 Aligned_cols=247 Identities=25% Similarity=0.440 Sum_probs=202.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+|.+.+.||.|+||.||+|.+..++ ..||+|.+... ......+..|+.++..+ .|+||++++++|...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 70 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKM------KHPNIVAFKESFEAD 70 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC----ceEEEEEEEcCcchHHHHHHHHHHHHHHhC------CCCCcceEEEEEEEC
Confidence 4899999999999999999998776 78999998643 23345667889999888 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+++|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+|+||+|.|||++. .+.++|+|||++.
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~ 148 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ-NGKVKLGDFGSAR 148 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC-CCcEEEcccCcce
Confidence 9999999999 67898888653 2334899999999999999999999999999999999999985 7789999999987
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+... .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------- 217 (255)
T cd08219 149 LLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG--SY--------- 217 (255)
T ss_pred eecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC--CC---------
Confidence 654322 23456788899999999989999999999999999999999999765544433322111 00
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
...+..++..+.+||.+||..||.+|||+.+||.-
T Consensus 218 --------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 --------------------------------------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------------------------------------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00112344678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.66 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=201.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.++..||+|+||+||+|.+...+......||||.+..... ....+..|+.+|..| .|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL------HHPNIVCLLGVVTQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC------CCCCeeeEEEEEec
Confidence 3489999999999999999987544434457899999874322 235677899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR--------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~--------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 709 (887)
...+||||||+ +++|.++|..... ...+++..+..++.||+.||.|||++||+|+||||+||||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 99999999999 5799998864221 22478899999999999999999999999999999999999
Q ss_pred CCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHH
Q 002732 710 EAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784 (887)
Q Consensus 710 ~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~ 784 (887)
. .+.++|+|||++....... .....++..|+|||++.+..++.++||||||||||+|++ |.+||.+......+.
T Consensus 159 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 159 E-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred C-CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 5 7789999999997653322 222344667999999998899999999999999999998 999998765544433
Q ss_pred HHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHh
Q 002732 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKI 864 (887)
Q Consensus 785 ~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~km 864 (887)
.+... ..+ ..+..++..+.+||.+|
T Consensus 238 ~~~~~-~~~------------------------------------------------------~~~~~~~~~~~~li~~c 262 (283)
T cd05090 238 MVRKR-QLL------------------------------------------------------PCSEDCPPRMYSLMTEC 262 (283)
T ss_pred HHHcC-CcC------------------------------------------------------CCCCCCCHHHHHHHHHH
Confidence 22110 000 01122346788999999
Q ss_pred cccCCCCCcCHHHHHhC
Q 002732 865 FVLDPEKRMTVAQALTH 881 (887)
Q Consensus 865 L~~DP~~RpTa~elL~H 881 (887)
|+.||..||++.+|+++
T Consensus 263 l~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 263 WQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cccCcccCcCHHHHHHH
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=309.20 Aligned_cols=249 Identities=32% Similarity=0.479 Sum_probs=207.1
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
|.+...||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+ .|++|++++++|.....
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTG----KEVAIKVIKLESKEKKEKIINEIQILKKC------KHPNIVKYYGSYLKKDE 71 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCC----cEEEEEEecccchhHHHHHHHHHHHHHhC------CCCCEeEEEEEEecCCe
Confidence 889999999999999999988766 7899999976543 456778899999998 79999999999999999
Q ss_pred EEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
.++|+||+. ++|.+++.... ..+++..+..++.||+.||.|||..||+|+||+|.||+++. ++.++|+|||++...
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~ 148 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS-DGEVKLIDFGLSAQL 148 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc-CCeEEEeeccccccc
Confidence 999999995 79999887642 35899999999999999999999999999999999999995 788999999999776
Q ss_pred CCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 727 GKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 727 ~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.... .....++..|+|||++.+..++.++||||||||||+|++|..||...+....+..+.. ...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~---------- 216 (253)
T cd05122 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPG---------- 216 (253)
T ss_pred cccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCC----------
Confidence 5543 3455678899999999988899999999999999999999999976544333322211 00000
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCC
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpw 883 (887)
......++..+.+||..||..||.+|||+.+||.|||
T Consensus 217 -----------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 -----------------------------------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------------------------------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0001113567899999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.84 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=205.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc-chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN-ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
++|.+++.||.|+||+||++.+..++ ..||||.+... ......+..|+.++..+ .||||+.++++|...
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~hp~i~~~~~~~~~~ 88 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATG----QEVAIKQMNLQQQPKKELIINEILVMREN------KHPNIVNYLDSYLVG 88 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCC----CEEEEEEeccccchHHHHHHHHHHHHhhc------CCCCeeehhheeeeC
Confidence 57999999999999999999987766 68999998643 22345677888888888 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|.||+++. .+.++|+|||++.
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~ 163 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCA 163 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC-CCCEEEccCccee
Confidence 9999999999 67999988652 3889999999999999999999999999999999999985 7789999999886
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....+++.|+|||++.+..++.++|||||||++|+|++|..||...+....+..+.. ...|
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~~-------- 233 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTP-------- 233 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CCCC--------
Confidence 544322 2334678889999999988899999999999999999999999976544322211100 0000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
....+..++..+.+||.+||..+|.+||++.+||.||
T Consensus 234 -------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 234 -------------------------------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred -------------------------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0001123456788999999999999999999999999
Q ss_pred CCCC
Q 002732 883 FISG 886 (887)
Q Consensus 883 wf~~ 886 (887)
||..
T Consensus 271 ~~~~ 274 (293)
T cd06647 271 FLKI 274 (293)
T ss_pred HHhc
Confidence 9975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.55 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=200.1
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
.|.+.+.||.|+||.||+|.+... ..+|||++.........+..|+.++..+ .|+||+++++++...+.
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGK-----IDVAIKMIREGAMSEDDFIEEAKVMMKL------SHPNLVQLYGVCTKQRP 73 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCC-----ccEEEEEeccCCCCHHHHHHHHHHHHhC------CCCCEEEEEEEEcCCCc
Confidence 488999999999999999987542 4799999876555556778899999998 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+|+||||+ +++|.+++..... .+++..++.|+.||+.||.|||+.||+|+||+|+|||++. ++.+||+|||++...
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~ 150 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE-DNVVKVSDFGLARYV 150 (256)
T ss_pred eEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC-CCcEEECCcccceec
Confidence 99999999 6789999876432 4899999999999999999999999999999999999985 788999999999765
Q ss_pred CCCCccCcc---cCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 727 GKNEITPYL---VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 727 ~~~~~~~~~---gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
......... ++..|+|||++.+..++.++||||||||||+|++ |.+||...+..+.+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------- 219 (256)
T cd05059 151 LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------- 219 (256)
T ss_pred ccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------
Confidence 543322222 2356999999999999999999999999999999 8999976655444332211100
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
...+..++.++.+||.+||..+|.+|||+.+||..
T Consensus 220 --------------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 --------------------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00112245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=310.75 Aligned_cols=248 Identities=30% Similarity=0.472 Sum_probs=206.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||.|+||.||+|.+...+ ..||||.+..... ....+..|+.++..+ .|++|+.+++++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG----DFVAIKQISLEKIKEEALKSIMQEIDLLKNL------KHPNIVKYIGSIET 70 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC----cEEEEEEecccccCHHHHHHHHHHHHHHHhC------CCCCccEEEEEEEe
Confidence 4889999999999999999987766 7899999976542 446678899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++. .+.++|+|||++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~ 146 (254)
T cd06627 71 SDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK-DGVVKLADFGVA 146 (254)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC-CCCEEEeccccc
Confidence 99999999999 569999987753 4999999999999999999999999999999999999995 788999999999
Q ss_pred eecCCCCc--cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKNEI--TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
........ ....++..|+|||++.+..++.++|||+||++||+|++|..||........+..+.. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~--------- 215 (254)
T cd06627 147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--DD--------- 215 (254)
T ss_pred eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--cC---------
Confidence 77654332 345678889999999888899999999999999999999999975543222211100 00
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.+..+..++..+.+||.+||..+|++|||+.++|.|
T Consensus 216 --------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 216 --------------------------------------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred --------------------------------------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 011122345788999999999999999999999999
Q ss_pred CCC
Q 002732 882 PFI 884 (887)
Q Consensus 882 pwf 884 (887)
|||
T Consensus 252 ~~~ 254 (254)
T cd06627 252 PWI 254 (254)
T ss_pred CCC
Confidence 998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=325.29 Aligned_cols=248 Identities=28% Similarity=0.372 Sum_probs=201.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.+++.||.|+||.||+|.+..++ ..||||++.... .....+..|+.++..+ .|+||+.++++|...
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 74 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTK----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC------DSPYITRYYGSYLKG 74 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCC----eEEEEEEeccccchHHHHHHHHHHHHHHcC------CCCccHhhhcccccC
Confidence 3677788999999999999987766 789999987432 2345678899999988 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+||||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++. ++.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE-QGDVKLADFGVAG 149 (277)
T ss_pred CceEEEEEccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC-CCCEEEccccccc
Confidence 9999999999 5688888753 34899999999999999999999999999999999999985 7889999999987
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
...... .....++..|+|||++.+..++.++|||||||+||+|++|..||........+..+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~------------- 216 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN------------- 216 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------------
Confidence 654322 22346788899999999989999999999999999999999999654332222111000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
. .+.....++..+.+||.+||..+|.+|||+.+||+||
T Consensus 217 --------------------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 217 --------------------------------S----------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred --------------------------------C----------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0 0001122446789999999999999999999999999
Q ss_pred CCC
Q 002732 883 FIS 885 (887)
Q Consensus 883 wf~ 885 (887)
||.
T Consensus 255 ~~~ 257 (277)
T cd06642 255 FIT 257 (277)
T ss_pred HHH
Confidence 986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.74 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=200.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+.+.||.|+||.||+|.+..++ ..||||.+... ......+..|+.+|+.+ .||||++++++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 71 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQL------NHPNVIKYLDSF 71 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhC------CCcceeeeeeeE
Confidence 46999999999999999999988777 79999987542 22234567899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
...+.+++||||+ +++|.+++..... ...+++..+..++.||+.||.|||++||+|+||+|+||||+. .+.++|+||
T Consensus 72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~-~~~~~l~d~ 150 (267)
T cd08228 72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA-TGVVKLGDL 150 (267)
T ss_pred EECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC-CCCEEECcc
Confidence 9999999999999 5699888865432 234899999999999999999999999999999999999985 778999999
Q ss_pred CcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHhhCCCChh
Q 002732 721 GNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN--DMLRLHMELKGPFPKK 796 (887)
Q Consensus 721 G~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~--~~l~~i~~~~g~~p~~ 796 (887)
|++....... .....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+ ... .+|
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~-~~~-- 226 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQC-DYP-- 226 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcC-CCC--
Confidence 9987765432 22356788899999999988999999999999999999999999643321 111111 000 000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+.....++..+.+||.+||..+|.+|||+.
T Consensus 227 --------------------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 256 (267)
T cd08228 227 --------------------------------------------------PLPTEHYSEKLRELVSMCIYPDPDQRPDIG 256 (267)
T ss_pred --------------------------------------------------CCChhhcCHHHHHHHHHHCCCCcccCcCHH
Confidence 001123456789999999999999999999
Q ss_pred HHHhC
Q 002732 877 QALTH 881 (887)
Q Consensus 877 elL~H 881 (887)
+||+.
T Consensus 257 ~vl~~ 261 (267)
T cd08228 257 YVHQI 261 (267)
T ss_pred HHHHH
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.26 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=203.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.++..||.|+||.||+|.+..++ ..||||++... ......+..|+.++..|... .|++|++++++|...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~---~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG----RVVALKIINLDTPDDDVSDIQREVALLSQLRQS---QPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccC---CCCCeeeEeeeeeeC
Confidence 3888999999999999999987776 79999998653 22335677899999999442 599999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+||||||+ +++|.+++... .+++..++.++.||+.||.|||+.||+|+||+|.|||++. .+.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~ 149 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN-TGNVKLCDFGVAA 149 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence 9999999999 66898888652 4899999999999999999999999999999999999995 7889999999997
Q ss_pred ecCCCC--ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~~--~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...... .....++..|+|||++.+. .++.++|||||||+||+|++|..||.+.........+.. ..
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~-------- 218 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SK-------- 218 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CC--------
Confidence 765432 2345678889999998754 578999999999999999999999976543222111000 00
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+..+ + ...++.++.+||..||..||.+|||+.++|.|
T Consensus 219 ----------------------------------~~~~-------~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 ----------------------------------PPRL-------E--DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----------------------------------CCCC-------C--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 0 00144678999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 256 ~~~~~ 260 (277)
T cd06917 256 KWIKA 260 (277)
T ss_pred hHhhc
Confidence 99964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.42 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=202.6
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+++.+.|.++++||.|+||.||+|.... + ..||||++.........+..|+.+|..| +|+||+++++++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~----~~~a~K~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~ 70 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNG-H----TKVAIKSLKQGSMSPEAFLAEANLMKQL------QHPRLVRLYAVV 70 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCC-C----ceEEEEEecCCCCcHHHHHHHHHHHHhc------CCcCeeeEEEEE
Confidence 4567789999999999999999998643 3 5799999987666667788999999999 899999999887
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
. ...+|+||||+ +++|.+++.... ...++...+..++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||
T Consensus 71 ~-~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~-~~~~~l~dfg 147 (260)
T cd05067 71 T-QEPIYIITEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE-TLCCKIADFG 147 (260)
T ss_pred c-cCCcEEEEEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC-CCCEEEccCc
Confidence 4 46789999999 679999887633 345899999999999999999999999999999999999995 7789999999
Q ss_pred cceecCCCCc---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++........ ....++..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+..+.+..+..... +
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~---- 222 (260)
T cd05067 148 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-M---- 222 (260)
T ss_pred ceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-C----
Confidence 9976553222 12334567999999999899999999999999999998 9999987765544433311100 0
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..+..++.++.+||.+||..+|.+|||+++
T Consensus 223 --------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 252 (260)
T cd05067 223 --------------------------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEY 252 (260)
T ss_pred --------------------------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 001123467899999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
|+.
T Consensus 253 l~~ 255 (260)
T cd05067 253 LRS 255 (260)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=329.73 Aligned_cols=290 Identities=18% Similarity=0.229 Sum_probs=200.6
Q ss_pred EeccC--CceEEEEEEEcCCCCCCCcEEEEEEecccch---hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 574 AHGKG--VFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 574 ~LG~G--~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
.||.| +||+||+|.+..++ ..||||++..... ..+.+..|+.++..| +|+||++++++|....++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTG----TLVTVRITDLENCTEEHLKALQNEVVLSHFF------RHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HhCCcccCceeEEEEEEcCCC----cEEEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcceEeeeEecCCce
Confidence 45665 99999999998777 8999999875322 235667888888877 899999999999999999
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||++||+|+||||+||||+. .+.++|+||+.+....
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEEecccCCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC-CCcEEEechHHHhhhh
Confidence 9999999 5699998887532 35899999999999999999999999999999999999984 7889999998653221
Q ss_pred CCC---------ccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 728 KNE---------ITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 728 ~~~---------~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
... .....++..|+|||++.+. .++.++|||||||+||+|++|.+||........+..++......|..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 110 0112345679999999874 47899999999999999999999998776655544443322221111
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCcccccc--CCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT--ASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
.................+ ...+... .+. ......+.. -.......++..+.+||.+||++||.+|||
T Consensus 233 ~~~~~~~~~~~~~~~~~~----~~~~~~~----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 233 ITTFPCEESRMKNSQSGV----DSGIGES----VVA---AGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred ccccchhhhhhccchhhh----hcccccc----hhc---cccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 100000000000000000 0000000 000 000000000 011123456788999999999999999999
Q ss_pred HHHHHhCCCCCC
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~elL~Hpwf~~ 886 (887)
+.+||+||||..
T Consensus 302 a~e~l~~~~~~~ 313 (328)
T cd08226 302 ASSLLSHAFFKQ 313 (328)
T ss_pred HHHHhhCHHHHH
Confidence 999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=356.97 Aligned_cols=144 Identities=24% Similarity=0.417 Sum_probs=127.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|.++.+||+|+||+||+|.+..++ ..||||++..... ....+..|+.++..| .|+||+.++.++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l------~hp~Iv~~~~~~ 73 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNS----KLYAVKVVKKADMINKNMVHQVQAERDALALS------KSPFIVHLYYSL 73 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCC----cEEEEEEEehhhccCHHHHHHHHHHHHHHHhc------CCCCcCeEEEEE
Confidence 45999999999999999999998776 7999999975322 235567788888888 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
....++||||||+ +++|..+|...+ .+++..++.|+.||+.||.|||.+||||+||||+||||+. .+.++|+|||
T Consensus 74 ~~~~~~~lVmEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~-~g~vkL~DFG 149 (669)
T cd05610 74 QSANNVYLVMEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN-EGHIKLTDFG 149 (669)
T ss_pred EECCEEEEEEeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC-CCCEEEEeCC
Confidence 9999999999999 779999997654 3899999999999999999999999999999999999984 7889999999
Q ss_pred cce
Q 002732 722 NAM 724 (887)
Q Consensus 722 ~a~ 724 (887)
++.
T Consensus 150 ls~ 152 (669)
T cd05610 150 LSK 152 (669)
T ss_pred CCc
Confidence 874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=335.03 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=198.3
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCC-CCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKA-GNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~-~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.+.+.||.|+||+||+|.+... .......||||++.... .....+..|+.+|..|. .||||++++++|
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~-----~HpnIv~l~~~~ 108 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHINIVNLLGAC 108 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc-----CCcceeeeeeee
Confidence 45799999999999999999975321 11223689999987532 23356778999999884 699999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-----------------------------------------------------
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR----------------------------------------------------- 668 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~----------------------------------------------------- 668 (887)
......||||||| +|+|.++|.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 9999999999999 6799988865321
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 669 -------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 669 -------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
...+++..+..|+.||+.||.|||++||||+||||.||||+. +..++|+|||++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIRND 267 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC-CCcEEEecCccceeccCc
Confidence 124788899999999999999999999999999999999984 778999999999765432
Q ss_pred Cc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 730 EI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 730 ~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
.. ....++..|+|||++.+..++.++|||||||+||+|++ |..||........+..++...
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-------------- 333 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG-------------- 333 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC--------------
Confidence 21 11233567999999999999999999999999999998 899997654432222111100
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.. +..+...+.++.+||.+||+.||.+|||+.+||+.
T Consensus 334 -----------------------------~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 -----------------------------YR-----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------------------------cc-----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 00011234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=346.63 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=217.2
Q ss_pred cCceecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 561 FGEILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 561 ~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
..++-..+..+...||+|.||.||+|....-. ....+.||||.++.. ......|.+|+.+|..| +|||||+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l------~H~nIVr 553 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL------QHPNIVR 553 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc------cCCCeEE
Confidence 33455567889999999999999999865432 234578999999864 33578999999999999 9999999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHhcc-----------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCC
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKFGR-----------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-----------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~N 705 (887)
|+|+|...+.+||||||| .|+|.++|..... ...|+..+.+.|+.|||.|+.||-++.+||+||...|
T Consensus 554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN 633 (774)
T KOG1026|consen 554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN 633 (774)
T ss_pred EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence 999999999999999999 8999999987653 1238899999999999999999999999999999999
Q ss_pred ccccCCCCeEEEEecCcceecCCCCccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 002732 706 MLVNEAKNVLKLCDFGNAMFAGKNEITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNN 780 (887)
Q Consensus 706 ILl~~~~~~vKL~DFG~a~~~~~~~~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~ 780 (887)
+||++ +.+|||+|||+++.+....+.-. .-.+.|||||.|....|++++||||+|||||||++ |..||.+.+++
T Consensus 634 CLVge-~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 634 CLVGE-NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred ceecc-ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 99995 88999999999976655444332 33567999999999999999999999999999999 99999999999
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
+++..|.+... ...+...+.++..|
T Consensus 713 EVIe~i~~g~l-------------------------------------------------------L~~Pe~CP~~vY~L 737 (774)
T KOG1026|consen 713 EVIECIRAGQL-------------------------------------------------------LSCPENCPTEVYSL 737 (774)
T ss_pred HHHHHHHcCCc-------------------------------------------------------ccCCCCCCHHHHHH
Confidence 99987744321 11234456789999
Q ss_pred HHHhcccCCCCCcCHHHH
Q 002732 861 LDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~el 878 (887)
+..||+..|.+||++.||
T Consensus 738 M~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 738 MLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHhhcCcccCCCHHHH
Confidence 999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.07 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=210.3
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
....|.+...||.|+||.||+|.+..++ ..||||++.........+..|+.+|..+ .|+||++++++|..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATG----KEVAIKKMRLRKQNKELIINEILIMKDC------KHPNIVDYYDSYLV 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCC----cEEEEEEEecCchhHHHHHHHHHHHHHC------CCCCeeEEEEEEEE
Confidence 3456999999999999999999987665 7899999986544456778899999998 89999999999999
Q ss_pred cCeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~ 163 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-DGSVKLADFGFA 163 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC-CCCEEECccchh
Confidence 999999999995 79999998754 24999999999999999999999999999999999999994 778999999988
Q ss_pred eecCCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...... ......++..|+|||++.+..++.++||||||||||+|++|..||........+..+... .++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~------ 235 (286)
T cd06614 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIPP------ 235 (286)
T ss_pred hhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCCC------
Confidence 654332 123345678899999999989999999999999999999999999765444333222110 0000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
......++..+.+||..||+.+|..|||+.+||.|
T Consensus 236 ---------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 ---------------------------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---------------------------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00012245678999999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||.+
T Consensus 271 ~~~~~ 275 (286)
T cd06614 271 PFLKK 275 (286)
T ss_pred hHhhc
Confidence 99975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.02 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=198.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.++..||+|+||+||+|.+..++......||||++... ......+..|+.++..| .|+||++++++|..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~g~~~~ 80 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICLT 80 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEcC
Confidence 46999999999999999999987766444456999998743 23345677899999988 89999999999876
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
. ..++|++|+ +|+|.+++.... ..++...++.++.||+.||.|||+.||||+||||+||||+. ++.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~-~~~~kl~DfG~a 156 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT-PQHVKITDFGLA 156 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC-CCcEEEcccccc
Confidence 5 467899988 789999988643 24889999999999999999999999999999999999984 778999999999
Q ss_pred eecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
........ ....++..|+|||++.+..++.++|||||||+||+|++ |..||.+....+... ++.....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~----- 230 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERL----- 230 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCC-----
Confidence 87653221 12233567999999999999999999999999999998 999997765443322 21111000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..++.++..+..||.+||..+|..|||+.+|
T Consensus 231 -------------------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 231 -------------------------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0112234578899999999999999999999
Q ss_pred HhC
Q 002732 879 LTH 881 (887)
Q Consensus 879 L~H 881 (887)
|.+
T Consensus 262 ~~~ 264 (316)
T cd05108 262 IIE 264 (316)
T ss_pred HHH
Confidence 976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.63 Aligned_cols=248 Identities=26% Similarity=0.318 Sum_probs=199.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+..++|.+.++||+|+||+||+|.+..+. .||||++.........+..|+.++..+ .|+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~valK~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~~~~~~~ 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVS 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-----eEEEEecccCccCHHHHHHHHHHHHhC------CCCCcceEEEEEC
Confidence 34567999999999999999999876543 599999986555556788899999998 8999999998775
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...+|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+|+|+||+|.|||++. ++.++|+|||+
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~-~~~~~L~dfg~ 148 (262)
T cd05071 72 -EEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGL 148 (262)
T ss_pred -CCCcEEEEEcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC-CCcEEeccCCc
Confidence 45689999999 569999997632 234899999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+......... ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+......+..+.... .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-~~----- 222 (262)
T cd05071 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-RM----- 222 (262)
T ss_pred eeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-CC-----
Confidence 9765543322 2334567999999999899999999999999999999 889997765544443321100 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.....++..+.+||.+||+.+|.+|||+.++
T Consensus 223 -------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 223 -------------------------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred -------------------------------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 0012344678899999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
++
T Consensus 254 ~~ 255 (262)
T cd05071 254 QA 255 (262)
T ss_pred HH
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=310.14 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=207.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||.|+||.||+|.+..++ ..||||++.... .....+..|+.+++.+ .|+||+.++++|..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 70 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN----QFYALKEVDLGSMSQKEREDAVNEIRILASV------NHPNIISYKEAFLD 70 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC----CEEEEEEEehhhccHHHHHHHHHHHHHHHhC------CCCCchhhhhhhcc
Confidence 4899999999999999999987776 789999987532 2234556788888888 79999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...+|+||||+ +++|..++..... ...+++..++.++.||+.||.|||+.||+|+||+|.||+++. .+.++|+|||+
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~-~~~~kl~d~g~ 149 (256)
T cd08530 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA-NDLVKIGDLGI 149 (256)
T ss_pred CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec-CCcEEEeeccc
Confidence 99999999999 6689988866321 245899999999999999999999999999999999999995 77899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
+............++..|+|||.+.+..++.++||||||+|+|+|++|..||...+.......+.. +.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~---------- 217 (256)
T cd08530 150 SKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR--GK---------- 217 (256)
T ss_pred hhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CC----------
Confidence 977665544445678899999999998999999999999999999999999977654433222211 00
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hp 882 (887)
.+.....++..+.+||.+||..+|.+|||+.++|+||
T Consensus 218 -------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 218 -------------------------------------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred -------------------------------------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 0111124457789999999999999999999999999
Q ss_pred CC
Q 002732 883 FI 884 (887)
Q Consensus 883 wf 884 (887)
++
T Consensus 255 ~~ 256 (256)
T cd08530 255 AV 256 (256)
T ss_pred CC
Confidence 85
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=323.71 Aligned_cols=253 Identities=24% Similarity=0.344 Sum_probs=204.7
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
.....|.++..||+|+||.||+|.+..++ ..||||++.... .....+..|+.+|..+ .|+||++++
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~----~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~ 91 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTN----EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI------KHPNSIEYK 91 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCC----cEEEEEEEecCCCCchHHHHHHHHHHHHHHhC------CCCCEEEEE
Confidence 33345889999999999999999987776 799999986432 2234567789999888 899999999
Q ss_pred ceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 640 SSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
++|......||||||+.++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|.|||++. .+.++|+|
T Consensus 92 ~~~~~~~~~~lv~e~~~g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~-~~~~kl~d 168 (317)
T cd06635 92 GCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE-PGQVKLAD 168 (317)
T ss_pred EEEeeCCeEEEEEeCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC-CCCEEEec
Confidence 9999999999999999888888876533 34899999999999999999999999999999999999984 78899999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
||++..... .....+++.|+|||++. +..++.++||||||||||+|++|..||........+..+.......
T Consensus 169 fg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 243 (317)
T cd06635 169 FGSASIASP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--- 243 (317)
T ss_pred CCCccccCC--cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---
Confidence 999865443 23456788999999985 3468999999999999999999999997655444433332111000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.....++..+.+||.+||+.+|..|||+.
T Consensus 244 ---------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 244 ---------------------------------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred ---------------------------------------------------CCCccccHHHHHHHHHHccCCcccCcCHH
Confidence 00112346789999999999999999999
Q ss_pred HHHhCCCCC
Q 002732 877 QALTHPFIS 885 (887)
Q Consensus 877 elL~Hpwf~ 885 (887)
++|+|||+-
T Consensus 273 ~il~~~~~~ 281 (317)
T cd06635 273 ELLKHMFVL 281 (317)
T ss_pred HHHhChhhh
Confidence 999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=314.25 Aligned_cols=250 Identities=28% Similarity=0.468 Sum_probs=199.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc------chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN------ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+|.+.+.||.|+||+||+|.+...+ ..+++|+++.. ......+..|+.++..+ +||||++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~ 70 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAV----AEERLKVLKEIPVGELNPNETVQANQEAQLLSKL------DHPAIVKFHAS 70 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCC----CcceEEEeccccccccCcchHHHHHHHHHHHHhC------CCCcHHHHHHH
Confidence 5899999999999999999987664 44666665431 11223455688888888 89999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
+.....+||||||+ +++|.+++.... ....+++..++.++.||+.||.|||+.||+|+||+|+|||++ .+.++|+|
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~--~~~~~l~d 148 (260)
T cd08222 71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGD 148 (260)
T ss_pred HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee--cCCEeecc
Confidence 99999999999999 568888886532 234599999999999999999999999999999999999997 35689999
Q ss_pred cCcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 720 FGNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 720 FG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
||++....... .....++..|+|||++.+..++.++||||||+|+|+|++|..||........+..+.. +.+
T Consensus 149 ~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~---- 222 (260)
T cd08222 149 FGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT---- 222 (260)
T ss_pred cCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC----
Confidence 99987654322 2345678889999999888899999999999999999999999975544333322211 111
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+..+..++..+.+||.+||..+|..||++.+
T Consensus 223 -------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 223 -------------------------------------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred -------------------------------------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 0112244578899999999999999999999
Q ss_pred HHhCCCC
Q 002732 878 ALTHPFI 884 (887)
Q Consensus 878 lL~Hpwf 884 (887)
||+||||
T Consensus 254 il~~~~~ 260 (260)
T cd08222 254 ILRNPFI 260 (260)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=314.29 Aligned_cols=255 Identities=19% Similarity=0.257 Sum_probs=203.1
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+..++|.++..||.|+||.||+|.+.... ......||||++.... .....+..|+.+|..+ .|+||+++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~ 76 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF------NCHHVVRLLG 76 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC------CCCceeEEEE
Confidence 44567999999999999999999876533 1234689999987543 2234567888888888 8999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGR-------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK 712 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 712 (887)
++.....+|+||||+ +++|.++|..... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++. +
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-~ 155 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-D 155 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC-C
Confidence 999999999999999 6799999876432 123788899999999999999999999999999999999995 7
Q ss_pred CeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHH
Q 002732 713 NVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHM 787 (887)
Q Consensus 713 ~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~ 787 (887)
+.+||+|||++....... .....++..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+....+..+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 889999999986544322 123345778999999998889999999999999999998 999997766554443332
Q ss_pred HhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhccc
Q 002732 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL 867 (887)
Q Consensus 788 ~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~ 867 (887)
.+..+ ..+..++..+.+||.+||+.
T Consensus 236 --~~~~~-----------------------------------------------------~~~~~~~~~~~~li~~~l~~ 260 (277)
T cd05032 236 --DGGHL-----------------------------------------------------DLPENCPDKLLELMRMCWQY 260 (277)
T ss_pred --cCCCC-----------------------------------------------------CCCCCCCHHHHHHHHHHcCC
Confidence 00000 00112346789999999999
Q ss_pred CCCCCcCHHHHHh
Q 002732 868 DPEKRMTVAQALT 880 (887)
Q Consensus 868 DP~~RpTa~elL~ 880 (887)
+|.+|||+.+|+.
T Consensus 261 ~p~~Rpt~~~l~~ 273 (277)
T cd05032 261 NPKMRPTFLEIVS 273 (277)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.42 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=200.6
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++..++|++++.||.|+||+||+|.+... ..||+|++.........+..|+.+|..| .|++|+.+++++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~~~~~~ 70 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGN-----TKVAVKTLKPGTMSPESFLEEAQIMKKL------RHDKLVQLYAVV 70 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCC-----ceeEEEEecCCCCCHHHHHHHHHHHHhc------CCCceEEEEeEE
Confidence 34556799999999999999999986543 4699999987655556788999999999 899999999987
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
. ...+||||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.||+|+||+|.|||++. ++.++|+|||
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~-~~~~~l~dfg 147 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD-GLVCKIADFG 147 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC-CceEEeCCce
Confidence 5 45689999999 579999987632 234899999999999999999999999999999999999985 7789999999
Q ss_pred cceecCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++......... ...++..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+..+.+..+.... .+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~---- 222 (260)
T cd05070 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-RM---- 222 (260)
T ss_pred eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence 99765443221 2234567999999998899999999999999999999 899998766554444332110 00
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..+..++..+.+||.+||..+|.+|||+.+
T Consensus 223 --------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 252 (260)
T cd05070 223 --------------------------------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEY 252 (260)
T ss_pred --------------------------------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHH
Confidence 011223467899999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
++.
T Consensus 253 l~~ 255 (260)
T cd05070 253 LQS 255 (260)
T ss_pred HHH
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=311.17 Aligned_cols=239 Identities=21% Similarity=0.294 Sum_probs=191.4
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||.|+||+||+|.+..++ ..||||++... ......+..|+.+|..| .|+||++++++|.....+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADN----TPVAVKSCRETLPPDLKAKFLQEARILKQY------SHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred ccCcccCccEEEEEEecCC----ceEEEEecCccCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEcCCCCeEEE
Confidence 6899999999999998776 78999987643 22345678899999998 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~ 730 (887)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|.|||++. ++.++|+|||++.......
T Consensus 72 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 72 MELVQGGDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGV 148 (252)
T ss_pred EeeccCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC-CCcEEECccccCccccccc
Confidence 9999 679999887533 34899999999999999999999999999999999999984 7789999999986544322
Q ss_pred ccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 731 ITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 731 ~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.... ..+..|+|||++.+..++.++||||||||||+|++ |.+||...........+... ..
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-~~------------- 214 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-VR------------- 214 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CC-------------
Confidence 2111 12346999999999899999999999999999998 88999655443332222110 00
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...+..++..+.+||.+||+.+|.+|||+.+|++
T Consensus 215 -----------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -----------------------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -----------------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011233467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.47 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=203.8
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
...|.++++||.|+||.||+|.+.. + ..||+|++..... ....+..|+.+|..| .|+||+++++++..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 73 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-R----VRVAIKILKSDDLLKQQDFQKEVQALKRL------RHKHLISLFAVCSV 73 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-C----CcEEEEeccccchhhHHHHHHHHHHHhcC------CCcchhheeeeEec
Confidence 3469999999999999999999877 4 6899999986544 456778899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+||||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||+|+||||+. ++.++|+|||++
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~-~~~~kl~d~g~~ 151 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE-DLVCKVADFGLA 151 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC-CceEEEccccch
Confidence 99999999999 569999997643 245899999999999999999999999999999999999984 788999999999
Q ss_pred eecCCCCc--cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 724 MFAGKNEI--TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
........ ....++..|+|||++.+..++.++|||||||+||+|++ |.+||.+....+.+..+..... +
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~------- 223 (261)
T cd05148 152 RLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M------- 223 (261)
T ss_pred hhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C-------
Confidence 76543322 22334567999999998899999999999999999998 8999987765555544432110 0
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..+..++..+.+||.+||+.||.+|||+.+|++
T Consensus 224 -----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -----------------------------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011234467889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=317.13 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=201.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+...||.|+||+||+|.+.... ......||||.+.... .....+..|+.+|..+ .|++|++++++|..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 78 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL------QHEHIVKFYGVCVE 78 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEec
Confidence 45999999999999999999864321 1223578999887532 3345678899999999 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR----------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~----------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 713 (887)
.+.+||||||+ +++|.++|..... ...+++..++.|+.||+.||.|||++||+|+||||+|||++. .+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~-~~ 157 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-NL 157 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc-CC
Confidence 99999999999 6799999876431 234899999999999999999999999999999999999984 78
Q ss_pred eEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 002732 714 VLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 714 ~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~ 788 (887)
.++|+|||++........ ....+++.|+|||++.+..++.++||||||||||+|++ |.+||........+..+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 899999999976543221 22334678999999999899999999999999999998 9999977665554443322
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
.. ++ ..+..++..+.+||.+||+.|
T Consensus 238 ~~--~~-----------------------------------------------------~~~~~~~~~l~~li~~~l~~~ 262 (288)
T cd05093 238 GR--VL-----------------------------------------------------QRPRTCPKEVYDLMLGCWQRE 262 (288)
T ss_pred CC--cC-----------------------------------------------------CCCCCCCHHHHHHHHHHccCC
Confidence 10 00 001123467899999999999
Q ss_pred CCCCcCHHHHHh
Q 002732 869 PEKRMTVAQALT 880 (887)
Q Consensus 869 P~~RpTa~elL~ 880 (887)
|.+|||+.+|+.
T Consensus 263 p~~Rpt~~~v~~ 274 (288)
T cd05093 263 PHMRLNIKEIHS 274 (288)
T ss_pred hhhCCCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.42 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=202.1
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
|..+..||.|+||+||+|.+..++ ..||||++.... .....+..|+.++..| .|+||+.++++|..
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~----~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 92 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTN----EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL------KHPNTIEYKGCYLK 92 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCC----cEEEEEEEeccccCchHHHHHHHHHHHHHHhC------CCCCCccEEEEEEe
Confidence 777888999999999999987776 799999986432 1224567788999988 89999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
...+||||||+.++|.+++.... ..+++..+..++.||+.||.|||++||+|+||+|.|||++. ++.++|+|||++.
T Consensus 93 ~~~~~lv~e~~~~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~-~~~~kL~dfg~~~ 169 (313)
T cd06633 93 EHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE-PGQVKLADFGSAS 169 (313)
T ss_pred CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC-CCCEEEeecCCCc
Confidence 99999999999888888886533 34899999999999999999999999999999999999984 7789999999986
Q ss_pred ecCCCCccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 725 FAGKNEITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~~~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
.... .....++..|+|||++. +..++.++||||||||||+|++|..||...+....+..+... ..|.
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~------ 239 (313)
T cd06633 170 KSSP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT------ 239 (313)
T ss_pred ccCC--CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCC------
Confidence 5332 23456788999999985 356889999999999999999999999766544433322110 0000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
...+.++..+.+||.+||+.+|.+|||+.++|.|
T Consensus 240 ----------------------------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ----------------------------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----------------------------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011234568899999999999999999999999
Q ss_pred CCCCC
Q 002732 882 PFISG 886 (887)
Q Consensus 882 pwf~~ 886 (887)
|||..
T Consensus 274 ~~~~~ 278 (313)
T cd06633 274 DFVRR 278 (313)
T ss_pred cccCC
Confidence 99964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.36 Aligned_cols=249 Identities=26% Similarity=0.304 Sum_probs=204.1
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+..++|.+.++||.|+||+||+|.+... ..||||++.........+..|+.+++.+ .|+||+++++++.
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 71 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT-----TKVAVKTLKPGTMSPEAFLQEAQIMKKL------RHDKLVQLYAVCS 71 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC-----ceEEEEEecCCccCHHHHHHHHHHHhhC------CCCCEeeeeeeee
Confidence 4557899999999999999999986533 5799999987666667788999999998 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+++||||+ +++|.+++.... ...+++..+..|+.||+.||.|||++||+|+||+|+||||+. ++.++|+|||+
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~-~~~~~l~d~g~ 149 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE-NLVCKIADFGL 149 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC-CCCEEECcccc
Confidence 989999999999 579999987632 234899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+......... ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+....+..+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------ 223 (261)
T cd05034 150 ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM------ 223 (261)
T ss_pred ceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 8766532221 1223467999999999899999999999999999998 99999877665555443221100
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..+..++..+.+||.+||..+|.+|||+.++
T Consensus 224 -------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 224 -------------------------------------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 0011224678899999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
++
T Consensus 255 ~~ 256 (261)
T cd05034 255 QS 256 (261)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=319.32 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=201.7
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCC---CCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGN---GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~---~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
++..++|.+.+.||+|+||.||+|.+..... .....||||++.... .....+..|+.++..+. .|+||++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~i~~ 88 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIIN 88 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc-----CCCCEee
Confidence 4455789999999999999999998754321 122479999997542 22345677888888883 6899999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCC
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 703 (887)
++++|...+.+||||||+ +++|.++|..... ...+++..++.|+.||+.||.|||++||+|+||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999 5799999976421 12488999999999999999999999999999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGAT 778 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~ 778 (887)
+|||++. ++.++|+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++ |..||.+.+
T Consensus 169 ~Nill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999985 6789999999987554321 111223467999999999899999999999999999998 889997655
Q ss_pred hHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHH
Q 002732 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 779 ~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 858 (887)
..+....+.... ....+..++.++.
T Consensus 248 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~ 272 (307)
T cd05098 248 VEELFKLLKEGH-------------------------------------------------------RMDKPSNCTNELY 272 (307)
T ss_pred HHHHHHHHHcCC-------------------------------------------------------CCCCCCcCCHHHH
Confidence 444333221100 0001123446889
Q ss_pred HHHHHhcccCCCCCcCHHHHHhC
Q 002732 859 DLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+||.+||..+|..|||+.+||++
T Consensus 273 ~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 273 MMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcccChhhCcCHHHHHHH
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=309.70 Aligned_cols=240 Identities=28% Similarity=0.458 Sum_probs=201.1
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
||.|+||.||+|.+..++ ..||||++..... ....+..|+.+++.+ .|++|+.+++.|.....+|+
T Consensus 1 lg~G~~~~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~~ 70 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG----KLYAMKVLKKKKIIKRKEVEHTLTERNILSRI------NHPFIVKLHYAFQTEEKLYL 70 (250)
T ss_pred CCCCCceEEEEEEECCCC----cEEEEEEeehhhhcchHHHHHHHHHHHHHHHc------CCCcHHHHHHHeecCCeeEE
Confidence 699999999999987766 7899999876432 234678899999999 79999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||+|.||+++. .+.++|+|||++......
T Consensus 71 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 71 VLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC-CCcEEEeecCcceecccC
Confidence 99999 789999987653 4899999999999999999999999999999999999985 778999999999775543
Q ss_pred --CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccc
Q 002732 730 --EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH 807 (887)
Q Consensus 730 --~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~ 807 (887)
......++..|+|||++.+..++.++|||||||++|+|++|..||........+..+......
T Consensus 147 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 211 (250)
T cd05123 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR--------------- 211 (250)
T ss_pred CCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC---------------
Confidence 344556788899999999888999999999999999999999999766554333333211000
Q ss_pred cccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH---HHHHhCCCC
Q 002732 808 FDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV---AQALTHPFI 884 (887)
Q Consensus 808 f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa---~elL~Hpwf 884 (887)
.+..++..+.+||.+||..||..|||+ .+++.||||
T Consensus 212 -----------------------------------------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 -----------------------------------------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------------------------------------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 111224678899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=316.89 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=200.7
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.|.+.+.||.|+||.||+|.+.... ..+..||||++..... ....+..|+.+|..+. +|++|+.++++|
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCC-CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc-----cCCChhceeeEe
Confidence 3889999999999999999875311 1237899999875322 2355678999999884 589999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.....+||||||+ +++|.++|.... .+++..+..++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg 150 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFG 150 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC-CCCEEEeeCc
Confidence 9999999999999 579999887643 4899999999999999999999999999999999999985 7889999999
Q ss_pred cceecCCCC---ccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 722 NAMFAGKNE---ITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 722 ~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
++....... .....++..|+|||++.+. .++.++||||||||||+|++|..||...........+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------- 223 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR------- 223 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-------
Confidence 987654322 2345678899999998763 4788999999999999999999999643222111111110
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc---
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM--- 873 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp--- 873 (887)
++. . .+..+..++..+.+||.+||..||..||
T Consensus 224 ---------------------------------~~~-~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~ 258 (290)
T cd05613 224 ---------------------------------ILK-S-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCG 258 (290)
T ss_pred ---------------------------------hhc-c-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 000 0 0011123456788999999999999997
Q ss_pred --CHHHHHhCCCCCC
Q 002732 874 --TVAQALTHPFISG 886 (887)
Q Consensus 874 --Ta~elL~Hpwf~~ 886 (887)
++.++|.||||+.
T Consensus 259 ~~~~~~l~~~~~~~~ 273 (290)
T cd05613 259 PSDADEIKKHPFFQK 273 (290)
T ss_pred CCCHHHHHcCccccc
Confidence 8999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.04 Aligned_cols=248 Identities=26% Similarity=0.319 Sum_probs=200.1
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+..++|.+...||.|+||+||+|.+.... .||||++.........+..|+.+|..| .|++|+.+++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~ 71 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-----KVAIKTLKPGTMMPEAFLQEAQIMKKL------RHDKLVPLYAVVS 71 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-----eEEEEEcccCCccHHHHHHHHHHHHhC------CCCCeeeEEEEEc
Confidence 44467999999999999999999876543 599999876655556788899999999 8999999998875
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.+..|+||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||+
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~-~~~~~l~dfg~ 148 (260)
T cd05069 72 -EEPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD-NLVCKIADFGL 148 (260)
T ss_pred -CCCcEEEEEcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC-CCeEEECCCcc
Confidence 46689999999 469999997642 234899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 723 AMFAGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
+......... ...++..|+|||++.+..++.++|||||||+||+|++ |.+||.+....+.+..+.... .+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----- 222 (260)
T cd05069 149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM----- 222 (260)
T ss_pred ceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence 9776443322 2234567999999998899999999999999999999 999998766554443321110 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..+..++..+.+||.+||..||.+|||+++|
T Consensus 223 -------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 223 -------------------------------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred -------------------------------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 0012234678999999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
++
T Consensus 254 ~~ 255 (260)
T cd05069 254 QS 255 (260)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.24 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=200.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc------chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN------ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
.|.+.+.||+|+||.||+|.+..++ ..||||++... ......+..|+.+++.| .|+||++++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l------~h~~i~~~~~~ 72 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTG----RELAVKQVPFDPDSQETSKEVNALECEIQLLKNL------RHDRIVQYYGC 72 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCC----CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc------CCCCcceEEEE
Confidence 5999999999999999999988777 79999987532 12234667899999999 89999999999
Q ss_pred eeec--CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 642 FKYR--NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 642 ~~~~--~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
+... ..+++||||+ +++|.+++.... .+++..+..|+.||+.||.|||++||+|+||+|+|||++. ++.++|+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~-~~~~~l~ 148 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS-AGNVKLG 148 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEEEC
Confidence 8764 5689999999 568999887643 3899999999999999999999999999999999999985 7789999
Q ss_pred ecCcceecCC-----CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 719 DFGNAMFAGK-----NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 719 DFG~a~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|||++..... ...+...++..|+|||++.+..++.++||||||||||+|++|.+||........+..+ ....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~ 225 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP 225 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC
Confidence 9999865432 1223456788999999999988999999999999999999999999754333222211 1000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+ .+..+..++..+.+||.+||+ +|..||
T Consensus 226 ~---------------------------------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~ 253 (264)
T cd06653 226 T---------------------------------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRP 253 (264)
T ss_pred C---------------------------------------------------CCCCCcccCHHHHHHHHHHhc-CcccCc
Confidence 0 011233456789999999999 579999
Q ss_pred CHHHHHhCCCC
Q 002732 874 TVAQALTHPFI 884 (887)
Q Consensus 874 Ta~elL~Hpwf 884 (887)
|+.++|.|||.
T Consensus 254 ~~~~~~~~~~~ 264 (264)
T cd06653 254 TAEFLLRHPFV 264 (264)
T ss_pred cHHHHhcCCCC
Confidence 99999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=363.49 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=214.3
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+.-+|.-...||.|.||.||-|.+..+| +..|+|-++.. ......+..|+.||..| +|||+|+++++
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tG----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~l------nHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTG----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL------NHPNLVRYYGV 1302 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCcc----chhhhhhhhcCccccccCcchHHHHHHHHhc------cCccccccCce
Confidence 3456888889999999999999999998 89999988743 33346678999999999 99999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
-.+...++|.|||| +|+|.++++.-.. +.+.....|..|||.||.|||++||||+||||.||||+. ++.||++||
T Consensus 1303 EvHRekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~-~g~iK~~DF 1378 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF-NGLIKYGDF 1378 (1509)
T ss_pred eecHHHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec-CCcEEeecc
Confidence 99999999999999 7899999987433 788888999999999999999999999999999999995 779999999
Q ss_pred CcceecCCCC------ccCcccCCcccchhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhC
Q 002732 721 GNAMFAGKNE------ITPYLVSRFYRAPEIILGLP---YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 721 G~a~~~~~~~------~~~~~gt~~Y~aPE~l~~~~---~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|.|..+.++. +..++||+-|||||++.+.. ...+.||||||||+.||+||+-||...+++-.+..++...
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g- 1457 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG- 1457 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc-
Confidence 9998766543 45678999999999998753 6789999999999999999999997766654443332211
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
-.|..+..++.+..+||..||+.||.+
T Consensus 1458 -----------------------------------------------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1458 -----------------------------------------------------HKPQIPERLSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred -----------------------------------------------------CCCCCchhhhHhHHHHHHHHHhcCchh
Confidence 123344558899999999999999999
Q ss_pred CcCHHHHHhCCCCC
Q 002732 872 RMTVAQALTHPFIS 885 (887)
Q Consensus 872 RpTa~elL~Hpwf~ 885 (887)
|++|.|||.|-|=.
T Consensus 1485 Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1485 RWTASQLLEHAFGK 1498 (1509)
T ss_pred hhHHHHHHHhhccc
Confidence 99999999998854
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=327.11 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=197.9
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
-.++|.++++||.|+||.||+|.+..++ ......||||++.... .....+..|+.++..+. .|+||++++++
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~-----~h~niv~~~~~ 79 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-----HHLNVVNLLGA 79 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc-----cCcchhheeee
Confidence 3457999999999999999999865432 1233689999987432 22345677899988883 68999999998
Q ss_pred eee-cCeEEEEEecc-hhhHHHHHHHhcc---------------------------------------------------
Q 002732 642 FKY-RNHLCLVFESL-HMNLREVLKKFGR--------------------------------------------------- 668 (887)
Q Consensus 642 ~~~-~~~~~lV~E~~-~gsL~~~L~~~~~--------------------------------------------------- 668 (887)
|.. ...+++||||+ +++|.++|.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 765 46789999999 6799988865321
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC----ccCcccC
Q 002732 669 -------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVS 737 (887)
Q Consensus 669 -------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt 737 (887)
...+++..+..|+.||+.||.|||+.||+|+||||+||||+. .+.++|+|||++..+.... .....++
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCC
Confidence 125899999999999999999999999999999999999995 7789999999997653322 1223446
Q ss_pred CcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccccccccccc
Q 002732 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHA 816 (887)
Q Consensus 738 ~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~ 816 (887)
..|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+...+.....
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 294 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR------------------------ 294 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC------------------------
Confidence 67999999999999999999999999999998 99999764433322211110000
Q ss_pred CcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 817 TEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+..+..++..+.+||.+||+.+|..|||+.+||+|
T Consensus 295 ------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 ------------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.77 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+...||.|+||.||+|.+..++ ..||||++..... ....+..|+.++..+. .|+||++++++|..
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~ 85 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTG----HVMAVKQMRRTGNKEENKRILMDLDVVLKSH-----DCPYIVKCYGYFIT 85 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCC----eEEEEEEEeccCChHHHHHHHHHHHHHHhcc-----CCCchHhhheeeec
Confidence 45999999999999999999988766 7899999975422 2234455666555541 68999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...+|+||||+.+.|..++..... .+++..+..++.||+.||.|||+ +||+|+||+|.|||++. ++.++|+|||++
T Consensus 86 ~~~~~~v~e~~~~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~ 162 (296)
T cd06618 86 DSDVFICMELMSTCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGIS 162 (296)
T ss_pred CCeEEEEeeccCcCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccc
Confidence 999999999998888888776432 58999999999999999999997 69999999999999984 788999999998
Q ss_pred eecCCC-CccCcccCCcccchhhhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHhhCCCChhh
Q 002732 724 MFAGKN-EITPYLVSRFYRAPEIILGLP----YDHPLDIWSVGCCLYELYTGKVLFPGATNN-DMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~~-~~~~~~gt~~Y~aPE~l~~~~----~s~~sDIwSLG~iL~elltG~~PF~~~~~~-~~l~~i~~~~g~~p~~~ 797 (887)
..+... ......++..|+|||++.+.. ++.++|||||||+||+|++|..||...... +.+..++... .+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~--- 237 (296)
T cd06618 163 GRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PP--- 237 (296)
T ss_pred hhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CC---
Confidence 654432 223345678899999997653 889999999999999999999999653221 2222111100 00
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
. ......++..+.+||.+||..||.+|||+.+
T Consensus 238 ----------------------------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 238 ----------------------------------------S--------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred ----------------------------------------C--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0 0001124567899999999999999999999
Q ss_pred HHhCCCCCC
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 lL~Hpwf~~ 886 (887)
||.||||..
T Consensus 270 il~~~~~~~ 278 (296)
T cd06618 270 LLQHPFIRR 278 (296)
T ss_pred HhcChhhhc
Confidence 999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=331.16 Aligned_cols=255 Identities=20% Similarity=0.308 Sum_probs=198.8
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCC-CCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~-~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.+.|.++++||.|+||+||+|.+..... .....||||++.... .....+..|+.+|..|. .||||++++++|
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~-----~HpnIv~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG-----PHLNIVNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC-----CCCCeeeEEEEE
Confidence 3569999999999999999998754331 123579999997532 22456788999999982 499999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-----------------------------------------------------
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR----------------------------------------------------- 668 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~----------------------------------------------------- 668 (887)
.....+||||||| +|+|.++|.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999 7899988865311
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccc
Q 002732 669 ----------------------------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708 (887)
Q Consensus 669 ----------------------------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl 708 (887)
...|++..++.|+.||+.||.|||+.+|+|+||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1247888899999999999999999999999999999999
Q ss_pred cCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHH
Q 002732 709 NEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783 (887)
Q Consensus 709 ~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l 783 (887)
+. ++.+||+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++ |..||........+
T Consensus 271 ~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~ 349 (400)
T cd05105 271 AQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349 (400)
T ss_pred eC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence 85 7789999999997654322 122345677999999999999999999999999999997 99999765433222
Q ss_pred HHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHH
Q 002732 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863 (887)
Q Consensus 784 ~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~k 863 (887)
...+..... +..+..++..+.+||.+
T Consensus 350 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~l~~li~~ 375 (400)
T cd05105 350 YNKIKSGYR------------------------------------------------------MAKPDHATQEVYDIMVK 375 (400)
T ss_pred HHHHhcCCC------------------------------------------------------CCCCccCCHHHHHHHHH
Confidence 211110000 00112345678999999
Q ss_pred hcccCCCCCcCHHHHHh
Q 002732 864 IFVLDPEKRMTVAQALT 880 (887)
Q Consensus 864 mL~~DP~~RpTa~elL~ 880 (887)
||+.+|.+|||+.+|++
T Consensus 376 cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 376 CWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HCccCHhHCcCHHHHHH
Confidence 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.93 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=202.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCC------------CCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGN------------GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENK 632 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~------------~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h 632 (887)
++|.+++.||.|+||.||+|.+...+. .....||+|++.... .....+..|+.+|..| .|
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l------~~ 78 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL------SD 78 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc------CC
Confidence 569999999999999999998765431 122468999987643 2345678899999999 89
Q ss_pred cceeEecceeeecCeEEEEEecc-hhhHHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCC
Q 002732 633 RHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGR--------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703 (887)
Q Consensus 633 ~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~--------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 703 (887)
+||++++++|.....+++||||+ +++|.++|..... ...+++..++.++.||+.||.|||++||+|+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 99999999999999999999999 6799999876541 12489999999999999999999999999999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT--GKVLFPGA 777 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt--G~~PF~~~ 777 (887)
+||||+. .+.++|+|||++....... .....+++.|+|||++.+..++.++|||||||+||+|++ +..||...
T Consensus 159 ~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999985 6889999999987644322 122345678999999998889999999999999999998 77888766
Q ss_pred ChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHH
Q 002732 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857 (887)
Q Consensus 778 ~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 857 (887)
+..+.+..+.......... .....+..++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~l 269 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQ------------------------------------------------IYLPRPPNCPKDI 269 (296)
T ss_pred ChHHHHHHHHhcccccccc------------------------------------------------ccCCCccCCCHHH
Confidence 6555544443221110000 0000112345788
Q ss_pred HHHHHHhcccCCCCCcCHHHHHh
Q 002732 858 KDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 858 ~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+||.+||+.||.+|||+.+|++
T Consensus 270 ~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 270 YELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccChhcCCCHHHHHH
Confidence 99999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.44 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=201.2
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
+.||.|+||.||+|.+.... .....||||++...... ...+..|+.++..+ .|++|+++++++.....++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKL------GHPNVVRLLGVCTEEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchhHHHHHHHHHHHHhhc------CCCChheeeeeecCCCceEE
Confidence 36899999999999987641 12278999999865433 46778899999998 79999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 651 VFESL-HMNLREVLKKFGR------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
||||+ +++|.+++..... ...+++..++.++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||++
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~-~~~~~l~dfg~~ 152 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE-DLVVKISDFGLS 152 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC-CCcEEEcccccc
Confidence 99999 7899999987521 245999999999999999999999999999999999999995 688999999999
Q ss_pred eecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
....... .....++..|+|||++.+..++.++||||||||||+|++ |..||......+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------- 224 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------- 224 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 7765432 334456788999999998899999999999999999999 699998775554444332100
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
....+..++.++.+||.+||..+|..|||+.+|
T Consensus 225 -----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 225 -----------------------------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred -----------------------------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence 001122345788999999999999999999999
Q ss_pred HhC
Q 002732 879 LTH 881 (887)
Q Consensus 879 L~H 881 (887)
+.+
T Consensus 258 ~~~ 260 (262)
T cd00192 258 VER 260 (262)
T ss_pred HHh
Confidence 975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.13 Aligned_cols=271 Identities=21% Similarity=0.269 Sum_probs=196.4
Q ss_pred CceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecc
Q 002732 579 VFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL 655 (887)
Q Consensus 579 ~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~ 655 (887)
+++.||++....++ ..||||++... ......+..|+.+|..| .|+||++++++|...+.+|+||||+
T Consensus 12 ~~~~v~~~~~~~~~----~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l------~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 12 DLMIVHLAKHKPTN----TLVAVKKINLDSCSKEDLKLLQQEIITSRQL------QHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred CCceEEEEEecCCC----CEEEEEEEeccccchhHHHHHHHHHHHHHhc------CCcchhhhhheeecCCeEEEEEecc
Confidence 45666666666666 78999998754 23346778899999999 8999999999999999999999999
Q ss_pred -hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC----
Q 002732 656 -HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE---- 730 (887)
Q Consensus 656 -~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~---- 730 (887)
+++|.+++.... ...+++..+..++.||+.||.|||+++|||+||+|+||||+. ++.++|+|||.+.......
T Consensus 82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 82 AYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec-CCceEEecCccceeecccccccc
Confidence 578989887642 234899999999999999999999999999999999999984 7889999999885432211
Q ss_pred -----ccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 731 -----ITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 731 -----~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.....++..|+|||++.+. .|+.++|||||||+||+|++|..||........+. ....+.++..+. ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~-~~~~ 236 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLD-KSTY 236 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccccc-cCch
Confidence 1233467789999999763 58899999999999999999999998765443332 222333222110 0000
Q ss_pred cccccccccccccC---cCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 804 TDQHFDQDLNFHAT---EEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 804 ~~~~f~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
. ......... ...+.. ...........++.++.+||..||.+||.+|||+.+||.
T Consensus 237 ~----~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 P----LYEDSMSQSRSSNEHPNN------------------RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred h----hhcCCcCcccccccccch------------------hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 000000000 000000 000011223456788999999999999999999999999
Q ss_pred CCCCCC
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 Hpwf~~ 886 (887)
||||..
T Consensus 295 ~p~~~~ 300 (314)
T cd08216 295 HSFFKQ 300 (314)
T ss_pred CchHhh
Confidence 999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.26 Aligned_cols=260 Identities=17% Similarity=0.263 Sum_probs=198.9
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCC------------CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCC
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAG------------NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPEN 631 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~------------~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~ 631 (887)
.++|++...||.|+||+||+|.+.... ......||||++.... .....+..|+.+|..| .
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l------~ 77 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL------K 77 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC------C
Confidence 457999999999999999998654311 1123579999987532 2345678899999999 8
Q ss_pred CcceeEecceeeecCeEEEEEecc-hhhHHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 632 KRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGR--------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 632 h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~--------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
|+||++++++|.....+||||||+ +++|.+++..... ...+++..+..++.||+.||.|||++||+|+|||
T Consensus 78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlk 157 (296)
T cd05095 78 DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157 (296)
T ss_pred CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999999999999999999999999 6799999876432 1237788999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCC
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT--GKVLFPG 776 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt--G~~PF~~ 776 (887)
|+||||+. ++.++|+|||++..+..... ....+++.|+|||++.+..++.++|||||||+||+|++ |..||..
T Consensus 158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 158 TRNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred hheEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999985 77899999999875533221 12233567999999998899999999999999999998 7789976
Q ss_pred CChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHH
Q 002732 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856 (887)
Q Consensus 777 ~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 856 (887)
.+..+.+.......... . . .. ....+..++..
T Consensus 237 ~~~~~~~~~~~~~~~~~-----------------------------------------~---~-~~---~~~~~~~~~~~ 268 (296)
T cd05095 237 LSDEQVIENTGEFFRDQ-----------------------------------------G---R-QV---YLPKPALCPDS 268 (296)
T ss_pred cChHHHHHHHHHHHhhc-----------------------------------------c---c-cc---cCCCCCCCCHH
Confidence 55544433221100000 0 0 00 00011234478
Q ss_pred HHHHHHHhcccCCCCCcCHHHHHh
Q 002732 857 FKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 857 ~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+.+||..||+.||.+|||+.+|++
T Consensus 269 ~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 269 LYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.26 Aligned_cols=260 Identities=19% Similarity=0.276 Sum_probs=200.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCC----------CCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCc
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAG----------NGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKR 633 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~----------~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~ 633 (887)
..+|.+.+.||+|+||.||+|.+..++ ......||||++... ......+..|+.+|..| .|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l------~h~ 77 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL------KNP 77 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC------CCC
Confidence 357999999999999999999875432 112346999998753 22335678899999999 899
Q ss_pred ceeEecceeeecCeEEEEEecc-hhhHHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCC
Q 002732 634 HCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGR---------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703 (887)
Q Consensus 634 ~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~---------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 703 (887)
||++++++|...+.+||||||+ +++|.+++..... ...+++..++.++.||+.||.|||+.||+|+||||
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp 157 (295)
T cd05097 78 NIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLAT 157 (295)
T ss_pred CcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccCh
Confidence 9999999999999999999999 6799998865321 12368889999999999999999999999999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT--GKVLFPGA 777 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt--G~~PF~~~ 777 (887)
+||||+. ++.+||+|||++........ ....++..|+|||++.+..++.++|||||||+||+|++ |..||...
T Consensus 158 ~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 9999984 77899999999865433221 12234567999999999899999999999999999998 67888776
Q ss_pred ChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHH
Q 002732 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857 (887)
Q Consensus 778 ~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 857 (887)
+..+.+..+......... ......++.++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~l 268 (295)
T cd05097 237 SDEQVIENTGEFFRNQGR------------------------------------------------QIYLSQTPLCPSPV 268 (295)
T ss_pred ChHHHHHHHHHhhhhccc------------------------------------------------cccCCCCCCCCHHH
Confidence 655544433221110000 00011122345789
Q ss_pred HHHHHHhcccCCCCCcCHHHHHh
Q 002732 858 KDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 858 ~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+||.+||..||.+|||+.+|++
T Consensus 269 ~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 269 FKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.12 Aligned_cols=250 Identities=17% Similarity=0.257 Sum_probs=195.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.+++.||.|+||.||.|.....+ .....||||++.... .....+..|+.+|..+ .|+||+++++++...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 73 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD-GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF------DHPNVMKLIGVCFEA 73 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC-CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC------CCCCeeeEEeeeccC
Confidence 567889999999999999875432 223679999987542 2235678899999988 899999999987664
Q ss_pred Ce------EEEEEecc-hhhHHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 646 NH------LCLVFESL-HMNLREVLKKFG---RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 646 ~~------~~lV~E~~-~gsL~~~L~~~~---~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
.. .++||||+ +++|..++.... ....+++..++.++.||+.||.|||+.+|+|+||||+|||++. ++.+
T Consensus 74 ~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~-~~~~ 152 (273)
T cd05035 74 SSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE-DMTV 152 (273)
T ss_pred CccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC-CCeE
Confidence 43 79999999 679988886532 2235899999999999999999999999999999999999985 7789
Q ss_pred EEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhh
Q 002732 716 KLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~ 790 (887)
||+|||++........ .....+..|+|||++.+..++.++||||||||||+|++ |.+||.+....+.+..+...
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 231 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG- 231 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999976543221 11234567999999998899999999999999999999 99999776655443322111
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
.. ...+..++..+.+||.+||+.||.
T Consensus 232 -~~-----------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 257 (273)
T cd05035 232 -NR-----------------------------------------------------LKQPEDCLDELYDLMYSCWRADPK 257 (273)
T ss_pred -CC-----------------------------------------------------CCCCcCCCHHHHHHHHHHcCCChh
Confidence 00 001123446789999999999999
Q ss_pred CCcCHHHHHhC
Q 002732 871 KRMTVAQALTH 881 (887)
Q Consensus 871 ~RpTa~elL~H 881 (887)
+|||+.+++.+
T Consensus 258 ~Rp~~~e~~~~ 268 (273)
T cd05035 258 DRPTFTKLREV 268 (273)
T ss_pred hCcCHHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=320.81 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=202.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..|.++..||.|+||+||+|.+..++ ..||||.+... ......+..|+.++..| .|+|++.++++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 84 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGCY 84 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCC----cEEEEEEEecccccChHHHHHHHHHHHHHHhC------CCCCcccEEEEE
Confidence 44888899999999999999988766 78999988642 12234566799999998 899999999999
Q ss_pred eecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 643 KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 643 ~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.....++|||||+.++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||+|.|||++. .+.++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~ 161 (308)
T cd06634 85 LREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGS 161 (308)
T ss_pred EcCCeeEEEEEccCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC-CCcEEECCccc
Confidence 9999999999999888888876533 34899999999999999999999999999999999999985 78899999999
Q ss_pred ceecCCCCccCcccCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 723 AMFAGKNEITPYLVSRFYRAPEIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 723 a~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+...... ....++..|+|||++.+ ..++.++||||||||||+|++|..||......+.+..+.... .|
T Consensus 162 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----- 232 (308)
T cd06634 162 ASIMAPA--NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SP----- 232 (308)
T ss_pred ceeecCc--ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC--CC-----
Confidence 8765432 34567889999999853 468889999999999999999999996654433332221100 00
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
......++..+.+||.+||..+|.+|||+.++|
T Consensus 233 -----------------------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 233 -----------------------------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred -----------------------------------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 000123456789999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||..
T Consensus 266 ~~~~~~~ 272 (308)
T cd06634 266 KHRFVLR 272 (308)
T ss_pred hCccccc
Confidence 9999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.62 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=201.6
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
|....+||.|+||.||++....++ ..||||.+.... .....+..|+.++..+ .|+||++++++|...++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 91 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSG----KLVAVKKMDLRKQQRRELLFNEVVIMRDY------QHENVVEMYNSYLVGDE 91 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCC----eEEEEEEecccchhHHHHHHHHHHHHHhc------CCcchhheeeEEEeCCE
Confidence 334467899999999999988777 799999886432 2345677899999988 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~ 166 (292)
T cd06657 92 LWVVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQV 166 (292)
T ss_pred EEEEEecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEcccccceec
Confidence 99999999 5688877643 23899999999999999999999999999999999999995 678999999998654
Q ss_pred CCC--CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 727 GKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 727 ~~~--~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
... ......+++.|+|||++.+..++.++||||||||+|+|++|..||.+......+..+... +|..+
T Consensus 167 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~------- 236 (292)
T cd06657 167 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN---LPPKL------- 236 (292)
T ss_pred ccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh---CCccc-------
Confidence 432 223356788899999998888999999999999999999999999765554443322111 10000
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
.....++..+.+||.+||..+|.+||++.+||.||||
T Consensus 237 -------------------------------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 237 -------------------------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred -------------------------------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHH
Confidence 0011234567899999999999999999999999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
..
T Consensus 274 ~~ 275 (292)
T cd06657 274 AK 275 (292)
T ss_pred hc
Confidence 75
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=328.55 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=203.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhH----HHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~----~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.-|..++.||-|+||.|.+|...++. .+||+|.+.+...... -.+.|-.||... ..+-||+||-.|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~----~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA------Dn~WVVrLyySF 698 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTR----ALYAMKTLRKADVLMRNQVAHVKAERDILAEA------DNEWVVRLYYSF 698 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchh----hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc------CCcceEEEEEEe
Confidence 45999999999999999999988776 8999999987544332 224566777666 778899999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++.+.+|+||+|+ +|+|..+|.+.+- |.+..+++|+.+|..|++++|.+|+|||||||+||||+. +++|||+|||
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr-dGHIKLTDFG 774 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFG 774 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc-CCceeeeecc
Confidence 9999999999999 7899999999876 999999999999999999999999999999999999995 8999999999
Q ss_pred cce---------ecCCCC-----------------------------------ccCcccCCcccchhhhcCCCCCchhhH
Q 002732 722 NAM---------FAGKNE-----------------------------------ITPYLVSRFYRAPEIILGLPYDHPLDI 757 (887)
Q Consensus 722 ~a~---------~~~~~~-----------------------------------~~~~~gt~~Y~aPE~l~~~~~s~~sDI 757 (887)
|++ +++... ....+||+.|+|||+|....|+..+||
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 983 111110 012467999999999999999999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCC
Q 002732 758 WSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837 (887)
Q Consensus 758 wSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (887)
||.|||||+|+.|++||...+..++-..++. |...|.|.
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~tq~kv~n-------------------w~~~l~~~---------------------- 893 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGETQYKVIN-------------------WRNFLHIP---------------------- 893 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcceeeeee-------------------hhhccccc----------------------
Confidence 9999999999999999976655433222210 11111111
Q ss_pred CccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---HHHHHhCCCCCC
Q 002732 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT---VAQALTHPFISG 886 (887)
Q Consensus 838 ~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT---a~elL~Hpwf~~ 886 (887)
..-+++.++.+||.++ ..+++.|+. +.+|-.||||.+
T Consensus 894 -----------~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 894 -----------YQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred -----------cccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccc
Confidence 1234668899999987 568889984 778999999985
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.30 Aligned_cols=252 Identities=22% Similarity=0.239 Sum_probs=197.6
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+..+||.|+||.||+|.+..++ ....++||.++.. ......+..|+.++.++. .||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-----~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG--LKMNAAIKMLKEFASENDHRDFAGELEVLCKLG-----HHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC--CcceeEEEEccccCCHHHHHHHHHHHHHHHhhc-----CCCchhheEEEEcc
Confidence 45999999999999999999887654 1234788887632 223356778999998883 58999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
.+.+|+||||+ +++|.++|..... ...+++..++.|+.||+.||.|||+.||||+||||+||||+.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 99999999999 6799999875321 124889999999999999999999999999999999999985
Q ss_pred CCCeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~ 788 (887)
++.+||+|||++....... ......+..|+|||++.+..++.++||||||||||+|++ |.+||......+.+..+..
T Consensus 155 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 -NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred -CCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 7789999999985432211 111223456999999999899999999999999999997 9999977665544432211
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
... +..+..++..+.+||.+||..+
T Consensus 234 ~~~-------------------------------------------------------~~~~~~~~~~~~~li~~~l~~~ 258 (297)
T cd05089 234 GYR-------------------------------------------------------MEKPRNCDDEVYELMRQCWRDR 258 (297)
T ss_pred CCC-------------------------------------------------------CCCCCCCCHHHHHHHHHHcCCC
Confidence 100 0011234577899999999999
Q ss_pred CCCCcCHHHHHhC
Q 002732 869 PEKRMTVAQALTH 881 (887)
Q Consensus 869 P~~RpTa~elL~H 881 (887)
|.+|||+.+|++.
T Consensus 259 p~~Rp~~~~i~~~ 271 (297)
T cd05089 259 PYERPPFAQISVQ 271 (297)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.85 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=219.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..+.++..||-|+||.|=++...... ..+|+|++++. .....-+..|-.||..+ ..+.||+||-.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~------~s~fIvrLYrTf 489 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQK----ATFALKILKKKHIVDTKQQEHVFSERNIMMEC------RSDFIVRLYRTF 489 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccc----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhc------CchHHHHHHHHh
Confidence 46888999999999999999876544 35899999864 33345667888999988 788999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.+..++||+||.| +|.|..+|...+. |...++++|+..++.|++|||.+|||+|||||+|+||+. .+.+||.|||
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~-~Gy~KLVDFG 565 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN-RGYLKLVDFG 565 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc-CCceEEeehh
Confidence 9999999999998 8999999988665 999999999999999999999999999999999999994 8999999999
Q ss_pred cceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 722 NAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 722 ~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+|..++... ..++|||+.|+|||++++...+.++|+|+||+++||||+|.+||.+.+...++..|+.....+
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i------- 638 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI------- 638 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-------
Confidence 999887654 567999999999999999999999999999999999999999999988888887776543221
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----H
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----V 875 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a 875 (887)
..+..++..+.+||.++...+|..|+. +
T Consensus 639 -----------------------------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI 671 (732)
T KOG0614|consen 639 -----------------------------------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGI 671 (732)
T ss_pred -----------------------------------------------hcccccchhHHHHHHHHHhcCcHhhhccccCCh
Confidence 012344567789999999999999996 8
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.+|-+|-||.+
T Consensus 672 ~DIkkH~Wf~g 682 (732)
T KOG0614|consen 672 NDIKKHRWFEG 682 (732)
T ss_pred HHHHhhhhhhc
Confidence 99999999975
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.52 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=195.4
Q ss_pred cCcE-EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRY-EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y-~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++| .++..||.|+||+||++............||||++..... ....+..|+.+|..| .|+||++++++|
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~ 75 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL------YHENIVKYKGCC 75 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC------CCCCEeeEEEEE
Confidence 3455 9999999999999998764332223347899999975422 345677899999999 899999999987
Q ss_pred eec--CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 643 KYR--NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 643 ~~~--~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
... ..+||||||+ +++|.+++... .+++..++.|+.||+.||.|||+.||+|+||||+||||+. ++.++|+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~d 150 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN-DRLVKIGD 150 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC-CCcEEEee
Confidence 653 4689999999 67899888653 3999999999999999999999999999999999999985 78899999
Q ss_pred cCcceecCCCCc-----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh-CCC
Q 002732 720 FGNAMFAGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK-GPF 793 (887)
Q Consensus 720 FG~a~~~~~~~~-----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~-g~~ 793 (887)
||++........ ....++..|+|||++.+..++.++|||||||+||+|++|..||...... +..++... +..
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~ 228 (283)
T cd05080 151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQM 228 (283)
T ss_pred cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhccccccc
Confidence 999976543221 2223456799999999888999999999999999999999998543221 11110000 000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
. ...+..++.... ....+..++..+.+||.+||..+|..||
T Consensus 229 ~-----------------------------~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 229 T-----------------------------VVRLIELLERGM----------RLPCPKNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred c-----------------------------hhhhhhhhhcCC----------CCCCCCCCCHHHHHHHHHHhccChhhCC
Confidence 0 000000000000 0111234567899999999999999999
Q ss_pred CHHHHHh
Q 002732 874 TVAQALT 880 (887)
Q Consensus 874 Ta~elL~ 880 (887)
|+.+||.
T Consensus 270 s~~~i~~ 276 (283)
T cd05080 270 TFRSLIP 276 (283)
T ss_pred CHHHHHH
Confidence 9999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.37 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=200.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..|.+.+.||.|+||.||+|.+.. + ..+|||++.........+..|+.++..+ .|++|+++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~----~~~~~k~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-K----RKVAIKTIREGAMSEEDFIEEAQVMMKL------SHPKLVQLYGVCTERS 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-C----CeEEEEECCCCCCCHHHHHHHHHHHHhC------CCCCeeeEEEEEccCC
Confidence 358999999999999999998753 3 4799999886655556788999999999 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||+|.|||++. ++.++|+|||++..
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~ 149 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE-NQVVKVSDFGMTRF 149 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC-CCeEEECCCcceee
Confidence 999999999 568988887532 24899999999999999999999999999999999999984 77899999999876
Q ss_pred cCCCCcc---CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~---~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
....... ...++..|+|||++.+..++.++|||||||+||+|++ |.+||........+..+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 221 (256)
T cd05112 150 VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-------- 221 (256)
T ss_pred cccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC--------
Confidence 5443322 2234567999999998899999999999999999998 999997665554444332110000
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
.+...+..+.+||.+||..+|..|||+.++|++
T Consensus 222 -----------------------------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 -----------------------------------------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 011124678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.72 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=200.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
++|.+...||+|+||+||+|.+...+ .....||||++.... .....+..|+.+|..+ +|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPG-KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF------DHPNIIRLEGVVTK 76 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCC-CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC------CCCCcceEeEEEec
Confidence 46999999999999999999886542 123579999987532 2235677899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||+|.||||+. ++.++|+|||++
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~-~~~~~l~dfg~~ 153 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCCEEECccchh
Confidence 99999999999 679999987643 25899999999999999999999999999999999999985 788999999999
Q ss_pred eecCC--CCccC--cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGK--NEITP--YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~--~~~~~--~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
..... ..... ..+++.|+|||++.+..++.++|||||||+||+|++ |..||...........+.... .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~----- 227 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY-RL----- 227 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC-CC-----
Confidence 77642 11221 233567999999999899999999999999999998 999997655544433332110 00
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..+..++..+.+||.+||+.+|..||++.+|
T Consensus 228 -------------------------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 228 -------------------------------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0011234678999999999999999999999
Q ss_pred HhC
Q 002732 879 LTH 881 (887)
Q Consensus 879 L~H 881 (887)
+++
T Consensus 259 ~~~ 261 (266)
T cd05033 259 VST 261 (266)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=310.34 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=199.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc----hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|.+...||.|+||.||+|.+..++ ..||||.+.... .....+.+|+.+++.+ .|+||++++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~ 71 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQL------NHPNVIKYYASF 71 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc------cCCchhhhhhee
Confidence 35889999999999999999987776 789999876422 2235667899999998 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
...+.+++||||+ +++|.+++..... ...+++..++.++.||+.||.|||+.||+|+||+|.|||++. ++.++|+||
T Consensus 72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~df 150 (267)
T cd08229 72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDL 150 (267)
T ss_pred EeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEECcc
Confidence 9999999999999 5699998875432 345899999999999999999999999999999999999985 778999999
Q ss_pred CcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHhhCCCChh
Q 002732 721 GNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN--DMLRLHMELKGPFPKK 796 (887)
Q Consensus 721 G~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~--~~l~~i~~~~g~~p~~ 796 (887)
|++....... .....++..|+|||++.+..++.++||||||||||+|++|..||.+.... .....+... .+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--- 225 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DY--- 225 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CC---
Confidence 9987654332 23456788999999999989999999999999999999999999654321 111100000 00
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+.....++..+.+||.+||..+|.+|||+.
T Consensus 226 -------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 226 -------------------------------------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred -------------------------------------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHH
Confidence 0001123557899999999999999999999
Q ss_pred HHHh
Q 002732 877 QALT 880 (887)
Q Consensus 877 elL~ 880 (887)
+|++
T Consensus 257 ~i~~ 260 (267)
T cd08229 257 YVYD 260 (267)
T ss_pred HHHH
Confidence 8764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.05 Aligned_cols=250 Identities=22% Similarity=0.279 Sum_probs=196.2
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
...|.++++||.|+||+||+|.+..++......||||++... ......+..|+.++..+ .|+||+.+++++.
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~ 79 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV------GSPYVCRLLGICL 79 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc------CCCCCceEEEEEc
Confidence 356999999999999999999987766333346899998643 22345667888888888 8999999999887
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
. ...++||+|+ +|+|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||++. .+.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~-~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS-PNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC-CCcEEECCCCc
Confidence 5 4578999998 679999887532 34899999999999999999999999999999999999984 77899999999
Q ss_pred ceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 723 AMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 723 a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+........ ....+++.|+|||++.+..++.++|||||||+||+|++ |..||...........+.. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~----- 229 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GER----- 229 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCc-----
Confidence 976643321 11233567999999999999999999999999999998 9999976544333221111 000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+..+..++..+.+||.+||..||..|||+.+
T Consensus 230 -------------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 230 -------------------------------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred -------------------------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0011234567889999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
||.
T Consensus 261 l~~ 263 (279)
T cd05109 261 LVD 263 (279)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=348.20 Aligned_cols=200 Identities=25% Similarity=0.336 Sum_probs=171.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.++++||.|+||.||+|.+..++ ..||||++... ......+..|+.++..| .||||+++++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L------~HPNIVkl~~v~ 71 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS----RRVALKKIREDLSENPLLKKRFLREAKIAADL------IHPGIVPVYSIC 71 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC----cEEEEEEECcccccCHHHHHHHHHHHHHHHhC------CCcCcCeEEEEE
Confidence 57999999999999999999998877 78999998753 22345678899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR--------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~--------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 713 (887)
...+.+||||||+ +++|.++|..... ...++...++.++.||+.||.|||+.||||+||||+||||+. .+
T Consensus 72 ~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~-dg 150 (932)
T PRK13184 72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL-FG 150 (932)
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC-CC
Confidence 9999999999999 6799999875321 123567788999999999999999999999999999999985 77
Q ss_pred eEEEEecCcceecCCC--------------------CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCC
Q 002732 714 VLKLCDFGNAMFAGKN--------------------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVL 773 (887)
Q Consensus 714 ~vKL~DFG~a~~~~~~--------------------~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~P 773 (887)
.++|+|||++...... .....+||+.|+|||++.+..++.++||||||||||+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 8999999999765210 01124689999999999999999999999999999999999999
Q ss_pred CCCC
Q 002732 774 FPGA 777 (887)
Q Consensus 774 F~~~ 777 (887)
|...
T Consensus 231 F~~~ 234 (932)
T PRK13184 231 YRRK 234 (932)
T ss_pred CCCc
Confidence 9663
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.91 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=195.1
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
.+.+.||.|.||.||.|............|+||++... ......+..|+.+|.++ +||||+++++++...+.
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~g~~~~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL------RHPNIVKLYGFCIENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH------SBTTBE-EEEEEESSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc------ccccccccccccccccc
Confidence 57889999999999999988433345578999999653 22357888999999999 99999999999998888
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
++|||||+ .++|.++|.... ...+++..+..|+.||+.||.|||+.+|||++|+|.||||+. ++.+||+|||++...
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS-NGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET-TTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccc
Confidence 99999999 579999999861 234999999999999999999999999999999999999995 789999999999776
Q ss_pred CCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 727 GKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 727 ~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
.... .........|+|||++.+..++.++||||||++||||++ |..||......+.+..+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---------- 223 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---------- 223 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 3221 122345667999999999889999999999999999999 7899987766555444421110
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...+..++..+.+||..||..+|.+|||+.+|++
T Consensus 224 ---------------------------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ---------------------------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------------------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------------------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0011234567889999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=310.21 Aligned_cols=249 Identities=17% Similarity=0.253 Sum_probs=192.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.+.+.||.|+||.||+|.+...+ ....||||.+... ......+..|+.+|..| .|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~--~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~ 72 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD--SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF------DHPNVMRLIGVCLQT 72 (272)
T ss_pred CccccccCcccCceEEEeEEccCC--CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEccC
Confidence 346788999999999999986654 1236999988653 23345677899999998 899999999876432
Q ss_pred ------CeEEEEEecc-hhhHHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 646 ------NHLCLVFESL-HMNLREVLKKFG---RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 646 ------~~~~lV~E~~-~gsL~~~L~~~~---~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
...++||||+ +++|..++.... ....+++..+..++.||+.||.|||++||+|+||||+|||++. ++.+
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~ 151 (272)
T cd05075 73 VESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE-NMNV 151 (272)
T ss_pred CcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC-CCCE
Confidence 3578999999 579988875422 2234899999999999999999999999999999999999985 7889
Q ss_pred EEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhh
Q 002732 716 KLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|+|||++........ ....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+......+..+...
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 230 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG- 230 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999976543321 12234667999999999999999999999999999999 89999776554433322110
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
.. ....+.++..+.+||.+||..||.
T Consensus 231 -~~-----------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~ 256 (272)
T cd05075 231 -NR-----------------------------------------------------LKQPPDCLDGLYSLMSSCWLLNPK 256 (272)
T ss_pred -CC-----------------------------------------------------CCCCCCCCHHHHHHHHHHcCCCcc
Confidence 00 001123446789999999999999
Q ss_pred CCcCHHHHHhC
Q 002732 871 KRMTVAQALTH 881 (887)
Q Consensus 871 ~RpTa~elL~H 881 (887)
+|||+.+|+++
T Consensus 257 ~Rps~~~l~~~ 267 (272)
T cd05075 257 DRPSFETLRCE 267 (272)
T ss_pred cCcCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=304.72 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=200.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+.+.||.|+||.||+|.+..++ ..||||.+... ......+..|+.++..+ .|++|+.++++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~------~~~~i~~~~~~~ 71 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQL------DHPNVIKYLASF 71 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC----CEEEEEEeecccccchhhHHHHHHHHHHHHhC------CCCCeeeeeeee
Confidence 46999999999999999999998776 78999988642 22245677899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEec
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DF 720 (887)
...+.+++||||+ +++|..++..... ...+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~-~~~~~l~d~ 150 (267)
T cd08224 72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA-TGVVKLGDL 150 (267)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC-CCcEEEecc
Confidence 9999999999999 5799999876432 345899999999999999999999999999999999999985 778899999
Q ss_pred CcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHhhCCCChh
Q 002732 721 GNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN--DMLRLHMELKGPFPKK 796 (887)
Q Consensus 721 G~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~--~~l~~i~~~~g~~p~~ 796 (887)
|++....... .....++..|+|||++.+..++.++||||||||+|+|++|..||...... .....+... .+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~--- 225 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DY--- 225 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CC---
Confidence 9987654332 23356788899999999989999999999999999999999999543211 111100000 00
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+.....++..+.+||.+||..+|..|||+.
T Consensus 226 -------------------------------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 256 (267)
T cd08224 226 -------------------------------------------------PPLPADHYSEELRDLVSRCINPDPEKRPDIS 256 (267)
T ss_pred -------------------------------------------------CCCChhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 0001123456889999999999999999999
Q ss_pred HHHh
Q 002732 877 QALT 880 (887)
Q Consensus 877 elL~ 880 (887)
+||+
T Consensus 257 ~il~ 260 (267)
T cd08224 257 YVLQ 260 (267)
T ss_pred HHHH
Confidence 9875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.41 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=202.3
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
..++|.+...||+|+||.||++.+.... ......||+|++..... ....+..|+.++..+. .|+||++++++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~~~~ 84 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINLLGV 84 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc-----CCCCeeeEEEE
Confidence 3467999999999999999999876432 12336799999875422 2245678888888883 68999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcc
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFG-------------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML 707 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~-------------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NIL 707 (887)
|.....++|||||+ +++|..++.... ....+++..++.|+.||+.||.|||+.||+|+||+|.|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999 679999987531 2235899999999999999999999999999999999999
Q ss_pred ccCCCCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 002732 708 VNEAKNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDM 782 (887)
Q Consensus 708 l~~~~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~ 782 (887)
++. ++.++|+|||++........ ....++..|+|||++.+..++.++||||||||||+|++ |..||.+....+.
T Consensus 165 ~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 165 VTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 984 78899999999976543321 12234567999999999899999999999999999997 9999987665544
Q ss_pred HHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHH
Q 002732 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLD 862 (887)
Q Consensus 783 l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~ 862 (887)
+..+.... . ...+..++..+.+||.
T Consensus 244 ~~~~~~~~--~-----------------------------------------------------~~~~~~~~~~~~~li~ 268 (293)
T cd05053 244 FKLLKEGY--R-----------------------------------------------------MEKPQNCTQELYHLMR 268 (293)
T ss_pred HHHHHcCC--c-----------------------------------------------------CCCCCCCCHHHHHHHH
Confidence 43321110 0 0011223467899999
Q ss_pred HhcccCCCCCcCHHHHHhC
Q 002732 863 KIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 863 kmL~~DP~~RpTa~elL~H 881 (887)
+||..||.+|||+.++|++
T Consensus 269 ~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 269 DCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcccCcccCcCHHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.97 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=201.6
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
.+..++|.+.+.||.|+||.||+|.+.... ......||||++.... .....+..|+.++.+|. .|+||++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 105 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-----NHENIVNLL 105 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc-----CCCCcceEE
Confidence 344567999999999999999999864321 1234689999987542 22356788999999883 589999999
Q ss_pred ceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEE
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~ 718 (887)
++|...+.+||||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+.+|+|+||||.|||++. ++.++|+
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~~l~ 183 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH-GKIVKIC 183 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC-CCeEEEC
Confidence 9999999999999999 5799999875322 23899999999999999999999999999999999999984 7789999
Q ss_pred ecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCC
Q 002732 719 DFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 719 DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|||++........ ....+++.|+|||++.+..++.++||||||||||+|++ |.+||......+.+..+.... +
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--~ 261 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--Y 261 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC--C
Confidence 9999875443221 12234677999999999999999999999999999998 999997665443332221100 0
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
.+..+..++..+.+||.+||..+|.+||
T Consensus 262 ----------------------------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp 289 (302)
T cd05055 262 ----------------------------------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRP 289 (302)
T ss_pred ----------------------------------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 0001122346789999999999999999
Q ss_pred CHHHHHh
Q 002732 874 TVAQALT 880 (887)
Q Consensus 874 Ta~elL~ 880 (887)
|+.+||+
T Consensus 290 t~~ell~ 296 (302)
T cd05055 290 TFKQIVQ 296 (302)
T ss_pred CHHHHHH
Confidence 9999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=335.90 Aligned_cols=257 Identities=27% Similarity=0.413 Sum_probs=216.4
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee-
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY- 644 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~- 644 (887)
.+.|+|+.+||.|.+|.||+++...++ +.+||||+..+....+.+..|.+||+.+. +|||++.++++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~----~~aa~kI~~~~~d~deEiE~eynil~~~~-----~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTG----QLAAIKIMDPTEDEEEEIELEYNMLKKYS-----HHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecC----ceeeeEeecCCccccHHHHHHHHHHHhcc-----CCCCcceEEEEEEEe
Confidence 356999999999999999999998888 89999999988888889999999999985 89999999999875
Q ss_pred ----cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 645 ----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 645 ----~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
.+.++|||||| +|+.-++++..- ...|.+..+.+|++.+|.||.+||...+||+|||-.|||++. .+.|||+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~-e~~VKLvD 166 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE-NAEVKLVD 166 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec-cCcEEEee
Confidence 46899999999 678888888765 456999999999999999999999999999999999999995 78889999
Q ss_pred cCcceecCCC--CccCcccCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCC
Q 002732 720 FGNAMFAGKN--EITPYLVSRFYRAPEIILGL-----PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 720 FG~a~~~~~~--~~~~~~gt~~Y~aPE~l~~~-----~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
||.+...... ...+++||++|||||++... .|+..+|+||||++.+||.-|.+||..+-. +.+++ .....
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP--mraLF-~IpRN 243 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP--MRALF-LIPRN 243 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--hhhhc-cCCCC
Confidence 9998665543 35678999999999999754 488889999999999999999999954422 22111 11111
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
+|..+ ..+.+.+.+|.+||..||..|-.+|
T Consensus 244 PPPkL--------------------------------------------------krp~kWs~~FndFIs~cL~Kd~e~R 273 (953)
T KOG0587|consen 244 PPPKL--------------------------------------------------KRPKKWSKKFNDFISTCLVKDYEQR 273 (953)
T ss_pred CCccc--------------------------------------------------cchhhHHHHHHHHHHHHHhhccccC
Confidence 11111 1245678999999999999999999
Q ss_pred cCHHHHHhCCCCCC
Q 002732 873 MTVAQALTHPFISG 886 (887)
Q Consensus 873 pTa~elL~Hpwf~~ 886 (887)
|++.++|.||||++
T Consensus 274 P~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 274 PSTEELLKHPFITE 287 (953)
T ss_pred cchhhhccCCcccc
Confidence 99999999999984
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=313.07 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=200.8
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccchh-hHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNETM-NKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+...||.|+||.||+|.+.... ......|++|.+...... ...+..|+.++..+ .|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL------QHEHIVKFYGVCGD 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC------CCCCcceEEEEEcc
Confidence 45999999999999999999865422 122356899988754332 35678899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
...++|||||+ +++|.++|..... ...+++..++.|+.||+.||.|||++||+|+||||.||||+.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999 6899999976432 234899999999999999999999999999999999999984
Q ss_pred CCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~ 785 (887)
++.++|+|||++....... .....+++.|+|||++.+..++.++||||||||||+|++ |.+||......+.+..
T Consensus 159 -~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 159 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred -CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7889999999997654322 123345678999999999999999999999999999998 9999977655544332
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+... .++ ..+..++..+.+||.+||
T Consensus 238 ~~~~--~~~-----------------------------------------------------~~~~~~~~~~~~li~~~l 262 (291)
T cd05094 238 ITQG--RVL-----------------------------------------------------ERPRVCPKEVYDIMLGCW 262 (291)
T ss_pred HhCC--CCC-----------------------------------------------------CCCccCCHHHHHHHHHHc
Confidence 2110 000 001123467899999999
Q ss_pred ccCCCCCcCHHHHHh
Q 002732 866 VLDPEKRMTVAQALT 880 (887)
Q Consensus 866 ~~DP~~RpTa~elL~ 880 (887)
+.+|.+|||+.+|++
T Consensus 263 ~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 263 QREPQQRLNIKEIYK 277 (291)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=316.89 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=196.5
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+...||.|+||+||+|.+..++ ....+|||.+... ......+..|+.+|.+|. .|+||++++++|..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~-----~h~~iv~~~~~~~~ 79 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEH 79 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCC--ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEECC
Confidence 45999999999999999999987654 2235677776542 223356678999998884 68999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
.+.+||||||+ +++|.++|..... ...|++..++.++.||+.||.|||+.||+|+||||+||||+.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence 99999999999 6799999976431 124899999999999999999999999999999999999984
Q ss_pred CCCeEEEEecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~ 788 (887)
.+.++|+|||++....... ......+..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+..+....+..
T Consensus 160 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 160 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred -CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 7789999999985432111 111223567999999998889999999999999999998 9999976655443322210
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
.+ ....+..++..+.+||.+||..+
T Consensus 239 ---~~----------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~ 263 (303)
T cd05088 239 ---GY----------------------------------------------------RLEKPLNCDDEVYDLMRQCWREK 263 (303)
T ss_pred ---CC----------------------------------------------------cCCCCCCCCHHHHHHHHHHcCCC
Confidence 00 00001123467889999999999
Q ss_pred CCCCcCHHHHHhC
Q 002732 869 PEKRMTVAQALTH 881 (887)
Q Consensus 869 P~~RpTa~elL~H 881 (887)
|..|||+.++|.+
T Consensus 264 p~~Rp~~~~il~~ 276 (303)
T cd05088 264 PYERPSFAQILVS 276 (303)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=315.75 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC---CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG---NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~---~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
..++|.+...||+|+||.||+|.+.... ......||||++.... .....+..|+.++..+. .|+||++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~ 84 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-----KHKNIINLL 84 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc-----CCCCeeeEE
Confidence 3467999999999999999999864322 1123579999987532 22345678898888883 599999999
Q ss_pred ceeeecCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCC
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~N 705 (887)
++|.....+||||||+ +++|.++|..... ...+++..+..|+.||+.||.|||++||+|+||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999 6799999976421 2348899999999999999999999999999999999
Q ss_pred ccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 002732 706 MLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNN 780 (887)
Q Consensus 706 ILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~ 780 (887)
|||+. ++.+||+|||++....... .....++..|+|||++.+..++.++||||||||||+|++ |..||.+....
T Consensus 165 ill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 165 VLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99985 7789999999997554321 112233457999999999899999999999999999999 89999776655
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
+.+..+.... . ...+..++.++.+|
T Consensus 244 ~~~~~~~~~~--~-----------------------------------------------------~~~~~~~~~~l~~l 268 (314)
T cd05099 244 ELFKLLREGH--R-----------------------------------------------------MDKPSNCTHELYML 268 (314)
T ss_pred HHHHHHHcCC--C-----------------------------------------------------CCCCCCCCHHHHHH
Confidence 5444332110 0 00012334678899
Q ss_pred HHHhcccCCCCCcCHHHHHh
Q 002732 861 LDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~ 880 (887)
|.+||..+|..|||+.++|+
T Consensus 269 i~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 269 MRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=319.51 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=203.0
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCC---CCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGN---GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~---~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
++...+|.+++.||+|+||.||+|.+...+. .....||||++.... .....+..|+.++.+|. .|+||++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~ 82 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG-----KHKNIIN 82 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc-----CCCCeee
Confidence 4455679999999999999999998754321 122468999887532 23456788999999884 6899999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCC
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKFG-------------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~-------------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP 703 (887)
++++|...+.+|+||||+ +++|.++|.... ....++...+..++.||+.||.|||.+||+|+||+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999999 679999987632 123478889999999999999999999999999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGAT 778 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~ 778 (887)
+||||+. ++.++|+|||++....... .....++..|+|||++.+..++.++||||||||||+|++ |.+||.+.+
T Consensus 163 ~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999985 7889999999997654322 122233467999999999999999999999999999998 889998776
Q ss_pred hHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHH
Q 002732 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 779 ~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 858 (887)
..+.+..+..... ...+..++.++.
T Consensus 242 ~~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~l~ 266 (334)
T cd05100 242 VEELFKLLKEGHR-------------------------------------------------------MDKPANCTHELY 266 (334)
T ss_pred HHHHHHHHHcCCC-------------------------------------------------------CCCCCCCCHHHH
Confidence 5554433321000 001112346788
Q ss_pred HHHHHhcccCCCCCcCHHHHHhC
Q 002732 859 DLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+||.+||..+|.+|||+.+||.+
T Consensus 267 ~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 267 MIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHcccChhhCcCHHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.09 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=199.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCC-CCCCCcEEEEEEeccc-chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKA-GNGEPEEVAIKIIRNN-ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~-~~~~~~~vAIKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..+|.+..+||.|+||.||+|..... .......||+|.+... ......+..|+.++..| .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 77 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL------QHQHIVRFYGVCT 77 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC------CCCCCceEEEEEe
Confidence 34689999999999999999975432 1123367999988643 33346778899999988 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccC------------CCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRN------------IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~------------~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
....+|+||||+ +++|.++|...... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 999999999999 67999998764321 24889999999999999999999999999999999999984
Q ss_pred CCCeEEEEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~ 785 (887)
++.++|+|||++........ ....+++.|+|||++.+..++.++||||||||||+|++ |.+||......+.+..
T Consensus 158 -~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 158 -GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred -CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 78899999999875543221 12234678999999999999999999999999999998 9999976655444333
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+.... . ...+..++..+.+||.+||
T Consensus 237 ~~~~~--~-----------------------------------------------------~~~~~~~~~~~~~li~~cl 261 (280)
T cd05092 237 ITQGR--E-----------------------------------------------------LERPRTCPPEVYAIMQGCW 261 (280)
T ss_pred HHcCc--c-----------------------------------------------------CCCCCCCCHHHHHHHHHHc
Confidence 21110 0 0001123467889999999
Q ss_pred ccCCCCCcCHHHHHh
Q 002732 866 VLDPEKRMTVAQALT 880 (887)
Q Consensus 866 ~~DP~~RpTa~elL~ 880 (887)
+.||.+||++.+|+.
T Consensus 262 ~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 262 QREPQQRMVIKDIHS 276 (280)
T ss_pred cCChhhCCCHHHHHH
Confidence 999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=311.80 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=197.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+|.+...||+|+||+||+|.+.... ......||+|++..... ....+..|+.+|..| .||||++++++|..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV------NHPHVIKLYGACSQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC------CCCCEeeEEEEEec
Confidence 4788999999999999999875422 12235799998875432 235677899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhcc---------------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGR---------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~---------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
.+.+++||||+ +++|.++|..... ...+++..++.++.||+.||.|||+.||||+||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 99999999999 5799998875321 1348899999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGA 777 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~ 777 (887)
|+||||+. ++.++|+|||++....... .....++..|+|||++.+..++.++|||||||+||+|++ |..||.+.
T Consensus 155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999984 7889999999986543221 122234667999999999899999999999999999998 99999776
Q ss_pred ChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHH
Q 002732 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857 (887)
Q Consensus 778 ~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 857 (887)
........+.... ....+..++..+
T Consensus 234 ~~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 258 (290)
T cd05045 234 APERLFNLLKTGY-------------------------------------------------------RMERPENCSEEM 258 (290)
T ss_pred CHHHHHHHHhCCC-------------------------------------------------------CCCCCCCCCHHH
Confidence 5443332211000 000112344678
Q ss_pred HHHHHHhcccCCCCCcCHHHHHh
Q 002732 858 KDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 858 ~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+||..||..+|.+||++.+|+.
T Consensus 259 ~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 259 YNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.04 Aligned_cols=251 Identities=18% Similarity=0.247 Sum_probs=199.5
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
..+.|.+.+.||.|+||.||+|.+..++ .....||||++... ......+..|+.++..+ .|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPG-RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF------SHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCC-CCceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCCCeeEEEEEE
Confidence 3456999999999999999999987544 12247999998754 22345677888888888 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...+.+||||||+ +++|..++.... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~-~~~~kl~dfg 152 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS-NLECKVSDFG 152 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC-CCcEEECCCc
Confidence 9999999999999 568988887532 34899999999999999999999999999999999999984 7789999999
Q ss_pred cceecCCCCcc-----CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 722 NAMFAGKNEIT-----PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 722 ~a~~~~~~~~~-----~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
++......... ....++.|+|||++.+..++.++|||||||+||+|++ |..||...+....+..+.... .+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~- 230 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP- 230 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC-
Confidence 98765432211 1122346999999998889999999999999999997 999997765554444332110 000
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
....++..+.+||.+||+.+|..||++
T Consensus 231 -----------------------------------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~ 257 (268)
T cd05063 231 -----------------------------------------------------APMDCPSAVYQLMLQCWQQDRARRPRF 257 (268)
T ss_pred -----------------------------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 001234678899999999999999999
Q ss_pred HHHHh
Q 002732 876 AQALT 880 (887)
Q Consensus 876 ~elL~ 880 (887)
.+|++
T Consensus 258 ~~i~~ 262 (268)
T cd05063 258 VDIVN 262 (268)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=305.25 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=200.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...|.+...||.|+||.||+|... + ..||||.+.........+..|+.++..+ .|+||+++++++...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~----~~v~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 72 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--G----QKVAVKCLKDDSTAAQAFLAEASVMTTL------RHPNLVQLLGVVLQG 72 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--C----cEEEEEEeccchhHHHHHHHHHHHHHhc------CCcceeeeEEEEcCC
Confidence 346899999999999999999864 3 6799999987655556788899999999 899999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..+|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++.
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~-~~~~~l~d~g~~~ 150 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE-DLVAKVSDFGLAK 150 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC-CCCEEEccccccc
Confidence 9999999999 4799999876442 24899999999999999999999999999999999999984 7889999999997
Q ss_pred ecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 725 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
...... .....+..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+... +
T Consensus 151 ~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~---------- 216 (256)
T cd05039 151 EASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---Y---------- 216 (256)
T ss_pred cccccc-ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---C----------
Confidence 764322 23344567999999998899999999999999999997 99999766544333222110 0
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
. ...+..++..+.+||.+||..+|.+|||+.+||.
T Consensus 217 -------------------------------~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 -------------------------------R-----------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -------------------------------C-----------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0011223477899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.29 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=200.6
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++..+.|.+.+.||+|+||.||+|.+... ..||||++.........+..|+.++..+ .|++|+++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~-----~~~~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~ 70 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKLVKLHAVV 70 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCC-----ccEEEEecCCChhHHHHHHHHHHHHHhc------CCCCcceEEEEE
Confidence 45677899999999999999999985443 4699999887655556788899999999 899999999998
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.. ..+++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.||+|+||+|+||||+. .+.++|+|||
T Consensus 71 ~~-~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~-~~~~~l~d~~ 147 (260)
T cd05073 71 TK-EPIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA-SLVCKIADFG 147 (260)
T ss_pred cC-CCeEEEEEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC-CCcEEECCCc
Confidence 87 7889999999 579999987632 234788999999999999999999999999999999999984 7889999999
Q ss_pred cceecCCCCc---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++........ ....++..|+|||++.+..++.++|||||||+||+|++ |.+||.+.+.......+... ++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---~~--- 221 (260)
T cd05073 148 LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---YR--- 221 (260)
T ss_pred ceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC---CC---
Confidence 9876543221 12234566999999998889999999999999999998 99999876555444322110 00
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
......++.++.+||.+||..+|.+||++.+
T Consensus 222 -------------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 252 (260)
T cd05073 222 -------------------------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEY 252 (260)
T ss_pred -------------------------------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence 0001223467899999999999999999998
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
++.
T Consensus 253 l~~ 255 (260)
T cd05073 253 IQS 255 (260)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=311.99 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=199.5
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.++..||.|+||.||+|.+.... ......||||++.... .....+..|+.++..| .|+||++++++|
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l------~h~~iv~~~~~~ 77 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DHPNIVKLLGVC 77 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc------CCCchheEEEEE
Confidence 356999999999999999999875310 1123689999987542 2345678899999999 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhcc-------------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGR-------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~-------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
.....+|+||||+ +++|.++|..... ...+++..++.++.||+.||.|||..+|+|+||+
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9999999999999 5799999875321 1247888999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGA 777 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~ 777 (887)
|.|||++. .+.++|+|||++....... ......++.|+|||++.+..++.++||||||||||+|++ |..||.+.
T Consensus 158 p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 158 TRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred HhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999984 7889999999987543322 122234567999999999999999999999999999997 88899776
Q ss_pred ChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHH
Q 002732 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857 (887)
Q Consensus 778 ~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 857 (887)
+..+.+..+... .+ ...+..++..+
T Consensus 237 ~~~~~~~~~~~~--~~-----------------------------------------------------~~~~~~~~~~l 261 (288)
T cd05050 237 AHEEVIYYVRDG--NV-----------------------------------------------------LSCPDNCPLEL 261 (288)
T ss_pred CHHHHHHHHhcC--CC-----------------------------------------------------CCCCCCCCHHH
Confidence 655544332110 00 00011234678
Q ss_pred HHHHHHhcccCCCCCcCHHHHHh
Q 002732 858 KDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 858 ~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+||.+||+.+|.+|||+.||++
T Consensus 262 ~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 262 YNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.80 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=198.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----hhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.|.+.+.||.|+||.||+|.+.... .....||||++.+... ....+..|+.++..+. +|++|+.++++|
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~-----~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR-----RCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc-cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc-----CCcchhhhheee
Confidence 3889999999999999999865322 2236899999875322 2345678889998884 589999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.....+||||||+ +++|..++... ..+++..++.++.||+.||.|||..||+|+||+|.||||+. ++.++|+|||
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~-~~~~~l~dfg 150 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS-EGHVVLTDFG 150 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEEECc
Confidence 9999999999999 56898888653 24899999999999999999999999999999999999985 6789999999
Q ss_pred cceecCCCC---ccCcccCCcccchhhhcCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 722 NAMFAGKNE---ITPYLVSRFYRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 722 ~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~~--~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
++....... .....++..|+|||++.+.. ++.++||||||||||+|++|..||...........+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------- 222 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-------- 222 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--------
Confidence 986543322 12345788999999998765 78999999999999999999999954322111111100
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC--
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-- 874 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-- 874 (887)
.++.. .+..+..++..+.+||.+||+.||..|||
T Consensus 223 --------------------------------~~~~~------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~ 258 (288)
T cd05583 223 --------------------------------RILKS------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGAN 258 (288)
T ss_pred --------------------------------HHHcc------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcc
Confidence 00000 01112234567899999999999999998
Q ss_pred -HHHHHhCCCCCC
Q 002732 875 -VAQALTHPFISG 886 (887)
Q Consensus 875 -a~elL~Hpwf~~ 886 (887)
+.++|+||||..
T Consensus 259 ~~~~~l~~~~~~~ 271 (288)
T cd05583 259 GADEIKNHPFFQG 271 (288)
T ss_pred hHHHHhcCccccc
Confidence 567899999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=312.87 Aligned_cols=264 Identities=17% Similarity=0.215 Sum_probs=189.3
Q ss_pred cCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHH-------HHHHHHHHHHhhCCCCCC
Q 002732 561 FGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKA-------GQTEVQILKKLAGADPEN 631 (887)
Q Consensus 561 ~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~-------~~~Ei~iL~~L~~~~~~~ 631 (887)
+.+++.++|.+.++||+|+||+||+|.+..+. .....+|+|+....... ... ...++..+..+ ....
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~-~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~---~~~~ 81 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDH-CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI---HNID 81 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCc-ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh---ccCC
Confidence 45677788999999999999999999987662 11256777765432111 000 01122222222 2347
Q ss_pred CcceeEecceeeecC----eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcc
Q 002732 632 KRHCIRFASSFKYRN----HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML 707 (887)
Q Consensus 632 h~~Iv~l~~~~~~~~----~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NIL 707 (887)
|++|+.+++++.... ..+++++++..++.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||
T Consensus 82 h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 82 HLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred CCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 899999988766543 457888888778877776543 2678889999999999999999999999999999999
Q ss_pred ccCCCCeEEEEecCcceecCCC---------CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 002732 708 VNEAKNVLKLCDFGNAMFAGKN---------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778 (887)
Q Consensus 708 l~~~~~~vKL~DFG~a~~~~~~---------~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~ 778 (887)
|+. .+.++|+|||+|..+... ......+|+.|+|||++.+..|+.++|||||||+||+|++|.+||.+..
T Consensus 159 l~~-~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 159 VDG-NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EcC-CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 985 678899999999764321 1223468999999999999999999999999999999999999998764
Q ss_pred hHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHH
Q 002732 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 779 ~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 858 (887)
....+.....+. + +..+. ... + ..+.++.++.
T Consensus 238 ~~~~~~~~~~~~--~---------------------------------~~~~~----~~~---~------~~~~~~~~~~ 269 (294)
T PHA02882 238 HNGNLIHAAKCD--F---------------------------------IKRLH----EGK---I------KIKNANKFIY 269 (294)
T ss_pred cchHHHHHhHHH--H---------------------------------HHHhh----hhh---h------ccCCCCHHHH
Confidence 333222111110 0 00000 000 0 0112346789
Q ss_pred HHHHHhcccCCCCCcCHHHHHh
Q 002732 859 DLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+||..||.++|.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 270 DFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999999999975
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=313.38 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=202.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCC---CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAG---NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~---~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
+...+|.+...||.|+||.||+|.+.... ......||||++.... .....+..|+.++..+. .|+||+++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~i~~~ 86 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-----KHKNIINL 86 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc-----cCCCchhe
Confidence 44567999999999999999999864311 1223579999987532 22356778999998884 68999999
Q ss_pred cceeeecCeEEEEEecc-hhhHHHHHHHhcc-------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCC
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~ 704 (887)
+++|.....+||||||+ +++|.++|..... ...+++..+..++.||+.||.|||+.||+|+||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999 6799999976421 234788899999999999999999999999999999
Q ss_pred CccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATN 779 (887)
Q Consensus 705 NILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~ 779 (887)
||||+. .+.++|+|||++....... .....+++.|+|||++.+..|+.++|||||||+||+|++ |..||.+.+.
T Consensus 167 Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999984 7889999999997654322 122334567999999999899999999999999999998 8899977665
Q ss_pred HHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHH
Q 002732 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 780 ~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 859 (887)
.+.+..+..... ...+..++..+.+
T Consensus 246 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~ 270 (304)
T cd05101 246 EELFKLLKEGHR-------------------------------------------------------MDKPANCTNELYM 270 (304)
T ss_pred HHHHHHHHcCCc-------------------------------------------------------CCCCCCCCHHHHH
Confidence 554443311100 0001134467899
Q ss_pred HHHHhcccCCCCCcCHHHHHhC
Q 002732 860 LLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~elL~H 881 (887)
||.+||..+|..|||+.+||+.
T Consensus 271 li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 271 MMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcccChhhCCCHHHHHHH
Confidence 9999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=304.28 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=195.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee-ec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK-YR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~-~~ 645 (887)
..|.+.+.||.|+||.||++.... ..||+|.+.... ....+..|+.++..+ .|++|+++++++. ..
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~k~~~~~~-~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~ 72 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA-TAQAFLAEASVMTQL------RHSNLVQLLGVIVEEK 72 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcC------CcEEEEEeCCCc-hHHHHHHHHHHHHhC------CCCCeeeEEEEEEcCC
Confidence 359999999999999999997653 569999987543 345678899999999 8999999998754 45
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++.
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~ 150 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE-DNVAKVSDFGLTK 150 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC-CCcEEecCCccce
Confidence 6799999999 5799999876432 34889999999999999999999999999999999999984 7889999999987
Q ss_pred ecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 725 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
...... .....+..|+|||++.+..++.++||||||||||+|++ |.+||...+..+....+... ++
T Consensus 151 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~--------- 217 (256)
T cd05082 151 EASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YK--------- 217 (256)
T ss_pred eccccC-CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CC---------
Confidence 544322 23344667999999999899999999999999999997 99999765544433322110 00
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+.....++..+.+||.+||..+|.+|||+.+|+.
T Consensus 218 -------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 -------------------------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011234467899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=328.58 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=209.9
Q ss_pred CceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc----chhhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 562 ~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
.++.+.+..+.++||+|+||.||+|.....+......||||..+.. ......+++|..+|++| +|+|||.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l------~H~NVVr 225 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL------NHPNVVR 225 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC------CCCCEEE
Confidence 3556667778899999999999999987654222233999998842 33457778999999999 9999999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
|||++.....++||||+| +|+|.++|++... .++..+...++.+.+.||.|||++++|||||...|+|++. ++++|
T Consensus 226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~-~~~vK 302 (474)
T KOG0194|consen 226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK-KGVVK 302 (474)
T ss_pred EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC-CCeEE
Confidence 999999999999999999 7899999998654 4999999999999999999999999999999999999994 77889
Q ss_pred EEecCcceecCCCCccC-c-ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCC
Q 002732 717 LCDFGNAMFAGKNEITP-Y-LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 717 L~DFG~a~~~~~~~~~~-~-~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
|+|||++.......... . .....|+|||.+....|++++|||||||++||+++ |..||++....+....|.......
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 99999987654222111 2 24567999999999999999999999999999999 889999998887777663322111
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
| .+...+..+..++.+|+..+|..||
T Consensus 383 ~------------------------------------------------------~~~~~p~~~~~~~~~c~~~~p~~R~ 408 (474)
T KOG0194|consen 383 P------------------------------------------------------IPSKTPKELAKVMKQCWKKDPEDRP 408 (474)
T ss_pred C------------------------------------------------------CCCCCHHHHHHHHHHhccCChhhcc
Confidence 1 1112346778899999999999999
Q ss_pred CHHHHHh
Q 002732 874 TVAQALT 880 (887)
Q Consensus 874 Ta~elL~ 880 (887)
|+.++.+
T Consensus 409 tm~~i~~ 415 (474)
T KOG0194|consen 409 TMSTIKK 415 (474)
T ss_pred CHHHHHH
Confidence 9998864
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=305.67 Aligned_cols=239 Identities=20% Similarity=0.291 Sum_probs=189.4
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
.||+|+||.||+|.+.... ....||||++.... .....+..|+.+|..+ .|+||+++++++.. ..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~-~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK--SEKTVAVKILKNDNNDPALKDELLREANVMQQL------DNPYIVRMIGICEA-ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCC--CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC------CCCCcceEEEEEcC-CCcEE
Confidence 5899999999999754322 23789999986432 2345678889999998 89999999998754 56799
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.+++.... .+++..+..|+.||+.||.|||++||+|+||||.||||+. ++.++|+|||++......
T Consensus 73 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 73 VMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGAD 148 (257)
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC-CCeEEECCCccccccCCC
Confidence 99999 468999987643 4899999999999999999999999999999999999985 778999999999765433
Q ss_pred Cc-----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 730 EI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 730 ~~-----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.. ....+++.|+|||++.+..++.++|||||||+||+|++ |.+||......+.+..+.... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~--~---------- 216 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE--R---------- 216 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--C----------
Confidence 21 12233568999999988889999999999999999998 999998766655444332110 0
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..+..++..+.+||.+||+.||..||++.+|..
T Consensus 217 -------------------------------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 -------------------------------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------------------------------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0011234567899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=304.88 Aligned_cols=241 Identities=21% Similarity=0.292 Sum_probs=191.2
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
++||+|+||.||+|.+.... .....||||++..... ....+..|+.+|+.+ .|+||+++++++. .+.+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~-~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS-GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL------DHPCIVRLIGVCK-GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccC-CCcceEEEEecccccchHHHHHHHHHHHHHHhc------CCCCeeeEEEEEc-CCceEE
Confidence 36899999999999865543 2336899999986544 446678899999988 8999999999876 456899
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.++|.... .+++..+..++.||+.||.|||..+|+|+||+|+||||+. ++.++|+|||++......
T Consensus 73 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 73 VMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence 99998 679999998644 4899999999999999999999999999999999999984 788999999999765433
Q ss_pred Cc--cC---cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccc
Q 002732 730 EI--TP---YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803 (887)
Q Consensus 730 ~~--~~---~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~ 803 (887)
.. .. ..++..|+|||++.+..++.++|||||||+||+|++ |.+||...+..+....+.... .
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~-~----------- 216 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE-R----------- 216 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c-----------
Confidence 21 11 112356999999999899999999999999999998 999997665544433221110 0
Q ss_pred cccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 804 ~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 217 -------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 -------------------------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred -------------------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011234467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.79 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=199.2
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|.++..||.|+||.||+|.+..+. ......||||++..... ....+..|+.++..| .|+||+++++++..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~ 79 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL------QHPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC------CCCCcCeEEEEEcC
Confidence 4788899999999999999876542 12236799999975432 235567888888888 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFG-------------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~-------------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
...+++|+||+ +++|.+++.... ....+++..++.++.||+.||.|||++||+|+||||.|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999 578888885321 1234888899999999999999999999999999999999984
Q ss_pred CCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~ 785 (887)
.+.+||+|||++....... .....+++.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..
T Consensus 160 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 160 -KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred -CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 6789999999986543222 123345678999999998899999999999999999998 8899987666555444
Q ss_pred HHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhc
Q 002732 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIF 865 (887)
Q Consensus 786 i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL 865 (887)
+...... ..+..++..+.+||..||
T Consensus 239 i~~~~~~-------------------------------------------------------~~~~~~~~~~~~li~~cl 263 (283)
T cd05091 239 IRNRQVL-------------------------------------------------------PCPDDCPAWVYTLMLECW 263 (283)
T ss_pred HHcCCcC-------------------------------------------------------CCCCCCCHHHHHHHHHHh
Confidence 3221100 001234467889999999
Q ss_pred ccCCCCCcCHHHHHhC
Q 002732 866 VLDPEKRMTVAQALTH 881 (887)
Q Consensus 866 ~~DP~~RpTa~elL~H 881 (887)
+.+|..||++.+|+..
T Consensus 264 ~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 264 NEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCCcccCCCHHHHHHH
Confidence 9999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=307.07 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=199.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
++|.+.+.||.|+||.||+|.+..++ .....||||.+.... .....+..|+.+|..+ .||||++++++|..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 76 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG-KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF------DHPNIIHLEGVVTK 76 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC-CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEec
Confidence 56999999999999999999876543 122479999986532 2345678899999988 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+||||||+ +++|.+++.... ..+++..+..|+.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~-~~~~~l~dfg~~ 153 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC-CCeEEeCCCCcc
Confidence 99999999999 579999987643 34899999999999999999999999999999999999984 788999999999
Q ss_pred eecCCCCc-----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 724 MFAGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~~~~-----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
........ .....+..|+|||++.+..++.++|||||||+||+|++ |..||......+.+..+.... .+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~--- 229 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-RLP--- 229 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC-cCC---
Confidence 76543221 11223457999999999899999999999999999887 999997665544443332110 000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
....++..+.+||.+||+.+|..|||+.+
T Consensus 230 ---------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (267)
T cd05066 230 ---------------------------------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQ 258 (267)
T ss_pred ---------------------------------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHH
Confidence 01123467889999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
+++
T Consensus 259 i~~ 261 (267)
T cd05066 259 IVS 261 (267)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=307.52 Aligned_cols=254 Identities=19% Similarity=0.318 Sum_probs=201.4
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..|.++..||.|+||+||+|...... ......||||++..... ....+..|+.+|..| .|+||++++++|.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL------SHKNVVRLLGLCR 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc------CCcceeeeEEEEC
Confidence 46999999999999999999976432 12346799998865432 246678899999999 8999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccC------CCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRN------IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~------~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
....+||||||+ +++|.++|...... ..+++..+..++.||+.||.|||++||+|+||||+||||+. .+.++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~-~~~~~ 157 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS-QREVK 157 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC-CCcEE
Confidence 999999999999 57999999865422 15899999999999999999999999999999999999985 77899
Q ss_pred EEecCcceecCCCC---ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCC
Q 002732 717 LCDFGNAMFAGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 717 L~DFG~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
|+|||++....... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||........+..+......
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence 99999986543222 223345667999999998889999999999999999998 88899765444333322111000
Q ss_pred CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCC
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
+ .....++..+.+||.+||+.+|.+|
T Consensus 238 ~------------------------------------------------------~~~~~~~~~l~~~i~~~l~~~p~~R 263 (275)
T cd05046 238 L------------------------------------------------------PVPEGCPSRLYKLMTRCWAVNPKDR 263 (275)
T ss_pred C------------------------------------------------------CCCCCCCHHHHHHHHHHcCCCcccC
Confidence 0 0011244678999999999999999
Q ss_pred cCHHHHHhC
Q 002732 873 MTVAQALTH 881 (887)
Q Consensus 873 pTa~elL~H 881 (887)
||+.+||.+
T Consensus 264 p~~~~~l~~ 272 (275)
T cd05046 264 PSFSELVSA 272 (275)
T ss_pred CCHHHHHHH
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.19 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=197.0
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
+||.|+||+||+|.+...+ .....||||++..... ....+..|+.+|.+| .|+||+++++++.. ..+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSG-GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL------DHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred cCCccCcccEEeeeEecCC-CCceEEEEeecCCcccHHHHHHHHHHHHHHhhc------CCCCccceeEEEcC-CeEEEE
Confidence 6899999999999986532 2234699999986544 356778899999999 89999999999988 899999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~ 730 (887)
|||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.+||+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec-CCEEEeccccccccccccc
Confidence 9999 6799999887542 35899999999999999999999999999999999999995 6889999999997654321
Q ss_pred -----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 731 -----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 731 -----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
.....++..|+|||++.+..++.++||||||||||+|++ |..||...+..+.+..+......+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------- 220 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL----------- 220 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC-----------
Confidence 112345678999999999899999999999999999998 999998776665554442210000
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
..+..++..+.+||.+||..+|.+|||+.+|++
T Consensus 221 -------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 -------------------------------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------------------------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 001123467889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.25 Aligned_cols=249 Identities=19% Similarity=0.245 Sum_probs=192.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+++.||.|+||+||+|.+..++......|++|++..... ....+..|+.++..+ .|+||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l------~h~~iv~~~~~~~~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL------DHAYIVRLLGICPG 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC------CCCCcceEEEEECC
Confidence 4689999999999999999998776633333578888754321 224455666666666 89999999998764
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..+++|+||+ +++|.+++.... ..+++..+..|+.||+.||.|||+.||+|+||||.|||++. ++.+||+|||++
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~-~~~~kl~Dfg~~ 156 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS-DSIVQIADFGVA 156 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC-CCcEEEcCCccc
Confidence 4578889998 689999997643 24899999999999999999999999999999999999985 788999999999
Q ss_pred eecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
....... .....++..|+|||++.+..++.++|||||||+||+|++ |..||.+.........+ .....++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~---- 231 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLA---- 231 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCC----
Confidence 7653321 223345678999999999899999999999999999998 99999776543332211 1000000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.+..++..+..||..||..||.+|||+.++
T Consensus 232 --------------------------------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 232 --------------------------------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred --------------------------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 001123567899999999999999999998
Q ss_pred Hh
Q 002732 879 LT 880 (887)
Q Consensus 879 L~ 880 (887)
++
T Consensus 262 ~~ 263 (279)
T cd05111 262 AN 263 (279)
T ss_pred HH
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.99 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=201.5
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
+++...||.|+||.||+|.+...+......||||++..... ....+..|+.+|..+ .|+||++++++|...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL------DHPNIVKLLGVCTEEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc------CCCchheEEEEEcCCC
Confidence 35678999999999999998765433447899999976543 356778899999998 8999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|+||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++..
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~ 152 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE-NLVVKISDFGLSRD 152 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc-CCeEEEcccCCcee
Confidence 999999999 5799999876432 12899999999999999999999999999999999999984 77899999999976
Q ss_pred cCCCCccC---cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEITP---YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~~---~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
........ ..+++.|+|||++.+..++.++||||||||+|+|++ |.+||...+....+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------
Confidence 65432211 235678999999988889999999999999999998 8899977655555443321100
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
......++.++.+||.+||..+|..|||+.+||+
T Consensus 223 ---------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 ---------------------------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------------------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011124578899999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=305.57 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=199.1
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.|.+.+.||.|+||.||+|.+..++. ....||||++... ......+..|+.++..+ .||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQF------DHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC-CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC------CCcCcceEEEEECC
Confidence 358999999999999999999876552 2246999998753 33346778899999998 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
...++|||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||+|.||||+. +..++|+|||++
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~-~~~~kl~dfg~~ 153 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS-NLVCKVSDFGLS 153 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC-CCcEEECCCccc
Confidence 99999999999 568988887643 34899999999999999999999999999999999999984 778999999998
Q ss_pred eecCCCCc----cCcc---cCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 724 MFAGKNEI----TPYL---VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 724 ~~~~~~~~----~~~~---gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
........ .... .+..|+|||++.+..++.++|||||||+||+|++ |..||........+..+.... .+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~~- 231 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RLP- 231 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCC-
Confidence 76543221 1111 1346999999999899999999999999999886 999997665544443331110 000
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.+..++..+.+||..||..+|.+||++
T Consensus 232 -----------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (269)
T cd05065 232 -----------------------------------------------------PPMDCPTALHQLMLDCWQKDRNARPKF 258 (269)
T ss_pred -----------------------------------------------------CcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 011234678899999999999999999
Q ss_pred HHHHhC
Q 002732 876 AQALTH 881 (887)
Q Consensus 876 ~elL~H 881 (887)
.+|+..
T Consensus 259 ~~i~~~ 264 (269)
T cd05065 259 GQIVST 264 (269)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.05 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=199.8
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..+|.+...||.|+||.||+|.+..++......||+|++... ......+..|+.+|..| .|+||+++++++.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~ 78 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL------SHQNILPILHVCI 78 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC------CCCCCCeEEEEEe
Confidence 457999999999999999999987643333478999988753 22345667899999988 8999999999876
Q ss_pred e-cCeEEEEEecc-hhhHHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 644 Y-RNHLCLVFESL-HMNLREVLKKFGRN-----IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 644 ~-~~~~~lV~E~~-~gsL~~~L~~~~~~-----~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
. ....+++++|+ +++|.++|...... ..|++..++.++.||+.||.|||+.+|+|+||+|.|||++. .+.+|
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~-~~~~k 157 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE-ELQVK 157 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC-CCcEE
Confidence 6 46789999998 57999998765322 45899999999999999999999999999999999999984 78899
Q ss_pred EEecCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhC
Q 002732 717 LCDFGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 717 L~DFG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g 791 (887)
|+|||++..+..... ....++..|+|||++.+..++.++|||||||+||+|++ |.+||...+..+....+...
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 235 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence 999999975433221 22344667999999999899999999999999999999 99999765544332211110
Q ss_pred CCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCC
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
+ .......++.++.+||.+||..||..
T Consensus 236 -~----------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~ 262 (280)
T cd05043 236 -Y----------------------------------------------------RLAQPINCPDELFAVMACCWALDPEE 262 (280)
T ss_pred -C----------------------------------------------------CCCCCCcCCHHHHHHHHHHcCCChhh
Confidence 0 00011223467899999999999999
Q ss_pred CcCHHHHHh
Q 002732 872 RMTVAQALT 880 (887)
Q Consensus 872 RpTa~elL~ 880 (887)
|||+.+|++
T Consensus 263 Rps~~~~~~ 271 (280)
T cd05043 263 RPSFSQLVQ 271 (280)
T ss_pred CCCHHHHHH
Confidence 999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.21 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=215.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
....+..+||-|.||.||.+.++... -.||||.++.+......|..|..||+.| +|||+|+|+++|..+.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkys----lTvAVKtLKEDtMeveEFLkEAAvMKei------kHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccc----eeeehhhhhhcchhHHHHHHHHHHHHhh------cCccHHHHhhhhccCC
Confidence 34667789999999999999998876 6899999998888889999999999999 9999999999999999
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|||+||| .|+|.+||..+.+. .++...+++++.||..|+.||...++|||||...|+||.+ +.+|||+|||++++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE-nhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc-cceEEeeccchhhh
Confidence 999999999 79999999998764 3888889999999999999999999999999999999996 88999999999999
Q ss_pred cCCCCccCcccC---CcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcc
Q 002732 726 AGKNEITPYLVS---RFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~~~~~~gt---~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+....++...|. +-|.|||-|..+.|+.++|||+|||+||||.| |-.||+|....+++.++.+..
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy----------- 483 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY----------- 483 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-----------
Confidence 998888887774 45999999999999999999999999999999 889999987665554332110
Q ss_pred cccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 802 ~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
.+.-+..+++.+..|+..||+|.|.+||+..||
T Consensus 484 --------------------------------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 484 --------------------------------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred --------------------------------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 112234556778999999999999999999887
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.23 Aligned_cols=257 Identities=19% Similarity=0.304 Sum_probs=200.4
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
-..+|.+.+.||.|+||.||+|.+.... ......||||++.... .....+..|+.+|..|. .|+||+.++++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~-----~H~niv~~~~~ 109 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG-----PHLNIVNLLGA 109 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC-----CCCCeEEEEEE
Confidence 3456899999999999999999875421 1223679999997542 22346778999999982 39999999999
Q ss_pred eeecCeEEEEEecc-hhhHHHHHHHhcc----------------------------------------------------
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGR---------------------------------------------------- 668 (887)
Q Consensus 642 ~~~~~~~~lV~E~~-~gsL~~~L~~~~~---------------------------------------------------- 668 (887)
|....++||||||+ +|+|.++|.....
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 99999999999999 6899999975321
Q ss_pred -------------------------------------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCC
Q 002732 669 -------------------------------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705 (887)
Q Consensus 669 -------------------------------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~N 705 (887)
...|++..++.|+.||+.||.|||+.+|+|+||||.|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 1236778889999999999999999999999999999
Q ss_pred ccccCCCCeEEEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 002732 706 MLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNN 780 (887)
Q Consensus 706 ILl~~~~~~vKL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~ 780 (887)
||++. .+.++|+|||++....... ....++++.|+|||++.+..++.++|||||||+||+|++ |..||......
T Consensus 270 iLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 270 VLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99985 7889999999997643221 122345778999999999899999999999999999998 89999765544
Q ss_pred HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHH
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 860 (887)
+.+...+... + .+..+..++.++.+|
T Consensus 349 ~~~~~~~~~~--~----------------------------------------------------~~~~p~~~~~~l~~l 374 (401)
T cd05107 349 EQFYNAIKRG--Y----------------------------------------------------RMAKPAHASDEIYEI 374 (401)
T ss_pred HHHHHHHHcC--C----------------------------------------------------CCCCCCCCCHHHHHH
Confidence 4332221100 0 000112345788999
Q ss_pred HHHhcccCCCCCcCHHHHHhC
Q 002732 861 LDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~elL~H 881 (887)
|.+||..+|..||++.+||..
T Consensus 375 i~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 375 MQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.80 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=199.1
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
-..+|.+..+||.|+||.||+|.+.... .....||||.+.... .....+.+|+.+++.+ .|+||++++++|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~------~h~~i~~~~~~~ 76 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPE-NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF------DHPHIVKLIGVI 76 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCC-CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCchhceeEEE
Confidence 3456999999999999999999876542 122469999887543 3345778899999999 899999999988
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
.. ...||||||+ +++|.++|..... .+++..++.++.||+.||.|||+.||+|+||+|+|||++. .+.++|+|||
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~-~~~~~l~d~g 152 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS-PDCVKLGDFG 152 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec-CCCeEEccCc
Confidence 75 5578999999 6799999976432 4899999999999999999999999999999999999985 7789999999
Q ss_pred cceecCCCCc---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
++........ +...++..|+|||++.+..++.++|||||||+||+|++ |..||.+.+..+.+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------ 226 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------ 226 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------
Confidence 9976544321 12223457999999988889999999999999999996 9999987765544432211100
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
...++.++..+.+||.+||..+|.+|||+.+
T Consensus 227 -------------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 227 -------------------------------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred -------------------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 0011234567899999999999999999999
Q ss_pred HHhC
Q 002732 878 ALTH 881 (887)
Q Consensus 878 lL~H 881 (887)
++..
T Consensus 258 ~~~~ 261 (270)
T cd05056 258 LKAQ 261 (270)
T ss_pred HHHH
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=321.06 Aligned_cols=208 Identities=25% Similarity=0.281 Sum_probs=176.0
Q ss_pred eecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh-hHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM-NKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 557 ~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
|+|..-...+++|.-...||+|+||+||+|..... ..||||.+...... ...|.+|+.+|.+| .|+||
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-----~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l------~H~Nl 133 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-----TVVAVKRLSSNSGQGEREFLNEVEILSRL------RHPNL 133 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-----CEEEEEEecCCCCcchhHHHHHHHHHhcC------CCcCc
Confidence 33333333457799899999999999999986543 57999988765543 45699999999999 89999
Q ss_pred eEecceeeecC-eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhcc---ceeccCCCCCCccccC
Q 002732 636 IRFASSFKYRN-HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC---GVLHCDIKPDNMLVNE 710 (887)
Q Consensus 636 v~l~~~~~~~~-~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~---gIvHrDLKP~NILl~~ 710 (887)
|.|+|||...+ +.+|||||| .|+|.+.|...... .|+|.....|+.++|.||.|||.. .|||+||||+||||+.
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 99999999988 599999999 68999999864432 699999999999999999999974 3999999999999994
Q ss_pred CCCeEEEEecCcceecCC-CCc-cCc-ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 002732 711 AKNVLKLCDFGNAMFAGK-NEI-TPY-LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~-~~~-~~~-~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~ 777 (887)
+...||+|||+|..... ... ... .||..|+|||++..+.++.++|||||||+|+||++|+.+....
T Consensus 213 -~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 213 -DFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred -CCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 88899999999976654 322 222 7899999999999989999999999999999999999887643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=338.56 Aligned_cols=276 Identities=17% Similarity=0.241 Sum_probs=179.3
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecce----
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASS---- 641 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~---- 641 (887)
.++|.+.++||+|+||+||+|.+..+.......||||.+.... ..|+.+...+... .+.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e~l~~~---~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNERVRRA---CPNSCADFVYGFLEP 201 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHHHHHhh---chhhHHHHHHhhhcc
Confidence 3579999999999999999999987722223789999876422 1223333333211 11122222211
Q ss_pred --eeecCeEEEEEecc-hhhHHHHHHHhccC-----------------CCCCHHHHHHHHHHHHHHHHhhhccceeccCC
Q 002732 642 --FKYRNHLCLVFESL-HMNLREVLKKFGRN-----------------IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI 701 (887)
Q Consensus 642 --~~~~~~~~lV~E~~-~gsL~~~L~~~~~~-----------------~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDL 701 (887)
......++|||||+ +++|.+++...... ..+....+..|+.||+.||.|||+.|||||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 23456799999999 56899888753210 01223456789999999999999999999999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCCC---CccCcccCCcccchhhhcCCC----------------------CCchhh
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGKN---EITPYLVSRFYRAPEIILGLP----------------------YDHPLD 756 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~~---~~~~~~gt~~Y~aPE~l~~~~----------------------~s~~sD 756 (887)
||+||||+...+.+||+|||+|...... ....+++++.|+|||++.... ++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999999865678999999999754322 234567899999999775332 344569
Q ss_pred HHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCC
Q 002732 757 IWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP 836 (887)
Q Consensus 757 IwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 836 (887)
|||||||||+|+++..++ ......+..++...+.-...|.. .+.....
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~------------------------------~~~~~~~ 409 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRK------------------------------LVEPRAS 409 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHH------------------------------hhccccc
Confidence 999999999999976554 33333333333322221111100 0000000
Q ss_pred CCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 837 KDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 837 ~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
..+...+. ........+++||.+||++||.+|||+.+||+||||++
T Consensus 410 ~~~~~~~~----~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 410 PDLRRGFE----VLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455 (566)
T ss_pred hhhhhhhh----hccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCC
Confidence 00000000 00011245679999999999999999999999999986
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.94 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=199.7
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
...|.+++.||+|+||+||+|.+..++......||+|++..... ....+..|+.+|..+ .|+||+++++++.
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~ 79 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV------DHPHVVRLLGICL 79 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC------CCCCcceEEEEEe
Confidence 35799999999999999999998776643445799998876532 235677899999998 8999999999988
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
. ..+++||||+ +++|.++|.... ..+++..+..++.||+.||.|||++||+|+||+|+|||++. .+.++|+|||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~-~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT-PQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC-CCeEEECCCcc
Confidence 7 7899999999 679999987643 24899999999999999999999999999999999999984 77899999999
Q ss_pred ceecCCCC--c--cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 723 AMFAGKNE--I--TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 723 a~~~~~~~--~--~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+....... . ....++..|+|||++....++.++|||||||++|+|++ |..||.+....+....+... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---- 230 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ERL---- 230 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CCC----
Confidence 97654322 1 11223567999999998899999999999999999998 99999876555443333211 000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..+...+..+.+||.+||..+|..|||+.+
T Consensus 231 --------------------------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~ 260 (279)
T cd05057 231 --------------------------------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKE 260 (279)
T ss_pred --------------------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 001123356789999999999999999999
Q ss_pred HHh
Q 002732 878 ALT 880 (887)
Q Consensus 878 lL~ 880 (887)
++.
T Consensus 261 l~~ 263 (279)
T cd05057 261 LIN 263 (279)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.45 Aligned_cols=280 Identities=28% Similarity=0.501 Sum_probs=217.0
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec-
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR- 645 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~- 645 (887)
+--..||.|+||+||-+.|..++ ..||+|.+.+ +-...+.+..|+.+|..+ .|.||+.+++.....
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdg----rrvalkK~pnvfq~L~s~krvFre~kmLcfF------kHdNVLSaLDILQPph 125 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSG----KRVALKKMPNVFQNLASCKRVFREIKMLSSF------RHDNVLSLLDILQPAN 125 (449)
T ss_pred CCCCcccccceeEEEeccCCCCc----cchhHhhcchHHHHHHHHHHHHHHHHHHHhh------ccccHHHHHHhcCCCC
Confidence 34468999999999999998888 7899998764 222345567788888888 888888877766543
Q ss_pred ----CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 646 ----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 646 ----~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
..+|+|+|.|..+|..+|-. ...|+...+..+++||+.||.|||+.+|+|+||||.|+|++ ++-++||||||
T Consensus 126 ~dfFqEiYV~TELmQSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFG 201 (449)
T KOG0664|consen 126 PSFFQELYVLTELMQSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-SNCILKICDFG 201 (449)
T ss_pred chHHHHHHHHHHHHHhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-cCceEEecccc
Confidence 34788889888888877765 34599999999999999999999999999999999999999 48899999999
Q ss_pred cceecCCCC---ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKNE---ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~---~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+|+...... ++.-+.|.+|.|||++.|. .|+.++||||+|||+.|||..+.+|...+..+++..|.+++|.+..+-
T Consensus 202 LARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 202 LARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred cccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 998765432 4556779999999999987 599999999999999999999999999999999999999999886554
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHH-hhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKII-FNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+-.+... ..-++ ...++.++..+.. .. .+.....+..+++.+||.+||.+|++..
T Consensus 282 Mr~ACEGA---------------------k~H~LR~~~k~Ps~~vLYt-ls-S~~~~~heav~~~~~~l~~d~dkris~~ 338 (449)
T KOG0664|consen 282 MKYACEGA---------------------KNHVLRAGLRAPDTQRLYK-IA-SPDDKNHEAVDLLQKLLHFDPDKRISVE 338 (449)
T ss_pred HHHHhhhh---------------------HHHhhccCCCCCCccceee-ec-CCcccchHHHHHHHHHhCCCCcccccHh
Confidence 32111100 00111 1122222222211 11 1112235678999999999999999999
Q ss_pred HHHhCCCCCC
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 elL~Hpwf~~ 886 (887)
++|.|+|+.+
T Consensus 339 ~A~~~~~~~e 348 (449)
T KOG0664|consen 339 EALQHRYLEE 348 (449)
T ss_pred hhcccccccc
Confidence 9999999753
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=318.35 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=195.0
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCC-CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++|.+++.||.|+||+||+|.+.... ......||||++.... .....+..|+.+|..|. +|+||++++++|
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~niv~~~~~~ 80 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLLGAC 80 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc-----CCccHhhhccee
Confidence 467999999999999999999865322 1234789999997532 22356778999999884 679999999987
Q ss_pred ee-cCeEEEEEecc-hhhHHHHHHHhcc----------------------------------------------------
Q 002732 643 KY-RNHLCLVFESL-HMNLREVLKKFGR---------------------------------------------------- 668 (887)
Q Consensus 643 ~~-~~~~~lV~E~~-~gsL~~~L~~~~~---------------------------------------------------- 668 (887)
.. ...++|||||+ +++|.++|.....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 45689999999 6799998865321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCCc----c
Q 002732 669 ------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----T 732 (887)
Q Consensus 669 ------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~----~ 732 (887)
...+++..+..|+.||+.||.|||++||+|+||||.|||++. .+.++|+|||++........ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcC
Confidence 123688888999999999999999999999999999999985 77899999999876432211 1
Q ss_pred CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccc
Q 002732 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQD 811 (887)
Q Consensus 733 ~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~ 811 (887)
...++..|+|||++.+..++.++||||||||||+|++ |..||........+...+.....
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 300 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------- 300 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-------------------
Confidence 2234567999999999899999999999999999997 99999764332221111100000
Q ss_pred cccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 812 LNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 812 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
...+..++..+.+||..||+.+|.+|||+.+||+|
T Consensus 301 -----------------------------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 -----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00011234578899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.43 Aligned_cols=228 Identities=21% Similarity=0.314 Sum_probs=182.5
Q ss_pred CCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecc-h
Q 002732 578 GVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-H 656 (887)
Q Consensus 578 G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~-~ 656 (887)
|.||.||+|.+..++ +.||||.+..... ...|...+... .||||+++++++...+.+||||||+ +
T Consensus 4 g~~~~v~~~~~~~~~----~~~~~K~i~~~~~----~~~~~~~~~~~------~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTRTQ----QTFILKGLRKSSE----YSRERLTIIPH------CVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEccCC----cEEEEEeecchhh----hhhHHHHHHhc------CCCceeehhhheecCCeEEEEEecCCC
Confidence 899999999998887 8999999976431 22333333333 6899999999999999999999999 5
Q ss_pred hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCCccCccc
Q 002732 657 MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736 (887)
Q Consensus 657 gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~g 736 (887)
++|.+++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++. .+.++|+|||++...... .....+
T Consensus 70 ~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~-~~~~~~ 144 (237)
T cd05576 70 GKLWSHISKFL---NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS-CDGEAV 144 (237)
T ss_pred CCHHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC-CCCEEEecccchhccccc-cccCCc
Confidence 79999987644 3899999999999999999999999999999999999995 778999999987655432 233455
Q ss_pred CCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccccccccccccc
Q 002732 737 SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHA 816 (887)
Q Consensus 737 t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~ 816 (887)
+..|+|||++.+..++.++||||||||+|+|++|..||..... .+. .
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~----------------~~~---------------~-- 191 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS----------------GIN---------------T-- 191 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch----------------hcc---------------c--
Confidence 6779999999888899999999999999999999988732110 000 0
Q ss_pred CcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH-----HHHHhCCCC
Q 002732 817 TEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV-----AQALTHPFI 884 (887)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa-----~elL~Hpwf 884 (887)
.. ....+..++..+.+||.+||+.||.+|||+ +++|.||||
T Consensus 192 -----------------~~----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 -----------------HT----------TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred -----------------cc----------ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 000112345788999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.70 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=193.5
Q ss_pred EeccCCceEEEEEEEcCCC--CCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAG--NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~--~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
.||.|+||.||+|.+.... ......||||.+.... .....+..|+.+|..+ .|+||++++++|.....+|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF------NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc------CCCCeeeEeeeecCCCCeE
Confidence 6899999999999876432 2233679999886543 3345677899999988 8999999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhc----cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC-----eEEEEe
Q 002732 650 LVFESL-HMNLREVLKKFG----RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-----VLKLCD 719 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~----~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----~vKL~D 719 (887)
+||||+ +++|.++|.... ....+++..+..++.||+.||.|||+.+|+|+||+|+||||+. .+ .++|+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE-KGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEec-CCCCCCcceEECC
Confidence 999999 679999987532 1234889999999999999999999999999999999999985 44 799999
Q ss_pred cCcceecCCCCc----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCC
Q 002732 720 FGNAMFAGKNEI----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 720 FG~a~~~~~~~~----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
||++........ .....+..|+|||++.+..++.++||||||||||+|++ |..||...+..+.+..+... ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~-- 231 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR-- 231 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc--
Confidence 999865443221 12234678999999999999999999999999999998 99999766554443322110 00
Q ss_pred hhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
...+..++..+.+||.+||..+|.+||+
T Consensus 232 ----------------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 259 (269)
T cd05044 232 ----------------------------------------------------LQKPENCPDKIYQLMTNCWAQDPSERPT 259 (269)
T ss_pred ----------------------------------------------------cCCcccchHHHHHHHHHHcCCCcccCCC
Confidence 0011234567899999999999999999
Q ss_pred HHHHHh
Q 002732 875 VAQALT 880 (887)
Q Consensus 875 a~elL~ 880 (887)
+.+|++
T Consensus 260 ~~~i~~ 265 (269)
T cd05044 260 FDRIQE 265 (269)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.27 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=197.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|.+++.||+|+||.||+|.....+......||||.+... ......+..|+.+|+.+ .|+||+++++++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~ 78 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL------YHENIVKYKGICTED 78 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC------CCCCeeeeeeEEecC
Confidence 3789999999999999999864433334478999998743 22345678899999999 899999999988875
Q ss_pred --CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 646 --NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 646 --~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
..++|||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||||+|||++. ++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~-~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES-EHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC-CCCEEECCCcc
Confidence 6789999999 679999987642 24899999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCC-----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 723 AMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 723 a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+....... .....++..|+|||++.+..++.++||||||||||+|+++..|+..... .+....++.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~ 230 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQM 230 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccc
Confidence 97654322 1234456779999999998999999999999999999998776532111 1111111111000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
... ..+ ..+..... ...+..++..+.+||.+||+.+|.+|||+.+
T Consensus 231 -----------------------~~~-~~~-~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 275 (284)
T cd05079 231 -----------------------TVT-RLV-RVLEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN 275 (284)
T ss_pred -----------------------cHH-HHH-HHHHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 000 001 11111000 1112345678999999999999999999999
Q ss_pred HHhC
Q 002732 878 ALTH 881 (887)
Q Consensus 878 lL~H 881 (887)
||.+
T Consensus 276 il~~ 279 (284)
T cd05079 276 LIEG 279 (284)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=306.43 Aligned_cols=241 Identities=19% Similarity=0.281 Sum_probs=186.6
Q ss_pred EeccCCceEEEEEEEcCCCC---CCCcEEEEEEecccc-hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGN---GEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~---~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
.||.|+||+||+|.+...+. .....||+|++.... ...+.+..|+.+|+.+ .|+||+.++++|......+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~------~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL------SHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC------CCCChhheeeEEEeCCCcE
Confidence 68999999999998765431 123458888876543 2335667888888888 8999999999999999999
Q ss_pred EEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC-------eEEEEecC
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-------VLKLCDFG 721 (887)
Q Consensus 650 lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------~vKL~DFG 721 (887)
|||||+ +++|..+|..... .+++..+..++.||+.||.|||++||+|+||||.|||++..+. .++|+|||
T Consensus 76 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999 5689999876432 4899999999999999999999999999999999999975333 37999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHHHcCC-CCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGK-VLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~elltG~-~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
++...... ....+++.|+|||++.+. .++.++|||||||+||+|++|. +||............ .....
T Consensus 154 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~------- 223 (258)
T cd05078 154 ISITVLPK--EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDRHQ------- 223 (258)
T ss_pred cccccCCc--hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcccc-------
Confidence 98655432 334678889999999874 5899999999999999999984 666443332221110 00000
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+...+.++.+||.+||+.||.+|||+.+||
T Consensus 224 -------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 254 (258)
T cd05078 224 -------------------------------------------------LPAPKWTELANLINQCMDYEPDFRPSFRAII 254 (258)
T ss_pred -------------------------------------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHH
Confidence 0111235688999999999999999999998
Q ss_pred hC
Q 002732 880 TH 881 (887)
Q Consensus 880 ~H 881 (887)
+.
T Consensus 255 ~~ 256 (258)
T cd05078 255 RD 256 (258)
T ss_pred Hh
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.12 Aligned_cols=238 Identities=21% Similarity=0.251 Sum_probs=186.9
Q ss_pred EeccCCceEEEEEEEcCCC------CCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 574 AHGKGVFSTVVRAKDLKAG------NGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~------~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
.||.|+||.||+|.+..++ ......|++|++.........+..|+.+|..+ .|+||+.+++++.. ..
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL------SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC------CCcchhheeeEEec-CC
Confidence 6899999999999987654 22224588888776544356778899999888 89999999999888 77
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC-------eEEEEe
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-------VLKLCD 719 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------~vKL~D 719 (887)
.+|||||+ +++|.+++..... .+++..+..++.||+.||.|||++||+|+||||.|||++. .+ .++|+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR-YGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEec-CccccCCceeEEeCC
Confidence 89999999 6799999886442 4899999999999999999999999999999999999985 44 699999
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||............. ....
T Consensus 152 fg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~---- 224 (259)
T cd05037 152 PGIPITVLS--REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHR---- 224 (259)
T ss_pred CCccccccc--ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCC----
Confidence 999976544 2234566789999999877 78999999999999999999 577775543221111000 0000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+. .....+.+||.+||..+|.+|||+.
T Consensus 225 -------------------------------------------------~~~---~~~~~~~~li~~~l~~~p~~Rpt~~ 252 (259)
T cd05037 225 -------------------------------------------------LPM---PDCAELANLINQCWTYDPTKRPSFR 252 (259)
T ss_pred -------------------------------------------------CCC---CCchHHHHHHHHHhccChhhCCCHH
Confidence 000 0015788999999999999999999
Q ss_pred HHHh
Q 002732 877 QALT 880 (887)
Q Consensus 877 elL~ 880 (887)
+||+
T Consensus 253 ~il~ 256 (259)
T cd05037 253 AILR 256 (259)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.07 Aligned_cols=241 Identities=17% Similarity=0.175 Sum_probs=182.9
Q ss_pred EeccCCceEEEEEEEcCCC--------CCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 574 AHGKGVFSTVVRAKDLKAG--------NGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~--------~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.||.|+||+||+|...... ......||||++..... ....+..|+.+|..+ .||||+++++++..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l------~hp~iv~~~~~~~~ 75 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV------SHKHIVLLYGVCVR 75 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC------CCCCEeeEEEEEec
Confidence 6899999999999853321 11234689998765322 234667788888888 89999999999999
Q ss_pred cCeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC------eEEE
Q 002732 645 RNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN------VLKL 717 (887)
Q Consensus 645 ~~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~------~vKL 717 (887)
....+|||||+. ++|..++.... ..+++..++.|+.||+.||.|||+.||||+||||.||||+..+. .++|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999994 67777766432 34899999999999999999999999999999999999974221 3899
Q ss_pred EecCcceecCCCCccCcccCCcccchhhhc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 718 CDFGNAMFAGKNEITPYLVSRFYRAPEIIL-GLPYDHPLDIWSVGCCLYELY-TGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 718 ~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~-~~~~s~~sDIwSLG~iL~ell-tG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
+|||++...... ....++..|+|||++. +..++.++|||||||+||+|+ +|..||......+... +... .+
T Consensus 154 ~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~--~~-- 226 (262)
T cd05077 154 SDPGIPITVLSR--QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG--QC-- 226 (262)
T ss_pred CCCCCCccccCc--ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc--Cc--
Confidence 999998654322 2346778899999987 457899999999999999998 5888886543222111 0000 00
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
......+..+.+||.+||+.||.+|||+
T Consensus 227 ----------------------------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~ 254 (262)
T cd05077 227 ----------------------------------------------------MLVTPSCKELADLMTHCMNYDPNQRPFF 254 (262)
T ss_pred ----------------------------------------------------cCCCCChHHHHHHHHHHcCCChhhCcCH
Confidence 0001123568899999999999999999
Q ss_pred HHHHhC
Q 002732 876 AQALTH 881 (887)
Q Consensus 876 ~elL~H 881 (887)
.+||.+
T Consensus 255 ~~il~~ 260 (262)
T cd05077 255 RAIMRD 260 (262)
T ss_pred HHHHHh
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.60 Aligned_cols=238 Identities=23% Similarity=0.300 Sum_probs=191.6
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
+||.|+||.||+|.+.. + ..||||++..... ....+..|+.+++.+ .|++|+.+++++.....+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~-~----~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-N----TEVAVKTCRSTLPPDLKRKFLQEAEILKQY------DHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred ccccCCCceEEEEEEeC-C----CcEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCeEEEEEEEecCCCeEEE
Confidence 68999999999999866 5 6899998875432 345678899999998 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~ 730 (887)
|||+ +++|.+++.... ..+++..+..++.+|+.||.|||+.+|+|+||+|+||||+. .+.++|+|||++.......
T Consensus 71 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 71 MELVPGGSLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EEcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC-CCcEEEeeccccccccCCc
Confidence 9999 678999887643 24899999999999999999999999999999999999984 7889999999987654322
Q ss_pred cc----CcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccc
Q 002732 731 IT----PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTD 805 (887)
Q Consensus 731 ~~----~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~ 805 (887)
.. ....+..|+|||++.+..++.++||||||||+|+|++ |..||...........+.... .
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~------------- 213 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-R------------- 213 (251)
T ss_pred ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-C-------------
Confidence 11 1122456999999998899999999999999999998 889997665433332221100 0
Q ss_pred cccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 806 QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 806 ~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...+..++..+.+||.+||..+|.+|||+.+||+
T Consensus 214 -----------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -----------------------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----------------------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0011223467899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.47 Aligned_cols=244 Identities=24% Similarity=0.281 Sum_probs=190.4
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||.|+||.||+|.+..++ ....+|+|.+... ......+..|+.++..+. .||||++++++|...+.+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-----~h~~iv~~~~~~~~~~~~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCCC--CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc-----cCCCeeeEEEEEecCCCceEE
Confidence 5899999999999987655 1235788888742 223456778999998884 689999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhc-------------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 652 FESL-HMNLREVLKKFG-------------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~-------------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
|||+ +++|.++|.... ....+++..++.++.||+.||.|||+.||+|+||||+|||++. ++.++|
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~-~~~~kl 153 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKI 153 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC-CCeEEE
Confidence 9999 679999987632 1124889999999999999999999999999999999999984 788999
Q ss_pred EecCcceecCCCC-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 718 CDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 718 ~DFG~a~~~~~~~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
+|||++....... ......+..|+|||++.+..++.++|||||||+||+|++ |..||.+.+..+.+..+... +
T Consensus 154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~-- 228 (270)
T cd05047 154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---Y-- 228 (270)
T ss_pred CCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC---C--
Confidence 9999985322111 111223556999999998899999999999999999997 99999766544433322100 0
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
....+..++..+.+||.+||..+|.+|||+
T Consensus 229 --------------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 258 (270)
T cd05047 229 --------------------------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSF 258 (270)
T ss_pred --------------------------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence 000011234678899999999999999999
Q ss_pred HHHHh
Q 002732 876 AQALT 880 (887)
Q Consensus 876 ~elL~ 880 (887)
.+||.
T Consensus 259 ~~il~ 263 (270)
T cd05047 259 AQILV 263 (270)
T ss_pred HHHHH
Confidence 99986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=297.08 Aligned_cols=239 Identities=22% Similarity=0.312 Sum_probs=191.1
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
+||.|+||.||+|... .+ ..||+|++..... ....+..|+.++..+ .|+||++++++|.....++||
T Consensus 2 ~ig~g~~g~vy~~~~~-~~----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DK----TPVAVKTCKEDLPQELKIKFLSEARILKQY------DHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred ccCCCCCceEEEEEec-CC----cEEEEEecCCcCCHHHHHHHHHHHHHHHhC------CCCCcCeEEEEEecCCccEEE
Confidence 6899999999999854 33 6899999875422 234577899999988 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~ 730 (887)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||+.||+|+||+|+||||+. .+.++|+|||++.......
T Consensus 71 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 71 MELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred EECCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC-CCeEEECCCccceeccccc
Confidence 9999 679998886533 34899999999999999999999999999999999999984 7789999999986544322
Q ss_pred c---cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccccc
Q 002732 731 I---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806 (887)
Q Consensus 731 ~---~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~ 806 (887)
. ....+++.|+|||++.+..++.++|||||||+||+|++ |..||...........+... +
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~------------- 211 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---Y------------- 211 (250)
T ss_pred cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 1 11233567999999998899999999999999999998 99999776554433322110 0
Q ss_pred ccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 807 ~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
....+..++..+.+||.+||..+|.+|||+.+|++.
T Consensus 212 ---------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 ---------------------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ---------------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 000112244678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.57 Aligned_cols=242 Identities=21% Similarity=0.340 Sum_probs=194.3
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
+.|.+...||+|+||.||++.. ++ ..||||++.... ....+..|+.+|..+ .|+||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~----~~~~iK~~~~~~-~~~~~~~e~~~l~~~------~~~~i~~~~~~~~~~- 71 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TG----QKVAVKNIKCDV-TAQAFLEETAVMTKL------HHKNLVRLLGVILHN- 71 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CC----CceEEEeecCcc-hHHHHHHHHHHHHhC------CCCCcCeEEEEEcCC-
Confidence 4599999999999999999864 33 579999987543 345678899999998 899999999988764
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++. ++.++|+|||++..
T Consensus 72 ~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~ 149 (254)
T cd05083 72 GLYIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE-DGVAKVSDFGLARV 149 (254)
T ss_pred CcEEEEECCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC-CCcEEECCCcccee
Confidence 479999999 5799999976432 34899999999999999999999999999999999999985 78899999999876
Q ss_pred cCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 726 AGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 726 ~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
.... ......+..|+|||++.+..++.++|||||||++|+|++ |.+||......+....+....
T Consensus 150 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------- 214 (254)
T cd05083 150 GSMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-------------- 214 (254)
T ss_pred cccc-CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC--------------
Confidence 4332 222334567999999998899999999999999999997 999997665544332221100
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
.+.....++..+.+||.+||..+|..|||+.+|+.
T Consensus 215 -----------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 -----------------------------------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -----------------------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011234577899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=299.68 Aligned_cols=240 Identities=20% Similarity=0.280 Sum_probs=188.5
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||.|+||.||+|.+.... ....||||++..... ....+..|+.+|+.| .|+||+++++++.. ..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~--~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l------~h~~ii~~~~~~~~-~~~~lv 72 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQL------DNPYIVRMIGVCEA-EALMLV 72 (257)
T ss_pred ccCCCCcccEEEEEEecCC--CceeEEEEEcccccChHHHHHHHHHHHHHHhc------CCCCeEEEEEEEcC-CCeEEE
Confidence 3899999999999765322 125699999875432 235578899999999 89999999998764 578999
Q ss_pred Eecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC
Q 002732 652 FESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~ 730 (887)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||.|||++. ++.+||+|||++.......
T Consensus 73 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 73 MEMASGGPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADD 149 (257)
T ss_pred EEeCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC-CCcEEeccCCccccccCCc
Confidence 9999 67999888753 235899999999999999999999999999999999999984 7889999999987543321
Q ss_pred -----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccccc
Q 002732 731 -----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFT 804 (887)
Q Consensus 731 -----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~ 804 (887)
.+...+++.|+|||++.+..++.++||||||||||+|++ |..||......+.+..+.... .
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------ 216 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------ 216 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C------------
Confidence 111223567999999998889999999999999999996 999997765544433221110 0
Q ss_pred ccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 805 DQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 805 ~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
+..++.++.++.+||.+||.++|..||++.+|++
T Consensus 217 ------------------------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ------------------------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ------------------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011233578899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.48 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=186.2
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||.|+||+||+|..... .....||||.+.... .....+.+|+.+++.+ .|+||++++++|.....+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG--MSKARVVVKELRASATPDEQLLFLQEVQPYREL------NHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred cCCccCCceEEEEEEecC--CCCeEEEEeecCccCChHHHHHHHHHHHHHHhC------CCCCcceEEEEECCCCceEEE
Confidence 589999999999975432 123578999876432 2234567888888888 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 652 FESL-HMNLREVLKKFGR--NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~--~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||+ +++|.++|..... ...+++..+..++.||+.||.|||++||+|+||||.||||+. ++.+||+|||++.....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYP 152 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC-CCcEEEecccccccccc
Confidence 9999 5799999977432 123567888999999999999999999999999999999995 78899999999865332
Q ss_pred CC----ccCcccCCcccchhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhC-CCCh
Q 002732 729 NE----ITPYLVSRFYRAPEIILG-------LPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKG-PFPK 795 (887)
Q Consensus 729 ~~----~~~~~gt~~Y~aPE~l~~-------~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g-~~p~ 795 (887)
.. .....+++.|+|||++.. ..++.++|||||||+||+|++ |.+||......+.+..+..... .+|
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~- 231 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP- 231 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCC-
Confidence 21 122334567999999743 357889999999999999999 8889977665554443322110 000
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.+.....++..+..++..|+ .||.+|||+
T Consensus 232 --------------------------------------------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~ 260 (269)
T cd05042 232 --------------------------------------------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTA 260 (269)
T ss_pred --------------------------------------------------CCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence 01112234567788898888 599999999
Q ss_pred HHHHh
Q 002732 876 AQALT 880 (887)
Q Consensus 876 ~elL~ 880 (887)
.+|+.
T Consensus 261 ~~v~~ 265 (269)
T cd05042 261 EEVHE 265 (269)
T ss_pred HHHHH
Confidence 99976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.14 Aligned_cols=262 Identities=18% Similarity=0.262 Sum_probs=213.9
Q ss_pred eecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcc
Q 002732 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRH 634 (887)
Q Consensus 557 ~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~ 634 (887)
+...+.++......++++||+|.||.|.+|.... +.+||||+++... .....|..|+.+|.+| .|||
T Consensus 528 k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL------khPN 596 (807)
T KOG1094|consen 528 KGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDATKNARNDFLKEIKILSRL------KHPN 596 (807)
T ss_pred cCcchhhcchhheehhhhhcCcccceeEEEEecC-----ceEEEEeecCcccchhHHHHHHHHHHHHhcc------CCCC
Confidence 3445566667789999999999999999998543 2689999998653 3347889999999999 9999
Q ss_pred eeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC
Q 002732 635 CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 635 Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 713 (887)
|+.|+++|...+.+|||+||| .|+|.++|.....+. +.-.....|+.||+.||.||.+++||||||.+.|||++ ...
T Consensus 597 IveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~-~e~ 674 (807)
T KOG1094|consen 597 IVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD-GEF 674 (807)
T ss_pred eeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeec-Ccc
Confidence 999999999999999999999 789999998865432 34455667999999999999999999999999999999 488
Q ss_pred eEEEEecCcceecCCCCccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHH
Q 002732 714 VLKLCDFGNAMFAGKNEITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT--GKVLFPGATNNDMLRLHM 787 (887)
Q Consensus 714 ~vKL~DFG~a~~~~~~~~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt--G~~PF~~~~~~~~l~~i~ 787 (887)
++||+|||+++-+....+... +-.+.|||||.|+.+++++++|||+||++|||+++ ...||...++.+.+.+.-
T Consensus 675 ~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~ 754 (807)
T KOG1094|consen 675 TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG 754 (807)
T ss_pred cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh
Confidence 999999999986555544332 34678999999999999999999999999999987 678998887777766554
Q ss_pred HhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhccc
Q 002732 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVL 867 (887)
Q Consensus 788 ~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~ 867 (887)
+++...+... .+..++-++..+..||..||..
T Consensus 755 ~~~~~~~~~~------------------------------------------------~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 755 EFFRDQGRQV------------------------------------------------VLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred hhcCCCCcce------------------------------------------------eccCCCcCcHHHHHHHHHHhch
Confidence 4433322111 1223445567888999999999
Q ss_pred CCCCCcCHHHHH
Q 002732 868 DPEKRMTVAQAL 879 (887)
Q Consensus 868 DP~~RpTa~elL 879 (887)
+-.+||+.++|.
T Consensus 787 es~~RPsFe~lh 798 (807)
T KOG1094|consen 787 ESEQRPSFEQLH 798 (807)
T ss_pred hhhcCCCHHHHH
Confidence 999999999983
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=297.21 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=203.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh----HHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~----~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+.|.++.+||.|+|+.|.++..+.+. +.||+|++++..... +-.+.|..++.+.. +||.+|.|+.+|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~----qiyamkvvkkel~nddedidwvqtek~vfe~as-----n~pflvglhscf 320 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTD----QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NNPFLVGLHSCF 320 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccc----eeeehhhHHHHhcCCcccchhHHhhHHHHHhcc-----CCCeEEehhhhh
Confidence 46999999999999999999999887 899999998643222 22355666666653 899999999999
Q ss_pred eecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++...+++|.||+ +|+|.-.++...+ |++..++.|...|+.||.|||+.|||++|||..||||+ +.++|||+|+|
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld-aeghikltdyg 396 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD-AEGHIKLTDYG 396 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc-cCCceeecccc
Confidence 9999999999999 6677766666443 99999999999999999999999999999999999999 58999999999
Q ss_pred cceec--CCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHHhhCCCChhh
Q 002732 722 NAMFA--GKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT--NNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~--~~~~l~~i~~~~g~~p~~~ 797 (887)
++.-. ......++|||+.|+|||++.|..|++.+|||+|||+||||+.|..||.... +.+
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d---------------- 460 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD---------------- 460 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----------------
Confidence 98542 2334677999999999999999999999999999999999999999996321 110
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC---
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT--- 874 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT--- 874 (887)
..+...+.++|... ..-.+..++..+..+|...|+.||..|+.
T Consensus 461 -----------------------~ntedylfqvilek-----------qiriprslsvkas~vlkgflnkdp~erlgc~~ 506 (593)
T KOG0695|consen 461 -----------------------MNTEDYLFQVILEK-----------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRP 506 (593)
T ss_pred -----------------------cchhHHHHHHHhhh-----------cccccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence 01111122222111 11123344566678899999999999974
Q ss_pred ---HHHHHhCCCCC
Q 002732 875 ---VAQALTHPFIS 885 (887)
Q Consensus 875 ---a~elL~Hpwf~ 885 (887)
..++-.||||.
T Consensus 507 ~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 507 QTGFSDIKSHAFFR 520 (593)
T ss_pred ccchhhhhcchhhh
Confidence 57888999985
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.81 Aligned_cols=241 Identities=20% Similarity=0.243 Sum_probs=183.0
Q ss_pred EeccCCceEEEEEEEcCCC--------------------CCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCC
Q 002732 574 AHGKGVFSTVVRAKDLKAG--------------------NGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENK 632 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~--------------------~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h 632 (887)
+||+|+||.||++....++ ......||||++..... ....+..|+.++..+ .|
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l------~h 75 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV------SH 75 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC------CC
Confidence 6899999999999753221 11224589998865432 234566777888877 89
Q ss_pred cceeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC
Q 002732 633 RHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 633 ~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~ 711 (887)
+||++++++|......||||||+ +++|..++.... ..+++..+..|+.||+.||.|||+.||+|+||||.||||+..
T Consensus 76 ~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 76 IHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred CCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 99999999999999999999999 568888876532 348999999999999999999999999999999999999742
Q ss_pred ------CCeEEEEecCcceecCCCCccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHH
Q 002732 712 ------KNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELY-TGKVLFPGATNNDML 783 (887)
Q Consensus 712 ------~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~ell-tG~~PF~~~~~~~~l 783 (887)
...++|+|||++...... ....++..|+|||++.+ ..++.++|||||||+||+|+ +|..||.+....+..
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred CcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 124899999988543322 23356788999999876 46899999999999999995 699999765443322
Q ss_pred HHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHH
Q 002732 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863 (887)
Q Consensus 784 ~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~k 863 (887)
..+ .....+ +......+.+||.+
T Consensus 232 ~~~-~~~~~~--------------------------------------------------------~~~~~~~~~~li~~ 254 (274)
T cd05076 232 RFY-EKKHRL--------------------------------------------------------PEPSCKELATLISQ 254 (274)
T ss_pred HHH-HhccCC--------------------------------------------------------CCCCChHHHHHHHH
Confidence 111 000000 00122467899999
Q ss_pred hcccCCCCCcCHHHHHhC
Q 002732 864 IFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 864 mL~~DP~~RpTa~elL~H 881 (887)
||+.+|.+|||+.+||++
T Consensus 255 cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 255 CLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HcccChhhCcCHHHHHHh
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=300.95 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=194.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee-
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY- 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~- 644 (887)
..|.+++.||.|+||+||+|.........+..||||.+..... ....+..|+.+|..| .|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 77 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL------QHDNIVKYKGVCYSA 77 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC------CCCCeeEEEEEEccC
Confidence 3599999999999999999975432222347899999875432 245678899999998 89999999987654
Q ss_pred -cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 -RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 -~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
...+||||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||||+. ++.++|+|||+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~-~~~~~l~dfg~ 154 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES-ENRVKIGDFGL 154 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC-CCeEEECCCcc
Confidence 35789999999 679999987642 24899999999999999999999999999999999999985 77899999999
Q ss_pred ceecCCCCc-----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 723 AMFAGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 723 a~~~~~~~~-----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+........ ....++..|+|||++.+..++.++||||||||||+|++|..|+..... ..+. ..+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~----~~~~~~~-- 227 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMR----MMGNDKQ-- 227 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhh----hcccccc--
Confidence 976543221 112234569999999998999999999999999999998877643221 1110 0000000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
.......+..++.... .......++..+.+||.+||..+|.+|||+.+
T Consensus 228 ----------------------~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 275 (284)
T cd05081 228 ----------------------GQMIVYHLIELLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSE 275 (284)
T ss_pred ----------------------cccchHHHHHHHhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 0000000111111100 01112345578999999999999999999999
Q ss_pred HHhC
Q 002732 878 ALTH 881 (887)
Q Consensus 878 lL~H 881 (887)
|+..
T Consensus 276 i~~~ 279 (284)
T cd05081 276 LALQ 279 (284)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=299.07 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=195.2
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-----------hhhHHHHHHHHHHHHhhCCCCCCCcceeE
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-----------TMNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-----------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
|.+...||.|+||.||+|.+..++ ...||||.+.... .....+..|+.++... ..|+||+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~---~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~ 73 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNG---QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ-----LRHPNIVR 73 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCC---CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc-----CCCCCeee
Confidence 888999999999999999987622 2789999885321 1112344566666542 18999999
Q ss_pred ecceeeecCeEEEEEecc-hhhHHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCe
Q 002732 638 FASSFKYRNHLCLVFESL-HMNLREVLKKF-GRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 638 l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~-~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~ 714 (887)
++++|...+++||||||+ +++|.+++... .....+++..++.++.||+.||.|||. .+|+|+||+|.|||++. .+.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~ 152 (269)
T cd08528 74 YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDK 152 (269)
T ss_pred EEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCc
Confidence 999999999999999999 56898888653 223459999999999999999999996 78999999999999985 778
Q ss_pred EEEEecCcceecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCC
Q 002732 715 LKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 715 vKL~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
++|+|||++...... ......++..|+|||++.+..++.++|||||||++|+|++|.+||...........+......
T Consensus 153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 231 (269)
T cd08528 153 VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE- 231 (269)
T ss_pred EEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC-
Confidence 999999999765544 344567788999999999988999999999999999999999999655443332222111000
Q ss_pred ChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCc
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+.....++..+.+||.+||+.||..||
T Consensus 232 -----------------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp 258 (269)
T cd08528 232 -----------------------------------------------------PLPEGMYSEDVTDVITSCLTPDAEARP 258 (269)
T ss_pred -----------------------------------------------------cCCcccCCHHHHHHHHHHCCCCCccCC
Confidence 000112346789999999999999999
Q ss_pred CHHHHHhC
Q 002732 874 TVAQALTH 881 (887)
Q Consensus 874 Ta~elL~H 881 (887)
|+.|+..+
T Consensus 259 ~~~e~~~~ 266 (269)
T cd08528 259 DIIQVSAM 266 (269)
T ss_pred CHHHHHHH
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.59 Aligned_cols=246 Identities=19% Similarity=0.295 Sum_probs=187.2
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||+|+||.||+|.+.... ....+|+|.+..... ....+..|+.++..| .|+||++++++|.....+|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGY--TPAQVVVKELRVSASVQEQMKFLEEAQPYRSL------QHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred cccccCCceEEEEEEcCCC--CceEEEEEecCCCCChHHHHHHHHHHHHHHhC------CCCCEeeEEEEEcCCCCcEEE
Confidence 5899999999999865422 236799998875432 234677899999999 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 652 FESL-HMNLREVLKKFGR--NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~--~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||+ +++|.++|..... ...+++..+..++.||+.||.|||+.+|+|+||||.|||++. .+.++|+|||++.....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYK 152 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC-CCcEEECCccccccccC
Confidence 9999 5799999876432 224677788899999999999999999999999999999985 78899999999865433
Q ss_pred CC----ccCcccCCcccchhhhcCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHh-hCCCCh
Q 002732 729 NE----ITPYLVSRFYRAPEIILGL-------PYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMEL-KGPFPK 795 (887)
Q Consensus 729 ~~----~~~~~gt~~Y~aPE~l~~~-------~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~-~g~~p~ 795 (887)
.. .....+++.|+|||++.+. .++.++|||||||+||+|++ |.+||......+.+...... ...++
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 231 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP- 231 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCC-
Confidence 22 1234567789999998642 36889999999999999996 99999776554443222110 00000
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.+.....++..+.+||..|+ .+|.+|||+
T Consensus 232 --------------------------------------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~ 260 (269)
T cd05087 232 --------------------------------------------------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSA 260 (269)
T ss_pred --------------------------------------------------CCccCCCCChHHHHHHHHHh-cCcccCCCH
Confidence 00011123456889999998 689999999
Q ss_pred HHHHh
Q 002732 876 AQALT 880 (887)
Q Consensus 876 ~elL~ 880 (887)
.+|+.
T Consensus 261 ~~l~~ 265 (269)
T cd05087 261 EEVHL 265 (269)
T ss_pred HHHHH
Confidence 99975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.18 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=200.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||.|+||.||+|.....+......||||++..... ....+..|+.+++.+ .|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l------~~~~i~~~~~~~~~ 77 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL------DHENIVKYKGVCEK 77 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC------CCCChheEEeeeec
Confidence 3588889999999999999987654333457899999986544 356788999999998 89999999999887
Q ss_pred --cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 645 --RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 645 --~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
...++|||||+ +++|.+++..... .+++..+..++.||+.||.|||++||+|+||+|.|||++. ++.++|+|||
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg 154 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES-EDLVKISDFG 154 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC-CCCEEEcccc
Confidence 56899999999 6799999976432 4899999999999999999999999999999999999985 7889999999
Q ss_pred cceecCCCCc-----cCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 722 NAMFAGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 722 ~a~~~~~~~~-----~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
++........ ....++..|+|||++.+..++.++|||||||+||+|++|..||....... +...+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~-- 227 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQ-- 227 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccc--
Confidence 9977653211 12234556999999998899999999999999999999999985432211 00000000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.......+..++..... ...+..++.++.+||.+||..+|.+|||+.
T Consensus 228 -----------------------~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 274 (284)
T cd05038 228 -----------------------GQMIVTRLLELLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFA 274 (284)
T ss_pred -----------------------ccccHHHHHHHHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHH
Confidence 00001111111111100 011223457899999999999999999999
Q ss_pred HHHh
Q 002732 877 QALT 880 (887)
Q Consensus 877 elL~ 880 (887)
+|++
T Consensus 275 ei~~ 278 (284)
T cd05038 275 DLIL 278 (284)
T ss_pred HHHH
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.91 Aligned_cols=243 Identities=19% Similarity=0.228 Sum_probs=185.7
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee-ecCeEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK-YRNHLCL 650 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~-~~~~~~l 650 (887)
.||.|+||+||+|.+.... .....||||.+... ......+..|+.+++.+ .||||+++++++. ..+..++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSD-GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF------SHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred cccccCCceEEEEEEecCC-CceEEEEEEecCccCCHHHHHHHHHHHHHHccC------CCCCcceEEEEeecCCCCcEE
Confidence 6899999999999875432 22357999988542 22345667888888888 8999999999765 4566899
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
||||+ +++|.+++..... .+++..+..++.||+.||.|||+.+|+|+||+|+||||+. .+.+||+|||++......
T Consensus 75 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK 151 (262)
T ss_pred EEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence 99999 6799999876432 3677888999999999999999999999999999999985 778999999998654322
Q ss_pred C------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 730 E------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 730 ~------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
. .....++..|+|||++.+..++.++|||||||+||+|++ |.+||......+....+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC---------
Confidence 1 122344667999999998899999999999999999999 56777655443332221100 00
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhC
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~H 881 (887)
+..+..++..+.+||.+||..+|.+||++.+||..
T Consensus 221 --------------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --------------------------------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --------------------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00011234678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=312.60 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=207.2
Q ss_pred cccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--------hhhHHHHHHHHHHHHhhCCCCC
Q 002732 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--------TMNKAGQTEVQILKKLAGADPE 630 (887)
Q Consensus 559 ~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--------~~~~~~~~Ei~iL~~L~~~~~~ 630 (887)
|.-...++.+|-++.+||.|+|+.||+|.|+... .+|||||-..+. .+.+-...|..|.+.|
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~Eq----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL------ 524 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQ----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL------ 524 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchh----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc------
Confidence 3445568899999999999999999999998877 899999976443 2334556788999888
Q ss_pred CCcceeEecceeeec-CeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhcc--ceeccCCCCCCc
Q 002732 631 NKRHCIRFASSFKYR-NHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC--GVLHCDIKPDNM 706 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~-~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~--gIvHrDLKP~NI 706 (887)
.||.||++|++|... ..+|-|+|||.| +|.-+|+... -+++.+++.|+.||+.||.||... .|||-||||.||
T Consensus 525 DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNI 601 (775)
T KOG1151|consen 525 DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNI 601 (775)
T ss_pred CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccE
Confidence 999999999999875 579999999965 6766776543 399999999999999999999965 699999999999
Q ss_pred cccCC--CCeEEEEecCcceecCCCC---------ccCcccCCcccchhhhcCC----CCCchhhHHHHHHHHHHHHcCC
Q 002732 707 LVNEA--KNVLKLCDFGNAMFAGKNE---------ITPYLVSRFYRAPEIILGL----PYDHPLDIWSVGCCLYELYTGK 771 (887)
Q Consensus 707 Ll~~~--~~~vKL~DFG~a~~~~~~~---------~~~~~gt~~Y~aPE~l~~~----~~s~~sDIwSLG~iL~elltG~ 771 (887)
||-.+ -+.|||+|||++.++.... ...+.||.||+|||++.-. ..+.++||||+|||+|.+|.|.
T Consensus 602 LLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGr 681 (775)
T KOG1151|consen 602 LLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGR 681 (775)
T ss_pred EEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccC
Confidence 99632 3579999999998876433 2346789999999998643 3789999999999999999999
Q ss_pred CCCCCCChH-HHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCC
Q 002732 772 VLFPGATNN-DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850 (887)
Q Consensus 772 ~PF~~~~~~-~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 850 (887)
.||...... ++|+... .+ +...+ .+| .-
T Consensus 682 KPFGhnqsQQdILqeNT----Il-----------------------------------------kAtEV-----qFP-~K 710 (775)
T KOG1151|consen 682 KPFGHNQSQQDILQENT----IL-----------------------------------------KATEV-----QFP-PK 710 (775)
T ss_pred CCCCCchhHHHHHhhhc----hh-----------------------------------------cceec-----cCC-CC
Confidence 999654322 2221110 00 00000 011 12
Q ss_pred hhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 851 ~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
|.++.++++||+.||++--.+|+.+.+|..||||.
T Consensus 711 PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 711 PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred CccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 45678999999999999999999999999999984
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=304.71 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=194.9
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||.|+||.||+|.+..++......||||++..... ....+..|+.++..+ .|+||++++++|..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~h~niv~~~~~~~~ 80 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM------DHPHLVRLLGVCLS 80 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC------CCCCcccEEEEEcC
Confidence 4589999999999999999998777643334689998875422 223567888888888 89999999998875
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
. ..++|++|+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||++. .+.+||+|||++
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~-~~~~kL~Dfg~~ 156 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS-PNHVKITDFGLA 156 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC-CCceEEcccccc
Confidence 4 467899999 578999887643 24899999999999999999999999999999999999984 678999999999
Q ss_pred eecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 724 MFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
....... .....++..|+|||++.+..++.++|||||||+||+|++ |..||.+.........+ .....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~----- 230 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL----- 230 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC-----
Confidence 7654322 122334668999999999999999999999999999997 99999765433322211 110000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
..++.++..+.+||..||..+|..||++.+|
T Consensus 231 -------------------------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 231 -------------------------------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 0011233577899999999999999999998
Q ss_pred HhC
Q 002732 879 LTH 881 (887)
Q Consensus 879 L~H 881 (887)
++.
T Consensus 262 ~~~ 264 (303)
T cd05110 262 AAE 264 (303)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=335.87 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=191.2
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+...|+.+.+||+||||.||+|+++-+| ..||||.|... ......+..|+.+|.+| +|||||+++..|
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDG----r~YAIKKIpl~~s~~~~skI~rEVk~LArL------nHpNVVRYysAW 546 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDG----REYAIKKIPLKASDKLYSKILREVKLLARL------NHPNVVRYYSAW 546 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccc----hhhhhhhccCchHHHHHHHHHHHHHHHhhc------CCcceeeeehhh
Confidence 3456999999999999999999999888 89999999765 33345667899999999 999999987332
Q ss_pred e------------------------------------------------------------------e------------
Q 002732 643 K------------------------------------------------------------------Y------------ 644 (887)
Q Consensus 643 ~------------------------------------------------------------------~------------ 644 (887)
. .
T Consensus 547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded 626 (1351)
T KOG1035|consen 547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED 626 (1351)
T ss_pred hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence 0 0
Q ss_pred ---------------------------------c--------CeEEEEEecchhhHHHHHHHhccCCCC-CHHHHHHHHH
Q 002732 645 ---------------------------------R--------NHLCLVFESLHMNLREVLKKFGRNIGL-KLTAVRAYAK 682 (887)
Q Consensus 645 ---------------------------------~--------~~~~lV~E~~~gsL~~~L~~~~~~~~l-s~~~~~~i~~ 682 (887)
. -.+||-||||..+|...+...+. .+ ....+|.+++
T Consensus 627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFr 704 (1351)
T KOG1035|consen 627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFR 704 (1351)
T ss_pred ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHH
Confidence 0 24789999996655544444332 12 4778999999
Q ss_pred HHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC--------------------CCCccCcccCCcccc
Q 002732 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--------------------KNEITPYLVSRFYRA 742 (887)
Q Consensus 683 qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~--------------------~~~~~~~~gt~~Y~a 742 (887)
+|+.||.|||++|||||||||.||||+ ..+.|||+|||+|+... ....|..+||..|+|
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999999999999999999999 48889999999996511 112466789999999
Q ss_pred hhhhcCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCC-hHHHHHHHHHhhCCCChhhhhcccccccccccccccccCc
Q 002732 743 PEIILGLP---YDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATE 818 (887)
Q Consensus 743 PE~l~~~~---~s~~sDIwSLG~iL~elltG~~PF~~~~-~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~ 818 (887)
||++.+.. |+.++||||||||||||+. ||...- -..++..+- .|.+|..- .+|
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~--------~f~---------- 840 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPA--------DFF---------- 840 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCc--------ccc----------
Confidence 99998765 9999999999999999996 674322 222333222 23333210 000
Q ss_pred CChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 819 EDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
.+.+ +.-..+|++||+.||.+||||.|+|++.||-
T Consensus 841 -------------------------------~~~~-~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 841 -------------------------------DPEH-PEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -------------------------------cccc-hHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 1112 2235899999999999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=315.21 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=205.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
...+..+||.|.||.||.|....-..+...-||||.++.+ ....+.|..|..||+.+ .||||++|+|+|..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf------dHphIikLIGv~~e- 462 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF------DHPHIIKLIGVCVE- 462 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC------CCcchhheeeeeec-
Confidence 3556678999999999999876654445567999999873 33467889999999999 99999999999876
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..++||||.+ -|.|..+|+.. ...|+...+..|++||+.||.|||+..+|||||...||||.. ...|||+|||+++
T Consensus 463 ~P~WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS-p~CVKLaDFGLSR 539 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS-PQCVKLADFGLSR 539 (974)
T ss_pred cceeEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC-cceeeecccchhh
Confidence 5689999998 68999999874 345999999999999999999999999999999999999984 7788999999999
Q ss_pred ecCCCCc-cCccc--CCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 725 FAGKNEI-TPYLV--SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~~-~~~~g--t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
++....+ +...+ .+-|||||-+.--.|+.++|||.|||+|||||. |..||.+..+.+++..|.+.-
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe---------- 609 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE---------- 609 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC----------
Confidence 8776543 23333 445999999999899999999999999999998 999999877766654332111
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
....++++++.+..|+.+||.++|.+||+..+|.
T Consensus 610 ---------------------------------------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 610 ---------------------------------------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---------------------------------------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 1234566778899999999999999999988764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=323.05 Aligned_cols=201 Identities=30% Similarity=0.437 Sum_probs=177.2
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.....||+|+||.||.+.++.+| ..||||.+.+.. ...+....|++||++| +|+|||+++++-+.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG----~~vAvK~~~~~~~~r~~e~~~~EieilkKL------nh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETG----RLVAVKTFNKESSLRPRERWCREIEILKKL------NHPNIVKLFDIEET 82 (732)
T ss_pred cceeehhhhcCCccceeeeecccccc----cchhHHhhhhhcccchHHHHHHHHHHHHHc------CchhhhhhcccCCc
Confidence 34777788999999999999999998 899999998643 3357778999999999 89999999987665
Q ss_pred cC------eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC---CCe
Q 002732 645 RN------HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA---KNV 714 (887)
Q Consensus 645 ~~------~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~~ 714 (887)
.. ...|||||| +|+|..+|.......+|++.+++.++..|+.||.|||.+|||||||||.||++-.+ ...
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Confidence 43 568999999 78999999998888889999999999999999999999999999999999998542 336
Q ss_pred EEEEecCcceecCCC-CccCcccCCcccchhhhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 002732 715 LKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGA 777 (887)
Q Consensus 715 vKL~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~~-~~~s~~sDIwSLG~iL~elltG~~PF~~~ 777 (887)
.||+|||.|+-...+ .+++++||..|++||++.. ..|+..+|+|||||++|+++||..||...
T Consensus 163 yKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred EeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 899999999876644 5788999999999999984 78999999999999999999999999643
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=295.38 Aligned_cols=246 Identities=18% Similarity=0.249 Sum_probs=185.6
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
.||+|+||+||++...... ....+++|.+.... .....+..|+.++..| .||||++++++|.....+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT--GVARVVVKELKANASSKEQNEFLQQGDPYRIL------QHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred cCCCCcCceEEEEEEEcCC--CcceEEEEEecCCCChHHHHHHHHHHHHHhcc------CCcchhheEEEecCCCccEEE
Confidence 5899999999999754432 22457777776432 2345678888888888 899999999999999999999
Q ss_pred Eecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 652 FESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 652 ~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
|||+ +++|.+++..... ...+++..++.++.||+.||.|||+.+|+|+||||+|||++. .+.++|+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC-CccEEecccccccccCcc
Confidence 9999 5799999876432 234677788999999999999999999999999999999984 778999999998543221
Q ss_pred ----CccCcccCCcccchhhhcC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhC-CCChh
Q 002732 730 ----EITPYLVSRFYRAPEIILG-------LPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKG-PFPKK 796 (887)
Q Consensus 730 ----~~~~~~gt~~Y~aPE~l~~-------~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g-~~p~~ 796 (887)
.....+++..|+|||++.. ..++.++|||||||++|+|++ |.+||......+.+..++.... .++
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-- 230 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLF-- 230 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccC--
Confidence 1223467788999999853 246789999999999999997 6778876665544443321100 000
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+.....++..+.+||..|| .+|.+|||+.
T Consensus 231 -------------------------------------------------~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~ 260 (268)
T cd05086 231 -------------------------------------------------KPQLELPYSERWYEVLQFCW-LSPEKRATAE 260 (268)
T ss_pred -------------------------------------------------CCccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence 01111224567889999999 6899999999
Q ss_pred HHHh
Q 002732 877 QALT 880 (887)
Q Consensus 877 elL~ 880 (887)
+|++
T Consensus 261 ~i~~ 264 (268)
T cd05086 261 EVHR 264 (268)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.18 Aligned_cols=250 Identities=17% Similarity=0.282 Sum_probs=192.5
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
|.+.+.||+|+||.||+|.+.... .....||||++.... .....+..|+.+|..| .||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~ 73 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSED-GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF------DHPNVIKLIGVSLRS 73 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccC-CCceEEEEEEeccccCChHHHHHHHHHHHHHhcC------CCCCcceEEEEEccC
Confidence 567889999999999999865431 234789999987532 2345677899999988 899999999988653
Q ss_pred C------eEEEEEecc-hhhHHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 646 N------HLCLVFESL-HMNLREVLKKFG---RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 646 ~------~~~lV~E~~-~gsL~~~L~~~~---~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
. ..++|++|+ +++|..++.... ....++...++.++.||+.||.|||+.||+|+||||+|||++. ...+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~-~~~~ 152 (273)
T cd05074 74 RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE-NMTV 152 (273)
T ss_pred CCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC-CCCE
Confidence 2 347888988 678888775321 1234889999999999999999999999999999999999984 7789
Q ss_pred EEEecCcceecCCCC----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhh
Q 002732 716 KLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 716 KL~DFG~a~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~ 790 (887)
+|+|||++....... .....+++.|++||++.+..++.++||||||||||+|++ |.+||.+.+..+....+....
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999987654322 122334567999999999899999999999999999999 899997665544333221110
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
.+ ...+.++..+.+|+.+||..+|.
T Consensus 233 -~~------------------------------------------------------~~~~~~~~~~~~l~~~~l~~~p~ 257 (273)
T cd05074 233 -RL------------------------------------------------------KQPPDCLEDVYELMCQCWSPEPK 257 (273)
T ss_pred -cC------------------------------------------------------CCCCCCCHHHHHHHHHHcCCChh
Confidence 00 00122346789999999999999
Q ss_pred CCcCHHHHHhC
Q 002732 871 KRMTVAQALTH 881 (887)
Q Consensus 871 ~RpTa~elL~H 881 (887)
.|||+.+++.+
T Consensus 258 ~Rps~~~~~~~ 268 (273)
T cd05074 258 CRPSFQHLRDQ 268 (273)
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=332.75 Aligned_cols=255 Identities=19% Similarity=0.274 Sum_probs=212.0
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCC-CCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~-~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+-.....+...||+|.||.||.|....... .....||||.+... ......|..|..+|..+ +|||||.+++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f------~HpNiv~liG 762 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF------DHPNIVSLIG 762 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC------CCcceeeEEE
Confidence 334568899999999999999998765431 12456999999865 44457888999999999 9999999999
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGR----NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~----~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v 715 (887)
++......+||+||| +|+|..+|..... ...|+...++.|+.|||.|+.||+++++|||||...|+||+. ..+|
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~-~r~V 841 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE-RRVV 841 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc-cCcE
Confidence 999999999999999 7899999998621 235999999999999999999999999999999999999996 6899
Q ss_pred EEEecCcceecCCCCccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhh
Q 002732 716 KLCDFGNAMFAGKNEITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~ 790 (887)
||+|||+|+.+....++.. .-...|||||.+....|+.++|||||||+|||||+ |.+||++.++.+++...+..-
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg 921 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG 921 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence 9999999985443333221 23457999999999999999999999999999999 999999998888776443322
Q ss_pred CCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCC
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
.+ ..+..++..+.+|+..||..+|.
T Consensus 922 -RL------------------------------------------------------~~P~~CP~~ly~lM~~CW~~~pe 946 (1025)
T KOG1095|consen 922 -RL------------------------------------------------------DPPSYCPEKLYQLMLQCWKHDPE 946 (1025)
T ss_pred -cc------------------------------------------------------CCCCCCChHHHHHHHHHccCChh
Confidence 11 12334557788999999999999
Q ss_pred CCcCHHHHHh
Q 002732 871 KRMTVAQALT 880 (887)
Q Consensus 871 ~RpTa~elL~ 880 (887)
+||+...|++
T Consensus 947 ~RP~F~~i~~ 956 (1025)
T KOG1095|consen 947 DRPSFRTIVE 956 (1025)
T ss_pred hCccHHHHHh
Confidence 9999999886
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=280.95 Aligned_cols=239 Identities=40% Similarity=0.622 Sum_probs=195.9
Q ss_pred CceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecch
Q 002732 579 VFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH 656 (887)
Q Consensus 579 ~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~ 656 (887)
+||.||+|.+..++ ..||+|++...... ...+..|+.++..+ .|++|+++++++......++||||+.
T Consensus 1 ~~g~v~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~l~~e~~~ 70 (244)
T smart00220 1 SFGKVYLARDKKTG----KLVAIKVIKKEKIKKKRERILREISILKKL------KHPNIVRLYDVFEDEDKLYLVMEYCD 70 (244)
T ss_pred CceEEEEEEECCCC----cEEEEEEecccccccHHHHHHHHHHHHHhC------CCCcHHHHHhheeeCCEEEEEEeCCC
Confidence 58999999988766 78999999764332 46778899999999 89999999999999999999999996
Q ss_pred h-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC-CccCc
Q 002732 657 M-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPY 734 (887)
Q Consensus 657 g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~-~~~~~ 734 (887)
+ +|.+++..... ++...++.++.+|+.+|.|||+.+|+|+||+|.||+++. ++.++|+|||++...... .....
T Consensus 71 ~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 71 GGDLFDLLKKRGR---LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccc
Confidence 5 99999876443 899999999999999999999999999999999999995 688999999999776553 34556
Q ss_pred ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH-HHHHHhhCCCChhhhhcccccccccccccc
Q 002732 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML-RLHMELKGPFPKKMLRKGAFTDQHFDQDLN 813 (887)
Q Consensus 735 ~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l-~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~ 813 (887)
.++..|+|||++.+..++.++|||+||+++|+|++|..||........+ ..+......+
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------- 206 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------- 206 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------
Confidence 7788899999999888999999999999999999999999763332222 2111000000
Q ss_pred cccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCC
Q 002732 814 FHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884 (887)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf 884 (887)
......++..+.+||.+||..+|.+||++.++|+||||
T Consensus 207 ---------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---------------------------------PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---------------------------------ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00011145788999999999999999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=301.30 Aligned_cols=300 Identities=28% Similarity=0.419 Sum_probs=213.0
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+...|.++.+||.|.|++||+|.+... ......||||.+..... ...+.+|+++|..|. .+.||+.+.+++..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~ts~-p~ri~~El~~L~~~g-----G~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRTSS-PSRILNELEMLYRLG-----GSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccccC-chHHHHHHHHHHHhc-----cchhhhcchhhhcc
Confidence 446699999999999999999998772 22348999999876433 366889999999996 56799999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
.+.+++||||+ +....+++.. ++...+..|+..|+.||.++|.+|||||||||.|||++.-.+...|+|||+|
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999 4566666554 8899999999999999999999999999999999999876677789999999
Q ss_pred eecCC----------------C------------------C------------ccCcccCCcccchhhhcCCC-CCchhh
Q 002732 724 MFAGK----------------N------------------E------------ITPYLVSRFYRAPEIILGLP-YDHPLD 756 (887)
Q Consensus 724 ~~~~~----------------~------------------~------------~~~~~gt~~Y~aPE~l~~~~-~s~~sD 756 (887)
..... . . ..+..||++|.|||++...+ -++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 51100 0 0 01135789999999998765 689999
Q ss_pred HHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHHhhCCCChhhhhccccccc---ccccccccccCcCChhhHHHHHHH-H
Q 002732 757 IWSVGCCLYELYTGKVLFPGA-TNNDMLRLHMELKGPFPKKMLRKGAFTDQ---HFDQDLNFHATEEDPVTKKAIKKI-I 831 (887)
Q Consensus 757 IwSLG~iL~elltG~~PF~~~-~~~~~l~~i~~~~g~~p~~~l~~~~~~~~---~f~~~l~~~~~~~~~~~~~~~~~~-~ 831 (887)
|||.||||+.++++..||... .+.+.+..|+.++|.-.-. +.+.... .|.. -+.+ ..+.....+..+ +
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mr---k~A~l~g~~~l~~k-sn~~---~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMR---KCAALPGRILLWQK-SNIP---TIPELRVNFETLHI 333 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHH---HHhhcCCceeeecc-cccc---ccHHHHhchhccCh
Confidence 999999999999999998654 4446666676666643211 1111110 0110 0000 001111111111 1
Q ss_pred hhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 832 FNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
..+.+.. ........-...++..+++||.+||..||.+|+||+++|.||||+.
T Consensus 334 ~~~~~~~--q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 334 ESIYKSR--QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred hhccccc--ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 1111100 0000011112234467899999999999999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=308.94 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=211.0
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+...++++||.|.||+|+.+.|... .+....||||++..... ....|..|+.+|..| .|+|+++||+++.+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~p-sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L------~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQP-SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL------QHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCC-CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc------cCcceeEEeeeecc
Confidence 3466788999999999999998774 35667899999986543 458899999999999 99999999999887
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..+.||||++ .|+|.+.|.+ .....|....+..|+.||+.||.||.++++|||||...||||.. ...|||+|||+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas-prtVKI~DFGLm 259 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS-PRTVKICDFGLM 259 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc-cceeeeecccce
Confidence 7789999999 7899999988 55566999999999999999999999999999999999999984 788999999999
Q ss_pred eecCCCC-ccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 724 MFAGKNE-ITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 724 ~~~~~~~-~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+.++.+. ++.+ .....|+|||.|....|+.++|||+|||+|||||+ |..||.|....++|.+|-+. ..+
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-erL---- 334 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-ERL---- 334 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-ccC----
Confidence 8776554 2211 12445999999999999999999999999999999 88999999888888766311 111
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..++.++..+.+++..||..+|.+|||+..
T Consensus 335 --------------------------------------------------pRPk~csedIY~imk~cWah~paDRptFsa 364 (1039)
T KOG0199|consen 335 --------------------------------------------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSA 364 (1039)
T ss_pred --------------------------------------------------CCCCCChHHHHHHHHHhccCCccccccHHH
Confidence 123456788999999999999999999998
Q ss_pred HHhC
Q 002732 878 ALTH 881 (887)
Q Consensus 878 lL~H 881 (887)
|...
T Consensus 365 ir~~ 368 (1039)
T KOG0199|consen 365 IRED 368 (1039)
T ss_pred HHHh
Confidence 8543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-33 Score=286.98 Aligned_cols=259 Identities=24% Similarity=0.301 Sum_probs=202.0
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
...+-+..||.|+||+|++..++..+ ...|||.|..+.. .+..+..|+.+..+-. +.|+||+|++.+..
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg----~~mAVKrIr~~n~~keq~rll~e~d~~mks~-----~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSG----KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSS-----NCPNIVKFYGALFS 134 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccC----cEEEEEEeeeccchHHHHHHHHHHHHHHhhc-----CCcHHHHHhhhhhc
Confidence 34556678999999999999999988 8999999975433 3455566666655543 88999999999999
Q ss_pred cCeEEEEEecchhhHHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHhhh-ccceeccCCCCCCccccCCCCeEEEEecC
Q 002732 645 RNHLCLVFESLHMNLREVLKKF--GRNIGLKLTAVRAYAKQLFIALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~--~~~~~ls~~~~~~i~~qIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~~vKL~DFG 721 (887)
++-.||.||+|..+|..+.+.. -....+++..+..|...++.||.||. ..+||||||||+||||+. .+.|||||||
T Consensus 135 EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFG 213 (361)
T KOG1006|consen 135 EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFG 213 (361)
T ss_pred CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeeccc
Confidence 9999999999987766543321 12344999999999999999999998 579999999999999995 7889999999
Q ss_pred cceecCCC-CccCcccCCcccchhhhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHhhCCCChhh
Q 002732 722 NAMFAGKN-EITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATN-NDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~-~~~~~~gt~~Y~aPE~l~~~--~~s~~sDIwSLG~iL~elltG~~PF~~~~~-~~~l~~i~~~~g~~p~~~ 797 (887)
++-.+... ..+.-+|..+|||||-+... .|+..+||||||++|||+.||..|+.+.+. .+++..+. .|.+|.-.
T Consensus 214 IcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~ 291 (361)
T KOG1006|consen 214 ICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILL 291 (361)
T ss_pred chHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeec
Confidence 98544332 23445788899999999644 599999999999999999999999987654 24443332 23332111
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
.....-.++..|..||.-||..|-..||...+
T Consensus 292 ------------------------------------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 292 ------------------------------------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred ------------------------------------------------CcccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 11122345678999999999999999999999
Q ss_pred HHhCCCCC
Q 002732 878 ALTHPFIS 885 (887)
Q Consensus 878 lL~Hpwf~ 885 (887)
|+.+||+.
T Consensus 324 Lk~~~fyr 331 (361)
T KOG1006|consen 324 LKKFPFYR 331 (361)
T ss_pred hhcCchhh
Confidence 99999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=304.86 Aligned_cols=276 Identities=20% Similarity=0.300 Sum_probs=185.9
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCC------------CCCCcEEEEEEecccch-h--------------hHHHHHHH
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAG------------NGEPEEVAIKIIRNNET-M--------------NKAGQTEV 618 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~------------~~~~~~vAIKii~~~~~-~--------------~~~~~~Ei 618 (887)
.++|.+.++||+|+||+||+|.+...+ ......||||.+..... . ......|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 457999999999999999999763322 11235799999864321 1 12223466
Q ss_pred HHHHHhhCCCCCCCcceeEecceeee--------cCeEEEEEecc-hhhHHHHHHHhcc---------------------
Q 002732 619 QILKKLAGADPENKRHCIRFASSFKY--------RNHLCLVFESL-HMNLREVLKKFGR--------------------- 668 (887)
Q Consensus 619 ~iL~~L~~~~~~~h~~Iv~l~~~~~~--------~~~~~lV~E~~-~gsL~~~L~~~~~--------------------- 668 (887)
.++.+|.+. +..+.+|+.++++|.. ....+|||||+ +++|.++|.....
T Consensus 224 ~~l~~l~~~-~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 224 YMCAKIKRN-PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHhhcc-cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666667432 2245566788887764 35689999999 6799988864211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC-ccC--cccCCcccchhh
Q 002732 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITP--YLVSRFYRAPEI 745 (887)
Q Consensus 669 ~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~-~~~--~~gt~~Y~aPE~ 745 (887)
...+++..++.|+.||+.||.|||..+|+|+||||.|||++. .+.+||+|||++....... ... ..+++.|+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 123567788999999999999999999999999999999985 6789999999996543321 122 234788999999
Q ss_pred hcCCC--------------------CC--chhhHHHHHHHHHHHHcCCC-CCCCCChHHHHHHHHHhhCCCChhhhhccc
Q 002732 746 ILGLP--------------------YD--HPLDIWSVGCCLYELYTGKV-LFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 746 l~~~~--------------------~s--~~sDIwSLG~iL~elltG~~-PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
+.... |+ ...||||||||||+|++|.. ||.+....... + .....
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~-~~~~~---------- 448 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--L-RQYDN---------- 448 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--H-hhccc----------
Confidence 86432 22 24799999999999999875 77432211110 0 00000
Q ss_pred ccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCC---CCCcCHHHHH
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDP---EKRMTVAQAL 879 (887)
Q Consensus 803 ~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP---~~RpTa~elL 879 (887)
+++ .+.. ++.... ....+...+..+++||.+||..+| .+|+|+.|||
T Consensus 449 --------~~~------------~~r~----~~~~~~------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 449 --------DLN------------RWRM----YKGQKY------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred --------hHH------------HHHh----hcccCC------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 000 0000 000000 001123456789999999999866 6899999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.||||..
T Consensus 499 ~Hp~f~~ 505 (507)
T PLN03224 499 SHRFFLP 505 (507)
T ss_pred CCCCcCC
Confidence 9999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=311.05 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=189.8
Q ss_pred EEEEEEeccCCceE-EEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 569 YEVTAAHGKGVFST-VVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 569 Y~i~~~LG~G~fg~-Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
|.--+++|.|..|+ ||++..-. +.||||.+... ....+.+||..|+.-. .|||||++++.-.+..+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~------R~VAVKrll~e--~~~~A~rEi~lL~eSD-----~H~NviRyyc~E~d~qF 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG------REVAVKRLLEE--FFDFAQREIQLLQESD-----EHPNVIRYYCSEQDRQF 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC------ceehHHHHhhH--hHHHHHHHHHHHHhcc-----CCCceEEEEeeccCCce
Confidence 44455789999887 67776533 67999987542 2356678999888763 89999999999999999
Q ss_pred EEEEEecchhhHHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC----CCeEEEEecCc
Q 002732 648 LCLVFESLHMNLREVLKKFGRNIG-LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA----KNVLKLCDFGN 722 (887)
Q Consensus 648 ~~lV~E~~~gsL~~~L~~~~~~~~-ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~~vKL~DFG~ 722 (887)
+||+.|.|..+|.++++....... ......+.++.|++.||+|||+++||||||||.||||... ...++|+|||+
T Consensus 578 ~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 578 LYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred EEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccc
Confidence 999999999999999987422111 1114568899999999999999999999999999999752 24689999999
Q ss_pred ceecCCCC-----ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 723 AMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 723 a~~~~~~~-----~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG-~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+....... .....||-+|+|||++....-+.++||||||||+|+.++| .+||...- +.-.+|+.. .+
T Consensus 658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~--~~--- 730 (903)
T KOG1027|consen 658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTG--NY--- 730 (903)
T ss_pred ccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcC--cc---
Confidence 98765443 3456789999999999998888899999999999999995 89995421 111112111 00
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+ ++.-.+. +. .++.+||.+||.++|..||+|.
T Consensus 731 -------~-------------------------------------L~~L~~~--~d--~eA~dLI~~ml~~dP~~RPsa~ 762 (903)
T KOG1027|consen 731 -------T-------------------------------------LVHLEPL--PD--CEAKDLISRMLNPDPQLRPSAT 762 (903)
T ss_pred -------c-------------------------------------eeeeccC--ch--HHHHHHHHHhcCCCcccCCCHH
Confidence 0 0000010 11 1678999999999999999999
Q ss_pred HHHhCCCCC
Q 002732 877 QALTHPFIS 885 (887)
Q Consensus 877 elL~Hpwf~ 885 (887)
++|.||||=
T Consensus 763 ~VL~HPlFW 771 (903)
T KOG1027|consen 763 DVLNHPLFW 771 (903)
T ss_pred HHhCCCccC
Confidence 999999883
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=305.59 Aligned_cols=251 Identities=20% Similarity=0.276 Sum_probs=215.9
Q ss_pred cCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.....|.++||.|.||.||.+..+..+ ..-..||||.++.. ......|..|..||-++ .||||++|.++..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pg-kre~~VAIKTLK~GytekqrrdFL~EAsIMGQF------dHPNIIrLEGVVT 700 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPG-KREITVAIKTLKAGYTEKQRRDFLSEASIMGQF------DHPNIIRLEGVVT 700 (996)
T ss_pred hhheEEEEEEecccccceecccccCCC-CcceeEEEeeeccCccHHHHhhhhhhhhhcccC------CCCcEEEEEEEEe
Confidence 355788899999999999999976655 34468999999863 45567889999999999 9999999999999
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....++||+||| +|+|..+|.... ..|+.-++..+++.|+.|+.||-++|+|||||...||||+ .+.++||+|||+
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFGL 777 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFGL 777 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec-cceEEEeccccc
Confidence 999999999999 799999998854 3499999999999999999999999999999999999999 488999999999
Q ss_pred ceecCCCC---ccCccc--CCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 723 AMFAGKNE---ITPYLV--SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 723 a~~~~~~~---~~~~~g--t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
++++.... +++.-| .+.|.|||+|...+++.++||||+||+|||.++ |.-||..+++.+.+..|.+....+|
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence 98775443 222212 456999999999999999999999999999998 9999999999999998876654332
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+..++..+..|+..||+.|=..||...
T Consensus 856 -----------------------------------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 856 -----------------------------------------------------PMDCPAALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred -----------------------------------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence 223457788999999999999999999
Q ss_pred HHHhC
Q 002732 877 QALTH 881 (887)
Q Consensus 877 elL~H 881 (887)
||+.+
T Consensus 883 qiV~~ 887 (996)
T KOG0196|consen 883 QIVST 887 (996)
T ss_pred HHHHH
Confidence 99863
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=291.13 Aligned_cols=198 Identities=26% Similarity=0.431 Sum_probs=178.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHH---------HHHHHHHHHhhCCCCCCCcceeEe
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---------QTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~---------~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
.|..++.||.|+||.|++|.++... ..|+||.|.+.....+.+ -.||.||..|+.. .|+||+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~----~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~---sH~NIlKl 634 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENN----YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH---SHENILKL 634 (772)
T ss_pred cceeeeeccccccceEEEeeecccc----eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc---Cccchhhh
Confidence 4999999999999999999998875 899999998865544444 4699999999654 59999999
Q ss_pred cceeeecCeEEEEEecch--hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEE
Q 002732 639 ASSFKYRNHLCLVFESLH--MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLK 716 (887)
Q Consensus 639 ~~~~~~~~~~~lV~E~~~--gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vK 716 (887)
+++|+..+++||+||..+ .+|.++|..... +++.++..|+.||+.|+++||+.||||||||-+||+++ +++.+|
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd-~~g~~k 710 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD-SNGFVK 710 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccCceecccccccEEEe-cCCeEE
Confidence 999999999999999873 489999987544 99999999999999999999999999999999999999 589999
Q ss_pred EEecCcceecCCCCccCcccCCcccchhhhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 717 L~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
|+|||.|.+..+..+..++||..|.|||++-|.+| +.+-|||+||++||-++....||.+
T Consensus 711 lidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999999999999999999999987 6778999999999999999888853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=316.42 Aligned_cols=186 Identities=22% Similarity=0.286 Sum_probs=156.5
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCe
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
.|....+||.|+||.||+|.+..++ ..||||.+..... ....|+.+|.++ .|||||+++++|.....
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~---~~~~~~~~l~~l------~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNG----MQFVVKEINDVNS---IPSSEIADMGKL------QHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCC----cEEEEEEccCCcc---ccHHHHHHHhhC------CCCCcceEEEEEEcCCC
Confidence 4677789999999999999987776 7899999864322 223567888888 89999999999999999
Q ss_pred EEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhh---ccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 648 LCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK---NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 648 ~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLH---s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
+||||||+ +++|.+++.. +++..+..|+.||+.||.||| ..+|||+||||+|||++. ...++++ ||.+
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC-CCceEEE-eccc
Confidence 99999999 6899999863 889999999999999999999 679999999999999984 5555554 6655
Q ss_pred eecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 724 MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 724 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
..... .....+++.|+|||++.+..|+.++||||||||||||++|+.||..
T Consensus 830 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 830 GLLCT--DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred ccccc--CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 33221 1234678899999999999999999999999999999999999953
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=296.51 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=205.8
Q ss_pred CceecCcEEEEEEeccCCceEEEEEEEcCCCCC---CCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCccee
Q 002732 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNG---EPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCI 636 (887)
Q Consensus 562 ~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~---~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv 636 (887)
.++...+..+.+.||.|.||.||+|........ ....||||.++... .....+..|+.+|+.+. .|+||+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g-----~H~niv 365 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG-----KHPNIV 365 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc-----CCcchh
Confidence 445555667788999999999999986543322 24689999998643 34678899999999995 799999
Q ss_pred EecceeeecCeEEEEEecc-hhhHHHHHHHhc---------c--C--CCCCHHHHHHHHHHHHHHHHhhhccceeccCCC
Q 002732 637 RFASSFKYRNHLCLVFESL-HMNLREVLKKFG---------R--N--IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 637 ~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~---------~--~--~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK 702 (887)
.++++|...+.+++|+||+ .|+|..+|.... . . ..|+...++.++.||+.|++||++.++|||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 9999999999999999999 799999998865 0 0 138999999999999999999999999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCCCCccC---ccc--CCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEITP---YLV--SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~~~~~~---~~g--t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~ 776 (887)
..||||+. +.++||+|||+|.......... ..+ ...|||||.+....|+.++||||+||+||||++ |..||++
T Consensus 446 aRNVLi~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 446 ARNVLITK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhEEecC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999995 7899999999998654433222 222 334999999999999999999999999999999 8899987
Q ss_pred CC-hHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHH
Q 002732 777 AT-NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855 (887)
Q Consensus 777 ~~-~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 855 (887)
.. ..+.+..+.... ....+..++.
T Consensus 525 ~~~~~~l~~~l~~G~-------------------------------------------------------r~~~P~~c~~ 549 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGN-------------------------------------------------------RMEQPEHCSD 549 (609)
T ss_pred CCcHHHHHHHHhcCC-------------------------------------------------------CCCCCCCCCH
Confidence 54 333332121110 1112334468
Q ss_pred HHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 856 NFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 856 ~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
++.+|+..||..+|.+||+..++..
T Consensus 550 eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 550 EIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHH
Confidence 8899999999999999999998864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=287.41 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=205.3
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh--hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM--NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~--~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
....++||.|+||+||++.+...+.....+||||++...... ...+..|..+|..| .||||++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl------dHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL------DHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC------CCchHHHHhhhcccch
Confidence 556679999999999999999988878889999999765443 57788899999999 9999999999998866
Q ss_pred eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+.||++|| .|+|.++++... ..|-....+.|++||+.||.|||.+.+|||||...||||.. -+.|||+|||+|..
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks-P~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS-PNHVKITDFGLAKL 847 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC-CCeEEEEecchhhc
Confidence 88999999 789999998743 34888999999999999999999999999999999999985 78899999999987
Q ss_pred cCCCC--ccC--cccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHhhCCCChhhhhc
Q 002732 726 AGKNE--ITP--YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 726 ~~~~~--~~~--~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
..... +.. ....+.|||-|.+....|++++|||||||++||||| |..|+.+....++-..+.... .
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-R-------- 918 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-R-------- 918 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-c--------
Confidence 66443 222 233566999999999999999999999999999999 999998877665543221110 0
Q ss_pred ccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHh
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~ 880 (887)
...++..+..+.-++.+||..|+..||++.++..
T Consensus 919 ----------------------------------------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ----------------------------------------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----------------------------------------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1123455677889999999999999999998753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=246.14 Aligned_cols=218 Identities=22% Similarity=0.324 Sum_probs=177.6
Q ss_pred CceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc--chhhHHHHHHHHHHHHhhCCCCCCCcceeEec
Q 002732 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 562 ~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
-++-.+....+..||.|++|.|-+..+..++ ...|+|.+... ...+.....|+.|.... ..+|++|.||
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg----~imAvKri~~tvn~q~q~r~L~dldi~~r~-----~~CPf~V~Fy 111 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSG----TIMAVKRIRATVNSQEQKRLLMDLDIIMRT-----VDCPFTVHFY 111 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCC----eEEEEeeehhhcChHHHHHHHHhhhhhccC-----CCCCeEEEee
Confidence 3445556677789999999999999999988 89999998753 33344555666665554 3789999999
Q ss_pred ceeeecCeEEEEEecchhhHHHHHHH-hccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEE
Q 002732 640 SSFKYRNHLCLVFESLHMNLREVLKK-FGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 640 ~~~~~~~~~~lV~E~~~gsL~~~L~~-~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
+.+.....++|.||.|..+|..+-.+ +.....+++..+-.|+..|+.||.|||+ ..||||||||+||||+. .+.|||
T Consensus 112 Ga~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKi 190 (282)
T KOG0984|consen 112 GALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKI 190 (282)
T ss_pred hhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEE
Confidence 99988899999999998888765543 2234569999999999999999999996 58999999999999995 899999
Q ss_pred EecCcceecCCCCc-cCcccCCcccchhhhcCC----CCCchhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHHh
Q 002732 718 CDFGNAMFAGKNEI-TPYLVSRFYRAPEIILGL----PYDHPLDIWSVGCCLYELYTGKVLFPG-ATNNDMLRLHMEL 789 (887)
Q Consensus 718 ~DFG~a~~~~~~~~-~~~~gt~~Y~aPE~l~~~----~~s~~sDIwSLG~iL~elltG~~PF~~-~~~~~~l~~i~~~ 789 (887)
||||++-++..... +.-.|...|||||.+... .|+-++||||||+.|+||.++..||+. .+..++|..+++-
T Consensus 191 CDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 191 CDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred cccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99999977655433 335778899999998643 699999999999999999999999976 4566777777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=284.48 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=206.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh-hHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM-NKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
..|.++..+|.|.||.||+|+++.++ +..|||+++..+.. ...++.|+-+++.. .|+|||-+++.|.-.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~----elaavkvVkLep~dd~~~iqqei~~~~dc------~h~nivay~gsylr~ 84 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSG----ELAAVKVVKLEPGDDFSGIQQEIGMLRDC------RHPNIVAYFGSYLRR 84 (829)
T ss_pred cchhheeeecCCcccchhhhcccccC----chhhheeeeccCCccccccccceeeeecC------CCcChHHHHhhhhhh
Confidence 56999999999999999999999988 89999999875443 35567888888888 999999999999999
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
..++|+|||| +|+|.++-+-.+ .|++.++.+.++..+.||+|||+.|-+|||||-.|||++. .+.|||+|||.+-
T Consensus 85 dklwicMEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd-~gDvklaDfgvsa 160 (829)
T KOG0576|consen 85 DKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD-EGDVKLADFGVSA 160 (829)
T ss_pred cCcEEEEEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc-cCceeecccCchh
Confidence 9999999999 568877765443 4999999999999999999999999999999999999994 7888999999986
Q ss_pred ecCCC--CccCcccCCcccchhhhc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhh
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~aPE~l~---~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
.+... ....++||++|||||+.. .+.|...+|||++|+...||---++|....-....+.++......+|
T Consensus 161 qitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp----- 235 (829)
T KOG0576|consen 161 QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP----- 235 (829)
T ss_pred hhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-----
Confidence 55432 346789999999999874 45799999999999999999887766533322222222211111111
Q ss_pred cccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHH
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQAL 879 (887)
Q Consensus 800 ~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL 879 (887)
.+ ...-+.+..|.+|+..+|..+|++|||++-+|
T Consensus 236 --------------------------------------~l--------kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 236 --------------------------------------TL--------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred --------------------------------------cc--------cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11 11224567899999999999999999999999
Q ss_pred hCCCCCC
Q 002732 880 THPFISG 886 (887)
Q Consensus 880 ~Hpwf~~ 886 (887)
.|||++.
T Consensus 270 ~h~fvs~ 276 (829)
T KOG0576|consen 270 QHPFVSQ 276 (829)
T ss_pred eceeecc
Confidence 9999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=238.03 Aligned_cols=181 Identities=35% Similarity=0.575 Sum_probs=157.7
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVF 652 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~ 652 (887)
||.|.+|.||++.+..++ ..++||++..... ....+..|+.++..+ .|++|+++++++......++||
T Consensus 1 l~~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~~~~~~ 70 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG----KKVAIKIIKKEDSSSLLEELLREIEILKKL------NHPNIVKLYGVFEDENHLYLVM 70 (215)
T ss_pred CCcCCceEEEEEEecCCC----cEEEEEEeccccchhHHHHHHHHHHHHHhc------CCCCeeeEeeeeecCCeEEEEE
Confidence 689999999999987655 7899999986544 246788999999999 7799999999999999999999
Q ss_pred ecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC-
Q 002732 653 ESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE- 730 (887)
Q Consensus 653 E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~- 730 (887)
|++. ++|.+++.... ..++...++.++.+|+.+|.+||..||+|+||+|.||+++...+.++|+|||++.......
T Consensus 71 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~ 148 (215)
T cd00180 71 EYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS 148 (215)
T ss_pred ecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc
Confidence 9996 79999988642 2489999999999999999999999999999999999998536789999999998766543
Q ss_pred -ccCcccCCcccchhhhcCC-CCCchhhHHHHHHHHHHH
Q 002732 731 -ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYEL 767 (887)
Q Consensus 731 -~~~~~gt~~Y~aPE~l~~~-~~s~~sDIwSLG~iL~el 767 (887)
.....+...|++||++... .++...|+|+||++||+|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4445677889999999887 789999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=251.19 Aligned_cols=198 Identities=22% Similarity=0.353 Sum_probs=163.8
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEec-ceee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFA-SSFK 643 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~-~~~~ 643 (887)
|.+.|.|.+.||.|-||.+.+|.+..+. ..+|||.+.........|..|+..--.|. .|.||+.-| ..|+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~----t~ivlKavp~p~tt~~dF~rEfhY~~~Ls-----~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSK----TRIVLKAVPRPQTTQADFVREFHYSFFLS-----PHQHIIDTYEVAFQ 92 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCc----eEEEeeccCcchhhHHHHHHHhccceeec-----cchhhhHHHHHHhh
Confidence 3466999999999999999999998887 89999999988777888888887655553 677888655 5578
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC-CCCeEEEEecC
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE-AKNVLKLCDFG 721 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~~vKL~DFG 721 (887)
..+.+++|+||+ .|+|..-+.. .++-+.....++.||+.||.|||+.+|||||||.+||||-. +...|||||||
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence 888999999999 5788776654 34899999999999999999999999999999999999954 34579999999
Q ss_pred cceecCCCCccCcccCCcccchhhhcCC-----CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGL-----PYDHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
++...+.. ..-...+..|.|||++... ...+.+|||.||+|||.+|+|.+||+.
T Consensus 169 ~t~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 169 LTRKVGTT-VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cccccCce-ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 99776542 2222345679999987643 357889999999999999999999964
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=260.59 Aligned_cols=190 Identities=23% Similarity=0.286 Sum_probs=157.4
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC-
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN- 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~- 646 (887)
...++.+||+|.||.||+|.... +.||||++... ....+.+|-.|.... ...|+||++|++.-....
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~------~~VAVKifp~~--~kqs~~~Ek~Iy~lp----~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN------RLVAVKIFPEQ--EKQSFQNEKNIYSLP----GMKHENILQFIGAEKRGTA 278 (534)
T ss_pred chhhHHHhhcCccceeehhhccC------ceeEEEecCHH--HHHHHHhHHHHHhcc----CccchhHHHhhchhccCCc
Confidence 37788899999999999998654 68999999653 346777787776655 448999999998876654
Q ss_pred ---eEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc---------cceeccCCCCCCccccCCCC
Q 002732 647 ---HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN---------CGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 647 ---~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs---------~gIvHrDLKP~NILl~~~~~ 713 (887)
.++||++|. .|+|.++|+.+- +++.....|+.-|+.||+|||. ..|+|||||..||||. ++.
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~Dl 353 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDL 353 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCC
Confidence 799999998 789999998753 8999999999999999999995 3599999999999998 588
Q ss_pred eEEEEecCcceecCCC----CccCcccCCcccchhhhcCC-CCC-----chhhHHHHHHHHHHHHcCCCCC
Q 002732 714 VLKLCDFGNAMFAGKN----EITPYLVSRFYRAPEIILGL-PYD-----HPLDIWSVGCCLYELYTGKVLF 774 (887)
Q Consensus 714 ~vKL~DFG~a~~~~~~----~~~~~~gt~~Y~aPE~l~~~-~~s-----~~sDIwSLG~iL~elltG~~PF 774 (887)
+..|+|||+|..+... ....-+||..|||||+|.+. .+. ..+||||+|.|||||++-..-+
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 9999999999776532 23346899999999999875 233 4689999999999999955433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=298.85 Aligned_cols=195 Identities=13% Similarity=0.160 Sum_probs=142.8
Q ss_pred cceeEeccee-------eecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCC
Q 002732 633 RHCIRFASSF-------KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705 (887)
Q Consensus 633 ~~Iv~l~~~~-------~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~N 705 (887)
.||+.++++| .....++++|||++++|.++|... ...|++..++.|+.||+.||.|||++|||||||||+|
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N 110 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC 110 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence 4666666766 223468888999999999999753 2349999999999999999999999999999999999
Q ss_pred ccccC------------------CCCeEEEEecCcceecCCC------------------CccCcccCCcccchhhhcCC
Q 002732 706 MLVNE------------------AKNVLKLCDFGNAMFAGKN------------------EITPYLVSRFYRAPEIILGL 749 (887)
Q Consensus 706 ILl~~------------------~~~~vKL~DFG~a~~~~~~------------------~~~~~~gt~~Y~aPE~l~~~ 749 (887)
|||+. ....+||+|||++...... .....++|++|||||++.+.
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 190 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS 190 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence 99953 2335667777776432100 01124678899999999999
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHH
Q 002732 750 PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKK 829 (887)
Q Consensus 750 ~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~ 829 (887)
.|+.++||||||||||||++|.+||.... ..+..+... .+|..+
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~--~~~~~~-------------------------------- 234 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR--VLPPQI-------------------------------- 234 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh--hcChhh--------------------------------
Confidence 99999999999999999999888874211 111111000 000000
Q ss_pred HHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
......+.+|+.+||..+|.+|||+.|||+||||.+
T Consensus 235 ---------------------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 235 ---------------------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred ---------------------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 000134568899999999999999999999999964
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=237.37 Aligned_cols=205 Identities=34% Similarity=0.547 Sum_probs=173.6
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
|.+...||.|+||+||+|....++ ..||||++..... ....+..|+.++..+ .|++|+.+++++....
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~------~~~~i~~~~~~~~~~~ 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG----ELVAVKVLKKEKTEKQREEFLREIRILKKL------KHPNIVKLYGVFEDPE 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC----cEEEEEeeccccchHHHHHHHHHHHHHHhC------CCCChhhheeeeecCC
Confidence 567889999999999999987766 7899999986533 356778899999988 7899999999999989
Q ss_pred eEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 647 HLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+++|+|++.+ +|.+++...... +++..+..++.+++.+|.|||.++|+|+||+|.||+++. .+.++|+|||++..
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~ 147 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM-DGLVKLADFGLARF 147 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeeCceeeE
Confidence 99999999955 999998874321 789999999999999999999999999999999999995 68899999999977
Q ss_pred cCCC---CccCcccCCcccchhhh-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CChH-HHHHHH
Q 002732 726 AGKN---EITPYLVSRFYRAPEII-LGLPYDHPLDIWSVGCCLYELYTGKVLFPG-ATNN-DMLRLH 786 (887)
Q Consensus 726 ~~~~---~~~~~~gt~~Y~aPE~l-~~~~~s~~sDIwSLG~iL~elltG~~PF~~-~~~~-~~l~~i 786 (887)
.... ......++..|++||++ ....++.++|||+|||+||+|++|..||.. .... .+...|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 6543 23445677889999999 666788899999999999999999999977 4444 333333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=246.98 Aligned_cols=196 Identities=22% Similarity=0.314 Sum_probs=160.5
Q ss_pred eecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCccee
Q 002732 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCI 636 (887)
Q Consensus 557 ~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv 636 (887)
.++-+.-.+..+..+++.||+|-||.||.|.+.. +.||||++..... ..+.+|.+|.+... ..|+||+
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrG------e~VAVKiF~srdE--~SWfrEtEIYqTvm----LRHENIL 268 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRG------EDVAVKIFSSRDE--RSWFRETEIYQTVM----LRHENIL 268 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccccC------CceEEEEecccch--hhhhhHHHHHHHHH----hccchhh
Confidence 4455566778889999999999999999999876 4599999976443 56677777776642 2899999
Q ss_pred Eecceeeec----CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-----c---ceeccCCCC
Q 002732 637 RFASSFKYR----NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-----C---GVLHCDIKP 703 (887)
Q Consensus 637 ~l~~~~~~~----~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-----~---gIvHrDLKP 703 (887)
.|++.-... ..++||++|. .|+|+++|... .++....+.++.-++.||.|||. + .|.|||||.
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 998765443 3699999999 79999999883 38999999999999999999994 2 499999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCC------CccCcccCCcccchhhhcCCC----C--CchhhHHHHHHHHHHHHc
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKN------EITPYLVSRFYRAPEIILGLP----Y--DHPLDIWSVGCCLYELYT 769 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~------~~~~~~gt~~Y~aPE~l~~~~----~--s~~sDIwSLG~iL~ellt 769 (887)
.||||.. ++++-|+|+|+|...... ..++.+||..|||||+|...- | -.-+||||||.||||++-
T Consensus 345 KNILVKk-n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 345 KNILVKK-NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred ccEEEcc-CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9999984 889999999999765543 235678999999999996531 1 244799999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=224.31 Aligned_cols=227 Identities=24% Similarity=0.285 Sum_probs=190.1
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++.++|.++++||.|+||.+|+|.....+ +.||||+-.... ....+..|..|...|. ....|+.+..++.
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~g----e~VAiK~Es~~a-~hpqL~yEskvY~iL~-----~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSG----EEVAIKLESSKA-KHPQLLYESKVYRILQ-----GGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCC----ceEEEEeecccC-CCcchhHHHHHHHHhc-----cCCCCchhhhhcc
Confidence 45788999999999999999999999888 899999876543 3456678889999885 3357788888888
Q ss_pred ecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCC--CCeEEEEecC
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA--KNVLKLCDFG 721 (887)
Q Consensus 644 ~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~~vKL~DFG 721 (887)
...+-.|||+.++.+|.+++..+.+. |+..+++.++-||+.-|+|+|..++||+||||+|+|+..+ -+.+.|||||
T Consensus 82 e~~ynvlVMdLLGPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 82 EKDYNVLVMDLLGPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred ccccceeeeeccCccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 99999999999999999999988764 9999999999999999999999999999999999999643 3468999999
Q ss_pred cceecCCC---------CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHh
Q 002732 722 NAMFAGKN---------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN---DMLRLHMEL 789 (887)
Q Consensus 722 ~a~~~~~~---------~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~---~~l~~i~~~ 789 (887)
+|..+... .-....||..|.+-.++.+..-+...|+-|+|.||..+.-|.+||++.... +....|.+.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 99654322 124467899999999998888899999999999999999999999986544 455666666
Q ss_pred hCCCChhhhhccc
Q 002732 790 KGPFPKKMLRKGA 802 (887)
Q Consensus 790 ~g~~p~~~l~~~~ 802 (887)
+...|-+.||++-
T Consensus 240 K~s~~ie~LC~G~ 252 (341)
T KOG1163|consen 240 KMSTPIEVLCKGF 252 (341)
T ss_pred hcCCCHHHHhCCC
Confidence 6667777766654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-24 Score=239.11 Aligned_cols=209 Identities=25% Similarity=0.288 Sum_probs=174.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh-hHHHHHHHHHHHHhhCCCCCCCcceeEeccee-eec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM-NKAGQTEVQILKKLAGADPENKRHCIRFASSF-KYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~-~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~-~~~ 645 (887)
+|.+..+||.|+||.||+|.+...+ ...+|+|+....... ...+..|+.+|..|.. .....+++.+++.+ ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~--~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK--KNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCCccchhHHHHHHHHhh--hcCCCCCCEEEEeccCCC
Confidence 7999999999999999999987764 357999988764322 2378899999999965 11346889999888 577
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC----CeEEEEecC
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK----NVLKLCDFG 721 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~~vKL~DFG 721 (887)
.+.||||+.++.+|.++..... ...|+..++..|+.|++.+|.+||+.|+|||||||.|+++.... ..++|+|||
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8999999999999999987766 56699999999999999999999999999999999999998643 469999999
Q ss_pred cce--ec-CCC--------C-ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 002732 722 NAM--FA-GKN--------E-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782 (887)
Q Consensus 722 ~a~--~~-~~~--------~-~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~ 782 (887)
+|. .+ ... . ...+.||..|+++.+..+...+...|+|||++++.+|+.|.+||.+......
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 997 21 111 1 1235599999999999999999999999999999999999999977654433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=221.25 Aligned_cols=166 Identities=24% Similarity=0.325 Sum_probs=126.6
Q ss_pred hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCCCccCccc
Q 002732 657 MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736 (887)
Q Consensus 657 gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~g 736 (887)
|+|.++|...+ ..|++..++.|+.||+.||.|||+.+ ||+|||++. ++.+++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~---~~~g 66 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW-DGLLKL--DGSVAFKTPE---QSRV 66 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC-ccceee--ccceEeeccc---cCCC
Confidence 57889998643 35999999999999999999999998 999999984 777888 9999776543 2367
Q ss_pred CCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHhhCCCChhhhhcccccccccccccccc
Q 002732 737 SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN-DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFH 815 (887)
Q Consensus 737 t~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~-~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~ 815 (887)
++.|+|||++.+..|+.++||||||||||+|++|.+||...... ..+..+........
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------------- 125 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD--------------------- 125 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC---------------------
Confidence 89999999999999999999999999999999999999654321 12221111100000
Q ss_pred cCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHH--HHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 816 ATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA--NFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
+ ........++. .+.+||..||..+|.+|||+.+||.|+|+.
T Consensus 126 --------------------~--------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 126 --------------------P--------RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred --------------------c--------cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0 00000112223 689999999999999999999999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=233.73 Aligned_cols=255 Identities=18% Similarity=0.200 Sum_probs=196.6
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCC-CCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNG-EPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~-~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
+...++.+..++-+|.||.||.|.+...... ..+.|.+|.++... ..-..+..|-.+|..+ .|||++.+.+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~------sH~nll~V~~ 354 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA------SHPNLLSVLG 354 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC------cCCCccceeE
Confidence 3446789999999999999999987654422 22457777776532 2234445555555555 7999999988
Q ss_pred eeeec-CeEEEEEecc-hhhHHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC
Q 002732 641 SFKYR-NHLCLVFESL-HMNLREVLKKFG-----RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 641 ~~~~~-~~~~lV~E~~-~gsL~~~L~~~~-----~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~ 713 (887)
++... ...++++.++ -|+|..+|..+. ....++-.++..++.||+.|+.|||+.||||.||...|++|+. ..
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd-~L 433 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD-QL 433 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh-he
Confidence 87664 5667778888 479999998543 2345788888999999999999999999999999999999994 78
Q ss_pred eEEEEecCcceecCCCCccCc----ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHH
Q 002732 714 VLKLCDFGNAMFAGKNEITPY----LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 714 ~vKL~DFG~a~~~~~~~~~~~----~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt-G~~PF~~~~~~~~l~~i~~ 788 (887)
.|||+|-.+++......+... .-...||+||.+.+..|+.++|||||||+||||+| |+.|+...++.++...+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 899999999876554433221 12456999999999999999999999999999999 9999988877777655432
Q ss_pred hhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccC
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
... ...+.+++.++..++..||..+
T Consensus 514 GyR-------------------------------------------------------laQP~NCPDeLf~vMacCWall 538 (563)
T KOG1024|consen 514 GYR-------------------------------------------------------LAQPFNCPDELFTVMACCWALL 538 (563)
T ss_pred cce-------------------------------------------------------ecCCCCCcHHHHHHHHHHHhcC
Confidence 211 0112345688899999999999
Q ss_pred CCCCcCHHHHHh
Q 002732 869 PEKRMTVAQALT 880 (887)
Q Consensus 869 P~~RpTa~elL~ 880 (887)
|..||+.+|+..
T Consensus 539 peeRPsf~Qlv~ 550 (563)
T KOG1024|consen 539 PEERPSFSQLVI 550 (563)
T ss_pred cccCCCHHHHHH
Confidence 999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=227.24 Aligned_cols=211 Identities=22% Similarity=0.262 Sum_probs=179.9
Q ss_pred ecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.-.|.|.++||+|+||++|++..+-++ +.||||.-.. .....++..|....+.|. ..++|++++-+...
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nn----e~VAIKfEPr-kS~APQLrdEYr~YKlL~-----g~~GIP~vYYFGqe 95 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNN----EPVAIKFEPR-KSEAPQLRDEYRTYKLLG-----GTEGIPQVYYFGQE 95 (449)
T ss_pred ecccceeccccccCcceeeecccccccC----ceEEEEeccc-cCCcchHHHHHHHHHHHc-----CCCCCCceeeeccc
Confidence 3445999999999999999999988877 8999997643 344577889999999996 45688888888888
Q ss_pred cCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC----CCCeEEEEec
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE----AKNVLKLCDF 720 (887)
Q Consensus 645 ~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~----~~~~vKL~DF 720 (887)
..+-.|||++++.+|.+++.-|++. |+..+++.++.||+.-++|+|++.+|+|||||+|+||.. ..+.|.|+||
T Consensus 96 G~~NiLVidLLGPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 96 GKYNILVIDLLGPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred cchhhhhhhhhCcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 8899999999999999999999874 999999999999999999999999999999999999964 2357999999
Q ss_pred CcceecCCCC---------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---hHHHHHHHH
Q 002732 721 GNAMFAGKNE---------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT---NNDMLRLHM 787 (887)
Q Consensus 721 G~a~~~~~~~---------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~---~~~~l~~i~ 787 (887)
|+|..+.... .....||..||+-...+|..-+...|+-|||-|++++|-|.+||+|.. +.+.+..|-
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 9997654322 345678999999999999999999999999999999999999998743 334455543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=260.13 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=187.6
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEec----ccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~----~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
....++|.|++|.|+.+...... ..++.|.+. ......+... .|...+.....+.|++++..+..+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~----~~~~~~~~r~~~~~~~s~~~~~~---~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDL----KSFPEKEFRVRVKPTESERKYNY---NITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred CccceeeecccCceEEEEecCCC----ccchhhhhhcccCCcccHHHHhh---hhhhheeecccccCCchhhhHHHHhhc
Confidence 45668899999988888776554 334444332 2111111111 144444444455999998887777776
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
...+-+||||.++|..++...+. |+...+..+++||+.||.|||.+||.|+||||+|||+.. .+.+||+|||.+..
T Consensus 394 ~~~~~~mE~~~~Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~-~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 394 DGILQSMEYCPYDLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE-NGILKIIDFGAASV 469 (601)
T ss_pred ccchhhhhcccHHHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec-CCceEEeecCccee
Confidence 65555699996699999887533 899999999999999999999999999999999999995 77999999999865
Q ss_pred cCCC------CccCcccCCcccchhhhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 726 AGKN------EITPYLVSRFYRAPEIILGLPYD-HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 726 ~~~~------~~~~~~gt~~Y~aPE~l~~~~~s-~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
.... .....+|+-+|+|||++.+..|. ..+||||.|+|++.|++|+.||......+...
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------------- 535 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------------- 535 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------------
Confidence 4322 23557889999999999999986 66899999999999999999996544332211
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
++.....+ ..++.........++.+...+|..||++||.+|+|+++|
T Consensus 536 ---------~~~~~~~~------------------------~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 536 ---------KTNNYSDQ------------------------RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred ---------hhhccccc------------------------cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 00000000 000111111223456788999999999999999999999
Q ss_pred HhCCCCCC
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~Hpwf~~ 886 (887)
|+.+||..
T Consensus 583 ~~d~W~~~ 590 (601)
T KOG0590|consen 583 LNDEWIRS 590 (601)
T ss_pred hhChHhhh
Confidence 99999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-22 Score=216.78 Aligned_cols=256 Identities=32% Similarity=0.495 Sum_probs=197.5
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch----hhHHHHHHHHHHHHhhCCCCCCCc-ceeEecceee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKR-HCIRFASSFK 643 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~-~Iv~l~~~~~ 643 (887)
|.++..||.|+|+.||++.+. ..+|+|++..... ....+..|+.++..+ .|+ +|+.+++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~------~~~~~i~~~~~~~~ 68 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASL------NHPPNIVKLYDFFQ 68 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHc------cCCcceeeEEEEEe
Confidence 788999999999999999986 3689999876433 346678888888888 555 7999999998
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.....++|++++ ++.|.+++........+....+..++.||+.+|.|+|..+|+|+||||+|||++.....++|+|||+
T Consensus 69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 878889999999 5677766665331124899999999999999999999999999999999999996443799999999
Q ss_pred ceecCCC--------CccCcccCCcccchhhhcC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHH
Q 002732 723 AMFAGKN--------EITPYLVSRFYRAPEIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATN----NDMLRLHM 787 (887)
Q Consensus 723 a~~~~~~--------~~~~~~gt~~Y~aPE~l~~---~~~s~~sDIwSLG~iL~elltG~~PF~~~~~----~~~l~~i~ 787 (887)
+...... .....+++..|+|||++.+ ..+...+|+|++|++++++++|..||..... ......+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence 8754432 2456788999999999998 5789999999999999999999999876653 22222222
Q ss_pred HhhCC-CChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcc
Q 002732 788 ELKGP-FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 788 ~~~g~-~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
....+ +...+ . ..........+.+||..|+.
T Consensus 229 ~~~~~~~~~~~------------------------------------------~------~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 229 ELPTPSLASPL------------------------------------------S------PSNPELISKAASDLLKKLLA 260 (384)
T ss_pred hcCCccccccc------------------------------------------C------ccccchhhHHHHHHHHHHHh
Confidence 22111 00000 0 00001223567899999999
Q ss_pred cCCCCCcCHHHHHhCCCCC
Q 002732 867 LDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 867 ~DP~~RpTa~elL~Hpwf~ 885 (887)
.+|..|.++.+.+.++|+.
T Consensus 261 ~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 261 KDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred cCchhcCCHHHHhhchHhh
Confidence 9999999999988887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-24 Score=243.68 Aligned_cols=239 Identities=27% Similarity=0.396 Sum_probs=193.5
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhH---HHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK---AGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~---~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
.+|.|.||.|+++.- ..+......||+|++++...... -...|-.++..+. .||.+|.+.-.|+....+++
T Consensus 1 vlg~g~~gkvfLvrk-~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~-----~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK-AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH-----NTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH-hccccccchhhhhcccccccccccccccccHHHHHhhcc-----CCCceeeeeeeeccccchhH
Confidence 379999999999863 33344557899999876433222 2234555555552 58999999999999999999
Q ss_pred EEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCCC
Q 002732 651 VFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 651 V~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
+++++ ++.|..-+.... .+.+..+..+...++.+|+++|+.+|+|+|+|++||+++. .|++++.|||+++..-..
T Consensus 75 ~ld~~rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhhcccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence 99999 567777666544 3889999999999999999999999999999999999995 899999999999775544
Q ss_pred CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccc
Q 002732 730 EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFD 809 (887)
Q Consensus 730 ~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~ 809 (887)
... |||..|||||++. ....++|+||||+++|+|++|..||.+ +++..|+...-.+|..
T Consensus 151 ~~~--cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~------------- 209 (612)
T KOG0603|consen 151 KIA--CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRE------------- 209 (612)
T ss_pred hhc--ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchh-------------
Confidence 444 9999999999998 578899999999999999999999976 6666665554444443
Q ss_pred cccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcC-----HHHHHhCCCC
Q 002732 810 QDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----VAQALTHPFI 884 (887)
Q Consensus 810 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a~elL~Hpwf 884 (887)
++..+.+||..|+..+|..|+- +.|+++|+||
T Consensus 210 -------------------------------------------l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~ 246 (612)
T KOG0603|consen 210 -------------------------------------------LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFF 246 (612)
T ss_pred -------------------------------------------hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchh
Confidence 4467789999999999999985 4799999999
Q ss_pred CC
Q 002732 885 SG 886 (887)
Q Consensus 885 ~~ 886 (887)
..
T Consensus 247 ~~ 248 (612)
T KOG0603|consen 247 QS 248 (612)
T ss_pred ee
Confidence 74
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-23 Score=242.08 Aligned_cols=218 Identities=25% Similarity=0.426 Sum_probs=166.7
Q ss_pred CcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
..|+.++.|..|+||.||++.++.+. +.+|+|+-+++- ||+.+... ...|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~tr----qrfa~kiNkq~l-----------ilRnilt~--a~npfvv---------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETR----QRFAMKINKQNL-----------ILRNILTF--AGNPFVV---------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccc----cchhhcccccch-----------hhhccccc--cCCccee----------
Confidence 35999999999999999999998877 789996543321 22211100 0233333
Q ss_pred eEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 647 HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 647 ~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
|+-..+++..+. ++... +.+++|||+.||||+|+||+|+||+. -+.+||+|||++...
T Consensus 136 ----------gDc~tllk~~g~---lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGP---LPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKG 193 (1205)
T ss_pred ----------chhhhhcccCCC---Ccchh--------hHHhHhhccCCeecCCCCCCcceeee-cccccccchhhhhhh
Confidence 455556655443 44433 78999999999999999999999994 889999999998532
Q ss_pred CCCC-----------------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHh
Q 002732 727 GKNE-----------------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789 (887)
Q Consensus 727 ~~~~-----------------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~ 789 (887)
.... -...|||+.|+||||+.-..|+..+|||+||+|+|+++.|..||.+.+.++.+...+..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 2110 12358999999999999999999999999999999999999999999998887766655
Q ss_pred hCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCC
Q 002732 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDP 869 (887)
Q Consensus 790 ~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP 869 (887)
.+.+|+. +..++.++.+||..+|..+|
T Consensus 274 ~i~wpE~-----------------------------------------------------dea~p~Ea~dli~~LL~qnp 300 (1205)
T KOG0606|consen 274 DIEWPEE-----------------------------------------------------DEALPPEAQDLIEQLLRQNP 300 (1205)
T ss_pred hcccccc-----------------------------------------------------CcCCCHHHHHHHHHHHHhCh
Confidence 5444433 23455789999999999999
Q ss_pred CCCc---CHHHHHhCCCCCC
Q 002732 870 EKRM---TVAQALTHPFISG 886 (887)
Q Consensus 870 ~~Rp---Ta~elL~Hpwf~~ 886 (887)
..|. .+-+|.+|+||..
T Consensus 301 ~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 301 LCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred Hhhcccchhhhhhhccceee
Confidence 9996 4668889999974
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4e-21 Score=214.60 Aligned_cols=161 Identities=22% Similarity=0.264 Sum_probs=123.2
Q ss_pred ceecCcEEEEEEeccCCceEEEEEEEcC-CCCCCCcEEEEEEeccc------chhhHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLK-AGNGEPEEVAIKIIRNN------ETMNKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 563 eil~~~Y~i~~~LG~G~fg~Vy~a~d~~-~~~~~~~~vAIKii~~~------~~~~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
..+.+.|.+...||+|+||+||+|.+.. ++ ..||||++... ......+..|+.+|..| .|++|
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L------~h~~i 83 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPG----TARAVRRRVSEVPWWSKPLARHLAAREIRALKTV------RGIGV 83 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCC----eEEEEEEecccccccccHHHHHHHHHHHHHHHhc------cCCCC
Confidence 3466789999999999999999998875 44 66899987532 12245678999999999 77787
Q ss_pred e-EecceeeecCeEEEEEecch-hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCC-CCCCccccCCC
Q 002732 636 I-RFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI-KPDNMLVNEAK 712 (887)
Q Consensus 636 v-~l~~~~~~~~~~~lV~E~~~-gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDL-KP~NILl~~~~ 712 (887)
+ .++.+ +..|||||||. ++|. .+. . .. ...++.||+.||.|||+.||||||| ||+||||+. +
T Consensus 84 v~~l~~~----~~~~LVmE~~~G~~L~-~~~---~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~-~ 148 (365)
T PRK09188 84 VPQLLAT----GKDGLVRGWTEGVPLH-LAR---P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP-D 148 (365)
T ss_pred CcEEEEc----CCcEEEEEccCCCCHH-HhC---c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC-C
Confidence 7 45442 45899999994 5665 221 1 11 1467899999999999999999999 999999974 6
Q ss_pred CeEEEEecCcceecCCC----------CccCcccCCcccchhhhcC
Q 002732 713 NVLKLCDFGNAMFAGKN----------EITPYLVSRFYRAPEIILG 748 (887)
Q Consensus 713 ~~vKL~DFG~a~~~~~~----------~~~~~~gt~~Y~aPE~l~~ 748 (887)
+.++|+|||+|..+... ..+..++++.|+|||++..
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 78999999999754322 1245567888999998853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=231.26 Aligned_cols=193 Identities=28% Similarity=0.381 Sum_probs=149.6
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc--hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.|...+.||.+.|=.|.+|++.. | .|+||++-+.. .....+.+.+.-++.+ ...+||++.|.-+....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-----~vVvKVFvk~~p~~sL~~~~qrL~~ik~~----l~~~pn~lPfqk~~~t~ 93 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-----LVVVKVFVKQDPTISLRPFKQRLEEIKFA----LMKAPNCLPFQKVLVTD 93 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-----eEEEEEEeccCCCCCchHHHHHHHHHHHH----hhcCCcccchHHHHHhh
Confidence 58899999999999999998654 2 59999986532 2234444444433322 12789999998887777
Q ss_pred CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 646 NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 646 ~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
...|||-+|+..+|++-|-... -|.+.+.+.|+-|||.||.-+|..||+|||||.+||||+ ..+.+.|+||..-+.
T Consensus 94 kAAylvRqyvkhnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT-SWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 94 KAAYLVRQYVKHNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT-SWNWLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHHHhhhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe-eechhhhhcccccCC
Confidence 7888999999889998876533 378888999999999999999999999999999999999 589999999986532
Q ss_pred --cCC---CCccCcccC----CcccchhhhcCC----------C-CCchhhHHHHHHHHHHHHc-CCCCC
Q 002732 726 --AGK---NEITPYLVS----RFYRAPEIILGL----------P-YDHPLDIWSVGCCLYELYT-GKVLF 774 (887)
Q Consensus 726 --~~~---~~~~~~~gt----~~Y~aPE~l~~~----------~-~s~~sDIwSLG~iL~ellt-G~~PF 774 (887)
+.. ..++-++-| .+|+|||-+... + .+++.||||+||+++||++ |.+||
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 221 122323323 369999988541 2 7899999999999999999 79999
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=203.42 Aligned_cols=203 Identities=22% Similarity=0.341 Sum_probs=128.1
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh----hHHHHHHHHHHHHhhCCCCC----CCcceeEecc
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM----NKAGQTEVQILKKLAGADPE----NKRHCIRFAS 640 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~----~~~~~~Ei~iL~~L~~~~~~----~h~~Iv~l~~ 640 (887)
+.....||.|+|+.||.+.+..++ +.+|||++...... .+.+..|.-....+...... .|-.++-.++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETG----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEccccccCCceEEEEEEEccCC----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 677889999999999999999988 99999998643211 12222222222211110000 0111222222
Q ss_pred eee---------ec---C-----eEEEEEecchhhHHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHhhhccceecc
Q 002732 641 SFK---------YR---N-----HLCLVFESLHMNLREVLKKFGRN----IGLKLTAVRAYAKQLFIALKHLKNCGVLHC 699 (887)
Q Consensus 641 ~~~---------~~---~-----~~~lV~E~~~gsL~~~L~~~~~~----~~ls~~~~~~i~~qIl~aL~yLHs~gIvHr 699 (887)
... .. . ..+++|+-+.++|.+++...... ..+.......+..|++..+++||..||||+
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 211 11 1 24778888888888776543211 112333445566899999999999999999
Q ss_pred CCCCCCccccCCCCeEEEEecCcceecCCCCccCcccCCcccchhhhcC--------CCCCchhhHHHHHHHHHHHHcCC
Q 002732 700 DIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILG--------LPYDHPLDIWSVGCCLYELYTGK 771 (887)
Q Consensus 700 DLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~s~~sDIwSLG~iL~elltG~ 771 (887)
||+|+|||++. ++.++|+||+.....+..... ...+..|.|||+... ..++++.|.|+||++||.|+||.
T Consensus 170 di~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-T-TS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcC-CCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999996 789999999988776653332 445678999998743 25899999999999999999999
Q ss_pred CCCCCC
Q 002732 772 VLFPGA 777 (887)
Q Consensus 772 ~PF~~~ 777 (887)
.||...
T Consensus 248 lPf~~~ 253 (288)
T PF14531_consen 248 LPFGLS 253 (288)
T ss_dssp -STCCC
T ss_pred CCCCCC
Confidence 999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=224.52 Aligned_cols=196 Identities=21% Similarity=0.340 Sum_probs=162.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+-...|.|-+.||.|+||+||+|.... + +.||||+-+... .+.+.-..+++.+|. +.--+.|+.+...+.
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~----~~~alK~e~P~~--~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-G----KLVALKVEKPPN--PWEFYICLQVMERLK---PQMLPSIMHISSAHV 764 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-C----cEEEEEeecCCC--ceeeeehHHHHHhhc---hhhhcchHHHHHHHc
Confidence 334579999999999999999999766 5 799999987543 355566677777875 223456777777778
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccC------CCCeEE
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE------AKNVLK 716 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~------~~~~vK 716 (887)
..+..+||++|. .|+|.+++. ....+++..+..|+.|||..|++||.++|||+||||+|+||.. ....|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cCCcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 888899999999 789999998 3456999999999999999999999999999999999999942 234689
Q ss_pred EEecCccee---cCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 002732 717 LCDFGNAMF---AGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772 (887)
Q Consensus 717 L~DFG~a~~---~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~ 772 (887)
|||||.+.- +... .+...++|-.|-++|++.|.++++.+|.|.|+.+++-||+|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999843 2333 4666778888999999999999999999999999999999964
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=195.88 Aligned_cols=178 Identities=11% Similarity=0.149 Sum_probs=132.8
Q ss_pred eecccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHH----------HHHHHHHHHHhhC
Q 002732 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA----------GQTEVQILKKLAG 626 (887)
Q Consensus 557 ~~~~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~----------~~~Ei~iL~~L~~ 626 (887)
|.--+.+++.++|.++++||.|+||.||++.+ . + ..||||++.......+. +..|+..+.+|
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~-~----~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-- 92 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-D-Y----GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-- 92 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-C-C----CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH--
Confidence 44555678899999999999999999999765 2 3 46999999753222222 56888899999
Q ss_pred CCCCCCcceeEecceeeec--------CeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhcccee
Q 002732 627 ADPENKRHCIRFASSFKYR--------NHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVL 697 (887)
Q Consensus 627 ~~~~~h~~Iv~l~~~~~~~--------~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIv 697 (887)
.|++|+.+.+++... +..+|||||+.| +|.++.. +++ .++.+|+.+|..||..||+
T Consensus 93 ----~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~ 157 (232)
T PRK10359 93 ----RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMV 157 (232)
T ss_pred ----HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCc
Confidence 677777777765532 458999999965 7877631 333 3466999999999999999
Q ss_pred ccCCCCCCccccCCCCeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHc
Q 002732 698 HCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT 769 (887)
Q Consensus 698 HrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~ellt 769 (887)
|+||+|+|||++. ++ ++|+|||........... .-+++...|..++|||+|||+|..+..
T Consensus 158 H~Dikp~Nili~~-~g-i~liDfg~~~~~~e~~a~----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 158 SGDPHKGNFIVSK-NG-LRIIDLSGKRCTAQRKAK----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred cCCCChHHEEEeC-CC-EEEEECCCcccccchhhH----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999999999985 55 899999987554322111 113444467789999999998876653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=179.74 Aligned_cols=183 Identities=17% Similarity=0.129 Sum_probs=134.5
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhH-----HHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK-----AGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~-----~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.+...|+.|+||+||++.... ..++.+.+...+.... .+..|+.+|.+|. ++++|++++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~-----~~~~vP~ll~~-- 70 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGE------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLD-----GLPRTPRLLHW-- 70 (218)
T ss_pred cccceeecCCCcceEEEeecCC------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcC-----CCCCCCEEEEE--
Confidence 4467789999999999887522 5688777766554333 5789999999994 34667777765
Q ss_pred ecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCC-CCCCccccCCCCeEEEEecC
Q 002732 644 YRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI-KPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 644 ~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~~vKL~DFG 721 (887)
+..|+||+|+.| +|...+.. ....++.||+.+|.+||.+||||+|| ||.|||++. ++.++|+|||
T Consensus 71 --~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~-~g~i~LIDFG 137 (218)
T PRK12274 71 --DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE-DGSPAVIDFQ 137 (218)
T ss_pred --cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC-CCCEEEEECC
Confidence 447999999955 66543211 12357889999999999999999999 799999985 6789999999
Q ss_pred cceecCCCCc-----c----------CcccCCcccchhhhcCC-CCC-chhhHHHHHHHHHHHHcCCCCCCCC
Q 002732 722 NAMFAGKNEI-----T----------PYLVSRFYRAPEIILGL-PYD-HPLDIWSVGCCLYELYTGKVLFPGA 777 (887)
Q Consensus 722 ~a~~~~~~~~-----~----------~~~gt~~Y~aPE~l~~~-~~s-~~sDIwSLG~iL~elltG~~PF~~~ 777 (887)
+|........ . -...++.|+.|+...-. ..+ ...++++.|+.+|.++|+..|+.+.
T Consensus 138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9976543321 0 01236678888765433 233 5679999999999999999887543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=183.04 Aligned_cols=139 Identities=22% Similarity=0.267 Sum_probs=102.9
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh---------------------------hHHHHHHHHHHHHh
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM---------------------------NKAGQTEVQILKKL 624 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~---------------------------~~~~~~Ei~iL~~L 624 (887)
...||.|+||+||+|.+. ++ +.||||++...... ......|+.+|..|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g----~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NG----EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CCccccccceEEEEEECC-CC----CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 457999999999999986 55 79999999754211 01223599999999
Q ss_pred hCCCCCCCcceeEecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhh-hccceeccCCC
Q 002732 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCDIK 702 (887)
Q Consensus 625 ~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yL-Hs~gIvHrDLK 702 (887)
..... .+|+++.. .. .+|||||++| +|...+.. ...+++..+..++.||+.+|.|| |..||||+|||
T Consensus 77 ~~~~v-~~p~~~~~------~~-~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlk 145 (190)
T cd05147 77 VTAGI-PCPEPILL------KS-HVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCRLVHADLS 145 (190)
T ss_pred HHCCC-CCCcEEEe------cC-CEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 54321 23443321 12 3799999965 44333222 23589999999999999999999 79999999999
Q ss_pred CCCccccCCCCeEEEEecCcceecCC
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 703 P~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|+||||+ .+.++|+|||+|.....
T Consensus 146 P~NIli~--~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 146 EYNLLYH--DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred HHHEEEE--CCcEEEEEccccccCCC
Confidence 9999998 36789999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=184.83 Aligned_cols=189 Identities=23% Similarity=0.331 Sum_probs=139.4
Q ss_pred CCCcceeEecceeeec---------------------------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHH
Q 002732 630 ENKRHCIRFASSFKYR---------------------------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682 (887)
Q Consensus 630 ~~h~~Iv~l~~~~~~~---------------------------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~ 682 (887)
..|||||.++.+|.+. ..+||||.-+..+|.++|-... .+......|+.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC----CchHHHHHHHH
Confidence 4899999998887532 3689999999999999987633 78888999999
Q ss_pred HHHHHHHhhhccceeccCCCCCCccccCCC---CeEEEEecCcceecCCCC--------ccCcccCCcccchhhhcCCC-
Q 002732 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAK---NVLKLCDFGNAMFAGKNE--------ITPYLVSRFYRAPEIILGLP- 750 (887)
Q Consensus 683 qIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~~vKL~DFG~a~~~~~~~--------~~~~~gt~~Y~aPE~l~~~~- 750 (887)
|||.|+.|||.+||.|+|||.+||||...+ .++.|+|||++.--.... ....-|.-..||||+....+
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999995322 267899999874322211 12223455689999987553
Q ss_pred -----CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHH
Q 002732 751 -----YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKK 825 (887)
Q Consensus 751 -----~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~ 825 (887)
--.+.|.|+.|.|.||+|+-..||.+...... . ...+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----~----------------~r~Y----------------- 470 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----D----------------TRTY----------------- 470 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhee-----c----------------hhhh-----------------
Confidence 12568999999999999999999965221100 0 0000
Q ss_pred HHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 826 AIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
...+.|..+..++..+.+|+.-+|+.||.+|+++.
T Consensus 471 ----------------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 471 ----------------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ----------------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 00123344455667889999999999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=194.02 Aligned_cols=178 Identities=25% Similarity=0.390 Sum_probs=137.4
Q ss_pred CeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
.++||+|++| ..+|.++|.........++...+.++.||+.|+.| +|.||+||||.||++.. +..+||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~-d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD-DDQLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccccc-chhhhhhhhhhee
Confidence 4689999999 67999999754444457888999999999999999 99999999999999974 6789999999986
Q ss_pred ecCCCC--------ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHH-hhCCCCh
Q 002732 725 FAGKNE--------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME-LKGPFPK 795 (887)
Q Consensus 725 ~~~~~~--------~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~-~~g~~p~ 795 (887)
...... .+..+||++||+||.|.+..|+.++|||+||+|||||+. +|. +..+.+..+.. -.|.+|+
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~--T~~er~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFS--TQFERIATLTDIRDGIIPP 479 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---Hhc--cHHHHHHhhhhhhcCCCCh
Confidence 544332 456789999999999999999999999999999999998 231 22222222222 1334443
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
.++. .+ +.-..||.+||...|.+||++
T Consensus 480 ~~~~----------------------------------------------------d~-p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 480 EFLQ----------------------------------------------------DY-PEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HHhh----------------------------------------------------cC-cHHHHHHHHhcCCCcccCchH
Confidence 3220 01 123589999999999999988
Q ss_pred HHHHhCCCCC
Q 002732 876 AQALTHPFIS 885 (887)
Q Consensus 876 ~elL~Hpwf~ 885 (887)
.+.--|+|..
T Consensus 507 ~~~~~~~~~~ 516 (516)
T KOG1033|consen 507 IEVALHEFLQ 516 (516)
T ss_pred HHHhhhhhcC
Confidence 8888888863
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.5e-18 Score=175.54 Aligned_cols=138 Identities=20% Similarity=0.211 Sum_probs=102.7
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh---------------------------hHHHHHHHHHHHHh
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM---------------------------NKAGQTEVQILKKL 624 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~---------------------------~~~~~~Ei~iL~~L 624 (887)
...||.|+||+||+|.+. ++ ..||||++...... ......|+..+.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG----EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC----CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 468999999999999976 55 79999999864211 11225688888888
Q ss_pred hCCCCCCCcceeEecceeeecCeEEEEEecchhh-HH-HHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCC
Q 002732 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LR-EVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDI 701 (887)
Q Consensus 625 ~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs-L~-~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDL 701 (887)
. +++|.....+... ..||||||++|. +. ..+.. ..++...+..++.||+.+|.+||. .||+|+||
T Consensus 77 ~------~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDl 144 (190)
T cd05145 77 Y------EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDL 144 (190)
T ss_pred H------hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 4 3443222111111 248999999653 33 33332 247888999999999999999999 99999999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCC
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
||+||||+ ++.++|+|||++.....
T Consensus 145 kP~NIll~--~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 145 SEYNILYH--DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ChhhEEEE--CCCEEEEEcccceecCC
Confidence 99999998 57889999999977654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=171.28 Aligned_cols=138 Identities=17% Similarity=0.253 Sum_probs=106.4
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc-chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecC---e
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN-ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN---H 647 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~---~ 647 (887)
..+||+|+||.||. +..+. . .+||++... ......+..|+.+|..|.+. ...||||+++++++++.. .
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~----~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~-~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDA----Q-RCIKIVYHRGDGGDKEIRRELKYYAHLSRR-LIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cceecCCCceEEEE--CCCCc----C-eEEEEEeccccchHHHHHHHHHHHHHhhcc-CCCCcccceeeEEEEeCCCCeE
Confidence 45899999999995 54443 3 479988753 22346789999999999653 347999999999999863 4
Q ss_pred EE-EEEecch---hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHH-HhhhccceeccCCCCCCccccC---CCCeEEEEe
Q 002732 648 LC-LVFESLH---MNLREVLKKFGRNIGLKLTAVRAYAKQLFIAL-KHLKNCGVLHCDIKPDNMLVNE---AKNVLKLCD 719 (887)
Q Consensus 648 ~~-lV~E~~~---gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL-~yLHs~gIvHrDLKP~NILl~~---~~~~vKL~D 719 (887)
++ +||||++ ++|.++|... .+++. ..++.|++.+| .|||+++|||+||||+|||++. +...++|+|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 34 7899954 7999999662 26655 35688888888 9999999999999999999974 234799999
Q ss_pred -cCcc
Q 002732 720 -FGNA 723 (887)
Q Consensus 720 -FG~a 723 (887)
||..
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 4543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.3e-18 Score=172.23 Aligned_cols=239 Identities=13% Similarity=0.176 Sum_probs=180.3
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
...++.+|.....|..|++++..+. +++|++... ......|..|+..|+.+ .||||+.+++.|..
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd------ivakil~vr~~t~risrdfneefp~lrif------shpnilpvlgacns 258 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND------IVAKILNVREVTARISRDFNEEFPALRIF------SHPNILPVLGACNS 258 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc------hhhhhhhhhhcchhhcchhhhhCcceeee------cCCchhhhhhhccC
Confidence 4667778899999999999987765 677887643 33446778888888888 89999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccc--eeccCCCCCCccccCCCCeEEE--Ee
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG--VLHCDIKPDNMLVNEAKNVLKL--CD 719 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~~vKL--~D 719 (887)
..++.++..|| .|+|+++|... ...-+...++..++.+|+.|+.|||+.. |.---|....|+|++ +.+.+| +|
T Consensus 259 ppnlv~isq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad 336 (448)
T KOG0195|consen 259 PPNLVIISQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMAD 336 (448)
T ss_pred CCCceEeeeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheeccc
Confidence 99999999999 68999999863 3344778899999999999999999875 444467888899985 554443 33
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChh
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPY---DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~---s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
--++... .....++.||+||.+...+- -.+.|+|||+++||||.|...||....+.+.-.+|.
T Consensus 337 ~kfsfqe-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------- 402 (448)
T KOG0195|consen 337 TKFSFQE-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------- 402 (448)
T ss_pred ceeeeec-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------
Confidence 2222111 11234678999999987653 367899999999999999999997665544322220
Q ss_pred hhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHH
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+.. -.+..+|.++.++..|+.-|+.-||.+||...
T Consensus 403 ----------------------------------leg-----------lrv~ippgis~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 403 ----------------------------------LEG-----------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred ----------------------------------hcc-----------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence 000 01234567788999999999999999999987
Q ss_pred HHH
Q 002732 877 QAL 879 (887)
Q Consensus 877 elL 879 (887)
.|+
T Consensus 438 miv 440 (448)
T KOG0195|consen 438 MIV 440 (448)
T ss_pred eeh
Confidence 763
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.4e-17 Score=171.78 Aligned_cols=143 Identities=18% Similarity=0.168 Sum_probs=107.7
Q ss_pred EEEEEEeccCCceEEEEEE-EcCCCCCCCcEEEEEEecccch-------------------------hhHHHHHHHHHHH
Q 002732 569 YEVTAAHGKGVFSTVVRAK-DLKAGNGEPEEVAIKIIRNNET-------------------------MNKAGQTEVQILK 622 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~-d~~~~~~~~~~vAIKii~~~~~-------------------------~~~~~~~Ei~iL~ 622 (887)
|.+...||.|+||.||+|. +..++ ..||||++..... ....+..|+.+|.
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g----~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSG----KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCC----cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 8899999999999999998 55555 7899999875321 0123467999999
Q ss_pred HhhCCCCCCCcceeEecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccc-eeccC
Q 002732 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG-VLHCD 700 (887)
Q Consensus 623 ~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g-IvHrD 700 (887)
.|... ...++.++.+ ...+|||||+++ +|..++.. ...+....+..++.||+.+|.+||..| |+|+|
T Consensus 106 ~L~~~----~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~D 174 (237)
T smart00090 106 RLYEA----GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEGELVHGD 174 (237)
T ss_pred HHHhc----CCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCC
Confidence 99531 2233444432 235899999966 45444322 223667778899999999999999999 99999
Q ss_pred CCCCCccccCCCCeEEEEecCcceecCC
Q 002732 701 IKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 701 LKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|||+||||+ .+.++|+|||++.....
T Consensus 175 ikp~NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 175 LSEYNILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CChhhEEEE--CCCEEEEEChhhhccCC
Confidence 999999998 56789999999876554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=162.75 Aligned_cols=133 Identities=18% Similarity=0.242 Sum_probs=104.7
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---------hhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---------MNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.||+|++|.||+|.+.. ..|+||+...... ....+..|+.++..| .+++|+....++.
T Consensus 2 ~~l~~G~~~~vy~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~p~~~~~ 69 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG------IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA------RKAGVNVPAVYFV 69 (211)
T ss_pred cccccCceEEEEEEeeCC------CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH------HHCCCCCCeEEEE
Confidence 578999999999998733 4689998653211 113456789999998 4555555555555
Q ss_pred ecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
.....+|||||+ +++|.+++... .. .+..++.+|+.+|.+||..||+|+||+|.|||++ .+.++|+|||+
T Consensus 70 ~~~~~~lv~e~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--~~~~~liDf~~ 140 (211)
T PRK14879 70 DPENFIIVMEYIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--GGKIYLIDFGL 140 (211)
T ss_pred eCCCCEEEEEEeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE--CCCEEEEECCc
Confidence 667789999999 56898888652 22 7889999999999999999999999999999998 57789999999
Q ss_pred ceec
Q 002732 723 AMFA 726 (887)
Q Consensus 723 a~~~ 726 (887)
+...
T Consensus 141 a~~~ 144 (211)
T PRK14879 141 AEFS 144 (211)
T ss_pred ccCC
Confidence 8663
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-17 Score=197.11 Aligned_cols=259 Identities=25% Similarity=0.316 Sum_probs=194.0
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.|.++..||+|+|+.|-++...... ...+|+|.+.... .....+..|+.+-+.+. .|.|++.+++....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~---~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s-----~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDP---ESSSATKPISIPPKSEDSSEHIDTETDIQKKLS-----KHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccchhhhhhhcCCC---cceeeccCCCCCCCccchhhhcCcccccccccc-----ccccccccCCccCC
Confidence 3888888999999999999765543 2567777765443 22233344666666663 39999999999999
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhh-ccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
....+++++|. ++++...+.. .....++...+..++.|+..+|.|+| ..++.|+||+|+|.|++..+..++++|||+
T Consensus 93 ~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 93 PRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred CcccccccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchh
Confidence 99999999997 5677776631 11125788889999999999999999 999999999999999996443889999999
Q ss_pred ceecCC-CC----ccCccc-CCcccchhhhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCCh
Q 002732 723 AMFAGK-NE----ITPYLV-SRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 723 a~~~~~-~~----~~~~~g-t~~Y~aPE~l~~~~-~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|..+.. +. ....+| ++.|+|||.+.+.. .....|+||+|+++.-+++|..||......... +
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---------~-- 240 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---------Y-- 240 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---------c--
Confidence 976554 22 344677 99999999999854 578899999999999999999999544322100 0
Q ss_pred hhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCH
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
+ .|. . .+ .......+..++....+++.+||..+|..|+++
T Consensus 241 ------------~----~~~----------------~-~~-------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~ 280 (601)
T KOG0590|consen 241 ------------S----SWK----------------S-NK-------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSI 280 (601)
T ss_pred ------------e----eec----------------c-cc-------cccccCccccCChhhhhcccccccCCchhcccc
Confidence 0 000 0 00 000122344556778899999999999999999
Q ss_pred HHHHhCCCCCC
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~elL~Hpwf~~ 886 (887)
.++-.+||++.
T Consensus 281 ~~~~~d~~~~~ 291 (601)
T KOG0590|consen 281 EELKLDNWLSS 291 (601)
T ss_pred ccccccccccc
Confidence 99999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=155.54 Aligned_cols=129 Identities=18% Similarity=0.210 Sum_probs=96.9
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch---------hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET---------MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~---------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.||+|+||+||++.... ..|+||+...... ....+..|+.++..|. ++++.....++..
T Consensus 1 ~ig~G~~~~vy~~~~~~------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------~~~i~~p~~~~~~ 68 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR------KAGVNTPVVYDVD 68 (199)
T ss_pred CCCCCceEEEEEeecCC------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH------HCCCCCCEEEEEE
Confidence 47999999999998432 4699998653211 1244567999999984 3333322223345
Q ss_pred cCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
....+|||||+ +++|.+++.... . .++.+|+.+|.+||+.||+|+||+|.|||++ ++.++|+|||++
T Consensus 69 ~~~~~lv~e~~~g~~l~~~~~~~~------~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--~~~~~liDfg~a 136 (199)
T TIGR03724 69 PDNKTIVMEYIEGKPLKDVIEEGN------D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--DDKLYLIDFGLG 136 (199)
T ss_pred CCCCEEEEEEECCccHHHHHhhcH------H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--CCcEEEEECCCC
Confidence 56678999999 568888765421 1 8899999999999999999999999999998 578899999998
Q ss_pred eec
Q 002732 724 MFA 726 (887)
Q Consensus 724 ~~~ 726 (887)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 663
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.2e-15 Score=155.64 Aligned_cols=137 Identities=23% Similarity=0.228 Sum_probs=101.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----------------------hhHHHHHHHHHHHHhh
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----------------------MNKAGQTEVQILKKLA 625 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----------------------~~~~~~~Ei~iL~~L~ 625 (887)
|.+...||.|+||.||+|... ++ ..||||++..... .......|+.++..+.
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DG----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CC----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 888899999999999999864 44 7899998764320 0123467888888884
Q ss_pred CCCCCCCcceeEecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCC
Q 002732 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 626 ~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~ 704 (887)
... ..++.+++. ...||||||+.| +|..++. ...+..++.+|+.+|.+||..||+|+||+|.
T Consensus 92 ~~~----i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~ 154 (198)
T cd05144 92 EEG----FPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEF 154 (198)
T ss_pred HcC----CCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcc
Confidence 321 133333332 345899999954 6654432 1345678899999999999999999999999
Q ss_pred CccccCCCCeEEEEecCcceecCC
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 705 NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
||||+. ++.++|+|||++.....
T Consensus 155 Nill~~-~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDD-DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcC-CCcEEEEECCccccCCC
Confidence 999985 78899999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.1e-15 Score=175.24 Aligned_cols=142 Identities=18% Similarity=0.223 Sum_probs=108.0
Q ss_pred ccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---------chhhHHHHHHHHHHHHhhCCCCC
Q 002732 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---------ETMNKAGQTEVQILKKLAGADPE 630 (887)
Q Consensus 560 ~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---------~~~~~~~~~Ei~iL~~L~~~~~~ 630 (887)
.........|...+.||+|+||+||++.+.... +++|+.... ......+..|+.+|..|
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------ 393 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEA------ 393 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCcc------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh------
Confidence 333333445677889999999999999875543 444432211 01124567899999999
Q ss_pred CCcceeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCcccc
Q 002732 631 NKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~ 709 (887)
.|++|+..+.++......+|||||+ +++|.+++. ....++.+|+.+|.|||+.||||+||||.||||+
T Consensus 394 ~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~ 462 (535)
T PRK09605 394 RRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR 462 (535)
T ss_pred cccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE
Confidence 6777777666666667789999999 668888775 3467899999999999999999999999999994
Q ss_pred CCCCeEEEEecCcceec
Q 002732 710 EAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 710 ~~~~~vKL~DFG~a~~~ 726 (887)
++.++|+|||++...
T Consensus 463 --~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 --DDRLYLIDFGLGKYS 477 (535)
T ss_pred --CCcEEEEeCcccccC
Confidence 677899999998664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=165.61 Aligned_cols=258 Identities=18% Similarity=0.198 Sum_probs=189.9
Q ss_pred CceecCcEEEEEEecc--CCceEEEEEEE--cCCCCCCCcEEEEEEeccc---chhhHHHHHHHHHHHHhhCCCCCCCcc
Q 002732 562 GEILDGRYEVTAAHGK--GVFSTVVRAKD--LKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRH 634 (887)
Q Consensus 562 ~eil~~~Y~i~~~LG~--G~fg~Vy~a~d--~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~ 634 (887)
...+...|.+...+|. |.+|.||.+.. ...+ ..+|+|.-+.. +.....-..|+.....+ ..|++
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~----~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i-----~~~~~ 179 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESP----HKFAVKKSKIPFSPPLDSKRKLREFLSHHKI-----DSHEN 179 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCC----cccccccccCCCCCccccccccchhhccccc-----Ccccc
Confidence 3445566888999999 99999999987 4444 78898874321 22223334455544444 37889
Q ss_pred eeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHH----HHHhhhccceeccCCCCCCccccC
Q 002732 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI----ALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 635 Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~----aL~yLHs~gIvHrDLKP~NILl~~ 710 (887)
++..+..|...+.+||-+|+++.+|..+..... ..++...++.++.+++. ||.++|+.+|+|-|++|.||++..
T Consensus 180 ~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 180 PVRDSPAWEGSGILFIQTELCGESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTS 257 (524)
T ss_pred ccccCcccccCCcceeeeccccchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccc
Confidence 999999999999999999999988888876543 24888999999999999 999999999999999999999986
Q ss_pred CCCeEEEEecCcceecCCCCccCc-------ccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 002732 711 AKNVLKLCDFGNAMFAGKNEITPY-------LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783 (887)
Q Consensus 711 ~~~~vKL~DFG~a~~~~~~~~~~~-------~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l 783 (887)
....++++|||+...++...+... .+...|++||++.+ -++...|||+||.++.+..+|..++...-+
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---- 332 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN---- 332 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC----
Confidence 437889999999988776653222 45667999999877 679999999999999999998766632100
Q ss_pred HHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHH
Q 002732 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863 (887)
Q Consensus 784 ~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~k 863 (887)
..| ..-...+. + .+.....+..+...+..
T Consensus 333 -----------~~W----~~~r~~~i-------p-----------------------------~e~~~~~s~~l~~~~~~ 361 (524)
T KOG0601|consen 333 -----------SSW----SQLRQGYI-------P-----------------------------LEFCEGGSSSLRSVTSQ 361 (524)
T ss_pred -----------CCc----cccccccC-------c-----------------------------hhhhcCcchhhhhHHHH
Confidence 001 00000000 0 00001122344458999
Q ss_pred hcccCCCCCcCHHHHHhCCCCCC
Q 002732 864 IFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 864 mL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
||..+|..|++++.+++|+++..
T Consensus 362 ~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 362 MLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHHhccccccc
Confidence 99999999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=7e-15 Score=167.66 Aligned_cols=143 Identities=23% Similarity=0.354 Sum_probs=120.8
Q ss_pred CCcceeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccce-eccCCCCCCccc
Q 002732 631 NKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGV-LHCDIKPDNMLV 708 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gI-vHrDLKP~NILl 708 (887)
.|.||.+|++.+.....+++|.+|| .|+|.++|.. ....++......++++|+.||.|||+..| +|+.|++.|+++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv 82 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV 82 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee
Confidence 7999999999999999999999999 6899999987 33458888999999999999999998765 999999999999
Q ss_pred cCCCCeEEEEecCcceecCC----CCccCcccCCcccchhhhcCCC-------CCchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 709 NEAKNVLKLCDFGNAMFAGK----NEITPYLVSRFYRAPEIILGLP-------YDHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 709 ~~~~~~vKL~DFG~a~~~~~----~~~~~~~gt~~Y~aPE~l~~~~-------~s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
+ ....+||+|||+..+... .......-...|.|||++.+.. .+.+.||||||+|++||++-.-||..
T Consensus 83 d-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 83 D-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred e-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9 488999999999866532 1112222345699999997642 46679999999999999999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-14 Score=147.01 Aligned_cols=136 Identities=26% Similarity=0.277 Sum_probs=93.9
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHH-------------------------HHHHHHHHHHhhC
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA-------------------------GQTEVQILKKLAG 626 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~-------------------------~~~Ei~iL~~L~~ 626 (887)
.+.||+|+||+||+|.+. ++ +.||||++......... ...|..++..+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~----~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~ 76 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DG----EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYE 76 (187)
T ss_pred CcccccccceeEEEEECC-CC----CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHH
Confidence 467999999999999876 44 78999998753221111 1345555666532
Q ss_pred CCCCCCcceeEecceeeecCeEEEEEecchh-hHH-HHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCC
Q 002732 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLR-EVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKP 703 (887)
Q Consensus 627 ~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~-~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP 703 (887)
. +..++.++.+ ...+|||||+.+ .+. ..|.... .. ..+..++.+|+.+|.+||. .||+|+||+|
T Consensus 77 ~----~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p 143 (187)
T cd05119 77 A----GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAGLVHGDLSE 143 (187)
T ss_pred c----CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCCh
Confidence 1 1123333332 236899999965 221 2222211 11 6678999999999999999 9999999999
Q ss_pred CCccccCCCCeEEEEecCcceecC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
+||||+ ++.++|+|||.+....
T Consensus 144 ~Nili~--~~~~~liDfg~a~~~~ 165 (187)
T cd05119 144 YNILVD--DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhEEEE--CCcEEEEECccccccc
Confidence 999998 6788999999995543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.5e-13 Score=130.64 Aligned_cols=133 Identities=24% Similarity=0.250 Sum_probs=106.7
Q ss_pred EEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 571 i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
++..||.|.++.||++.... ..++||++..... ...+..|+.++..|... ..++++++.++...+..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~----~~~~p~~~~~~~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREK-GADREREVAILQLLARK----GLPVPKVLASGESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC------CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc----CCCCCeEEEEcCCCCccEE
Confidence 45789999999999998744 3699999876543 45678999999999543 2467777777777788999
Q ss_pred EEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhcc---ceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 651 VFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC---GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 651 V~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
||||+.+ .+..+ +......++.+++.+|.+||.. +|+|+||+|.|||++. .+.++|+|||++..
T Consensus 71 v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 9999955 33322 4566678899999999999985 7999999999999985 68899999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.4e-13 Score=142.69 Aligned_cols=133 Identities=17% Similarity=0.194 Sum_probs=95.1
Q ss_pred Eec-cCCceEEEEEEEcCCCCCCCcEEEEEEecccc--------------hhhHHHHHHHHHHHHhhCCCCCCCcceeEe
Q 002732 574 AHG-KGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--------------TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 574 ~LG-~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~--------------~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
.|| .|+.|+||.+... + ..+|||.+.... .....+..|+.++..|.... ..++.+
T Consensus 38 ~lg~~~g~gtv~~v~~~--~----~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~g----i~vP~p 107 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--G----VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAG----LPVPRP 107 (239)
T ss_pred eeecCCCCccEEEEEeC--C----ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCC----CCCcee
Confidence 566 7888888888754 2 568998875311 11244577999999994331 123555
Q ss_pred cceeeec-C---eEEEEEecchh--hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCC
Q 002732 639 ASSFKYR-N---HLCLVFESLHM--NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK 712 (887)
Q Consensus 639 ~~~~~~~-~---~~~lV~E~~~g--sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 712 (887)
++++... . ..+||||++.| +|.+++... .++.. .+.+|+.+|.+||..||+|+||||.||||+. +
T Consensus 108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~-~ 178 (239)
T PRK01723 108 IAARVVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP-D 178 (239)
T ss_pred EeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC-C
Confidence 5544332 2 23599999953 888887542 25554 3678999999999999999999999999985 5
Q ss_pred CeEEEEecCccee
Q 002732 713 NVLKLCDFGNAMF 725 (887)
Q Consensus 713 ~~vKL~DFG~a~~ 725 (887)
+.++|+|||.+..
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 6899999998865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.2e-14 Score=168.13 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=184.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
+.+++.+-.|.|+.++.+.-..++ -..++|+....+......... ++..-.....+.+|.++...-.|.....+
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sg----h~~~~~v~~~ap~i~~~~~~s--~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSG----HTRPSKVHGLAPKIRTNDYES--IRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred ceecccccCCCCcccccCCccccc----cccchhhhccchhhccccccc--cCCccCccccCCCCceecccCCCCCCCCc
Confidence 677778899999999999766665 345555544322211110111 11111111112557777766667777889
Q ss_pred EEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 649 CLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 649 ~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
+||++|+ +++|...|+..+ .++...++.++..+..+++|||...++|+|++|.|+|+.. .+..++++||+....+
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~-~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY-DGHRPLTDFGTLSKVG 955 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccchhhcccccccchhhcc-cCCcccCccccccccc
Confidence 9999999 568888887755 3788888999999999999999999999999999999985 7778999998432110
Q ss_pred -------C--------------------------CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 002732 728 -------K--------------------------NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774 (887)
Q Consensus 728 -------~--------------------------~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF 774 (887)
. ......++|+.|.+||.+++.....++|||++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0012345788899999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhH
Q 002732 775 PGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854 (887)
Q Consensus 775 ~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 854 (887)
...+....+.+|.....+.| .-+...+
T Consensus 1036 na~tpq~~f~ni~~~~~~~p-----------------------------------------------------~g~~~~s 1062 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWP-----------------------------------------------------EGPEEGS 1062 (1205)
T ss_pred CCcchhhhhhccccCCCCCC-----------------------------------------------------CCccccC
Confidence 88777666655533222221 1112345
Q ss_pred HHHHHHHHHhcccCCCCCcCHH---HHHhCCCCCC
Q 002732 855 ANFKDLLDKIFVLDPEKRMTVA---QALTHPFISG 886 (887)
Q Consensus 855 ~~~~dLL~kmL~~DP~~RpTa~---elL~Hpwf~~ 886 (887)
..+.+++..+|..+|.+|..|. ++-.||||..
T Consensus 1063 ~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1063 YEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred hhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 6788999999999999999988 8889999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.5e-13 Score=139.85 Aligned_cols=141 Identities=18% Similarity=0.297 Sum_probs=109.2
Q ss_pred CCcceeEecceeeecC-----eEEEEEecc-hhhHHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHhhhccc--eeccCC
Q 002732 631 NKRHCIRFASSFKYRN-----HLCLVFESL-HMNLREVLKKFGRN-IGLKLTAVRAYAKQLFIALKHLKNCG--VLHCDI 701 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~~~-----~~~lV~E~~-~gsL~~~L~~~~~~-~~ls~~~~~~i~~qIl~aL~yLHs~g--IvHrDL 701 (887)
.|.|||+++.||.... ...+++||| .|+|..+|++..++ ..+....+..|+.||+.||.|||++. |+|++|
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 6788999999988754 588999999 78999999876543 34888889999999999999999984 999999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCC------CCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGK------NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~------~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~ 772 (887)
....|++.. ++.|||.--........ .......+-++|.+||.-...+.+.++|||++|++..+|..+..
T Consensus 205 Tc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 205 TCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred chhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999984 77777643222111110 01112234577999998877788899999999999999988764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.8e-12 Score=143.18 Aligned_cols=158 Identities=24% Similarity=0.373 Sum_probs=119.4
Q ss_pred cEEEEEEecccch-hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecchhhHHHHHHHhccCCCCCHH
Q 002732 597 EEVAIKIIRNNET-MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675 (887)
Q Consensus 597 ~~vAIKii~~~~~-~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~ 675 (887)
.+|.|.+++.... ....+.+-+.-|+.| .||+|+.+++.++..+++|||+|-+. .|..+|+. +...
T Consensus 38 ~~vsVF~~~~~~~~~~~~~~~A~k~lKtl------RHP~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~------l~~~ 104 (690)
T KOG1243|consen 38 GPVSVFVYKRSNGEVTELAKRAVKRLKTL------RHPNILSYLDTTEEEGTLYLVTERVR-PLETVLKE------LGKE 104 (690)
T ss_pred CceEEEEEeCCCchhhHHHHHHHHHhhhc------cCchhhhhhhhhcccCceEEEeeccc-cHHHHHHH------hHHH
Confidence 6788877765433 223445556666666 99999999999999999999999873 45667776 4577
Q ss_pred HHHHHHHHHHHHHHhhh-ccceeccCCCCCCccccCCCCeEEEEecCcceecCCCC--ccCcccCCcccchhhhcCCCCC
Q 002732 676 AVRAYAKQLFIALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYD 752 (887)
Q Consensus 676 ~~~~i~~qIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s 752 (887)
.+...+.||+.||.||| .++++|++|+-..|+|+. .+.+||++|.++....... ......-..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 88899999999999997 789999999999999996 7788999998875433221 11111222366776554333
Q ss_pred chhhHHHHHHHHHHHHcC
Q 002732 753 HPLDIWSVGCCLYELYTG 770 (887)
Q Consensus 753 ~~sDIwSLG~iL~elltG 770 (887)
-..|.|.|||++++++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-11 Score=140.73 Aligned_cols=251 Identities=19% Similarity=0.129 Sum_probs=174.5
Q ss_pred eecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh---HHHHHHHHHHHHhhCCCCCCCcceeEecc
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN---KAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 564 il~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~---~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
....+|.++..||.|.|+.||.+.....+ ...|++|-+.+..... .....|+.++..|. .|.+++.++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~---~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~-----~~~~~~g~~~ 333 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEG---DCIYAAKELLNGLATFASDIFSLGEVILEAILG-----SHLPSVGKNS 333 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCC---CceEeChhhhccccchHhhhcchhhhhHhhHhh-----cccccCCCCC
Confidence 44567999999999999999998743222 2689999876542221 22245666666663 6778898888
Q ss_pred eeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
.|......||-.||| ++++..-+... ..+.+...+.+..|++.+|.++|++.++|.|++|+||++...+...++.|
T Consensus 334 ~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 334 SWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred CccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccc
Confidence 888888888999999 55444333211 23788899999999999999999999999999999999985447778999
Q ss_pred cCcceecCCCCccCcccCCcc-cchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhhh
Q 002732 720 FGNAMFAGKNEITPYLVSRFY-RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y-~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
||++..+.-......-.+..| .++.++...++..+.|+|+||.-+.+.+++.+.-..... ...|
T Consensus 411 ~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i------------ 475 (524)
T KOG0601|consen 411 FGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTI------------ 475 (524)
T ss_pred cccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceee------------
Confidence 998864222111111223334 355555566789999999999999999998753211100 0000
Q ss_pred hcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHH
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~el 878 (887)
........+.....+..+...|+..+|..++.+.++
T Consensus 476 --------------------------------------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 476 --------------------------------------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred --------------------------------------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhh
Confidence 000011112333677899999999999999999999
Q ss_pred HhCCCC
Q 002732 879 LTHPFI 884 (887)
Q Consensus 879 L~Hpwf 884 (887)
..|+=|
T Consensus 512 ~~~~~~ 517 (524)
T KOG0601|consen 512 SLHSEF 517 (524)
T ss_pred cccchh
Confidence 888744
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.3e-11 Score=122.01 Aligned_cols=142 Identities=22% Similarity=0.268 Sum_probs=99.7
Q ss_pred EEeccCCceEEEEEEEcCC--CCCCCcEEEEEEecccc-----------------------hhhHHH----HHHHHHHHH
Q 002732 573 AAHGKGVFSTVVRAKDLKA--GNGEPEEVAIKIIRNNE-----------------------TMNKAG----QTEVQILKK 623 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~--~~~~~~~vAIKii~~~~-----------------------~~~~~~----~~Ei~iL~~ 623 (887)
..||.|.-+.||.|..... +......+|||+.+... .....+ ..|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4789999999999985431 01123589999985310 011222 379999999
Q ss_pred hhCCCCCCCcceeEecceeeecCeEEEEEecchhh-HH-HHHHHhccCCCCCHHHHHHHHHHHHHHHHhh-hccceeccC
Q 002732 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LR-EVLKKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCD 700 (887)
Q Consensus 624 L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs-L~-~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yL-Hs~gIvHrD 700 (887)
|.... ..++.++.+ ...+|||||++++ +. ..|.. ..++...+..++.+++.+|..| |.+||||+|
T Consensus 83 l~~~G----v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 83 MQKAG----IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHcC----CCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 96553 234455443 4568999999653 21 22322 1256667778889999999998 899999999
Q ss_pred CCCCCccccCCCCeEEEEecCcceecCC
Q 002732 701 IKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 701 LKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
|+|.|||+. ++.++|+|||.+.....
T Consensus 151 Ls~~NIL~~--~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH--DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE--CCcEEEEECCCceeCCC
Confidence 999999997 46689999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=5.8e-11 Score=118.82 Aligned_cols=128 Identities=18% Similarity=0.121 Sum_probs=92.7
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
++.|+.|.++.||++... + ..|+||+.............|+.++..|.... .++.++.++. ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~----~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~-----~~P~~~~~~~--~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--N----KKYVVRIPGNGTELLINRENEAENSKLAAEAG-----IGPKLYYFDP--ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEEC--C----eEEEEEeCCCCcccccCHHHHHHHHHHHHHhC-----CCCceEEEeC--CCCeEE
Confidence 467899999999999864 2 57999998665433345678999999985432 2344544433 235799
Q ss_pred Eecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccce-----eccCCCCCCccccCCCCeEEEEecCccee
Q 002732 652 FESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGV-----LHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 652 ~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gI-----vHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
|||+.| +|... ......++.+|+.+|..||..++ +|+||+|.|||++ ++.++|+||+.+..
T Consensus 70 ~e~i~G~~l~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 70 TEFIEGSELLTE-----------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred EEecCCCccccc-----------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 999965 44322 01123467899999999999885 9999999999998 45789999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.1e-11 Score=138.86 Aligned_cols=146 Identities=20% Similarity=0.293 Sum_probs=89.9
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch-----------------------------------hhH
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-----------------------------------MNK 612 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~-----------------------------------~~~ 612 (887)
.|+. ..||.|++|+||.|....+| +.||||++.+... ...
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G----~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNG----REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCC----CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 3666 78999999999999987766 7899999975421 011
Q ss_pred HHHHHHHHH------HHhhCCC-CCCCcceeEecceeeecCeEEEEEecc-hhhHHHH--HHHhcc-CCCCCHHHHHHHH
Q 002732 613 AGQTEVQIL------KKLAGAD-PENKRHCIRFASSFKYRNHLCLVFESL-HMNLREV--LKKFGR-NIGLKLTAVRAYA 681 (887)
Q Consensus 613 ~~~~Ei~iL------~~L~~~~-~~~h~~Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~--L~~~~~-~~~ls~~~~~~i~ 681 (887)
.+..|+.++ .++...- ....-.|+.++.-+ ....+|||||+ ++.|.++ +...+. ...+....+..++
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~--st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY--CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc--CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 122233333 3332110 00111223333222 34468999999 4577664 322221 0114444555556
Q ss_pred HHHHHHHHhhhccceeccCCCCCCccccCCCC----eEEEEecCcceecCC
Q 002732 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN----VLKLCDFGNAMFAGK 728 (887)
Q Consensus 682 ~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~----~vKL~DFG~a~~~~~ 728 (887)
.||+ ..||+|+|++|.||||+. ++ .++++|||++.....
T Consensus 274 ~Qif-------~~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVF-------RDGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHH-------hCCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence 6655 489999999999999985 44 899999999976654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-10 Score=132.00 Aligned_cols=140 Identities=22% Similarity=0.257 Sum_probs=90.8
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHH--------------------------------------
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-------------------------------------- 614 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~-------------------------------------- 614 (887)
..||.|++|+||+|... +| +.||||+...... ..+
T Consensus 123 ~plasaSigQVh~A~l~-~G----~~VaVKv~rp~i~--~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DG----KEVAVKVLRPGIE--KTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred cceeeeehhheEEEEec-CC----CEEEEEeeCCCcH--HHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 57999999999999864 44 7899999875321 112
Q ss_pred -----HHHHHHHHHhhCCCCCCCcc--eeEecceeeecCeEEEEEecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHH
Q 002732 615 -----QTEVQILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686 (887)
Q Consensus 615 -----~~Ei~iL~~L~~~~~~~h~~--Iv~l~~~~~~~~~~~lV~E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~ 686 (887)
..|...+.++...- .++++ |+.++.. .....+|||||+ +.+|.+++..... .+. ...++..++.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~-~~~~~v~vP~v~~~--~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 196 RELDLRREAANASELGENF-KNDPGVYVPEVYWD--RTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLAR 267 (437)
T ss_pred HHHCHHHHHHHHHHHHHhc-CCCCCEEeCCEehh--hcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHH
Confidence 22333333332111 12232 3333322 234468999999 5577776543211 122 2345555555
Q ss_pred -HHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 687 -ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 687 -aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
.+..+|..||+|+|++|.|||+.. ++.++|+|||++..+..
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEECC-CCcEEEEeCCCeeECCH
Confidence 467889999999999999999984 77899999999976653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=107.87 Aligned_cols=143 Identities=17% Similarity=0.164 Sum_probs=105.0
Q ss_pred EEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc---------cchhhHHHHHHHHHHHHhhCCCCCCCcceeEecce
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---------NETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 571 i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~---------~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
.+.+|-+|+-+.|+.+.+.. +.++||.-.. ..........|..+|.++.... -.++.+ +
T Consensus 11 ~l~likQGAEArv~~~~~~G------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~G----I~~P~l--~ 78 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALG----IPAPRL--I 78 (229)
T ss_pred cceeeeccceeeEeeeccCC------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhC----CCCceE--E
Confidence 67788999999999998755 4577775321 1222344578999999885442 122333 3
Q ss_pred eeecCeEEEEEecchh--hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeE--EE
Q 002732 642 FKYRNHLCLVFESLHM--NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL--KL 717 (887)
Q Consensus 642 ~~~~~~~~lV~E~~~g--sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~v--KL 717 (887)
|.+...-+|+|||+.| ++.+++....... ........++++|-..|.-||..+|||+||..+||||...++.+ .|
T Consensus 79 ~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 79 FIDTYGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EEecCCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence 4455566899999977 8999888765433 33334478999999999999999999999999999998655544 89
Q ss_pred EecCcceec
Q 002732 718 CDFGNAMFA 726 (887)
Q Consensus 718 ~DFG~a~~~ 726 (887)
+|||++...
T Consensus 158 Idfgls~~s 166 (229)
T KOG3087|consen 158 IDFGLSSVS 166 (229)
T ss_pred Eeecchhcc
Confidence 999998654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-09 Score=106.22 Aligned_cols=131 Identities=16% Similarity=0.178 Sum_probs=92.5
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc---------chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---------ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~---------~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
..+++|+-+.||.+.+.. ..+++|.=.+. ........+|..+|.++.... -+++.+++ .
T Consensus 2 ~~i~~GAEa~i~~~~~~g------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~G----V~~P~v~d--v 69 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG----VPVPIVYD--V 69 (204)
T ss_pred chhhCCcceeEEeeeccC------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcC----CCCCeEEE--E
Confidence 357899999999996643 23677754321 111234467999999986542 23344433 3
Q ss_pred ecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCc
Q 002732 644 YRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~ 722 (887)
+.+...|||||+.| .|.++|... ...++..|-..+.-||..||||+||.++||++.. +.+.++|||+
T Consensus 70 D~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~--~~i~~IDfGL 137 (204)
T COG3642 70 DPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG--GRIYFIDFGL 137 (204)
T ss_pred cCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC--CcEEEEECCc
Confidence 44556799999966 566677652 2567788888889999999999999999999973 4478999999
Q ss_pred ceecC
Q 002732 723 AMFAG 727 (887)
Q Consensus 723 a~~~~ 727 (887)
+.+..
T Consensus 138 g~~s~ 142 (204)
T COG3642 138 GEFSD 142 (204)
T ss_pred ccccc
Confidence 97543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.6e-08 Score=113.48 Aligned_cols=168 Identities=19% Similarity=0.247 Sum_probs=127.7
Q ss_pred CceEEEEEEEcCCCCCCCcEEEEEEecccchhh-HHHHHHHHHHHHhhCCCCCCCcceeEecceeee----cCeEEEEEe
Q 002732 579 VFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQTEVQILKKLAGADPENKRHCIRFASSFKY----RNHLCLVFE 653 (887)
Q Consensus 579 ~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~-~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~----~~~~~lV~E 653 (887)
--.+.|+|....+| ..|++|.++.+.... .....-++++++| .|.|||.|.++|.. ...++|||+
T Consensus 288 ~~~Ttyk~~s~~DG----~~YvLkRlhg~r~~~~nk~t~lve~wkkl------~h~NvV~frevf~t~tF~D~SlvlvYD 357 (655)
T KOG3741|consen 288 FSITTYKATSNVDG----NAYVLKRLHGDRDQSTNKDTSLVEAWKKL------CHTNVVPFREVFLTYTFGDLSLVLVYD 357 (655)
T ss_pred ccceeEeeeeccCC----ceeeeeeeccccccCcccchHHHHHHHHh------ccCceeehhhhhhhhccCcceEEEEEe
Confidence 44678999887777 789999996543322 2334567899999 89999999999884 357899999
Q ss_pred cch--hhHHHHHHHhc------------cCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEe
Q 002732 654 SLH--MNLREVLKKFG------------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 654 ~~~--gsL~~~L~~~~------------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~D 719 (887)
|+. ++|.++.-... .+..+++..+|.|+.||..||.+||+.|+...-|.|.+||++. +..|+|..
T Consensus 358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G-~~RIriS~ 436 (655)
T KOG3741|consen 358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG-KMRIRISG 436 (655)
T ss_pred cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC-cceEEEec
Confidence 984 58887653321 1335788999999999999999999999999999999999983 55888887
Q ss_pred cCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 002732 720 FGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772 (887)
Q Consensus 720 FG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~ 772 (887)
.|+..+...+...+ +.+ -..-|.=.||.||+.|.||..
T Consensus 437 C~i~Dvl~~d~~~~------------le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 437 CGIMDVLQEDPTEP------------LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ccceeeecCCCCcc------------hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 77776665543111 111 235688999999999999853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.6e-10 Score=132.09 Aligned_cols=151 Identities=23% Similarity=0.325 Sum_probs=109.5
Q ss_pred HHHHHHHhhhc-cceeccCCCCCCccccCCCCeEEEEecCcceecCCCCc------cC-----cccCCcccchhhhcCCC
Q 002732 683 QLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------TP-----YLVSRFYRAPEIILGLP 750 (887)
Q Consensus 683 qIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~------~~-----~~gt~~Y~aPE~l~~~~ 750 (887)
+++.||.|+|. .++||++|.|++|+++. ++.+||+.|+++.....+.. ++ ......|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 34499999995 68999999999999995 88889999998865443211 11 11244699999999988
Q ss_pred CCchhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHH
Q 002732 751 YDHPLDIWSVGCCLYELY-TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKK 829 (887)
Q Consensus 751 ~s~~sDIwSLG~iL~ell-tG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~ 829 (887)
.+.++|+|||||++|-++ .|+..|.+.+...... +.......
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~------------------------------------ 228 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNA------------------------------------ 228 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccccc------------------------------------
Confidence 999999999999999999 5666664433221111 00000000
Q ss_pred HHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCCC
Q 002732 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~~ 886 (887)
........++.++.+=|.+||..++..||++.+++..|||.+
T Consensus 229 ---------------~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D 270 (700)
T KOG2137|consen 229 ---------------GAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSD 270 (700)
T ss_pred ---------------ccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCC
Confidence 001112456688899999999999999999999999999975
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.7e-09 Score=111.26 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=93.3
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec---Ce
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR---NH 647 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~---~~ 647 (887)
..|+.|.++.||++.... + ..|+||+...... ....+..|+.++..|... +..+++++.+.... +.
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~----~~~vp~~~~~~~~~~~~~~ 74 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-G----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGT----GVPVPKVLALCEDPSVLGT 74 (223)
T ss_pred eecCCCccceEEEEEecC-C----cceEEEeCCCcccCcccccHHHHHHHHHHhhCC----CCCCCCEEEECCCCCccCC
Confidence 578999999999998643 2 5699999875433 345778999999999543 12344455544443 36
Q ss_pred EEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc---------------------------------
Q 002732 648 LCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN--------------------------------- 693 (887)
Q Consensus 648 ~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs--------------------------------- 693 (887)
.++||||+.| +|...+.. ..+++.....++.+|+.+|.+||+
T Consensus 75 ~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 75 PFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred ceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 7899999954 44333210 124444444555555555555542
Q ss_pred -----------------------cceeccCCCCCCccccCC-CCeEEEEecCccee
Q 002732 694 -----------------------CGVLHCDIKPDNMLVNEA-KNVLKLCDFGNAMF 725 (887)
Q Consensus 694 -----------------------~gIvHrDLKP~NILl~~~-~~~vKL~DFG~a~~ 725 (887)
..+||+|+.|.|||++.. .+.+.|+||+.+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 347999999999999853 45678999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.9e-08 Score=110.27 Aligned_cols=193 Identities=13% Similarity=0.135 Sum_probs=126.8
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecc------eee
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFAS------SFK 643 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~------~~~ 643 (887)
.....||+|+-+.+|-.-...+ .+-||++..+.....-+ +..|.. . ..||-+-.-+. +..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-------~VAKIYh~Pppa~~aqk--~a~la~---~--p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-------QVAKIYHAPPPAAQAQK--VAELAA---T--PDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred CCCccccCCccceeeecchhhc-------hhheeecCCCchHHHHH--HHHhcc---C--CCCcchhhhhcccHHHhhCC
Confidence 3456899999999997654333 35588876543322211 222222 1 13433221011 111
Q ss_pred ec-CeEEEEEecchh--hHHHHHH---HhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEE
Q 002732 644 YR-NHLCLVFESLHM--NLREVLK---KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 644 ~~-~~~~lV~E~~~g--sL~~~L~---~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL 717 (887)
.. ..+.++|+.+.| .+..++. .......+.+..++..++.|+.+...||..|.+-+|+.++|||+.. ...|.|
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd-~~~V~L 158 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSD-DSKVVL 158 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeec-CceEEE
Confidence 12 236788887743 2222221 1112234788899999999999999999999999999999999984 777888
Q ss_pred EecCcceecCCC-CccCcccCCcccchhhhc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCC
Q 002732 718 CDFGNAMFAGKN-EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTG-KVLFPGA 777 (887)
Q Consensus 718 ~DFG~a~~~~~~-~~~~~~gt~~Y~aPE~l~-----~~~~s~~sDIwSLG~iL~elltG-~~PF~~~ 777 (887)
+|-..-.+..+. .+-..++...|.+||... +..-+...|.|.||++||+||.| .+||.|.
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 876544333332 244557788999999765 44567889999999999999996 8999763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.5e-08 Score=103.61 Aligned_cols=128 Identities=24% Similarity=0.301 Sum_probs=79.6
Q ss_pred EEEEEEEcCCCCCCCcEEEEEEecccc---------------------------hhhHHHHHHHHHHHHhhCCCCCCCcc
Q 002732 582 TVVRAKDLKAGNGEPEEVAIKIIRNNE---------------------------TMNKAGQTEVQILKKLAGADPENKRH 634 (887)
Q Consensus 582 ~Vy~a~d~~~~~~~~~~vAIKii~~~~---------------------------~~~~~~~~Ei~iL~~L~~~~~~~h~~ 634 (887)
.||.|..... ..||||+..... ........|+.+|..|.... -+
T Consensus 1 ~Vy~~~~~~~-----~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~G----v~ 71 (188)
T PF01163_consen 1 DVYHAIDPDG-----EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAG----VP 71 (188)
T ss_dssp EEEEEEECTT-----EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-----S
T ss_pred CEEEEECCCC-----CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCC----cc
Confidence 4888886432 589999975310 01123367999999995442 23
Q ss_pred eeEecceeeecCeEEEEEecch--hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHh-hhccceeccCCCCCCccccCC
Q 002732 635 CIRFASSFKYRNHLCLVFESLH--MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH-LKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 635 Iv~l~~~~~~~~~~~lV~E~~~--gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~y-LHs~gIvHrDLKP~NILl~~~ 711 (887)
++.++.+. ..+|||||++ |.....|.... ++......++.+|+..+.. ||..||||+||.+.|||++.
T Consensus 72 vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~- 142 (188)
T PF01163_consen 72 VPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD- 142 (188)
T ss_dssp S--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET-
T ss_pred CCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec-
Confidence 55555432 3479999997 64333343322 2244567788888885555 58999999999999999985
Q ss_pred CCeEEEEecCcceecCC
Q 002732 712 KNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 712 ~~~vKL~DFG~a~~~~~ 728 (887)
+.+.|||||.+.....
T Consensus 143 -~~~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 143 -GKVYIIDFGQAVDSSH 158 (188)
T ss_dssp -TCEEE--GTTEEETTS
T ss_pred -ceEEEEecCcceecCC
Confidence 3789999999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-07 Score=101.09 Aligned_cols=108 Identities=13% Similarity=0.121 Sum_probs=80.5
Q ss_pred HHHHHHHHHHHhhCCCCCCCcceeEecceeee-----cCeEEEEEecchh--hHHHHHHHhccCCCCCHHHHHHHHHHHH
Q 002732 613 AGQTEVQILKKLAGADPENKRHCIRFASSFKY-----RNHLCLVFESLHM--NLREVLKKFGRNIGLKLTAVRAYAKQLF 685 (887)
Q Consensus 613 ~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~-----~~~~~lV~E~~~g--sL~~~L~~~~~~~~ls~~~~~~i~~qIl 685 (887)
.+..|+..+..|..... ..|. ++.+++. ....+||||++++ +|.+++.... ...........++.+|+
T Consensus 74 ~a~rE~~~l~~L~~~GI-ptP~---pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la 148 (268)
T PRK15123 74 GADREWRAIHRLHEVGV-DTMT---GVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVA 148 (268)
T ss_pred HHHHHHHHHHHHHHcCC-CCCC---eeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHH
Confidence 46789999998854432 2233 3333332 2357899999965 7888886432 12356778889999999
Q ss_pred HHHHhhhccceeccCCCCCCccccC------CCCeEEEEecCccee
Q 002732 686 IALKHLKNCGVLHCDIKPDNMLVNE------AKNVLKLCDFGNAMF 725 (887)
Q Consensus 686 ~aL~yLHs~gIvHrDLKP~NILl~~------~~~~vKL~DFG~a~~ 725 (887)
..+.-||..||+|+||+|.||||+. ....+.||||+.+..
T Consensus 149 ~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 149 TMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999999999999999999999974 245789999998854
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.1e-07 Score=98.07 Aligned_cols=138 Identities=21% Similarity=0.224 Sum_probs=96.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEeccc-----------------------chhhHHHHHHHHHHHHhh
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN-----------------------ETMNKAGQTEVQILKKLA 625 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~-----------------------~~~~~~~~~Ei~iL~~L~ 625 (887)
+.+..+||-|.-+.||.|.+... .++|||+-... ......+..|+.+|..|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g-----~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG-----RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HhhccccccCccceEEEEECCCC-----CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 66788999999999999997643 58999975321 111234578999999994
Q ss_pred CCCCCCCcceeEecceeeecCeEEEEEecchhh-HHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCC
Q 002732 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 626 ~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs-L~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~ 704 (887)
... -.|+..+++ +..++|||++.|. |..+ .++...+-.|+..|+.-+..+-..||||+||.+-
T Consensus 168 ~~G----~~VP~P~~~----nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSef 231 (304)
T COG0478 168 PEG----VKVPKPIAW----NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEF 231 (304)
T ss_pred hcC----CCCCCcccc----ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchh
Confidence 221 234554443 6789999999663 3221 1234455566666666666666899999999999
Q ss_pred CccccCCCCeEEEEecCcceecCC
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 705 NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
||||+. ++.+.|+||-.+.....
T Consensus 232 NIlV~~-dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 232 NILVTE-DGDIVVIDWPQAVPISH 254 (304)
T ss_pred eEEEec-CCCEEEEeCcccccCCC
Confidence 999995 77778999987755443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=91.67 Aligned_cols=108 Identities=23% Similarity=0.331 Sum_probs=81.5
Q ss_pred HHHHHHHHHHHHhhCCCCCCCcceeEecceeeec----CeEEEEEecchh--hHHHHHHHhccCCCCCHHHHHHHHHHHH
Q 002732 612 KAGQTEVQILKKLAGADPENKRHCIRFASSFKYR----NHLCLVFESLHM--NLREVLKKFGRNIGLKLTAVRAYAKQLF 685 (887)
Q Consensus 612 ~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~----~~~~lV~E~~~g--sL~~~L~~~~~~~~ls~~~~~~i~~qIl 685 (887)
.....|...+..|..... .++..+.+.+.. ...+||+|++.+ +|.+++..... ++......++.+|+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi----~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGI----PTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHcCC----CCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHH
Confidence 456788888888864432 233344444332 345899999954 78888886433 67778899999999
Q ss_pred HHHHhhhccceeccCCCCCCccccCCC--CeEEEEecCcceec
Q 002732 686 IALKHLKNCGVLHCDIKPDNMLVNEAK--NVLKLCDFGNAMFA 726 (887)
Q Consensus 686 ~aL~yLHs~gIvHrDLKP~NILl~~~~--~~vKL~DFG~a~~~ 726 (887)
..+.-||..||+|+||+|.||||+..+ ..+.||||+.+...
T Consensus 129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999999998633 26889999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.4e-06 Score=88.57 Aligned_cols=146 Identities=18% Similarity=0.216 Sum_probs=94.6
Q ss_pred ccCceecCcEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHH----------HHHHHHHHHHhhCC--
Q 002732 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA----------GQTEVQILKKLAGA-- 627 (887)
Q Consensus 560 ~~~eil~~~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~----------~~~Ei~iL~~L~~~-- 627 (887)
-+..+++++|.+++++-......|.+..-.. ..+++|.........+. ....+..+..+...
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIei~~------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~ 97 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIEIDG------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF 97 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEEECC------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence 3456778999999999999988888886433 57999988653222111 12344444444221
Q ss_pred CCCCCcceeEecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCc
Q 002732 628 DPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNM 706 (887)
Q Consensus 628 ~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NI 706 (887)
....-+.++-..-.+......+|||||+.| .|.++.. +++ .++..|+.+|.-||..|++|+|++|.|+
T Consensus 98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNF 166 (229)
T PF06176_consen 98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNF 166 (229)
T ss_pred cccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcE
Confidence 111222333322333334556799999965 5554432 333 2456677889999999999999999999
Q ss_pred cccCCCCeEEEEecCcce
Q 002732 707 LVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 707 Ll~~~~~~vKL~DFG~a~ 724 (887)
+++ ++.++|+||+...
T Consensus 167 lv~--~~~i~iID~~~k~ 182 (229)
T PF06176_consen 167 LVS--NNGIRIIDTQGKR 182 (229)
T ss_pred EEE--CCcEEEEECcccc
Confidence 998 3457899997653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=90.68 Aligned_cols=139 Identities=22% Similarity=0.219 Sum_probs=96.5
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHH-------------------------HHHHHHHHHHhhC
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKA-------------------------GQTEVQILKKLAG 626 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~-------------------------~~~Ei~iL~~L~~ 626 (887)
...|..|.-+.||+|.... + ..||||++......... ...|+.-|.++..
T Consensus 53 ~g~istGKEA~Vy~a~~~~-~----~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e 127 (268)
T COG1718 53 VGCISTGKEANVYLAETGD-G----RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE 127 (268)
T ss_pred EeeecCCcceEEEeeccCC-C----ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 3477889999999998532 2 68999999754322211 1457777777754
Q ss_pred CCCCCCcceeEecceeeecCeEEEEEecchhh--HHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhc-cceeccCCCC
Q 002732 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHMN--LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKP 703 (887)
Q Consensus 627 ~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs--L~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIvHrDLKP 703 (887)
+. -.+++.+.++. ..|||||++.. -.-.|.. ..+....+..+..+|+..+.-|-. +++||+||..
T Consensus 128 AG----VrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 128 AG----VRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred cC----CCCCCceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 42 23444444433 47999999643 1112222 124444788889999999988876 9999999999
Q ss_pred CCccccCCCCeEEEEecCcceecCCC
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 704 ~NILl~~~~~~vKL~DFG~a~~~~~~ 729 (887)
-|||+. ++.+.||||+.|.....+
T Consensus 196 yNiL~~--~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 196 YNILVH--DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred hheEEE--CCeEEEEECccccccCCC
Confidence 999998 678899999999776643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.5e-06 Score=85.02 Aligned_cols=138 Identities=13% Similarity=0.069 Sum_probs=99.5
Q ss_pred ccCCceEEEEEEEcCCCCCCCcEEEEEEecc----c---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee----
Q 002732 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN----N---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY---- 644 (887)
Q Consensus 576 G~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~----~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~---- 644 (887)
|.||-+.|+...... ..|-||...+ + +.....+..|+..|..|.....+ +++++ ++..
T Consensus 27 ~rgG~SgV~r~~~~g------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP----VP~pv-f~~~~k~~ 95 (216)
T PRK09902 27 RRNGMSGVQCVERNG------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI----VPKIV-FGEAVKIE 95 (216)
T ss_pred CCCCcceEEEEEeCC------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC----CCccc-eeeeeccC
Confidence 667888888765432 2477776542 1 33457889999999999766432 44444 2221
Q ss_pred -cCeEEEEEecch--hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCC-eEEEEec
Q 002732 645 -RNHLCLVFESLH--MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-VLKLCDF 720 (887)
Q Consensus 645 -~~~~~lV~E~~~--gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-~vKL~DF 720 (887)
.-.-+||+|-++ .+|.+++..... ...+......++.+|+.+|.-||..||.|+|+.+.|||++..+. .|.++||
T Consensus 96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 96 GEWRALLVTEDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred CceEEEEEEEeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 234689999887 589888865322 23577778899999999999999999999999999999974332 4899999
Q ss_pred Cccee
Q 002732 721 GNAMF 725 (887)
Q Consensus 721 G~a~~ 725 (887)
.-+..
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-05 Score=82.98 Aligned_cols=143 Identities=20% Similarity=0.249 Sum_probs=81.6
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee---eecCeE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF---KYRNHL 648 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~---~~~~~~ 648 (887)
+..|+.|..+.||++.... + .++||+.... .....+..|..++..|..... .++.++.+. ......
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-----~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~----pvP~~~~~~~~~~~~~~~ 70 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-----RYVLKFYRPP-DAAERLRREAAVLRQLAEHGI----PVPRVLAFDTSDEFNGFP 70 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-----EEEEEEESSH-HHHHHHHHHHHHHHHHHHTTS----BS--EEEEEEETEETSEE
T ss_pred CccCCCCCeeeEEEEEECC-c-----EEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCC----CCceEEeecccccccccc
Confidence 5689999999999998655 3 6999998665 445677889999999964432 344554433 334467
Q ss_pred EEEEecchh-hHHH----------------HHHHhcc----CCCCCHHH------HHHH---------------HHHHHH
Q 002732 649 CLVFESLHM-NLRE----------------VLKKFGR----NIGLKLTA------VRAY---------------AKQLFI 686 (887)
Q Consensus 649 ~lV~E~~~g-sL~~----------------~L~~~~~----~~~ls~~~------~~~i---------------~~qIl~ 686 (887)
+++|+++.| .+.. +|..... ...+.... ...+ +..+..
T Consensus 71 ~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (239)
T PF01636_consen 71 YLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEE 150 (239)
T ss_dssp EEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHH
T ss_pred eEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHH
Confidence 999999844 3333 2221111 01111100 0000 011222
Q ss_pred -HHHhhh-------ccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 687 -ALKHLK-------NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 687 -aL~yLH-------s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+..|+ ...+||+|+.|.|||++..++.|-|+||+.+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 151 RLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 223332 356999999999999994456668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.7e-08 Score=109.72 Aligned_cols=186 Identities=15% Similarity=0.126 Sum_probs=140.8
Q ss_pred cEEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcc-eeEecceeeecC
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH-CIRFASSFKYRN 646 (887)
Q Consensus 568 ~Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~-Iv~l~~~~~~~~ 646 (887)
.|.+...+++|+++.+++++...+. ....+++... ....-++++|.++ +||| .+..++.+..+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaek-----lL~h~fvs~~----l~~rl~~eLLdK~------n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEK-----LLQHPFVSQT----LSRRLAIELLDKV------NNPNPVVRYLEDYDGED 307 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhh-----heeceeeccc----hhhHHHHHHHHHc------cCCCCcccccccCCccc
Confidence 3666677899999999999887765 3346766543 4445678889988 7888 778888888899
Q ss_pred eEEEEEecchhh--HHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcce
Q 002732 647 HLCLVFESLHMN--LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 647 ~~~lV~E~~~gs--L~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~ 724 (887)
+.+|+++++.+. ....+. .....|-+.+...++..-+.+|++||+.-=+|+| |||.. .+.+++.+|+.+.
T Consensus 308 ~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s--~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 308 YLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS--EEEVKLLDFAVPP 379 (829)
T ss_pred ccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc--ccccccccccCCc
Confidence 999999999432 221111 1122355666677888888999999998768888 88886 3667999999886
Q ss_pred ecCCC-CccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 002732 725 FAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776 (887)
Q Consensus 725 ~~~~~-~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF~~ 776 (887)
.+... ...+..+++.++|||++....+....|+|++|+-..+|--|.+|-..
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 55433 24567789999999999999999999999999887788888777643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.7e-05 Score=97.37 Aligned_cols=236 Identities=20% Similarity=0.267 Sum_probs=143.9
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEec--ccchhh--HHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMN--KAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~--~~~~~~--~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
|..-.+|+|++.++..........+-++.-. ...... .....|+..+..+ .|.|++.++.|........+
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~------~~~n~~~~~~~~le~~~~g~ 259 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKI------AHDNLGGYFVYGLERLFRGI 259 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhh------ccccccceeEEeehhhcchH
Confidence 6777788888887643210000111111110 000111 1223345555556 78888888777655433333
Q ss_pred EE----ecc-hhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCC---CccccCCCCeEEEE--ec
Q 002732 651 VF----ESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD---NMLVNEAKNVLKLC--DF 720 (887)
Q Consensus 651 V~----E~~-~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~---NILl~~~~~~vKL~--DF 720 (887)
|+ ++| ..+|..+++..+. ++..+++.+..+++.||.|+|+....|.-|... +..++ ..+++.++ ||
T Consensus 260 ~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~ 335 (1351)
T KOG1035|consen 260 VLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVD-GEGVVAISLSDF 335 (1351)
T ss_pred HHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccC-ccceeecchhhh
Confidence 33 344 3477777777654 899999999999999999999986555544443 22222 23344544 88
Q ss_pred CcceecCCCCc-cCcccCCcccchhhhcCCCCCch--hhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhhCCCChhh
Q 002732 721 GNAMFAGKNEI-TPYLVSRFYRAPEIILGLPYDHP--LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 721 G~a~~~~~~~~-~~~~gt~~Y~aPE~l~~~~~s~~--sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+.+........ .....+..+.+||......+..+ .|+|+||.++..++.|..+-... ..|..+
T Consensus 336 ~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~--------------~~~~~~ 401 (1351)
T KOG1035|consen 336 DSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS--------------AVPVSL 401 (1351)
T ss_pred cccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc--------------cchhhh
Confidence 87766554332 22334556888888877766555 69999999999999876432100 000000
Q ss_pred hhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChhhHHHHHHHHHHhcccCCCCCcCHHH
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+ ... ......+++.+|+.-++..|+++.+
T Consensus 402 l-----------------------------------------~~~----------~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 402 L-----------------------------------------DVL----------STSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred h-----------------------------------------ccc----------cchhhhhhhhhhcchhhhhccchhh
Confidence 0 000 0014578999999999999999999
Q ss_pred HHhCCCCC
Q 002732 878 ALTHPFIS 885 (887)
Q Consensus 878 lL~Hpwf~ 885 (887)
+|.|||+.
T Consensus 431 ll~~~f~~ 438 (1351)
T KOG1035|consen 431 LLTHPFLR 438 (1351)
T ss_pred hhhchhcc
Confidence 99999975
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00022 Score=83.70 Aligned_cols=141 Identities=22% Similarity=0.289 Sum_probs=83.9
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHH------------------------------------
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT------------------------------------ 616 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~------------------------------------ 616 (887)
..|+.++-|+||.|.... | +.||||+..++-. ..+..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G----~~VAVKVqrPgi~--~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-G----EEVAVKVQRPGIR--ERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred CchhhhhHhhheeEEecC-C----CEEEEEecCCChH--HHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 578999999999999765 4 7999999875421 11111
Q ss_pred -------HHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecchh-hHHHH--HHHhccCCCCCHHHHHHHHHHHHH
Q 002732 617 -------EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREV--LKKFGRNIGLKLTAVRAYAKQLFI 686 (887)
Q Consensus 617 -------Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~--L~~~~~~~~ls~~~~~~i~~qIl~ 686 (887)
|..-+.++...- .+.+.|.--.-+++..+.-.|+|||+.| .+.++ +... +++...+...+.+++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf-~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d~k~ia~~~~~~f- 277 (517)
T COG0661 204 EELDYRREAANAERFRENF-KDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GIDRKELAELLVRAF- 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHc-CCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCCHHHHHHHHHHHH-
Confidence 222222221110 1223322222233334556899999965 56655 4432 255333333222222
Q ss_pred HHHhhhccceeccCCCCCCccccCCCCeEEEEecCcceecCC
Q 002732 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 687 aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~ 728 (887)
+..+-..|++|+|.+|.||++.. ++.+.+.|||+...+..
T Consensus 278 -~~q~~~dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 -LRQLLRDGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -HHHHHhcCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence 22223479999999999999995 68888999999865544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.8e-05 Score=80.49 Aligned_cols=72 Identities=13% Similarity=0.045 Sum_probs=50.8
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEE
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVF 652 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~ 652 (887)
.+||.|..+.||++. + ..+++|+..... .......|..++..|.... -.++.++.+....+.+++||
T Consensus 7 ~~i~~G~t~~~y~~~----~----~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~g----lpvP~~~~~~~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----T----GKWMLKLYNPGF-DKETIKREFDASRKVFSLG----IPTPHPFDLVEDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEec----C----CCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcC----CCCCceEEEEecCCeeeeee
Confidence 478999999999742 2 347889886533 3355688999999996332 12455566666667788999
Q ss_pred ecchh
Q 002732 653 ESLHM 657 (887)
Q Consensus 653 E~~~g 657 (887)
+++.|
T Consensus 74 e~i~G 78 (226)
T TIGR02172 74 ELIVG 78 (226)
T ss_pred eecCC
Confidence 99865
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=6.9e-05 Score=77.36 Aligned_cols=132 Identities=22% Similarity=0.237 Sum_probs=95.7
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-----------------hhhHHHHHHHHHHHHhhCCCCCCCcce
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-----------------TMNKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-----------------~~~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
..||.|+.=.||.--+- ...+||++.... ........|+.....|.......+.+|
T Consensus 7 ~~i~~G~~R~cy~HP~d-------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i 79 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDD-------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI 79 (199)
T ss_pred cccccCCCceEEECCCC-------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence 46899999999954322 347999997655 224666788888888863334467899
Q ss_pred eEecceeeecCeEEEEEecc---h----hhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCCCccc
Q 002732 636 IRFASSFKYRNHLCLVFESL---H----MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV 708 (887)
Q Consensus 636 v~l~~~~~~~~~~~lV~E~~---~----gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~NILl 708 (887)
.+++|+.++.-.+.+|+|.+ . .+|.+++... .++. .+...|-.-..||-..+|+.+||+|.||++
T Consensus 80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVV 151 (199)
T ss_pred ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEE
Confidence 99999999998899999976 2 3688887542 2555 333334445577888999999999999999
Q ss_pred cCC--CC-eEEEEe
Q 002732 709 NEA--KN-VLKLCD 719 (887)
Q Consensus 709 ~~~--~~-~vKL~D 719 (887)
... +. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 642 22 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG4676 consensus Splicing factor, arginine/serine-rich [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.90 E-value=2.2e-06 Score=92.33 Aligned_cols=22 Identities=32% Similarity=0.157 Sum_probs=10.4
Q ss_pred CCCCCcccccccccCccchhhc
Q 002732 126 GRSRSHDVVKERSRSQSVMEEE 147 (887)
Q Consensus 126 ~r~~~~~r~~~r~~s~~~~~~~ 147 (887)
..+..|..+++++.+.++.-.+
T Consensus 177 ev~ya~~ask~~s~~c~~sf~~ 198 (479)
T KOG4676|consen 177 EVSYAHTASKSRSSSCSHSFRK 198 (479)
T ss_pred hhhhhhhhccCCCcchhhhHhh
Confidence 4444555555555544444333
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.6e-05 Score=79.60 Aligned_cols=70 Identities=17% Similarity=0.078 Sum_probs=47.1
Q ss_pred eccCCc-eEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEe
Q 002732 575 HGKGVF-STVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE 653 (887)
Q Consensus 575 LG~G~f-g~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E 653 (887)
|-.|.+ ..||.+.... ..++||+..... ......|+.+|..|... .-+++++.++...+..+|||+
T Consensus 6 ~~~g~~~~~v~~~~~~~------~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-----~~vP~v~~~~~~~~~~~lv~e 72 (244)
T cd05150 6 VTEGQSGATVYRLDGKN------PGLYLKIAPSGP--TYELEREAERLRWLAGK-----LPVPEVIDYGSDDGRAWLLTS 72 (244)
T ss_pred cCCCCCcCeEEEEcCCC------CcEEEEecCCCc--ccchHHHHHHHHHHHhc-----CCCCeEEEEEecCCccEEEEE
Confidence 333444 7889886432 368889876543 34567899999999633 235566666666567889999
Q ss_pred cchh
Q 002732 654 SLHM 657 (887)
Q Consensus 654 ~~~g 657 (887)
++.|
T Consensus 73 ~i~G 76 (244)
T cd05150 73 AVPG 76 (244)
T ss_pred eeCC
Confidence 9854
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00015 Score=74.52 Aligned_cols=127 Identities=20% Similarity=0.226 Sum_probs=89.1
Q ss_pred CcEEEEEEeccCCc-eEEEEEEEcCCCCCCCcEEEEEEecc----c-----------c-------hhhHHHHHHHHHHHH
Q 002732 567 GRYEVTAAHGKGVF-STVVRAKDLKAGNGEPEEVAIKIIRN----N-----------E-------TMNKAGQTEVQILKK 623 (887)
Q Consensus 567 ~~Y~i~~~LG~G~f-g~Vy~a~d~~~~~~~~~~vAIKii~~----~-----------~-------~~~~~~~~Ei~iL~~ 623 (887)
..+++++.||.|.- |.||++.... ..||||++.. . . ....-+..|....-+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgR 110 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGR 110 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC------eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHH
Confidence 56999999999999 9999998644 5799999321 0 0 222345678888888
Q ss_pred hhCCCCCCCcce--eEecceeeec------------------CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHH
Q 002732 624 LAGADPENKRHC--IRFASSFKYR------------------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQ 683 (887)
Q Consensus 624 L~~~~~~~h~~I--v~l~~~~~~~------------------~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~q 683 (887)
|... .+.++ |++++|+.-. ....||.||+...- .++ ..-+.+
T Consensus 111 Lke~---~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~ 172 (207)
T PF13095_consen 111 LKEA---GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQ 172 (207)
T ss_pred HHhc---cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHH
Confidence 7655 34445 7777776322 12467777663321 122 234566
Q ss_pred HHHHHHhhhccceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 684 Il~aL~yLHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
|+.-|..||.+||+-+||++.|..=. +|+|||.+
T Consensus 173 ~~~dl~~~~k~gI~~~Dv~~~ny~~G------~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILHKLGIVPRDVKPRNYRGG------KLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHCCeeeccCccccccCC------EEEecccC
Confidence 78888899999999999999998833 79999975
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.9e-05 Score=76.37 Aligned_cols=130 Identities=24% Similarity=0.255 Sum_probs=89.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
..+...|++|.+|.||++.+.. ..+|+|+-..+ .....+..|.+||..+.... -.++++.+ +..
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~------~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~-----~~p~vy~y----g~~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG------GEVALKVRRRD-SPRRNLEKEAKILEILAGEG-----VTPEVYFY----GED 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC------ceEEEEEecCC-cchhhHHHHHHHHHHhhhcC-----CCceEEEe----chh
Confidence 4566789999999999998765 36999987654 44578889999999995332 22344443 234
Q ss_pred EEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCC-C-CCccccCCCCeEEEEecCccee
Q 002732 649 CLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK-P-DNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 649 ~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLK-P-~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+++|||+.| .|..+... .+ ..-+..++....-|-..||-|..|. | .||+++ .+.+.||||..|++
T Consensus 88 ~i~me~i~G~~L~~~~~~------~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG------GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN--DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhc------cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec--CCcEEEEEccchhh
Confidence 567999966 76655432 11 3334456666666778899999987 4 356664 44778999999974
Q ss_pred c
Q 002732 726 A 726 (887)
Q Consensus 726 ~ 726 (887)
.
T Consensus 156 k 156 (201)
T COG2112 156 K 156 (201)
T ss_pred c
Confidence 3
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00036 Score=74.11 Aligned_cols=75 Identities=12% Similarity=0.036 Sum_probs=43.6
Q ss_pred EEeccCCce-EEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 573 AAHGKGVFS-TVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 573 ~~LG~G~fg-~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
..|+.|+.. .||.+. ..++||+.... .....+..|..+|..|........|.++..-.........|+|
T Consensus 3 ~~~~~gG~~n~vy~~~---------~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG---------DDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC---------CceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467777766 488762 13788876542 2345788899999999643222344433321111112345788
Q ss_pred Eecchh
Q 002732 652 FESLHM 657 (887)
Q Consensus 652 ~E~~~g 657 (887)
|+++.|
T Consensus 73 ~~~i~G 78 (235)
T cd05155 73 YRWLEG 78 (235)
T ss_pred EEeecC
Confidence 998744
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG4676 consensus Splicing factor, arginine/serine-rich [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.2e-05 Score=84.85 Aligned_cols=14 Identities=29% Similarity=0.418 Sum_probs=6.3
Q ss_pred CCCCCccccccccc
Q 002732 81 PMEDDQSYLHDRRK 94 (887)
Q Consensus 81 ~~~~~~~~~~~~~~ 94 (887)
++-|.-+|-|-.-+
T Consensus 173 ~r~Gev~ya~~ask 186 (479)
T KOG4676|consen 173 ERKGEVSYAHTASK 186 (479)
T ss_pred hhcchhhhhhhhcc
Confidence 34444445554333
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00061 Score=72.09 Aligned_cols=73 Identities=16% Similarity=0.283 Sum_probs=45.8
Q ss_pred EEEeccCCceEEEEEEEcC-CCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEE
Q 002732 572 TAAHGKGVFSTVVRAKDLK-AGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCL 650 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~-~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~l 650 (887)
++.|..|-...||++.... .+ ..|++|+........-....|+.++..|.... .++.++..+. + .+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~----~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~g-----l~P~v~~~~~--~--~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQ----DAVLVRVYGNKTELIIDRERELRIHKLLSKHG-----LAPKLYATFQ--N--GL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCC----CeEEEEEccCCccceecHHHHHHHHHHHHhCC-----CCCeEEEEeC--C--cE
Confidence 4577888889999986432 12 57999987654322233457999999996443 1234443332 1 37
Q ss_pred EEecchh
Q 002732 651 VFESLHM 657 (887)
Q Consensus 651 V~E~~~g 657 (887)
||||+.|
T Consensus 70 l~e~i~G 76 (235)
T cd05157 70 IYEFIPG 76 (235)
T ss_pred EEEeeCC
Confidence 9999843
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00038 Score=81.48 Aligned_cols=144 Identities=17% Similarity=0.231 Sum_probs=85.0
Q ss_pred EEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh--------------------------------HHHHHHHHH
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--------------------------------KAGQTEVQI 620 (887)
Q Consensus 573 ~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~--------------------------------~~~~~Ei~i 620 (887)
+.||..+.|+|+.|.... | +.||||+.++.-... ..+..|+..
T Consensus 167 ~piaaASlaQVhrA~L~~-G----~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-G----EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred chhhhcchhheEEEEecC-C----CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 478999999999999766 5 799999987531110 001112222
Q ss_pred HHH----------hhCCCCCCCcceeEecceeeecCeEEEEEecchh-hHH--HHHHHhccCCCCCHHHHHHHHHHHHHH
Q 002732 621 LKK----------LAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLR--EVLKKFGRNIGLKLTAVRAYAKQLFIA 687 (887)
Q Consensus 621 L~~----------L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~--~~L~~~~~~~~ls~~~~~~i~~qIl~a 687 (887)
+.. +.+......-.|++++-.+. ..-.|+||||.| .+. +.|.+.+ ++...+...+.++..
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g----i~~~~i~~~l~~~~~- 314 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG----ISPHDILNKLVEAYL- 314 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC----CCHHHHHHHHHHHHH-
Confidence 221 11111000112444433332 346899999955 332 4454433 666644443333332
Q ss_pred HHhhhccceeccCCCCCCccccC---CCCeEEEEecCcceecCCC
Q 002732 688 LKHLKNCGVLHCDIKPDNMLVNE---AKNVLKLCDFGNAMFAGKN 729 (887)
Q Consensus 688 L~yLHs~gIvHrDLKP~NILl~~---~~~~vKL~DFG~a~~~~~~ 729 (887)
..|=..|++|+|-+|.||||.. .+..+.|.|||+...+...
T Consensus 315 -~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 315 -EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2233568999999999999983 4667889999998665543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00036 Score=76.68 Aligned_cols=140 Identities=24% Similarity=0.313 Sum_probs=95.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchh-----------------------hH----HHHHHHHHH
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM-----------------------NK----AGQTEVQIL 621 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~-----------------------~~----~~~~Ei~iL 621 (887)
-.|-.+|..|.-+.||.|.... | ..+||||++.+-.. .+ =+..|+.-|
T Consensus 146 ~~inGCiSTGKEANVYHat~~d-G----~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEED-G----SEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred eecccccccCccceeEeeecCC-C----ceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence 3455688889999999997443 3 56999998632100 01 114688888
Q ss_pred HHhhCCCCCCCcceeEecceeeecCeEEEEEecchhh--HHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhh-hccceec
Q 002732 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN--LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLH 698 (887)
Q Consensus 622 ~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs--L~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yL-Hs~gIvH 698 (887)
++|..+.. .+|-.+-| ....|||+|++.+ -.-.|+. ..|+...+..+..|++..+.-| |.|++||
T Consensus 221 kRl~~aGI-P~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd----~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVH 288 (520)
T KOG2270|consen 221 KRLNNAGI-PCPEPILL-------KNHVLVMEFLGRDGWAAPKLKD----ASLSTSKARELYQQCVRIMRRLYQKCRLVH 288 (520)
T ss_pred HHHHhcCC-CCCCceee-------ecceEeeeeccCCCCcCccccc----ccCChHHHHHHHHHHHHHHHHHHHHhceec
Confidence 88865542 22222222 1257999999642 2233332 3378788888888888888777 6799999
Q ss_pred cCCCCCCccccCCCCeEEEEecCcceecC
Q 002732 699 CDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727 (887)
Q Consensus 699 rDLKP~NILl~~~~~~vKL~DFG~a~~~~ 727 (887)
.||.--|+|+. ++.|.|||.+.+.-..
T Consensus 289 ADLSEfN~Lyh--dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 289 ADLSEFNLLYH--DGKLYIIDVSQSVEHD 315 (520)
T ss_pred cchhhhhheEE--CCEEEEEEccccccCC
Confidence 99999999997 6889999999886544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.001 Score=83.46 Aligned_cols=82 Identities=12% Similarity=0.078 Sum_probs=52.6
Q ss_pred EEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccch--hhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec---
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR--- 645 (887)
Q Consensus 571 i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~--- 645 (887)
.+..|+.|.+..+|++.....+ ....++||+...... ....+..|+.+|..|.... ...+++++.+|...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~--~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~---~vpVP~v~~~~~d~~v~ 116 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGG--SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHT---DVPVPKVYCLCTDASVI 116 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCC--cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcC---CCCCCcEEEEecCCCcC
Confidence 3567899999999998754321 113577777654321 2346789999999995321 12345566655543
Q ss_pred CeEEEEEecchh
Q 002732 646 NHLCLVFESLHM 657 (887)
Q Consensus 646 ~~~~lV~E~~~g 657 (887)
+..||||||+.|
T Consensus 117 G~~flVME~v~G 128 (822)
T PLN02876 117 GTAFYIMEYLEG 128 (822)
T ss_pred CCceEEEEecCC
Confidence 467899999855
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0017 Score=72.09 Aligned_cols=144 Identities=15% Similarity=0.107 Sum_probs=78.5
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEec-c--eeeecCeE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFA-S--SFKYRNHL 648 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~-~--~~~~~~~~ 648 (887)
++.|+.|....+|.+.... ..++||++.. ........|+.++..|..... ..|.++.-. + +....+..
T Consensus 27 ~~~l~~G~~n~~y~v~t~~------g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~gl-pvP~~i~~~~G~~~~~~~g~~ 97 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ------GEYVLTLFER--LTAEDLPFFLGLMQHLAARGV-PVPAPVARRDGAALGELAGKP 97 (319)
T ss_pred cchhccccccceEEEEeCC------CcEEEEEecc--CChHHhHHHHHHHHHHHHCCC-CCCcceeCCCCCEeeeeCCEE
Confidence 4456778878999887432 2589998752 223455567788888864432 234433311 1 12235667
Q ss_pred EEEEecchhh------------HHHHHHHhcc---C------CCCCHHHHHH---------------HHHH-HHHHHHhh
Q 002732 649 CLVFESLHMN------------LREVLKKFGR---N------IGLKLTAVRA---------------YAKQ-LFIALKHL 691 (887)
Q Consensus 649 ~lV~E~~~gs------------L~~~L~~~~~---~------~~ls~~~~~~---------------i~~q-Il~aL~yL 691 (887)
++||+|+.|. +...|..... . .......... .+.+ +...+..+
T Consensus 98 ~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (319)
T PRK05231 98 AAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFL 177 (319)
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhh
Confidence 8999998542 2222222110 0 0011111100 1111 11112222
Q ss_pred h-------ccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 692 K-------NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 692 H-------s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
. ..++||+|+.|.|||++. +..+-|+||+.++.
T Consensus 178 ~~~~~~~lp~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~~ 217 (319)
T PRK05231 178 ASAAWPALPRGVIHADLFRDNVLFEG-DRLSGFIDFYFACN 217 (319)
T ss_pred hccccccCCcccCCCCCCCCcEEEEC-CceEEEEecccccC
Confidence 2 247999999999999983 55557999998744
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.003 Score=69.65 Aligned_cols=79 Identities=13% Similarity=0.038 Sum_probs=53.9
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee---ec
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK---YR 645 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~---~~ 645 (887)
..-+..||.|..+.||....... .++||+.+. ......+..|...|+.|...... .|+++++++. ..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~------~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~v---pVP~V~~~~~~~~~~ 85 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG------NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTV---RMPTVYGVMTHEQSP 85 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC------CEEEEEecc-cccchHHHHHHHHHHHHccCCCC---CcCcEEEEeccCCcC
Confidence 44567899999999999864332 477888543 22346889999999999654322 3455554443 34
Q ss_pred CeEEEEEecchh
Q 002732 646 NHLCLVFESLHM 657 (887)
Q Consensus 646 ~~~~lV~E~~~g 657 (887)
+..+||||++.|
T Consensus 86 g~~~LVmE~i~G 97 (297)
T PRK10593 86 GPDVLLLERLRG 97 (297)
T ss_pred CCeEEEEeccCC
Confidence 678999999853
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00063 Score=77.54 Aligned_cols=169 Identities=22% Similarity=0.266 Sum_probs=103.7
Q ss_pred HHHHHHHHHHhhCCCCCCCcceeEecceeeec-CeEEEEEecchhhHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhh
Q 002732 614 GQTEVQILKKLAGADPENKRHCIRFASSFKYR-NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692 (887)
Q Consensus 614 ~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~-~~~~lV~E~~~gsL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLH 692 (887)
+.--+.+++.+ .|+++.+++++-... ....+|+|+++.+|.+++.... ...++ + +
T Consensus 29 ilgr~~~lktl------~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~-l~~~s------~----~------- 84 (725)
T KOG1093|consen 29 ILGRFQYLKSL------QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN-LKDES------L----L------- 84 (725)
T ss_pred HhhhhHHHHhh------cCccceeeEeeecCccceEEEEehhhccchHHHHHhcc-cchhh------h----c-------
Confidence 33445566666 899999988876543 4588999999999999987632 11011 0 0
Q ss_pred ccceeccCCCCCCccccCCCCeEEEEecCcceecCCCCccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCC
Q 002732 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772 (887)
Q Consensus 693 s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~ 772 (887)
.+++.| -||+ +++| -++... | .+..+++|||+||.|+.+++.|..
T Consensus 85 ~~~~~~-----~~~~--------~~td-~~~t~~----------------~-----~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 85 AHGVLH-----LNII--------YITD-HFLTKY----------------P-----SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ccccce-----ehhh--------hccc-cccccC----------------C-----CCCCcchhhhhHHHHHHHHHHhhH
Confidence 222222 1222 2333 111000 0 012249999999999999999998
Q ss_pred CCCCCChHHHHHHHHHhhCCCChhhhhcccccccccccccccccCcCChhhHHHHHHHHhhcCCCCccccccCCCCCChh
Q 002732 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852 (887)
Q Consensus 773 PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~f~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (887)
.|......+.+..|.+... .+...+ ......++. -.
T Consensus 130 l~~~~~~s~~l~~i~k~~~-~d~~~~-------------------------~~a~e~~~~------------------~~ 165 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYT-DDQELL-------------------------STAMEHLIQ------------------LL 165 (725)
T ss_pred HHHHHHHHHHHHHHHHhcc-CchhHH-------------------------HHHHHHHHH------------------Hh
Confidence 8877666666655544321 111110 001111111 12
Q ss_pred hHHHHHHHHHHhcccCCCCCcCHHHHHhCCCCC
Q 002732 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885 (887)
Q Consensus 853 ~s~~~~dLL~kmL~~DP~~RpTa~elL~Hpwf~ 885 (887)
+...+..++.+|+-..|..||...++++|+-|+
T Consensus 166 ~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ 198 (725)
T KOG1093|consen 166 ADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT 198 (725)
T ss_pred hhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence 446788999999999999999999999998775
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0027 Score=70.34 Aligned_cols=147 Identities=18% Similarity=0.135 Sum_probs=80.8
Q ss_pred EEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecc---eeeecC
Q 002732 570 EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFAS---SFKYRN 646 (887)
Q Consensus 570 ~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~---~~~~~~ 646 (887)
..+..|+.|....||++.. .. ..+++|+..... .......|+.++..|..... ..|-++...+ +....+
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~-----~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~-pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DV-----GRYILTLYEKRV-KAEELPFFLALTTHLAARGL-PVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred eeccccCCccccceEEEEe-CC-----CcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCC-CCCccccCCCCCeehhcCC
Confidence 3456778887889998863 22 258889875421 12445677888888854332 2333332211 112246
Q ss_pred eEEEEEecchhh------------HHHHHHHhc---cC--CC----CCHHHHH---------------HHHHHHHHHHHh
Q 002732 647 HLCLVFESLHMN------------LREVLKKFG---RN--IG----LKLTAVR---------------AYAKQLFIALKH 690 (887)
Q Consensus 647 ~~~lV~E~~~gs------------L~~~L~~~~---~~--~~----ls~~~~~---------------~i~~qIl~aL~y 690 (887)
..++||+|+.|. +...|.... .. .. +...... .....|...+.+
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999998441 112221111 10 00 0011000 001112334444
Q ss_pred hh-------ccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 691 LK-------NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 691 LH-------s~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
|. ..++||+|+.+.||+++. ++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEEC-CceEEEeecccccC
Confidence 43 268999999999999985 55668999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0069 Score=69.21 Aligned_cols=76 Identities=21% Similarity=0.195 Sum_probs=51.8
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc------c--chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceee
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN------N--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~------~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++.||-|.+..||.+.+...+ ..|+||.... . +........|..+|..+....+ .++++++.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~----~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p---~~VPkV~~~D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGG----KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP---DLVPKVYHYDE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCC----eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC---CCCCeEEEECC
Confidence 467899999999999875432 4699997541 1 2234566778888988864432 35666665533
Q ss_pred ecCeEEEEEecch
Q 002732 644 YRNHLCLVFESLH 656 (887)
Q Consensus 644 ~~~~~~lV~E~~~ 656 (887)
...+|||||+.
T Consensus 104 --~~~~lVME~L~ 114 (401)
T PRK09550 104 --ELAVTVMEDLS 114 (401)
T ss_pred --CCCEEEEecCC
Confidence 45789999884
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0024 Score=70.05 Aligned_cols=144 Identities=17% Similarity=0.104 Sum_probs=80.5
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEe-cc--eeeecCeE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRF-AS--SFKYRNHL 648 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l-~~--~~~~~~~~ 648 (887)
+..|..|....||++.... ..++||+... ........|+.++..|..... ..|.++.. -+ +....+..
T Consensus 19 i~~i~~G~~n~~y~v~~~~------~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~-~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS------GRYVLTLFEK--VSAEELPFFLALLDHLAERGL-PVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred eecccCccccceEEEEeCC------CcEEEEEcCC--CChHhccHHHHHHHHHHHCCC-CCCccccCCCCcEeeeeCCce
Confidence 5577778888999886422 3589998764 233566788999999865431 12222211 11 11334567
Q ss_pred EEEEecchh-h-----------HHHHHHHhc---cC--CC----CCHHHHH------------HHHHHHHHHHHhhhc--
Q 002732 649 CLVFESLHM-N-----------LREVLKKFG---RN--IG----LKLTAVR------------AYAKQLFIALKHLKN-- 693 (887)
Q Consensus 649 ~lV~E~~~g-s-----------L~~~L~~~~---~~--~~----ls~~~~~------------~i~~qIl~aL~yLHs-- 693 (887)
++||+|+.| . +...|.... .. .. ....... .....+..++.+|..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 899998854 1 112221111 00 00 0000000 011112333444432
Q ss_pred -----cceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 694 -----CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 694 -----~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.++||+|+.|.|||++. ++.+.|+||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDG-DELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeC-CceEEEeehhhhcC
Confidence 47999999999999984 56668999998744
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00026 Score=76.55 Aligned_cols=135 Identities=21% Similarity=0.242 Sum_probs=91.1
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccc-----------------------hhhHHHHHHHHHHHHhh
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-----------------------TMNKAGQTEVQILKKLA 625 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~-----------------------~~~~~~~~Ei~iL~~L~ 625 (887)
|.+...||-|.-+.||++-+... .++++|+-.... ...-+...|+..|+.|.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G-----~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEG-----NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred hhhccccccccccceEEEecCCC-----CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 78889999999999999987543 468888643110 11123467888888885
Q ss_pred CCCCCCCcceeEecceeeecCeEEEEEecchh-hHHHHHHHhccCCCCCHHHHHHHHHHHHHHHHhhhccceeccCCCCC
Q 002732 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 626 ~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~g-sL~~~L~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIvHrDLKP~ 704 (887)
... --|+..+++ +..|+|||++.| .|..+-+- ... ..+...|...+.-|-.+|+||||+.--
T Consensus 169 e~g----fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEF 231 (465)
T KOG2268|consen 169 ERG----FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDP---PTLYDDLMGLIVRLANHGLIHGDFNEF 231 (465)
T ss_pred HcC----CCCCCcccc----cceeeHHHhhcccceeeeeec------CCh---HHHHHHHHHHHHHHHHcCceecccchh
Confidence 322 234455544 567999998844 55443221 222 334445555566777899999999999
Q ss_pred CccccCCCCeEEEEecCcceec
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 705 NILl~~~~~~vKL~DFG~a~~~ 726 (887)
||||.. ...+++|||-.....
T Consensus 232 Nimv~d-d~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 232 NIMVKD-DDKIVVIDFPQMVST 252 (465)
T ss_pred eeEEec-CCCEEEeechHhhcc
Confidence 999985 777899999866443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00085 Score=68.85 Aligned_cols=99 Identities=26% Similarity=0.328 Sum_probs=74.7
Q ss_pred HHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecch-hhHHHH---HHHhccCCCCCHHHHHHHHHHHHHHHHh
Q 002732 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREV---LKKFGRNIGLKLTAVRAYAKQLFIALKH 690 (887)
Q Consensus 615 ~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~-gsL~~~---L~~~~~~~~ls~~~~~~i~~qIl~aL~y 690 (887)
..|.-+|+.|.. .+++++++|+|-. ++|+||++ +.+... |..+ ...++.....|+.+|+..+.+
T Consensus 7 ~~E~lll~~l~~-----~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~---~~~~w~~R~~iA~~lL~~l~~ 74 (188)
T PF12260_consen 7 NNEPLLLQLLQG-----SEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF---LQSPWEQRAKIALQLLELLEE 74 (188)
T ss_pred ccHHHHHHHcCC-----CCCCCCeeeECCC----EEEEEeecCccccccccccccc---cccCHHHHHHHHHHHHHHHHH
Confidence 357888888842 2489999999853 67889885 344311 1111 125899999999999999999
Q ss_pred hhc---cceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 691 LKN---CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 691 LHs---~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
|+. ..+..+|++|+||.|+ .++.+||+|...+...
T Consensus 75 l~~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 75 LDHGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVE 112 (188)
T ss_pred HhcCCCCcEEEeecchHHeEEe-CCCcEEEEechhcchh
Confidence 987 3488899999999999 4778999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.012 Score=66.40 Aligned_cols=145 Identities=16% Similarity=0.206 Sum_probs=79.2
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV 651 (887)
+..|-.|-.-.||++............|++|+........-....|+.++..|.... -. ++++++|... .|
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~g--l~---P~~~~~~~~g----~v 111 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHG--QG---PRLLGRFPNG----RV 111 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcC--CC---CceEEEECCc----eE
Confidence 345555888889988643321112367999988664333333478999999996543 12 3344444322 46
Q ss_pred Eecchh-hH--------------HHHHHHhcc-C--C---CCCHHHHHHHHHHHH-----------------HHHHh---
Q 002732 652 FESLHM-NL--------------REVLKKFGR-N--I---GLKLTAVRAYAKQLF-----------------IALKH--- 690 (887)
Q Consensus 652 ~E~~~g-sL--------------~~~L~~~~~-~--~---~ls~~~~~~i~~qIl-----------------~aL~y--- 690 (887)
++|+.+ +| ...|.+... . . ......+..++.++. ..+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 676633 21 122222211 0 0 011122223322211 11111
Q ss_pred -----hhccceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 691 -----LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 691 -----LHs~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+...++|+||++.|||++..++.+.|+||.++..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12346899999999999985456799999998854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0076 Score=66.42 Aligned_cols=57 Identities=12% Similarity=0.225 Sum_probs=36.9
Q ss_pred EEEeccCCceEEEEEEEcCC--CCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCC
Q 002732 572 TAAHGKGVFSTVVRAKDLKA--GNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~--~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~ 628 (887)
+..|..|-...||++..... ....+..|+||+.............|+.++..|....
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g 61 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERN 61 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCC
Confidence 34566677778888864321 0111257999997765444456688999999996543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0077 Score=64.74 Aligned_cols=134 Identities=22% Similarity=0.207 Sum_probs=74.4
Q ss_pred eccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhh-HHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEe
Q 002732 575 HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN-KAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE 653 (887)
Q Consensus 575 LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~-~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E 653 (887)
|..|-...+|++.. .+ ..++||+........ -....|+.+|+.|..... .|.++ ..+. -++||+
T Consensus 4 ~~~G~tn~~y~~~~--~~----~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~--~P~~i---~~~~----~~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PG----ISFVWRPQSPVCKALGVDRQREYQILQALSALGL--APKPI---LVNE----HWLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEe--CC----ccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC--CCceE---EEeC----CEEEEE
Confidence 45677788998862 22 468899865432221 245789999999965431 23433 2222 268999
Q ss_pred cchh-h--------------HHHHHHHhcc----CCCCCHH-HHHHHHHHH---------HHHHHhhh--------ccce
Q 002732 654 SLHM-N--------------LREVLKKFGR----NIGLKLT-AVRAYAKQL---------FIALKHLK--------NCGV 696 (887)
Q Consensus 654 ~~~g-s--------------L~~~L~~~~~----~~~ls~~-~~~~i~~qI---------l~aL~yLH--------s~gI 696 (887)
|+.| . +..+|..... ...++.. .+..+..+| ...+..+- ...+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9854 2 2222332211 1112221 122222222 11122221 1258
Q ss_pred eccCCCCCCccccCCCCeEEEEecCccee
Q 002732 697 LHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 697 vHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
+|+||.|.|||++. ++ +.|+||..|..
T Consensus 149 ~H~Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeC-CC-CEEEeccccCc
Confidence 99999999999985 44 68999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.00066 Score=85.30 Aligned_cols=143 Identities=13% Similarity=-0.005 Sum_probs=104.5
Q ss_pred CCcceeEecceeee--cCeEEEEEecc-hhhHHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHhhhcc-----ceeccCC
Q 002732 631 NKRHCIRFASSFKY--RNHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNC-----GVLHCDI 701 (887)
Q Consensus 631 ~h~~Iv~l~~~~~~--~~~~~lV~E~~-~gsL~~~L~~~~~-~~~ls~~~~~~i~~qIl~aL~yLHs~-----gIvHrDL 701 (887)
.|+++...+.-... ....+++++|+ .|.+.++|.+--. ...+....+....++.+.+..-+|.. -.+|.+|
T Consensus 1287 ~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~L 1366 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSL 1366 (2724)
T ss_pred hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhh
Confidence 66666654433332 24567888888 7899998876432 23344444444555557777777743 2789999
Q ss_pred CCCCccccCCCCeEEEEecCcceecCCCC--ccCcccCCcccchhhhcCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774 (887)
Q Consensus 702 KP~NILl~~~~~~vKL~DFG~a~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~s~~sDIwSLG~iL~elltG~~PF 774 (887)
++-|.||.. +..+++++||+.++..... ....++++.|+.|++.....++.++|||.+||.+|.+..|..+|
T Consensus 1367 kf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1367 KFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 999999984 6668999999998443321 34456678899999999999999999999999999999998888
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0065 Score=68.11 Aligned_cols=30 Identities=27% Similarity=0.487 Sum_probs=26.2
Q ss_pred eeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 696 VLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 696 IvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
++|.||.|.|||++..++.++||||.+|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 899999999999985567899999998844
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.061 Score=59.33 Aligned_cols=30 Identities=27% Similarity=0.409 Sum_probs=25.1
Q ss_pred cceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 694 ~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.+|||+|+.+.|||++. +.+.|+||+.+.+
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECccccc
Confidence 57999999999999984 4568999997643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.036 Score=62.95 Aligned_cols=75 Identities=19% Similarity=0.159 Sum_probs=48.6
Q ss_pred EEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc----c---chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeee
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN----N---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~----~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+..||-|.-..||++.+...+ .-|+||--.. . +........|..+|+.+....+ .++++++.+ +
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~----~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P---~~VP~vy~~--D 104 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKN----ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP---GLVPKVYLF--D 104 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCC----ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC---CcCCeEEEE--C
Confidence 678899999999999874212 3588885431 1 3334566778899998865543 235555432 3
Q ss_pred cCeEEEEEecc
Q 002732 645 RNHLCLVFESL 655 (887)
Q Consensus 645 ~~~~~lV~E~~ 655 (887)
.....+|||++
T Consensus 105 ~e~~~~vMEdL 115 (409)
T PRK12396 105 SVMNCCVMEDL 115 (409)
T ss_pred cHHhhHHHHhC
Confidence 34456788877
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.066 Score=59.90 Aligned_cols=72 Identities=17% Similarity=0.080 Sum_probs=42.6
Q ss_pred CceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCC-CCcceeEecc--eeeecCeEEEEEecc
Q 002732 579 VFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPE-NKRHCIRFAS--SFKYRNHLCLVFESL 655 (887)
Q Consensus 579 ~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~-~h~~Iv~l~~--~~~~~~~~~lV~E~~ 655 (887)
.-..||.+.... + ..|++|+..........+..|+.++..|...... --| +..-+ .+...+..+.|++++
T Consensus 37 ~eN~vy~v~~~~-~----~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p--~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGDED-G----RRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAP--LAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEecCC-C----CEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCC--ccCCCCEEEEECCEEEEEEeee
Confidence 345688876432 2 4699998865444456677899999888654221 111 11112 123346678899988
Q ss_pred hh
Q 002732 656 HM 657 (887)
Q Consensus 656 ~g 657 (887)
.|
T Consensus 110 ~G 111 (325)
T PRK11768 110 GG 111 (325)
T ss_pred CC
Confidence 54
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.033 Score=63.65 Aligned_cols=21 Identities=14% Similarity=-0.006 Sum_probs=17.0
Q ss_pred CHHHHHHHHHHHHHHHHhhhc
Q 002732 673 KLTAVRAYAKQLFIALKHLKN 693 (887)
Q Consensus 673 s~~~~~~i~~qIl~aL~yLHs 693 (887)
...+-++|+..+|.-+..||.
T Consensus 540 sYaqQLflALklLK~c~vlHa 560 (752)
T KOG0670|consen 540 SYAQQLFLALKLLKKCGVLHA 560 (752)
T ss_pred HHHHHHHHHHHHHHhcCeeec
Confidence 345567888999999999995
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.047 Score=61.35 Aligned_cols=73 Identities=16% Similarity=0.127 Sum_probs=46.1
Q ss_pred EeccCCceEEEEEEEcCCCCCCCcEEEEEEecc-------c-chhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeec
Q 002732 574 AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-------N-ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 574 ~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~-------~-~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.||-|....||++.+...+ .-|+||.-.. + +........|..+|..+....+ .++++++.+ +.
T Consensus 2 EigdGnlN~VfrV~~~~g~----~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P---~~vP~vy~~--D~ 72 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGD----RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVP---HLVPRIFHF--DT 72 (370)
T ss_pred cCCCCceEEEEEEEcCCCC----eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCc---cccCeEEEE--cc
Confidence 4799999999999864321 3588886531 1 2333455678888887755433 245555432 34
Q ss_pred CeEEEEEecc
Q 002732 646 NHLCLVFESL 655 (887)
Q Consensus 646 ~~~~lV~E~~ 655 (887)
....+|||++
T Consensus 73 e~~~~vMEdL 82 (370)
T TIGR01767 73 EMAVTVMEDL 82 (370)
T ss_pred ccceehHhhC
Confidence 4556889977
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.079 Score=57.84 Aligned_cols=32 Identities=28% Similarity=0.521 Sum_probs=25.7
Q ss_pred ceeccCCCCCCccccCCCCeEEEEecCcceec
Q 002732 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 695 gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~~ 726 (887)
.+||+|++|.|||++..+..+-|+||+.+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 48999999999999843345569999988553
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.028 Score=58.58 Aligned_cols=32 Identities=34% Similarity=0.543 Sum_probs=21.3
Q ss_pred cceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 694 ~gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.-++|+||.|.|||++..++.++||||.+|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 45899999999999944578899999998844
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.057 Score=61.72 Aligned_cols=76 Identities=13% Similarity=0.021 Sum_probs=49.4
Q ss_pred EEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecc-----cc---hhhHHHHHHHHHHHHhhCCCCCCCcceeEeccee
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-----NE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 571 i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~-----~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++.||-|....||++.+.. ..|+||.-.. .. ........|...|..+.... ..++++++.++
T Consensus 36 ~~~eiggGn~N~VyrV~~~~------~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~---p~~VPkVy~~d 106 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS------GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC---PDHVPEVYHFD 106 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC------ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC---CCCCCeEEEEC
Confidence 36688999999999988632 3488997651 11 13344456677777775432 23567777766
Q ss_pred eecCeEEEEEecchh
Q 002732 643 KYRNHLCLVFESLHM 657 (887)
Q Consensus 643 ~~~~~~~lV~E~~~g 657 (887)
. ...+||||++.+
T Consensus 107 e--d~~vlvME~L~~ 119 (418)
T PLN02756 107 R--TMALIGMRYLEP 119 (418)
T ss_pred C--CCCEEEEeecCC
Confidence 6 335788998843
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.056 Score=60.40 Aligned_cols=139 Identities=22% Similarity=0.285 Sum_probs=79.3
Q ss_pred CceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCC-CCCcceeEec----ceeeecCeEEEEEe
Q 002732 579 VFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADP-ENKRHCIRFA----SSFKYRNHLCLVFE 653 (887)
Q Consensus 579 ~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~-~~h~~Iv~l~----~~~~~~~~~~lV~E 653 (887)
.-..||++...... ++||+.... .....+..|+.+|..|..... +.-| |..+= ..+....+.+-|++
T Consensus 37 ~eN~~f~~~~~~g~------~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~P-l~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 37 EENSNFRVQTEDGR------YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAP-LPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccCceEEEEecCCC------eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCC-ccCCCcchhhhccCCceeEEEEE
Confidence 45678888765433 699999887 667888899999999965432 2222 33222 22222237788888
Q ss_pred cchhh-HH------------HHHHHh---ccCC------C---CCHH----HH---------HHHHHHHHHHHHhhh---
Q 002732 654 SLHMN-LR------------EVLKKF---GRNI------G---LKLT----AV---------RAYAKQLFIALKHLK--- 692 (887)
Q Consensus 654 ~~~gs-L~------------~~L~~~---~~~~------~---ls~~----~~---------~~i~~qIl~aL~yLH--- 692 (887)
|+.|. +. .+|-.. .... . +.+. .. .....++...+..+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 88542 22 111111 1100 0 1111 00 012233344444333
Q ss_pred -----ccc--eeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 693 -----NCG--VLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 693 -----s~g--IvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
..+ |||+|+.|.|||++.....+-++||+-++.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 344 999999999999996433578999998743
|
|
| >KOG3263 consensus Nucleic acid binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.006 Score=59.25 Aligned_cols=13 Identities=38% Similarity=0.608 Sum_probs=7.0
Q ss_pred HhHHHHHHHHHHH
Q 002732 400 EEQEEEDLDRIME 412 (887)
Q Consensus 400 ~~~e~~e~~k~~e 412 (887)
++.|+.||||+|.
T Consensus 139 ~eeEeiEMmk~MG 151 (196)
T KOG3263|consen 139 KEEEEIEMMKIMG 151 (196)
T ss_pred CCHHHHHHHHHhC
Confidence 3344456666654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.071 Score=58.49 Aligned_cols=77 Identities=19% Similarity=0.172 Sum_probs=49.4
Q ss_pred EEEEEEeccCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeE
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHL 648 (887)
Q Consensus 569 Y~i~~~LG~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~ 648 (887)
..-+..|+-|....+|.+. ..+ ..+.||+-. ......+..|..-|+.|.... .-.|++++.+....+..
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~----~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~---~~~vP~vi~~G~~~~~~ 87 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDG----GSYFVKVNS--ESGRDMFEGEAEGLKALAEAN---PIRVPKVIAWGEYDDDA 87 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-----EEEEEEEE--GGGCCHHHHHHHHHHHHCHTT---TSBS--EEEEEE-SSCC
T ss_pred eeeeEecCCCChhheEEEE--CCC----ccEEEEecC--hhhHHHHHHHHHHHHHHHhcC---CCCCCeEEEEEeecCCc
Confidence 3445678889999999887 223 579999876 334467889999999995443 34566777777776777
Q ss_pred EEEEecch
Q 002732 649 CLVFESLH 656 (887)
Q Consensus 649 ~lV~E~~~ 656 (887)
||||||+.
T Consensus 88 fLlle~l~ 95 (288)
T PF03881_consen 88 FLLLEFLE 95 (288)
T ss_dssp EEEEE---
T ss_pred eEEEEeec
Confidence 99999983
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.11 Score=59.33 Aligned_cols=129 Identities=16% Similarity=0.147 Sum_probs=0.0
Q ss_pred EEEeccCCceEEEEEEEcCCC--CCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEE
Q 002732 572 TAAHGKGVFSTVVRAKDLKAG--NGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 572 ~~~LG~G~fg~Vy~a~d~~~~--~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~ 649 (887)
+..|..|-...+|++...... ......|++.+.-......-....|+.|++.|. .+..-+++++.|.. +
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls-----~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLG-----DNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHH-----hCCCCCeEEEecCC----E
Q ss_pred EEEecchhhHHHHHHHhccCCCCCHHHHH--HHHHHHHHHHHhhhc----------------------------------
Q 002732 650 LVFESLHMNLREVLKKFGRNIGLKLTAVR--AYAKQLFIALKHLKN---------------------------------- 693 (887)
Q Consensus 650 lV~E~~~gsL~~~L~~~~~~~~ls~~~~~--~i~~qIl~aL~yLHs---------------------------------- 693 (887)
+|+||+.|. .++...+. .++..|+..|.-||.
T Consensus 126 ~l~efIeGr------------~l~~~dl~~p~~~~~IA~~La~lH~~~~~~~p~~~~~~p~~~~~i~~w~~~~~~~~~~~ 193 (383)
T PTZ00384 126 TIQEWVEGN------------TMGIDSLQNLSVLTGIASSLAKFHKRVTELVPKEWDRTPMFLTKISTWSQHVERIIKKY 193 (383)
T ss_pred EEEEEeccc------------cCChhHhcCHHHHHHHHHHHHHHhcccccCCCccccCcchHHHHHHHHHHHHHHHHHhh
Q ss_pred ---------------------------------cceeccCCCCCCccccCCCCeEEEEecCcc
Q 002732 694 ---------------------------------CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 694 ---------------------------------~gIvHrDLKP~NILl~~~~~~vKL~DFG~a 723 (887)
..++|.||.+.|||++ ++.+.||||..|
T Consensus 194 ~~~~~~~~l~~~~~~~~~~L~~~l~~~~~~~~~~VfCHNDL~~gNIL~~--~~~l~lID~EYA 254 (383)
T PTZ00384 194 NLDFDYNELVQNYELFKKILNNHLNTSNSITNSVLFCHNDLFFTNILDF--NQGIYFIDFDFA 254 (383)
T ss_pred ccccCHHHHHHHHHHHHHHHHHhhccccccccceeeeeccCCcccEEec--CCCEEEEEeccc
|
|
| >PF08648 DUF1777: Protein of unknown function (DUF1777); InterPro: IPR013957 This entry shows eukaryotic proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.055 Score=55.13 Aligned_cols=130 Identities=27% Similarity=0.489 Sum_probs=0.0
Q ss_pred cccccccccccCCCCCCCCCccccccccCCC-cccccccccCCCCCCCCCcccccccCCCCCCCCCCc-CCCCCCCCCCC
Q 002732 270 ERDRSRDRARVNDRDMDRQRDREKDRVRDNN-LERERERRRDRSRDKGRDIESDREKGASPKDSYSNR-DRYKHSRHLKH 347 (887)
Q Consensus 270 ~r~r~r~r~r~r~r~r~r~r~r~r~r~r~r~-~~r~r~r~r~r~r~r~r~~~~~r~~~r~~~~~~~~~-~r~~~~~~~~~ 347 (887)
.++|+ ...+.++++++..+++.+.+.++++ ..+.+++.+++++++.+.+.+.+...+.....++.+ ........+..
T Consensus 2 ~rsRs-~~~R~r~r~R~~~r~Rrr~r~rdRdr~~R~r~R~r~r~Rdr~~~R~R~r~~~r~~Rsrsp~r~~~~~~rs~sr~ 80 (180)
T PF08648_consen 2 GRSRS-RRRRRRDRDRSRRRDRRRSRDRDRDRRDRDRDRDRDRDRDRDRRRDRSRDRRRSRRSRSPRRSRSRRHRSRSRS 80 (180)
T ss_pred CCCcc-cccccccccccccccccccCCcccccccccccccccccccCcccccccccccccccccCccccccccccccccC
Q ss_pred CCCCCCCCCCCCCcccccccCCCCcccCCCCCCCCCcccccchHHHHHHHhhHhHHHHHHHHHH
Q 002732 348 DDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIM 411 (887)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ee~~~~~~~~~e~~e~~k~~ 411 (887)
..+...+........... ..........+.....+...++.++.++.+|||+|
T Consensus 81 ~~r~~~R~~~~~~~~~~~-----------~r~r~~~~~~~~~~~~~~~~~e~~~~de~~mmk~M 133 (180)
T PF08648_consen 81 PSRRRDRRRRRDRRRRSP-----------ERSRERQESEDGENEDEEEDLEGEDDDEEEMMKMM 133 (180)
T ss_pred cccccccccccccccccc-----------ccccccccccccccccccccccccchhHHHHHHhh
|
Some of the proteins are putative nucleic acid binding proteins. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.19 Score=55.65 Aligned_cols=136 Identities=11% Similarity=0.098 Sum_probs=0.0
Q ss_pred cCCceEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecc------eeeecCeEEE
Q 002732 577 KGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFAS------SFKYRNHLCL 650 (887)
Q Consensus 577 ~G~fg~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~------~~~~~~~~~l 650 (887)
.|.-+.||++...... ++||.+.........+..-+..|..- .-++++.++- ++...+..|+
T Consensus 16 ~~~~~~v~~v~T~~G~------~~Lk~~~~~~~~l~~~~~~~~~L~~~------G~~~~~~~~~t~~G~~~~~~~~~~~~ 83 (309)
T TIGR02904 16 EQVTGKLFKVYTDQGV------FALKKLYADRNTIESFVSQIQVLSEK------GFSRIVPVYPTKDGSYYLFHGHFLYY 83 (309)
T ss_pred ecccCcEEEEEeCCCC------EEEEEeccchHhHHHHHHHHHHHHHc------CCCcCCceeecCCCCeeeEECCEEEE
Q ss_pred EEecchhh--------------HHHHHHHhccC--------CCCCHHHHHHHH---------------------------
Q 002732 651 VFESLHMN--------------LREVLKKFGRN--------IGLKLTAVRAYA--------------------------- 681 (887)
Q Consensus 651 V~E~~~gs--------------L~~~L~~~~~~--------~~ls~~~~~~i~--------------------------- 681 (887)
||+++.|. ....|+..... ...........+
T Consensus 84 L~~wi~G~~~~~~~~~~~~~~~~LA~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~fe~~~ 163 (309)
T TIGR02904 84 LMPWLDIERNEERNYQHESMFQELALLHRKTVKTERVTEEELKKHYERTLSRWENIPEGLEEFIVEAEAKWYMSPFELQA 163 (309)
T ss_pred EeCCcccccccCCHHHHHHHHHHHHHHHHhhhCCCcccHhHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHH
Q ss_pred --------HHHHHHHHhhhcc------------ceeccCCCCCCccccCCCCeEEEEecCccee
Q 002732 682 --------KQLFIALKHLKNC------------GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 682 --------~qIl~aL~yLHs~------------gIvHrDLKP~NILl~~~~~~vKL~DFG~a~~ 725 (887)
.++..++..|... +|||+|+.+.|||++ .++.+.|+||..+++
T Consensus 164 ~~~~~~~~~~~~~a~~~l~~~~~~~~~~~~~~~~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 164 CTYYHEVMQAAEFAQNKLEDWHEATKEKESWRTVLVHGKLSLSHFLYD-ETRGGYFINFEKASF 226 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcceeeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.5 Score=49.60 Aligned_cols=190 Identities=22% Similarity=0.236 Sum_probs=0.0
Q ss_pred eEEEEEEEcCCCCCCCcEEEEEEecccchhhHHHHHHHHHHHHhhCCCCCCCcceeEecceeeecCeEEEEEecchhh--
Q 002732 581 STVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-- 658 (887)
Q Consensus 581 g~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~~~lV~E~~~gs-- 658 (887)
|.|-.|....++. ..|.||+ +.......+..|+.-|..|... +...|++++.+....++.||||+|+...
T Consensus 27 G~inea~~v~dg~---~~~FvK~--n~~~~~~~f~AEa~gL~~la~s---~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 27 GDINEAWRLRDGT---DPFFVKC--NQREQLSMFTAEADGLELLARS---NTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccccceeEeecCC---cceEEEe--cchhhHHHHHHHHHHHHHHHhc---CCccccceEEecCCCCeeEEEEeeccCCCC
Q ss_pred --------------------------------------------------------HHHHHHHhccCCCCCHHHHHHHHH
Q 002732 659 --------------------------------------------------------LREVLKKFGRNIGLKLTAVRAYAK 682 (887)
Q Consensus 659 --------------------------------------------------------L~~~L~~~~~~~~ls~~~~~~i~~ 682 (887)
...+....+ ++...+-.++.
T Consensus 99 d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~rg----~~f~did~~~~ 174 (286)
T COG3001 99 DAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARERG----LTFGDIDAIVE 174 (286)
T ss_pred CchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHhC----CCccCHHHHHH
Q ss_pred HHHHHHHhhhccc-eeccCCCCCCccccCCCCeEEEEecCcceecCCCCccCcccCCc-ccchhhhcCCC--------CC
Q 002732 683 QLFIALKHLKNCG-VLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YRAPEIILGLP--------YD 752 (887)
Q Consensus 683 qIl~aL~yLHs~g-IvHrDLKP~NILl~~~~~~vKL~DFG~a~~~~~~~~~~~~gt~~-Y~aPE~l~~~~--------~s 752 (887)
.|..-|.--.... ++|+||-..|+++...+-.+ |.-|++.+...+.-.+.+++ =.+||+..+.. |.
T Consensus 175 ~v~elL~~hqpqPsLlHGDLW~gN~a~~~~GPv~----fDPA~y~GDrE~Dlam~elFggfp~efy~gY~sv~PL~~G~~ 250 (286)
T COG3001 175 KIQELLADHQPQPSLLHGDLWSGNCAFGKDGPVI----FDPACYWGDRECDLAMLELFGGFPPEFYDGYQSVSPLPAGYL 250 (286)
T ss_pred HHHHHHhcCCCCcceeecccccccccccCCCCee----eccccccCCcccceehhhhhcCCcHHHHHhhhccCCCCCchH
Q ss_pred chhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHhh
Q 002732 753 HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 753 ~~sDIwSLG~iL~elltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
..-.||- ||.|+.-...|.+.=..+....|..++
T Consensus 251 eRk~iYq----LY~llnh~~~FGg~Y~~~a~k~i~~iL 284 (286)
T COG3001 251 ERKPIYQ----LYHLLNHANLFGGHYLVEAQKSIDRIL 284 (286)
T ss_pred HHhHHHH----HHHHHHHHHHhCcHHHHHHHHHHHHHh
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 887 | ||||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-43 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-43 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-42 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-42 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-42 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-42 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-42 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-40 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-40 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-40 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-38 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-38 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-32 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-32 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-30 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-29 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-27 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-27 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-27 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-26 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-26 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-26 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-26 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-26 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-26 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-26 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-26 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-26 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-26 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-26 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-26 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-26 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-26 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-26 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-26 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-26 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-26 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-26 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-26 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-26 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-26 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-26 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-26 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-26 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-26 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-26 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-26 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-25 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-25 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-25 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-25 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-25 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-25 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-25 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-25 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-25 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-25 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-25 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-25 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-25 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-25 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-25 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-25 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-25 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-25 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-25 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-25 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-25 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-25 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-25 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-25 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-25 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-25 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-25 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-25 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-25 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-25 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-25 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-25 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-25 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-25 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-25 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-25 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 8e-25 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-25 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-25 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-24 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-24 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-24 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-24 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-24 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-24 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-24 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-24 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-24 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-24 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-24 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-24 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-24 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-24 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-24 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-24 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-23 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-23 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-23 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-23 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-23 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-23 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-23 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-23 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-23 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-23 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-23 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-23 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-23 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-22 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-22 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-22 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-22 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-21 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-21 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-21 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-21 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-21 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-21 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-21 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-21 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-21 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-21 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-21 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-20 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-14 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-12 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-12 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-12 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 7e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-12 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-12 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-05 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-05 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-05 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-05 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-05 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-05 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-04 |
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-152
Identities = 119/359 (33%), Positives = 179/359 (49%), Gaps = 17/359 (4%)
Query: 540 KIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEV 599
K R +D +DD Y + GE RYE+ + GKG F VV+A D E V
Sbjct: 27 KKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ----EWV 82
Query: 600 AIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL 659
AIKII+N + Q EV++L+ + D E K + + F +RNHLCLVFE L NL
Sbjct: 83 AIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNL 142
Query: 660 REVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN--CGVLHCDIKPDN-MLVNEAKNVLK 716
++L+ G+ L R +A+Q+ AL L ++HCD+KP+N +L N ++ +K
Sbjct: 143 YDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201
Query: 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
+ DFG++ G I Y+ SRFYR+PE++LG+PYD +D+WS+GC L E++TG+ LF G
Sbjct: 202 IVDFGSSCQLG-QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260
Query: 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP 836
A D + +E+ G P +L + + F++ + + K K K
Sbjct: 261 ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKL 320
Query: 837 KDI--------GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+I G G FKDL+ ++ DP+ R+ AL H F
Sbjct: 321 HNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 438 bits (1127), Expect = e-146
Identities = 113/347 (32%), Positives = 171/347 (49%), Gaps = 16/347 (4%)
Query: 548 DNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN 607
+DD +G Y + + RYEV GKG F VV+A D K + VA+K++RN
Sbjct: 78 GGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVH----QHVALKMVRNE 133
Query: 608 ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFG 667
+ ++ E++IL+ L D +N + I +F +RNH+C+ FE L MNL E++KK
Sbjct: 134 KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK-N 192
Query: 668 RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKNVLKLCDFGNAMFA 726
+ G L VR +A + L L ++HCD+KP+N +L + ++ +K+ DFG++ +
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252
Query: 727 GKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH 786
+ Y+ SRFYRAPE+ILG Y P+D+WS+GC L EL TG L PG D L
Sbjct: 253 H-QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
Query: 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFH-----ATEEDPVTKKAIKKIIFNIK-PKDIG 840
+EL G +K+L + V + ++ P +
Sbjct: 312 IELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
A G D + F D L + DP RMT QAL HP++ +
Sbjct: 372 EWGNALKGCDDPL---FLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 419 bits (1080), Expect = e-140
Identities = 109/356 (30%), Positives = 164/356 (46%), Gaps = 35/356 (9%)
Query: 550 WDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET 609
DD EG+ R G+ L RYE+ G+G F VV D G +VA+KIIRN
Sbjct: 2 EDDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGK---SQVALKIIRNVGK 58
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
+A + E+ +LKK+ D ENK C+ + F + H+C+ FE L N E LK+
Sbjct: 59 YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN-F 117
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA------------------ 711
L VR A QL AL+ L + H D+KP+N+L +
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 712 KNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
+++ DFG+A F ++ T + +R YR PE+IL L + P D+WS+GC L+E Y G
Sbjct: 178 NTSIRVADFGSATFDHEH-HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
Query: 772 VLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKII 831
LF N + L + ++ GP P M+ + + L + D K K +
Sbjct: 237 TLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL 296
Query: 832 FNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+ +D DL+ ++ DP +R+T+A+AL HPF +G
Sbjct: 297 KSYML------------QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 418 bits (1076), Expect = e-140
Identities = 98/350 (28%), Positives = 173/350 (49%), Gaps = 35/350 (10%)
Query: 555 GYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
+ + G++L RYE+ G+G F VV D KAG VA+KI++N + +A
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGG---RHVAVKIVKNVDRYCEAA 58
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
++E+Q+L+ L DP + C++ F++ H+C+VFE L ++ + +K+ G +L
Sbjct: 59 RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL-PFRL 117
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV------------------LK 716
+R A Q+ ++ L + + H D+KP+N+L ++ +K
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 717 LCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
+ DFG+A + ++ T + +R YRAPE+IL L + P D+WS+GC L E Y G +FP
Sbjct: 178 VVDFGSATYDDEHHST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP 836
+ + L + + GP PK M++K L++ +E + + +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW---DEHSSAGRYVSR-----AC 288
Query: 837 KDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
K + + + E ++ DL+ K+ DP KR+T+ +AL HPF
Sbjct: 289 KPLKEFMLSQDVEHERLF----DLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 409 bits (1052), Expect = e-136
Identities = 95/367 (25%), Positives = 161/367 (43%), Gaps = 43/367 (11%)
Query: 543 RSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK 602
R L+ DD ++S++ G +L+ + V G G F V+ + + + A+K
Sbjct: 11 RENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK----KYYAVK 66
Query: 603 IIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREV 662
++RN + ++ + E ILKK+ D N + +++ F Y +H+CL+FE L +L E+
Sbjct: 67 VVRNIKKYTRSAKIEADILKKIQNDDINNN-NIVKYHGKFMYYDHMCLIFEPLGPSLYEI 125
Query: 663 LKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE------------ 710
+ + N G + ++ Y ++ AL +L+ + H D+KP+N+L+++
Sbjct: 126 ITRNNYN-GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR 184
Query: 711 ------------AKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIW 758
+KL DFG A F + +R YRAPE+IL L +D D+W
Sbjct: 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-HGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 759 SVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQH-FDQDLNFHAT 817
S GC L ELYTG +LF + + L + + P PK ML + T+ +
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 818 EEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877
+ + K + P F D L I +DP R + A+
Sbjct: 304 WPENASSINSIKHVKKCL-----------PLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
Query: 878 ALTHPFI 884
L H F+
Sbjct: 353 LLKHKFL 359
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-126
Identities = 100/359 (27%), Positives = 164/359 (45%), Gaps = 42/359 (11%)
Query: 551 DDAEGYYSYRFGEIL-DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET 609
GY+ GE D RY + G G FSTV AKD+ VA+KI+R ++
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKV 57
Query: 610 MNKAGQTEVQILKKLAGADPENK-----RHCIRFASSFKYRN----HLCLVFESLHMNLR 660
+A + E+++L+++ AD + H ++ F ++ H+ +VFE L NL
Sbjct: 58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 117
Query: 661 EVLKKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCDIKPDNMLV-----NEAKNV 714
++KK+ + G+ L V+ +KQL + L ++ + CG++H DIKP+N+L+ E
Sbjct: 118 ALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176
Query: 715 LKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774
+K+ D GNA + T + +R YR+PE++LG P+ DIWS C ++EL TG LF
Sbjct: 177 IKIADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235
Query: 775 PGAT------NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
++D + +EL G P +LR G +T F+
Sbjct: 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS---------- 285
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+K + ++T D L + LDP KR + HP++
Sbjct: 286 ----KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-69
Identities = 102/397 (25%), Positives = 171/397 (43%), Gaps = 81/397 (20%)
Query: 550 WDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET 609
GY+ + G++ +GRY V G G FSTV + D++ + VA+K++++ E
Sbjct: 20 DYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGK----KFVAMKVVKSAEH 75
Query: 610 MNKAGQTEVQILKKLAGADPE--NKRHCIRFASSFKYR----NHLCLVFESLHMNLREVL 663
+ E+++LK + +DP N+ ++ FK H+C+VFE L +L + +
Sbjct: 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWI 135
Query: 664 KKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCDIKPDNMLV-------------- 708
K GL L V+ +Q+ L +L C ++H DIKP+N+L+
Sbjct: 136 IKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 709 ----------------------------------NEAKNVLKLCDFGNAMFAGKNEITPY 734
N K +K+ D GNA + T
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-VHKHFTED 253
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN------DMLRLHME 788
+ +R YR+ E+++G Y+ P DIWS C +EL TG LF + D + L +E
Sbjct: 254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
Query: 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPG 848
L G P+K++ G ++ + F + + K I +KP + ++
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDL--------------KHITKLKPWGLFEVLVEKYE 359
Query: 849 EDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ A F D L + L PEKR T A+ L HP+++
Sbjct: 360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-57
Identities = 84/328 (25%), Positives = 141/328 (42%), Gaps = 44/328 (13%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQIL 621
GE + Y G G F V +AK +++ EVAIK + ++ E+QI+
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESD-----EVAIKKVLQDKRFK---NRELQIM 86
Query: 622 KKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR-NIGLKLTAV 677
+ + N + K L LV E + + + + + + + +
Sbjct: 87 RIV---KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLV 736
+ Y QL +L ++ + G+ H DIKP N+L++ VLKL DFG+A + Y+
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 737 SRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
SR+YRAPE+I G Y +DIWS GC + EL G+ LFPG + D L +++ G +
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
+ ++ + ++ I+P + P P +
Sbjct: 264 EQIKT---------------------MNPNYMEHKFPQIRPHPFSKVF--RPRTPPDAI- 299
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DL+ ++ P R+T +AL HPF
Sbjct: 300 ---DLISRLLEYTPSARLTAIEALCHPF 324
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-57
Identities = 96/372 (25%), Positives = 153/372 (41%), Gaps = 43/372 (11%)
Query: 518 PCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGK 577
P F E+ V++ +K+ R + Y T G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 578 GVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPEN---KRH 634
G F V +AK +G E VAIK + ++ E+QI++KL D N R+
Sbjct: 65 GSFGVVYQAKLCDSG----ELVAIKKVLQDKRFK---NRELQIMRKL---DHCNIVRLRY 114
Query: 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKN 693
+ K +L LV + + + V + + R L + V+ Y QLF +L ++ +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYRAPEIILGLP-Y 751
G+ H DIKP N+L++ VLKLCDFG+A Y+ SR+YRAPE+I G Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234
Query: 752 DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQD 811
+D+WS GC L EL G+ +FPG + D L +++ G ++ +R+
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE----------- 283
Query: 812 LNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871
+ + IK + P P+ + L ++ P
Sbjct: 284 ----------MNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAI----ALCSRLLEYTPTA 327
Query: 872 RMTVAQALTHPF 883
R+T +A H F
Sbjct: 328 RLTPLEACAHSF 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-56
Identities = 91/325 (28%), Positives = 139/325 (42%), Gaps = 40/325 (12%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGA 627
R++V G+G F TV K+ G VAIK + + E+QI++ LA
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTG----MSVAIKKVIQDPRFRN---RELQIMQDLAVL 76
Query: 628 DPEN---KRHCIRFASSFKYRN-HLCLVFESLHMNLREVLKKFGR-NIGLKLTAVRAYAK 682
N + R+ +L +V E + L + + R + ++ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 683 QLFIALK--HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-TPYLVSRF 739
QL ++ HL + V H DIKP N+LVNEA LKLCDFG+A +E Y+ SR+
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY 196
Query: 740 YRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
YRAPE+I G Y +DIWSVGC E+ G+ +F G + L + + G +++L
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
RK + ++N K ++ K
Sbjct: 257 RK---------------------LNPSHTDVDLYNSKGIPWSNVF---SDHSLKDAKEAY 292
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPF 883
DLL + PE+RM +AL HP+
Sbjct: 293 DLLSALLQYLPEERMKPYEALCHPY 317
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 78/326 (23%), Positives = 136/326 (41%), Gaps = 52/326 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKL 624
+YE G+G + V + ++ G + VAIK + + K E+++LK+L
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTG----QIVAIKKFLESEDDPVIKKIALREIRMLKQL 59
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+H + F+ + L LVFE + L + G+ V++
Sbjct: 60 --------KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITW 109
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI-TPYLVSRFY 740
Q A+ +H D+KP+N+L+ +V+KLCDFG A + G ++ + +R+Y
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
R+PE+++G Y P+D+W++GC EL +G L+PG ++ D L L + G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGD-L----- 222
Query: 800 KGAFTDQHFDQDLNFHATEED-P-VTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ + P+D+ + P L
Sbjct: 223 -----------------IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL--- 262
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
LL +DP +R+T Q L HP+
Sbjct: 263 -GLLKGCLHMDPTERLTCEQLLHHPY 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 102/345 (29%), Positives = 156/345 (45%), Gaps = 53/345 (15%)
Query: 554 EGYYSYRFGEIL---DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---N 607
+G+Y + Y G G + +V A D ++G E+VAIK + +
Sbjct: 8 KGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSG----EKVAIKKLSRPFQS 63
Query: 608 ETMNKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLK 664
E K E+ +LK + EN ASS + LV + +L++++
Sbjct: 64 EIFAKRAYRELLLLKHM---QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 120
Query: 665 KFGRNIGLKLTA--VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722
K + ++ Q+ LK++ + GV+H D+KP N+ VNE LK+ DFG
Sbjct: 121 L-------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGL 172
Query: 723 AMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
A A E+T Y+V+R+YRAPE+IL Y+ +DIWSVGC + E+ TGK LF G D
Sbjct: 173 ARHAD-AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
Query: 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGS 841
L +++ G + ++K + KA K I ++
Sbjct: 232 QLTQILKVTGVPGTEFVQK---------------------LNDKAAKSYIQSLPQTPRKD 270
Query: 842 IVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
P P+ DLL+K+ LD +KR+T AQALTHPF
Sbjct: 271 FTQLFPRASPQAA----DLLEKMLELDVDKRLTAAQALTHPFFEP 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-50
Identities = 91/344 (26%), Positives = 151/344 (43%), Gaps = 52/344 (15%)
Query: 555 GYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NE 608
G+Y + + Y G G + V A D + G +VAIK + +E
Sbjct: 10 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRPFQSE 65
Query: 609 TMNKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKK 665
K E+++LK + EN + LV + +L +++K
Sbjct: 66 LFAKRAYRELRLLKHM---RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 666 FGRNIGLKLTA--VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723
KL ++ Q+ L+++ G++H D+KP N+ VNE LK+ DFG A
Sbjct: 123 ------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLA 175
Query: 724 MFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
A +E+T Y+V+R+YRAPE+IL Y +DIWSVGC + E+ TGK LF G+ + D
Sbjct: 176 RQAD-SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
L+ M++ G P + +++ + K + + +
Sbjct: 235 LKEIMKVTGTPPAEFVQR---------------------LQSDEAKNYMKGLPELEKKDF 273
Query: 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ P + +LL+K+ VLD E+R+T +AL HP+
Sbjct: 274 ASILTNASPLAV----NLLEKMLVLDAEQRVTAGEALAHPYFES 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-49
Identities = 92/353 (26%), Positives = 141/353 (39%), Gaps = 63/353 (17%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-------------------- 602
E +Y + G G F V D+++G + A+K
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESG----KRFALKKVLQDPRYKNRELDIMKVLD 58
Query: 603 ---------IIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE 653
KL G + H + +L ++ E
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 654 SLHMNLREVLKKFGR-NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK 712
+ L +VLK F R + + + Y QLF A+ + + G+ H DIKP N+LVN
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 713 NVLKLCDFGNAMFAGKNEI-TPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTG 770
N LKLCDFG+A +E Y+ SRFYRAPE++LG Y +D+WS+GC EL G
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 771 KVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKI 830
K LF G T+ D L +++ G K+ + + + +
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIR---------------------MNPHYTEVR 277
Query: 831 IFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+K KD I+ P P + DLL++I +P+ R+ +A+ HPF
Sbjct: 278 FPTLKAKDWRKIL---PEGTPSLAI---DLLEQILRYEPDLRINPYEAMAHPF 324
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-49
Identities = 95/343 (27%), Positives = 162/343 (47%), Gaps = 37/343 (10%)
Query: 554 EGYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---N 607
+YS G+ + RY+ G G V A D VAIK + N
Sbjct: 9 NNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQN 64
Query: 608 ETMNKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLK 664
+T K E+ ++K + + +N + S + + +V E + NL +V++
Sbjct: 65 QTHAKRAYRELVLMKCV---NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 121
Query: 665 KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724
L + Q+ +KHL + G++H D+KP N++V + LK+ DFG A
Sbjct: 122 M-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 175
Query: 725 FAGKNEI-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
AG + + TPY+V+R+YRAPE+ILG+ Y +DIWSVGC + E+ G VLFPG + D
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIV 843
+E G + ++K T + + ++ +A + +K+ ++ +
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA-------GYSFEKLFPDVLFP---ADS 285
Query: 844 TASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ + + DLL K+ V+D KR++V +AL HP+I+
Sbjct: 286 EHNKLKASQAR----DLLSKMLVIDASKRISVDEALQHPYINV 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-49
Identities = 81/342 (23%), Positives = 149/342 (43%), Gaps = 51/342 (14%)
Query: 554 EGYYSYRFGEILDG---RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETM 610
Y+ Y + G Y++ G+G +S V A ++ E+V +KI++
Sbjct: 20 REYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKP--VK 73
Query: 611 NKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKF 666
K + E++IL+ L G N ++ S LVFE + + + +++ +
Sbjct: 74 KKKIKREIKILENLRGG--PNIITLADIVKDPVSRT----PALVFEHVNNTDFKQLYQT- 126
Query: 667 GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726
L +R Y ++ AL + + G++H D+KP N++++ L+L D+G A F
Sbjct: 127 -----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181
Query: 727 G-KNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKV-LFPGATNNDML 783
E + SR+++ PE+++ YD+ LD+WS+GC L + K F G N D L
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241
Query: 784 RLHMELKG-PFPKKMLRK-GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGS 841
++ G + K D F+ L H ++K ++ + + +
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH-------SRKRWERFVHSENQHLV-- 292
Query: 842 IVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
P+ L D LDK+ D + R+T +A+ HP+
Sbjct: 293 --------SPEAL----DFLDKLLRYDHQSRLTAREAMEHPY 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-49
Identities = 98/346 (28%), Positives = 161/346 (46%), Gaps = 52/346 (15%)
Query: 552 DAEGYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-- 606
+ +Y + + RY+ + G G + +V A D K G VA+K +
Sbjct: 11 ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPF 66
Query: 607 -NETMNKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREV 662
+ K E+++LK + EN A S + N + LV + +L +
Sbjct: 67 QSIIHAKRTYRELRLLKHM---KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 123
Query: 663 LKKFGRNIGLKLTA--VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720
+K KLT V+ Q+ LK++ + ++H D+KP N+ VN LK+ DF
Sbjct: 124 VK------CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDF 176
Query: 721 GNAMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATN 779
G A +E+T Y+ +R+YRAPEI+L Y+ +DIWSVGC + EL TG+ LFPG +
Sbjct: 177 GLARHTA-DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235
Query: 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDI 839
D L+L + L G ++L+K ++ ++ + I ++
Sbjct: 236 IDQLKLILRLVGTPGAELLKK---------------------ISSESARNYIQSLTQMPK 274
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ G +P + DLL+K+ VLD +KR+T AQAL H + +
Sbjct: 275 MNFANVFIGANPLAV----DLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 85/342 (24%), Positives = 140/342 (40%), Gaps = 59/342 (17%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIK-IIRNNETMNKAGQTEVQILKK 623
L RY G G V A D + VAIK I+ + K E++I+++
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD----KRVAIKKIVLTDPQSVKHALREIKIIRR 64
Query: 624 LAGADPEN-----------KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGL 672
L D +N S N + +V E + +L VL++
Sbjct: 65 L---DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ------G 115
Query: 673 KLTA--VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-----MF 725
L R + QL LK++ + VLH D+KP N+ +N VLK+ DFG A +
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 726 AGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
+ K ++ LV+++YR+P ++L Y +D+W+ GC E+ TGK LF GA + ++
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT 844
L +E ++D + I N + +
Sbjct: 236 LILESIPV-VH-------------EEDRQE-------LLSVI-PVYIRNDMTEPHKPLTQ 273
Query: 845 ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
PG + + D L++I P R+T +AL+HP++S
Sbjct: 274 LLPGISREAV----DFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 91/326 (27%), Positives = 145/326 (44%), Gaps = 46/326 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAG--QT---EVQIL 621
RYE A G G + TV +A+D +G VA+K +R N G + EV +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSG----HFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 622 KKLAGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
++L + N + + S + LVFE + +LR L K GL ++
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAETIKD 124
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSR 738
+Q L L ++H D+KP+N+LV +KL DFG A +++ + +TP +V+
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
+YRAPE++L Y P+D+WSVGC E++ K LF G + D L +L G P
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-P---- 238
Query: 799 RKGAFTDQHFDQDLNFHATEED-PVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
E+D P + P+ + S+V P +
Sbjct: 239 ------------------PEDDWPRDVSLPRGAFPPRGPRPVQSVV---PEMEESGA--- 274
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
LL ++ +P KR++ +AL H +
Sbjct: 275 -QLLLEMLTFNPHKRISAFRALQHSY 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-48
Identities = 82/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKL 624
+YE G+G + V++ ++ G VAIK ++ + K E+++LK+L
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTG----RIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
RH + K + LVFE + + + L+ GL V+ Y
Sbjct: 82 --------RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLF 131
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI-TPYLVSRFY 740
Q+ + + ++H DIKP+N+LV++ V+KLCDFG A A E+ + +R+Y
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWY 190
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
RAPE+++G Y +D+W++GC + E++ G+ LFPG ++ D L M G +
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN-LIPRHQ 249
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
+ F+++ F + ++ + + P ++ D
Sbjct: 250 EL------FNKNPVFAGVRLPEIKEREPLERRY--------------PKLSEVVI----D 285
Query: 860 LLDKIFVLDPEKRMTVAQALTHPF 883
L K +DP+KR A+ L H F
Sbjct: 286 LAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-48
Identities = 95/343 (27%), Positives = 158/343 (46%), Gaps = 37/343 (10%)
Query: 554 EGYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---N 607
+YS G+ + RY+ G G V A D VAIK + N
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQN 101
Query: 608 ETMNKAGQTEVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLK 664
+T K E+ ++K + + +N + + + + LV E + NL +V++
Sbjct: 102 QTHAKRAYRELVLMKCV---NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ 158
Query: 665 KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724
L + Q+ +KHL + G++H D+KP N++V + LK+ DFG A
Sbjct: 159 M-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLAR 212
Query: 725 FAGKNEI-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
AG + + TPY+V+R+YRAPE+ILG+ Y +DIWSVGC + E+ K+LFPG D
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272
Query: 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIV 843
+E G + ++K T +++ ++ +A K+ +
Sbjct: 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA-------GLTFPKLFPDSLFPADSE-- 323
Query: 844 TASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ + + DLL K+ V+DP KR++V AL HP+I+
Sbjct: 324 -HNKLKASQAR----DLLSKMLVIDPAKRISVDDALQHPYINV 361
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-48
Identities = 76/351 (21%), Positives = 138/351 (39%), Gaps = 56/351 (15%)
Query: 556 YYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK 612
+ Y V G + V D + VAIK + N + +
Sbjct: 8 AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-----IPVAIKRVFNTVSDGR 62
Query: 613 AGQT------------EVQILKKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHM 657
E+++L N R + L LV E +
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHF---HHPNILGLRDIFVHFEEPAM-HKLYLVTELMRT 118
Query: 658 NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717
+L +V+ + I + ++ + + + L L GV+H D+ P N+L+ N + +
Sbjct: 119 DLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITI 175
Query: 718 CDFGNA-MFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFP 775
CDF A T Y+ R+YRAPE+++ + +D+WS GC + E++ K LF
Sbjct: 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235
Query: 776 GATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIK 835
G+T + L +E+ G PK +D+ ++ + ++ + N+
Sbjct: 236 GSTFYNQLNKIVEVVGT-PK-------------IEDVVMFSSPS---ARDYLRNSLSNVP 278
Query: 836 PKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ ++V P DP L DL+ K+ +P++R++ QAL HP+
Sbjct: 279 ARAWTAVV---PTADPVAL----DLIAKMLEFNPQRRISTEQALRHPYFES 322
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-48
Identities = 93/323 (28%), Positives = 145/323 (44%), Gaps = 42/323 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE A G+G + V +A+DLK G VA+K +R E M + EV +L+ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 625 AGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+ N + + S L LVFE + +L L K G+ ++
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMF 127
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYR 741
QL L L + V+H D+KP N+LV +KL DFG A +++ + +T +V+ +YR
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
APE++L Y P+D+WSVGC E++ K LF G+++ D L +++ G P
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-P------- 238
Query: 802 AFTDQHFDQDLNFHATEED-PVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
EED P ++ + + I V D DL
Sbjct: 239 ---------------GEEDWPRDVALPRQAFHSKSAQPIEKFV---TDIDELGK----DL 276
Query: 861 LDKIFVLDPEKRMTVAQALTHPF 883
L K +P KR++ AL+HP+
Sbjct: 277 LLKCLTFNPAKRISAYSALSHPY 299
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-47
Identities = 95/335 (28%), Positives = 148/335 (44%), Gaps = 53/335 (15%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILK 622
+ RY + G+G + V A D VAIK I E +T E++IL
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNK----VRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 623 KLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA--V 677
+ EN IR A + + + +V + + +L ++LK L+ +
Sbjct: 81 RF---RHENIIGINDIIR-APTIEQMKDVYIVQDLMETDLYKLLKT------QHLSNDHI 130
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-----IT 732
+ Q+ LK++ + VLH D+KP N+L+N LK+CDFG A A + +T
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLT 189
Query: 733 PYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
Y+ +R+YRAPEI+L Y +DIWSVGC L E+ + + +FPG D L + + G
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
+DLN + + + ++ K+ P D
Sbjct: 250 SPS--------------QEDLNC-------IINLKARNYLLSLPHKNKVPWNRLFPNADS 288
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
K L DLLDK+ +P KR+ V QAL HP++
Sbjct: 289 KAL----DLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-47
Identities = 89/346 (25%), Positives = 146/346 (42%), Gaps = 67/346 (19%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILK 622
+ +++ + G+G + V A G E VAIK I + A +T E++ILK
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTG----EIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 623 KLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
EN + R SF+ N + ++ E + +L V+ L+
Sbjct: 65 HF---KHENIITIFNIQR-PDSFENFNEVYIIQELMQTDLHRVIS------TQMLSDDH- 113
Query: 680 YAKQLFI-----ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------------N 722
Q FI A+K L V+H D+KP N+L+N + LK+CDFG +
Sbjct: 114 --IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNS 170
Query: 723 AMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
++ + ++ +R+YRAPE++L Y +D+WS GC L EL+ + +FPG
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH 230
Query: 782 MLRLHMELKG-PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIG 840
L L + G P LR + ++ I ++
Sbjct: 231 QLLLIFGIIGTPHSDNDLRC---------------------IESPRAREYIKSLPMYPAA 269
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ P +PK + DLL ++ V DP KR+T +AL HP++
Sbjct: 270 PLEKMFPRVNPKGI----DLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (406), Expect = 5e-44
Identities = 91/327 (27%), Positives = 144/327 (44%), Gaps = 57/327 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+Y G+G + V +A++ G E A+K IR +E + E+ ILK+L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYG----ETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+H ++ + L LVFE L +L+++L GL+ +++
Sbjct: 58 --------KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLL 107
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFY 740
QL + + + VLH D+KP N+L+N + LK+ DFG A G + T +V+ +Y
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
RAP++++G Y +DIWSVGC E+ G LFPG + D L + G P
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-P----- 220
Query: 800 KGAFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
++ P VT+ +P S + G D +
Sbjct: 221 -----------------NSKNWPNVTELPKYDPNFTVYEPLPWESFL---KGLDESGI-- 258
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPF 883
DLL K+ LDP +R+T QAL H +
Sbjct: 259 --DLLSKMLKLDPNQRITAKQALEHAY 283
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-43
Identities = 90/329 (27%), Positives = 147/329 (44%), Gaps = 51/329 (15%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLA 625
+++ G G ++TV + + G VA+K ++ + E E+ ++K+L
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTG----VYVALKEVKLDSEEGTPSTAIREISLMKEL- 60
Query: 626 GADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNI---GLKLTAVRAY 680
+H +R N L LVFE + +L++ + GL+L V+ +
Sbjct: 61 -------KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK--NEITPYLVSR 738
QL L +LH D+KP N+L+N+ + LKL DFG A G N + +V+
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 739 FYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+YRAP++++G Y +DIWS GC L E+ TGK LFPG + + L+L ++ G P
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT-P--- 228
Query: 798 LRKGAFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
E P VTK I P+D+ ++ +
Sbjct: 229 -------------------NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT--KEPLD 267
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
N D L + L+P+ R++ QAL HP+
Sbjct: 268 GNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 91/329 (27%), Positives = 149/329 (45%), Gaps = 58/329 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAG--QT---EVQIL 621
RYE G+G F+TV +A+D + VAIK I+ + + K G +T E+++L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 622 KKLAGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
++L H I +F +++++ LVF+ + +L ++K ++ L + ++A
Sbjct: 67 QEL--------SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKA 116
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVS 737
Y L++L +LH D+KP+N+L++E VLKL DFG A G T +V+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVT 175
Query: 738 RFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
R+YRAPE++ G Y +D+W+VGC L EL PG ++ D L E G P
Sbjct: 176 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT-P-- 232
Query: 797 MLRKGAFTDQHFDQDLNFHATEED-P-VTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
TEE P + + + I +L
Sbjct: 233 --------------------TEEQWPDMCSLPDYVTFKSFPGIPLHHIF---SAAGDDLL 269
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DL+ +F+ +P R+T QAL +
Sbjct: 270 ----DLIQGLFLFNPCARITATQALKMKY 294
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 88/325 (27%), Positives = 132/325 (40%), Gaps = 52/325 (16%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLA 625
Y G+G ++TV + K VA+K IR + E EV +LK L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDL- 57
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + L LVFE L +L++ L + + V+ + QL
Sbjct: 58 -----KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLL 110
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRAP 743
L + VLH D+KP N+L+NE + LKL DFG A +V+ +YR P
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169
Query: 744 EIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802
+I+LG Y +D+W VGC YE+ TG+ LFPG+T + L + G P
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT-P-------- 220
Query: 803 FTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNI-KPKDIGSIVTASPGEDPKMLANFK 858
TEE P + + K + + + + S P D
Sbjct: 221 --------------TEETWPGILSNEEFKTYNYPKYRAEALLSHA---PRLDSDGA---- 259
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPF 883
DLL K+ + R++ A+ HPF
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPF 284
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-43
Identities = 94/326 (28%), Positives = 147/326 (45%), Gaps = 54/326 (16%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+Y+ G+G + V +AKD G VA+K IR +E + E+ +LK+L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQG----RIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ + + L LVFE + +L++VL + GL+ + ++ Y QL
Sbjct: 77 ------HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQL 128
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFYRA 742
+ H +LH D+KP N+L+N LKL DFG A G T +V+ +YRA
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRA 187
Query: 743 PEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
P++++G Y +DIWS+GC E+ TGK LFPG T++D L + G P
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGT-P------- 239
Query: 802 AFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIF-NIKPKDIGSIVTASPGEDPKMLANF 857
+ P V + K+ F + K SI+ PG + +
Sbjct: 240 ---------------NPREWPQVQELPLWKQRTFQVFEKKPWSSII---PGFCQEGI--- 278
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPF 883
DLL + DP KR++ A+ HP+
Sbjct: 279 -DLLSNMLCFDPNKRISARDAMNHPY 303
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 68/345 (19%), Positives = 116/345 (33%), Gaps = 97/345 (28%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQ 619
+ Y + G G S V + + K + AIK + +N+T++ + E+
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLNEKK-----QIYAIKYVNLEEADNQTLDSY-RNEIA 78
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
L KL + IR ++ +V E +++L LKK + ++
Sbjct: 79 YLNKLQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKS 131
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEI------ 731
Y K + A+ + G++H D+KP N L+ +LKL DFG N M +
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 732 -TPYLVSRFYRAPEIILGLP-----------YDHPLDIWSVGCCLYELYTGKVLFPGATN 779
T Y PE I + D+WS+GC LY + GK F N
Sbjct: 190 GTVN-----YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244
Query: 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDI 839
+ II +
Sbjct: 245 QI-------------------------------------------SKLHAIIDPNHEIEF 261
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
I + +D+L DP++R+++ + L HP++
Sbjct: 262 PDIP--EK--------DLQDVLKCCLKRDPKQRISIPELLAHPYV 296
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 88/331 (26%), Positives = 140/331 (42%), Gaps = 59/331 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
RY G+G + V +A D E VAIK IR E + EV +LK+L
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTN----ETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+H I S + + L L+FE +L++ + +N + + ++++
Sbjct: 91 --------QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD---KNPDVSMRVIKSFLY 139
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEA----KNVLKLCDFGNAMFAG--KNEITPYLV 736
QL + + LH D+KP N+L++ + VLK+ DFG A G + T ++
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 737 SRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
+ +YR PEI+LG Y +DIWS+ C E+ LFPG + D L E+ G P
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL-P- 257
Query: 796 KMLRKGAFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNIKPKDIGSIVTASPGEDPK 852
+ P VT K+ + K + ++ D +
Sbjct: 258 ---------------------DDTTWPGVTALPDWKQSFPKFRGKTLKRVLG--ALLDDE 294
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
L DLL + +DP KR++ AL HP+
Sbjct: 295 GL----DLLTAMLEMDPVKRISAKNALEHPY 321
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 89/328 (27%), Positives = 141/328 (42%), Gaps = 57/328 (17%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE G+G + TV +AK+ + E VA+K +R ++E + + E+ +LK+L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+H +R L LVFE +L++ N L V+++
Sbjct: 59 --------KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLF 108
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG--KNEITPYLVSRFY 740
QL L + VLH D+KP N+L+N LKL +FG A G + +V+ +Y
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 741 RAPEIILGLP-YDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798
R P+++ G Y +D+WS GC EL G+ LFPG +D L+ L G P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT-P---- 222
Query: 799 RKGAFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
TEE P +TK K + ++V P +
Sbjct: 223 ------------------TEEQWPSMTKLPDYKPYPMYPATTSLVNVV---PKLNATGR- 260
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPF 883
DLL + +P +R++ +AL HP+
Sbjct: 261 ---DLLQNLLKCNPVQRISAEEALQHPY 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 68/348 (19%), Positives = 117/348 (33%), Gaps = 97/348 (27%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQ 619
+ Y + G G S V + + K + AIK + +N+T++ + E+
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLNEKK-----QIYAIKYVNLEEADNQTLDSY-RNEIA 59
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
L KL + IR ++ +V E +++L LKK + ++
Sbjct: 60 YLNKLQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKS 112
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEI------ 731
Y K + A+ + G++H D+KP N L+ +LKL DFG N M +
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 732 -TPYLVSRFYRAPEIILGLP-----------YDHPLDIWSVGCCLYELYTGKVLFPGATN 779
T Y PE I + D+WS+GC LY + GK F N
Sbjct: 171 GTVN-----YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDI 839
+ II +
Sbjct: 226 QIS-------------------------------------------KLHAIIDPNHEIEF 242
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
I + +D+L DP++R+++ + L HP++ +
Sbjct: 243 PDIP--EK--------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-41
Identities = 95/357 (26%), Positives = 159/357 (44%), Gaps = 64/357 (17%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQIL 621
+ +YE+ GKG + V ++ D + G E VA+K I + N T + E+ IL
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTG----EVVAVKKIFDAFQNSTDAQRTFREIMIL 62
Query: 622 KKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
+L+ EN + +R A + + LVF+ + +L V++ L V
Sbjct: 63 TELS--GHENIVNLLNVLR-ADND---RDVYLVFDYMETDLHAVIR------ANILEPVH 110
Query: 679 ----AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------------- 721
Y QL +K+L + G+LH D+KP N+L+N A+ +K+ DFG
Sbjct: 111 KQYVVY--QLIKVIKYLHSGGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTN 167
Query: 722 ----------NAMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTG 770
+ +T Y+ +R+YRAPEI+LG Y +D+WS+GC L E+ G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 771 KVLFPGATNNDMLRLHMELKG-PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKK 829
K +FPG++ + L + + P + + + + + L + +
Sbjct: 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESL--------KEKVEIRQS 279
Query: 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+I K ++ +P D A DLLDK+ +P KR++ AL HPF+S
Sbjct: 280 NKRDIFTKWKNLLLKINPKADCNEEA--LDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 67/348 (19%), Positives = 116/348 (33%), Gaps = 97/348 (27%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQ 619
+ Y + G G S V + + K + AIK + +N+T++ + E+
Sbjct: 53 VKGRIYSILKQIGSGGSSKVFQVLNEKK-----QIYAIKYVNLEEADNQTLDSY-RNEIA 106
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRA 679
L KL + IR ++ +V E +++L LKK + ++
Sbjct: 107 YLNKLQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKS---IDPWERKS 159
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEI------ 731
Y K + A+ + G++H D+KP N L+ +LKL DFG N M +
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 732 -TPYLVSRFYRAPEIILGLP-----------YDHPLDIWSVGCCLYELYTGKVLFPGATN 779
Y PE I + D+WS+GC LY + GK F N
Sbjct: 218 GAVN-----YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
Query: 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDI 839
+ II +
Sbjct: 273 QI-------------------------------------------SKLHAIIDPNHEIEF 289
Query: 840 GSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
I + +D+L DP++R+++ + L HP++ +
Sbjct: 290 PDIP--EK--------DLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-39
Identities = 86/396 (21%), Positives = 144/396 (36%), Gaps = 87/396 (21%)
Query: 547 HDNWDDAEGYYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKI 603
H + + Y G + Y + G+G + V A D + VAIK
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTE----KNVAIKK 58
Query: 604 IRN---NETMNKAGQTEVQILKKLAGADPENKRH----CIR---FASSFKYRNHLCLVFE 653
+ + K E+ IL +L + + + L +V E
Sbjct: 59 VNRMFEDLIDCKRILREITILNRL--------KSDYIIRLYDLIIPDDLLKFDELYIVLE 110
Query: 654 SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713
+L+++ K I L ++ L + + G++H D+KP N L+N
Sbjct: 111 IADSDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN-QDC 166
Query: 714 VLKLCDFG------------------------NAMFAGKNEITPYLVSRFYRAPEIILGL 749
+K+CDFG K ++T ++V+R+YRAPE+IL
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 750 P-YDHPLDIWSVGCCLYELYTG-----------KVLFPGATNNDMLRLHMELKGPFPKKM 797
Y +DIWS GC EL LFPG++ P
Sbjct: 227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCF-----------PLSPDR 275
Query: 798 LRKGAFTDQHFDQ-DLNFHA----TEED--PVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
K + DQ ++ F+ TE+D + K + K I + ++ P
Sbjct: 276 NSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ +LL+ + +P KR+T+ QAL HP++
Sbjct: 336 DDGI----NLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 87/376 (23%), Positives = 146/376 (38%), Gaps = 78/376 (20%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQIL 621
+ RYE+ G G + V A D VAIK I + K E+ IL
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEK----RVVAIKKILRVFEDLIDCKRILREIAIL 106
Query: 622 KKLAGADPEN---KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
+L + ++ + K+ + L +V E + +++ + + L ++
Sbjct: 107 NRL---NHDHVVKVLDIVIPKDVEKF-DELYVVLEIADSDFKKLFRT---PVYLTELHIK 159
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG----------------- 721
L + +K++ + G+LH D+KP N LVN +K+CDFG
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 722 ------------NAMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELY 768
K ++T ++V+R+YRAPE+IL Y +D+WS+GC EL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 769 T-----------GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQ-DLNFHA 816
LFPG+ P K T + DQ ++ F+
Sbjct: 279 NMIKENVAYHADRGPLFPGS--------SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 817 ----TEED--PVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870
+EED + K+ K+ I ++ + P + LL ++ V +P
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI----HLLKRMLVFNPN 386
Query: 871 KRMTVAQALTHPFISG 886
KR+T+ + L HPF
Sbjct: 387 KRITINECLAHPFFKE 402
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 51/361 (14%), Positives = 93/361 (25%), Gaps = 93/361 (25%)
Query: 554 EGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNET 609
+G + E L G S V +D++ E+ A+K+ N+ +
Sbjct: 59 QGERKLKLVEPL----------RVGDRSVVFLVRDVERL----EDFALKVFTMGAENSRS 104
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSF--------------------KYRNHLC 649
+ +L G PE R R +
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 650 LVFESLHMNLREVLKKFGRNIG----LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN 705
L+ + ++L + + A+ QL +L++ G++H PDN
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224
Query: 706 MLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCC 763
+ + L L D G V Y E + + H L+ W +G
Sbjct: 225 LFIMP-DGRLMLGDVSALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 764 LYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVT 823
+Y ++ + F T L F
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGT--------------DSLAF--------- 319
Query: 824 KKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
G + K L+ + D +R+ +A+ P
Sbjct: 320 ------------------------GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355
Query: 884 I 884
Sbjct: 356 F 356
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 87/339 (25%), Positives = 139/339 (41%), Gaps = 65/339 (19%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNET--MNKAGQTEVQILKKL 624
+YE A G+G F V +A+ K G ++VA+K + NE E++IL+ L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 625 AGADPENKRH----------CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
+H + + + + + LVF+ +L +L + L
Sbjct: 74 --------KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTL 123
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF------AGK 728
+ ++ + L L ++ +LH D+K N+L+ VLKL DFG A +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQP 182
Query: 729 NEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
N T +V+ +YR PE++LG Y P+D+W GC + E++T + G T L L
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEED-P-VTK-KAIKKIIFNIKPKDIGSIVT 844
+L G T E P V + +K+ K
Sbjct: 243 QLCGS-I----------------------TPEVWPNVDNYELYEKLELVKGQKRKVKDRL 279
Query: 845 ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+ DP L DL+DK+ VLDP +R+ AL H F
Sbjct: 280 KAYVRDPYAL----DLIDKLLVLDPAQRIDSDDALNHDF 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 82/337 (24%), Positives = 120/337 (35%), Gaps = 93/337 (27%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN----KAGQTEVQILK 622
+ + G+G FS V RA L G VA+K ++ + M+ E+ +LK
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 623 KLAGADPENKRHC--IRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGR-NIGLKL 674
+L H I++ +SF N L +V E L ++K F + +
Sbjct: 88 QL--------NHPNVIKYYASFIEDNELNIVLELADAGDLS----RMIKHFKKQKRLIPE 135
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI-- 731
V Y QL AL+H+ + V+H DIKP N+ + A V+KL D G F+ K
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 732 ----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
TPY Y +PE I Y+ DIWS+GC LYE+ + F G N
Sbjct: 195 SLVGTPY-----YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ +P P+ P D S
Sbjct: 250 IEQCDYP--------------------------PL-------------PSDHYS------ 264
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ L++ DPEKR V
Sbjct: 265 -------EELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 58/319 (18%), Positives = 103/319 (32%), Gaps = 86/319 (26%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G + V + + + G A+K + K EV +K+
Sbjct: 66 GHGSYGEVFKVRSKEDG----RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG-----QH 116
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
C+R +++ L L E +L++ + +G + L V Y + +AL HL
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGAS--LPEAQVWGYLRDTLLALAHLH 174
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFG------NAMFAGKNEITPYLVSRFYRAPEII 746
+ G++H D+KP N+ + + KL DFG A E P Y APE++
Sbjct: 175 SQGLVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----YMAPELL 228
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
G Y D++S+G + E+ +
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNM----------------------------------E 253
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML-ANFKDLLDKIF 865
+ +++ P E L + + +L +
Sbjct: 254 LPHGGEGWQQ----------LRQGYL--------------PPEFTAGLSSELRSVLVMML 289
Query: 866 VLDPEKRMTVAQALTHPFI 884
DP+ R T L P +
Sbjct: 290 EPDPKLRATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 70/334 (20%), Positives = 122/334 (36%), Gaps = 95/334 (28%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKK 623
+Y G+G F + K + G + IK I +++ ++ + EV +L
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDG----RQYVIKEINISRMSSKEREES-RREVAVLAN 79
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR 678
+ + +++ SF+ L +V + L + + + + + +
Sbjct: 80 M------KHPNIVQYRESFEENGSLYIVMDYCEGGDLF----KRINAQ-KGVLFQEDQIL 128
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------- 731
+ Q+ +ALKH+ + +LH DIK N+ + + ++L DFG A
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIG 187
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME-LK 790
TPY Y +PEI PY++ DIW++GC LYEL T K F M L ++ +
Sbjct: 188 TPY-----YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA---GSMKNLVLKIIS 239
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
G FP H+ DL
Sbjct: 240 GSFPP--------VSLHYSYDL-------------------------------------- 253
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ L+ ++F +P R +V L FI
Sbjct: 254 -------RSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 61/367 (16%), Positives = 115/367 (31%), Gaps = 98/367 (26%)
Query: 532 KTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKA 591
+T EG+ + +++ E + + G+G F V R KD +
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRV----------GRGSFGEVHRMKDKQT 82
Query: 592 GNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651
G + A+K +R + E+ L + + + + + +
Sbjct: 83 G----FQCAVKKVR----LEVFRVEELVACAGL------SSPRIVPLYGAVREGPWVNIF 128
Query: 652 FE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNM 706
E SL +++K+ G L Y Q L++L +LH D+K DN+
Sbjct: 129 MELLEGGSLG----QLIKQMGC---LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 707 LVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAPEIILGLPYDHPLDIWS 759
L++ + LCDFG+A+ + + L++ + APE+++G P D +DIWS
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241
Query: 760 VGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEE 819
C + + G P+ +
Sbjct: 242 SCCMMLHMLNGC---H----------------PWT-----------------------QY 259
Query: 820 DPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML-ANFKDLLDKIFVLDPEKRMTVAQA 878
KI P E P + + +P R + +
Sbjct: 260 FRG--PLCLKIASEPPPIR----------EIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
Query: 879 LTHPFIS 885
+
Sbjct: 308 RRKVGKA 314
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 63/350 (18%), Positives = 111/350 (31%), Gaps = 78/350 (22%)
Query: 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-- 614
+ + +IL G+G + V R + K G + AIK+ N +
Sbjct: 9 HLWLLSDIL----------GQGATANVFRGRHKKTG----DLFAIKVFNNISFLRPVDVQ 54
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSF--KYRNHLCLVFESLHMN---LREVLKKFGRN 669
E ++LKKL N ++ ++ + H L+ E L VL++
Sbjct: 55 MREFEVLKKL------NHKNIVKLFAIEEETTTRHKVLIME--FCPCGSLYTVLEEPSNA 106
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFGNAMFA 726
GL + + + + HL+ G++H +IKP N++ + ++V KL DFG A
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 727 GKNEI------TPYLVSRFYRAPEIILGL--------PYDHPLDIWSVGCCLYELYTGKV 772
+E T Y P++ Y +D+WS+G Y TG +
Sbjct: 167 EDDEQFVSLYGTEE-----YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF 832
F + M G ++ D + +++ +
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL-- 279
Query: 833 NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882
+L I D EK Q
Sbjct: 280 -------------------------TPVLANILEADQEKCWGFDQFFAET 304
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 68/338 (20%), Positives = 110/338 (32%), Gaps = 94/338 (27%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKK 623
YEV G G + + + G + + K + +EV +L++
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQML-VSEVNLLRE 61
Query: 624 LAGADPENKRHCIRFASSFKYR--NHLCLVFESL-HMNLREVLKKFGR-NIGLKLTAVRA 679
L + +R+ R L +V E +L V+ K + L V
Sbjct: 62 L------KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 680 YAKQLFIALKHL-----KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--- 731
QL +ALK VLH D+KP N+ ++ K +KL DFG A +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAK 174
Query: 732 ----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
TPY Y +PE + + Y+ DIWS+GC LYEL F L
Sbjct: 175 TFVGTPY-----YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---FSQKELAG 226
Query: 788 E-LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTAS 846
+ +G F + + +L
Sbjct: 227 KIREGKFRR--------IPYRYSDEL---------------------------------- 244
Query: 847 PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+++ ++ L R +V + L +P I
Sbjct: 245 -----------NEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 47/287 (16%), Positives = 103/287 (35%), Gaps = 32/287 (11%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNETMNKAGQTEVQIL 621
++ V G+G F+ V A + + ++ +K+ + A E I
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIG 114
Query: 622 KKLAGA-DPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLT--AV 677
+L P + ++F S+ ++N LV E + L + + + V
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN----------EAKNVLKLCDFGNA---- 723
++A ++ ++ + +C ++H DIKPDN ++ + L L D G +
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 724 MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
+F T + ++ E++ P+++ +D + V +Y + G +
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK-NEGGEC 293
Query: 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKI 830
+ + M ++ F LN P +K+
Sbjct: 294 KPEGLFRRLPHLDMW------NEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 61/338 (18%), Positives = 104/338 (30%), Gaps = 93/338 (27%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKL--- 624
++ G G F V +AK G + IK ++ N N+ + EV+ L KL
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDG----KTYVIKRVKYN---NEKAEREVKALAKLDHV 64
Query: 625 -------AGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTA 676
+ SS L + E L + ++K R L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVL 123
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----- 731
+Q+ + ++ + +++ D+KP N+ + + K V K+ DFG +
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV-KIGDFGLVTSLKNDGKRTRSK 182
Query: 732 -TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL- 789
T Y +PE I Y +D++++G L EL L T + + +L
Sbjct: 183 GTLR-----YMSPEQISSQDYGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDLR 232
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
G FD+
Sbjct: 233 DGIIS-----------DIFDKKE------------------------------------- 244
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K LL K+ PE R ++ L + K
Sbjct: 245 --------KTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 55/346 (15%), Positives = 103/346 (29%), Gaps = 101/346 (29%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLAG 626
Y G+G FS V + L G A+K I + + + Q E + +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDG----HFYALKRILCHEQQDREEAQREADMHRLF-- 83
Query: 627 ADPENKRHCIRFASSF----KYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAV 677
N + +R + ++ L+ +L + + K L +
Sbjct: 84 ----NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF---LTEDQI 136
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA------------MF 725
+ L+ + G H D+KP N+L+ + + L D G+
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 726 AGKNEI----TPYLVSRFYRAPEIILGLPY---DHPLDIWSVGCCLYELYTGKVLFPGAT 778
++ T YRAPE+ + D D+WS+GC LY + G
Sbjct: 196 TLQDWAAQRCTIS-----YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG-------- 242
Query: 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKD 838
+GP + + + + +I
Sbjct: 243 -----------EGP---------------------YDMVFQKGDSVALAVQNQLSIPQ-- 268
Query: 839 IGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
P+ + LL+ + +DP +R + L+
Sbjct: 269 -----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 74/339 (21%), Positives = 133/339 (39%), Gaps = 63/339 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G+G + V +AK + + + A+K I ++ + E+ +L++L +H
Sbjct: 30 GRGTYGHVYKAKRKDGKDDK--DYALKQIEG-TGISMSACREIALLREL--------KHP 78
Query: 635 ---CIRFASSFKYRNHLCLVFESLHMNLREVLKKFG------RNIGLKLTAVRAYAKQLF 685
++ + L+F+ +L ++K + + L V++ Q+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKN---VLKLCDFGNAMFAGK-----NEITPYLVS 737
+ +L VLH D+KP N+LV +K+ D G A ++ P +V+
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 738 RFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
+YRAPE++LG Y +DIW++GC EL T + +F +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED---------------- 242
Query: 797 MLRKGAFTDQHFDQ-DLNFHA----TEED-------PVTKKAIKKIIFNIKPKDIGSIVT 844
H DQ D F+ ++D P +K F S++
Sbjct: 243 ---IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD--FRRNTYTNCSLIK 297
Query: 845 ASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
K + LL K+ +DP KR+T QA+ P+
Sbjct: 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 64/349 (18%), Positives = 126/349 (36%), Gaps = 100/349 (28%)
Query: 552 DAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN 611
+G + +F + G+G F TV + D + EVA +++ +
Sbjct: 22 SNDGRF-LKFDIEI----------GRGSFKTVYKGLDTETT----VEVAWCELQDRKLTK 66
Query: 612 KAGQ---TEVQILKKLAGADPENKRHCIRFASSF----KYRNHLCLVFESLHM-NLREVL 663
Q E ++LK L + +RF S+ K + + LV E + L+ L
Sbjct: 67 SERQRFKEEAEMLKGL------QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 664 KKFGRNIGLKLTAVRAYAKQLFIALKHL--KNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721
K+F +K+ +R++ +Q+ L+ L + ++H D+K DN+ + +K+ D G
Sbjct: 121 KRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 722 NAMFAGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
A + TP + APE+ YD +D+++ G C+ E+ T +
Sbjct: 178 LATLKRASFAKAVIGTPE-----FMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY---- 227
Query: 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN-IK 835
P+ E I + + + +K
Sbjct: 228 ---------------PYS-----------------------ECQNA--AQIYRRVTSGVK 247
Query: 836 PKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
P + P K++++ + ++R ++ L H F
Sbjct: 248 PASFDKV------AIP----EVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 51/347 (14%), Positives = 100/347 (28%), Gaps = 105/347 (30%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+ G G F +V + G AIK + + EV L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDG----CIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRA 679
H +R+ S++ +H+ + E SL + E + K ++
Sbjct: 68 G-----QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY---FKEAELKD 119
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNE------------------AKNVLKLCDFG 721
Q+ L+++ + ++H DIKP N+ ++ K + K+ D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 722 NAMFAGKNEI---TPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
+ ++ + A E++ + DI+++ + + L
Sbjct: 180 HVTRISSPQVEEGDSR-----FLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--- 231
Query: 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837
N D H +G P+ Q Q+
Sbjct: 232 RNGDQ--WHEIRQGRLPR--------IPQVLSQEF------------------------- 256
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+LL + DPE+R + + H +
Sbjct: 257 --------------------TELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 66/358 (18%), Positives = 125/358 (34%), Gaps = 102/358 (28%)
Query: 558 SYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTE 617
S R+ +E A G+G F VV+A++ AIK IR+ E +E
Sbjct: 1 SLRYAS----DFEEIAVLGQGAFGQVVKARNALDS----RYYAIKKIRHTEEKLSTILSE 52
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN--------------LREVL 663
V +L L N ++ +R+ +++ R + ++ L +++
Sbjct: 53 VMLLASL------NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 664 KKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-- 721
N+ + +Q+ AL ++ + G++H D+KP N+ ++E++NV K+ DFG
Sbjct: 107 HS--ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV-KIGDFGLA 163
Query: 722 ----NAMFAGKNEITPYLVSR----------FYRAPEIILGLP-YDHPLDIWSVGCCLYE 766
++ K + S Y A E++ G Y+ +D++S+G +E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 767 LYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKA 826
+ G ++L K LR + F +D K
Sbjct: 224 MIYP--FSTGMERVNIL------------KKLRSVSI---------EFPPDFDDNKMKVE 260
Query: 827 IKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
K ++ + DP KR L ++
Sbjct: 261 -------------------------------KKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 78/388 (20%), Positives = 127/388 (32%), Gaps = 125/388 (32%)
Query: 556 YYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR------NNET 609
Y+ L +Y + A G+G + V A + + AIKI+ N
Sbjct: 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTR----AIRAIKIMNKNKIRQINPK 70
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE---------------- 653
+ +TEV+++KKL + R ++ ++CLV E
Sbjct: 71 DVERIKTEVRLMKKLHH------PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 654 --------------------SLHMNLREVLKKFGRNIGLKLT--AVRAYAKQLFIALKHL 691
+ + F ++ + +Q+F AL +L
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 692 KNCGVLHCDIKPDNMLVNEAKN-VLKLCDFGNAMFAGKNEI-----------TPYLVSRF 739
N G+ H DIKP+N L + K+ +KL DFG + K TPY
Sbjct: 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY----- 239
Query: 740 YRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+ APE++ Y D WS G L+ L G V FPG + D +
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS------------Q 287
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ L F + ++ A
Sbjct: 288 VLNK---------KLCFENPNYNVLSPLA------------------------------- 307
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+DLL + + ++R +AL HP+IS
Sbjct: 308 RDLLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-32
Identities = 63/349 (18%), Positives = 112/349 (32%), Gaps = 78/349 (22%)
Query: 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-- 614
+ + +IL G+G + V R + K G + AIK+ N +
Sbjct: 9 HLWLLSDIL----------GQGATANVFRGRHKKTG----DLFAIKVFNNISFLRPVDVQ 54
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRN--HLCLVFESLHMN---LREVLKKFGRN 669
E ++LKKL N ++ ++ + + H L+ E L VL++
Sbjct: 55 MREFEVLKKL------NHKNIVKLFAIEEETTTRHKVLIME--FCPCGSLYTVLEEPSNA 106
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFGNAMFA 726
GL + + + + HL+ G++H +IKP N++ + ++V KL DFG A
Sbjct: 107 YGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 727 GKNEI------TPYLVSRFYRAPEIILGL--------PYDHPLDIWSVGCCLYELYTGKV 772
+E T Y P++ Y +D+WS+G Y TG +
Sbjct: 167 EDDEQFVSLYGTEE-----YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF 832
F + M G ++ D + +++ +
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL-- 279
Query: 833 NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881
+L I D EK Q
Sbjct: 280 -------------------------TPVLANILEADQEKCWGFDQFFAE 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 77/331 (23%), Positives = 114/331 (34%), Gaps = 89/331 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ-----TEVQIL 621
RY GKG F+ D E A KI+ + K Q E+ I
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTK----EVFAGKIV-PKSLLLKPHQREKMSMEISIH 69
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAY 680
+ L +H + F F+ + + +V E L E+ K+ L R Y
Sbjct: 70 RSL------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYY 120
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI------TP 733
+Q+ + ++L V+H D+K N+ +NE V K+ DFG E TP
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV-KIGDFGLATKVEYDGERKKVLCGTP 179
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
Y APE++ + +D+WS+GC +Y L GK PF
Sbjct: 180 N-----YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP-------------------PF 215
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
L T IKK ++I PK I +P
Sbjct: 216 E--------------TSCL--------KETYLRIKKNEYSI-PKHI------NPVA---- 242
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
L+ K+ DP R T+ + L F
Sbjct: 243 ----ASLIQKMLQTDPTARPTINELLNDEFF 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-31
Identities = 66/333 (19%), Positives = 106/333 (31%), Gaps = 62/333 (18%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKL 624
G +E+ G G F V+R G E+VAIK R + + E+QI+KKL
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTG----EQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 625 AGADPENKRH--------CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLK 673
H + L E + LR+ L +F GLK
Sbjct: 70 --------NHPNVVSAREVPDGLQKLAPNDLPLLAME--YCEGGDLRKYLNQFENCCGLK 119
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV--NEAKNVLKLCDFGNAMFAGKNEI 731
+R + AL++L ++H D+KP+N+++ + + K+ D G A + E+
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 732 TPYLV-SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
V + Y APE++ Y +D WS G +E TG F + K
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK 239
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
+ F + P I
Sbjct: 240 SNEH-------IVVYDDLTGAVKFSSVLPTPNHLSGILAGKL------------------ 274
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+ L + + +R T Q
Sbjct: 275 -------ERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 83/360 (23%), Positives = 123/360 (34%), Gaps = 121/360 (33%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII----------RNNE 608
Y EIL G+GV S V R +E A+KII +
Sbjct: 19 YEPKEIL----------GRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQ 64
Query: 609 TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------R 660
+ +A EV IL+K++G + I+ +++ LVF+ L
Sbjct: 65 ELREATLKEVDILRKVSGH-----PNIIQLKDTYETNTFFFLVFD-----LMKKGELFDY 114
Query: 661 EVLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718
K L+ R + L + L ++H D+KP+N+L+++ N +KL
Sbjct: 115 LTEKV-------TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN-IKLT 166
Query: 719 DFGNAMFAGKNEI------TPYLVSRFYRAPEIILGL------PYDHPLDIWSVGCCLYE 766
DFG + E TP Y APEII Y +D+WS G +Y
Sbjct: 167 DFGFSCQLDPGEKLREVCGTPS-----YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 221
Query: 767 LYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKA 826
L G F MLR M+ G + F + E D +
Sbjct: 222 LLAGSPPFWHRKQMLMLR------------MIMSGNYQ---------FGSPEWDDYSDTV 260
Query: 827 IKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
KDL+ + V+ P+KR T +AL HPF
Sbjct: 261 -------------------------------KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 71/347 (20%), Positives = 123/347 (35%), Gaps = 107/347 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTE 617
+ F E+L G G FS V K G + A+K I+ + + + E
Sbjct: 11 FIFMEVL----------GSGAFSEVFLVKQRLTG----KLFALKCIKKSPAFRDSSLENE 56
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFGRN 669
+ +LKK+ + + ++ H LV + L R + +
Sbjct: 57 IAVLKKI------KHENIVTLEDIYESTTHYYLVMQ-----LVSGGELFDRILERG---- 101
Query: 670 IGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV--NEAKNVLKLCDFGNAMF 725
T +Q+ A+K+L G++H D+KP+N+L E + + + DFG +
Sbjct: 102 ---VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158
Query: 726 AGKNEI-----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
+ TP Y APE++ PY +D WS+G Y L G F T +
Sbjct: 159 EQNGIMSTACGTPG-----YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIG 840
+ +++G + F + D +++ A
Sbjct: 214 KLFE------------KIKEGYYE---------FESPFWDDISESA-------------- 238
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + + DP +R T +AL+HP+I G
Sbjct: 239 -----------------KDFICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 80/350 (22%), Positives = 130/350 (37%), Gaps = 110/350 (31%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y E L GKG FS V R G E A KII + + Q
Sbjct: 8 YDVKEEL----------GKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLE 53
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFG 667
E +I +KL + +R S + + LVF+ L V ++
Sbjct: 54 REARICRKL------QHPNIVRLHDSIQEESFHYLVFD-----LVTGGELFEDIVARE-- 100
Query: 668 RNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNA 723
+ +Q+ ++ + + G++H ++KP+N +L ++AK +KL DFG A
Sbjct: 101 -----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
Query: 724 MFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
+ +E TP Y +PE++ PY P+DIW+ G LY L G F
Sbjct: 156 IEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 210
Query: 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837
+ + ++ GA+ + + E D VT +A
Sbjct: 211 DQHRLYA------------QIKAGAYD---------YPSPEWDTVTPEA----------- 238
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K L+D + ++P+KR+T QAL P+I +
Sbjct: 239 --------------------KSLIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 63/346 (18%), Positives = 107/346 (30%), Gaps = 97/346 (28%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLA 625
+E G+G F V AK+ AIK IR N E + EV+ L KL
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDD----CNYAIKRIRLPNRELAREKVMREVKALAKL- 60
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLH-------M------NLREVLKKFGRNIGL 672
+R+ +++ +N + S M NL++ +
Sbjct: 61 -----EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 673 KLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG----------N 722
+ + Q+ A++ L + G++H D+KP N+ +V+K+ DFG
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEE 174
Query: 723 AMFAGKNEITPYLVSR----FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
+ Y +PE I G Y H +DI+S+G L+EL
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------- 225
Query: 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKD 838
PF +M R TD ++ + F
Sbjct: 226 -------------PFSTQMERVRTLTD---------------------VRNLKFPPLFTQ 251
Query: 839 IGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
P ++ + P +R + +
Sbjct: 252 K------YP--------CEYVMVQDMLSPSPMERPEAINIIENAVF 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-31
Identities = 60/342 (17%), Positives = 112/342 (32%), Gaps = 88/342 (25%)
Query: 555 GYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
G S+ ++L G G T+V G + +VA+K I
Sbjct: 22 GKISFCPKDVL----------GHGAEGTIV-----YRGMFDNRDVAVKRI--LPECFSFA 64
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
EVQ+L++ + IR+ + K R + E L+E +++ ++
Sbjct: 65 DREVQLLRESDE-----HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLG 117
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV----NEAKNVLKLCDFGNAMFAGKNE 730
+Q L HL + ++H D+KP N+L+ K + DFG
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
Query: 731 ITPYLV-----SRFYRAPEIILGLP---YDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
+ + + APE++ + +DI+S GC Y + + G +
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
+L + H ++ + A
Sbjct: 238 AN-----------ILLGACSLDCLHPEKHEDVIA-------------------------- 260
Query: 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
++L++K+ +DP+KR + L HPF
Sbjct: 261 ---------------RELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 71/350 (20%), Positives = 132/350 (37%), Gaps = 103/350 (29%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
Y E++ GKG FS V R + + G ++ A+KI+ + + G
Sbjct: 26 YELCEVI----------GKGPFSVVRRCINRETG----QQFAVKIVDVAKFTSSPGLSTE 71
Query: 615 --QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN----LREVLKKFGR 668
+ E I L H + ++ L +VFE M+ E++K+
Sbjct: 72 DLKREASICHML------KHPHIVELLETYSSDGMLYMVFE--FMDGADLCFEIVKRADA 123
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFA 726
Y +Q+ AL++ + ++H D+KP +L ++ + +KL FG A+
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 727 GKNEI-------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFP--GA 777
G++ + TP+ + APE++ PY P+D+W G L+ L +G
Sbjct: 184 GESGLVAGGRVGTPH-----FMAPEVVKREPYGKPVDVWGCGVILFILLSG---CLPFYG 235
Query: 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837
T + + KG + + +++ A
Sbjct: 236 TKERLFE------------GIIKG---------KYKMNPRQWSHISESA----------- 263
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ ++ +LDP +R+TV +AL HP++ +
Sbjct: 264 --------------------KDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 76/331 (22%), Positives = 114/331 (34%), Gaps = 89/331 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ-----TEVQIL 621
RY GKG F+ D E A KI+ + K Q E+ I
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTK----EVFAGKIV-PKSLLLKPHQREKMSMEISIH 95
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAY 680
+ L +H + F F+ + + +V E L E+ K+ L R Y
Sbjct: 96 RSL------AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYY 146
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI------TP 733
+Q+ + ++L V+H D+K N+ +NE +K+ DFG E TP
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
Y APE++ + +D+WS+GC +Y L GK PF
Sbjct: 206 N-----YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP-------------------PF 241
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
L T IKK ++I PK I +P
Sbjct: 242 E--------------TSCL--------KETYLRIKKNEYSI-PKHI------NPVA---- 268
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
L+ K+ DP R T+ + L F
Sbjct: 269 ----ASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLAGADPENKRH 634
GKG + V +DL +AIK I + ++ E+ + K L ++
Sbjct: 31 GKGTYGIVYAGRDLSNQ----VRIAIKEIPERDSRYSQPLHEEIALHKHL------KHKN 80
Query: 635 CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+++ SF + + E SL LR N + Y KQ+ LK
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLK 136
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLV-SRFYRAPEIIL 747
+L + ++H DIK DN+L+N VLK+ DFG + AG N T + Y APEII
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIID 196
Query: 748 GLP--YDHPLDIWSVGCCLYELYTGK 771
P Y DIWS+GC + E+ TGK
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 73/334 (21%), Positives = 126/334 (37%), Gaps = 98/334 (29%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G FS + K+ + A+KII ++ M Q E+ LK G +
Sbjct: 20 GEGSFSICRKCVHKKSN----QAFAVKII--SKRMEANTQKEITALKLCEGH-----PNI 68
Query: 636 IRFASSFKYRNHLCLVFESL-------------HMNLREVLKKFGRNIGLKLTAVRAYAK 682
++ F + H LV E L H + E +
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA---------------SYIMR 113
Query: 683 QLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNA-MFAGKNEI------TP 733
+L A+ H+ + GV+H D+KP+N+L +E N +K+ DFG A + N+ T
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
+ Y APE++ YD D+WS+G LY + +G+V F + +E+
Sbjct: 174 H-----YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI---- 224
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
K ++KG F+ F V+++A
Sbjct: 225 -MKKIKKGDFS---------FEGEAWKNVSQEA--------------------------- 247
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ + +DP KR+ ++ + ++
Sbjct: 248 ----KDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-31
Identities = 72/335 (21%), Positives = 128/335 (38%), Gaps = 83/335 (24%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y+ + L G G + V+ +D E AIKIIR +
Sbjct: 39 YQRVKKL----------GSGAYGEVLLCRDKVTH----VERAIKIIRKTSVSTSSNSKLL 84
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKL 674
EV +LK L + + ++ F+ + + LV E L + + +
Sbjct: 85 EEVAVLKLL------DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNE 135
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKNEIT 732
KQ+ + +L ++H D+KP+N +L ++ K+ ++K+ DFG + +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 733 PYLV-SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
+ + +Y APE++ YD D+WS+G L+ L G F G T+ ++LR
Sbjct: 196 KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------- 247
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
+ KG F + E V++ A
Sbjct: 248 -----KVEKG---------KYTFDSPEWKNVSEGA------------------------- 268
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
KDL+ ++ D ++R++ QAL HP+I
Sbjct: 269 ------KDLIKQMLQFDSQRRISAQQALEHPWIKE 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 78/354 (22%), Positives = 125/354 (35%), Gaps = 106/354 (29%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII-RNNETMNKAGQTEVQIL 621
E+ + R V +G F+ V A+D+ +G E A+K + N E N+A EV +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSG----REYALKRLLSNEEEKNRAIIQEVCFM 79
Query: 622 KKLAGADPENKRHCIRFASSFKYRNH--------LCLVFESLHMNLREVLKKFGRNIGLK 673
KKL+ + ++F S+ L+ E L E LKK L
Sbjct: 80 KKLS-----GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 674 LTAVRAYAKQLFIALKHL--KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-------- 723
V Q A++H+ + ++H D+K +N+L++ + KLCDFG+A
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI-KLCDFGSATTISHYPD 193
Query: 724 -------MFAGKNEI----TPYLVSRFYRAPEII---LGLPYDHPLDIWSVGCCLYELYT 769
+ EI TP YR PEII P DIW++GC LY L
Sbjct: 194 YSWSAQRRALVEEEITRNTTPM-----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 770 GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKK 829
+ PF + K I
Sbjct: 249 R-------------------QHPF--------------------------EDGAKLRIVN 263
Query: 830 IIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
++I P F L+ + ++PE+R+++A+ +
Sbjct: 264 GKYSIPP-------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 75/342 (21%), Positives = 128/342 (37%), Gaps = 94/342 (27%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
Y+ +L GKG F V+ KD G +E A+K+I + K
Sbjct: 28 YKGQRVL----------GKGSFGEVILCKDKITG----QECAVKVISKRQVKQKTDKESL 73
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLK 673
EVQ+LK+L + + ++ F+ + + LV E L + + R
Sbjct: 74 LREVQLLKQL------DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FS 124
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKNEI 731
+Q+ + ++ ++H D+KP+N +L +++K+ +++ DFG + ++
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 732 ------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
T Y Y APE++ G YD D+WS G LY L +G F GA D+L+
Sbjct: 185 MKDKIGTAY-----YIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK- 237
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845
+ KG F + V++ A
Sbjct: 238 -----------KVEKG---------KYTFELPQWKKVSESA------------------- 258
Query: 846 SPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ P R++ AL H +I
Sbjct: 259 ------------KDLIRKMLTYVPSMRISARDALDHEWIQTY 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-30
Identities = 78/346 (22%), Positives = 131/346 (37%), Gaps = 64/346 (18%)
Query: 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTE 617
+ GE+ D +E + G G V + +G +A K+I + E
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIKPAIRNQIIRE 81
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKL 674
+Q+L + N + + F +F + + E HM+ L +VLKK GR +
Sbjct: 82 LQVLHEC------NSPYIVGFYGAFYSDGEISICME--HMDGGSLDQVLKKAGR---IPE 130
Query: 675 TAVRAYAKQLFIALKHLKNCG-VLHCDIKPDNMLVNEAKNVLKLCDFG------NAM--- 724
+ + + L +L+ ++H D+KP N+LVN + KLCDFG ++M
Sbjct: 131 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI-KLCDFGVSGQLIDSMANS 189
Query: 725 FAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR 784
F G +R Y +PE + G Y DIWS+G L E+ G+ +P
Sbjct: 190 FVG---------TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR--YPIP------- 231
Query: 785 LHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVT 844
P + D + K + + P I ++
Sbjct: 232 ---------PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
Query: 845 ASPGEDPKML------ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
E P L F+D ++K + +P +R + Q + H FI
Sbjct: 283 YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 77/341 (22%), Positives = 124/341 (36%), Gaps = 93/341 (27%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y +L GKG F V++ KD +E A+K+I NK
Sbjct: 24 YNIVCML----------GKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTIL 69
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKL 674
EV++LKKL + + ++ + + +V E L + + K R
Sbjct: 70 REVELLKKL------DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSE 120
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKNEI- 731
KQ+F + ++ ++H D+KP+N +L ++ K+ +K+ DFG + +N
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 732 -----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH 786
T Y Y APE++ G YD D+WS G LY L +G F G D+L+
Sbjct: 181 KDRIGTAY-----YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-- 232
Query: 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTAS 846
+ G F + ++ A
Sbjct: 233 ----------RVETG---------KYAFDLPQWRTISDDA-------------------- 253
Query: 847 PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ P R+T Q L HP+I
Sbjct: 254 -----------KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 74/332 (22%), Positives = 122/332 (36%), Gaps = 93/332 (28%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT-----EVQIL 621
+E+ GKG F V A++ ++ +A+K++ + KAG EV+I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSK----FILALKVL-FKAQLEKAGVEHQLRREVEIQ 63
Query: 622 KKLAGADPENKRH--CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVR 678
L RH +R F + L+ E + + L+K +
Sbjct: 64 SHL--------RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTA 112
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-----TP 733
Y +L AL + + V+H DIKP+N+L+ LK+ DFG ++ A + T
Sbjct: 113 TYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTL 171
Query: 734 -YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
YL PE+I G +D +D+WS+G YE GK P
Sbjct: 172 DYL------PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------P 206
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
F T K I ++ F P + + G
Sbjct: 207 FE----------------------ANTYQETYKRISRVEFTF-PDFV------TEG---- 233
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+DL+ ++ +P +R + + L HP+I
Sbjct: 234 ----ARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 65/345 (18%), Positives = 118/345 (34%), Gaps = 103/345 (29%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
Y E L G+G F V R + + + K ++ T + E+
Sbjct: 7 YMIAEDL----------GRGEFGIVHRCVETSSK----KTYMAKFVKVKGTDQVLVKKEI 52
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNI--G 671
IL R+ + SF+ L ++FE + F R
Sbjct: 53 SILNIA------RHRNILHLHESFESMEELVMIFEFISGLDI----------FERINTSA 96
Query: 672 LKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKNVLKLCDFGNAMFAGK 728
+L + +Y Q+ AL+ L + + H DI+P+N + + +K+ +FG A
Sbjct: 97 FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
Query: 729 NEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
+ P Y APE+ D+WS+G +Y L +G F TN +
Sbjct: 157 GDNFRLLFTAPE-----YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
+ + + F ++ F + ++ +A
Sbjct: 212 IE--NIMNAEY--------TFDEEAFKE-----------ISIEA---------------- 234
Query: 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
D +D++ V + + RMT ++AL HP++ K
Sbjct: 235 ---------------MDFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-30
Identities = 69/352 (19%), Positives = 117/352 (33%), Gaps = 104/352 (29%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
Y L G G + V+ K+ E AIK+I+ ++
Sbjct: 38 YFKVRKL----------GSGAYGEVLLCKEKNGH----SEKAIKVIKKSQFDKGRYSDDN 83
Query: 615 ----------QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVL 663
E+ +LK L + + I+ F+ + + LV E L E +
Sbjct: 84 KNIEKFHEEIYNEISLLKSL------DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI 137
Query: 664 KKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFG 721
+ KQ+ + +L ++H DIKP+N +L N+ +K+ DFG
Sbjct: 138 INRHK---FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 722 NAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFP 775
+ F K+ T Y Y APE++ Y+ D+WS G +Y L G F
Sbjct: 195 LSSFFSKDYKLRDRLGTAY-----YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFG 248
Query: 776 GATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIK 835
G + D+++ + KG F + ++ +A
Sbjct: 249 GQNDQDIIK------------KVEKG---------KYYFDFNDWKNISDEA--------- 278
Query: 836 PKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K+L+ + D KR T +AL +I
Sbjct: 279 ----------------------KELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 88/441 (19%), Positives = 149/441 (33%), Gaps = 123/441 (27%)
Query: 478 DQSFSVKKSPPQNGVTALDKTSV--RGGLGDGSPKSETSNHIPCDDIFGETPVGVRKTGK 535
D F+ ++ + + L + R + + + + T
Sbjct: 12 DNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTEN 71
Query: 536 AEGLKIIRSGLHDNWDDAEGYYS-YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNG 594
+ +W A+ +Y Y +++ G+GV S V R G
Sbjct: 72 LYFQSMGPEDELPDWAAAKEFYQKYDPKDVI----------GRGVSSVVRRCVHRATG-- 119
Query: 595 EPEEVAIKII---------RNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645
E A+KI+ E + +A + E IL+++AG H I S++
Sbjct: 120 --HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH-----PHIITLIDSYESS 172
Query: 646 NHLCLVFESLHMNL--------REVLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCG 695
+ + LVF+ L K L+ R+ + L A+ L
Sbjct: 173 SFMFLVFD-----LMRKGELFDYLTEKV-------ALSEKETRSIMRSLLEAVSFLHANN 220
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------TPYLVSRFYRAPEIILGL 749
++H D+KP+N+L+++ ++L DFG + E TP Y APEI+
Sbjct: 221 IVHRDLKPENILLDDNMQ-IRLSDFGFSCHLEPGEKLRELCGTPG-----YLAPEILKCS 274
Query: 750 ------PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803
Y +D+W+ G L+ L G F MLR M+ +G +
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR------------MIMEGQY 322
Query: 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863
F + E D + KDL+ +
Sbjct: 323 ---------QFSSPEWDDRSSTV-------------------------------KDLISR 342
Query: 864 IFVLDPEKRMTVAQALTHPFI 884
+ +DPE R+T QAL HPF
Sbjct: 343 LLQVDPEARLTAEQALQHPFF 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-30
Identities = 80/350 (22%), Positives = 130/350 (37%), Gaps = 110/350 (31%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y E L GKG FS V R G E A KII + + Q
Sbjct: 31 YDVKEEL----------GKGAFSVVRRCVHKTTG----LEFAAKIINTKKLSARDFQKLE 76
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFG 667
E +I +KL + +R S + + LVF+ L V ++
Sbjct: 77 REARICRKL------QHPNIVRLHDSIQEESFHYLVFD-----LVTGGELFEDIVARE-- 123
Query: 668 RNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNA 723
+ +Q+ ++ + + G++H ++KP+N +L ++AK +KL DFG A
Sbjct: 124 -----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 724 MFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
+ +E TP Y +PE++ PY P+DIW+ G LY L G F
Sbjct: 179 IEVNDSEAWHGFAGTPG-----YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 233
Query: 778 TNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPK 837
+ + ++ GA+ + + E D VT +A
Sbjct: 234 DQHRLYA------------QIKAGAYD---------YPSPEWDTVTPEA----------- 261
Query: 838 DIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K L+D + ++P+KR+T QAL P+I +
Sbjct: 262 --------------------KSLIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 81/432 (18%), Positives = 147/432 (34%), Gaps = 109/432 (25%)
Query: 475 HLADQSFSVKKSPPQNG--VTALDKTSVRGGLGDGSPKSETSNHIPCDDIFGETPVGVRK 532
H + + Q+ D S + ++ + +P
Sbjct: 8 HSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIP 67
Query: 533 TGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAG 592
A I + + +Y+ EIL G G F V + ++ G
Sbjct: 68 APPAPFDHRIVTAKQGAVNS---FYTVSKTEIL----------GGGRFGQVHKCEETATG 114
Query: 593 NGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLV 651
++A KII+ +K + E+ ++ +L + + I+ +F+ +N + LV
Sbjct: 115 ----LKLAAKIIKTRGMKDKEEVKNEISVMNQL------DHANLIQLYDAFESKNDIVLV 164
Query: 652 FE-----SLHMNLREVLKKFGRNI--GLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIK 702
E L F R I LT + KQ+ ++H+ +LH D+K
Sbjct: 165 MEYVDGGEL----------FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 703 PDN-MLVNEAKNVLKLCDFGNAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPL 755
P+N + VN +K+ DFG A E TP + APE++ P
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE-----FLAPEVVNYDFVSFPT 269
Query: 756 DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFH 815
D+WSVG Y L +G F G + + L L + D+ F
Sbjct: 270 DMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILACRW--------DLEDEEFQD----- 314
Query: 816 ATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875
++++A K+ + K+ + + R++
Sbjct: 315 ------ISEEA-------------------------------KEFISKLLIKEKSWRISA 337
Query: 876 AQALTHPFISGK 887
++AL HP++S
Sbjct: 338 SEALKHPWLSDH 349
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 58/333 (17%), Positives = 105/333 (31%), Gaps = 97/333 (29%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKII---RNNETMNKAGQTEVQILKKLAGADPENK 632
G+G F+ V + G +E A K + R + E+ +L+
Sbjct: 38 GRGKFAVVRQCISKSTG----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC----- 88
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFGRNIGLKLT--AVRAYAK 682
I ++ + + L+ E + + ++ V K
Sbjct: 89 PRVINLHEVYENTSEIILILE-----YAAGGEIFSLCLPELAEM-----VSENDVIRLIK 138
Query: 683 QLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKNEI------TPY 734
Q+ + +L ++H D+KP N +L + +K+ DFG + G TP
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPE 198
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
Y APEI+ P D+W++G Y L T F G N + +
Sbjct: 199 -----YLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--NISQVNV- 250
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
++++ F V++ A
Sbjct: 251 -------DYSEETFSS-----------VSQLA---------------------------- 264
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
D + + V +PEKR T L+H ++
Sbjct: 265 ---TDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 39/292 (13%), Positives = 84/292 (28%), Gaps = 59/292 (20%)
Query: 553 AEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNE 608
E + G +L G+ + A D + G E + +
Sbjct: 74 GERPRTLVRGTVL----------GQEDPYAYLEATDQETG----ESFEVHVPYFTERPPS 119
Query: 609 TMNKAGQTEVQILKKLAGA-DPENKRHCIRFASSFKYRNH-------------------- 647
K + EV L+ L G + + + +RF F
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179
Query: 648 LCLVFESLHMNLREVLKKFGRNIG----LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703
++ + NL+ + + L A Q+ L L + G++H ++P
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 239
Query: 704 DNMLVNEAKNVLKLCDFGNAMFAGKNEIT---PYLVSRFYRAPEIILGLP-----YDHPL 755
++++++ V L F + + G + ++ A ++
Sbjct: 240 VDIVLDQRGGV-FLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 756 DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP-------KKMLRK 800
D W++G +Y ++ + P + LR
Sbjct: 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRY 350
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 74/355 (20%), Positives = 122/355 (34%), Gaps = 115/355 (32%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
Y GE L G G F+ V + + G +E A K I+ +
Sbjct: 7 YEMGEEL----------GSGQFAIVRKCRQKGTG----KEYAAKFIKKRRLSSSRRGVSR 52
Query: 615 ---QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVL 663
+ EV IL+++ + I F+ + + L+ E L
Sbjct: 53 EEIEREVNILREI------RHPNIITLHDIFENKTDVVLILE-----LVSGGELFDFLAE 101
Query: 664 KKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLC 718
K+ LT + KQ+ + +L + + H D+KP+N+++ N +KL
Sbjct: 102 KES-------LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI 154
Query: 719 DFGNAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772
DFG A TP + APEI+ P D+WS+G Y L +G
Sbjct: 155 DFGIAHKIEAGNEFKNIFGTPE-----FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
Query: 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF 832
F G T + L + F +++F ++ A
Sbjct: 210 PFLGETKQETLT--NISAVNY--------DFDEEYFSN-----------TSELA------ 242
Query: 833 NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + ++ V DP++RMT+AQ+L H +I
Sbjct: 243 -------------------------KDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 75/331 (22%), Positives = 123/331 (37%), Gaps = 88/331 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT-----EVQIL 621
++V GKG F+ V RA+ + G EVAIK+I + + M KAG EV+I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTG----LEVAIKMI-DKKAMYKAGMVQRVQNEVKIH 65
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAY 680
+L + + F+ N++ LV E H + LK + R +
Sbjct: 66 CQL------KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHF 117
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI------TP 733
Q+ + +L + G+LH D+ N+L+ N +K+ DFG +E TP
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
Y +PEI + D+WS+GC Y L G+ PF
Sbjct: 177 N-----YISPEIATRSAHGLESDVWSLGCMFYTLLIGRP-------------------PF 212
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
T+ T + + + P + S
Sbjct: 213 D----------------------TDTVKNTLNKVVLADYEM-PSFL------SIEA---- 239
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KDL+ ++ +P R++++ L HPF+
Sbjct: 240 ----KDLIHQLLRRNPADRLSLSSVLDHPFM 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 75/340 (22%), Positives = 123/340 (36%), Gaps = 91/340 (26%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y +L GKG F V++ KD +E A+K+I NK
Sbjct: 24 YNIVCML----------GKGSFGEVLKCKDRITQ----QEYAVKVINKASAKNKDTSTIL 69
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675
EV++LKKL + + ++ + + +V E E+ + +
Sbjct: 70 REVELLKKL------DHPNIMKLFEILEDSSSFYIVGE--LYTGGELFDEIIKRKRFSEH 121
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKNEI-- 731
KQ+F + ++ ++H D+KP+N +L ++ K+ +K+ DFG + +N
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 732 ----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
T Y Y APE++ G YD D+WS G LY L +G F G D+L+
Sbjct: 182 DRIGTAY-----YIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK--- 232
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ G F + ++ A
Sbjct: 233 ---------RVETG---------KYAFDLPQWRTISDDA--------------------- 253
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ P R+T Q L HP+I
Sbjct: 254 ----------KDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 68/349 (19%), Positives = 116/349 (33%), Gaps = 108/349 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
Y E + G G +S R E A+KII + + E+
Sbjct: 24 YEVKEDI----------GVGSYSVCKRCIHKATN----MEFAVKII---DKSKRDPTEEI 66
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFGRNI 670
+IL + + I + ++ +V E L + + +K
Sbjct: 67 EILLRYGQH-----PNIITLKDVYDDGKYVYVVTE-----LMKGGELLDKILRQK----- 111
Query: 671 GLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFGNA-M 724
+ A + +++L GV+H D+KP N+L + +++CDFG A
Sbjct: 112 --FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 725 FAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
+N + T + APE++ YD DIWS+G LY + TG F
Sbjct: 170 LRAENGLLMTPCYTAN-----FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224
Query: 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKD 838
++ + + G F + + V+ A
Sbjct: 225 DDTPEEI---------LARIGSGKF---------SLSGGYWNSVSDTA------------ 254
Query: 839 IGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ +DP +R+T A L HP+I
Sbjct: 255 -------------------KDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 63/360 (17%), Positives = 117/360 (32%), Gaps = 111/360 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
+IL G G TVV G+ + VA+K + E+
Sbjct: 17 VVSEKIL----------GYGSSGTVV-----FQGSFQGRPVAVKRM--LIDFCDIALMEI 59
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFG----RNIGLKL 674
++L + ++ + IR+ S L + E ++NL+++++ K
Sbjct: 60 KLLTES-----DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV------------LKLCDFGN 722
+ +Q+ + HL + ++H D+KP N+LV+ + + + DFG
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 723 AMFAGKNEI-----------TPYLVSRFYRAPEIILGL-------PYDHPLDIWSVGCCL 764
+ T +RAPE++ +DI+S+GC
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSG-----WRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
Query: 765 YELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTK 824
Y + + G P F + +
Sbjct: 230 YYILSK--------------------GKHP-------------FGDKYS---------RE 247
Query: 825 KAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
I + IF++ D ++A DL+ ++ DP KR T + L HP
Sbjct: 248 SNIIRGIFSLDEMK--------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 72/332 (21%), Positives = 118/332 (35%), Gaps = 93/332 (28%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT-----EVQIL 621
+++ GKG F V A++ + +A+K++ + K G E++I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNK----FIMALKVL-FKSQLEKEGVEHQLRREIEIQ 68
Query: 622 KKLAGADPENKRH--CIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVR 678
L RH +R + F R + L+ E + L + L+K GR
Sbjct: 69 SHL--------RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSA 117
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-----TP 733
+ ++L AL + V+H DIKP+N+L+ K LK+ DFG ++ A T
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGY-KGELKIADFGWSVHAPSLRRRTMCGTL 176
Query: 734 -YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
YL PE+I G +D +D+W G YE G P
Sbjct: 177 DYL------PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP-------------------P 211
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
F T + I + P + S G
Sbjct: 212 F--------------DSPSH--------TETHRRIVNVDLKF-PPFL------SDG---- 238
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KDL+ K+ P +R+ + + HP++
Sbjct: 239 ----SKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 71/359 (19%), Positives = 126/359 (35%), Gaps = 106/359 (29%)
Query: 555 GYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
G ++ ++ D Y++ G G F+ V + ++ G E A K I+ ++
Sbjct: 1 GMEPFKQQKVED-FYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRR 55
Query: 615 -------QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL-------- 659
+ EV IL+++ + I ++ R + L+ E L
Sbjct: 56 GVSREEIEREVSILRQVLH------HNVITLHDVYENRTDVVLILE-----LVSGGELFD 104
Query: 660 REVLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNV 714
K+ L+ ++ KQ+ + +L + H D+KP+N+++ N
Sbjct: 105 FLAQKES-------LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 715 LKLCDFGNAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY 768
+KL DFG A TP + APEI+ P D+WS+G Y L
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPE-----FVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
+G F G T + L + F ++ F ++ A
Sbjct: 213 SGASPFLGDTKQETLA--NITSVSY--------DFDEEFFSH-----------TSELA-- 249
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + K+ V + KR+T+ +AL HP+I+
Sbjct: 250 -----------------------------KDFIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G+G F V +AK + +VAIK I + E+ KA E++ L ++ H
Sbjct: 17 GRGAFGVVCKAK----WRAK--DVAIKQIES-ESERKAFIVELRQLSRV--------NHP 61
Query: 635 -CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIA----- 687
++ + N +CLV E +L VL ++ Q +
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ--CSQGVAY 117
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIIL 747
L ++ ++H D+KP N+L+ VLK+CDFG A + +T S + APE+
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-QTHMTNNKGSAAWMAPEVFE 176
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
G Y D++S G L+E+ T + F
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 81/349 (23%), Positives = 139/349 (39%), Gaps = 99/349 (28%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII---------RNNET 609
Y + L G G V A + K ++VAI+II
Sbjct: 137 YIMSKTL----------GSGACGEVKLAFERKTC----KKVAIRIISKRKFAIGSAREAD 182
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
+TE++ILKKL N I+ + F ++ +V E M E+ K N
Sbjct: 183 PALNVETEIEILKKL------NHPCIIKIKNFFDAEDY-YIVLE--LMEGGELFDKVVGN 233
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN--VLKLCDFGNAMFAG 727
LK + Y Q+ +A+++L G++H D+KP+N+L++ + ++K+ DFG++ G
Sbjct: 234 KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 728 KNEI------TPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
+ + TP Y APE+++ + Y+ +D WS+G L+ +G +P
Sbjct: 294 ETSLMRTLCGTPT-----YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG---YP--- 342
Query: 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKD 838
P F++ L K I +N P+
Sbjct: 343 -------------P----------FSEHRTQVSL-----------KDQITSGKYNFIPEV 368
Query: 839 IGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+ S A DL+ K+ V+DP+ R T +AL HP++ +
Sbjct: 369 WAEV---SEK------A--LDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 43/296 (14%), Positives = 88/296 (29%), Gaps = 64/296 (21%)
Query: 552 DAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII----RNN 607
E + G +L G+ + A D + G E + + R
Sbjct: 68 LGERPRTLVRGTVL----------GQEDPYAYLEATDQETG----ESFEVHVPYFTERPP 113
Query: 608 ETMNKAGQTEVQILKKLAGA-DPENKRHCIRFASSF--------------------KYRN 646
K + EV L+ L G + + + +RF F +
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 647 HLCLVFESLHMNLREVLKKFGRNIGLK----LTAVRAYAKQLFIALKHLKNCGVLHCDIK 702
++ + NL+ + + A Q+ L L + G++H ++
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 233
Query: 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIIL-----------GLPY 751
P ++++++ V L F + + G ++ VSR + PE+
Sbjct: 234 PVDIVLDQRGGV-FLTGFEHLVRDGARVVSS--VSRGFEPPELEARRATISYHRDRRTLM 290
Query: 752 DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP-------KKMLRK 800
D W++G +Y ++ + P + LR
Sbjct: 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 68/329 (20%), Positives = 126/329 (38%), Gaps = 72/329 (21%)
Query: 568 RYEVTAAH-GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
Y+++ G GV V+ + G ++ A+K++ ++ + EV + +G
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTG----QKCALKLLYDSPKA----RQEVDHHWQASG 80
Query: 627 ADPENKRHCIR----FASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT--AVRAY 680
H + + + + L ++ E M E+ + T
Sbjct: 81 -----GPHIVCILDVYENMHHGKRCLLIIME--CMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNAMFAGKNEITPYLVSR 738
+ + A++ L + + H D+KP+N+L ++ K+ VLKL DFG A +N + +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP 193
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
+Y APE++ YD D+WS+G +Y L G F T + P K+ +
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--------PGMKRRI 245
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
R G + F E V++ A K
Sbjct: 246 RLGQYG---------FPNPEWSEVSEDA-------------------------------K 265
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFISGK 887
L+ + DP +R+T+ Q + HP+I+
Sbjct: 266 QLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-29
Identities = 69/347 (19%), Positives = 113/347 (32%), Gaps = 106/347 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTE 617
Y E L G G F V R + G A K + +K + E
Sbjct: 159 YDIHEEL----------GTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKETVRKE 204
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFGRN 669
+Q + L + +F+ N + +++E + +
Sbjct: 205 IQTMSVL------RHPTLVNLHDAFEDDNEMVMIYE-----FMSGGELFEKVADEHN--- 250
Query: 670 IGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKNVLKLCDFGNAMFA 726
K++ Y +Q+ L H+ +H D+KP+N M + N LKL DFG
Sbjct: 251 ---KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 727 GKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
+ T + APE+ G P + D+WSVG Y L +G F G ++
Sbjct: 308 DPKQSVKVTTGTAE-----FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362
Query: 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIG 840
+ LR + D F +++
Sbjct: 363 ETLR--NVKSCDW--------NMDDSAFSG-----------ISEDG-------------- 387
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + K+ + DP RMT+ QAL HP+++
Sbjct: 388 -----------------KDFIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 78/347 (22%), Positives = 123/347 (35%), Gaps = 107/347 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
+ L G+G S V R K + A+K+++ +TE+
Sbjct: 55 FEVESEL----------GRGATSIVYRCKQKGTQ----KPYALKVLKKTVDKKIV-RTEI 99
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFG--------RNI 670
+L +L + + I+ F+ + LV E L G +
Sbjct: 100 GVLLRL------SHPNIIKLKEIFETPTEISLVLE---------LVTGGELFDRIVEKG- 143
Query: 671 GLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNAMFA 726
+ KQ+ A+ +L G++H D+KP+N+L A + LK+ DFG +
Sbjct: 144 --YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201
Query: 727 GKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780
+ TP Y APEI+ G Y +D+WSVG Y L G F +
Sbjct: 202 EHQVLMKTVCGTPG-----YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
Query: 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIG 840
+ L + F + D V+ A
Sbjct: 257 QFM-FRRILNC-------------------EYYFISPWWDEVSLNA-------------- 282
Query: 841 SIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ VLDP+KR+T QAL HP+++GK
Sbjct: 283 -----------------KDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-29
Identities = 74/346 (21%), Positives = 119/346 (34%), Gaps = 104/346 (30%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTE 617
Y E L G G F V R + G K I ++K + E
Sbjct: 53 YDILEEL----------GSGAFGVVHRCVEKATG----RVFVAKFINTPYPLDKYTVKNE 98
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNI-- 670
+ I+ +L + I +F+ + + L+ E L F R
Sbjct: 99 ISIMNQL------HHPKLINLHDAFEDKYEMVLILEFLSGGEL----------FDRIAAE 142
Query: 671 GLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKNVLKLCDFGNAMFAG 727
K++ V Y +Q LKH+ ++H DIKP+N M + + +K+ DFG A
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202
Query: 728 KNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781
+EI T + APEI+ P D+W++G Y L +G F G + +
Sbjct: 203 PDEIVKVTTATAE-----FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257
Query: 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGS 841
L+ + + F + F V+ +A
Sbjct: 258 TLQ--NVKRCDW--------EFDEDAFSS-----------VSPEA--------------- 281
Query: 842 IVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + + +P KR+TV AL HP++ G
Sbjct: 282 ----------------KDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 62/342 (18%), Positives = 111/342 (32%), Gaps = 53/342 (15%)
Query: 567 GRYEVTAAHGKGV--FSTVVRAKDLKAGNGEPEEVAIKII---RNNETMNKAGQTEVQIL 621
G YE+ GKG TV A+ G E V ++ I + M Q E+ +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTG----EYVTVRRINLEACSNEMVTFLQGELHVS 80
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVR 678
K N + + + ++F N L +V M ++++ G+ A+
Sbjct: 81 KLF------NHPNIVPYRATFIADNELWVVTS--FMAYGSAKDLIC-THFMDGMNELAIA 131
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG------------NAMFA 726
+ + AL ++ + G +H +K ++L++ V L +
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV-YLSGLRSNLSMISHGQRQRVVHD 190
Query: 727 GKNEI--TPYLVSRFYRAPEII--LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
+ +PE++ YD DI+SVG EL G V P
Sbjct: 191 FPKYSVKVLP-----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV--PFKDMPAT 243
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
L +L G P + ++ A + N
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
T SP +F +++ +P+ R + + L H F
Sbjct: 304 RTFSP--------HFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 64/338 (18%), Positives = 115/338 (34%), Gaps = 89/338 (26%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII-RNNETMNKAGQTE 617
Y + G+G + V A A K I + + E
Sbjct: 11 YTLENTI----------GRGSWGEVKIAVQKGTR----IRRAAKKIPKYFVEDVDRFKQE 56
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAV 677
++I+K L + + IR +F+ + LV E E+ ++ + +
Sbjct: 57 IEIMKSL------DHPNIIRLYETFEDNTDIYLVME--LCTGGELFERVVHKRVFRESDA 108
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLV--NEAKNVLKLCDFGNAMFAGKNEI---- 731
K + A+ + V H D+KP+N L + + LKL DFG A ++
Sbjct: 109 ARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168
Query: 732 --TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
TPY Y +P+++ G Y D WS G +Y L G F T+++++
Sbjct: 169 VGTPY-----YVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML----- 217
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
+R+G F + V+ +A
Sbjct: 218 -------KIREG---------TFTFPEKDWLNVSPQA----------------------- 238
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+ L+ ++ P++R+T QAL H + +
Sbjct: 239 --------ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 72/359 (20%), Positives = 128/359 (35%), Gaps = 106/359 (29%)
Query: 555 GYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
G +++ ++ D Y++ G G F+ V + ++ G E A K I+ ++
Sbjct: 1 GMETFKQQKVED-FYDIGEELGSGQFAIVKKCREKSTG----LEYAAKFIKKRQSRASRR 55
Query: 615 -------QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL-------- 659
+ EV IL+++ + I ++ R + L+ E L
Sbjct: 56 GVCREEIEREVSILRQV------LHPNIITLHDVYENRTDVVLILE-----LVSGGELFD 104
Query: 660 REVLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNV 714
K+ L+ ++ KQ+ + +L + H D+KP+N+++ N
Sbjct: 105 FLAQKES-------LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 715 LKLCDFGNAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELY 768
+KL DFG A TP + APEI+ P D+WS+G Y L
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPE-----FVAPEIVNYEPLGLEADMWSIGVITYILL 212
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
+G F G T + L + F ++ F Q ++ A
Sbjct: 213 SGASPFLGDTKQETLA--NITAVSY--------DFDEEFFSQ-----------TSELA-- 249
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + K+ V + KR+T+ +AL HP+I+
Sbjct: 250 -----------------------------KDFIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 71/341 (20%), Positives = 120/341 (35%), Gaps = 97/341 (28%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII--RNNETMNKAGQT 616
+ F L G G F V ++ +G E IK I ++ + +
Sbjct: 24 FIFKRKL----------GSGAFGDVHLVEERSSG----LERVIKTINKDRSQVPMEQIEA 69
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIG 671
E+++LK L + + I+ F+ +++ +V E L L ++ R
Sbjct: 70 EIEVLKSL------DHPNIIKIFEVFEDYHNMYIVMETCEGGEL---LERIVSAQARGKA 120
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDN-MLVNEAKN-VLKLCDFGNAMFAGKN 729
L V KQ+ AL + + V+H D+KP+N + + + + +K+ DFG A +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 730 EI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
E T Y APE+ DIWS G +Y L TG + F G + ++
Sbjct: 181 EHSTNAAGTAL-----YMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ 234
Query: 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIV 843
+ + E P+T +A
Sbjct: 235 ------------QKATYKEPN---YA-------VECRPLTPQA----------------- 255
Query: 844 TASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
DLL ++ DPE+R + AQ L H +
Sbjct: 256 --------------VDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 73/359 (20%), Positives = 121/359 (33%), Gaps = 108/359 (30%)
Query: 568 RYEVTAAH-GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLA 625
Y++ G+G + V +L +E A+KII ++ EV++L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITS----QEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESL-------------HMNLREVLKKFGRNIGL 672
G R+ + F+ + LVFE + H N E
Sbjct: 69 G-----HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA---------- 113
Query: 673 KLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNAMFAGKNE 730
+ + AL L N G+ H D+KP+N+L + + +K+CDF N
Sbjct: 114 -----SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168
Query: 731 I--------------TPYLVSRFYRAPEIILGL-----PYDHPLDIWSVGCCLYELYTGK 771
+ Y APE++ YD D+WS+G LY L +G
Sbjct: 169 DCSPISTPELLTPCGSAE-----YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
Query: 772 VLFPGATNNDMLRLHMELKGPFPKKMLR---KGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
F G +D E + +G + F + ++ A
Sbjct: 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE---------FPDKDWAHISCAA-- 272
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL+ K+ V D ++R++ AQ L HP++ G
Sbjct: 273 -----------------------------KDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 80/359 (22%), Positives = 138/359 (38%), Gaps = 119/359 (33%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII---------RNNET 609
Y + L G G V A + K ++VAIKII
Sbjct: 12 YIMSKTL----------GSGACGEVKLAFERKTC----KKVAIKIISKRKFAIGSAREAD 57
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------RE 661
+TE++ILKKL N I+ + F ++ +V E L +
Sbjct: 58 PALNVETEIEILKKL------NHPCIIKIKNFFDAEDY-YIVLE-----LMEGGELFDKV 105
Query: 662 VLKKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN--VLKL 717
V K +L + Y Q+ +A+++L G++H D+KP+N+L++ + ++K+
Sbjct: 106 VGNK-------RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKI 158
Query: 718 CDFGNAMFAGKNEI------TPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELY 768
DFG++ G+ + TP Y APE+++ + Y+ +D WS+G L+
Sbjct: 159 TDFGHSKILGETSLMRTLCGTPT-----YLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 769 TGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIK 828
+G +P P F++ L K I
Sbjct: 214 SG---YP----------------P----------FSEHRTQVSL-----------KDQIT 233
Query: 829 KIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
+N P+ + S A DL+ K+ V+DP+ R T +AL HP++ +
Sbjct: 234 SGKYNFIPEVWAEV---SEK------A--LDLVKKLLVVDPKARFTTEEALRHPWLQDE 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 84/351 (23%), Positives = 134/351 (38%), Gaps = 111/351 (31%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--- 615
Y+ E L GKG FS V R + AG +E A II + + Q
Sbjct: 13 YQLFEEL----------GKGAFSVVRRCVKVLAG----QEYAAMIINTKKLSARDHQKLE 58
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVLKKFG 667
E +I + L + +R S H L+F+ L V ++
Sbjct: 59 REARICRLL------KHPNIVRLHDSISEEGHHYLIFD-----LVTGGELFEDIVARE-- 105
Query: 668 RNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNA 723
+ +Q+ A+ H GV+H ++KP+N+L ++ K +KL DFG A
Sbjct: 106 -----YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
Query: 724 -MFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
G+ + TP Y +PE++ PY P+D+W+ G LY L G F
Sbjct: 161 IEVEGEQQAWFGFAGTPG-----YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215
Query: 777 ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKP 836
+ + + ++ GA+ F + E D VT +A
Sbjct: 216 EDQHRLYQ------------QIKAGAYD---------FPSPEWDTVTPEA---------- 244
Query: 837 KDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KDL++K+ ++P KR+T A+AL HP+IS +
Sbjct: 245 ---------------------KDLINKMLTINPSKRITAAEALKHPWISHR 274
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 76/355 (21%), Positives = 123/355 (34%), Gaps = 115/355 (32%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
Y GE L G G F+ V + ++ G + A K I+ T +
Sbjct: 13 YDTGEEL----------GSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSR 58
Query: 615 ---QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNL--------REVL 663
+ EV ILK++ + I ++ + + L+ E L
Sbjct: 59 EDIEREVSILKEI------QHPNVITLHEVYENKTDVILILE-----LVAGGELFDFLAE 107
Query: 664 KKFGRNIGLKLT--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLC 718
K+ LT + KQ+ + +L + + H D+KP+N+++ N K +K+
Sbjct: 108 KES-------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 719 DFGNAMFAGKNEI------TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKV 772
DFG A TP + APEI+ P D+WS+G Y L +G
Sbjct: 161 DFGLAHKIDFGNEFKNIFGTPE-----FVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215
Query: 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIF 832
F G T + L + F D++F + A
Sbjct: 216 PFLGDTKQETLA--NVSAVNY--------EFEDEYFSN-----------TSALA------ 248
Query: 833 NIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
KD + ++ V DP+KRMT+ +L HP+I K
Sbjct: 249 -------------------------KDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 69/340 (20%), Positives = 129/340 (37%), Gaps = 82/340 (24%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQIL 621
I+D + G G+ V++ + + E+ A+K++++ + EV++
Sbjct: 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDCPKA----RREVELH 108
Query: 622 KKLAGADPENKRHCIR----FASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT-- 675
+ + H +R + + + R L +V E ++ E+ + T
Sbjct: 109 WRASQC-----PHIVRIVDVYENLYAGRKCLLIVME--CLDGGELFSRIQDRGDQAFTER 161
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNAMFAGKNEI-- 731
K + A+++L + + H D+KP+N+L ++ N +LKL DFG A +
Sbjct: 162 EASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 732 ----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
TPY Y APE++ YD D+WS+G +Y L G F N L +
Sbjct: 222 TPCYTPY-----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISP 273
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
+ K +R G + F E V+++
Sbjct: 274 GM-----KTRIRMGQYE---------FPNPEWSEVSEEV--------------------- 298
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K L+ + +P +RMT+ + + HP+I
Sbjct: 299 ----------KMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 86/329 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII---RNNETMNKAGQTEVQILKK 623
G Y + GKG F+ V A+ + G EVAIKII + N T + EV+I+K
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTG----REVAIKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQ 683
L N + ++ + L L+ E + + EV + +K R+ +Q
Sbjct: 71 L------NHPNIVKLFEVIETEKTLYLIME--YASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEIT----PYLVS 737
+ A+++ ++H D+K +N+L++ N+ K+ DFG N G P
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNI-KIADFGFSNEFTVGGKLDAFCGAPP--- 178
Query: 738 RFYRAPEIILGLPYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
Y APE+ G YD P +D+WS+G LY L +G + F G
Sbjct: 179 --YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------------ 218
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML-A 855
++ + + + I P +
Sbjct: 219 -----------------------LKELRERVLRGKYRI----------------PFYMST 239
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ ++LL + VL+P KR T+ Q + +I
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 17/220 (7%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-------Q 615
E L+ +Y+V G G F +V + VAIK + + +
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVP 94
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675
EV +LKK++ IR F+ + L+ E ++++ L+
Sbjct: 95 MEVVLLKKVSSGFS----GVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEE 149
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R++ Q+ A++H NCGVLH DIK +N+L++ + LKL DFG+ T +
Sbjct: 150 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 736 VSRFYRAPEIILGLPYD-HPLDIWSVGCCLYELYTGKVLF 774
+R Y PE I Y +WS+G LY++ G + F
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G F TV RA+ +G +VA+KI+ + + EV I+K+L
Sbjct: 46 GAGSFGTVHRAE----WHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRL-------- 91
Query: 633 RH--CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIA-- 687
RH + F + +L +V E L +L +L K G L + A +A
Sbjct: 92 RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD--VAKG 149
Query: 688 ---LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR--A 742
L H +N ++H ++K N+LV++ V K+CDFG + ++ + A
Sbjct: 150 MNYL-HNRNPPIVHRNLKSPNLLVDKKYTV-KVCDFGLSRLKASTFLSSKSAAGTPEWMA 207
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
PE++ P + D++S G L+EL T + +
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 63/328 (19%), Positives = 110/328 (33%), Gaps = 92/328 (28%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G + V + + + +G + +A+K IR N K ++ I + +
Sbjct: 16 GRGAYGVVEKMRHVPSG----QIMAVKRIRATVNSQEQKRLLMDLDISMRTV-----DCP 66
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY-AKQLFIALKHLK 692
+ F + + + E + +L + K+ + A + AL+HL
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 693 -NCGVLHCDIKPDNMLVNEAKNVLKLCDFG------NAM----FAGKNEITPYLVSRFYR 741
V+H D+KP N+L+N V K+CDFG + + AG Y
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQV-KMCDFGISGYLVDDVAKDIDAG----CK-----PYM 176
Query: 742 APEIILG----LPYDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFPKK 796
APE I Y DIWS+G + EL + FP + +L ++ P P+
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQ- 233
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
L F+ +
Sbjct: 234 -LPADKFSAE-------------------------------------------------- 242
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPFI 884
F D + + ++R T + + HPF
Sbjct: 243 FVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 63/325 (19%), Positives = 113/325 (34%), Gaps = 73/325 (22%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILKKL 624
+++ G+G + V A + E VA+KI+ ++ E+ I K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
N + ++F + N L E + + E+ + +IG+ + + QL
Sbjct: 63 ------NHENVVKFYGHRREGNIQYLFLE--YCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV----SRFY 740
+ +L G+ H DIKP+N+L++E N LK+ DFG A N L + Y
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 741 RAPEIILGLPYDHPL-DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
APE++ + D+WS G L + G++ + +++ +
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------QEYS 219
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
+K + K I
Sbjct: 220 -------------------------DWKEKKTYLNPWKKI------DSAP--------LA 240
Query: 860 LLDKIFVLDPEKRMTVAQALTHPFI 884
LL KI V +P R+T+ +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 69/327 (21%), Positives = 119/327 (36%), Gaps = 77/327 (23%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
RY+ G G F +D E VA+K I +++ Q E+ + L
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTK----ELVAVKYIERGAAIDENVQREIINHRSL-- 73
Query: 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ +RF HL ++ E + + E+ ++ R + +QL
Sbjct: 74 ----RHPNIVRFKEVILTPTHLAIIME--YASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 687 ALKHLKNCGVLHCDIKPDNMLV--NEAKNVLKLCDFGNAMFAGKNEI------TPYLVSR 738
+ + + + H D+K +N L+ + A LK+CDFG + + + TP
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPA---- 182
Query: 739 FYRAPEIILGLPYDHPL-DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y APE++L YD + D+WS G LY + G F R K
Sbjct: 183 -YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR-----------KT 230
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+++ I + ++I P D + SP
Sbjct: 231 IQR--------------------------ILSVKYSI-PDD----IRISPE--------C 251
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFI 884
L+ +IFV DP R+++ + TH +
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWF 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 70/329 (21%), Positives = 116/329 (35%), Gaps = 90/329 (27%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G+G + +V + +G + +A+K IR +E K ++ ++ + + +
Sbjct: 31 GRGAYGSVNKMVHKPSG----QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-----DCP 81
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT-AVRAY-AKQLFIALKHL 691
+ ++F + + E + + + K + + + AL HL
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 692 K-NCGVLHCDIKPDNMLVNEAKNVLKLCDFG----------NAMFAGKNEITPYLVSRFY 740
K N ++H DIKP N+L++ + N+ KLCDFG AG Y
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGNI-KLCDFGISGQLVDSIAKTRDAG----CR-----PY 191
Query: 741 RAPEII----LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR-LHMELKGPFPK 795
APE I YD D+WS+G LYEL TG+ FP N + L +KG P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPP- 248
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
S E+ +
Sbjct: 249 ------------------------------------------------QLSNSEEREFSP 260
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+F + ++ D KR + L HPFI
Sbjct: 261 SFINFVNLCLTKDESKRPKYKELLKHPFI 289
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 21/223 (9%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-------Q 615
E + Y + GKG F TV L +VAIK+I N + +
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDR----LQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675
EV +L K+ IR F+ + LV E + +++ L
Sbjct: 83 LEVALLWKVGAGGGH--PGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEG 139
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R + Q+ A++H + GV+H DIK +N+L++ + KL DFG PY
Sbjct: 140 PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG---SGALLHDEPYT 196
Query: 736 V---SRFYRAPEIILGLPYD-HPLDIWSVGCCLYELYTGKVLF 774
+R Y PE I Y P +WS+G LY++ G + F
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 40/224 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QTEVQILKKLAGADPE 630
G G F V RA G+ EVA+K R++ + + + E ++ L
Sbjct: 16 GIGGFGKVYRAF----WIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAML------ 63
Query: 631 NKRH--CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+H I +LCLV E L VL + + +A Q IA
Sbjct: 64 --KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQ--IA 115
Query: 688 -----LKHLKNCGVLHCDIKPDNMLVNE-------AKNVLKLCDFGNAMFAGKNEITPYL 735
L ++H D+K N+L+ + + +LK+ DFG A +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATN 779
+ + APE+I + D+WS G L+EL TG+V F G
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/335 (20%), Positives = 117/335 (34%), Gaps = 87/335 (25%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QT 616
G + G Y + G G F V + G +VA+KI+ N + + +
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG----HKVAVKIL-NRQKIRSLDVVGKIKR 60
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA 676
E+Q LK H I+ +V E +++ E+ ++ ++
Sbjct: 61 EIQNLKLF------RHPHIIKLYQVISTPTDFFMVME--YVSGGELFDYICKHGRVEEME 112
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----- 731
R +Q+ A+ + V+H D+KP+N+L++ N K+ DFG + E
Sbjct: 113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRTSC 171
Query: 732 -TPYLVSRFYRAPEIILGLPYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
+P Y APE+I G Y P +DIWS G LY L G + F
Sbjct: 172 GSPN-----YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----------- 215
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
+ +K I+ +F I P+ + +
Sbjct: 216 ----VPTLFKK--------------------------IRGGVFYI-PEYL------NRSV 238
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
LL + +DP KR T+ H +
Sbjct: 239 --------ATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTEVQILKKLAGADPENK 632
G G F TV + K +G+ VA+K++ +A + EV +L+K
Sbjct: 33 GSGSFGTVYKGK----WHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-------- 77
Query: 633 RHC--IRF--ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
RH + F S+ L +V + +L L ++ + A+Q
Sbjct: 78 RHVNILLFMGYST---APQLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARG 132
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR----FYRAP 743
+ +L ++H D+K +N+ ++E N +K+ DFG A + + + AP
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
Query: 744 EIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATN 779
E+I PY D+++ G LYEL TG++ + N
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 44/272 (16%), Positives = 85/272 (31%), Gaps = 73/272 (26%)
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
DP + ++ + + +L + + NL++ + + + Q+
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--------------NAMFAGKNEIT 732
A++ L + G++H D+KP N+ V K+ DFG T
Sbjct: 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVV-KVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 733 PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
+ ++ Y +PE I G Y H +DI+S+G L+EL
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY----------------------S 272
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
F +M R TD ++ + F + P E
Sbjct: 273 FSTQMERVRIITD---------------------VRNLKFPLLFTQK------YPQE--- 302
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
++ + P +R + +
Sbjct: 303 -----HMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 63/325 (19%), Positives = 113/325 (34%), Gaps = 73/325 (22%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT--EVQILKKL 624
+++ G+G + V A + E VA+KI+ ++ E+ I K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
N + ++F + N L E + + E+ + +IG+ + + QL
Sbjct: 63 ------NHENVVKFYGHRREGNIQYLFLE--YCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV----SRFY 740
+ +L G+ H DIKP+N+L++E N LK+ DFG A N L + Y
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 741 RAPEIILGLPYDHPL-DIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
APE++ + D+WS G L + G++ + +++ +
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--------------QEYS 219
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
+K + K I
Sbjct: 220 -------------------------DWKEKKTYLNPWKKI------DSAP--------LA 240
Query: 860 LLDKIFVLDPEKRMTVAQALTHPFI 884
LL KI V +P R+T+ +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWY 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 44/236 (18%), Positives = 83/236 (35%), Gaps = 56/236 (23%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--------QTEVQILKKLAGA 627
GKG F V + + +K VAIK + ++ + Q EV I+ L
Sbjct: 28 GKGGFGLVHKGRLVKDK----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL--- 80
Query: 628 DPENKRH--CIRF--ASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAK 682
H ++ N +V E + +L L + +K +
Sbjct: 81 -----NHPNIVKLYGLM----HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLML 129
Query: 683 QLFIALKHL--KNCGVLHCDIKPDNMLVNE----AKNVLKLCDFG------NAM--FAGK 728
+ + ++++ +N ++H D++ N+ + A K+ DFG +++ G
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG- 188
Query: 729 NEITPYLVSRFYRAPEIILG--LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM 782
+ APE I Y D +S LY + TG+ F + +
Sbjct: 189 ---NFQ-----WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 33/218 (15%), Positives = 71/218 (32%), Gaps = 40/218 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
+ + + + G ++ +K+++ + + + E L+
Sbjct: 19 NENHSGELWKGRW----QGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIF-------- 64
Query: 633 RH--CIRF--ASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
H + A H L+ + +L VL + G N + + +A +A
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALD--MA 121
Query: 688 -----LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEITPYLVSRFYR 741
L H + + +++++E ++ F + +
Sbjct: 122 RGMAFL-HTLEPLIPRHALNSRSVMIDE-DMTARISMADVKFSFQSPGRMYAPA----WV 175
Query: 742 APEIILGLPYDHPL---DIWSVGCCLYELYTGKVLFPG 776
APE + P D D+WS L+EL T +V F
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 67/327 (20%), Positives = 112/327 (34%), Gaps = 91/327 (27%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G G V + + K G +A+K +R N+ NK ++ ++ K +
Sbjct: 34 GSGTCGQVWKMRFRKTG----HVIAVKQMRRSGNKEENKRILMDLDVVLKSH-----DCP 84
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ ++ +F + + E + ++ K+ I ++ + AL +LK
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKE 142
Query: 694 C-GVLHCDIKPDNMLVNEAKNVLKLCDFG------NAM----FAGKNEITPYLVSRFYRA 742
GV+H D+KP N+L++E + KLCDFG + AG Y A
Sbjct: 143 KHGVIHRDVKPSNILLDERGQI-KLCDFGISGRLVDDKAKDRSAG----CA-----AYMA 192
Query: 743 PEII-----LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
PE I YD D+WS+G L EL TG+ FP
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP---------------------- 228
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+ + D ++ +E+P P +F
Sbjct: 229 -----YKNCKTDFEVLTKVLQEEP--------------PL---------LPGHMGFSGDF 260
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ + D KR + L H FI
Sbjct: 261 QSFVKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 70/363 (19%), Positives = 119/363 (32%), Gaps = 124/363 (34%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII---------------------- 604
+Y + GKG + V A + A+K++
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDN----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 605 -----RNNETMNKAGQTEVQILKKLAGADPENKRH--------CIRFASSFKYRNHLCLV 651
+ E+ ILKKL H + + +HL +V
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKL--------DHPNVVKLVEVLDDPN----EDHLYMV 116
Query: 652 FESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711
FE +N V++ L R Y + L +++L ++H DIKP N+LV E
Sbjct: 117 FE--LVNQGPVMEVPTLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED 173
Query: 712 KNVLKLCDFG-NAMFAGKNEI------TPYLVSRFYRAPEIILGL--PYDHP-LDIWSVG 761
++ K+ DFG + F G + + TP + APE + + LD+W++G
Sbjct: 174 GHI-KIADFGVSNEFKGSDALLSNTVGTPA-----FMAPESLSETRKIFSGKALDVWAMG 227
Query: 762 CCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDP 821
LY G+ PF D+ +
Sbjct: 228 VTLYCFVFGQC-------------------PFM--------------DERI--------M 246
Query: 822 VTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881
IK P + P + + KDL+ ++ +PE R+ V + H
Sbjct: 247 CLHSKIKSQALEF-P------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293
Query: 882 PFI 884
P++
Sbjct: 294 PWV 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 53/360 (14%), Positives = 113/360 (31%), Gaps = 104/360 (28%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR------------------NNE 608
Y + +G F+ ++ + + A+K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDN------KFYALKKYEKSLLEKKRDFTKSNNDKISIK 84
Query: 609 TMNKAGQTEVQILKKLAGADPENKRH--CIRFASSFKYRNHLCLVFESLHMN---LREVL 663
+ + E+QI+ + ++ C+ + + +++E +M + +
Sbjct: 85 SKYDDFKNELQIITDI--------KNEYCLTCEGIITNYDEVYIIYE--YMENDSILKFD 134
Query: 664 KKFGR-----NIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCDIKPDNMLVNEAKNVLKL 717
+ F + + ++ K + + ++ + H D+KP N+L+++ V KL
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV-KL 193
Query: 718 CDFGNAMFAGKNEI-----TPYLVSRFYRAPEIILGLP--YDHPLDIWSVGCCLYELYTG 770
DFG + + +I T + PE +DIWS+G CLY ++
Sbjct: 194 SDFGESEYMVDKKIKGSRGTYE-----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
Query: 771 KVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKI 830
V P F ++ I+
Sbjct: 249 VV--P--------------------------------FSLKISL------VELFNNIRTK 268
Query: 831 IFNIKPKDIGSIVTASPGEDPKMLANF-----KDLLDKIFVLDPEKRMTVAQALTHPFIS 885
P D + + NF D L +P +R+T AL H +++
Sbjct: 269 NIEY-PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 69/342 (20%), Positives = 112/342 (32%), Gaps = 103/342 (30%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII-----RNNETMNKAGQTEVQIL 621
G+Y + G+G + V D + A+KI+ R + E+Q+L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETL----CRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 622 KKLAGADPENKRH--------CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLK 673
++L RH + + + +V E ++E+L
Sbjct: 61 RRL--------RHKNVIQLVDVLYNEE----KQKMYMVMEYCVCGMQEMLDSVPEK-RFP 107
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEI 731
+ Y QL L++L + G++H DIKP N+L+ LK+ G A+ +
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADD 166
Query: 732 -------TPYLVSRFYRAPEIILGL-PYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDM 782
+P ++ PEI GL + +DIWS G LY + TG F G
Sbjct: 167 TCRTSQGSPA-----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---- 217
Query: 783 LRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSI 842
K+ I K + I P D
Sbjct: 218 -----------IYKLFEN--------------------------IGKGSYAI-PGDC--- 236
Query: 843 VTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
P DLL + +P KR ++ Q H +
Sbjct: 237 ---GPP--------LSDLLKGMLEYEPAKRFSIRQIRQHSWF 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 73/278 (26%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTE 617
G+I++ RY++ G G STV A+D +VAIK I E K + E
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILN----IKVAIKAIFIPPREKEETLKRFERE 61
Query: 618 VQILKKLAGADP----------ENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKF 666
V +L+ E+ + Y LV E + L E ++
Sbjct: 62 VHNSSQLS--HQNIVSMIDVDEEDDCY---------Y-----LVMEYIEGPTLSEYIESH 105
Query: 667 GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726
G L + + Q+ +KH + ++H DIKP N+L++ K + K+ DFG A
Sbjct: 106 GP---LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTL-KIFDFGIAKAL 161
Query: 727 GKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
+ +T L + Y +PE G D DI+S+G LYE+ G+ F G T +
Sbjct: 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA 221
Query: 784 RLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDP 821
H++ P +RK Q ++ ATE+D
Sbjct: 222 IKHIQDSVPNVTTDVRKD--IPQSLS-NVILRATEKDK 256
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 68/335 (20%), Positives = 115/335 (34%), Gaps = 77/335 (22%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKII--RNNETMNKAGQTEVQILKKLA 625
YE+ G G + V A E+VAIK I +T E+Q + +
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKK----EKVAIKRINLEKCQTSMDELLKEIQAMSQC- 70
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVR---- 678
+ + + + +SF ++ L LV + ++ + +++K K +
Sbjct: 71 -----HHPNIVSYYTSFVVKDELWLVMK--LLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 679 AY-AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
A +++ L++L G +H D+K N+L+ E +V ++ DFG + F
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV-QIADFGVSAFLATGGDITRNKV 182
Query: 738 R-------FYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
R + APE++ YD DIWS G EL TG
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA---A-------------- 225
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
P+ + K + + N P
Sbjct: 226 --PY------------------HKYPPM-------KVLMLTLQNDPPSLETG--VQDKEM 256
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
K +F+ ++ DPEKR T A+ L H F
Sbjct: 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 52/223 (23%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
GKG F V + +GE VAI++I +NE KA + EV ++
Sbjct: 42 GKGRFGQVYHGR----WHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQT-------- 86
Query: 633 RHC--IRFASSFKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
RH + F + HL ++ L V++ I L + R A+++ +
Sbjct: 87 RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMG 144
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-------YRA 742
+L G+LH D+K N+ + + + DFG +G + + A
Sbjct: 145 YLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 743 PEII---------LGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
PEII LP+ D++++G YEL+ + F
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 67/330 (20%), Positives = 124/330 (37%), Gaps = 88/330 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QTEVQIL 621
G Y + G+G F V A K ++VA+K I + + + K+ + E+ L
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQ----QKVALKFI-SRQLLKKSDMHMRVEREISYL 63
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
K L H I+ + +V E L + + + R + R +
Sbjct: 64 KLL------RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKR---MTEDEGRRFF 114
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI------TPYL 735
+Q+ A+++ ++H D+KP+N+L+++ NV K+ DFG + +P
Sbjct: 115 QQIICAIEYCHRHKIVHRDLKPENLLLDDNLNV-KIADFGLSNIMTDGNFLKTSCGSPN- 172
Query: 736 VSRFYRAPEIILGLPYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
Y APE+I G Y P +D+WS G LY + G++ F
Sbjct: 173 ----YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--------------- 213
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
+ +K + ++ + P + SPG
Sbjct: 214 PNLFKK--------------------------VNSCVYVM-PDFL------SPGA----- 235
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ L+ ++ V DP +R+T+ + P+
Sbjct: 236 ---QSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 63/337 (18%), Positives = 119/337 (35%), Gaps = 101/337 (29%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
++L G G+ V++ + + E+ A+K++++ + EV
Sbjct: 20 KVTSQVL----------GLGINGKVLQIFNKRTQ----EKFALKMLQDCPKA----RREV 61
Query: 619 QILKKLAGADPENKRHCIR----FASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
++ + + H +R + + + R L +V E ++ E+ +
Sbjct: 62 ELHWRASQ-----CPHIVRIVDVYENLYAGRKCLLIVME--CLDGGELFSRIQDRGDQAF 114
Query: 675 T--AVRAYAKQLFIALKHLKNCGVLHCDIKPDNML-VNEAKN-VLKLCDFGNAMFAGKNE 730
T K + A+++L + + H D+KP+N+L ++ N +LKL DFG
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------- 165
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
A E G YD D+WS+G +Y L G F N L + +
Sbjct: 166 ----------FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGM- 210
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
K +R G F E V+++
Sbjct: 211 ----KTRIRMG---------QYEFPNPEWSEVSEEV------------------------ 233
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
K L+ + +P +RMT+ + + HP+I
Sbjct: 234 -------KMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 76/328 (23%), Positives = 133/328 (40%), Gaps = 84/328 (25%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAG 626
+Y G+G TV A D+ G +EVAI+ + + K E+ ++++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMREN-- 74
Query: 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + + S+ + L +V E L +L +V+ + + A ++
Sbjct: 75 ----KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECL 126
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------- 738
AL+ L + V+H DIK DN+L+ +V KL DFG F + ITP R
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSV-KLTDFG---FCAQ--ITPEQSKRSTMVGTP 180
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
++ APE++ Y +DIWS+G E+ G+ P P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---P----------------P------ 215
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML-ANF 857
+ + E+P+ +A+ I N P+ ++P+ L A F
Sbjct: 216 --------YLN---------ENPL--RALYLIATNGTPEL----------QNPEKLSAIF 246
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+D L++ +D EKR + + L H F+
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 39/223 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRH 634
GKG F ++ E + +K + + + EV++++ L H
Sbjct: 19 GKGCFGQAIKVTH----RETGEVMVMKELIRFDEETQRTFLKEVKVMRCL--------EH 66
Query: 635 --CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIA--LK 689
++F L + E + LR ++K + + ++AK IA +
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKD--IASGMA 122
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR-------- 741
+L + ++H D+ N LV E + + DFG A + P + +
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 742 --------APEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG 776
APE+I G YD +D++S G L E+ P
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 69/320 (21%), Positives = 127/320 (39%), Gaps = 84/320 (26%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRH 634
G+G V A++ +G +VA+K++ + + EV I++ +
Sbjct: 54 GEGSTGIVCLAREKHSG----RQVAVKMMDLRKQQRRELLFNEVVIMRDY------QHFN 103
Query: 635 CIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ S+ L ++ E L L +++ + L + + + AL +L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA 159
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-------FYRAPEII 746
GV+H DIK D++L+ V KL DFG F + I+ + R ++ APE+I
Sbjct: 160 QGVIHRDIKSDSILLTLDGRV-KLSDFG---FCAQ--ISKDVPKRKSLVGTPYWMAPEVI 213
Query: 747 LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
Y +DIWS+G + E+ G+ P P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE---P----------------P-------------- 240
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML-ANFKDLLDKIF 865
+F + PV +A+K++ + PK ++ + +D L+++
Sbjct: 241 YFS---------DSPV--QAMKRLRDSPPPKL----------KNSHKVSPVLRDFLERML 279
Query: 866 VLDPEKRMTVAQALTHPFIS 885
V DP++R T + L HPF+
Sbjct: 280 VRDPQERATAQELLDHPFLL 299
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 39/239 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQT--EVQILKKLAGADPEN 631
G+G FSTVV A++L E AIKI+ NK E ++ +L
Sbjct: 39 GEGSFSTVVLARELATS----REYAIKILEKRHIIKENKVPYVTRERDVMSRL------- 87
Query: 632 KRH--CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFI 686
H ++ +F+ L + L + ++K G T R Y ++
Sbjct: 88 -DHPFFVKLYFTFQDDEKLYFGLS--YAKNGELLKYIRKIGS---FDETCTRFYTAEIVS 141
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF------- 739
AL++L G++H D+KP+N+L+NE ++ ++ DFG A K +R
Sbjct: 142 ALEYLHGKGIIHRDLKPENILLNEDMHI-QITDFGTA----KVLSPESKQARANSFVGTA 196
Query: 740 -YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
Y +PE++ D+W++GC +Y+L G F + + ++L+ FP+K
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 40/237 (16%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTE 617
L RYE+ G G S V A+DL+ +VA+K++R + + + E
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDH----RDVAVKVLRADLARDPSFYLRFRRE 62
Query: 618 VQILKKLA----------GADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKF 666
Q L G A Y +V E + + LR+++
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETP-------AGPLPY-----IVMEYVDGVTLRDIVHTE 110
Query: 667 GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726
G + AL G++H D+KP N++++ V K+ DFG A
Sbjct: 111 GP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV-KVMDFGIARAI 166
Query: 727 GKNEIT-----PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
+ + + + Y +PE G D D++S+GC LYE+ TG+ F G +
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---------- 616
+Y + G G F V A D + +EV +K I E + +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKN----KEVVVKFI-KKEKVLEDCWIEDPKLGKVTL 78
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTA 676
E+ IL ++ + I+ F+ + LV E H + ++ R+ L
Sbjct: 79 EIAILSRV------EHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFIDRHPRLDEPL 131
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP-YL 735
+QL A+ +L+ ++H DIK +N+++ E + KL DFG+A + L
Sbjct: 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI-KLIDFGSA-----AYLERGKL 185
Query: 736 VSRF-----YRAPEIILGLPYDHP-LDIWSVGCCLYELYTG 770
F Y APE+++G PY P L++WS+G LY L
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 75/330 (22%), Positives = 117/330 (35%), Gaps = 87/330 (26%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QTEVQIL 621
G Y + G G F V K G +VA+KI+ N + + + E+Q L
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTG----HKVAVKIL-NRQKIRSLDVVGKIRREIQNL 70
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
K H I+ + + +V E +++ E+ +N L R
Sbjct: 71 KLF------RHPHIIKLYQVISTPSDIFMVME--YVSGGELFDYICKNGRLDEKESRRLF 122
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG--NAMFAGKNEITPYLV--- 736
+Q+ + + V+H D+KP+N+L++ N K+ DFG N M G+ +L
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGE-----FLRTSC 176
Query: 737 -SRFYRAPEIILGLPYDHP-LDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
S Y APE+I G Y P +DIWS G LY L G + F
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------------- 221
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
+ +K I IF P+ + +P
Sbjct: 222 PTLFKK--------------------------ICDGIFYT-PQYL------NPSV----- 243
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
LL + +DP KR T+ H +
Sbjct: 244 ---ISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 30/214 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLA 625
+ GKG F V + D + + VAIKII E ++ Q E+ +L +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQ----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC- 77
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ + ++ S+ L ++ E L + ++L+ L T + +++
Sbjct: 78 -----DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREI 128
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEI--TPYLVS 737
L +L + +H DIK N+L++E V KL DFG +N TP+
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLSEHGEV-KLADFGVAGQLTDTQIKRNTFVGTPF--- 184
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
+ APE+I YD DIWS+G EL G+
Sbjct: 185 --WMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 49/237 (20%), Positives = 85/237 (35%), Gaps = 51/237 (21%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN--NETMNKAGQTEVQ 619
G+I+ G+YEV G + A D V +K + + + E Q
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNG---RPVVLKGLVHSGDAEAQAMAMAERQ 131
Query: 620 ILKKLA----------GADPENKRHCIRFASSFKYRNHLCLVFESLH-MNLREVLKKFGR 668
L ++ + + + +V E + +L+ +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGY-----------IVMEYVGGQSLKRSKG--QK 178
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA----- 723
L + AY ++ AL +L + G+++ D+KP+N+++ E LKL D G
Sbjct: 179 ---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRINS 233
Query: 724 --MFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT 778
G TP ++APEI+ P DI++VG L L G
Sbjct: 234 FGYLYG----TPG-----FQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 52/241 (21%), Positives = 99/241 (41%), Gaps = 37/241 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADPEN 631
G+G F V + G+ A K + + G E +IL K+ +
Sbjct: 194 GRGGFGEVFACQ--MKATGK--LYACKKLNKKRLKKRKGYQGAMVEKKILAKV------H 243
Query: 632 KRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
R + A +F+ + LCLV + ++ V + + Y Q+
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVS 300
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-F-----Y 740
L+HL +++ D+KP+N+L+++ NV ++ D G A ++ + +
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNV-RISDLGLA----VELKAGQTKTKGYAGTPGF 355
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG----ATNNDMLRLHMELKGPFPKK 796
APE++LG YD +D +++G LYE+ + F N ++ + +E +P K
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 797 M 797
Sbjct: 416 F 416
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGA 627
++V G+G + +V +A + G + VAIK + + + E+ I+++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETG----QIVAIKQVPVESDLQEI-IKEISIMQQC--- 81
Query: 628 DPENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQL 684
+ H +++ S+ L +V E + + ++++ + L + +
Sbjct: 82 ---DSPHVVKYYGSYFKNTDLWIVME--YCGAGSVSDIIRLRNK--TLTEDEIATILQST 134
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------ 738
L++L +H DIK N+L+N + KL DFG AG+ +T + R
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLNTEGHA-KLADFG---VAGQ--LTDTMAKRNTVIGT 188
Query: 739 -FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK 771
F+ APE+I + Y+ DIWS+G E+ GK
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 53/241 (21%), Positives = 88/241 (36%), Gaps = 51/241 (21%)
Query: 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQ 619
R G G Y + G+G V A+D VA+K++
Sbjct: 28 REGTQF-GPYRLRRLVGRGGMGDVYEAEDTVRE----RIVALKLMSET------------ 70
Query: 620 ILKKLAGADPENKRHCIRF------ASSFKYRN------------HLCLVFESLH-MNLR 660
L+ +DP + R A + + L + ++ ++L
Sbjct: 71 ----LS-SDPVFRT---RMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLA 122
Query: 661 EVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720
+L++ G L A +Q+ AL G H D+KP+N+LV+ L DF
Sbjct: 123 AMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFA-YLVDF 178
Query: 721 GNAMFAGKNEIT---PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGA 777
G A ++T + + +Y APE + DI+++ C LYE TG + G
Sbjct: 179 GIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238
Query: 778 T 778
Sbjct: 239 Q 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 52/234 (22%), Positives = 95/234 (40%), Gaps = 52/234 (22%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRH 634
G G F V +AK+ + G A K+I E++IL + +
Sbjct: 28 GDGAFGKVYKAKNKETG----ALAAAKVIETKSEEELEDYIVEIEILATC------DHPY 77
Query: 635 CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
++ ++ + L ++ E + ++ + R GL ++ +Q+ AL L
Sbjct: 78 IVKLLGAYYHDGKLWIMIE--FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFL 133
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI----------TPYLVSRFYR 741
+ ++H D+K N+L+ ++ +L DFG + KN TPY +
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDI-RLADFG---VSAKNLKTLQKRDSFIGTPY-----WM 184
Query: 742 APEIIL-----GLPYDHPLDIWSVGCCLYELYTG----------KVLFPGATNN 780
APE+++ PYD+ DIWS+G L E+ +VL A ++
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 55/238 (23%), Positives = 101/238 (42%), Gaps = 34/238 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADPEN 631
GKG F V + G+ A K + + G E QIL+K+ N
Sbjct: 193 GKGGFGEVCACQ--VRATGK--MYACKKLEKKRIKKRKGEAMALNEKQILEKV------N 242
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
R + A +++ ++ LCLV MN L+ + G+ G YA ++ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLT--LMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGL 299
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAP 743
+ L +++ D+KP+N+L+++ ++ ++ D G A+ + + Y AP
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHI-RISDLGLAVHVPEGQTI----KGRVGTVGYMAP 354
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG----ATNNDMLRLHMELKGPFPKKM 797
E++ Y D W++GC LYE+ G+ F ++ RL E+ + ++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERF 412
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 48/244 (19%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADP 629
G+G FS V V+ K + A+KI+ + + + + E +L
Sbjct: 70 GRGAFSEVAVVKMKQTG------QVYAMKIMNKWDMLKRGEVSCFREERDVLVNG----- 118
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFI 686
++R + +F+ N+L LV E + L +L KFG I ++ R Y ++ +
Sbjct: 119 -DRRWITQLHFAFQDENYLYLVME--YYVGGDLLTLLSKFGERIPAEMA--RFYLAEIVM 173
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--------TP-YLVS 737
A+ + G +H DIKPDN+L++ ++ +L DFG+ + + TP YL
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHI-RLADFGSCLKLRADGTVRSLVAVGTPDYL-- 230
Query: 738 RFYRAPEIILGL-------PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
+PEI+ + Y D W++G YE++ G+ F + + + K
Sbjct: 231 ----SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286
Query: 791 GPFP 794
Sbjct: 287 EHLS 290
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 49/245 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEV-AIKIIRNNETMNKAGQ-----TEVQILKKLAGADP 629
GKG + V + + K ++ A+K+++ + A E IL+++
Sbjct: 26 GKGGYGKVFQVR--KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV----- 78
Query: 630 ENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLTAVRAY 680
+H + +F+ L L+ E L L++ G Y
Sbjct: 79 ---KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ------LEREGI---FMEDTACFY 126
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPYLVS 737
++ +AL HL G+++ D+KP+N+++N +V KL DFG ++ G T
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGTVTHT----- 180
Query: 738 RF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
F Y APEI++ ++ +D WS+G +Y++ TG F G + ++ K
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239
Query: 793 FPKKM 797
P +
Sbjct: 240 LPPYL 244
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKK 623
+ G G F V A+D++ E VAIK + + + EV+ L+K
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQ 683
L + I++ + + LV E + ++L+ L+ + A
Sbjct: 111 L------RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHG 162
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-NAMFAGKNEI--TPYLVSRFY 740
L +L + ++H D+K N+L++E V KL DFG ++ A N TPY +
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLV-KLGDFGSASIMAPANSFVGTPY-----W 216
Query: 741 RAPEIILGL---PYDHPLDIWSVGCCLYELYTGK 771
APE+IL + YD +D+WS+G EL K
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 59/248 (23%), Positives = 101/248 (40%), Gaps = 58/248 (23%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V K + AIK ++ +++ TM E ++L
Sbjct: 26 GKGSFGKVFLAEFKKTN------QFFAIKALKKDVVLMDDDVECTM-----VEKRVLSL- 73
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAV 677
H +F+ + +L V E L +++ KF L+
Sbjct: 74 ------AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKF------DLSRA 120
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEITPY 734
YA ++ + L+ L + G+++ D+K DN+L+++ ++ K+ DFG M T
Sbjct: 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNT-- 177
Query: 735 LVSRF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
F Y APEI+LG Y+H +D WS G LYE+ G+ F G ++
Sbjct: 178 ----FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
Query: 790 KGPFPKKM 797
+P+ +
Sbjct: 234 NPFYPRWL 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 71/340 (20%), Positives = 120/340 (35%), Gaps = 93/340 (27%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
G +E+ G G + V + + +K G + AIK++ + + E+ +LKK +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTG----QLAAIKVMDVTGDEEEEIKQEINMLKKYS- 78
Query: 627 ADPENKRHCIRFASSF------KYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAV 677
+ R+ + +F + L LV E + +++K + LK +
Sbjct: 79 ----HHRNIATYYGAFIKKNPPGMDDQLWLVME--FCGAGSVTDLIKNT-KGNTLKEEWI 131
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG-----NAMFAGKNEI- 731
+++ L HL V+H DIK N+L+ E V KL DFG + +N
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-KLVDFGVSAQLDRTVGRRNTFI 190
Query: 732 -TPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL 785
TPY + APE+I YD D+WS+G E+
Sbjct: 191 GTPY-----WMAPEVIACDENPDATYDFKSDLWSLGITAIEM------------------ 227
Query: 786 HMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTA 845
E P + H +A+ I N P+
Sbjct: 228 -AEGAPPL------------------CDMHPM-------RALFLIPRNPAPRL------- 254
Query: 846 SPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ K F+ ++ V + +R Q + HPFI
Sbjct: 255 ---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-18
Identities = 59/244 (24%), Positives = 103/244 (42%), Gaps = 51/244 (20%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V VR K A+K II +E T+ TE ++L+
Sbjct: 14 GKGTFGKVILVREKATG------RYYAMKILRKEVIIAKDEVAHTV-----TESRVLQNT 62
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREV---LKKFGRNIGLKLTAVRA 679
RH +F+ + LC V E + N E+ L + R
Sbjct: 63 --------RHPFLTALKYAFQTHDRLCFVME--YANGGELFFHLSRERV---FTEERARF 109
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR- 738
Y ++ AL++L + V++ DIK +N+++++ ++ K+ DFG K I+ +
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI-KITDFGLC----KEGISDGATMKT 164
Query: 739 F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
F Y APE++ Y +D W +G +YE+ G++ F + + L + + F
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 794 PKKM 797
P+ +
Sbjct: 225 PRTL 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 47/243 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--------ETMNKAGQTEVQILKKLAGA 627
G+G F V K +G+ + A+K+++ T E IL ++
Sbjct: 33 GQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTK-----MERDILVEV--- 83
Query: 628 DPENKRH--CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAY 680
H ++ +F+ L L+ + L L + F V+ Y
Sbjct: 84 -----NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMF------TEEDVKFY 131
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-F 739
+L +AL HL + G+++ D+KP+N+L++E ++ KL DFG + K I + F
Sbjct: 132 LAELALALDHLHSLGIIYRDLKPENILLDEEGHI-KLTDFGLS----KESIDHEKKAYSF 186
Query: 740 -----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
Y APE++ + D WS G ++E+ TG + F G + + + ++ K P
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246
Query: 795 KKM 797
+ +
Sbjct: 247 QFL 249
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 60/248 (24%), Positives = 101/248 (40%), Gaps = 58/248 (23%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V R K+ + A+K I+++++ TM TE +IL
Sbjct: 32 GKGSFGKVMLARVKETG------DLYAVKVLKKDVILQDDDVECTM-----TEKRILSL- 79
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLT 675
+ H + F+ + L V E + H ++K R
Sbjct: 80 ------ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH------IQKSRR---FDEA 124
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R YA ++ AL L + G+++ D+K DN+L++ + KL DFG K I +
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMC----KEGICNGV 179
Query: 736 VSR-F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
+ F Y APEI+ + Y +D W++G LYE+ G F +D+ +
Sbjct: 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
Query: 790 KGPFPKKM 797
+ +P +
Sbjct: 240 EVVYPTWL 247
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 43/233 (18%), Positives = 75/233 (32%), Gaps = 60/233 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG + V K + E+VA+K+ E + +TE+ + RH
Sbjct: 46 GKGRYGEVWMGK-WRG-----EKVAVKVFFTTEEASWFRETEIYQTVLM--------RHE 91
Query: 635 --------CIRFASSFKYRNHLCLVFESLHM-NLREVLKK----FGRNIGLKLTAVRAYA 681
I+ L L+ + +L + LK + L ++V
Sbjct: 92 NILGFIAADIK---GTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSG-- 146
Query: 682 KQLFIALKHL--------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP 733
L HL + H D+K N+LV + + D G A+ +
Sbjct: 147 ------LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC-CIADLGLAVKFISDTNEV 199
Query: 734 YLVS------RFYRAPEIILG------LPYDHPLDIWSVGCCLYELYTGKVLF 774
+ + Y PE++ D++S G L+E+ V
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 58/248 (23%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V K E A+K +I++++ TM E ++L
Sbjct: 29 GKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTM-----VEKRVLALP 77
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLT 675
+ + S F+ + L V E + H +++ GR K
Sbjct: 78 G-------KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH------IQQVGR---FKEP 121
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
YA ++ I L L++ G+++ D+K DN++++ ++ K+ DFG K I +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI-KIADFGMC----KENIWDGV 176
Query: 736 VSR-F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
++ F Y APEII PY +D W+ G LYE+ G+ F G +++ + ME
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
Query: 790 KGPFPKKM 797
+PK M
Sbjct: 237 NVAYPKSM 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 55/240 (22%), Positives = 101/240 (42%), Gaps = 46/240 (19%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADP 629
G G F V V+ K+ A+KI+ + + E +IL+ +
Sbjct: 50 GTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV----- 98
Query: 630 ENKRH--CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQL 684
++ SFK ++L +V E ++ + L++ GR R YA Q+
Sbjct: 99 ---NFPFLVKLEFSFKDNSNLYMVME--YVAGGEMFSHLRRIGR---FSEPHARFYAAQI 150
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-------TPYLVS 737
+ ++L + +++ D+KP+N+L+++ + ++ DFG FA + + TP
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYI-QVTDFG---FAKRVKGRTWTLCGTPE--- 203
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
APEIIL Y+ +D W++G +YE+ G F + + K FP
Sbjct: 204 --ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 50/226 (22%), Positives = 78/226 (34%), Gaps = 54/226 (23%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG F V R K + EEVA+KI + E + + E+ L RH
Sbjct: 51 GKGRFGEVWRGK-WRG-----EEVAVKIFSSREERSWFREAEIYQTVML--------RHE 96
Query: 635 -CIRF-ASSFKYRN---HLCLVFESLHM-NLREVLKK----FGRNIGLKLTAVRAYAKQL 684
+ F A+ K L LV + +L + L + I L L+
Sbjct: 97 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASG----- 151
Query: 685 FIALKHL--------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
L HL + H D+K N+LV + + D G A+ T +
Sbjct: 152 ---LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC-CIADLGLAVRHDSATDTIDIA 207
Query: 737 S------RFYRAPEIILG------LPYDHPLDIWSVGCCLYELYTG 770
+ Y APE++ DI+++G +E+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 54/244 (22%), Positives = 101/244 (41%), Gaps = 54/244 (22%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKLAG 626
G G F V + NG A+K ++R + T + E +L +
Sbjct: 15 GTGSFGRVHLIR--SRHNGRY--YAMKVLKKEIVVRLKQVEHTND-----ERLMLSIV-- 63
Query: 627 ADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREV---LKKFGRNIGLKLTAVRAYA 681
H IR +F+ + ++ + ++ E+ L+K R + YA
Sbjct: 64 ------THPFIIRMWGTFQDAQQIFMIMD--YIEGGELFSLLRKSQR---FPNPVAKFYA 112
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI-------TP- 733
++ +AL++L + +++ D+KP+N+L+++ ++ K+ DFG FA TP
Sbjct: 113 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHI-KITDFG---FAKYVPDVTYTLCGTPD 168
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
Y+ APE++ PY+ +D WS G +YE+ G F + + + F
Sbjct: 169 YI------APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF 222
Query: 794 PKKM 797
P
Sbjct: 223 PPFF 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 57/246 (23%), Positives = 100/246 (40%), Gaps = 50/246 (20%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADP 629
GKG F V V+ D K + A+K + + + + E+QI++ L
Sbjct: 24 GKGSFGKVCIVQKNDTK------KMYAMKYMNKQKCVERNEVRNVFKELQIMQGL----- 72
Query: 630 ENKRH--CIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQL 684
H + SF+ + +V + + LR L++ K V+ + +L
Sbjct: 73 ---EHPFLVNLWYSFQDEEDMFMVVD--LLLGGDLRYHLQQNVH---FKEETVKLFICEL 124
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT-------PYLVS 737
+AL +L+N ++H D+KPDN+L++E +V + DF A + PY+
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLDEHGHV-HITDFNIAAMLPRETQITTMAGTKPYM-- 181
Query: 738 RFYRAPEIIL---GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRL-HMELKGP- 792
APE+ G Y +D WS+G YEL G+ + ++ + H
Sbjct: 182 ----APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237
Query: 793 -FPKKM 797
+P
Sbjct: 238 TYPSAW 243
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 24/233 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
G+G F V + KA G+ A+K + K G+ E +L ++ D
Sbjct: 198 GRGGFGEVYGCR--KADTGK--MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC-- 251
Query: 632 KRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
+ + +F + L + + MN L L + G +R YA ++ + L
Sbjct: 252 -PFIVCMSYAFHTPDKLSFILD--LMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGL 305
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIIL- 747
+H+ N V++ D+KP N+L++E +V ++ D G A K + + + Y APE++
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 748 GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND---MLRLHMELKGPFPKKM 797
G+ YD D +S+GC L++L G F D + R+ + + P
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 54/247 (21%), Positives = 102/247 (41%), Gaps = 52/247 (21%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADP 629
G+G F V V+ K+ + A+KI+ E + +A + E +L
Sbjct: 83 GRGAFGEVAVVKLKNAD------KVFAMKILNKWEMLKRAETACFREERDVLVNG----- 131
Query: 630 ENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ + +F+ N+L LV + L L + + + R Y ++
Sbjct: 132 -DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM------ARFYLAEM 184
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--------TP-YL 735
IA+ + +H DIKPDN+L++ ++ +L DFG+ + ++ TP Y+
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 736 VSRFYRAPEIILGLP-----YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR--LHME 788
+PEI+ + Y D WS+G C+YE+ G+ F + + ++ +
Sbjct: 244 ------SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 789 LKGPFPK 795
+ FP
Sbjct: 298 ERFQFPT 304
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 47/228 (20%), Positives = 79/228 (34%), Gaps = 54/228 (23%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG + V R GE VA+KI + + + +TE+ L RH
Sbjct: 17 GKGRYGEVWRGS----WQGE--NVAVKIFSSRDEKSWFRETELYNTVML--------RHE 62
Query: 635 -CIRF----ASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ F +S L L+ SL+ L+ + + L+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASG----- 117
Query: 685 FIALKHL--------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
L HL + H D+K N+LV + + D G A+ ++ +
Sbjct: 118 ---LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC-CIADLGLAVMHSQSTNQLDVG 173
Query: 737 S------RFYRAPEIILGLP------YDHPLDIWSVGCCLYELYTGKV 772
+ + Y APE++ +DIW+ G L+E+ V
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 58/244 (23%), Positives = 97/244 (39%), Gaps = 50/244 (20%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V R K + A+K I++ E M +E +L K
Sbjct: 47 GKGSFGKVLLARHKAEE------VFYAVKVLQKKAILKKKEEKHIM-----SERNVLLK- 94
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESLHMNLREV---LKKFGRNIGLKLTAVRA 679
N +H + SF+ + L V + ++N E+ L++ R
Sbjct: 95 ------NVKHPFLVGLHFSFQTADKLYFVLD--YINGGELFYHLQRERC---FLEPRARF 143
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR- 738
YA ++ AL +L + +++ D+KP+N+L++ ++ L DFG K I +
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI-VLTDFGLC----KENIEHNSTTST 198
Query: 739 F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
F Y APE++ PYD +D W +G LYE+ G F +M +
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL 258
Query: 794 PKKM 797
+
Sbjct: 259 KPNI 262
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 57/237 (24%), Positives = 99/237 (41%), Gaps = 36/237 (15%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNK----AGQTEVQILKKLAGADP 629
GKG F V V+ K A+KI++ + K TE ++L
Sbjct: 157 GKGTFGKVILVKEKATG------RYYAMKILKKEVIVAKDEVAHTLTENRVL-------- 202
Query: 630 ENKRH--CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+N RH SF+ + LC V E + N E+ R R Y ++ A
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVME--YANGGELFFHLSRERVFSEDRARFYGAEIVSA 260
Query: 688 LKHL-KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR-F-----Y 740
L +L V++ D+K +N+++++ ++ K+ DFG K I + F Y
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGHI-KITDFGLC----KEGIKDGATMKTFCGTPEY 315
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
APE++ Y +D W +G +YE+ G++ F + + L + + FP+ +
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 49/244 (20%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKLAGADP 629
G+G F V VR K + + A+K++ E + ++ E I+
Sbjct: 78 GRGAFGEVQLVRHKSTR------KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA----- 126
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQLFI 686
N ++ +F+ +L +V E +M L ++ + + R Y ++ +
Sbjct: 127 -NSPWVVQLFYAFQDDRYLYMVME--YMPGGDLVNLMSNYD----VPEKWARFYTAEVVL 179
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI--------TP-YLVS 737
AL + + G +H D+KPDNML++++ ++ KL DFG M K + TP Y+
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHL-KLADFGTCMKMNKEGMVRCDTAVGTPDYI-- 236
Query: 738 RFYRAPEIILG----LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLR--LHMELKG 791
+PE++ Y D WSVG LYE+ G F + ++ +
Sbjct: 237 ----SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292
Query: 792 PFPK 795
FP
Sbjct: 293 TFPD 296
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 62/250 (24%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
GKG F V K E A+K +I++++ TM E ++L
Sbjct: 350 GKGSFGKVMLSERKGTD------ELYAVKILKKDVVIQDDDVECTM-----VEKRVLALP 398
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLT 675
+ + S F+ + L V E + H +++ GR K
Sbjct: 399 G-------KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH------IQQVGR---FKEP 442
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG---NAMFAGKNEIT 732
YA ++ I L L++ G+++ D+K DN++++ ++ K+ DFG ++ G T
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGVTTKT 501
Query: 733 PYLVSRF-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
F Y APEII PY +D W+ G LYE+ G+ F G +++ + M
Sbjct: 502 ------FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 788 ELKGPFPKKM 797
E +PK M
Sbjct: 556 EHNVAYPKSM 565
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 36/234 (15%), Positives = 59/234 (25%), Gaps = 52/234 (22%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTE 617
I +GRY + HG +A D +VA+ + + + + +
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALD----RQVALTFVDPQGVLPDDVLQETLSR 81
Query: 618 VQILKKLAGADPENKRHCIRFASSF---KYRNHLCLVFESLH-MNLREVLKKFGRNIGLK 673
L ++ P A R +V E + +L+EV
Sbjct: 82 TLRLSRID--KP-------GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPS 127
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP 733
+ L A GV P + V+ +V L
Sbjct: 128 PVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDV-VLAYPA------------ 174
Query: 734 YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
+ DI +G LY L + P A L
Sbjct: 175 ------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 52/257 (20%), Positives = 103/257 (40%), Gaps = 67/257 (26%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
G+G ++ V VR K A+K + + + TE + ++
Sbjct: 18 GRGSYAKVLLVRLKKTD------RIYAMKVVKKELVNDDEDIDWVQ-----TEKHVFEQ- 65
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLT 675
H + S F+ + L V E + H +++ + L
Sbjct: 66 ------ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH------MQRQRK---LPEE 110
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R Y+ ++ +AL +L G+++ D+K DN+L++ ++ KL D+G K + P
Sbjct: 111 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYGMC----KEGLRPGD 165
Query: 736 VSR-F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFP---------GATNN 780
+ F Y APEI+ G Y +D W++G ++E+ G+ F T +
Sbjct: 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 225
Query: 781 DMLRLHMELKGPFPKKM 797
+ ++ +E + P+ +
Sbjct: 226 YLFQVILEKQIRIPRSL 242
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 48/239 (20%), Positives = 81/239 (33%), Gaps = 43/239 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
+G F V +A+ E VA+KI + + + EV L + +H
Sbjct: 33 ARGRFGCVWKAQL----LNE--YVAVKIFPIQDKQSWQNEYEVYSLPGM--------KHE 78
Query: 635 --------CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR--A 679
R L L+ SL L+ + + + T R A
Sbjct: 79 NILQFIGAEKR---GTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLA 135
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF 739
Y + LK + H DIK N+L+ + DFG A+ + +
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA-CIADFGLALKFEAGKSAGDTHGQV 194
Query: 740 ----YRAPEII-----LGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
Y APE++ +D++++G L+EL + G + ML E+
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 47/253 (18%), Positives = 78/253 (30%), Gaps = 52/253 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G+G + V + L VA+K+ N + + + + H
Sbjct: 22 GRGRYGAVYKGS-LDE-----RPVAVKVFSFANRQNFINEKNIYRVPLM--------EHD 67
Query: 635 --------CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR--A 679
R + R LV E SL L + + L + R A
Sbjct: 68 NIARFIVGDER--VTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF 739
Y H K + H D+ N+LV + DFG +M N +
Sbjct: 126 YLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTC-VISDFGLSMRLTGNRLVRPGEEDN 183
Query: 740 ----------YRAPEIILGL-------PYDHPLDIWSVGCCLYELYTGK-VLFPGATNND 781
Y APE++ G +D++++G +E++ LFPG + +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 782 MLRLHMELKGPFP 794
G P
Sbjct: 244 YQMAFQTEVGNHP 256
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEV-AIKIIRNNETMNKAGQ-----TEVQILKKLAGADP 629
G G + V + K + ++ A+K+++ + KA TE Q+L
Sbjct: 63 GTGAYGKVFLVR--KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL-------- 112
Query: 630 ENKRHC---IRFASSFKYRNHLCLVFESLHMN---LREVLKKFGRNIGLKLTAVRAYAKQ 683
E+ R + +F+ L L+ + ++N L L + R V+ Y +
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILD--YINGGELFTHLSQRER---FTEHEVQIYVGE 167
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---- 739
+ +AL+HL G+++ DIK +N+L++ +V L DFG + K + +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHV-VLTDFGLS----KEFVADETERAYDFCG 222
Query: 740 ---YRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPG----ATNNDMLRLHMELK 790
Y AP+I+ G +D +D WS+G +YEL TG F + ++ R ++ +
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 791 GPFPKKM 797
P+P++M
Sbjct: 283 PPYPQEM 289
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 51/257 (19%), Positives = 103/257 (40%), Gaps = 67/257 (26%)
Query: 576 GKGVFSTV--VRAKDLKAGNGEPEEVAIK------IIRNNE---TMNKAGQTEVQILKKL 624
G+G ++ V VR K A++ + + + TE + ++
Sbjct: 61 GRGSYAKVLLVRLKKTD------RIYAMRVVKKELVNDDEDIDWVQ-----TEKHVFEQ- 108
Query: 625 AGADPENKRH--CIRFASSFKYRNHLCLVFESL-------HMNLREVLKKFGRNIGLKLT 675
H + S F+ + L V E + H +++ + L
Sbjct: 109 ------ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH------MQRQRK---LPEE 153
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R Y+ ++ +AL +L G+++ D+K DN+L++ ++ KL D+G K + P
Sbjct: 154 HARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI-KLTDYGMC----KEGLRPGD 208
Query: 736 VSR-F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFP---------GATNN 780
+ F Y APEI+ G Y +D W++G ++E+ G+ F T +
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
Query: 781 DMLRLHMELKGPFPKKM 797
+ ++ +E + P+ +
Sbjct: 269 YLFQVILEKQIRIPRSL 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 8e-14
Identities = 44/224 (19%), Positives = 91/224 (40%), Gaps = 35/224 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G + V VA+K ++ + + E ++K++ +H
Sbjct: 229 GGGQYGEVYEGV----WKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI--------KHP 276
Query: 635 --------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
C R ++ E + + NL + L++ R + + A Q+
Sbjct: 277 NLVQLLGVCTR-------EPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQIS 328
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRA 742
A+++L+ +H ++ N LV E +++K+ DFG + + T + ++F + A
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
PE + + D+W+ G L+E+ T G +PG + + L
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 431
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 46/226 (20%), Positives = 90/226 (39%), Gaps = 39/226 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G + V VA+K ++ + + E ++K++ +H
Sbjct: 22 GGGQYGEVYEGVW----KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI--------KHP 69
Query: 635 --------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQ 683
C R ++ E M NL + L++ R + + A Q
Sbjct: 70 NLVQLLGVCTR-------EPPFYIITE--FMTYGNLLDYLRECNRQE-VSAVVLLYMATQ 119
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---Y 740
+ A+++L+ +H D+ N LV E +++K+ DFG + + T + ++F +
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
APE + + D+W+ G L+E+ T G +PG + + L
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 45/232 (19%), Positives = 88/232 (37%), Gaps = 44/232 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT----EVQILKKLAGADPEN 631
G G F V R + A +G+ VA+K ++ + EV + L
Sbjct: 27 GDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------- 78
Query: 632 KRH---------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRA 679
H + + +V E +L + L+K + L +
Sbjct: 79 -DHRNLIRLYGVVLT--------PPMKMVTE--LAPLGSLLDRLRKHQGHFLLGT--LSR 125
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVS 737
YA Q+ + +L++ +H D+ N+L+ ++++K+ DFG + +
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 738 RF-YR--APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ + APE + + H D W G L+E++T G+ + G + +L
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 50/215 (23%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G G F V A K +VA+K ++ +A E ++K L
Sbjct: 197 GAGQFGEVWMATYNK-----HTKVAVKTMKPGSMSVEAFLAEANVMKTL------QHDKL 245
Query: 636 IRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
++ + + + ++ E + +L + LK + L + ++ Q+ + ++
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQR 303
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPY 751
+H D++ N+LV+ V K+ DFG A NE T ++F + APE I +
Sbjct: 304 NYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 752 DHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
D+WS G L E+ T G++ +PG +N +++R
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 38/237 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENKR 633
GKG F +V + + E VA+K ++++ T + E++ILK L
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSL------QHD 71
Query: 634 HCIRF--ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ +++ R +L L+ E L + +LR+ L+K I + Y Q+ +++
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEY 129
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPE 744
L +H D+ N+LV +N +K+ DFG +++ + V F+ APE
Sbjct: 130 LGTKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEF-FKVKEPGESPIFWYAPE 187
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT----------------GKVLFPGATNNDMLRL 785
+ + D+WS G LYEL+T G ++ L
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 51/218 (23%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V+ + +VA+K I+N+ +A E ++ +L +
Sbjct: 30 GKGEFGDVMLGD-YR-----GNKVAVKCIKND-ATAQAFLAEASVMTQL------RHSNL 76
Query: 636 IR-FASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
++ + + L +V E +M +L + L+ GR++ L + ++ + A+++L
Sbjct: 77 VQLLGVIVEEKGGLYIVTE--YMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 133
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR--APEIILG 748
+ +H D+ N+LV+E NV K+ DFG K + + + APE +
Sbjct: 134 EGNNFVHRDLAARNVLVSE-DNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALRE 188
Query: 749 LPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ D+WS G L+E+Y+ G+V +P D++
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 49/224 (21%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G F V ++VAIK IR + E +++ KL H
Sbjct: 17 GSGQFGLVHLGY-WLN----KDKVAIKTIREGAMSEEDFIEEAEVMMKL--------SHP 63
Query: 635 --------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
C+ + +CLV E + H L + L+ + +
Sbjct: 64 KLVQLYGVCLE-------QAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVC 114
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRA 742
+ +L+ V+H D+ N LV E V+K+ DFG F ++ T ++F + +
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
PE+ Y D+WS G ++E+++ GK+ + +N++++
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 55/237 (23%), Positives = 97/237 (40%), Gaps = 38/237 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENKR 633
GKG F +V + + E VA+K ++++ T + E++ILK L
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSL------QHD 102
Query: 634 HCIRF--ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ +++ R +L L+ E L + +LR+ L+K I + Y Q+ +++
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEY 160
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPE 744
L +H D+ N+LV +N +K+ DFG +++ Y V F+ APE
Sbjct: 161 LGTKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPE 218
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT----------------GKVLFPGATNNDMLRL 785
+ + D+WS G LYEL+T G ++ L
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQILKKLAGADPENKRH 634
GKG F +V + G+ VA+K ++++ + Q E+QILK L +
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL------HSDF 85
Query: 635 CIRF--ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+++ S R L LV E L LR+ L++ + + Y+ Q+ +++L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYL 143
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPEI 745
+ +H D+ N+LV + +K+ DFG A ++ Y+V F+ APE
Sbjct: 144 GSRRCVHRDLAARNILVES-EAHVKIADFGLAKLLPLDKDY-YVVREPGQSPIFWYAPES 201
Query: 746 ILGLPYDHPLDIWSVGCCLYELYT 769
+ + D+WS G LYEL+T
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 26/169 (15%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQI 620
++ + V G G F + K+L E VAIK+ E M E +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTN----EYVAIKL----EPMKSRAPQLHLEYRF 57
Query: 621 LKKLAGAD--PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
K+L D P F KY +V E L +L ++ R LK T +
Sbjct: 58 YKQLGSGDGIP----QVYYFGPCGKYN---AMVLELLGPSLEDLFDLCDRTFSLK-TVLM 109
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLV----NEAKNVLKLCDFGNA 723
A QL ++++ + +++ D+KP+N L+ N+ + V+ + DF A
Sbjct: 110 -IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G F V VAIK ++ +A E Q++KKL
Sbjct: 193 GQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKL 241
Query: 636 IRFASSFKY----RNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
++ Y + +V E +M +L + LK L+L + A Q+ +
Sbjct: 242 VQL-----YAVVSEEPIYIVTE--YMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGM 293
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEI 745
+++ +H D++ N+LV E V K+ DFG A NE T ++F + APE
Sbjct: 294 AYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 746 ILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
L + D+WS G L EL T G+V +PG N ++L
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 393
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 3e-12
Identities = 44/255 (17%), Positives = 73/255 (28%), Gaps = 2/255 (0%)
Query: 116 RSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNE 175
+ T +G + + + R L R R+
Sbjct: 176 VDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDR 235
Query: 176 RHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRD 235
R ER+ R + ERRR ER K K + R R
Sbjct: 236 DRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRS 295
Query: 236 KNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDR 295
+ R + E + G + D ++ RDR+++R
Sbjct: 296 RERARRERER-KEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRER 354
Query: 296 VRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKH-DDDKGSY 354
R + ERER R RDR RD+ R+ + +D + + +D + Y
Sbjct: 355 RRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMY 414
Query: 355 GDRTRKDDLAKIHSS 369
+ D +
Sbjct: 415 MESEGGDGYLAPENG 429
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 3e-12
Identities = 48/260 (18%), Positives = 79/260 (30%)
Query: 119 DEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHG 178
D R V R R ++ + R + + R R
Sbjct: 170 DGRRVLVDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLP 229
Query: 179 SRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNR 238
RD RD ERE R R RE R R R R ++E+ + + + +
Sbjct: 230 HRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRK 289
Query: 239 EQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRD 298
+S RE + E + D +++ RD
Sbjct: 290 RRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRD 349
Query: 299 NNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRT 358
+ ER R R +R R + RD + DR++ + S R R + D+
Sbjct: 350 RDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGND 409
Query: 359 RKDDLAKIHSSNSYSMEGSG 378
+D + + Y +G
Sbjct: 410 SRDMYMESEGGDGYLAPENG 429
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 3e-11
Identities = 42/246 (17%), Positives = 76/246 (30%), Gaps = 2/246 (0%)
Query: 110 RSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLV 169
R ++ + +PL + + +
Sbjct: 188 RPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRE 247
Query: 170 RRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVD 229
R ER SR R R R + R+ +R R ER + + +
Sbjct: 248 RDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKE 307
Query: 230 RERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQR 289
R + + + ++ EK RDR R+R R + + +R+R
Sbjct: 308 ELRGGGGDMAEPSEAG-DAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRR 366
Query: 290 DREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDD 349
DR++DR RD + ER +R RD+ R ++ G + S + +
Sbjct: 367 DRDRDRDRDRE-HKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEGGDGYLA 425
Query: 350 DKGSYG 355
+ Y
Sbjct: 426 PENGYL 431
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 3e-11
Identities = 31/248 (12%), Positives = 52/248 (20%)
Query: 71 AKRNSYHDFDPMEDDQSYLHDRRKSVSSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRS 130
+ + + P RR R R H R R R
Sbjct: 179 ERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRE 238
Query: 131 HDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREH 190
+ + E R + D E+ R R ++ R RE
Sbjct: 239 RERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRER 298
Query: 191 RTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGR 250
R E + + + + RDR+ R
Sbjct: 299 ARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSH 358
Query: 251 EERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRD 310
R + R + + R R D ++ N R+ +
Sbjct: 359 RSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESE 418
Query: 311 RSRDKGRD 318
Sbjct: 419 GGDGYLAP 426
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 40/225 (17%), Positives = 71/225 (31%)
Query: 170 RRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVD 229
G R G+ +R R+ + Y R H R+ +RER R +
Sbjct: 195 GLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRERDKERER 254
Query: 230 RERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQR 289
R R R +SR RD R R+RS+ ++ DR RR + R+R+R +
Sbjct: 255 RRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELRGGGG 314
Query: 290 DREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDD 349
D + + + E R++ + S+ + + R D
Sbjct: 315 DMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDRDRDR 374
Query: 350 DKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEER 394
D+ + + + + D + E
Sbjct: 375 DREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEG 419
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 3e-09
Identities = 36/223 (16%), Positives = 58/223 (26%)
Query: 184 RDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRD 243
R T V + R + + DRER R + +
Sbjct: 191 RLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRERDK 250
Query: 244 RDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLER 303
R RDR R R + R+RS+D+ R R R R+R + R
Sbjct: 251 ERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELR 310
Query: 304 ERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDL 363
+ G D G D + R + S +R R D
Sbjct: 311 GGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDR 370
Query: 364 AKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEED 406
+ E ++ + ++ L +
Sbjct: 371 DRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDM 413
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 8e-08
Identities = 37/236 (15%), Positives = 72/236 (30%)
Query: 184 RDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRD 243
+ R +G R + R R+ + RD++R++ R+
Sbjct: 181 GRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERE 240
Query: 244 RDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLER 303
R +++R R R RRR +R R +R D+ RDR++ R R
Sbjct: 241 RRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERAR 300
Query: 304 ERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDL 363
R++ R G D+ E G +P D + + + +R R
Sbjct: 301 RERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRS 360
Query: 364 AKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQ 419
+ + + + E + + Q+ + +
Sbjct: 361 ERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYME 416
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 46/259 (17%), Positives = 82/259 (31%), Gaps = 19/259 (7%)
Query: 37 KVYNEQHGNGELPRENGRENYKQWRESKSPSRRSAKRNSYHDFDPMEDDQSYLHDRRKSV 96
+ G G R N + + S + D+ R
Sbjct: 188 RPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRE 247
Query: 97 SSESSGDKYSPALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYH 156
+ + S + R RS D+ RR R RS D +
Sbjct: 248 RDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKD-------------------KDRDR 288
Query: 157 ERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRR 216
+R ++ S + R R E + E + E + E+ R
Sbjct: 289 KRRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGR 348
Query: 217 EWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRD 276
+ +RE+ + +RERRRD++R++ RDR+ RG +R R E G ++ + +
Sbjct: 349 DRDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGN 408
Query: 277 RARVNDRDMDRQRDREKDR 295
+R + +
Sbjct: 409 DSRDMYMESEGGDGYLAPE 427
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 3e-07
Identities = 42/243 (17%), Positives = 79/243 (32%)
Query: 177 HGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEVDRERRRDK 236
G R LV + + R +G R R R+ + +
Sbjct: 170 DGRRVLVDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLP 229
Query: 237 NREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRV 296
+R++ RDR+ R R+R + E R R R++ R R +R +D+++DR
Sbjct: 230 HRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRK 289
Query: 297 RDNNLERERERRRDRSRDKGRDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGD 356
R ++ RER RR +++ R D + + D+ + D + D
Sbjct: 290 RRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRD 349
Query: 357 RTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQDDFEERVALKLEEQEEEDLDRIMEESRK 416
R R+ + ++ + ER + + +
Sbjct: 350 RDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGND 409
Query: 417 RRQ 419
R
Sbjct: 410 SRD 412
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 1e-05
Identities = 30/226 (13%), Positives = 48/226 (21%), Gaps = 2/226 (0%)
Query: 49 PRENGRENYKQWRESKSPSRRSAKRNSYHDFDPMEDDQSYLHDRRKSVSSESSGDKYSPA 108
S + D D + + +R K S +
Sbjct: 205 DVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRERDKERERRRSRSRDRRR 264
Query: 109 LRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDERL 168
R + + E + D + +
Sbjct: 265 RSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELRGGGGDMAEPSEAGD 324
Query: 169 VRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLEV 228
D E R +R+R R+ +RE K E
Sbjct: 325 APPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDRDRDRDRE-HKRGER 383
Query: 229 DRERRRDKNREQSRDRDIHR-GREERDRSRYEEVDRGRRREKERDR 273
ER RD+ R +D G R Y E + G +
Sbjct: 384 GSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEGGDGYLAPENG 429
|
| >3pgw_S U1-70K; protein-RNA complex, U1 snRNA, SM fold, SM core, RRM, splici SNRNPS, splicing factors; HET: DNA; 4.40A {Homo sapiens} PDB: 3cw1_K 2l5i_A 2l5j_A* Length = 437 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 44/251 (17%), Positives = 84/251 (33%), Gaps = 1/251 (0%)
Query: 203 DRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVD 262
R ++ER R + R + + RR + R +
Sbjct: 171 GRRVLVDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPH 230
Query: 263 RGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESD 322
R R R++ER+R D++ +R+R R +DR R + + ERRR R R K +D +
Sbjct: 231 RDRDRDRERERRERSRE-RDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRK 289
Query: 323 REKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKIT 382
R S + + R+R + R D + S DD
Sbjct: 290 RRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRD 349
Query: 383 KDEDEQDDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVE 442
+D + + + + + D DR + + + ++ + Q + +
Sbjct: 350 RDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGND 409
Query: 443 TDEKPSEHSSQ 453
+ + E
Sbjct: 410 SRDMYMESEGG 420
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
GKG F V+ + +VA+K I+N+ +A E ++ +L RH
Sbjct: 202 GKGEFGDVMLGD-YR-----GNKVAVKCIKND-ATAQAFLAEASVMTQL--------RHS 246
Query: 635 -CIR-FASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
++ + + L +V E + +L + L+ GR++ L + ++ + A+++L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL 305
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR--APEIILG 748
+ +H D+ N+LV+E NV K+ DFG K + + + APE +
Sbjct: 306 EGNNFVHRDLAARNVLVSE-DNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALRE 360
Query: 749 LPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ D+WS G L+E+Y+ G+V +P D++
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 398
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-MNKAG-QTEVQILKKLAGADPENKR 633
G+G F V + G+ E+VA+K ++ + A + E++IL+ L
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL------YHE 83
Query: 634 HCIRF--ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ +++ + N + L+ E L +L+E L K I LK YA Q+ + +
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKGMDY 141
Query: 691 LKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPE 744
L + +H D+ N+LV ++ +K+ DFG ++ Y V F+ APE
Sbjct: 142 LGSRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPE 199
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT 769
++ + D+WS G L+EL T
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 45/224 (20%), Positives = 91/224 (40%), Gaps = 37/224 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G F V K G+ +VA+K+I+ E Q + KL H
Sbjct: 17 GSGQFGVVKLGK----WKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKL--------SHP 63
Query: 635 --------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
C + + +V E + + L L+ G+ L+ + + +
Sbjct: 64 KLVKFYGVCSK-------EYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVC 114
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRA 742
+ L++ +H D+ N LV+ +K+ DFG + ++ + ++F + A
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA 173
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
PE+ Y D+W+ G ++E+++ GK+ + TN++++
Sbjct: 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK 217
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 31/221 (14%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G+G F V VAIK ++ +A E Q++KKL
Sbjct: 276 GQGCFGEVWMGTWNG-----TTRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKL 324
Query: 636 IRFASSFKY----RNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
++ Y + +V E +M +L + LK L+L + A Q+ +
Sbjct: 325 VQL-----YAVVSEEPIYIVTE--YMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGM 376
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEI 745
+++ +H D++ N+LV E V K+ DFG A NE T ++F + APE
Sbjct: 377 AYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 746 ILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
L + D+WS G L EL T G+V +PG N ++L
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 41/226 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G F V +VA+K ++ A E ++K+L +H
Sbjct: 22 GAGQFGEVWMGYYNG-----HTKVAVKSLKQGSMSPDAFLAEANLMKQL--------QHQ 68
Query: 635 --------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQ 683
+ + ++ E +M +L + LK I L + + A Q
Sbjct: 69 RLVRLYAVVT--------QEPIYIITE--YMENGSLVDFLKT-PSGIKLTINKLLDMAAQ 117
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR- 741
+ + ++ +H D++ N+LV++ K+ DFG A NE T ++F +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 742 -APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
APE I + D+WS G L E+ T G++ +PG TN ++++
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 52/231 (22%), Positives = 93/231 (40%), Gaps = 44/231 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G F TV + + G VAIK +R T KA + E ++ +
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-------- 74
Query: 633 RH---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLK-LTAVRAYA 681
+ C+ + + L+ + + L + +++ NIG + L +
Sbjct: 75 DNPHVCRLLGICLT--------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN---WC 123
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS---- 737
Q+ + +L++ ++H D+ N+LV +K+ DFG A G E Y
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKE-YHAEGGKV 181
Query: 738 --RFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
++ A E IL Y H D+WS G ++EL T G + G +++ +
Sbjct: 182 PIKWM-ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G+G F V + + VAIK +N T + + E +++ +
Sbjct: 24 GEGQFGDVHQGI-YMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF------DH 75
Query: 633 RHCIRFASSFKY----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
H ++ N + ++ E LR L+ + L L ++ YA QL A
Sbjct: 76 PHIVKL-----IGVITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTA 128
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPE 744
L +L++ +H DI N+LV+ + +KL DFG + + + + + APE
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
I + D+W G C++E+ G F G NND++
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 39/229 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G V + L+ VAIK ++ + + +E I+ +
Sbjct: 58 GSGDSGEVCYGR-LRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQF-------- 107
Query: 633 RH---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAK 682
H R +V E + + +L L+ + + +
Sbjct: 108 DHPNIIRLEGVVTR-------GRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLR 158
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS--RF- 739
+ +++L + G +H D+ N+LV+ V K+ DFG + + Y + +
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 740 YR--APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
R APE I + D+WS G ++E+ G+ + TN D++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS 266
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 47/224 (20%), Positives = 83/224 (37%), Gaps = 27/224 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPENKR 633
G+G F V L +G+ A+K + + + Q TE I+K +
Sbjct: 98 GRGHFGCVYHGT-LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHP 150
Query: 634 HCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLK-LTAVRAYAKQLFIAL 688
+ + + +V +M +LR ++ N +K L + Q+ +
Sbjct: 151 NVLSLLGICLRSEGSPLVVLP--YMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGM 205
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR------A 742
K L + +H D+ N +++E K +K+ DFG A E + A
Sbjct: 206 KFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
E + + D+WS G L+EL T G +P D+
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G+G F V GE VA+K + + + +E I+K L +
Sbjct: 21 GEGFFGEVYEGV-YTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNL------DH 72
Query: 633 RHCIRFASSFKY----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
H ++ ++ E + L L++ + LK+ + Y+ Q+ A
Sbjct: 73 PHIVKL-----IGIIEEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKA 125
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPE 744
+ +L++ +H DI N+LV +KL DFG + + + V+R + +PE
Sbjct: 126 MAYLESINCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPE 184
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
I + D+W C++E+ + GK F N D++ +
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 27/224 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPENKR 633
G+G F V L +G+ A+K + + + Q TE I+K +
Sbjct: 34 GRGHFGCVYHGT-LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHP 86
Query: 634 HCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLK-LTAVRAYAKQLFIAL 688
+ + + +V +M +LR ++ N +K L + Q+ +
Sbjct: 87 NVLSLLGICLRSEGSPLVVLP--YMKHGDLRNFIRNETHNPTVKDLIG---FGLQVAKGM 141
Query: 689 KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR------A 742
K+L + +H D+ N +++E K +K+ DFG A E + A
Sbjct: 142 KYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
E + + D+WS G L+EL T G +P D+
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 47/229 (20%), Positives = 88/229 (38%), Gaps = 40/229 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPENKR 633
G GVF TV + + G V IK+I + + + L
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL--------D 73
Query: 634 H---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQ 683
H C + L LV + L +L + +++ +G +L + + Q
Sbjct: 74 HAHIVRLLGLCPG--------SSLQLVTQYLPLGSLLDHVRQHRGALGPQL--LLNWGVQ 123
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR-- 741
+ + +L+ G++H ++ N+L+ + +++ DFG A ++ L+ +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDK--QLLYSEAKTP 180
Query: 742 ----APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
A E I Y H D+WS G ++EL T G + G ++ L
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL 229
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 50/225 (22%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRH- 634
G G F V K + +VAIK+I+ E +++ L H
Sbjct: 33 GTGQFGVVKYGK-WR----GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL--------SHE 79
Query: 635 --------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQ 683
C + + + ++ E +M L L++ + + K
Sbjct: 80 KLVQLYGVCTK-------QRPIFIITE--YMANGCLLNYLREMRHR--FQTQQLLEMCKD 128
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-YR- 741
+ A+++L++ LH D+ N LVN+ + V+K+ DFG + + +E T + S+F R
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187
Query: 742 -APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784
PE+++ + DIW+ G ++E+Y+ GK+ + TN++
Sbjct: 188 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 49/277 (17%), Positives = 104/277 (37%), Gaps = 21/277 (7%)
Query: 518 PCDDIFGETPVGVRKTGKAEGLKIIRSGLHDNWDDAEGYYSYRFGEILDGRYEVTAAHGK 577
D + P + K + + S + D E + D G
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGC 346
Query: 578 GVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHC 635
G F +V + + + +VAIK+++ + + E QI+ +L + +
Sbjct: 347 GNFGSVRQGV-YRMRKKQ-IDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPYI 398
Query: 636 IRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
+R + L LV E L + L + ++ V Q+ + +K+L+
Sbjct: 399 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYLEEK 455
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRF---YRAPEIILGL 749
+H ++ N+L+ ++ K+ DFG + + A + T ++ + APE I
Sbjct: 456 NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 750 PYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ D+WS G ++E + G+ + +++
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 551
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 26/169 (15%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQI 620
++ Y+V G+G F + +L ++VAIK E E +
Sbjct: 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIK----FEPRRSDAPQLRDEYRT 58
Query: 621 LKKLAGAD--PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
K LAG P + F + LV + L +L ++L GR +K T
Sbjct: 59 YKLLAGCTGIP----NVYYFGQEGLHN---VLVIDLLGPSLEDLLDLCGRKFSVK-TVAM 110
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLV----NEAKNVLKLCDFGNA 723
AKQ+ ++ + +++ DIKPDN L+ ++ N++ + DFG
Sbjct: 111 -AAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 46/219 (21%), Positives = 89/219 (40%), Gaps = 21/219 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G F V + LK + + VAIK ++ K + E I+ + +
Sbjct: 54 GAGEFGEVCSGR-LKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQF------DH 105
Query: 633 RHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
+ IR + +V E + + +L L+K + + + + +K+L
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL 163
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS--RF---YRAPEII 746
+ G +H D+ N+L+N V K+ DFG + Y + + +PE I
Sbjct: 164 SDMGYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 747 LGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784
+ D+WS G L+E+ + G+ + +N D+++
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 40/230 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPEN 631
G G F V + LK +G+ E VAIK ++ K E I+ +
Sbjct: 53 GAGEFGEVYKGM-LKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF------- 103
Query: 632 KRH---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYA 681
H + + ++ E + + L + L++ + +
Sbjct: 104 -SHHNIIRLEGVISK-------YKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGML 153
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS--RF 739
+ + +K+L N +H D+ N+LVN V K+ DFG + + Y S +
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 740 -YR--APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
R APE I + D+WS G ++E+ T G+ + +N+++++
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 262
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 34/178 (19%), Positives = 72/178 (40%), Gaps = 25/178 (14%)
Query: 562 GEILD----GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTE 617
G++LD ++ + G G F + A E+ A +++ N +E
Sbjct: 28 GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKP----EKDARHVVKVEYQENGPLFSE 83
Query: 618 VQILKKLAGADPENKR------------HCIRF-ASSFKYRNHLCLVFESLHMNLREVLK 664
++ +++A D K + FK R++ +V E L ++L+++
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143
Query: 665 KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK-NVLKLCDFG 721
+ G K + V ++ L+++ +H DIK N+L+ + + L D+G
Sbjct: 144 QNGT---FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 44/167 (26%), Positives = 69/167 (41%), Gaps = 24/167 (14%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQI 620
+ RY + G G F + D+ AG EEVAIK+ E + E +I
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKL----ECVKTKHPQLHIESKI 57
Query: 621 LKKLAGAD--PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
K + G P + Y +V E L +L ++ R LK V
Sbjct: 58 YKMMQGGVGIP----TIRWCGAEGDYN---VMVMELLGPSLEDLFNFCSRKFSLK--TVL 108
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK--NVLKLCDFGNA 723
A Q+ ++++ + +H D+KPDN L+ K N++ + DFG A
Sbjct: 109 LLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQILKKLAGADPENKR 633
G+G F V +G E VA+K ++ + + E+ IL+ L
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL------YHE 93
Query: 634 HCIRF--ASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL 691
H I++ L LV E ++ L L+ + + L + +A+Q+ + +L
Sbjct: 94 HIIKYKGCCEDAGAASLQLVME--YVPLGS-LRDYLPRHSIGLAQLLLFAQQICEGMAYL 150
Query: 692 KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR------FYRAPEI 745
+H D+ N+L++ ++K+ DFG A + Y V F+ APE
Sbjct: 151 HAQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAPEC 208
Query: 746 ILGLPYDHPLDIWSVGCCLYELYT 769
+ + + D+WS G LYEL T
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLT 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G+G F V + + VAIK +N T + + E +++ +
Sbjct: 399 GEGQFGDVHQGI-YMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQF------DH 450
Query: 633 RHCIRFASSFKY----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
H ++ N + ++ E LR L+ + L L ++ YA QL A
Sbjct: 451 PHIVKL-----IGVITENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTA 503
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPE 744
L +L++ +H DI N+LV+ + +KL DFG + + + + + APE
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 562
Query: 745 IILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
I + D+W G C++E+ G F G NND++
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 46/230 (20%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ----TEVQILKKLAGADPEN 631
G G F TV + + + VA+KI++N E + A + E ++++L
Sbjct: 26 GSGNFGTVKKGY-YQMKKVV-KTVAVKILKN-EANDPALKDELLAEANVMQQL------- 75
Query: 632 KRH---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYA 681
+ C LV E L + L++ N +K +
Sbjct: 76 -DNPYIVRMIGICEA--------ESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELV 123
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRF 739
Q+ + +K+L+ +H D+ N+L+ ++ K+ DFG + + A +N ++
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 740 ---YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
+ APE I + D+WS G ++E ++ G+ + G +++ +
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 42/225 (18%), Positives = 80/225 (35%), Gaps = 29/225 (12%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPENKR 633
GKG F V + + AIK + M + E +++ L N
Sbjct: 30 GKGHFGVVYHGE-YIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL------NHP 82
Query: 634 HCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ + ++ +M +L + ++ RN + + ++ Q+ ++
Sbjct: 83 NVLALIGIMLPPEGLPHVLLP--YMCHGDLLQFIRSPQRN--PTVKDLISFGLQVARGME 138
Query: 690 HL--KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR------ 741
+L + +H D+ N +++E +K+ DFG A E R R
Sbjct: 139 YLAEQKF--VHRDLAARNCMLDE-SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 742 APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
A E + + D+WS G L+EL T G + D+
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 44/224 (19%), Positives = 90/224 (40%), Gaps = 31/224 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G F +V + + + +VAIK+++ T + E QI+ +L +
Sbjct: 19 GCGNFGSVRQGV-YRMRKKQ-IDVAIKVLKQG-TEKADTEEMMREAQIMHQL------DN 69
Query: 633 RHCIRFASSFKY----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+ +R L LV E L + L + ++ V Q+ +
Sbjct: 70 PYIVRL-----IGVCQAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMG 122
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA--MFAGKNEITPYLVSRF---YRA 742
+K+L+ +H D+ N+L+ ++ K+ DFG + + A + T ++ + A
Sbjct: 123 MKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
PE I + D+WS G ++E + G+ + +++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF 225
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G G F TV + + G VAIK +R T KA + E ++ +
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASV-------- 74
Query: 633 RH---------CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAK 682
+ C+ + + L+ + + L + +++ NIG + + +
Sbjct: 75 DNPHVCRLLGICLT--------STVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCV 124
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS----- 737
Q+ + +L++ ++H D+ N+LV +K+ DFG A G E Y
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKE-YHAEGGKVP 182
Query: 738 -RFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
++ A E IL Y H D+WS G ++EL T G + G +++ +
Sbjct: 183 IKWM-ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 32/178 (17%), Positives = 66/178 (37%), Gaps = 22/178 (12%)
Query: 562 GEILD----GRYEVTAAHGKGVFSTVVRAKDLKAGNGEP----EEVAIKIIRNNET---- 609
G +L ++++ + + + A + ++ ++K+ +
Sbjct: 33 GTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNE 92
Query: 610 ----MNKAGQTEVQILKKLAGADPENKRHCIRFASS-FKYRNHLCLVFESLHMNLREVLK 664
A +V KKL C+ F KYR LV SL +L+ L
Sbjct: 93 QNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALD 149
Query: 665 KFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK-NVLKLCDFG 721
+++ L +V A +L AL+ L +H ++ +N+ V+ + + L +G
Sbjct: 150 VSPKHV-LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 31/222 (13%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--TEVQILKKLAGADPENKR 633
G+G F V + + VA+K R + + E +ILK+ +
Sbjct: 123 GRGNFGEVFSGRL----RADNTLVAVKSCRETLPPDLKAKFLQEARILKQY------SHP 172
Query: 634 HCIRF---ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFIA 687
+ +R + + + +V E + + L+ G L++ +
Sbjct: 173 NIVRLIGVCTQ---KQPIYIVME--LVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAG 225
Query: 688 LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF--YR--AP 743
+++L++ +H D+ N LV E KNVLK+ DFG + R + AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784
E + Y D+WS G L+E ++ G +P +N
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 42/241 (17%), Positives = 86/241 (35%), Gaps = 52/241 (21%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
GKG F +V A+ LK +G +VA+K+++ + + + E +K+
Sbjct: 32 GKGEFGSVREAQ-LKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-------- 82
Query: 633 RH---------CIRFASSFKYRNHLCLVFESLHM---NLREVLKK---FGRNIGLKLTAV 677
H +R + + ++ M +L L L L +
Sbjct: 83 DHPHVAKLVGVSLR-SRAKGRLPIPMVILP--FMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
+ + +++L + +H D+ N ++ E + + DFG + +
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGDY------ 192
Query: 738 RFYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784
YR A E + Y D+W+ G ++E+ T G+ + G N ++
Sbjct: 193 --YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 785 L 785
Sbjct: 251 Y 251
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 44/242 (18%), Positives = 80/242 (33%), Gaps = 60/242 (24%)
Query: 576 GKGVFSTVVRAK---DLKAGNGEPEEVAIKIIRNNETMNKAG--QTEVQILKKLAGADPE 630
G+G F+ + + G EV +K++ N + ++ KL
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKL------ 69
Query: 631 NKRH---------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVR 678
H C+ + LV E + +L LKK + +
Sbjct: 70 --SHKHLVLNYGVCVC-------GDENILVQE--FVKFGSLDTYLKKNKNC--INILWKL 116
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK-------NVLKLCDFGNAMFAGKNEI 731
AKQL A+ L+ ++H ++ N+L+ + +KL D G ++ +I
Sbjct: 117 EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 732 TPYLVSRFYR------APEIIL-GLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ PE I + D WS G L+E+ + G + L
Sbjct: 177 --------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 784 RL 785
+
Sbjct: 229 QF 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 24/167 (14%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT---EVQI 620
+ ++ + G G F + +++ EEVAIK+ E + E +I
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKL----ENVKTKHPQLLYESKI 55
Query: 621 LKKLAGAD--PENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVR 678
+ L G P + F Y LV + L +L ++ R + LK T +
Sbjct: 56 YRILQGGTGIP----NVRWFGVEGDYN---VLVMDLLGPSLEDLFNFCSRKLSLK-TVLM 107
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK--NVLKLCDFGNA 723
A Q+ ++ + + LH DIKPDN L+ + N + + DFG A
Sbjct: 108 L-ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 29/179 (16%), Positives = 70/179 (39%), Gaps = 24/179 (13%)
Query: 562 GEILD----GRYEVTAAHGKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNETMNKAGQT 616
GEI+ ++V G+G F + A + + +K+ ++ N T
Sbjct: 26 GEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD---NGPLFT 82
Query: 617 EVQILKKLAGADPENKRHCIRFASS-------------FKYRNHLCLVFESLHMNLREVL 663
E++ ++ A + K R +++ ++ + +L+++
Sbjct: 83 ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY 142
Query: 664 KKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN-EAKNVLKLCDFG 721
+ + K V + ++ L+++ +H DIK N+L+N + + + L D+G
Sbjct: 143 EANAKRFSRK--TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 87/606 (14%), Positives = 159/606 (26%), Gaps = 184/606 (30%)
Query: 5 MAYC---LFGVGEDAMKDNIG-KQIGD---DVVSSSICDKVYNEQHGNGELPR------- 50
Y + V EDA DN K + D ++S D + + R
Sbjct: 14 HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLS 73
Query: 51 --ENG---------RENYK----QWR-ESKSPSRRSAKRNSYHDFDPMEDDQSYLHDRRK 94
E R NYK + E + PS + D + +D
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR--DRLYNDNQVFAKY-- 129
Query: 95 SVSSESSGDKYSPALRSPSRDRSYDEYH--TRRGRS-------RSHDV------------ 133
+VS K AL R G++ S+ V
Sbjct: 130 NVSRLQPYLKLRQALLE-LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN 188
Query: 134 VKERSRSQSVMEEEAPLKR---SNYHERDAN--------DSEDERLVRRGRNERHGSRDL 182
+K + ++V+E L N+ R + S L R +++ + + L
Sbjct: 189 LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 183 VRDD--EREH--------RTSYTTRYVGREDR----HHSREIERERRREWEREKSKHL-- 226
V + + + TTR+ D + ++ K L
Sbjct: 249 VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 227 -----EVDRERRRDKNREQSRDRDIH---------RGREERDRS-RYEEVDRGRRREKER 271
R + R+ ++ V+ +
Sbjct: 309 KYLDCRPQDLPREVL--------TTNPRRLSIIAESIRDGLATWDNWKHVNC-DKLTTII 359
Query: 272 DRSRDRARVNDRDMDRQRDREKDRV--RDN-------------NLERERERRRDRSRDKG 316
+ S +N + R + ++ + D
Sbjct: 360 ESS-----LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---------DVM 405
Query: 317 RDIESDREKGASPKDSYSNRDRYKHSRHLKHDDDKGSYGDRTRKDDLAKIHSS--NSYSM 374
+ + K + S +L+ + + ++ +H S + Y++
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISI-PSIYLEL---------KVKLENEYALHRSIVDHYNI 455
Query: 375 EGSGDKITKDEDEQDD-FEERVA--LKLEEQEEED-------LD-RIMEESRKRRQAI-- 421
+ D D F + LK E E LD R +E +K R
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE--QKIRHDSTA 513
Query: 422 -------------LEKYKNQHLQQQ--KDSNLVDVETD--EKPSEH--SSQSTD-VNNKL 461
L+ YK ++ K LV+ D K E+ S+ TD + L
Sbjct: 514 WNASGSILNTLQQLKFYK-PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIAL 572
Query: 462 QNDSNG 467
+
Sbjct: 573 MAEDEA 578
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-07
Identities = 75/626 (11%), Positives = 175/626 (27%), Gaps = 154/626 (24%)
Query: 339 YKHSRHLKHDDDKGSYGDRTRKDDLAKIHSSNSYSMEGSGDKITKDEDEQD--DFEERVA 396
+ H H+ + + Y + D+ + D + D +D D + +
Sbjct: 1 HHHHHHMDFETGEHQYQYK----DILSVFE----------DAFVDNFDCKDVQDMPKSI- 45
Query: 397 LKLEE--------QEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEK-P 447
L EE R+ +++ +++K+ + L+ + ++T+++ P
Sbjct: 46 LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 448 SEHSSQSTDVNNKLQNDSNGRIDGVNVHLADQSFSVKKS----PPQNGVTALDKTSVRGG 503
S + + ++L ND N NV ++++ P V + G
Sbjct: 106 SMMTRMYIEQRDRLYND-NQVFAKYNVSRLQPYLKLRQALLELRPAKNVL------IDGV 158
Query: 504 LGDGSPKS----ETSNHIPCDDIFGETPVGV-----RKTGKAEGLKIIRSGLHDNWDDAE 554
LG G K+ + + + E + + L D
Sbjct: 159 LGSG--KTWVALDVCLSYKVQCKM---DFKIFWLNLKNCNSPETVLEMLQKLLYQIDP-- 211
Query: 555 GYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
++ ++ + ++++K + + ++ N
Sbjct: 212 ---NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN--------CLLVLLN-------- 252
Query: 615 QTEVQILKKLAGADPENKRHC-----IRFAS-----SFKYRNHLCLVFESLHMNLREVLK 664
VQ K + C RF S H+ L S+ + EV
Sbjct: 253 ---VQNAKAWNAFNL----SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 665 KFGRNIGLKLTAVRAYAKQ---LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD-F 720
+ + + + +++ I+ + K+V CD
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSI-----IAES---IRDGLATWDNWKHV--NCDKL 355
Query: 721 GNAMFAGKNEITPYLVSRFYRA----------PEIILGL-----PYDHPLDIWSVGCCLY 765
+ + N + P + + P I+L L + + +
Sbjct: 356 TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV------VN 409
Query: 766 ELYTGKVLFPGATNNDMLRLH---MELKGPFP------KKMLRK---------GAFTDQH 807
+L+ L + + +ELK + ++ +
Sbjct: 410 KLHK-YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPY 468
Query: 808 FD----QDLNFHATEEDPVTKKAI-KKIIFN---IKPKDIGS-IVTASPGEDPKMLANFK 858
D + H + + + + + + ++ K + G L K
Sbjct: 469 LDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFI 884
I DP+ V A+ F+
Sbjct: 529 FYKPYICDNDPKYERLV-NAILD-FL 552
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 43/235 (18%), Positives = 86/235 (36%), Gaps = 41/235 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ---TEVQILKKLAGADPENK 632
G+G F +V+ LK +G +VA+K ++ + + + + +E +K
Sbjct: 43 GEGEFGSVMEGN-LKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-------- 93
Query: 633 RH---------CIRFASSFKYRNHLCLVFESLHM---NLREVLKKF-GRNIGLKLTAVR- 678
H CI S + ++ M +L L +
Sbjct: 94 SHPNVIRLLGVCIE--MSSQGIPKPMVILP--FMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 679 -AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
+ + + +++L N LH D+ N ++ + + + DFG + + Y
Sbjct: 150 LKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGDY--YRQG 206
Query: 738 RFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
R + A E + Y D+W+ G ++E+ T G +PG N++M
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 3e-07
Identities = 17/116 (14%), Positives = 44/116 (37%), Gaps = 37/116 (31%)
Query: 199 VGREDRHHSREIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRY 258
+ + DR + E E R+W REE+ + R
Sbjct: 74 IAQADR--LTQ-EPESIRKW-------------------------------REEQRK-RL 98
Query: 259 EEVDRGRRREKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRD 314
+E+D + ++ R++A+ + + ++++ + ++ + NN ++ + D
Sbjct: 99 QELDAASKVMEQE--WREKAKKDLEEWNQRQSEQVEKNKINNRIADKAFYQQPDAD 152
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 56/236 (23%), Positives = 98/236 (41%), Gaps = 39/236 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENK 632
G+G F V+ A VA+K+++ + ++A +E++IL + +
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-----GHH 90
Query: 633 RHCIRF-ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKH 690
+ + + K L ++ E NL L+ RN + + F+ L+H
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS-KRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 691 L----------------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPY 734
L + C +H D+ N+L++E KNV+K+CDFG A K+ Y
Sbjct: 150 LICYSFQVAKGMEFLASRKC--IHRDLAARNILLSE-KNVVKICDFGLARDIYKDPD--Y 204
Query: 735 LVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ R APE I Y D+WS G L+E+++ G +PG ++
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 50/243 (20%), Positives = 94/243 (38%), Gaps = 41/243 (16%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENK 632
G G F VV A + VA+K+++ + T +A +E+++L L N
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NH 86
Query: 633 RHCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKK--------FGRNIGLKLTAVRAY 680
+ + + ++ E + +L L++ ++ +
Sbjct: 87 MNIVNLLGACTI-GGPTLVITE--YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 681 AKQLF-----IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP 733
+ L +A + L + +H D+ N+L+ + K+CDFG A +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN-- 200
Query: 734 YLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG-ATNNDMLRL 785
Y+V R APE I Y D+WS G L+EL++ G +PG ++ ++
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 786 HME 788
E
Sbjct: 261 IKE 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 57/242 (23%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE---VAIKIIRNN--ETMNKAGQTEVQILKKLAGADPE 630
G+G F VV A+ + +P+E VA+K+++++ E +E++++K +
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-----G 98
Query: 631 NKRHCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
++ I + + L ++ E + NLRE L+ R G++ + + +
Sbjct: 99 KHKNIINLLGACTQ-DGPLYVIVE--YASKGNLREYLRA-RRPPGMEYSYDINRVPEEQM 154
Query: 687 ALKHL----------------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
K L + C +H D+ N+LV E NV+K+ DFG A +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC--IHRDLAARNVLVTE-NNVMKIADFGLARDINNID 211
Query: 731 ITPYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
Y + R APE + Y H D+WS G ++E++T G +PG ++
Sbjct: 212 Y--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 784 RL 785
+L
Sbjct: 270 KL 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 50/241 (20%), Positives = 86/241 (35%), Gaps = 53/241 (21%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENK 632
G+G F V EPE VAIK + +M + E ++K+ N
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NC 87
Query: 633 RHCIRF-ASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR---AYAKQ 683
H +R + ++ E L LR + N L ++ A +
Sbjct: 88 HHVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR----- 738
+ + +L +H D+ N +V E +K+ DFG ++R
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAE-DFTVKIGDFG--------------MTRDIYET 191
Query: 739 -FYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR 784
+YR +PE + + D+WS G L+E+ T + + G +N +LR
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
Query: 785 L 785
Sbjct: 252 F 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 49/243 (20%), Positives = 87/243 (35%), Gaps = 57/243 (23%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE--VAIKIIRNNETMNKAG--QTEVQILKKLAGADPEN 631
G G F V + + +P VA+K + + E I+ K N
Sbjct: 39 GHGAFGEVYEGQ-VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF------N 91
Query: 632 KRHCIRF-ASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
++ +R S + ++ E L LRE + + L + + A+
Sbjct: 92 HQNIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD-- 148
Query: 686 IA--LKHLKNCGVLHCDIKPDNMLVNEA--KNVLKLCDFGNAMFAGKNEITPYLVSR--- 738
IA ++L+ +H DI N L+ V K+ DFG ++R
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------------MARDIY 194
Query: 739 ---FYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDM 782
+YR PE + + D WS G L+E+++ G + +P +N ++
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254
Query: 783 LRL 785
L
Sbjct: 255 LEF 257
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 59/240 (24%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE---VAIKIIRNNETMN--KAGQTEVQILKKLAGADPE 630
G+G F VV A+ + +P VA+K+++++ T +E++++K +
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI-----G 132
Query: 631 NKRHCIRF-ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIAL 688
++ I + + L ++ E NLRE L+ R GL+ + ++ + ++
Sbjct: 133 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSS 190
Query: 689 KHL----------------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT 732
K L K C +H D+ N+LV E NV+K+ DFG A +
Sbjct: 191 KDLVSCAYQVARGMEYLASKKC--IHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDY- 246
Query: 733 PYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRL 785
Y + R APE + Y H D+WS G L+E++T G +PG ++ +L
Sbjct: 247 -YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/242 (23%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEE---VAIKIIRNN--ETMNKAGQTEVQILKKLAGADPE 630
G+G F VV A+ + +P+E VA+K+++++ E +E++++K +
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI-----G 144
Query: 631 NKRHCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
++ I + + L ++ E + NLRE L+ R G++ + + +
Sbjct: 145 KHKNIINLLGACTQ-DGPLYVIVE--YASKGNLREYLRA-RRPPGMEYSYDINRVPEEQM 200
Query: 687 ALKHL----------------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
K L + C +H D+ N+LV E NV+K+ DFG A +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC--IHRDLAARNVLVTE-NNVMKIADFGLARDINNID 257
Query: 731 ITPYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
Y + R APE + Y H D+WS G ++E++T G +PG ++
Sbjct: 258 Y--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 784 RL 785
+L
Sbjct: 316 KL 317
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 54/242 (22%), Positives = 95/242 (39%), Gaps = 50/242 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRN-NETMNKAGQTEVQILKKLAGADPENKR 633
G+G F V A+ + + VA+K +++ K Q E ++L L
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL------QHE 77
Query: 634 HCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLF---- 685
H ++F + L +VFE +M +L + L+ G + + + AK
Sbjct: 78 HIVKFYGVCGD-GDPLIMVFE--YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 686 -------IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
IA + +L + +H D+ N LV ++K+ DFG + T Y
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGA-NLLVKIGDFG---MSRDVYSTDY-- 188
Query: 737 SRFYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
YR PE I+ + D+WS G L+E++T GK + +N +++
Sbjct: 189 ---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 784 RL 785
Sbjct: 246 EC 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 56/244 (22%), Positives = 94/244 (38%), Gaps = 53/244 (21%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENK 632
G G F VV A G + +VA+K++++ +A +E++I+ L
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG------- 107
Query: 633 RH---------CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVR 678
+H C + ++ E L LR + + +
Sbjct: 108 QHENIVNLLGACTH-------GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 679 AYAKQLF-----IA--LKHL--KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729
A + L +A + L KNC +H D+ N+L+ +V K+ DFG A +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNC--IHRDVAARNVLLTN-GHVAKIGDFGLARDIMND 217
Query: 730 EITPYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG-ATNND 781
Y+V R APE I Y D+WS G L+E+++ G +PG N+
Sbjct: 218 SN--YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 782 MLRL 785
+L
Sbjct: 276 FYKL 279
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 49/242 (20%), Positives = 86/242 (35%), Gaps = 55/242 (22%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENK 632
G G F V + N +VA+K + + E I+ K N
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF------NH 133
Query: 633 RHCIRF-ASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
++ +R S + ++ E L LRE + + L + + A+ I
Sbjct: 134 QNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD--I 190
Query: 687 A--LKHLKNCGVLHCDIKPDNMLVNEA--KNVLKLCDFGNAMFAGKNEITPYLVSR---- 738
A ++L+ +H DI N L+ V K+ DFG ++R
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG--------------MARDIYR 236
Query: 739 --FYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+YR PE + + D WS G L+E+++ G + +P +N ++L
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296
Query: 784 RL 785
Sbjct: 297 EF 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 49/249 (19%), Positives = 89/249 (35%), Gaps = 63/249 (25%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNNETMNKAG--QTEVQILKKLAGADPENK 632
G+ F V + GE VAIK +++ + E + +L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL------QH 71
Query: 633 RHCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLF--- 685
+ + K L ++F + +L E L + + T K
Sbjct: 72 PNVVCLLGVVTK-DQPLSMIFS--YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 686 --------IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
IA +++L + V+H D+ N+LV + K +K+ D G
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD-KLNVKISDLG-------------- 173
Query: 736 VSR------FYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPG 776
+ R +Y+ APE I+ + DIWS G L+E+++ G + G
Sbjct: 174 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 233
Query: 777 ATNNDMLRL 785
+N D++ +
Sbjct: 234 YSNQDVVEM 242
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 6e-06
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 54/242 (22%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQILKKLAGADPENKR 633
G+G F V++A+ +K +G + AIK ++ + + + E+++L KL
Sbjct: 34 GEGNFGQVLKAR-IK-KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-------H 84
Query: 634 H---------CIRFASSFKYRNHLCLVFE-----SLHMNLRE--VLKKFGRNIGLKLTAV 677
H C R +L L E +L LR+ VL+ TA
Sbjct: 85 HPNIINLLGACEH-------RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 678 RAYAKQLF-----IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
++QL +A + +L +H D+ N+LV E V K+ DFG + E
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFG---LSRGQE 193
Query: 731 ITPYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
+ Y+ R A E + Y D+WS G L+E+ + G + G T ++
Sbjct: 194 V--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 784 RL 785
Sbjct: 252 EK 253
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 10/161 (6%)
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ KR SS + + +SL E + L L + Y+ Q+ ++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR------AP 743
L + +H D+ N+L++E V K+CDFG A K+ Y+ R AP
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVV-KICDFGLARDIYKDPD--YVRKGDARLPLKWMAP 264
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDML 783
E I Y D+WS G L+E+++ G +PG ++
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 9e-06
Identities = 31/219 (14%), Positives = 68/219 (31%), Gaps = 5/219 (2%)
Query: 108 ALRSPSRDRSYDEYHTRRGRSRSHDVVKERSRSQSVMEEEAPLKRSNYHERDANDSEDER 167
+R ++D++H R V + + K + N
Sbjct: 578 RVRGAVASVTFDDFHKNSARIIRMAVFGFEMSEDTGPDGTLLPKARDQAVFPQNGLVVSS 637
Query: 168 LVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSREIERERRREWEREKSKHLE 227
+ + + TT +H ++ +E+E R ER+K +
Sbjct: 638 VDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKIL-DQ 696
Query: 228 VDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREKERDRSRDRARVNDRDMDR 287
+ E+ R + E E ++ E R E + S +A++ + +
Sbjct: 697 SEAEKARKELLELEAMS---MAVESTGNAKAEAESRAEAARIEGEGSVLQAKLKAQALAI 753
Query: 288 QRDREKDRVRD-NNLERERERRRDRSRDKGRDIESDREK 325
+ + E +RV+ +E R + ++ E
Sbjct: 754 ETEAELERVKKVREMELIYARAQLELEVSKAQQLANVEA 792
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 51/254 (20%), Positives = 93/254 (36%), Gaps = 58/254 (22%)
Query: 576 GKGVFSTVVRAK-DLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENK 632
G G F V+ A + G +VA+K+++ + +A +E++++ +L
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG------- 106
Query: 633 RH---------CIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYA- 681
H C + L+FE + +L L+
Sbjct: 107 SHENIVNLLGACTL-------SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 682 ------------KQLF-----IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722
+ L +A ++ L+ +H D+ N+LV V+K+CDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGL 218
Query: 723 AMFAGKNEITPYLVSRFYR------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFP 775
A + Y+V R APE + Y D+WS G L+E+++ G +P
Sbjct: 219 ARDIMSDSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 776 G-ATNNDMLRLHME 788
G + + +L
Sbjct: 277 GIPVDANFYKLIQN 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 61/247 (24%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRN-NETMNKAGQTEVQILKKLAGADPENKR 633
G+G F V A+ + + VA+K ++ +E+ + Q E ++L L +
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML------QHQ 103
Query: 634 HCIRF-ASSFKYRNHLCLVFESLHM---NLREVLKKFGRNIGLKLTAVRAYAKQLF---- 685
H +RF + L +VFE +M +L L+ G + L L
Sbjct: 104 HIVRFFGVCTE-GRPLLMVFE--YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 686 ------IA--LKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
+A + +L +H D+ N LV + V+K+ DFG +S
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ-GLVVKIGDFG--------------MS 205
Query: 738 R------FYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGAT 778
R +YR PE IL + D+WS G L+E++T GK + +
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 779 NNDMLRL 785
N + +
Sbjct: 266 NTEAIDC 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 59/251 (23%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPE-EVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENK 632
G+G F VV+A VA+K+++ N + + +E +LK++ N
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV------NH 85
Query: 633 RHCIRF-ASSFKYRNHLCLVFE-----SLHMNLRE---VLKKFGRNIGLKLTAVRAYAKQ 683
H I+ + + L L+ E SL LRE V + + G + ++ + +
Sbjct: 86 PHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 684 LFIALKHL----------------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727
+ + L +H D+ N+LV E +K+ DFG +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKL--VHRDLAARNILVAE-GRKMKISDFG---LSR 198
Query: 728 KNEITPYLVSRFYR------------APEIILGLPYDHPLDIWSVGCCLYELYT-GKVLF 774
Y A E + Y D+WS G L+E+ T G +
Sbjct: 199 DVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 775 PGATNNDMLRL 785
PG + L
Sbjct: 254 PGIPPERLFNL 264
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 36/242 (14%), Positives = 64/242 (26%), Gaps = 60/242 (24%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---------NNETMNKAGQTEVQILKKLAG 626
G+GVF V + VAIKII +++ + E+ I K+L+
Sbjct: 29 GEGVFGEVFQTIADH------TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 627 ADPENKRHCIRFASSF-------KYRNHLCLVFESLH----------------------- 656
E F Y L ++ +
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 657 -MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHL-KNCGVLHCDIKPDNMLVNEAKNV 714
L++ + L ++ QL +L + H D+ N+L+ +
Sbjct: 143 FEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK 201
Query: 715 LKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF 774
KL N S + + Y ++ + LF
Sbjct: 202 -KLHYTLNG-----------KSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 775 PG 776
G
Sbjct: 250 TG 251
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 39/259 (15%), Positives = 90/259 (34%), Gaps = 4/259 (1%)
Query: 208 REIERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRR 267
+ R++ + D E +R K R+Q + ++ ++ + E+ +
Sbjct: 842 LFFXIXPLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLCEEKNLLQEKL 901
Query: 268 EKERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGA 327
+ E + + + R ++++ E+ E E R + + + + ++
Sbjct: 902 QAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEEEEERSQQLQAEKKKMQQQMLDLE 961
Query: 328 SPKDSYSNRDRYKHSRHLKHDDDKGSYGD--RTRKDDLAKIHSSNSYSMEGSGDKITKDE 385
+ + + D D +D K+ E D T
Sbjct: 962 EQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSDLTTNLA 1021
Query: 386 DEQDDFEERVALKLE-EQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETD 444
+E++ + LK + E +L+ +++ K RQ LEK K + + D + E
Sbjct: 1022 EEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQE-LEKIKRKLEGESSDLHEQIAELQ 1080
Query: 445 EKPSEHSSQSTDVNNKLQN 463
+ +E +Q +LQ
Sbjct: 1081 AQIAELKAQLAKKEEELQA 1099
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 41/298 (13%), Positives = 102/298 (34%), Gaps = 19/298 (6%)
Query: 150 LKRSNYHERDANDSEDERLVRRGRNERHGSRDLVRDDEREHRTSYTTRYVGREDRHHSRE 209
+ ++ L + E ++D +E + E +H
Sbjct: 832 MNVXHWPWMXLFFXIXPLLKVTRQEEEMQAKDEELQRTKERQQKAEAELKELEQKHTQLC 891
Query: 210 IERERRREWEREKSKHLEVDRERRRDKNREQSRDRDIHRGREERDRSRYEEVDRGRRREK 269
E+ +E ++ E E+ R R + +E + E R E+
Sbjct: 892 EEKNLLQE---------KLQAETELYAEAEEMRVRLAAKKQELEEILHEME----ARIEE 938
Query: 270 ERDRSRDRARVNDRDMDRQRDREKDRVRDNNLERERERRRDRSRDKGRDIESDREKGASP 329
E +RS+ + M +Q ++++ + E R++ + I+ +
Sbjct: 939 EEERSQQLQAEK-KKMQQQMLDLEEQLEE--EEAARQKLQLEKVTADGKIKKMEDDILIM 995
Query: 330 KDSYSNRDRYKHSRHLKHDDDKGSYGDRTRK-DDLAKIHSSNSYSMEGSGDKITKDEDEQ 388
+D + + + + D + + K +L K+ + + + ++ K+E +
Sbjct: 996 EDQNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSR 1055
Query: 389 DDFEERVALKLEEQEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVETDEK 446
+ E+ + E E DL + E + + + + + + Q ++ ET +K
Sbjct: 1056 QELEKI--KRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEELQAALARLEDETSQK 1111
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 51/264 (19%), Positives = 89/264 (33%), Gaps = 85/264 (32%)
Query: 576 GKGVFSTVVR--AKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQILKKLAGADPEN 631
G+G F V + A L VA+K+++ + + Q E ++ +
Sbjct: 56 GEGAFGRVFQARAPGLL-PYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------- 107
Query: 632 KRH---------CIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNIGLKLTAV 677
+ C +CL+FE L+ LR + ++ +
Sbjct: 108 -DNPNIVKLLGVCAV-------GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 678 RAYAK-----------QLFIAL------KHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720
RA QL IA +L +H D+ N LV E V+K+ DF
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADF 218
Query: 721 GNAMFAGKNEITPYLVSR------FYR------------APEIILGLPYDHPLDIWSVGC 762
G +SR +Y+ PE I Y D+W+ G
Sbjct: 219 G--------------LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 763 CLYELYT-GKVLFPGATNNDMLRL 785
L+E+++ G + G + +++
Sbjct: 265 VLWEIFSYGLQPYYGMAHEEVIYY 288
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 887 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-44 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-43 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-34 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-28 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-28 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-27 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-27 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-26 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-24 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-14 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-54
Identities = 70/327 (21%), Positives = 128/327 (39%), Gaps = 32/327 (9%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQI 620
E+ D +E + G G V + +G +A K+I + E+Q+
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIKPAIRNQIIRELQV 57
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRA 679
L + N + + F +F + + E + +L +VLKK GR + +
Sbjct: 58 LHEC------NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGK 108
Query: 680 YAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR 738
+ + L +L+ ++H D+KP N+LVN + +KLCDFG + + ++ +R
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMANSFVGTR 167
Query: 739 FYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM-LRLHMELKGPFPKKM 797
Y +PE + G Y DIWS+G L E+ G+ P ++ L +++G +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
R ++ I P + S F
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS-------------LEF 274
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFI 884
+D ++K + +P +R + Q + H FI
Sbjct: 275 QDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-48
Identities = 88/332 (26%), Positives = 144/332 (43%), Gaps = 47/332 (14%)
Query: 557 YSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT 616
SY +++ G G F V +AK +G E VAIK + ++ +
Sbjct: 20 VSYTDTKVI----------GNGSFGVVYQAKLCDSG----ELVAIKKVLQDK---RFKNR 62
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR-NIGLKLT 675
E+QI++KL + R+ + K +L LV + + + V + + R L +
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP-Y 734
V+ Y QLF +L ++ + G+ H DIKP N+L++ VLKLCDFG+A + E Y
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
Query: 735 LVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPF 793
+ SR+YRAPE+I G Y +D+WS GC L EL G+ +FPG + D L +++ G
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853
++ +R+ + + IK + P+
Sbjct: 243 TREQIRE---------------------MNPNYTEFKFPQIKAHPWTKVF------RPRT 275
Query: 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
L ++ P R+T +A H F
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 82/331 (24%), Positives = 139/331 (41%), Gaps = 43/331 (12%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKK 623
+YE A G+G F V +A+ K G ++VA+K + E E++IL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 624 LAGADPENKRHCIRFASS--FKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
L + N R +S + + + LVF+ +L +L + L+ ++
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVM 123
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP------YL 735
+ L L ++ +LH D+K N+L+ VLKL DFG A + + +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 736 VSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
V+ +YR PE++LG Y P+D+W GC + E++T + G T L L +L G
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
++ + N+ E+ + K +K+ +K
Sbjct: 243 PEV----------WPNVDNYELYEKLELVKGQKRKVKDRLKA--------------YVRD 278
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
DL+DK+ VLDP +R+ AL H F
Sbjct: 279 PYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 6e-48
Identities = 85/326 (26%), Positives = 144/326 (44%), Gaps = 38/326 (11%)
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILK 622
D +YE A G+G + V +A+DLK G VA+K +R E M + EV +L+
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 623 KLAGADPEN--KRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
L + N + + S L LVFE + +L L K G+ ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-GVPTETIKDM 121
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFY 740
QL L L + V+H D+KP N+LV + + +++ + +T +V+ +Y
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 741 RAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800
RAPE++L Y P+D+WSVGC E++ K LF G+++ D L +++ G ++
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE---- 237
Query: 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
+ +D+ + + I+K + +I KDL
Sbjct: 238 ------DWPRDVALPRQAFHSKSAQPIEKFVTDIDE-------------------LGKDL 272
Query: 861 LDKIFVLDPEKRMTVAQALTHPFISG 886
L K +P KR++ AL+HP+
Sbjct: 273 LLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (433), Expect = 2e-47
Identities = 95/350 (27%), Positives = 158/350 (45%), Gaps = 40/350 (11%)
Query: 556 YYSYRFGEIL-DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG 614
Y+ GE D RY + G G FSTV AKD+ VA+KI+R ++ +A
Sbjct: 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKVYTEAA 56
Query: 615 QTEVQILKKLAGADPE-----NKRHCIRFASSFKYRN----HLCLVFESLHMNLREVLKK 665
+ E+++L+++ AD H ++ F ++ H+ +VFE L NL ++KK
Sbjct: 57 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK 116
Query: 666 FGRNIGLKLTAVRAYAKQLFIALKHLK-NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724
+ + G+ L V+ +KQL + L ++ CG++H DIKP+N+L+ + L A
Sbjct: 117 Y-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 175
Query: 725 FAGKNEITP----YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPG---- 776
+ +R YR+PE++LG P+ DIWS C ++EL TG LF
Sbjct: 176 LGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235
Query: 777 --ATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI 834
++D + +EL G P +LR G +T F+ + + + I +
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN--------------SRGLLRNISKL 281
Query: 835 KPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
K + ++T D L + LDP KR + HP++
Sbjct: 282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 85/321 (26%), Positives = 149/321 (46%), Gaps = 50/321 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR------NNETMNKAGQTEVQILKKLAGADP 629
G+G F+TV +A+D + VAIK I+ + +N+ E+++L++L
Sbjct: 7 GEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL----- 57
Query: 630 ENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALK 689
+ + I +F +++++ LVF+ + +L ++K ++ L + ++AY L+
Sbjct: 58 -SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 114
Query: 690 HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAPEIIL 747
+L +LH D+KP+N+L++E VLKL DFG A G T +V+R+YRAPE++
Sbjct: 115 YLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 748 GL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQ 806
G Y +D+W+VGC L EL PG ++ D L E G +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE----------- 222
Query: 807 HFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866
E+ P + F P + ++ G+D DL+ +F+
Sbjct: 223 -----------EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDD------LLDLIQGLFL 265
Query: 867 LDPEKRMTVAQALTHPFISGK 887
+P R+T QAL + S +
Sbjct: 266 FNPCARITATQALKMKYFSNR 286
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 1e-45
Identities = 65/331 (19%), Positives = 117/331 (35%), Gaps = 69/331 (20%)
Query: 560 RFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN-NETMNKAGQTEV 618
+ +LD Y++ G G F V R + G A K + +E+ + + E+
Sbjct: 20 KHDHVLD-HYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKETVRKEI 74
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAV 677
Q + L + +F+ N + +++E + L E + + +
Sbjct: 75 QTMSVL------RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEA 126
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-VLKLCDFGNAMFAGKNEITPYLV 736
Y +Q+ L H+ +H D+KP+N++ ++ LKL DFG +
Sbjct: 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 186
Query: 737 -SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795
+ + APE+ G P + D+WSVG Y L +G F G +++ LR
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD- 245
Query: 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLA 855
+
Sbjct: 246 ---------------------------------------------------DSAFSGISE 254
Query: 856 NFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ KD + K+ + DP RMT+ QAL HP+++
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 2e-45
Identities = 68/329 (20%), Positives = 116/329 (35%), Gaps = 69/329 (20%)
Query: 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-QTEVQI 620
G + D Y++ G G F V R + G K I ++K + E+ I
Sbjct: 25 GSVYD-YYDILEELGSGAFGVVHRCVEKATG----RVFVAKFINTPYPLDKYTVKNEISI 79
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRA 679
+ +L + I +F+ + + L+ E L L + + + + V
Sbjct: 80 MNQL------HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVIN 131
Query: 680 YAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-VLKLCDFGNAMFAGKNEITPYLV-S 737
Y +Q LKH+ ++H DIKP+N++ K +K+ DFG A +EI +
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+ APEI+ P D+W++G Y L +G F G + + L+ F +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
+
Sbjct: 252 F----------------------------------------------------SSVSPEA 259
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFISG 886
KD + + +P KR+TV AL HP++ G
Sbjct: 260 KDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 89/325 (27%), Positives = 139/325 (42%), Gaps = 45/325 (13%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
++ G+G + V +A++ G E VA+K IR E + E+ +LK+L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
N + ++ N L LVFE LH +L++ + G+ L +++Y QL
Sbjct: 59 ------NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQL 111
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRA 742
L + VLH D+KP N+L+N + +KL DFG A G T +V+ +YRA
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 743 PEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
PEI+LG Y +DIWS+GC E+ T + LFPG + D L G + +
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW--- 227
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
+ K +D +V P + + + LL
Sbjct: 228 -----------------PGVTSMPDYKPSFPKWARQDFSKVV-------PPLDEDGRSLL 263
Query: 862 DKIFVLDPEKRMTVAQALTHPFISG 886
++ DP KR++ AL HPF
Sbjct: 264 SQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-44
Identities = 94/337 (27%), Positives = 154/337 (45%), Gaps = 31/337 (9%)
Query: 556 YYSYRFGE---ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NET 609
+YS G+ + RY+ G G V A D VAIK + N+T
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQT 58
Query: 610 MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRN 669
K E+ ++K + + + + + + + LV E + NL +V++
Sbjct: 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-- 116
Query: 670 IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN 729
+ Q+ +KHL + G++H D+KP N++V LK+ DFG A AG +
Sbjct: 117 ---DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTS 172
Query: 730 EI-TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788
+ TPY+V+R+YRAPE+ILG+ Y +DIWSVGC + E+ K+LFPG D +E
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPG 848
G + ++K T +++ ++ K S+ A
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENR--------------PKYAGLTFPKLFPDSLFPADSE 278
Query: 849 EDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
+ + +DLL K+ V+DP KR++V AL HP+I+
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 61/328 (18%), Positives = 121/328 (36%), Gaps = 68/328 (20%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILK 622
E+ + +Y + G+G F V R + + + K ++ T + E+ IL
Sbjct: 2 ELYE-KYMIAEDLGRGEFGIVHRCVETSSK----KTYMAKFVKVKGTDQVLVKKEISILN 56
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYA 681
R+ + SF+ L ++FE + +++ E + L + +Y
Sbjct: 57 IA------RHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYV 108
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN-VLKLCDFGNAMFAGKNEI-TPYLVSRF 739
Q+ AL+ L + + H DI+P+N++ ++ +K+ +FG A + +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
Y APE+ D+WS+G +Y L +G F TN ++ M + F ++
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF- 227
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
++ D
Sbjct: 228 ---------------------------------------------------KEISIEAMD 236
Query: 860 LLDKIFVLDPEKRMTVAQALTHPFISGK 887
+D++ V + + RMT ++AL HP++ K
Sbjct: 237 FVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 7e-44
Identities = 84/323 (26%), Positives = 136/323 (42%), Gaps = 47/323 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+Y G+G + V +A++ E A+K IR +E + E+ ILK+L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYG-----ETFALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+ ++ + L LVFE L +L+++L GL+ +++ QL
Sbjct: 58 ------KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQL 109
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEIT--PYLVSRFYRA 742
+ + + VLH D+KP N+L+N + LK+ DFG A G +V+ +YRA
Sbjct: 110 LNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 743 PEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
P++++G Y +DIWSVGC E+ G LFPG + D L + G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN------- 221
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
++ + K N + + G D + DLL
Sbjct: 222 ----------------SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDE----SGIDLL 261
Query: 862 DKIFVLDPEKRMTVAQALTHPFI 884
K+ LDP +R+T QAL H +
Sbjct: 262 SKMLKLDPNQRITAKQALEHAYF 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 8e-44
Identities = 92/340 (27%), Positives = 155/340 (45%), Gaps = 42/340 (12%)
Query: 554 EGYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NN 607
G+Y + + Y G G + V A D + G +VAIK + +
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRPFQS 57
Query: 608 ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFG 667
E K E+++LK + + + LV + +L +++K
Sbjct: 58 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--- 114
Query: 668 RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727
+ L ++ Q+ L+++ G++H D+KP N+ VNE LK+ DFG A A
Sbjct: 115 -HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQAD 172
Query: 728 KNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH 786
+E+T Y+V+R+YRAPE+IL + Y +DIWSVGC + E+ TGK LF G+ + D L+
Sbjct: 173 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTAS 846
M++ G P + +++ + K + ++ KD SI+T +
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKN------------------YMKGLPELEKKDFASILTNA 273
Query: 847 PGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+LL+K+ VLD E+R+T +AL HP+
Sbjct: 274 SPL-------AVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 2e-43
Identities = 68/334 (20%), Positives = 121/334 (36%), Gaps = 71/334 (21%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG--QT 616
++ E + Y+ G G FS V+ A+D + + VAIK I K G +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ----KLVAIKCIAKKALEGKEGSMEN 56
Query: 617 EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLT 675
E+ +L K+ + + ++ HL L+ + + L + + + G
Sbjct: 57 EIAVLHKI------KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTER 107
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN--EAKNVLKLCDFGNAMFAGKNEITP 733
Q+ A+K+L + G++H D+KP+N+L + + + + DFG + +
Sbjct: 108 DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167
Query: 734 YLV-SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792
+ Y APE++ PY +D WS+G Y L G F + + ++ +
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227
Query: 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852
F
Sbjct: 228 FDSPYW----------------------------------------------------DD 235
Query: 853 MLANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886
+ + KD + + DPEKR T QAL HP+I+G
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-43
Identities = 62/324 (19%), Positives = 114/324 (35%), Gaps = 75/324 (23%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQILKK 623
+E+ GKG F V A++ ++ +A+K++ + + EV+I
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAK 682
L + +R F + L+ E + L+K + Y
Sbjct: 63 L------RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYIT 113
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
+L AL + + V+H DIKP+N+L+ LK+ DFG ++ A + T + Y
Sbjct: 114 ELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTTLCGTLDYLP 172
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802
PE+I G +D +D+WS+G YE GK F ++ ++
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE---------------ANTYQETYKR-- 215
Query: 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLD 862
I + +DL+
Sbjct: 216 ---------------------------------------ISRVEFTFPDFVTEGARDLIS 236
Query: 863 KIFVLDPEKRMTVAQALTHPFISG 886
++ +P +R + + L HP+I+
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (395), Expect = 3e-43
Identities = 76/335 (22%), Positives = 117/335 (34%), Gaps = 83/335 (24%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----------NNETMNKAGQTE 617
YE G+GV S V R +E A+KII + + +A E
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTA 676
V IL+K++G + I+ +++ LVF+ + L + L + L
Sbjct: 60 VDILRKVSG-----HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKE 111
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-ITPYL 735
R + L + L ++H D+KP+N+L+++ +KL DFG + E +
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEKLREVC 170
Query: 736 VSRFYRAPEIILG------LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMEL 789
+ Y APEII Y +D+WS G +Y L G F MLR+ M
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
F E
Sbjct: 231 NYQFG----------------------------------------------------SPE 238
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
KDL+ + V+ P+KR T +AL HPF
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-43
Identities = 90/328 (27%), Positives = 144/328 (43%), Gaps = 43/328 (13%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILK 622
+ RY + G+G + V A D VAIK I ++T + E++IL
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNK----VRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+ + IR A + + + LV + +L ++LK L + +
Sbjct: 62 RFRHENIIGINDIIR-APTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLY 116
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE-----ITPYLVS 737
Q+ LK++ + VLH D+KP N+L+N LK+CDFG A A + +T Y+ +
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 738 RFYRAPEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
R+YRAPEI+L Y +DIWSVGC L E+ + + +FPG D L + + G ++
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
L + + + ++ K+ P D K
Sbjct: 236 DLNC---------------------IINLKARNYLLSLPHKNKVPWNRLFPNADSK---- 270
Query: 857 FKDLLDKIFVLDPEKRMTVAQALTHPFI 884
DLLDK+ +P KR+ V QAL HP++
Sbjct: 271 ALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 6e-43
Identities = 60/334 (17%), Positives = 127/334 (38%), Gaps = 78/334 (23%)
Query: 562 GEILDGRY-EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NETMNKAGQTE 617
G DGR+ + G+G F TV + D + EVA +++ ++ + + E
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEE 58
Query: 618 VQILKKLAGADPENKRHCIR----FASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGL 672
++LK L + +R + S+ K + + LV E + L+ LK+F +
Sbjct: 59 AEMLKGL------QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---M 109
Query: 673 KLTAVRAYAKQLFIALK--HLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
K+ +R++ +Q+ L+ H + ++H D+K DN+ + +K+ D G A +
Sbjct: 110 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
+ + + APE+ YD +D+++ G C+ E+ T + + N +
Sbjct: 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------- 221
Query: 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGED 850
+++ +KP D
Sbjct: 222 ------------------------------------YRRVTSGVKPASF----------D 235
Query: 851 PKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ K++++ + ++R ++ L H F
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-42
Identities = 92/338 (27%), Positives = 152/338 (44%), Gaps = 42/338 (12%)
Query: 555 GYYSYRFGEIL---DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN---NE 608
+Y + + RY+ + G G + +V A D K G VA+K + +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSI 58
Query: 609 TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGR 668
K E+++LK + + A S + N + LV + +L ++K
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK- 117
Query: 669 NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728
L V+ Q+ LK++ + ++H D+KP N+ VNE LK+ DFG A
Sbjct: 118 ---LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARHTDD 173
Query: 729 NEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHM 787
+R+YRAPEI+L + Y+ +DIWSVGC + EL TG+ LFPG + D L+L +
Sbjct: 174 EMTGYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 788 ELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASP 847
L G ++L+K ++ ++ + I ++ +
Sbjct: 233 RLVGTPGAELLKK---------------------ISSESARNYIQSLTQMPKMNFANVFI 271
Query: 848 GEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPFIS 885
G +P DLL+K+ VLD +KR+T AQAL H + +
Sbjct: 272 GANPL----AVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 63/328 (19%), Positives = 120/328 (36%), Gaps = 75/328 (22%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLAG 626
+E+ G G F V +A++ + A K+I +E + E+ IL
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETS----VLAAAKVIDTKSEEELEDYMVEIDILASC-- 66
Query: 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + ++ +F Y N+L ++ E + V+ + R L + ++ KQ
Sbjct: 67 ----DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTL 120
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAP 743
AL +L + ++H D+K N+L +KL DFG + + ++ + ++ AP
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
Query: 744 EIILGL-----PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
E+++ PYD+ D+WS+G L E+ + +L + + P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA--- 236
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
+ + +NFK
Sbjct: 237 --------------------------------------------------QPSRWSSNFK 246
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFISG 886
D L K + + R T +Q L HPF++
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 82/325 (25%), Positives = 141/325 (43%), Gaps = 47/325 (14%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKL 624
+YE G+G + TV +AK+ + E VA+K +R ++E + + E+ +LK+L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
++ +R L LVFE +L++ ++ ++ V+++ QL
Sbjct: 59 ------KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQL 110
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRA 742
L + VLH D+KP N+L+N LKL +FG A G + +V+ +YR
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169
Query: 743 PEIILGLP-YDHPLDIWSVGCCLYELYTGKV-LFPGATNNDMLRLHMELKGPFPKKMLRK 800
P+++ G Y +D+WS GC EL LFPG +D L+ L G ++
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860
+ + KP + T+ PK+ A +DL
Sbjct: 230 M---------------------------TKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 861 LDKIFVLDPEKRMTVAQALTHPFIS 885
L + +P +R++ +AL HP+ S
Sbjct: 263 LQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-41
Identities = 63/326 (19%), Positives = 117/326 (35%), Gaps = 73/326 (22%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKL 624
+++ G+G + V A + E VA+KI+ + + E+ I K L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
N + ++F + N L E + + E+ + +IG+ + + QL
Sbjct: 61 ------NHENVVKFYGHRREGNIQYLFLE--YCSGGELFDRIEPDIGMPEPDAQRFFHQL 112
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFY 740
+ +L G+ H DIKP+N+L++E ++ LK+ DFG A N + + Y
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 741 RAPEIILGLPYD-HPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799
APE++ + P+D+WS G L + G++ + +++
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------------ 219
Query: 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859
+K + K I S
Sbjct: 220 ---------------------------KEKKTYLNPWKKIDS--------------APLA 238
Query: 860 LLDKIFVLDPEKRMTVAQALTHPFIS 885
LL KI V +P R+T+ + +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 70/336 (20%), Positives = 119/336 (35%), Gaps = 75/336 (22%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-------NNETMNKAGQ 615
E +D Y+ G G F+ V + ++ G + A K I+ + +
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675
EV ILK++ + I ++ + + L+ E + E+ L
Sbjct: 62 REVSILKEI------QHPNVITLHEVYENKTDVILILE--LVAGGELFDFLAEKESLTEE 113
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLV---NEAKNVLKLCDFGNA-MFAGKNEI 731
+ KQ+ + +L + + H D+KP+N+++ N K +K+ DFG A NE
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
+ + APEI+ P D+WS+G Y L +G F G T + L +
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
F +
Sbjct: 234 EFEDEYF----------------------------------------------------S 241
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFISGK 887
A KD + ++ V DP+KRMT+ +L HP+I K
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-41
Identities = 63/321 (19%), Positives = 114/321 (35%), Gaps = 70/321 (21%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR-NNETMNKAGQTEVQILKKLA 625
+Y G+G TV A D+ G +EVAI+ + + + E+ ++++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMREN- 74
Query: 626 GADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLF 685
+ + + S+ + L +V E L L + + A ++
Sbjct: 75 -----KNPNIVNYLDSYLVGDELWVVMEYLAGGS---LTDVVTETCMDEGQIAAVCRECL 126
Query: 686 IALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPYLVSRFYRAP 743
AL+ L + V+H DIK DN+L+ +KL DFG + + + + ++ AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 744 EIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGAF 803
E++ Y +DIWS+G E+ G+ + L
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-------------------- 225
Query: 804 TDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDK 863
I N P+ K+ A F+D L++
Sbjct: 226 ------------------------YLIATNGTPE---------LQNPEKLSAIFRDFLNR 252
Query: 864 IFVLDPEKRMTVAQALTHPFI 884
+D EKR + + L H F+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 30/253 (11%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-------QTE 617
L+ +Y+V G G F +V + VAIK + + + E
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPME 57
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN--LREVLKKFGRNIGLKLT 675
V +LKK++ IR F+ + L+ E L + + + G L+
Sbjct: 58 VVLLKKVSSGFS----GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEE 110
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL 735
R++ Q+ A++H NCGVLH DIK +N+L++ + LKL DFG+ T +
Sbjct: 111 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 736 VSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
+R Y PE I Y +WS+G LY++ G + F + +++R + +
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEIIRGQVFFRQRVS 228
Query: 795 -------KKMLRK 800
+ L
Sbjct: 229 SECQHLIRWCLAL 241
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-40
Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 31/247 (12%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
++FG+IL G+G FSTVV A++L E AIKI+ + +
Sbjct: 10 FKFGKIL----------GEGSFSTVVLARELATS----REYAIKILEKRHIIKENKVPYV 55
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKL 674
E ++ +L + ++ +F+ L + E+LK +
Sbjct: 56 TRERDVMSRL------DHPFFVKLYFTFQDDEKLYFGLS--YAKNGELLKYIRKIGSFDE 107
Query: 675 TAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE---- 730
T R Y ++ AL++L G++H D+KP+N+L+NE +++ DFG A
Sbjct: 108 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQAR 166
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790
++ + Y +PE++ D+W++GC +Y+L G F + + ++L+
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226
Query: 791 GPFPKKM 797
FP+K
Sbjct: 227 YDFPEKF 233
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-40
Identities = 65/330 (19%), Positives = 112/330 (33%), Gaps = 80/330 (24%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLA 625
YEV G G + + + G + + K + E + +EV +L++L
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLREL- 60
Query: 626 GADPENKRHCIRFASSFKYR--NHLCLVFESL-HMNLREVLKKFGRNIG-LKLTAVRAYA 681
+ +R+ R L +V E +L V+ K + L V
Sbjct: 61 -----KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 682 KQLFIALKHL-----KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE--ITPY 734
QL +ALK VLH D+KP N+ ++ K +KL DFG A + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAF 174
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
+ + +Y +PE + + Y+ DIWS+GC LYEL F + ++ E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
+ +L
Sbjct: 235 ----------PYRYSDEL------------------------------------------ 242
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+++ ++ L R +V + L +P I
Sbjct: 243 ---NEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 147 bits (372), Expect = 1e-39
Identities = 73/334 (21%), Positives = 138/334 (41%), Gaps = 39/334 (11%)
Query: 556 YYSYRFGEILDG---RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNK 612
Y+ Y + G Y++ G+G +S V A ++ E+V +KI++ + K
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKPVKK--K 74
Query: 613 AGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGL 672
+ E++IL+ L + I A K H+N + + + L
Sbjct: 75 KIKREIKILENLR-----GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---L 126
Query: 673 KLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA-MFAGKNEI 731
+R Y ++ AL + + G++H D+KP N++++ L+L D+G A + E
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 732 TPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKV-LFPGATNNDMLRLHMEL 789
+ SR+++ PE+++ YD+ LD+WS+GC L + K F G N D L ++
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 790 KGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGE 849
G + ++ + E DP + + + +
Sbjct: 247 LGT-------------EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFV------HSEN 287
Query: 850 DPKMLANFKDLLDKIFVLDPEKRMTVAQALTHPF 883
+ D LDK+ D + R+T +A+ HP+
Sbjct: 288 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 64/327 (19%), Positives = 123/327 (37%), Gaps = 71/327 (21%)
Query: 567 GRYEVTAAH-GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLA 625
Y+VT+ G G+ V++ + + E+ A+K++++ + EV++ + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDCPKARR----EVELHWRAS 62
Query: 626 GADPENKRHCIR----FASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAY 680
H +R + + + R L +V E L L ++ G +
Sbjct: 63 -----QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEI 116
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN--VLKLCDFGNAMFAGKNE-ITPYLVS 737
K + A+++L + + H D+KP+N+L + +LKL DFG A + +T +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
+Y APE++ YD D+WS+G +Y L G F +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------- 222
Query: 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANF 857
P K I+ + E ++
Sbjct: 223 -----------------------PGMKTRIRMGQYEFPNP-----------EWSEVSEEV 248
Query: 858 KDLLDKIFVLDPEKRMTVAQALTHPFI 884
K L+ + +P +RMT+ + + HP+I
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWI 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (363), Expect = 1e-38
Identities = 61/326 (18%), Positives = 113/326 (34%), Gaps = 76/326 (23%)
Query: 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQIL 621
+ + G G F V A+D++ E VAIK + + + EV+ L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYA 681
+KL + I++ + + LV E + ++L+ L+ + A
Sbjct: 70 QKL------RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV--HKKPLQEVEIAAVT 121
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYR 741
L +L + ++H D+K N+L++E ++KL DFG+A ++ + ++
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAPA--NSFVGTPYWM 178
Query: 742 APEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798
APE+IL + YD +D+WS+G EL K L + + P +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--- 235
Query: 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858
H+ + +
Sbjct: 236 ------SGHWSEYF---------------------------------------------R 244
Query: 859 DLLDKIFVLDPEKRMTVAQALTHPFI 884
+ +D P+ R T L H F+
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 3e-36
Identities = 51/254 (20%), Positives = 89/254 (35%), Gaps = 28/254 (11%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKK 623
++ Y+V G+G F + +L ++VAIK + + E + K
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPR-RSDAPQLRDEYRTYKL 56
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQ 683
LA + H LV + L +L ++L GR + V AKQ
Sbjct: 57 LA-----GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQ 109
Query: 684 LFIALKHLKNCGVLHCDIKPDNMLVNE----AKNVLKLCDFGNAMFAGK---------NE 730
+ ++ + +++ DIKPDN L+ N++ + DFG F E
Sbjct: 110 MLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 731 ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH---M 787
+ Y + LG D+ ++G G + + G + +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 788 ELKGPFPKKMLRKG 801
E K P + L G
Sbjct: 230 EKKQSTPLRELCAG 243
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-35
Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 30/246 (12%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG---- 614
+ ++L GKG F V A+ K + AIK ++ + +
Sbjct: 4 FILHKML----------GKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDDDVECT 49
Query: 615 QTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLK 673
E ++L +F+ + +L V E L +L ++ +
Sbjct: 50 MVEKRVLSLAW-----EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FD 101
Query: 674 LTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF--AGKNEI 731
L+ YA ++ + L+ L + G+++ D+K DN+L+++ +K+ DFG G +
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGDAKT 160
Query: 732 TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
+ + Y APEI+LG Y+H +D WS G LYE+ G+ F G ++
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220
Query: 792 PFPKKM 797
+P+ +
Sbjct: 221 FYPRWL 226
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (329), Expect = 2e-34
Identities = 60/333 (18%), Positives = 108/333 (32%), Gaps = 78/333 (23%)
Query: 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR----NNETMNKAGQTEVQI 620
L RYE+ G G S V A+DL+ +VA+K++R + + + E Q
Sbjct: 5 LSDRYELGEILGFGGMSEVHLARDLRLH----RDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNH----LCLVFESL-HMNLREVLKKFGRNIGLKLT 675
L N + + + +V E + + LR+++ G +
Sbjct: 61 AAAL------NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPK 111
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV-LKLCDFGNAMFAGKNEITP- 733
AL G++H D+KP N++++ V + A+ N +T
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 734 --YLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
+ + Y +PE G D D++S+GC LYE+ TG+ F G + + H+
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231
Query: 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDP 851
P
Sbjct: 232 IPPSA----------------------------------------------------RHE 239
Query: 852 KMLANFKDLLDKIFVLDPEKRMTVAQALTHPFI 884
+ A+ ++ K +PE R A + +
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 1e-33
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 28/244 (11%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQ 619
EI DG+ V G G F TV + K +VA+K++ +A + EV
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKW-------HGDVAVKMLNVTAPTPQQLQAFKNEVG 56
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVR 678
+L+K + + F + L +V + +L L ++ +
Sbjct: 57 VLRKT------RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLI 107
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPY 734
A+Q + +L ++H D+K +N+ ++E V K+ DFG A +
Sbjct: 108 DIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV-KIGDFGLATVKSRWSGSHQFEQL 166
Query: 735 LVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791
S + APE+I PY D+++ G LYEL TG++ + N D + +
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226
Query: 792 PFPK 795
P
Sbjct: 227 LSPD 230
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (321), Expect = 6e-33
Identities = 45/233 (19%), Positives = 96/233 (41%), Gaps = 18/233 (7%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKL 624
+++ G G F V + G A+K+++ + E +L +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNG----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
IR +F+ + ++ + ++ E+ ++ + YA ++
Sbjct: 62 ------THPFIIRMWGTFQDAQQIFMIMD--YIEGGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPE 744
+AL++L + +++ D+KP+N+L+++ +K+ DFG A + T + Y APE
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDVTYT-LCGTPDYIAPE 171
Query: 745 IILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
++ PY+ +D WS G +YE+ G F + + + FP
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 54/243 (22%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
+ + + GKG F V+ +VA+K I+N+ T +A E
Sbjct: 9 LKLLQTI----------GKGEFGDVMLGDYRG------NKVAVKCIKNDATA-QAFLAEA 51
Query: 619 QILKKLAGADPENKRHCIRF-ASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTA 676
++ +L + ++ + + L +V E + +L + L+ GR++ L
Sbjct: 52 SVMTQL------RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDC 104
Query: 677 VRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV 736
+ ++ + A+++L+ +H D+ N+LV+E NV K+ DFG A + T +
Sbjct: 105 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDTGK-L 162
Query: 737 SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFP 794
+ APE + + D+WS G L+E+Y+ G+V +P D++ + K P
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 222
Query: 795 KKM 797
Sbjct: 223 DGC 225
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 1e-31
Identities = 55/249 (22%), Positives = 91/249 (36%), Gaps = 26/249 (10%)
Query: 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAG 626
RY + G G F + D+ AG EEVAIK+ +T + E +I K +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECV-KTKHPQLHIESKIYKMM-- 59
Query: 627 ADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFI 686
+ ++ +V E L +L ++ R L V A Q+
Sbjct: 60 ---QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMIS 114
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAK--NVLKLCDFGNAMFAGKNEI---------TPYL 735
++++ + +H D+KPDN L+ K N++ + DFG A
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 736 VSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND---MLRLHMELKGP 792
+ Y + LG+ D+ S+G L G + + G E K
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234
Query: 793 FPKKMLRKG 801
P ++L KG
Sbjct: 235 TPIEVLCKG 243
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (313), Expect = 2e-31
Identities = 60/330 (18%), Positives = 114/330 (34%), Gaps = 75/330 (22%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQT----EVQILKK 623
+ V G+G F V + G + A+K + K G+T E +L
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAK 682
++ D + + +F + L + + + +L L + G +R YA
Sbjct: 61 VSTGDCPF---IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAA 114
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
++ + L+H+ N V++ D+KP N+L++E +V ++ D G A K + + + Y A
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPHASVGTHGYMA 173
Query: 743 PEIIL-GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801
PE++ G+ YD D +S+GC L++L G F D
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------------------ 215
Query: 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861
I ++ + + + LL
Sbjct: 216 ------------------------EIDRMTLTMAVE-----------LPDSFSPELRSLL 240
Query: 862 DKIFVLDPEKRMTV-----AQALTHPFISG 886
+ + D +R+ + PF
Sbjct: 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 19/235 (8%)
Query: 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKKL 624
++ GKG F V+ ++ G A+KI+R + K TE ++L+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 625 AGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQL 684
+F+ + LC V E + N E+ R R Y ++
Sbjct: 63 ------RHPFLTALKYAFQTHDRLCFVME--YANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 685 FIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV--SRFYRA 742
AL++L + V++ DIK +N+++++ +K+ DFG + T + Y A
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
PE++ Y +D W +G +YE+ G++ F + + L + + FP+ +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 228
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 18/240 (7%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILK 622
EI + G+G F V VAIK ++ +A E Q++K
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMK 67
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
KL ++ + + +V E + K L+L + A
Sbjct: 68 KL------RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP---YLVSRF 739
Q+ + +++ +H D++ N+LV E V K+ DFG A NE T
Sbjct: 121 QIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIK 179
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
+ APE L + D+WS G L EL T G+V +PG N ++L + P P +
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (285), Expect = 1e-28
Identities = 39/245 (15%), Positives = 90/245 (36%), Gaps = 16/245 (6%)
Query: 558 SYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTE 617
+Y E+ + G G + V K VA+K ++ + + E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKE 63
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAV 677
++K++ + ++ ++ E + + + +
Sbjct: 64 AAVMKEI------KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVS 737
A Q+ A+++L+ +H D+ N LV E +++K+ DFG + + T + +
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 738 RF---YRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME--LKGP 792
+F + APE + + D+W+ G L+E+ T + + + +E +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 793 FPKKM 797
P+
Sbjct: 237 RPEGC 241
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 1e-28
Identities = 54/235 (22%), Positives = 103/235 (43%), Gaps = 20/235 (8%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQILKK 623
+++ G G F V+ K ++G A+KI+ + + E +IL+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESG----NHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 624 LAGADPENKRHCIRFASSFKYRNHLCLVFESLHMN-LREVLKKFGRNIGLKLTAVRAYAK 682
+ N ++ SFK ++L +V E + + L++ GR R YA
Sbjct: 98 V------NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAA 148
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRA 742
Q+ + ++L + +++ D+KP+N+L+++ + +++ DFG A T + A
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGRTWT-LCGTPEALA 206
Query: 743 PEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797
PEIIL Y+ +D W++G +YE+ G F + + K FP
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 48/240 (20%), Positives = 92/240 (38%), Gaps = 18/240 (7%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILK 622
E+ ++ G G F V +VA+K ++ A E ++K
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGY-YNGH----TKVAVKSLKQGSMSPDAFLAEANLMK 63
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAK 682
+L + +R + + + ++ E + K I L + + A
Sbjct: 64 QL------QHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 683 QLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI---TPYLVSRF 739
Q+ + ++ +H D++ N+LV++ + K+ DFG A NE
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 740 YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
+ APE I + D+WS G L E+ T G++ +PG TN ++++ + P
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 7e-28
Identities = 50/243 (20%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG----QTEVQ 619
I + + G G F V R + A +G+ VA+K ++ + EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGE-WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIG-LKLTAVR 678
+ L + R+ IR + +V E L +L + ++ G L +
Sbjct: 64 AMHSL------DHRNLIRLYGVV-LTPPMKMVTE--LAPLGSLLDRLRKHQGHFLLGTLS 114
Query: 679 AYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSR 738
YA Q+ + +L++ +H D+ N+L+ ++++K+ DFG +N+ +
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 739 F-----YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGP 792
+ APE + + H D W G L+E++T G+ + G + +L +
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233
Query: 793 FPK 795
P+
Sbjct: 234 LPR 236
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (280), Expect = 9e-28
Identities = 48/246 (19%), Positives = 91/246 (36%), Gaps = 20/246 (8%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMN--KAGQTEVQI 620
EI ++ G G F V K VAIK +++ T + +E I
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHL-KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+ + + + I + ++ E + + + + V
Sbjct: 81 MGQF------DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG-M 133
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF- 739
+ + +K+L + +H D+ N+LVN V K+ DFG + F + P S
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 740 ------YRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLR-LHMELKG 791
+ APE I + D+WS G ++E+ + G+ + TN D++ + + +
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 792 PFPKKM 797
P P
Sbjct: 253 PPPMDC 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 47/245 (19%), Positives = 90/245 (36%), Gaps = 30/245 (12%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEV 618
F + + G G F V L ++VAIK IR + E
Sbjct: 7 LTFVQEI----------GSGQFGLVHLGYWLNK-----DKVAIKTIREGAMSEEDFIEEA 51
Query: 619 QILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAV 677
+++ KL + ++ + +CLVFE + L + L+ + +
Sbjct: 52 EVMMKL------SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETL 103
Query: 678 RAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP---Y 734
+ + +L+ V+H D+ N LV E V+K+ DFG F ++ T
Sbjct: 104 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 735 LVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML--RLHMELKGP 792
+ +PE+ Y D+WS G ++E+++ + +N + + +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 222
Query: 793 FPKKM 797
P+
Sbjct: 223 KPRLA 227
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-27
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 47/270 (17%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIR--NNETMNKAGQ 615
FG++L G G F V+ A G +VA+K+++ + + +A
Sbjct: 39 LEFGKVL----------GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 88
Query: 616 TEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNLREVLKKFGRNI 670
+E++++ +L + + + + + L+FE L LR +KF +
Sbjct: 89 SELKMMTQLG-----SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 671 ----------------GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNV 714
L + +A Q+ ++ L+ +H D+ N+LV K V
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 715 LKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT- 769
K+CDFG A + + + APE + Y D+WS G L+E+++
Sbjct: 204 -KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 770 GKVLFPGATNNDMLRLHME--LKGPFPKKM 797
G +PG + ++ K P
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYA 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-27
Identities = 65/335 (19%), Positives = 121/335 (36%), Gaps = 78/335 (23%)
Query: 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAG-----QTEVQILK 622
+E+ G G + V + + G+ + A+K+++ + KA +TE Q+L+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKIS-GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 623 KLAGADPENKRHCIRFASSFKYRNHLCLVFE-SLHMNLREVLKKFGRNIGLKLTAVRAYA 681
+ + +F+ L L+ + L L + R V+ Y
Sbjct: 84 HI-----RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYV 135
Query: 682 KQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITP---YLVSR 738
++ +AL+HL G+++ DIK +N+L++ + L DFG + +E + +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 739 FYRAPEIILGLP--YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796
Y AP+I+ G +D +D WS+G +YEL TG F +
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-------- 246
Query: 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLAN 856
I+ + P +M A
Sbjct: 247 --------------------------------------------RILKSEPPYPQEMSAL 262
Query: 857 FKDLLDKIFVLDPEKRM-----TVAQALTHPFISG 886
KDL+ ++ + DP+KR+ + H F
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (276), Expect = 3e-27
Identities = 45/243 (18%), Positives = 92/243 (37%), Gaps = 37/243 (15%)
Query: 576 GKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENK 632
G+G F V +A+ EP VA+K+++ + M Q E ++ + +
Sbjct: 22 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DN 75
Query: 633 RHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRN---------------------I 670
+ ++ +CL+FE + + +L E L+ +
Sbjct: 76 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135
Query: 671 GLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE 730
L A+Q+ + +L +H D+ N LV E V+K+ DFG + +
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSAD 194
Query: 731 I----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVL-FPGATNNDMLRL 785
+ + PE I Y D+W+ G L+E+++ + + G + +++
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 786 HME 788
+
Sbjct: 255 VRD 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 8e-27
Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 17/230 (7%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G G F TV + + G VAIK +R + NK E ++ + +
Sbjct: 18 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNP 71
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
H R + L + +++ NIG + + + Q+ + +L++
Sbjct: 72 HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLED 129
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL----VSRFYRAPEIILGL 749
++H D+ N+LV +K+ DFG A G E + V + A E IL
Sbjct: 130 RRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 750 PYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
Y H D+WS G ++EL T G + G +++ + + + P P
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 8e-27
Identities = 47/227 (20%), Positives = 98/227 (43%), Gaps = 18/227 (7%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
G G F V K + +VAIK+I+ E +++ L +
Sbjct: 13 GTGQFGVVKYGK-WRGQ----YDVAIKMIKEGSMSEDEFIEEAKVMMNL------SHEKL 61
Query: 636 IRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG 695
++ + + ++ E + + R+ + + K + A+++L++
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 696 VLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF---YRAPEIILGLPYD 752
LH D+ N LVN+ + V+K+ DFG + + +E T + S+F + PE+++ +
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 753 HPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
DIW+ G ++E+Y+ GK+ + TN++ + L+ P
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 3e-26
Identities = 44/232 (18%), Positives = 93/232 (40%), Gaps = 22/232 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR---NNETMNKAGQTEVQILKKLAGADPENK 632
G G F TV + + VA+KI++ N+ + E ++++L +
Sbjct: 16 GSGNFGTVKKGYYQMKKVVK--TVAVKILKNEANDPALKDELLAEANVMQQL------DN 67
Query: 633 RHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ +R + LV E L + K +N +K + Q+ + +K+L+
Sbjct: 68 PYIVRMIGICEA-ESWMLVME--MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAPEIIL 747
+H D+ N+L+ ++ K+ DFG + +E + + APE I
Sbjct: 125 ESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 748 GLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
+ D+WS G ++E ++ G+ + G +++ + + + P
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 43/234 (18%), Positives = 82/234 (35%), Gaps = 17/234 (7%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN--NETMNKAGQTEVQILKKLAGADPENKR 633
G G F V + + + VAIK ++ E E I+ + +
Sbjct: 16 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF------SHH 69
Query: 634 HCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN 693
+ IR + ++ E + + + ++ + + + + +K+L N
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 694 CGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAPEIILG 748
+H D+ N+LVN V K+ DFG + + Y S + APE I
Sbjct: 129 MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 749 LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME--LKGPFPKKMLRK 800
+ D+WS G ++E+ T +N + + + P P
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 241
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-25
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 43/268 (16%)
Query: 549 NWDDAEGYYSYRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE 608
+W+D +F +++ G+G F V++A+ K +G + AIK ++
Sbjct: 8 DWND------IKFQDVI----------GEGNFGQVLKARIKK--DGLRMDAAIKRMKEYA 49
Query: 609 TMNKAGQT--EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKK 665
+ + E+++L KL + + I + ++R +L L E H NL + L+K
Sbjct: 50 SKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
Query: 666 F-------------GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAK 712
L + +A + + +L +H D+ N+LV E
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-N 163
Query: 713 NVLKLCDFGNAMFAGKNEITPYLV-SRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-G 770
V K+ DFG + + A E + Y D+WS G L+E+ + G
Sbjct: 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 223
Query: 771 KVLFPGATNNDMLRLHME-LKGPFPKKM 797
+ G T ++ + + P
Sbjct: 224 GTPYCGMTCAELYEKLPQGYRLEKPLNC 251
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-25
Identities = 43/246 (17%), Positives = 83/246 (33%), Gaps = 29/246 (11%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQ--T 616
F E++ G+G F V L +G+ A+K + + + Q T
Sbjct: 29 VHFNEVI----------GRGHFGCVYHGTLLD-NDGKKIHCAVKSLNRITDIGEVSQFLT 77
Query: 617 EVQILKKLAGADPENKRHCIR-FASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLT 675
E I+K + + + + +V + + +
Sbjct: 78 EGIIMKDF------SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVK 130
Query: 676 AVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI---- 731
+ + Q+ +K L + +H D+ N +++E V K+ DFG A E
Sbjct: 131 DLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV-KVADFGLARDMYDKEFDSVH 189
Query: 732 --TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVL-FPGATNNDMLRLHME 788
T + + A E + + D+WS G L+EL T +P D+ ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 789 LKGPFP 794
+
Sbjct: 250 GRRLLQ 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 50/242 (20%), Positives = 90/242 (37%), Gaps = 23/242 (9%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNETMNKAGQ--TEVQ 619
E+ + ++ G+G F V EP VAIK + +M + + E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 75
Query: 620 ILKKLAGADPENKRHCIRFASSFKYRNHLCLVFE-----SLHMNL---REVLKKFGRNIG 671
++K+ N H +R ++ E L L R +
Sbjct: 76 VMKEF------NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 672 LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI 731
L+ + A ++ + +L +H D+ N +V E V K+ DFG + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV-KIGDFGMTRDIYETDY 188
Query: 732 ----TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATNNDMLRLH 786
L+ + +PE + + D+WS G L+E+ T + + G +N +LR
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 787 ME 788
ME
Sbjct: 249 ME 250
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-25
Identities = 45/232 (19%), Positives = 93/232 (40%), Gaps = 22/232 (9%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIR--NNETMNKAGQTEVQILKKLAGADPENKR 633
G G F +V + +VAIK+++ + + E QI+ +L +
Sbjct: 18 GCGNFGSVRQGVYRMRKKQI--DVAIKVLKQGTEKADTEEMMREAQIMHQL------DNP 69
Query: 634 HCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLK 692
+ +R + L LV E L + L G+ + ++ V Q+ + +K+L+
Sbjct: 70 YIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 693 NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRF-----YRAPEIIL 747
+H D+ N+L+ ++ K+ DFG + G ++ S + APE I
Sbjct: 127 EKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 748 GLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPKKM 797
+ D+WS G ++E + G+ + +++ + + P +
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 237
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 3e-25
Identities = 58/260 (22%), Positives = 108/260 (41%), Gaps = 31/260 (11%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPE---EVAIKIIRNNETMNKAGQ--TE 617
E+ R + G+G F VV A+ + +P +VA+K+++++ T +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 618 VQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGR-------- 668
++++K + ++ I + L ++ E NLRE L+
Sbjct: 69 MEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 669 -----NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723
L + + A Q+ +++L + +H D+ N+LV E NV+K+ DFG A
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLA 182
Query: 724 MFAGKNEIT----PYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGAT 778
+ + + APE + Y H D+WS G L+E++T G +PG
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 779 NNDMLRLHME-LKGPFPKKM 797
++ +L E + P
Sbjct: 243 VEELFKLLKEGHRMDKPSNC 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 9e-25
Identities = 52/325 (16%), Positives = 103/325 (31%), Gaps = 68/325 (20%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHC 635
GKG F V R K EEVA+KI + E + + E+ L +
Sbjct: 12 GKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVML------RHENI 59
Query: 636 IRFASSFKYRN----HLCLVFE-SLHMNLREVLKKFGRN----IGLKLTAVRAYAKQLFI 686
+ F ++ N L LV + H +L + L ++ I L L+ A
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 119
Query: 687 ALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLV------SRFY 740
+ + H D+K N+LV + + D G A+ T + ++ Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 741 RAPEIILG------LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794
APE++ DI+++G +E+ + + + + P
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKML 854
++M + +Q ++ + + L
Sbjct: 239 EEMRK--VVCEQKLRPNIPNRW--------------------------------QSCEAL 264
Query: 855 ANFKDLLDKIFVLDPEKRMTVAQAL 879
++ + + + R+T +
Sbjct: 265 RVMAKIMRECWYANGAARLTALRIK 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-24
Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 17/242 (7%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN--NETMNKAGQTEVQI 620
EI R E+ G+G F V + + VAIK +N ++++ + E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIY-MSPENPALAVAIKTCKNCTSDSVREKFLQEALT 61
Query: 621 LKKLAGADPENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAY 680
+++ + H ++ N + ++ E + R L L ++ Y
Sbjct: 62 MRQF------DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILY 113
Query: 681 AKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEI---TPYLVS 737
A QL AL +L++ +H DI N+LV+ V KL DFG + + + + +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV-KLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 738 RFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHME-LKGPFPK 795
+ APE I + D+W G C++E+ G F G NND++ + P P
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 796 KM 797
Sbjct: 233 NC 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 4e-23
Identities = 49/265 (18%), Positives = 98/265 (36%), Gaps = 42/265 (15%)
Query: 559 YRFGEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNETMNKAGQT- 616
FG+ L G G F VV A + VA+K+++ + + +
Sbjct: 25 LSFGKTL----------GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 617 -EVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRN----- 669
E+++L L N + + + ++ E + +L L++ +
Sbjct: 75 SELKVLSYLG-----NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 670 ----------IGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719
+ L L + +++ Q+ + L + +H D+ N+L+ + K+CD
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICD 188
Query: 720 FGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLF 774
FG A + + + APE I Y D+WS G L+EL++ G +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 775 PGATNNDMLRLHME--LKGPFPKKM 797
PG + ++ + P+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 7e-21
Identities = 51/252 (20%), Positives = 92/252 (36%), Gaps = 22/252 (8%)
Query: 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEP-EEVAIKIIRNNETMNKAGQTEVQIL 621
E R ++ G+G F V+ A VA+K+++ T ++ ++
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 622 KKLAGADPENKRHCIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIG--------- 671
+ N + + K L ++ E NL L+
Sbjct: 69 ILIHIGHHLNVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 672 ----LKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAG 727
L L + Y+ Q+ ++ L + +H D+ N+L++E KNV+K+CDFG A
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 185
Query: 728 KNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDML 783
K+ + + APE I Y D+WS G L+E+++ D
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 784 RLHMELKGPFPK 795
+G +
Sbjct: 246 FCRRLKEGTRMR 257
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 1e-14
Identities = 29/198 (14%), Positives = 61/198 (30%), Gaps = 22/198 (11%)
Query: 576 GKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKK-LAGADPENKRH 634
G+G S V K E +K + T K + + + + R+
Sbjct: 9 GEGKESAVFNCYSEKF-----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 635 CIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNC 694
R + + + L E L +++ + + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYHR 122
Query: 695 GVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYL------VSRFYRAPEIILG 748
G++H D+ N+LV+E + + DF ++ G+ L + ++
Sbjct: 123 GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174
Query: 749 LPYDHPLDIWSVGCCLYE 766
Y DI S + +
Sbjct: 175 -TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 887 | |||
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.72 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 86.15 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=412.84 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=225.4
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCE
Q ss_conf 2434858899885137851899999767899998179999960560-203777999999999609999999525686401
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
.++ ++|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| .||||++++++
T Consensus 23 ~il-~~Y~i~~~lG~G~fg~Vy~~~~~~~g----~~vAvK~i~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~ 91 (350)
T d1koaa2 23 HVL-DHYDIHEELGTGAFGVVHRVTERATG----NNFAAKFVMTPHESDKETVRKEIQTMSVL------RHPTLVNLHDA 91 (350)
T ss_dssp CGG-GTEEEEEEEEEETTEEEEEEEETTTT----EEEEEEEECCCSHHHHHHHHHHHHHHHHT------CCTTBCCEEEE
T ss_pred CCC-CCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECCCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEE
T ss_conf 786-57589889840768199999988999----89999998452431699999999999867------99799929999
Q ss_pred EEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC-CCCEEEEEE
Q ss_conf 11268389997621-1239999998166789999999999999999997421156231578899731258-999099982
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE-AKNVLKLCD 719 (887)
Q Consensus 642 ~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~-~~~~iKL~D 719 (887)
|...+.+||||||| +|+|.++|.... ..|++..++.|+.||+.||.|||++||||+||||+||||+. .++.+||+|
T Consensus 92 ~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 92 FEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEE
T ss_conf 998999999998579988999997623--789999999999999999999975697600015467364168898699954
Q ss_pred CCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 2742005889-866765577655524460899994356999999999999099999999918999999985099976653
Q 002732 720 FGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 720 FG~a~~~~~~-~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
||+|...... .....+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+++..|......++...
T Consensus 170 FG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~- 248 (350)
T d1koaa2 170 FGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA- 248 (350)
T ss_dssp CTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG-
T ss_pred CCHHEECCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCC-
T ss_conf 5210442565432000686242188997589987267655465999999859899899799999999984788989422-
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 01666663443333556676782469999999861598874542248999995658999999998031398999699989
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei 878 (887)
.+.++..+.+||.+||+.||.+|||+.||
T Consensus 249 ---------------------------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 249 ---------------------------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp ---------------------------------------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf ---------------------------------------------------35899999999999756896679089998
Q ss_pred HHCCCCCC
Q ss_conf 84798779
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~HPwl~~ 886 (887)
|+||||+.
T Consensus 278 l~hp~~~~ 285 (350)
T d1koaa2 278 LEHPWLTP 285 (350)
T ss_dssp HHSTTTSC
T ss_pred HCCCCCCC
T ss_conf 62913288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=417.28 Aligned_cols=296 Identities=24% Similarity=0.395 Sum_probs=224.7
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
Q ss_conf 243485889988513785189999976789999817999996056--020377799999999960999999952568640
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
|+.+++|.+++.||+|+||+||+|.+..++ ..||||++... ......+.+|+.+|..| +||||+++++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~ 71 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSG----LVMARKLIHLEIKPAIRNQIIRELQVLHEC------NSPYIVGFYG 71 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTT----EEEEEEEEECCCCTTHHHHHHHHGGGGGGC------CCTTBCCEEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCHHHHHHHHHHHHHHHHC------CCCCCCCEEE
T ss_conf 787568889789712778099999998999----699999987540978999999999999867------9999994999
Q ss_pred EEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCCCCCCCCCCCEEEEE
Q ss_conf 111268389997621-12399999981667899999999999999999974211-5623157889973125899909998
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 641 ~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIiHrDLKP~NILi~~~~~~iKL~ 718 (887)
+|...+++||||||+ +|+|.+++...+. +++..++.++.||+.||.|||+ +||||+||||+||||+. ++.+||+
T Consensus 72 ~~~~~~~~~iVmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~ 147 (322)
T d1s9ja_ 72 AFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLC 147 (322)
T ss_dssp EEECSSEEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEEC
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECC-CCCEEEE
T ss_conf 99989999999976799868998742499---9999999999999999999998599971445779946878-9989995
Q ss_pred ECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHHHHCCCCHHH
Q ss_conf 2274200588986676557765552446089999435699999999999909999999991899-999998509997665
Q 002732 719 DFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDM-LRLHMELKGPFPKKM 797 (887)
Q Consensus 719 DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~-l~~i~~~~g~~p~~~ 797 (887)
|||+|........+.++||+.|+|||++.+.+|+.++||||||||||+|++|..||.+.+.... +..+....+......
T Consensus 148 DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 148 DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp CCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCC
T ss_conf 48776256788621113771411946875899894888998999999999888998998878999999887517754577
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
............... ....+.........+....+..+ ....++.++++||.+||++||.+||||.|
T Consensus 228 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~s~~~~dli~~~L~~dP~~R~ta~e 294 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGM----DSRPPMAIFELLDYIVNEPPPKL---------PSGVFSLEFQDFVNKCLIKNPAERADLKQ 294 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCC---------CBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCCCCCCCC----CCCCCHHHHHHHHHHHCCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 421233322111122----23541347788766502687667---------64448999999999986899467908999
Q ss_pred HHHCCCCC
Q ss_conf 98479877
Q 002732 878 ALTHPFIS 885 (887)
Q Consensus 878 iL~HPwl~ 885 (887)
||+||||+
T Consensus 295 ~L~Hpf~~ 302 (322)
T d1s9ja_ 295 LMVHAFIK 302 (322)
T ss_dssp HHTSHHHH
T ss_pred HHHCHHHC
T ss_conf 96098647
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=413.42 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=223.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEEC
Q ss_conf 858899885137851899999767899998179999960560-2037779999999996099999995256864011126
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+.|.+++.||.|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| +||||++++++|...
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATG----RVFVAKFINTPYPLDKYTVKNEISIMNQL------HHPKLINLHDAFEDK 98 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCSHHHHHHHHHHHHHHTTC------CSTTBCCEEEEEECS
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECCCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEEEEEC
T ss_conf 03599899931778299999998999----79999998872646799999999999867------997989199999989
Q ss_pred CEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC-CCCEEEEEECCCC
Q ss_conf 8389997621-1239999998166789999999999999999997421156231578899731258-9990999822742
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE-AKNVLKLCDFGNA 723 (887)
Q Consensus 646 ~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~-~~~~iKL~DFG~a 723 (887)
+.+||||||| +|+|.+++.... ..|++..++.|+.||+.||.|||++||||+||||+||||+. ..+.+||+|||+|
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEECCCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCC
T ss_conf 99999998289980888898638--9989999999999999999999977926513144553113467884899525630
Q ss_pred EECCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCC
Q ss_conf 0058898-667655776555244608999943569999999999990999999999189999999850999766530166
Q 002732 724 MFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 724 ~~~~~~~-~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
....... ....++++.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..+.+..|......+|...
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~----- 251 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----- 251 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST-----
T ss_pred EECCCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----
T ss_conf 343788720100476453489997479989763338989999999968899899799999999984788989300-----
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHCC
Q ss_conf 66634433335566767824699999998615988745422489999956589999999980313989996999898479
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTHP 882 (887)
Q Consensus 803 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~HP 882 (887)
++.++..+.+||.+||+.||.+|||+.|||+||
T Consensus 252 -----------------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp 284 (352)
T d1koba_ 252 -----------------------------------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284 (352)
T ss_dssp -----------------------------------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred -----------------------------------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf -----------------------------------------------247999999999997569966891899996097
Q ss_pred CCCC
Q ss_conf 8779
Q 002732 883 FISG 886 (887)
Q Consensus 883 wl~~ 886 (887)
||++
T Consensus 285 ~~~~ 288 (352)
T d1koba_ 285 WLKG 288 (352)
T ss_dssp TTSS
T ss_pred HHCC
T ss_conf 3488
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=414.03 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=224.2
Q ss_pred CCEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 824348588998851378518999997678999981799999605602--037779999999996099999995256864
Q 002732 562 GEILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 562 geil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
.+.+.+.|.+++.||.|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..| +||||++++
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~ 73 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQ----KLVAIKCIAKKALEGKEGSMENEIAVLHKI------KHPNIVALD 73 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTC----CEEEEEEEEC----------CHHHHHHHTC------CCTTBCCEE
T ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEECHHHHHHHHHHHHHHHHHHHHC------CCCCCCCEE
T ss_conf 7877666699889940658399999999999----899999981577312899999999999867------998999198
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC--CCCEEE
Q ss_conf 0111268389997621-1239999998166789999999999999999997421156231578899731258--999099
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE--AKNVLK 716 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~--~~~~iK 716 (887)
++|...+.+||||||+ +|+|.++|...+ .|++..+..|+.||+.||.|||++||||+||||+|||+.. .++.+|
T Consensus 74 ~~~~~~~~~~lvmE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vk 150 (307)
T d1a06a_ 74 DIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIM 150 (307)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEE
T ss_conf 99998998889885268984888653036---788789999999999998752413055687046300110468882499
Q ss_pred EEECCCCEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCH
Q ss_conf 98227420058898-66765577655524460899994356999999999999099999999918999999985099976
Q 002732 717 LCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 717 L~DFG~a~~~~~~~-~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|+|||+|....... ....+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+......+..+......++.
T Consensus 151 l~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 230 (307)
T d1a06a_ 151 ISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS 230 (307)
T ss_dssp ECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT
T ss_pred EECCCEEEECCCCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 83154358725897044003284225918873799980787345159999998597999998999999998616877787
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 65301666663443333556676782469999999861598874542248999995658999999998031398999699
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
. .++.++..+.+||.+||..||.+|||+
T Consensus 231 ~----------------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~ 258 (307)
T d1a06a_ 231 P----------------------------------------------------YWDDISDSAKDFIRHLMEKDPEKRFTC 258 (307)
T ss_dssp T----------------------------------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred C----------------------------------------------------CCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 6----------------------------------------------------666789999999999760897579189
Q ss_pred HHHHHCCCCCC
Q ss_conf 98984798779
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~eiL~HPwl~~ 886 (887)
.|||+||||++
T Consensus 259 ~eil~hp~~~~ 269 (307)
T d1a06a_ 259 EQALQHPWIAG 269 (307)
T ss_dssp HHHHHSTTTTS
T ss_pred HHHHCCHHHCC
T ss_conf 99862984479
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.03 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=218.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 4858899885137851899999767899998179999960560-203777999999999609999999525686401112
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.++|.+++.||+|+||+||+|.+..++ ..||||++.... ...+.+..|+.+|+.| +||||++++++|..
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~----~~vAvK~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~ 88 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATG----QEVAIRQMNLQQQPKKELIINEILVMREN------KNPNIVNYLDSYLV 88 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTC----CEEEEEEEEGGGCSCHHHHHHHHHHHHHC------CCTTBCCEEEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCC----CEEEEEEEECCCCHHHHHHHHHHHHHHHC------CCCCEEEEEEEEEE
T ss_conf 105388789812858299999998999----89999998430172799999999999867------99988058577988
Q ss_pred CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCC
Q ss_conf 68389997621-12399999981667899999999999999999974211562315788997312589990999822742
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a 723 (887)
.+++||||||+ +|+|.+++... .|++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||+|
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~vkl~DFG~a 163 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFC 163 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTC
T ss_pred CCEEEEEEEECCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC-CCCEEECCCHHH
T ss_conf 99989999703798089886415----9999999999999999999999879722677688868878-996864251564
Q ss_pred EECCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 005889--866765577655524460899994356999999999999099999999918999999985099976653016
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
...... .....+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.+....+..+.....+.
T Consensus 164 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 235 (293)
T d1yhwa1 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE-------- 235 (293)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC--------
T ss_pred EEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC--------
T ss_conf 132136664444444777368266447998801203137299999804889989979999999998579998--------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
...++.++..+.+||.+||..||.+|||+.|||+|
T Consensus 236 ---------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 ---------------------------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---------------------------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---------------------------------------------88855379999999999866996689099999649
Q ss_pred CCCC
Q ss_conf 9877
Q 002732 882 PFIS 885 (887)
Q Consensus 882 Pwl~ 885 (887)
|||+
T Consensus 271 p~~~ 274 (293)
T d1yhwa1 271 QFLK 274 (293)
T ss_dssp GGGG
T ss_pred HHHC
T ss_conf 9657
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=410.98 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=221.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 85889988513785189999976789999817999996056----02037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||+|+||+||+|.+..++ ..||||++.+. ......+..|+.+|..| +||||++++++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~ 75 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSK----FILALKVLFKAQLEKAGVEHQLRREVEIQSHL------RHPNILRLYGYF 75 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC------CCTTBCCEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCCCEEEEEE
T ss_conf 37699889851778589999998999----49999998168856768999999999999856------888888599999
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +|+|.++|..... +++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 76 ~~~~~~~ivmEy~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~-~~~~kl~DFG 151 (263)
T d2j4za1 76 HDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFG 151 (263)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCC
T ss_pred EECCEEEEEEEECCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECC-CCCEEECCCC
T ss_conf 989998999850479858988750489---999999999999999999999889465220234414668-9987115556
Q ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 42005889866765577655524460899994356999999999999099999999918999999985099976653016
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+|...........+||+.|+|||++.+.+|+.++|||||||+||+|++|.+||.+.+..+.+..+......+|
T Consensus 152 ~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p------- 224 (263)
T d2j4za1 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP------- 224 (263)
T ss_dssp SCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------
T ss_pred EEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC-------
T ss_conf 3354488852355788763499997589989314404675999998329999888999999999971899998-------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
..++..+.+||.+||..||.+|||+.|||+|
T Consensus 225 -------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 -------------------------------------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -------------------------------------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------------------------------------------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------------------------------------------------6689999999999764797689099999719
Q ss_pred CCCCC
Q ss_conf 98779
Q 002732 882 PFISG 886 (887)
Q Consensus 882 Pwl~~ 886 (887)
|||++
T Consensus 256 p~~~~ 260 (263)
T d2j4za1 256 PWITA 260 (263)
T ss_dssp HHHHH
T ss_pred CCCCC
T ss_conf 07078
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.62 Aligned_cols=292 Identities=32% Similarity=0.532 Sum_probs=242.3
Q ss_pred CCCEECCCCCE---ECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCC
Q ss_conf 89310122824---3485889988513785189999976789999817999996056---02037779999999996099
Q 002732 554 EGYYSYRFGEI---LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGA 627 (887)
Q Consensus 554 ~g~~~~~~gei---l~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~ 627 (887)
+|||...++++ +.++|.++++||.|+||+||+|.+..++ +.||||++.+. ......+.+|+.+|+.|
T Consensus 2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--- 74 (346)
T d1cm8a_ 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTG----AKVAIKKLYRPFQSELFAKRAYRELRLLKHM--- 74 (346)
T ss_dssp CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTC----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHC---
T ss_pred CCCEEEECCCCEEECCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHC---
T ss_conf 985788536733344771899889801778199999999999----8999999852225969999999999999866---
Q ss_pred CCCCCCCEEEECCEEEECC------EEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCC
Q ss_conf 9999952568640111268------3899976211239999998166789999999999999999997421156231578
Q 002732 628 DPENKRHCIRFASSFKYRN------HLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDI 701 (887)
Q Consensus 628 ~~~~h~~Iv~l~~~~~~~~------~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDL 701 (887)
+||||++++++|...+ ++||||||++.+|..++... .|++..++.|+.||+.||.|||++||||+||
T Consensus 75 ---~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDi 147 (346)
T d1cm8a_ 75 ---RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 147 (346)
T ss_dssp ---CBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred ---CCCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf ---898754799986357655554159999840552189998740----2269999999999999999987378764566
Q ss_pred CCCCCCCCCCCCEEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 899731258999099982274200588986676557765552446089-9994356999999999999099999999918
Q 002732 702 KPDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 702 KP~NILi~~~~~~iKL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~-~~t~~sDIwSLGviL~eLltG~~PF~~~~~~ 780 (887)
||+|||++. ++.+||+|||+|..... ..+...+++.|+|||++.+. .++.++||||||||||+|++|.+||.+.+..
T Consensus 148 Kp~NIL~~~-~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~ 225 (346)
T d1cm8a_ 148 KPGNLAVNE-DCELKILDFGLARQADS-EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225 (346)
T ss_dssp CGGGEEECT-TCCEEECCCTTCEECCS-SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCHHHCCC-CCCCCCCCCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH
T ss_conf 851111210-01221134310220687-6310245533358899817878996501030038999999786998889768
Q ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99999998509997665301666663443333556676782469999999861598874542248999995658999999
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDL 860 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dL 860 (887)
..+..+....+.+|..++....... .......+.......+.. ..+.++..+++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~dl 280 (346)
T d1cm8a_ 226 DQLKEIMKVTGTPPAEFVQRLQSDE------------------AKNYMKGLPELEKKDFAS-------ILTNASPLAVNL 280 (346)
T ss_dssp HHHHHHHHHHCCCCHHHHHTCSCHH------------------HHHHHHHSCCCCCCCGGG-------TCTTCCHHHHHH
T ss_pred HHHHHHHHCCCCCCHHHHHHHCCHH------------------HHHHHCCCCCCCCCCHHH-------HCCCCCHHHHHH
T ss_conf 9999998503788488886530003------------------443311578666556677-------556899999999
Q ss_pred HHHHCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 99803139899969998984798779
Q 002732 861 LDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 861 L~kmL~~DP~~RpTa~eiL~HPwl~~ 886 (887)
|.+||.+||.+||||.|||+||||++
T Consensus 281 i~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 281 LEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 99977299557929999963962375
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.59 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=226.4
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-------HHHHHHHHHHHHHHHHHCCCCCCCCCE
Q ss_conf 2434858899885137851899999767899998179999960560-------203777999999999609999999525
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-------TMNKAGQTEVQILKKLAGADPENKRHC 635 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-------~~~~~~~~Ei~iL~~L~~~~~~~h~~I 635 (887)
+.+.++|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+.+|+.+|..| +||||
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l------~HpnI 75 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTG----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI------QHPNV 75 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC------CCTTB
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHC------CCCCC
T ss_conf 885567798279811789599999999999----89999998756632134068999999999999867------99899
Q ss_pred EEECCEEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCC-
Q ss_conf 68640111268389997621-1239999998166789999999999999999997421156231578899731258999-
Q 002732 636 IRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN- 713 (887)
Q Consensus 636 v~l~~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~- 713 (887)
++++++|...+.+||||||| +|+|.++|...+. +++..++.|+.||+.||.|||+.+|||+||||+|||++..+.
T Consensus 76 v~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSS
T ss_pred CCEEEEEEECCEEEEEEECCCCCCCCCHHCCCCC---CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCC
T ss_conf 9388999979989999986778643100103564---2155789999999999876662542211333012798258986
Q ss_pred --EEEEEECCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf --0999822742005889-8667655776555244608999943569999999999990999999999189999999850
Q 002732 714 --VLKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELK 790 (887)
Q Consensus 714 --~iKL~DFG~a~~~~~~-~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~ 790 (887)
.+||+|||+|...... ......+++.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..+....
T Consensus 153 ~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp SCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred CCCEEECCHHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 66469643344210577763122477774309999818999976652214099999970889988999999999998168
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
Q ss_conf 99976653016666634433335566767824699999998615988745422489999956589999999980313989
Q 002732 791 GPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 791 g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
..++...+ +.++..+.+||.+||..||.
T Consensus 233 ~~~~~~~~----------------------------------------------------~~~s~~~~~li~~~L~~dP~ 260 (293)
T d1jksa_ 233 YEFEDEYF----------------------------------------------------SNTSALAKDFIRRLLVKDPK 260 (293)
T ss_dssp CCCCHHHH----------------------------------------------------TTSCHHHHHHHHTTSCSSGG
T ss_pred CCCCCHHC----------------------------------------------------CCCCHHHHHHHHHHCCCCHH
T ss_conf 88870104----------------------------------------------------78899999999998638966
Q ss_pred CCCCHHHHHHCCCCCC
Q ss_conf 9969998984798779
Q 002732 871 KRMTVAQALTHPFISG 886 (887)
Q Consensus 871 ~RpTa~eiL~HPwl~~ 886 (887)
+|||+.|||+||||++
T Consensus 261 ~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 261 KRMTIQDSLQHPWIKP 276 (293)
T ss_dssp GSCCHHHHHHSTTTCC
T ss_pred HCCCHHHHHCCCCCCC
T ss_conf 8919999961904188
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.58 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=220.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 858899885137851899999767899998179999960560----2037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||.|+||.||+|.+..++ ..||||++.+.. .....+..|+.+|..+ +||||++++++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATG----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNT------RHPFLTALKYAF 74 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CCTTBCCEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEE
T ss_conf 74289889831768499999998999----89999998156544979999999999999867------999887787640
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +|+|..++...+. +++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~-~g~vkl~DFG 150 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFG 150 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCT
T ss_pred CCCCCCCCCEECCCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC-CCCEEEEECC
T ss_conf 356421110003579860555532567---759999999999965211343159622464777847658-9988882056
Q ss_pred CCEECCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHH
Q ss_conf 4200588--98667655776555244608999943569999999999990999999999189999999850999766530
Q 002732 722 NAMFAGK--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLR 799 (887)
Q Consensus 722 ~a~~~~~--~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~ 799 (887)
+|..... .....++||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+....+..+......+|
T Consensus 151 ~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----- 225 (337)
T d1o6la_ 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----- 225 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----
T ss_pred CCCCCCCCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC-----
T ss_conf 520035678620551008899666650489888333102230678899878999999699999999852899898-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----C
Q ss_conf 16666634433335566767824699999998615988745422489999956589999999980313989996-----9
Q 002732 800 KGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----T 874 (887)
Q Consensus 800 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----T 874 (887)
..++..+++||.+||+.||.+|+ +
T Consensus 226 ---------------------------------------------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~ 254 (337)
T d1o6la_ 226 ---------------------------------------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSD 254 (337)
T ss_dssp ---------------------------------------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred ---------------------------------------------------CCCCHHHHHHHHHHCCCCCHHHCCCCCCC
T ss_conf ---------------------------------------------------66899999999866638934422565234
Q ss_pred HHHHHHCCCCCC
Q ss_conf 998984798779
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~eiL~HPwl~~ 886 (887)
+++||+||||.+
T Consensus 255 ~~eil~Hp~f~~ 266 (337)
T d1o6la_ 255 AKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHTSGGGTT
T ss_pred HHHHHCCCCCCC
T ss_conf 999972915036
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.17 Aligned_cols=258 Identities=23% Similarity=0.412 Sum_probs=228.3
Q ss_pred ECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 34858899885137851899999767899998179999960560203777999999999609999999525686401112
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+-++|.+++.||+|+||+||+|.+..++ ..||||++.........+..|+.+|..+ +||||++++++|..
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~----~~~AiK~i~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~~~~ 72 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSK----KTYMAKFVKVKGTDQVLVKKEISILNIA------RHRNILHLHESFES 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECCCTHHHHHHHHHHHHHHHS------CCTTBCCEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECCCCCCHHHHHHHHHHHHHC------CCCCCCEEEEEEEE
T ss_conf 7010588789831778399999998999----6999999757866599999999999857------99798909899988
Q ss_pred CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCC-CCEEEEEECCC
Q ss_conf 68389997621-12399999981667899999999999999999974211562315788997312589-99099982274
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA-KNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~-~~~iKL~DFG~ 722 (887)
.+++||||||| +++|.++|...+ ..|++..++.|+.||+.||.|||++||+|+||||+||||+.. ...+||+|||+
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCH
T ss_conf 998899995389980889987538--999999999999999999999987699751355444344378851899764411
Q ss_pred CEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 20058898-66765577655524460899994356999999999999099999999918999999985099976653016
Q 002732 723 AMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 723 a~~~~~~~-~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+....... ....++++.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..+.+..|+.....+|...+
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 227 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--- 227 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH---
T ss_pred HHCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHC---
T ss_conf 10034677532122332223402104877784011302799999998289999998999999999838999880223---
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
+.++..+.+||.+||..||.+|||+.|||+|
T Consensus 228 -------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 228 -------------------------------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -------------------------------------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -------------------------------------------------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -------------------------------------------------6789999999999866996689099999639
Q ss_pred CCCCC
Q ss_conf 98779
Q 002732 882 PFISG 886 (887)
Q Consensus 882 Pwl~~ 886 (887)
|||++
T Consensus 259 p~~~~ 263 (321)
T d1tkia_ 259 PWLKQ 263 (321)
T ss_dssp HHHHS
T ss_pred HHHCC
T ss_conf 96566
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.41 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=213.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 4858899885137851899999767899998179999960560--20377799999999960999999952568640111
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.++|.+++.||+|+||+||+|.+..++ ..||||++.... .....+.+|+.+|..| +||||++++++|.
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~~~~~~~ 73 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE----EAVAVKIVDMKRAVDCPENIKKEICINKML------NHENVVKFYGHRR 73 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECC-------CHHHHHHHHHTC------CCTTBCCEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHC------CCCCEEEEEEEEC
T ss_conf 746089989721748099999999999----799999984566412799999999999857------9988846965404
Q ss_pred ECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf 268389997621-1239999998166789999999999999999997421156231578899731258999099982274
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~ 722 (887)
..+.+||||||+ +|+|.++|.... .+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||+
T Consensus 74 ~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~-~~~~KL~DFG~ 149 (271)
T d1nvra_ 74 EGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGL 149 (271)
T ss_dssp ETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTT
T ss_pred CCCEEEEEEECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECC-CCCEEECCCHH
T ss_conf 6743679886458980899975379---9999999999999999999999759835754689978878-99879832314
Q ss_pred CEECCCC----CCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf 2005889----8667655776555244608999-9435699999999999909999999991899999998509997665
Q 002732 723 AMFAGKN----EITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 723 a~~~~~~----~~~~~~gt~~Y~APE~l~~~~~-t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
|...... ..+..+||+.|+|||++.+..| +.++||||||||||+|++|.+||.+.........+......+
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---- 225 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---- 225 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----
T ss_pred HEEECCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC----
T ss_conf 2240468865311132557474287286189999971016173799999982997888898599999998638887----
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
...++.++..+.+||.+||+.||.+|||+.|
T Consensus 226 -------------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 226 -------------------------------------------------LNPWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp -------------------------------------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -------------------------------------------------8864469999999999976799668909999
Q ss_pred HHHCCCCCC
Q ss_conf 984798779
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 iL~HPwl~~ 886 (887)
||+||||+.
T Consensus 257 il~hpwf~~ 265 (271)
T d1nvra_ 257 IKKDRWYNK 265 (271)
T ss_dssp HTTCTTTTC
T ss_pred HHCCHHHCC
T ss_conf 961984585
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.45 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=218.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC-CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEEC
Q ss_conf 85889988513785189999976789999817999996056-02037779999999996099999995256864011126
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN-ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~-~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+.|.+++.||.|+||+||+|.+..++ ..||||++... ......+..|+.+|..| +||||++++++|...
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS----VLAAAKVIDTKSEEELEDYMVEIDILASC------DHPNIVKLLDAFYYE 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECSSSGGGGGTHHHHHHHHHC------CCTTBCCEEEEEEET
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCC----EEEEEEEECCCCHHHHHHHHHHHHHHHHC------CCCCCCEEEEEEEEC
T ss_conf 37598479930778199999999999----39999998728999999999999999867------999988498898009
Q ss_pred CEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCE
Q ss_conf 8389997621-123999999816678999999999999999999742115623157889973125899909998227420
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~ 724 (887)
+.+||||||+ +|+|.+++.... ..|++..+..|+.||+.||.|||++||||+||||+||||+. ++.+||+|||+|.
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL-DGDIKLADFGVSA 158 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECC-CCCEEEEECHHHH
T ss_conf 95899996279981889998628--99999999999999999999999889887140700314878-9998997161230
Q ss_pred ECCCC--CCCCCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf 05889--866765577655524460-----89999435699999999999909999999991899999998509997665
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIIL-----GLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~APE~l~-----~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
..... .....+||+.|+|||++. +..|+.++|||||||+||+|++|.+||.+.+..+.+..+.....+.
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~---- 234 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT---- 234 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC----
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC----
T ss_conf 3577864100102562647999983202578888806657878999999820889999989999999997079987----
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
...++.++..+.+||.+||+.||.+|||+.|
T Consensus 235 -------------------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 235 -------------------------------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp -------------------------------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -------------------------------------------------7765669999999999976699668919999
Q ss_pred HHHCCCCCC
Q ss_conf 984798779
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 iL~HPwl~~ 886 (887)
||+||||+.
T Consensus 266 ll~hp~~~~ 274 (288)
T d2jfla1 266 LLQHPFVTV 274 (288)
T ss_dssp HTTSGGGCC
T ss_pred HHCCCCCCC
T ss_conf 962923188
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=401.63 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=219.2
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 858899885137851899999767899998179999960560----2037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.+|..| +||||++++++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~ 110 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESG----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAV------NFPFLVKLEFSF 110 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC------CCTTBCCEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEECCCCC
T ss_conf 37089889611768089999998999----89999998267745889999999999999974------877274034444
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
.....+++||||+ +|+|..++...+. |++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 111 ~~~~~~~~v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~-~g~ikL~DFG 186 (350)
T d1rdqe_ 111 KDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFG 186 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCC-CCCEEEEECE
T ss_conf 322222322223346622666751589---899999999999999899998599861767999936077-8978861010
Q ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 42005889866765577655524460899994356999999999999099999999918999999985099976653016
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+|..... .....+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+....+..|......+|
T Consensus 187 ~a~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------- 258 (350)
T d1rdqe_ 187 FAKRVKG-RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP------- 258 (350)
T ss_dssp TCEECSS-CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred EEEECCC-CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC-------
T ss_conf 3332256-66433676356788997179988533114500789999758899899599999999861798897-------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHH
Q ss_conf 666634433335566767824699999998615988745422489999956589999999980313989996-----999
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVA 876 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~ 876 (887)
..++..+.+||.+||..||.+|+ |+.
T Consensus 259 -------------------------------------------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ 289 (350)
T d1rdqe_ 259 -------------------------------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289 (350)
T ss_dssp -------------------------------------------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTH
T ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHH
T ss_conf -------------------------------------------------6689999999999834099860655345499
Q ss_pred HHHHCCCCCC
Q ss_conf 8984798779
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 eiL~HPwl~~ 886 (887)
+||+||||.+
T Consensus 290 ell~Hp~f~~ 299 (350)
T d1rdqe_ 290 DIKNHKWFAT 299 (350)
T ss_dssp HHHTSGGGTT
T ss_pred HHHCCCCCCC
T ss_conf 9971905158
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=400.09 Aligned_cols=256 Identities=21% Similarity=0.363 Sum_probs=212.5
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH----HHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 8588998851378518999997678999981799999605602----037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||.|+||+||+|.+..++ ..||||++.+... ....+..|..++..+... +||||++++++|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~---~hpnIv~l~~~~ 76 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTG----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMSYAF 76 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS---CCTTBCCEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCC---CCCCEEEEEEEE
T ss_conf 76851018842889099999999999----79999998458754266799999999999998508---998588999999
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +|+|.++|..... +++..++.|+.||+.||.|||++||||+||||+||||+. .+.+||+|||
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~-~g~iKl~DFG 152 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLG 152 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SSCEEECCCT
T ss_pred EECCEEEEEEEECCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECC-CCCEEEEEEC
T ss_conf 989988999991489838999873255---327899999999999999999779622044422167858-8967982201
Q ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHC
Q ss_conf 420058898667655776555244608-9999435699999999999909999999991899999998509997665301
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~APE~l~~-~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
+|...........+||+.|+|||++.+ ..|+.++||||||||||+|++|..||.+....+....+.....
T Consensus 153 la~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--------- 223 (364)
T d1omwa3 153 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------- 223 (364)
T ss_dssp TCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------
T ss_pred EEEECCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC---------
T ss_conf 02333788643311345542168760389998441046778999999859998888998999999986046---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----H
Q ss_conf 66666344333355667678246999999986159887454224899999565899999999803139899969-----9
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT-----V 875 (887)
Q Consensus 801 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT-----a 875 (887)
.....+..++..+.+||.+||..||.+||| |
T Consensus 224 --------------------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a 259 (364)
T d1omwa3 224 --------------------------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259 (364)
T ss_dssp --------------------------------------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTH
T ss_pred --------------------------------------------CCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCH
T ss_conf --------------------------------------------888788778999999999985669888088743579
Q ss_pred HHHHHCCCCCC
Q ss_conf 98984798779
Q 002732 876 AQALTHPFISG 886 (887)
Q Consensus 876 ~eiL~HPwl~~ 886 (887)
++||+||||.+
T Consensus 260 ~eil~Hp~f~~ 270 (364)
T d1omwa3 260 QEVKESPFFRS 270 (364)
T ss_dssp HHHHTSGGGTT
T ss_pred HHHHCCCCCCC
T ss_conf 99974910237
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.28 Aligned_cols=250 Identities=26% Similarity=0.497 Sum_probs=219.0
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 858899885137851899999767899998179999960560----2037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++|.+++.||+|+||+||+|.+..++ ..||||++.+.. .....+..|+.+|..| +||||++++++|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~ 77 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATS----REYAIKILEKRHIIKENKVPYVTRERDVMSRL------DHPFFVKLYFTF 77 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC------CSTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEE
T ss_conf 87789889850879099999998999----79999998657755777899999999999876------888861799999
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +|+|.+++...+. |++..++.++.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 78 ~~~~~~~ivmEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~-~~~vkl~DFG 153 (288)
T d1uu3a_ 78 QDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFG 153 (288)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCT
T ss_pred EECCEEEEEEECCCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCC-CCEEEECCCC
T ss_conf 989988999970489877776531599---999999999999999997621650884767741236688-8538860321
Q ss_pred CCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf 42005889----86676557765552446089999435699999999999909999999991899999998509997665
Q 002732 722 NAMFAGKN----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~----~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+|...... .....+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+...++..|......+|
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p--- 230 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP--- 230 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC---
T ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC---
T ss_conf 02422567764333555677552584400268989666230456999998038899899599999999971899998---
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
..++..+.+||.+||+.||.+|||+.|
T Consensus 231 -----------------------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 231 -----------------------------------------------------EKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp -----------------------------------------------------TTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred -----------------------------------------------------CCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -----------------------------------------------------547999999999985579768919789
Q ss_pred ------HHHCCCCCC
Q ss_conf ------984798779
Q 002732 878 ------ALTHPFISG 886 (887)
Q Consensus 878 ------iL~HPwl~~ 886 (887)
+++||||.+
T Consensus 258 ~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 258 MEGYGPLKAHPFFES 272 (288)
T ss_dssp GTCHHHHHTSGGGTT
T ss_pred HCCCHHHHCCCCCCC
T ss_conf 737789876976478
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=397.64 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=212.3
Q ss_pred CEECCCE-EEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
Q ss_conf 2434858-899885137851899999767899998179999960560---203777999999999609999999525686
Q 002732 563 EILDGRY-EVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~rY-~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
...+++| .+..+||+|+||+||+|.+..++ ..||+|++.... .....+.+|+.+|..| +||||+++
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~ 73 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETT----VEVAWCELQDRKLTKSERQRFKEEAEMLKGL------QHPNIVRF 73 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC------CCTTBCCE
T ss_pred CCCCCCEEEEEEEEECCCCCEEEEEEECCCC----EEEEEEEECHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEE
T ss_conf 4778877885169700828499999999999----5999999851227989999999999999857------99985069
Q ss_pred CCEEEE----CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--EECCCCCCCCCCCCCC
Q ss_conf 401112----68389997621-1239999998166789999999999999999997421156--2315788997312589
Q 002732 639 ASSFKY----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCG--VLHCDIKPDNMLVNEA 711 (887)
Q Consensus 639 ~~~~~~----~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~g--IiHrDLKP~NILi~~~ 711 (887)
+++|.. ...+||||||+ +|+|.+++..... +++..++.|+.||+.||.|||+++ |||+||||+||||+..
T Consensus 74 ~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~ 150 (270)
T d1t4ha_ 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 150 (270)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred EEEEEECCCCCCEEEEEEECCCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECC
T ss_conf 99984033458889999957898948999751355---469999999999999999999789979968767435116679
Q ss_pred CCEEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 99099982274200588986676557765552446089999435699999999999909999999991899999998509
Q 002732 712 KNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 712 ~~~iKL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
++.+||+|||+|...........+||+.|+|||++.+ .|+.++||||||||||+|++|..||.+......+...+.. +
T Consensus 151 ~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~ 228 (270)
T d1t4ha_ 151 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G 228 (270)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T
T ss_pred CCCEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHC-C
T ss_conf 9988980057654236876677553813008988478-9998671100799999998788999876559999999973-8
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99766530166666344333355667678246999999986159887454224899999565899999999803139899
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
..|..+ +..++..+.+||.+||..||.+
T Consensus 229 ~~~~~~----------------------------------------------------~~~~~~~~~~li~~~l~~dp~~ 256 (270)
T d1t4ha_ 229 VKPASF----------------------------------------------------DKVAIPEVKEIIEGCIRQNKDE 256 (270)
T ss_dssp CCCGGG----------------------------------------------------GGCCCHHHHHHHHHHSCSSGGG
T ss_pred CCCCCC----------------------------------------------------CCCCCHHHHHHHHHHCCCCHHH
T ss_conf 998656----------------------------------------------------7557899999999976379758
Q ss_pred CCCHHHHHHCCCCC
Q ss_conf 96999898479877
Q 002732 872 RMTVAQALTHPFIS 885 (887)
Q Consensus 872 RpTa~eiL~HPwl~ 885 (887)
|||+.|||+||||+
T Consensus 257 R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 257 RYSIKDLLNHAFFQ 270 (270)
T ss_dssp SCCHHHHHTSGGGC
T ss_pred CCCHHHHHCCCCCC
T ss_conf 92999996775409
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=396.62 Aligned_cols=249 Identities=22% Similarity=0.416 Sum_probs=218.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 858899885137851899999767899998179999960560----2037779999999996099999995256864011
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.+|.+++.||.|+||+||+|.+..++ ..||||++.+.. .....+..|+.+|..| .||||++++++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~ 73 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNG----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV------THPFIIRMWGTF 73 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC------CBTTBCCEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCHHHEEEEE
T ss_conf 47088889720768089999998999----79999998457754889999999999999863------696753303568
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +++|..++..... +++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 74 ~~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~-~g~vkL~DFG 149 (316)
T d1fota_ 74 QDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFG 149 (316)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TSCEEECCCS
T ss_pred EECCEEEEEEEECCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECC-CCCEEEECCC
T ss_conf 528800567650378632234322221---110079999999987655412476770556810503868-9988983175
Q ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 42005889866765577655524460899994356999999999999099999999918999999985099976653016
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
+|...... ....+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..+......+|
T Consensus 150 ~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p------- 221 (316)
T d1fota_ 150 FAKYVPDV-TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP------- 221 (316)
T ss_dssp SCEECSSC-BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC-------
T ss_pred CCEEECCC-CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCC-------
T ss_conf 21671245-6434576343599998389998043046533368999759899999699999999970898899-------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHH
Q ss_conf 666634433335566767824699999998615988745422489999956589999999980313989996-----999
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-----TVA 876 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-----Ta~ 876 (887)
+.++..+.+||.+||..||.+|+ |++
T Consensus 222 -------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~ 252 (316)
T d1fota_ 222 -------------------------------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTE 252 (316)
T ss_dssp -------------------------------------------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTH
T ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHH
T ss_conf -------------------------------------------------7789999999999954499766643102199
Q ss_pred HHHHCCCCCC
Q ss_conf 8984798779
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 eiL~HPwl~~ 886 (887)
+||+||||.+
T Consensus 253 ~il~Hp~f~~ 262 (316)
T d1fota_ 253 DVKNHPWFKE 262 (316)
T ss_dssp HHHTSGGGSS
T ss_pred HHHCCCCCCC
T ss_conf 9981935146
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=396.80 Aligned_cols=302 Identities=32% Similarity=0.526 Sum_probs=239.4
Q ss_pred CCEECCCCC-EE--CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCCC
Q ss_conf 931012282-43--485889988513785189999976789999817999996056---020377799999999960999
Q 002732 555 GYYSYRFGE-IL--DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 555 g~~~~~~ge-il--~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~ 628 (887)
.||++.+|+ ++ .++|.++++||.|+||+||+|.+..++ ..||||++.+. ......+..|+.+|..+
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l---- 73 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCV---- 73 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTT----EEEEEEEEESTTSSHHHHHHHHHHHHHHHHC----
T ss_pred CCEEEEECCCCEEECCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHC----
T ss_conf 98799958940453377599889621758599999999999----8999999882336979999999999999864----
Q ss_pred CCCCCCEEEECCEEEE------CCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 9999525686401112------6838999762112399999981667899999999999999999974211562315788
Q 002732 629 PENKRHCIRFASSFKY------RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 629 ~~~h~~Iv~l~~~~~~------~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLK 702 (887)
+||||++++++|.. .+++||||||+.++|...+. ..+++..++.++.||+.||.|||++||+|+|||
T Consensus 74 --~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlK 146 (355)
T d2b1pa1 74 --NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146 (355)
T ss_dssp --CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred --CCCCEEEEEEEEECCCCCCCCCEEEEEEECCCHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf --8987648998970256434576269998414467787650-----389999999999999999988652211245677
Q ss_pred CCCCCCCCCCCEEEEEECCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 997312589990999822742005889-8667655776555244608999943569999999999990999999999189
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND 781 (887)
Q Consensus 703 P~NILi~~~~~~iKL~DFG~a~~~~~~-~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~ 781 (887)
|+|||++. ++.++|+|||++...... ..+..++|+.|+|||++.+..|++++|||||||++|+|++|.+||.+.+...
T Consensus 147 P~Nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 147 PSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGGEEECT-TCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCCCCCC-CCCEEEECHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH
T ss_conf 63211365-44313201023211466655332214655558133147777877433356625789865989988897788
Q ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99999985099976653016666634433335566767824699999998615988745422489999956589999999
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLL 861 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL 861 (887)
++..++...+.++..++.........+.......... .. ..++. ..............+..+++||
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~-------~~~~~~~~~~~~~~s~~~~dll 291 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL--TF-----PKLFP-------DSLFPADSEHNKLKASQARDLL 291 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCC--CH-----HHHSC-------GGGSCCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--CC-----CCCCC-------CCCCCCCCCCCCCCCHHHHHHH
T ss_conf 9999997205898799987656677776417543566--64-----21264-------3335432101333799999999
Q ss_pred HHHCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 9803139899969998984798779
Q 002732 862 DKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 862 ~kmL~~DP~~RpTa~eiL~HPwl~~ 886 (887)
.+||.+||.+||||.|||+||||+.
T Consensus 292 ~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 292 SKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 9987699457908999966942087
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=392.42 Aligned_cols=284 Identities=30% Similarity=0.483 Sum_probs=226.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 485889988513785189999976789999817999996056---02037779999999996099999995256864011
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
+++|.+++.||+|+||+||+|.+..++ ++.||||++... ......+.+|+.+|+.|... +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~---~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNG---GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTT---TEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHT---CCTTBCCEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCC---CEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHC---CCCCCCEEEEEE
T ss_conf 589798889921558699999998889---98999999802324516799999999999987425---898802366322
Q ss_pred EE-----CCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEE
Q ss_conf 12-----6838999762112399999981667899999999999999999974211562315788997312589990999
Q 002732 643 KY-----RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKL 717 (887)
Q Consensus 643 ~~-----~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL 717 (887)
.. ..++|||||++.+.+..++... ....+++..++.|+.||+.||.|||+++|||+||||+|||++. .+.+||
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~-~~~~kl 157 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKL 157 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEE
T ss_pred CCCCCCCCCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECC-CCCEEE
T ss_conf 14666667469999974058714444430-3789998999999999999999997588983579862789858-997542
Q ss_pred EECCCCEECCCC-CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 822742005889-8667655776555244608999943569999999999990999999999189999999850999766
Q 002732 718 CDFGNAMFAGKN-EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 718 ~DFG~a~~~~~~-~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+|||++...... .....+||+.|+|||++.+.+|+.++||||||||||+|++|.+||.+.+..+++..++...+.++..
T Consensus 158 ~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 158 ADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf 10001011002345777654851148310017988811100032899999987879989989899999999840799611
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 53016666634433335566767824699999998615988745422489999956589999999980313989996999
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
.+............. . .... .......++..+++||.+||++||.+||||.
T Consensus 238 ~~~~~~~~~~~~~~~-----~-----------------~~~~-------~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 238 DWPRDVALPRQAFHS-----K-----------------SAQP-------IEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp GSCTTCSSCGGGSCC-----C-----------------CCCC-------GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCCHHHHHCC-----C-----------------CCCC-------HHHCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 053211110333022-----3-----------------4564-------5440445899999999998748966791899
Q ss_pred HHHHCCCCCC
Q ss_conf 8984798779
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 eiL~HPwl~~ 886 (887)
|||+||||++
T Consensus 289 e~L~Hpff~~ 298 (305)
T d1blxa_ 289 SALSHPYFQD 298 (305)
T ss_dssp HHHTSGGGTT
T ss_pred HHHCCHHHCC
T ss_conf 9966963407
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=397.57 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=211.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH----HHHHHHHHHHHHHHHHCCCCCCCCCEEEECCE
Q ss_conf 48588998851378518999997678999981799999605602----03777999999999609999999525686401
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
...|.+++.||+|+||+||+|.+..++ ..||||++..... ....+.+|+.+|..| .||||++++++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~~~~~ 83 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNS----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL------RHPNTIQYRGC 83 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEE
T ss_conf 785676279701888099999998999----39999998444435889999999999999977------89998238999
Q ss_pred EEECCEEEEEEECCH-HHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf 112683899976211-2399999981667899999999999999999974211562315788997312589990999822
Q 002732 642 FKYRNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~l~lV~E~~~-gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
|...+.+|||||||. ++|..++... ..|++..++.|+.||+.||.|||++||||+||||+||||+. ++.+||+||
T Consensus 84 ~~~~~~~~iv~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~~Kl~DF 159 (309)
T d1u5ra_ 84 YLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDF 159 (309)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTEEEECCC
T ss_pred EEECCEEEEEEEECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECC-CCCEEEEEC
T ss_conf 99899889999806999457899737---99999999999999999999998689766678842179879-997898443
Q ss_pred CCCEECCCCCCCCCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf 7420058898667655776555244608---9999435699999999999909999999991899999998509997665
Q 002732 721 GNAMFAGKNEITPYLVSRFYRAPEIILG---LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 721 G~a~~~~~~~~~~~~gt~~Y~APE~l~~---~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
|+|..... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|..||.+.+..+.+..+.....+.+
T Consensus 160 G~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 234 (309)
T d1u5ra_ 160 GSASIMAP--ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--- 234 (309)
T ss_dssp TTCBSSSS--BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred CCCCCCCC--CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---
T ss_conf 65334677--8731347663688998346788867214545589999999878899999799999999982899988---
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
.+..++..+.+||.+||+.||.+|||+.|
T Consensus 235 ---------------------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 235 ---------------------------------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp ---------------------------------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ---------------------------------------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf ---------------------------------------------------87888999999999977379657918999
Q ss_pred HHHCCCCCC
Q ss_conf 984798779
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 iL~HPwl~~ 886 (887)
||+||||..
T Consensus 264 ll~Hp~~~~ 272 (309)
T d1u5ra_ 264 LLKHRFVLR 272 (309)
T ss_dssp HTTCHHHHS
T ss_pred HHHCHHHCC
T ss_conf 971997537
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.57 Aligned_cols=279 Identities=31% Similarity=0.513 Sum_probs=226.4
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE---
Q ss_conf 58899885137851899999767899998179999960560203777999999999609999999525686401112---
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY--- 644 (887)
Q Consensus 568 rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~--- 644 (887)
.|..+++||+|+||+||+|.+..++ +.||||++.... ....+|+.+|..| +|+||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~---~~~~~Ei~il~~l------~h~niv~~~~~~~~~~~ 87 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSG----ELVAIKKVLQDK---RFKNRELQIMRKL------DHCNIVRLRYFFYSSGE 87 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEECCS---SSCCHHHHHHHHC------CCTTBCCEEEEEEEC--
T ss_pred CCEEEEEEEECCCEEEEEEEECCCC----CEEEEEEECCCC---HHHHHHHHHHHHC------CCCCCCCEEEEEEECCC
T ss_conf 7675169821768399999999999----799999988160---6899999999866------89898738789974476
Q ss_pred ---CCEEEEEEECCHHHHHHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf ---6838999762112399999981-667899999999999999999974211562315788997312589990999822
Q 002732 645 ---RNHLCLVFESLHMNLREVLKKF-GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 645 ---~~~l~lV~E~~~gsL~~lL~~~-~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
..++||||||+++++...+... .....|++..++.|+.||+.||.|||++||||+||||+||||+..+..+||+||
T Consensus 88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECC
T ss_conf 57731899998416886078888631036899999999999999999999986687645788603787358971167336
Q ss_pred CCCEECCC-CCCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 74200588-986676557765552446089-9994356999999999999099999999918999999985099976653
Q 002732 721 GNAMFAGK-NEITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|++..... ......++++.|+|||++.+. .|+.++||||||||||+|++|.+||.+.+..+++..+...+|.++..++
T Consensus 168 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 168 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCHHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf 60544047765320025555568277640468882100024652778550287998987999999999997489817765
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 01666663443333556676782469999999861598874542248999995658999999998031398999699989
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei 878 (887)
.........+ .+.... .... .....+.++..+.+||.+||.+||.+||||.||
T Consensus 248 ~~~~~~~~~~----~~~~~~-----------------~~~~------~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 248 REMNPNYTEF----KFPQIK-----------------AHPW------TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp HHHCC---CC----CCCCCC-----------------CCCG------GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHCCCHHHC----CCCCCC-----------------CCCH------HHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 4306210110----355445-----------------6744------443156899999999999765895579299999
Q ss_pred HHCCCCCC
Q ss_conf 84798779
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~HPwl~~ 886 (887)
|+||||.+
T Consensus 301 L~Hp~f~~ 308 (350)
T d1q5ka_ 301 CAHSFFDE 308 (350)
T ss_dssp HTSGGGGG
T ss_pred HCCHHHCC
T ss_conf 66984524
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.88 Aligned_cols=281 Identities=31% Similarity=0.506 Sum_probs=229.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 858899885137851899999767899998179999960560---20377799999999960999999952568640111
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+++.||+|+||+||+|.+..++ +.||||++.... .....+..|+.+|++| +||||++++++|.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l------~Hp~Iv~~~~~~~ 71 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG----EVVALKKIRLDTETEGVPSTAIREISLLKEL------NHPNIVKLLDVIH 71 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEC-------CCHHHHHHHHHHTTC------CCTTBCCEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEECCCCC
T ss_conf 99776517723768099999999999----7999999802225758999999999999867------9983887445332
Q ss_pred ECCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCC
Q ss_conf 26838999762112399999981667899999999999999999974211562315788997312589990999822742
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a 723 (887)
..+++||||||+++++..++.... ...|++..++.|+.||+.||.|||++||||+||||+|||++. ++.+||+|||+|
T Consensus 72 ~~~~~~iv~e~~~~~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a 149 (298)
T d1gz8a_ 72 TENKLYLVFEFLHQDLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLA 149 (298)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSTTHH
T ss_pred CCCCEEEEEEECCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECC-CCCCEECCCCCC
T ss_conf 243203788623774455544202-568888999999999999999865288992135711401134-676210357861
Q ss_pred EECCCC--CCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHC
Q ss_conf 005889--866765577655524460899-99435699999999999909999999991899999998509997665301
Q 002732 724 MFAGKN--EITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~-~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... ......+++.|+|||++.... ++.++|||||||+||+|++|..||.+.+..+++..+....+.++...+..
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred EECCCCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCC
T ss_conf 34368864100103652154112213665777422103333134279668799898899999999998328983331444
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 66666344333355667678246999999986159887454224899999565899999999803139899969998984
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
......+.. .+......... ...+.++..+++||.+||++||.+||||.|||+
T Consensus 230 ~~~~~~~~~---~~~~~~~~~~~------------------------~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 230 VTSMPDYKP---SFPKWARQDFS------------------------KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGGSTTCCT---TSCCCCCCCHH------------------------HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCC---CCCCCCCCCHH------------------------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 222421243---45432222044------------------------416678999999999976399557918999967
Q ss_pred CCCCCC
Q ss_conf 798779
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 HPwl~~ 886 (887)
||||++
T Consensus 283 H~ff~~ 288 (298)
T d1gz8a_ 283 HPFFQD 288 (298)
T ss_dssp SGGGTT
T ss_pred CHHHCC
T ss_conf 870146
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=394.53 Aligned_cols=276 Identities=29% Similarity=0.489 Sum_probs=221.9
Q ss_pred EEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH------HHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 998851378518999997678999981799999605602------03777999999999609999999525686401112
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET------MNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 571 i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
.+++||+|+||+||+|.+..++ +.||||++..... ....+..|+.+|..| +||||++++++|..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~~~~~~~~ 71 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTN----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL------SHPNIIGLLDAFGH 71 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCC----SEEEEEEC------------CTHHHHHHHHHHHC------CCTTBCCEEEEECC
T ss_pred CCEEECCCCCEEEEEEEECCCC----CEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHC------CCCCEEEEEEEECC
T ss_conf 5638512728299999999999----6999999842021245679999999999999867------99998689854225
Q ss_pred CCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCE
Q ss_conf 68389997621123999999816678999999999999999999742115623157889973125899909998227420
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 645 ~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~ 724 (887)
.+++||||||+.+.+...+.. ....+++..++.|+.||+.||.|||++||||+||||+|||++. .+.+||+|||+|.
T Consensus 72 ~~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~ 148 (299)
T d1ua2a_ 72 KSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAK 148 (299)
T ss_dssp TTCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCGGGS
T ss_pred CCCEEEHHHHHCCHHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECC-CCCCCCCCCCCCC
T ss_conf 874022045534507765541--2667789999999999999998863163550357762588537-7841146576100
Q ss_pred ECCCC--CCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 05889--86676557765552446089-9994356999999999999099999999918999999985099976653016
Q 002732 725 FAGKN--EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 725 ~~~~~--~~~~~~gt~~Y~APE~l~~~-~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... .....++|+.|+|||++.+. .|+.++||||||||||+|++|.+||.+.+..+++..|....+.++...+...
T Consensus 149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred CCCCCCCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCH
T ss_conf 05787554330204733363999726778880564363042899998596999999999999999985189972545210
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
........ +.... ...+..+ .+.++..+++||.+||++||.+||||.|||+|
T Consensus 229 ~~~~~~~~----~~~~~-----------------~~~~~~~-------~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 229 CSLPDYVT----FKSFP-----------------GIPLHHI-------FSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TSSTTCCC----CCCCC-----------------CCCHHHH-------CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HCCCHHHH----HCCCC-----------------CCCHHHH-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 00213443----03478-----------------9886785-------65689999999999763894569089999679
Q ss_pred CCCCCC
Q ss_conf 987799
Q 002732 882 PFISGK 887 (887)
Q Consensus 882 Pwl~~~ 887 (887)
|||++.
T Consensus 281 p~f~~~ 286 (299)
T d1ua2a_ 281 KYFSNR 286 (299)
T ss_dssp GGGTSS
T ss_pred HHHCCC
T ss_conf 965789
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.33 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=214.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 858899885137851899999767899998179999960560---20377799999999960999999952568640111
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|++++.||+|+||+||+|.+..++ ..||||++.... .....+..|+.+|..| +||||++++++|.
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~ 73 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLREL------KHPNIVRYYDRII 73 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSC------CCTTBCCEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEE
T ss_conf 33799679830889199999999999----7999999874657979999999999999977------8999824899999
Q ss_pred E--CCEEEEEEECC-HHHHHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHCCC-----EECCCCCCCCCCCCCCCCE
Q ss_conf 2--68389997621-123999999816-6789999999999999999997421156-----2315788997312589990
Q 002732 644 Y--RNHLCLVFESL-HMNLREVLKKFG-RNIGLKLTAVRAYAKQLFIALKHLKNCG-----VLHCDIKPDNMLVNEAKNV 714 (887)
Q Consensus 644 ~--~~~l~lV~E~~-~gsL~~lL~~~~-~~~~ls~~~~~~i~~qIl~aL~yLHs~g-----IiHrDLKP~NILi~~~~~~ 714 (887)
. .+.+||||||+ +|+|.+++.... ....|++..++.|+.||+.||.|||+.+ |||+||||+||||+. ++.
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-~~~ 152 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQN 152 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT-TSC
T ss_pred ECCCCEEEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCC-CCC
T ss_conf 1789989999956899938999985154578999999999999999999999971677887885867654257478-885
Q ss_pred EEEEECCCCEECCCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 999822742005889--866765577655524460899994356999999999999099999999918999999985099
Q 002732 715 LKLCDFGNAMFAGKN--EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 715 iKL~DFG~a~~~~~~--~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
+||+|||+|...... .....+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+..+.+..+.....+
T Consensus 153 vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~ 232 (269)
T d2java1 153 VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232 (269)
T ss_dssp EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred EEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 79800100032245777556677882327999983999993898875278999980188998998999999999718998
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 97665301666663443333556676782469999999861598874542248999995658999999998031398999
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
..+..++.++.+||.+||+.||.+|
T Consensus 233 -------------------------------------------------------~~~~~~s~~l~~li~~~L~~dp~~R 257 (269)
T d2java1 233 -------------------------------------------------------RIPYRYSDELNEIITRMLNLKDYHR 257 (269)
T ss_dssp -------------------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred -------------------------------------------------------CCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf -------------------------------------------------------8974359999999999767995579
Q ss_pred CCHHHHHHCCCC
Q ss_conf 699989847987
Q 002732 873 MTVAQALTHPFI 884 (887)
Q Consensus 873 pTa~eiL~HPwl 884 (887)
||+.|||+|||+
T Consensus 258 ps~~ell~hp~i 269 (269)
T d2java1 258 PSVEEILENPLI 269 (269)
T ss_dssp CCHHHHHTSTTC
T ss_pred CCHHHHHHCCCC
T ss_conf 189999729819
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=387.36 Aligned_cols=257 Identities=29% Similarity=0.430 Sum_probs=221.0
Q ss_pred ECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH----------HHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 348588998851378518999997678999981799999605602----------0377799999999960999999952
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----------MNKAGQTEVQILKKLAGADPENKRH 634 (887)
Q Consensus 565 l~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~----------~~~~~~~Ei~iL~~L~~~~~~~h~~ 634 (887)
|.++|++++.||+|+||+||+|.+..++ ..||||++.+... ....+.+|+.+|..|. .|||
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~----~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~hpn 71 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTC----KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS-----GHPN 71 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT-----TCTT
T ss_pred CCCCCEECEEEECCCCEEEEEEEECCCC----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHC-----CCCC
T ss_conf 9663888528841768499999999999----899999996244641147888999999999999999850-----7997
Q ss_pred EEEECCEEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCC
Q ss_conf 568640111268389997621-1239999998166789999999999999999997421156231578899731258999
Q 002732 635 CIRFASSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 635 Iv~l~~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~ 713 (887)
|++++++|...+++||||||+ +|+|.++|...+. +++..++.|+.||+.||.|||++||||+||||+||||+. ++
T Consensus 72 Iv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~-~~ 147 (277)
T d1phka_ 72 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DM 147 (277)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TC
T ss_pred EEEEEEECCCCCCEEEEEECCCCCHHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CC
T ss_conf 47997621467605999976898668999986599---999999999999999999998759943234625489868-99
Q ss_pred EEEEEECCCCEECCCC-CCCCCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 0999822742005889-8667655776555244608------99994356999999999999099999999918999999
Q 002732 714 VLKLCDFGNAMFAGKN-EITPYLVSRFYRAPEIILG------LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLH 786 (887)
Q Consensus 714 ~iKL~DFG~a~~~~~~-~~~~~~gt~~Y~APE~l~~------~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i 786 (887)
.+||+|||++...... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|.+||.+.+....+..+
T Consensus 148 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i 227 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227 (277)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CEEECCCHHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHH
T ss_conf 83871240316726887213452467888988860534456788992331856560231032288898899999999999
Q ss_pred HHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 98509997665301666663443333556676782469999999861598874542248999995658999999998031
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
......++. ...+.++.++.+||.+||+
T Consensus 228 ~~~~~~~~~----------------------------------------------------~~~~~~s~~~~~li~~~L~ 255 (277)
T d1phka_ 228 MSGNYQFGS----------------------------------------------------PEWDDYSDTVKDLVSRFLV 255 (277)
T ss_dssp HHTCCCCCT----------------------------------------------------TTGGGSCHHHHHHHHHHCC
T ss_pred HHCCCCCCC----------------------------------------------------CCCCCCCHHHHHHHHHHCC
T ss_conf 818988898----------------------------------------------------5434689999999999765
Q ss_pred CCCCCCCCHHHHHHCCCCCC
Q ss_conf 39899969998984798779
Q 002732 867 LDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 867 ~DP~~RpTa~eiL~HPwl~~ 886 (887)
.||.+|||+.|||+||||++
T Consensus 256 ~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 256 VQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp SSGGGSCCHHHHTTSGGGCT
T ss_pred CCHHHCCCHHHHHCCHHHHH
T ss_conf 89668919999973978797
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.06 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=215.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH----HHHHHHHHHHHHH-HHHCCCCCCCCCEEEECCE
Q ss_conf 8588998851378518999997678999981799999605602----0377799999999-9609999999525686401
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET----MNKAGQTEVQILK-KLAGADPENKRHCIRFASS 641 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~----~~~~~~~Ei~iL~-~L~~~~~~~h~~Iv~l~~~ 641 (887)
++|.+++.||.|+||+||+|.+..++ +.||||++.+... ....+..|..++. .+ +||||++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~----~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~------~hp~Iv~~~~~ 71 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTN----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW------EHPFLTHMFCT 71 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT------TCTTBCCEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHC------CCCCEEEEEEE
T ss_conf 97188658940878289999999999----899999980555338489999999999999847------99968789889
Q ss_pred EEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf 11268389997621-12399999981667899999999999999999974211562315788997312589990999822
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
|...+.+||||||+ +|+|.++|..... +++..++.|+.||+.||.|||+++|||+||||+|||++. .+.+||+||
T Consensus 72 ~~~~~~~yivmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~-~~~~kl~DF 147 (320)
T d1xjda_ 72 FQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADF 147 (320)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC-CCCEECCCC
T ss_conf 7049831677750379808998640478---999999999999999999998689340347654044448-996301555
Q ss_pred CCCEECCC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 74200588--9866765577655524460899994356999999999999099999999918999999985099976653
Q 002732 721 GNAMFAGK--NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 721 G~a~~~~~--~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|+|..... ...+..+||+.|+|||++.+..|+.++||||||||||+|++|..||.+.+...++..+......+
T Consensus 148 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----- 222 (320)
T d1xjda_ 148 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----- 222 (320)
T ss_dssp TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----
T ss_pred CHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC-----
T ss_conf 302323566533454578777689999827998832320112278989873889999989999999997189989-----
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-H
Q ss_conf 016666634433335566767824699999998615988745422489999956589999999980313989996999-8
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA-Q 877 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~-e 877 (887)
+..++..+.+||.+||..||.+|||+. +
T Consensus 223 ---------------------------------------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~ 251 (320)
T d1xjda_ 223 ---------------------------------------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGD 251 (320)
T ss_dssp ---------------------------------------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSC
T ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf ---------------------------------------------------75679999999999654489878388999
Q ss_pred HHHCCCCCC
Q ss_conf 984798779
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 iL~HPwl~~ 886 (887)
+|+||||.+
T Consensus 252 l~~hpff~~ 260 (320)
T d1xjda_ 252 IRQHPLFRE 260 (320)
T ss_dssp GGGSGGGTT
T ss_pred HHHCCHHCC
T ss_conf 980901315
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.53 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=210.6
Q ss_pred CCCEEEEE-EECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 48588998-85137851899999767899998179999960560203777999999999609999999525686401112
Q 002732 566 DGRYEVTA-AHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 566 ~~rY~i~~-~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
-++|.++. .||.|+||+||+|.+..++ ..||||++... ..+..|+.++.++. +||||++++++|..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~----~~~~~E~~~~~~~~-----~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ----EKFALKMLQDC----PKARREVELHWRAS-----QCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTC----CEEEEEEEECS----HHHHHHHHHHHHHT-----TSTTBCCEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEECCC----HHHHHHHHHHHHHC-----CCCCCCEEEEEEEE
T ss_conf 1487981079654548699999988999----89999998974----77999999999866-----99997829899950
Q ss_pred ----CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCC--CCEEEE
Q ss_conf ----68389997621-12399999981667899999999999999999974211562315788997312589--990999
Q 002732 645 ----RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA--KNVLKL 717 (887)
Q Consensus 645 ----~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~--~~~iKL 717 (887)
..++||||||| +|+|.++|...+ ...|++..++.|+.||+.||.|||++||+|+||||+|||++.. .+.+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3468978999997789984999998627-877579999999999999999999769864441002201135555663113
Q ss_pred EECCCCEECCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 82274200588-98667655776555244608999943569999999999990999999999189999999850999766
Q 002732 718 CDFGNAMFAGK-NEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 718 ~DFG~a~~~~~-~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
+|||+|..... ......+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+.......+.......
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~--- 232 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--- 232 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC---
T ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCC---
T ss_conf 54551233368886432267756379277748988888888764516778865889988988778899999998538---
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 53016666634433335566767824699999998615988745422489999956589999999980313989996999
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
...+ ....+..++..+.+||.+||+.||.+|||+.
T Consensus 233 --------------~~~~-------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 267 (335)
T d2ozaa1 233 --------------QYEF-------------------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267 (335)
T ss_dssp --------------SSSC-------------------------------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred --------------CCCC-------------------------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf --------------8888-------------------------------9854346999999999997569965790999
Q ss_pred HHHHCCCCCC
Q ss_conf 8984798779
Q 002732 877 QALTHPFISG 886 (887)
Q Consensus 877 eiL~HPwl~~ 886 (887)
|||+||||.+
T Consensus 268 eil~hp~~~~ 277 (335)
T d2ozaa1 268 EFMNHPWIMQ 277 (335)
T ss_dssp HHHHSHHHHT
T ss_pred HHHCCHHHHC
T ss_conf 9970987617
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.35 Aligned_cols=283 Identities=28% Similarity=0.462 Sum_probs=223.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 85889988513785189999976789999817999996056---020377799999999960999999952568640111
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+++.||+|+||+||+|.+..++ +.||||++... ......+.+|+.+|..| +|+||+.++++|.
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~h~nii~~~~~~~ 79 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTG----QKVALKKVLMENEKEGFPITALREIKILQLL------KHENVVNLIEICR 79 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEC----CTTSSCHHHHHHHHHHHHC------CCTTBCCEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHH------CCCCCCCEEEEEE
T ss_conf 79889999722748299999998999----7999999842224637899999999999983------5999660676540
Q ss_pred E--------CCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEE
Q ss_conf 2--------68389997621123999999816678999999999999999999742115623157889973125899909
Q 002732 644 Y--------RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 644 ~--------~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~i 715 (887)
. .+++|+|||++.+.+...+... ...+++..++.|+.||+.||.|||++||||+||||+||||+. ++.+
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~-~~~~ 156 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVL 156 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCE
T ss_pred CCCCCCCCCCCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECC-CCCE
T ss_conf 2465444457638999853578741012220--344330899999999999998852299885676722203668-9968
Q ss_pred EEEECCCCEECCCC------CCCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 99822742005889------86676557765552446089-999435699999999999909999999991899999998
Q 002732 716 KLCDFGNAMFAGKN------EITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 716 KL~DFG~a~~~~~~------~~~~~~gt~~Y~APE~l~~~-~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~ 788 (887)
||+|||++...... .....++|+.|+|||++.+. .|+.++||||||||||+|++|.+||.+......+..+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 76313500223554443211356602497874289970799989178700678646617448799899899999999998
Q ss_pred HHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 50999766530166666344333355667678246999999986159887454224899999565899999999803139
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
..+.++..++........... .......... ....+.. ...+..+++||.+||++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~---------------------~~~~~~~~dLl~~mL~~d 292 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEK--LELVKGQKRK-VKDRLKA---------------------YVRDPYALDLIDKLLVLD 292 (318)
T ss_dssp HHCCCCTTTSTTCCCC---------CCSSCCBC-HHHHHHH---------------------HHCCHHHHHHHHHHSCSS
T ss_pred HCCCCCHHHCCCCCHHHHHHH--HCCCCCCCCC-CHHHHCC---------------------CCCCHHHHHHHHHHCCCC
T ss_conf 418998255344320344433--2013344555-0334044---------------------459989999999987389
Q ss_pred CCCCCCHHHHHHCCCCCC
Q ss_conf 899969998984798779
Q 002732 869 PEKRMTVAQALTHPFISG 886 (887)
Q Consensus 869 P~~RpTa~eiL~HPwl~~ 886 (887)
|.+||||.|||+||||+.
T Consensus 293 P~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 293 PAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTTSCCHHHHHHSGGGSS
T ss_pred HHHCCCHHHHHCCHHHCC
T ss_conf 658909999974950156
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.41 Aligned_cols=278 Identities=31% Similarity=0.479 Sum_probs=223.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 485889988513785189999976789999817999996056--020377799999999960999999952568640111
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+.+|.++..||.|+||+||+|.+..++ ..||||++.+. ......+..|+.+|..| +||+|+++++++.
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l------~hp~iv~~~~~~~ 76 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNK----VRVAIKKISPFEHQTYCQRTLREIKILLRF------RHENIIGINDIIR 76 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTC----SEEEEEEECCTTCHHHHHHHHHHHHHHHHC------CCTTBCCCCEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEEHHCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEEEE
T ss_conf 898599789940648099999999999----499999980310958999999999999976------8989885888995
Q ss_pred EC-----CEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEE
Q ss_conf 26-----8389997621123999999816678999999999999999999742115623157889973125899909998
Q 002732 644 YR-----NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 644 ~~-----~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~ 718 (887)
.. .++|||+++++++|.+++... .|++..++.++.||+.||.|||++||||+||||+||||+. .+.+||+
T Consensus 77 ~~~~~~~~~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~-~~~~kl~ 151 (345)
T d1pmea_ 77 APTIEQMKDVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKIC 151 (345)
T ss_dssp CSSTTTCCCEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEEC
T ss_pred ECCCCCCCEEEEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CCCEEEC
T ss_conf 0564554149999962598656644058----9999999999999999999999789867778764378879-9977875
Q ss_pred ECCCCEECCCC-----CCCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 22742005889-----8667655776555244608-99994356999999999999099999999918999999985099
Q 002732 719 DFGNAMFAGKN-----EITPYLVSRFYRAPEIILG-LPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 719 DFG~a~~~~~~-----~~~~~~gt~~Y~APE~l~~-~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
|||+|...... .....++++.|+|||++.. ..|+.++||||||||+|+|++|..||.+.+..++...+...+..
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred CCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCC
T ss_conf 45705650477764101011026520003878604788874101004670133776697997888889999987652069
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 9766530166666344333355667678246999999986159---8874542248999995658999999998031398
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIK---PKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDP 869 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP 869 (887)
++........... ......... ...... ..+.++..+++||.+||.+||
T Consensus 232 ~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~dP 283 (345)
T d1pmea_ 232 PSQEDLNCIINLK---------------------ARNYLLSLPHKNKVPWNR-------LFPNADSKALDLLDKMLTFNP 283 (345)
T ss_dssp CCHHHHHTCCCHH---------------------HHHHHHTSCCCCCCCHHH-------HCTTSCHHHHHHHHHHSCSST
T ss_pred CCHHHHHHHHHHH---------------------HHCCCCCCCCCCCCCHHH-------HCCCCCHHHHHHHHHHCCCCH
T ss_conf 9756642343322---------------------220244677557787778-------378999999999999764895
Q ss_pred CCCCCHHHHHHCCCCCC
Q ss_conf 99969998984798779
Q 002732 870 EKRMTVAQALTHPFISG 886 (887)
Q Consensus 870 ~~RpTa~eiL~HPwl~~ 886 (887)
.+||||.|||+||||+.
T Consensus 284 ~~R~ta~e~L~hpf~~~ 300 (345)
T d1pmea_ 284 HKRIEVEQALAHPYLEQ 300 (345)
T ss_dssp TTSCCHHHHHTSGGGTT
T ss_pred HHCCCHHHHHCCHHHCC
T ss_conf 67908999861986555
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.54 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=210.8
Q ss_pred ECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH-------HHHHHHHHHHHHHHHHCCCCCCCCCEEE
Q ss_conf 348588998851378518999997678999981799999605602-------0377799999999960999999952568
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-------MNKAGQTEVQILKKLAGADPENKRHCIR 637 (887)
Q Consensus 565 l~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~-------~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~ 637 (887)
+.++|.+.+.||+|+||+||+|.+..++ ..||||++.+... ....+..|+.+|..+.. .||||++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~----~h~nIv~ 73 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDN----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS----GFSGVIR 73 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTC----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS----SSCSBCC
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCC----CCCCCCE
T ss_conf 7883799679840878399999999999----7999999856884433455679999999999997435----8988127
Q ss_pred ECCEEEECCEEEEEEECCH--HHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEE
Q ss_conf 6401112683899976211--23999999816678999999999999999999742115623157889973125899909
Q 002732 638 FASSFKYRNHLCLVFESLH--MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVL 715 (887)
Q Consensus 638 l~~~~~~~~~l~lV~E~~~--gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~i 715 (887)
++++|...+.+|+|||++. ++|..++..... +++..++.|+.||+.||.|||++||||+||||+||||+...+.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred EEEEEEECCEEEEEEEECCCCCHHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEE
T ss_conf 999983099689999833686228999861589---99999999999999999999877975566761114774478848
Q ss_pred EEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 998227420058898667655776555244608999-9435699999999999909999999991899999998509997
Q 002732 716 KLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPY-DHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 716 KL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~-t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
||+|||+|........+..+||+.|+|||++.+..+ +.++||||||||||+|++|..||.+.. . +....
T Consensus 151 kl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~~---- 220 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRGQ---- 220 (273)
T ss_dssp EECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHCC----
T ss_pred EECCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH--H----HHHCC----
T ss_conf 9775465353244455665658774799998489978865332554034536756889988736--7----76154----
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 66530166666344333355667678246999999986159887454224899999565899999999803139899969
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
...++.++.++.+||.+||+.||.+|||
T Consensus 221 ----------------------------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s 248 (273)
T d1xwsa_ 221 ----------------------------------------------------VFFRQRVSSECQHLIRWCLALRPSDRPT 248 (273)
T ss_dssp ----------------------------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf ----------------------------------------------------4778779999999999976089758939
Q ss_pred HHHHHHCCCCCC
Q ss_conf 998984798779
Q 002732 875 VAQALTHPFISG 886 (887)
Q Consensus 875 a~eiL~HPwl~~ 886 (887)
+.|||+||||++
T Consensus 249 ~~eil~hp~~~~ 260 (273)
T d1xwsa_ 249 FEEIQNHPWMQD 260 (273)
T ss_dssp HHHHHTSGGGSS
T ss_pred HHHHHCCHHHCC
T ss_conf 999853986678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=380.86 Aligned_cols=279 Identities=30% Similarity=0.493 Sum_probs=225.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 858899885137851899999767899998179999960560---20377799999999960999999952568640111
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.++++||.|+||+||+|.+. ++ +.||||++.... .....+.+|+.+|..| +||||++++++|.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~hpnIv~~~~~~~ 70 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YG----ETFALKKIRLEKEDEGIPSTTIREISILKEL------KHSNIVKLYDVIH 70 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGC------CCTTBCCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEECC
T ss_conf 99634318722778189999968-99----9999999812326858999999999999867------9986876601204
Q ss_pred ECCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCC
Q ss_conf 26838999762112399999981667899999999999999999974211562315788997312589990999822742
Q 002732 644 YRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 644 ~~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a 723 (887)
..+.+|+||+++.+.+...+... ...|++..++.|+.||+.||.|||+.+|||+||||+||||+. ++.+||+|||+|
T Consensus 71 ~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~-~~~~kl~DfG~a 147 (286)
T d1ob3a_ 71 TKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLA 147 (286)
T ss_dssp CSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCTTHH
T ss_pred CCCCEEEEEEEEHHHHHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECC-CCCEEECCCCCC
T ss_conf 67731589974004567899860--477514456899999999999860574882678775056868-997873236643
Q ss_pred EECCCCC--CCCCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHC
Q ss_conf 0058898--6676557765552446089-999435699999999999909999999991899999998509997665301
Q 002732 724 MFAGKNE--ITPYLVSRFYRAPEIILGL-PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 724 ~~~~~~~--~~~~~gt~~Y~APE~l~~~-~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
....... .....+++.|+|||++.+. .++.++|||||||+||+|++|.+||.+.+..+++..+....+.++...+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred EECCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 01146765410102431101378871788888410021117589999779799898898999999998638997110421
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 66666344333355667678246999999986159887454224899999565899999999803139899969998984
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
......+ ...... .. +.. .....+.++..+.+||.+||++||.+||||.|||+
T Consensus 228 ~~~~~~~-~~~~~~--~~-----------------~~~-------~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKY-DPNFTV--YE-----------------PLP-------WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTC-CTTCCC--CC-----------------CCC-------GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHC-CCCCCC--CC-----------------CCC-------HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2333221-433333--56-----------------764-------66651258999999999986689668909999856
Q ss_pred CCCCCC
Q ss_conf 798779
Q 002732 881 HPFISG 886 (887)
Q Consensus 881 HPwl~~ 886 (887)
||||++
T Consensus 281 Hp~f~~ 286 (286)
T d1ob3a_ 281 HAYFKE 286 (286)
T ss_dssp SGGGGC
T ss_pred CCCCCC
T ss_conf 922074
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=375.70 Aligned_cols=311 Identities=30% Similarity=0.528 Sum_probs=244.7
Q ss_pred CEECCCCCEEC-CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCC----
Q ss_conf 31012282434-8588998851378518999997678999981799999605602037779999999996099999----
Q 002732 556 YYSYRFGEILD-GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPE---- 630 (887)
Q Consensus 556 ~~~~~~geil~-~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~---- 630 (887)
|||+.+|++|. ++|.++++||.|+||+||+|.+..++ +.||||++.+..........|+.+|+.|.+....
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g----~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNN----THVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CCCCCCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEECCCCCHHHHHHHHHHHHHHCCHHHHHHHH
T ss_conf 97888888844785799899750778189999999999----79999998343133689999999999840145555542
Q ss_pred -CCCCEEEECCEEEEC--CEEEEEEECC--HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCEECCCCCCC
Q ss_conf -995256864011126--8389997621--12399999981667899999999999999999974211-56231578899
Q 002732 631 -NKRHCIRFASSFKYR--NHLCLVFESL--HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN-CGVLHCDIKPD 704 (887)
Q Consensus 631 -~h~~Iv~l~~~~~~~--~~l~lV~E~~--~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs-~gIiHrDLKP~ 704 (887)
.|+||+++++++... ...++|+.++ .+........ .....+++..++.++.||+.||.|||+ .||+|+||||+
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~ 155 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 155 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred CCCCCEEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 2767647899876312565202343200035420000012-234678689999999999999888764058646567705
Q ss_pred CCCCCCCCC-----EEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-
Q ss_conf 731258999-----09998227420058898667655776555244608999943569999999999990999999999-
Q 002732 705 NMLVNEAKN-----VLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT- 778 (887)
Q Consensus 705 NILi~~~~~-----~iKL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~- 778 (887)
||||+..+. .++|+|||.+..... .....++++.|+|||++.+..|+.++|||||||+|++|++|+.||....
T Consensus 156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 156 NVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred HEEEECCCCCCCCCEEEEEECCCCCCCCC-CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 70563057656443056753144212344-54223665210571321466777643201237899999878899898755
Q ss_pred -----HHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHH
Q ss_conf -----189999999850999766530166666344333355667678246999999986159887454224899999565
Q 002732 779 -----NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853 (887)
Q Consensus 779 -----~~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 853 (887)
..+.+..++.++|.+|..++..+.+...+|+.............. .....+..........
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW--------------PLEDVLTEKYKFSKDE 300 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC--------------CHHHHHHHTTCCCHHH
T ss_pred CCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCC--------------CHHHHCCCCCCCCCCC
T ss_conf 43210268999999983799878862453220001320122024323577--------------6444210001567435
Q ss_pred HHHHHHHHHHHCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 899999999803139899969998984798779
Q 002732 854 LANFKDLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 854 s~~~~dLL~kmL~~DP~~RpTa~eiL~HPwl~~ 886 (887)
+..+++||.+||.+||.+||||.|||+||||++
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 899999999987799457908999966934078
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=377.23 Aligned_cols=283 Identities=26% Similarity=0.440 Sum_probs=216.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE-
Q ss_conf 4858899885137851899999767899998179999960560203777999999999609999999525686401112-
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY- 644 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~- 644 (887)
.++|.++++||+|+||+||+|.+..++ +.||||+++... ...+..|+.+|..|. .||||++++++|..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~----~~vAiK~i~~~~--~~~~~~Ei~il~~l~-----~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNN----EKVVVKILKPVK--KKKIKREIKILENLR-----GGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSSC--HHHHHHHHHHHHHHT-----TSTTBCCEEEEEECT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECHHH--HHHHHHHHHHHHHCC-----CCCCCCEEEEEEEEC
T ss_conf 867189789831748199999988999----799999988899--999999999998515-----799876799999816
Q ss_pred -CCEEEEEEECCH-HHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf -683899976211-239999998166789999999999999999997421156231578899731258999099982274
Q 002732 645 -RNHLCLVFESLH-MNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 645 -~~~l~lV~E~~~-gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~ 722 (887)
..++|+||||+. ++|..++ ..|++..++.++.||+.||.|||++||||+||||+||||+..+..+||+|||+
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred CCCCEEEEEEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCC
T ss_conf 877126888631798589974------68999999999999999998876433443456441237748998366415654
Q ss_pred CEECCCC-CCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHHHHCCCC-HHHH
Q ss_conf 2005889-866765577655524460899-9943569999999999990999999999-1899999998509997-6653
Q 002732 723 AMFAGKN-EITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFP-KKML 798 (887)
Q Consensus 723 a~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~t~~sDIwSLGviL~eLltG~~PF~~~~-~~~~l~~i~~~~g~~p-~~~l 798 (887)
|...... .....++|+.|+|||++.+.. |+.++|||||||+||+|++|..||.... ...+...+...++.+. ..++
T Consensus 177 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 177 AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 26646887444322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred HCCCCCC-CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 0166666-344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 799 RKGAFTD-QHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 799 ~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
....... ..+...+... ....... .........++.++++||.+||.+||.+||||.|
T Consensus 257 ~~~~~~~~~~~~~~~~~~-------------------~~~~~~~--~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRH-------------------SRKRWER--FVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHTTCCCCGGGGGTCCCC-------------------CCCCGGG--GCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHCCCCCCCCCCHHCCCC-------------------CCCCHHH--CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 422544474300000333-------------------4331121--1552112448999999999986699568908999
Q ss_pred HHHCCCCCC
Q ss_conf 984798779
Q 002732 878 ALTHPFISG 886 (887)
Q Consensus 878 iL~HPwl~~ 886 (887)
||+||||+.
T Consensus 316 ~L~Hp~F~~ 324 (328)
T d3bqca1 316 AMEHPYFYT 324 (328)
T ss_dssp HHTSGGGTT
T ss_pred HHCCCCCCC
T ss_conf 964935588
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.91 Aligned_cols=288 Identities=33% Similarity=0.522 Sum_probs=229.0
Q ss_pred CCEECCCCC-EE--CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCC
Q ss_conf 931012282-43--4858899885137851899999767899998179999960560---20377799999999960999
Q 002732 555 GYYSYRFGE-IL--DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGAD 628 (887)
Q Consensus 555 g~~~~~~ge-il--~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~ 628 (887)
+||...++. ++ .++|.+++.||.|+||+||+|.+..++ +.||||++.+.. .....+.+|+.+|..|
T Consensus 3 ~~~~~~~~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l---- 74 (348)
T d2gfsa1 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTG----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHM---- 74 (348)
T ss_dssp CEEEEECSSSEEEEETTEEEEEECGGGTTSSEEEEEETTTT----EEEEEEECSCTTSSHHHHHHHHHHHHHHHHC----
T ss_pred CCEEEECCCCCCCCCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECCHHCCHHHHHHHHHHHHHHHHC----
T ss_conf 70787037755458987188889831788399999999999----7999999882002868999999999999866----
Q ss_pred CCCCCCEEEECCEEEEC------CEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCC
Q ss_conf 99995256864011126------838999762112399999981667899999999999999999974211562315788
Q 002732 629 PENKRHCIRFASSFKYR------NHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIK 702 (887)
Q Consensus 629 ~~~h~~Iv~l~~~~~~~------~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLK 702 (887)
.|+||++++++|... +++|+++++++++|.+++.. ..|++..++.|+.||+.||.|||++||||+|||
T Consensus 75 --~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiK 148 (348)
T d2gfsa1 75 --KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 148 (348)
T ss_dssp --CCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred --CCCCEEEEEEEEEECCCCCCCCEEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf --89874259999963464566864999996258862320022----453099999999999999999973887651667
Q ss_pred CCCCCCCCCCCEEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 997312589990999822742005889866765577655524460899-9943569999999999990999999999189
Q 002732 703 PDNMLVNEAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVLFPGATNND 781 (887)
Q Consensus 703 P~NILi~~~~~~iKL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~-~t~~sDIwSLGviL~eLltG~~PF~~~~~~~ 781 (887)
|+|||++. ++.+||+|||++..... ......|++.|+|||++.+.. ++.++|||||||+||+|++|.+||.+.+...
T Consensus 149 p~NILi~~-~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 149 PSNLAVNE-DCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp GGGEEECT-TCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred CCCCCCCC-CCCCCCCCCCHHCCCCC-CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 76334554-32200132100012575-44443454355583553377567855124320589999976889978898899
Q ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 99999985099976653016666634433335566767824699999998615---988745422489999956589999
Q 002732 782 MLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNI---KPKDIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 782 ~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~~~~~~~~~~s~~~~ 858 (887)
....+....+.++..+........ ........ ....+.. ....++..++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~ 278 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSES---------------------ARNYIQSLTQMPKMNFAN-------VFIGANPLAV 278 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHH---------------------HHHHHTTSCCCCCCCHHH-------HSTTCCHHHH
T ss_pred HHHHHHHHCCCCCHHHHHHCCCHH---------------------HHHHHHHCCCCCCCCHHH-------HCCCCCHHHH
T ss_conf 999999730799757732001024---------------------454443035578755566-------2678999999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 9999803139899969998984798779
Q 002732 859 DLLDKIFVLDPEKRMTVAQALTHPFISG 886 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~eiL~HPwl~~ 886 (887)
+||.+||.+||.+||||.|||+||||++
T Consensus 279 dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 279 DLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 9999977588345938999855995487
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.71 Aligned_cols=279 Identities=28% Similarity=0.433 Sum_probs=223.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 858899885137851899999767899998179999960560---20377799999999960999999952568640111
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE---TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~---~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
++|.+++.||+|+||+||+|.+..++ ..||||+++... .....+.+|+.+|+.+ .|+||++++++|.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~~ 71 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH----EIVALKRVRLDDDDEGVPSSALREICLLKEL------KHKNIVRLHDVLH 71 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTC------CCTTBCCEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCC----CEEEEEEEEHHHCCHHHHHHHHHHHHHHHHC------CCCCEEEECCCCC
T ss_conf 99786269712868199999999999----6999999803217868999999999999856------7578882135444
Q ss_pred ECCEEEEEEECCHH-HHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf 26838999762112-39999998166789999999999999999997421156231578899731258999099982274
Q 002732 644 YRNHLCLVFESLHM-NLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~l~lV~E~~~g-sL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~ 722 (887)
....++||++++.+ .|..++... ..+++..++.++.||+.||.|||.+||||+||||+|||++. .+.+||+|||.
T Consensus 72 ~~~~~~iv~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~-~~~~kl~DFG~ 147 (292)
T d1unla_ 72 SDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGL 147 (292)
T ss_dssp CSSEEEEEEECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTT
T ss_pred CCCCEEEEEEECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCC-CCCEEEEECCH
T ss_conf 443115886302332221121235---65403678999999999987743399860014676121133-78266520460
Q ss_pred CEECCCCC--CCCCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHCCCCC-CCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 20058898--66765577655524460899-99435699999999999909999-9999918999999985099976653
Q 002732 723 AMFAGKNE--ITPYLVSRFYRAPEIILGLP-YDHPLDIWSVGCCLYELYTGKVL-FPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~--~~~~~gt~~Y~APE~l~~~~-~t~~sDIwSLGviL~eLltG~~P-F~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|....... .....++..|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+.+..+....+.++...+
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred HHCCCCCCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 11046887510010344310146675069888804440265418899851899998899999999999861189973551
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 01666663443333556676782469999999861598874542248999995658999999998031398999699989
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei 878 (887)
........+.. ..............+.++..+.+||.+||++||.+||||+||
T Consensus 228 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 228 PSMTKLPDYKP---------------------------YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TTGGGSTTCCC---------------------------CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHCCCCCC---------------------------CCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 34432221133---------------------------444544310433065689999999999864996689099999
Q ss_pred HHCCCCCC
Q ss_conf 84798779
Q 002732 879 LTHPFISG 886 (887)
Q Consensus 879 L~HPwl~~ 886 (887)
|+||||++
T Consensus 281 L~Hp~f~~ 288 (292)
T d1unla_ 281 LQHPYFSD 288 (292)
T ss_dssp TTSGGGSS
T ss_pred HCCHHHCC
T ss_conf 64953407
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.55 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=213.6
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCC-CCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 2434858899885137851899999767899-99817999996056--02037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~-~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++-.++|.++++||.|+||+||+|.+...+. .....||+|++... ......+..|+.+|..|. +|||||+++
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~l~ 107 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG-----SHENIVNLL 107 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-----CCCCEEEEE
T ss_conf 577899397019830788199999985788554204999999663358789999999999999715-----899686877
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEEC
Q ss_conf 0111268389997621-1239999998166--------------------789999999999999999997421156231
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR--------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLH 698 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~--------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIiH 698 (887)
++|...+.+||||||+ +|+|.++|..... ...|++..++.|+.||+.||.|||+++|||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCCCCCCCCCEEEEEECCCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 57889973125899909998227420058898----667655776555244608999943569999999999990-9999
Q 002732 699 CDIKPDNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVL 773 (887)
Q Consensus 699 rDLKP~NILi~~~~~~iKL~DFG~a~~~~~~~----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~P 773 (887)
+||||+|||++. ++.+||+|||+|....... .....+|+.|+|||++.+..|+.++||||||||||+|++ |.+|
T Consensus 188 RDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 188 RDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp TTCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCCCHHCCCCCC-CCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCC
T ss_conf 527032144345-9828985142222045778615623435787657838872799996330300039999998389999
Q ss_pred CCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHH
Q ss_conf 99999189999999850999766530166666344333355667678246999999986159887454224899999565
Q 002732 774 FPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKM 853 (887)
Q Consensus 774 F~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 853 (887)
|.+.+....+..++.....+ ..+..+
T Consensus 267 f~~~~~~~~~~~~~~~~~~~------------------------------------------------------~~p~~~ 292 (325)
T d1rjba_ 267 YPGIPVDANFYKLIQNGFKM------------------------------------------------------DQPFYA 292 (325)
T ss_dssp STTCCCSHHHHHHHHTTCCC------------------------------------------------------CCCTTC
T ss_pred CCCCCHHHHHHHHHHCCCCC------------------------------------------------------CCCCCC
T ss_conf 99989899999998569989------------------------------------------------------988767
Q ss_pred HHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 8999999998031398999699989847
Q 002732 854 LANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 854 s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
+..+.+||.+||+.||.+|||+.|||+|
T Consensus 293 ~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 8999999999758896689399999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.57 Aligned_cols=251 Identities=18% Similarity=0.227 Sum_probs=209.9
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 24348588998851378518999997678999981799999605602037779999999996099999995256864011
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
++-..+|.+.+.||.|+||+||+|.+..++ ..||||++..+......+.+|+.+|..| +||||++++++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~ 82 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEI------KHPNLVQLLGVC 82 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGT----EEEEEEECCTTCSCHHHHHHHHHHHHHC------CCTTBCCEEEEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCC----EEEEEEEECCCCCHHHHHHHHHHHHHHC------CCCCEECCCCCE
T ss_conf 745799398659820888089999999999----6999999777610399999999999867------999882677527
Q ss_pred EECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 1268389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 643 KYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 643 ~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
...+.+||||||+ +|+|..+|.... ...+++..+..|+.||+.||.|||++||||+||||+||||+. ++.+||+|||
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DFG 160 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFG 160 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCC
T ss_pred EECCEEEEEEECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CCCEEECCCC
T ss_conf 45785478763146760677753035-541579999999999999788898789305760457689989-9928983244
Q ss_pred CCEECCCCCC---CCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHHHHCCCCHHH
Q ss_conf 4200588986---6765577655524460899994356999999999999099999-99991899999998509997665
Q 002732 722 NAMFAGKNEI---TPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLF-PGATNNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 722 ~a~~~~~~~~---~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF-~~~~~~~~l~~i~~~~g~~p~~~ 797 (887)
+|........ ....+++.|+|||++.+..|+.++|||||||+||+|++|..|| .+.+.......+... ..
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~-~~----- 234 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YR----- 234 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC-----
T ss_pred CEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC-CC-----
T ss_conf 546537887221035566546669278727999810430217899999986799887742599999998558-88-----
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+..+..++..+.+||.+||+.||.+|||+.+
T Consensus 235 -------------------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 265 (287)
T d1opja_ 235 -------------------------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAE 265 (287)
T ss_dssp -------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -------------------------------------------------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -------------------------------------------------8887433099999999975779768939999
Q ss_pred HHH
Q ss_conf 984
Q 002732 878 ALT 880 (887)
Q Consensus 878 iL~ 880 (887)
|++
T Consensus 266 i~~ 268 (287)
T d1opja_ 266 IHQ 268 (287)
T ss_dssp HHH
T ss_pred HHH
T ss_conf 999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=365.53 Aligned_cols=256 Identities=24% Similarity=0.366 Sum_probs=213.3
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
Q ss_conf 2434858899885137851899999767899998179999960560----203777999999999609999999525686
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE----TMNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
..+.++|.+++.||.|+||+||+|.+..++ +.||||++.+.. .....+..|+.+|..+ +||||+++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~------~hpniv~~ 72 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLH----RDVAVKVLRADLARDPSFYLRFRREAQNAAAL------NHPAIVAV 72 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTT----EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC------CCTTBCCE
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCCCCC
T ss_conf 570620698689960899299999999999----89999998556646989999999999999856------99988731
Q ss_pred CCEEEECC----EEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCC
Q ss_conf 40111268----389997621-1239999998166789999999999999999997421156231578899731258999
Q 002732 639 ASSFKYRN----HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKN 713 (887)
Q Consensus 639 ~~~~~~~~----~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~ 713 (887)
++++...+ .+||||||+ +++|..++...+. +++..++.|+.||+.||.|||++||||+||||+||||+. .+
T Consensus 73 ~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~-~~ 148 (277)
T d1o6ya_ 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TN 148 (277)
T ss_dssp EEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TS
T ss_pred CCEEEECCCCCCEEEEEEECCCCCEEHHHHCCCCC---CCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCC-CC
T ss_conf 14354326887669999977889871011203589---999999999999999999998579527634675566575-43
Q ss_pred EEEEEECCCCEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 0999822742005889-----86676557765552446089999435699999999999909999999991899999998
Q 002732 714 VLKLCDFGNAMFAGKN-----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHME 788 (887)
Q Consensus 714 ~iKL~DFG~a~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~ 788 (887)
.++|+|||.+...... .....+||+.|+|||++.+..|+.++||||||||||+|++|.+||.+.+..+.+..++.
T Consensus 149 ~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp CEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 20100344432212354433334642576243699998399999663202652899999769799899699999999984
Q ss_pred HHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 50999766530166666344333355667678246999999986159887454224899999565899999999803139
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
....+|... ++.++..+.+||.+||..|
T Consensus 229 ~~~~~~~~~----------------------------------------------------~~~~s~~l~~li~~~L~~d 256 (277)
T d1o6ya_ 229 EDPIPPSAR----------------------------------------------------HEGLSADLDAVVLKALAKN 256 (277)
T ss_dssp CCCCCGGGT----------------------------------------------------SSSCCHHHHHHHHHHTCSS
T ss_pred CCCCCCCHH----------------------------------------------------CCCCCHHHHHHHHHHCCCC
T ss_conf 699997100----------------------------------------------------3478999999999986679
Q ss_pred CCCCCCHHHHHHCCCC
Q ss_conf 8999699989847987
Q 002732 869 PEKRMTVAQALTHPFI 884 (887)
Q Consensus 869 P~~RpTa~eiL~HPwl 884 (887)
|.+||+..+.|.|+|+
T Consensus 257 p~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 257 PENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGSCSSHHHHHHHHH
T ss_pred HHHCHHHHHHHHHHHH
T ss_conf 7677739999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.47 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=211.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-----HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCE
Q ss_conf 858899885137851899999767899998179999960560-----203777999999999609999999525686401
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-----TMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-----~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
++|.+++.||+|+||+||+|.+.... ..++.||||++.+.. .....+..|+.+|.+|. +||||++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~-----h~pnIv~~~~~ 97 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYA 97 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST-TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH-----TCTTBCCEEEE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCC-CCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCC-----CCCEEEEEEEE
T ss_conf 02599989832878399999987658-8794899999836772101689999999999998646-----79839996200
Q ss_pred EEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf 11268389997621-12399999981667899999999999999999974211562315788997312589990999822
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
|.....+++||||+ +++|..++..... +++..+..++.||+.||.|||+++|||+||||+||||+. ++.+||+||
T Consensus 98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~-~~~vkL~DF 173 (322)
T d1vzoa_ 98 FQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDF 173 (322)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEESCS
T ss_pred ECCCCCEEEEEECCCCCHHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECC-CCCEEEEEC
T ss_conf 0248730012312341179999873045---437888888999999998851499896547732012469-998887413
Q ss_pred CCCEECCCC---CCCCCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCH
Q ss_conf 742005889---86676557765552446089--9994356999999999999099999999918999999985099976
Q 002732 721 GNAMFAGKN---EITPYLVSRFYRAPEIILGL--PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 721 G~a~~~~~~---~~~~~~gt~~Y~APE~l~~~--~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
|+|...... ......+++.|+|||++.+. .++.++|||||||+||+|++|..||.+.+..+....+.......
T Consensus 174 G~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-- 251 (322)
T d1vzoa_ 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 251 (322)
T ss_dssp SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--
T ss_pred CCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC--
T ss_conf 202220344443221222333331068760577688713251777799999976899988887777999999833568--
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC--
Q ss_conf 653016666634433335566767824699999998615988745422489999956589999999980313989996--
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM-- 873 (887)
Q Consensus 796 ~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp-- 873 (887)
.+..+..++..+.+||.+||.+||.+||
T Consensus 252 --------------------------------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~ 281 (322)
T d1vzoa_ 252 --------------------------------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281 (322)
T ss_dssp --------------------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred --------------------------------------------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCC
T ss_conf --------------------------------------------------998865479999999999744589881999
Q ss_pred ---CHHHHHHCCCCCC
Q ss_conf ---9998984798779
Q 002732 874 ---TVAQALTHPFISG 886 (887)
Q Consensus 874 ---Ta~eiL~HPwl~~ 886 (887)
||+|||+||||.+
T Consensus 282 ~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 282 GPRDADEIKEHLFFQK 297 (322)
T ss_dssp STTTHHHHHTSGGGTT
T ss_pred CCCCHHHHHCCHHHCC
T ss_conf 7450999974972348
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.25 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=209.7
Q ss_pred EECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 43485889988513785189999976789999817999996056020377799999999960999999952568640111
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+...+|.+++.||.|+||+||+|.+.. + ..||||++.......+.+..|+.+|.+| .||||+++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNG-H----TKVAVKSLKQGSMSPDAFLAEANLMKQL------QHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-T----EEEEEEEECTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECC-C----CEEEEEEECCCCCCHHHHHHHHHHHHHC------CCCCEEEEEEEEC
T ss_conf 388993886798107982899999999-9----9999999864768889999999999867------9998857873104
Q ss_pred ECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf 268389997621-1239999998166789999999999999999997421156231578899731258999099982274
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~ 722 (887)
. +.+||||||+ +|+|.+++.... ...|++..+..|+.||+.||.|||+++|+|+||||+||||+. ++.+||+|||+
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~-~~~~Kl~DFGl 155 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGL 155 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred C-CCEEEEEEECCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC-CCCEEECCCCC
T ss_conf 5-97699999578982888875147-898878899999999999999997489546756422515620-24404234101
Q ss_pred CEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 20058898---6676557765552446089999435699999999999909-9999999918999999985099976653
Q 002732 723 AMFAGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 723 a~~~~~~~---~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
|....... .....+++.|+|||++.+..|+.++||||||||||+|+|| .+||......+.+..+.....
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~------- 228 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------- 228 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred EEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-------
T ss_conf 4773588644203567744445828983799982456452579999999689888888899999999970688-------
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 01666663443333556676782469999999861598874542248999995658999999998031398999699989
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei 878 (887)
+..+..++..+.+||.+||..||.+|||+.++
T Consensus 229 ------------------------------------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei 260 (272)
T d1qpca_ 229 ------------------------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (272)
T ss_dssp ------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------------------------------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf ------------------------------------------------88965571999999999758897689399999
Q ss_pred HH--CCCCC
Q ss_conf 84--79877
Q 002732 879 LT--HPFIS 885 (887)
Q Consensus 879 L~--HPwl~ 885 (887)
++ |+||+
T Consensus 261 ~~~L~~~ft 269 (272)
T d1qpca_ 261 RSVLEDFFT 269 (272)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
T ss_conf 998611321
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=360.51 Aligned_cols=253 Identities=19% Similarity=0.255 Sum_probs=208.9
Q ss_pred EECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCE
Q ss_conf 43485889988513785189999976789999817999996056--0203777999999999609999999525686401
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 564 il~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
+....|.+.+.||+|+||+||+|.+..++. ....||||++... ......+.+|+.+|.+| +||||++++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~ 95 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQF------DHPNVIHLEGV 95 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC------CCTTBCCEEEE
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCC-EEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCCCCEEEE
T ss_conf 080042785698027882999999957997-88999999978445989999999999999857------99888618999
Q ss_pred EEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf 11268389997621-12399999981667899999999999999999974211562315788997312589990999822
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
|...+.+||||||+ +|+|.+++.... ..+++..+..|+.||+.||.|||+++|||+||||+||||+. ++.+||+||
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DF 172 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVSDF 172 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred EEECCEEEEEEEECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECC-CCCEEECCC
T ss_conf 962887799997227985300210456--79999999999999999889885279835761504489889-991998884
Q ss_pred CCCEECCCCC-------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 7420058898-------667655776555244608999943569999999999990-99999999918999999985099
Q 002732 721 GNAMFAGKNE-------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGP 792 (887)
Q Consensus 721 G~a~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~ 792 (887)
|+|....... .....+|+.|+|||++.+..|+.++||||||||||||+| |.+||.+.+..+.+..+......
T Consensus 173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 252 (299)
T d1jpaa_ 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252 (299)
T ss_dssp -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred CCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 43157567777653650256668830038788836997861214453578999986799999999999999999737889
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 97665301666663443333556676782469999999861598874542248999995658999999998031398999
Q 002732 793 FPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKR 872 (887)
Q Consensus 793 ~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~R 872 (887)
..+..++..+.+||.+||..||.+|
T Consensus 253 -------------------------------------------------------~~~~~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 253 -------------------------------------------------------PPPMDCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp -------------------------------------------------------CCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred -------------------------------------------------------CCCCCCHHHHHHHHHHHCCCCHHHC
T ss_conf -------------------------------------------------------9974226999999999758797689
Q ss_pred CCHHHHHHC
Q ss_conf 699989847
Q 002732 873 MTVAQALTH 881 (887)
Q Consensus 873 pTa~eiL~H 881 (887)
||+.|||++
T Consensus 278 Ps~~ei~~~ 286 (299)
T d1jpaa_ 278 PKFGQIVNT 286 (299)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
T ss_conf 299999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.62 Aligned_cols=246 Identities=21% Similarity=0.327 Sum_probs=209.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEECC
Q ss_conf 85889988513785189999976789999817999996056020377799999999960999999952568640111268
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
.+|.+++.||+|+||+||+|.+... ..||||++.........+..|+.++..| +||||++++++|...+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~vAvK~i~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAMSEEDFIEEAEVMMKL------SHPKLVQLYGVCLEQA 73 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTT-----EEEEEEECCSSSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECSSS
T ss_pred HHCEEEEEEEECCCEEEEEEEECCC-----CEEEEEEECCCCCCHHHHHHHHHHHHHC------CCCCCCCCCCEECCCC
T ss_conf 9958888982088829999998899-----9999999878867689999999999966------8997565352431599
Q ss_pred EEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCEE
Q ss_conf 389997621-1239999998166789999999999999999997421156231578899731258999099982274200
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~ 725 (887)
.+||||||+ +|+|.+++.... ..+++..+..|+.||+.||.|||+++|+|+||||+||||+. ++.+||+|||++..
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRF 150 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG-GGCEEECSCC----
T ss_pred CEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECC-CCCEEECCCCHHEE
T ss_conf 3379998369991899752013--47889999999999999877653164310443153266668-87768655321002
Q ss_pred CCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 58898---667655776555244608999943569999999999990-99999999918999999985099976653016
Q 002732 726 AGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~---~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... .....+|+.|+|||++.+..|+.++|||||||+||+|+| |.+||.+.+..+.+..+.......
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-------- 222 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------- 222 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC--------
T ss_pred CCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--------
T ss_conf 368873350430017666785786079998403321059999999878988877899999999998068889--------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
.+..++..+.+||.+||..||.+|||+.+||+|
T Consensus 223 -----------------------------------------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 -----------------------------------------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -----------------------------------------------954367999999999765797689199999999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.74 Aligned_cols=252 Identities=19% Similarity=0.265 Sum_probs=207.7
Q ss_pred CCEEEEEE-ECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 85889988-513785189999976789999817999996056--020377799999999960999999952568640111
Q 002732 567 GRYEVTAA-HGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 567 ~rY~i~~~-LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.+|.+... ||.|+||+||+|.+...+ ....||||++... ......+.+|+.+|.+| +||||++++++|.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRK--KQIDVAIKVLKQGTEKADTEEMMREAQIMHQL------DNPYIVRLIGVCQ 79 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC-----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC------CCTTBCCEEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCC--CCEEEEEEEECHHCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEC
T ss_conf 471887848730608099999996089--76899999988203978999999999999867------9988806865603
Q ss_pred ECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCC
Q ss_conf 268389997621-1239999998166789999999999999999997421156231578899731258999099982274
Q 002732 644 YRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGN 722 (887)
Q Consensus 644 ~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~ 722 (887)
. +.+||||||+ +|+|.+++... ...+++..+..|+.||+.||.|||+++|||+||||+||||+. ++.+||+|||+
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGl 155 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGL 155 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-TTEEEECCCTT
T ss_pred C-CEEEEEEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECC-CCCEEECCCHH
T ss_conf 6-8079999807899689975212--569999999999999999878998688105767646604546-88542033134
Q ss_pred CEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 20058898-----667655776555244608999943569999999999990-999999999189999999850999766
Q 002732 723 AMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKK 796 (887)
Q Consensus 723 a~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~ 796 (887)
|....... .....+|+.|+|||++.+..|+.++|||||||+|||||| |..||.+.+..+.+..+.....
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~----- 230 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----- 230 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----
T ss_conf 211554343211356211374335868872799995412322017899999389999999799999999981899-----
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 53016666634433335566767824699999998615988745422489999956589999999980313989996999
Q 002732 797 MLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVA 876 (887)
Q Consensus 797 ~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ 876 (887)
+..++.++..+.+||.+||..+|.+|||+.
T Consensus 231 --------------------------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~ 260 (285)
T d1u59a_ 231 --------------------------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFL 260 (285)
T ss_dssp --------------------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred --------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf --------------------------------------------------999976789999999997577976890999
Q ss_pred HH---HHCCCCC
Q ss_conf 89---8479877
Q 002732 877 QA---LTHPFIS 885 (887)
Q Consensus 877 ei---L~HPwl~ 885 (887)
+| |+|+|++
T Consensus 261 ~i~~~L~~~~~~ 272 (285)
T d1u59a_ 261 TVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHH
T ss_conf 999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.93 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=205.5
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 243485889988513785189999976789999817999996056---02037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++-.++|.+++.||+|+||+||+|... ..||||++... ......+..|+.+|..| +||||++++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~ 70 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH-------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT------RHVNILLFM 70 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS-------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC------CCTTBCCEE
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEEC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEE
T ss_conf 315451899889830788589999999-------9899999973469989999999999999847------998786456
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEE
Q ss_conf 0111268389997621-123999999816678999999999999999999742115623157889973125899909998
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLC 718 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~ 718 (887)
+++.. ..+||||||+ +|+|.++|.... ..+++..+..|+.||+.||.|||+++|||+||||+||||+. ++.+||+
T Consensus 71 ~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~-~~~~Kl~ 146 (276)
T d1uwha_ 71 GYSTA-PQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE-DLTVKIG 146 (276)
T ss_dssp EEECS-SSCEEEEECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TSSEEEC
T ss_pred EEEEC-CEEEEEEECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECC-CCCEEEC
T ss_conf 79715-58999996589988899985235--78999999999999999988875099951614789979818-9978875
Q ss_pred ECCCCEECCCC----CCCCCCCCCCCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 22742005889----86676557765552446089---999435699999999999909999999991899999998509
Q 002732 719 DFGNAMFAGKN----EITPYLVSRFYRAPEIILGL---PYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG 791 (887)
Q Consensus 719 DFG~a~~~~~~----~~~~~~gt~~Y~APE~l~~~---~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g 791 (887)
|||+|...... ......||+.|+|||++.+. +|+.++|||||||+||+|+||..||.+.+....+..++....
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 226 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS
T ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 00221333556776312566557431799999505689999531516359999999978899899896999999996588
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 99766530166666344333355667678246999999986159887454224899999565899999999803139899
Q 002732 792 PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEK 871 (887)
Q Consensus 792 ~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~ 871 (887)
..|.. ...+..++..+.+||.+||..||.+
T Consensus 227 ~~p~~--------------------------------------------------~~~~~~~~~~l~~li~~cl~~dp~~ 256 (276)
T d1uwha_ 227 LSPDL--------------------------------------------------SKVRSNCPKAMKRLMAECLKKKRDE 256 (276)
T ss_dssp CCCCG--------------------------------------------------GGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCC--------------------------------------------------HHCCCCCHHHHHHHHHHHCCCCHHH
T ss_conf 89860--------------------------------------------------0036555499999999975889768
Q ss_pred CCCHHHHHHCC
Q ss_conf 96999898479
Q 002732 872 RMTVAQALTHP 882 (887)
Q Consensus 872 RpTa~eiL~HP 882 (887)
|||+.+||++-
T Consensus 257 RPt~~~il~~L 267 (276)
T d1uwha_ 257 RPLFPQILASI 267 (276)
T ss_dssp SCCHHHHHHHH
T ss_pred CCCHHHHHHHH
T ss_conf 92999999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.79 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=207.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 85889988513785189999976789999817999996056--0203777999999999609999999525686401112
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
..|.+++.||.|+||+||+|.+..++......||+|.+... ......+..|+.+|..| +||||++++++|..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV------DNPHVCRLLGICLT 82 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC------CCTTBCCEEEEEES
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEEC
T ss_conf 999783198208992999999958998898999999965134979999999999999867------99888158999961
Q ss_pred CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCC
Q ss_conf 68389997621-12399999981667899999999999999999974211562315788997312589990999822742
Q 002732 645 RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNA 723 (887)
Q Consensus 645 ~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a 723 (887)
.+ .++|++++ +++|.+++.... ..+++..++.|+.||+.||.|||+++|||+||||+||||+. ++.+||+|||+|
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~-~~~~kl~DFGla 158 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLA 158 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-TTEEEECCCSHH
T ss_pred CC-EEEEEEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECC-CCCEEEECCCCC
T ss_conf 98-369998426874010111334--57999999999999999999998769504762120311679-987586025522
Q ss_pred EECCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHHHH
Q ss_conf 0058898----667655776555244608999943569999999999990-99999999918999999985099976653
Q 002732 724 MFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKML 798 (887)
Q Consensus 724 ~~~~~~~----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l 798 (887)
....... .....||+.|+|||++.+..|+.++|||||||+||+|+| |.+||.+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~------- 231 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER------- 231 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-------
T ss_pred EECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-------
T ss_conf 2335444532236510586446708874699983565440799999999779999999998999999975998-------
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 01666663443333556676782469999999861598874542248999995658999999998031398999699989
Q 002732 799 RKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA 878 (887)
Q Consensus 799 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei 878 (887)
+..++.++..+.+||.+||..||.+|||+.+|
T Consensus 232 ------------------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 263 (317)
T d1xkka_ 232 ------------------------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263 (317)
T ss_dssp ------------------------------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf ------------------------------------------------99985568999999998478993469199999
Q ss_pred HHCC
Q ss_conf 8479
Q 002732 879 LTHP 882 (887)
Q Consensus 879 L~HP 882 (887)
|.|.
T Consensus 264 l~~l 267 (317)
T d1xkka_ 264 IIEF 267 (317)
T ss_dssp HHHH
T ss_pred HHHH
T ss_conf 9999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.07 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=201.5
Q ss_pred EEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEECCEEE
Q ss_conf 88513785189999976789999817999996056---020377799999999960999999952568640111268389
Q 002732 573 AAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN---ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLC 649 (887)
Q Consensus 573 ~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~---~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~l~ 649 (887)
++||+|+||+||+|.+.... ....||||++... ......+..|+.+|.+| +||||++++++|.. +.+|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~g~~~~-~~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQL------DNPYIVRMIGICEA-ESWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTC------CCTTBCCEEEEEES-SSEE
T ss_pred CCCCCCCCEEEEEEEECCCC--CCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHC------CCCCCCEEEEEECC-CCEE
T ss_conf 78345878299999981697--385999999880108989999999999999867------99898527777505-9779
Q ss_pred EEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
Q ss_conf 997621-1239999998166789999999999999999997421156231578899731258999099982274200588
Q 002732 650 LVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFAGK 728 (887)
Q Consensus 650 lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~~~~ 728 (887)
|||||+ +|+|.+++.... .+++..+..|+.||+.||.|||+++|||+||||+||||+. .+.+||+|||+|.....
T Consensus 84 lvmE~~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCT
T ss_pred EEEECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCC-CCCCCCCCHHHHHHCCC
T ss_conf 9997478896899975225---7899999999999999976687479556777611310235-67512341345331343
Q ss_pred CC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCC
Q ss_conf 98-----667655776555244608999943569999999999990-999999999189999999850999766530166
Q 002732 729 NE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKGA 802 (887)
Q Consensus 729 ~~-----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~ 802 (887)
.. .....+|+.|+|||++.+..|+.++|||||||+||+|++ |.+||.+.+..+.+..+.....
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~----------- 228 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER----------- 228 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----------
T ss_conf 234432244567784203916653799984344303403132896589999999899999999982899-----------
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHH---H
Q ss_conf 6663443333556676782469999999861598874542248999995658999999998031398999699989---8
Q 002732 803 FTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQA---L 879 (887)
Q Consensus 803 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~ei---L 879 (887)
+..+..++..+.+||.+||..||.+|||+.+| |
T Consensus 229 --------------------------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L 264 (277)
T d1xbba_ 229 --------------------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264 (277)
T ss_dssp --------------------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred --------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf --------------------------------------------999865679999999997588976890989999985
Q ss_pred HCCCC
Q ss_conf 47987
Q 002732 880 THPFI 884 (887)
Q Consensus 880 ~HPwl 884 (887)
+|+|+
T Consensus 265 ~~~~~ 269 (277)
T d1xbba_ 265 RNYYY 269 (277)
T ss_dssp HHHHH
T ss_pred HCHHH
T ss_conf 28875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.61 Aligned_cols=246 Identities=19% Similarity=0.285 Sum_probs=211.7
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEECC
Q ss_conf 85889988513785189999976789999817999996056020377799999999960999999952568640111268
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRN 646 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~ 646 (887)
.+|.++++||+|+||+||+|... ++ ..||||++++.......+.+|+.++..+ +||||++++++|...+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~----~~vAvK~l~~~~~~~~~~~~Ev~~~~~l------~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQ----YDVAIKMIKEGSMSEDEFIEEAKVMMNL------SHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TT----EEEEEEEEESSSSCHHHHHHHHHHHHTC------CCTTBCCEEEEECCSS
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CC----CEEEEEEECCCCCCHHHHHHHHHHHHHC------CCCCEEEEEEEEEECC
T ss_conf 99799689820788399999988-99----8999999874757789999999999966------8986015889985078
Q ss_pred EEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCEE
Q ss_conf 389997621-1239999998166789999999999999999997421156231578899731258999099982274200
Q 002732 647 HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 647 ~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~ 725 (887)
.+++||||+ +|+|..++.... ..+++..+..|+.||+.||.|||++||+|+||||+||||+. ++.+||+|||++..
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRY 149 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT-TCCEEECCCSSCCB
T ss_pred CEEEEEECCCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECC-CCCEEECCCHHHEE
T ss_conf 1699997048993888641024--67768999999999999999875468434665413588769-98479886144202
Q ss_pred CCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCC
Q ss_conf 58898---667655776555244608999943569999999999990-99999999918999999985099976653016
Q 002732 726 AGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRKG 801 (887)
Q Consensus 726 ~~~~~---~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~~ 801 (887)
..... .....+++.|+|||++.+..|+.++|||||||++|+|+| |..||.+.+..++...+......+
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 221 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------- 221 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred CCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC--------
T ss_conf 357872252465788775780786379988521033643246739755999988999999999998079789--------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 66663443333556676782469999999861598874542248999995658999999998031398999699989847
Q 002732 802 AFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 802 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~H 881 (887)
.+..++..+.+||.+||+.||.+|||+.+||+|
T Consensus 222 -----------------------------------------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 -----------------------------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -----------------------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf -----------------------------------------------965465999999999766897689399999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.77 Aligned_cols=252 Identities=24% Similarity=0.300 Sum_probs=209.5
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEEC
Q ss_conf 48588998851378518999997678999981799999605602037779999999996099999995256864011126
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
.++|.+.+.||+|+||+||+|.+..+ ..||||++.......+.+..|+.+|.+| +|+||++++++|..
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-----~~vAiK~l~~~~~~~~~~~~E~~~l~~l------~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-----TRVAIKTLKPGTMSPEAFLQEAQVMKKL------RHEKLVQLYAVVSE- 83 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-----EEEEEEECCTTSSCHHHHHHHHHHHHHC------CCTTBCCEEEEECS-
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCC-----CEEEEEEECCCCCCHHHHHHHHHHHHHC------CCCCEEEEEEEEEC-
T ss_conf 79979846993079809999999999-----9999999880448889999999999866------66788689999823-
Q ss_pred CEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCE
Q ss_conf 8389997621-123999999816678999999999999999999742115623157889973125899909998227420
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~ 724 (887)
+.++|||||+ +|+|..++.... ...+++..+..|+.||+.||.|||+++|+|+||||+||||+. ++.+||+|||+|.
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~-~~~~kl~DfGla~ 161 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLAR 161 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCTTC
T ss_pred CCEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECC-CCCEEECCCCHHH
T ss_conf 97599999447994354200003-553059999999999999999875411433531230799989-9929984425554
Q ss_pred ECCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHHCCCCHHHHHC
Q ss_conf 058898---6676557765552446089999435699999999999909-999999991899999998509997665301
Q 002732 725 FAGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 725 ~~~~~~---~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
...... .....+++.|+|||++.+..++.++||||||||||+|++| .+||.+....+.+..+.....
T Consensus 162 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred HCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC---------
T ss_conf 25688733524545566545808983799891774132358999998689999988889999999982689---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 66666344333355667678246999999986159887454224899999565899999999803139899969998984
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
+..++.++..+.+||.+||..||.+|||+.+++.
T Consensus 233 ----------------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 233 ----------------------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp ----------------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ----------------------------------------------9998323799999999975669758919999999
Q ss_pred --CCCCCC
Q ss_conf --798779
Q 002732 881 --HPFISG 886 (887)
Q Consensus 881 --HPwl~~ 886 (887)
++||+.
T Consensus 267 ~L~~~~~~ 274 (285)
T d1fmka3 267 FLEDYFTS 274 (285)
T ss_dssp HHHTTTSC
T ss_pred HHHHHHCC
T ss_conf 87666238
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.84 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=209.4
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
Q ss_conf 243485889988513785189999976789999817999996056--020377799999999960999999952568640
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
++..++|.+++.||.|+||+||+|.+..++ .....||||++... ......+..|+.+|..| +||||+++++
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~-~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~ 75 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPE-NPALAVAIKTCKNCTSDSVREKFLQEALTMRQF------DHPHIVKLIG 75 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC------CCTTBCCEEE
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEEECCC-CEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEE
T ss_conf 768899698779930788299999993699-644999999936566879999999999999868------9999856988
Q ss_pred EEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 111268389997621-1239999998166789999999999999999997421156231578899731258999099982
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~D 719 (887)
+|. .+.+||||||+ +|+|..++.... ..+++..++.++.||+.||.|||+++|||+||||+|||++. .+.+||+|
T Consensus 76 ~~~-~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~-~~~~Kl~D 151 (273)
T d1mp8a_ 76 VIT-ENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGD 151 (273)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECC
T ss_pred EEE-CCEEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECC-CCCEEECC
T ss_conf 995-374799998406980776542247--89999999999999987752302267441410265532067-89678765
Q ss_pred CCCCEECCCCC---CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCH
Q ss_conf 27420058898---667655776555244608999943569999999999990-99999999918999999985099976
Q 002732 720 FGNAMFAGKNE---ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPK 795 (887)
Q Consensus 720 FG~a~~~~~~~---~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~ 795 (887)
||+|....... .+...+|+.|+|||++.+..|+.++|||||||+||+|++ |.+||.+.+..+.+..+.....
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~---- 227 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 227 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred CHHHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC----
T ss_conf 0342133677623305400583103266751699887452444247899998269999888999999999981899----
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 65301666663443333556676782469999999861598874542248999995658999999998031398999699
Q 002732 796 KMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTV 875 (887)
Q Consensus 796 ~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa 875 (887)
+..++.++..+.+||.+||..||.+|||+
T Consensus 228 ---------------------------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 256 (273)
T d1mp8a_ 228 ---------------------------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRF 256 (273)
T ss_dssp ---------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred ---------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf ---------------------------------------------------98987779999999999768797689299
Q ss_pred HHHHHC
Q ss_conf 989847
Q 002732 876 AQALTH 881 (887)
Q Consensus 876 ~eiL~H 881 (887)
.+|++|
T Consensus 257 ~ei~~~ 262 (273)
T d1mp8a_ 257 TELKAQ 262 (273)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.59 Aligned_cols=254 Identities=18% Similarity=0.228 Sum_probs=204.9
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECC
Q ss_conf 243485889988513785189999976789999817999996056--020377799999999960999999952568640
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFAS 640 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~ 640 (887)
|+-...|.+.++||+|+||+||+|....++......||||++... ......+..|+.+|..| +||||+++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l------~H~nIv~~~g 76 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF------SHHNIIRLEG 76 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEE
T ss_conf 5788996861598117790999999968998787999999988445968999999999999856------8987832367
Q ss_pred EEEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 111268389997621-1239999998166789999999999999999997421156231578899731258999099982
Q 002732 641 SFKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCD 719 (887)
Q Consensus 641 ~~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~D 719 (887)
+|.....+++||||+ ++.|.+++.... ..+++..+..|+.||+.||.|||+++|||+||||+||||+. ++.+||+|
T Consensus 77 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~-~~~~Kl~D 153 (283)
T d1mqba_ 77 VISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSD 153 (283)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECC
T ss_pred EEECCCCEEEEEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECC-CCEEEECC
T ss_conf 7833880389997213574022210234--54208999999999998541212123425765644278889-98499845
Q ss_pred CCCCEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 27420058898-----66765577655524460899994356999999999999099-9999999189999999850999
Q 002732 720 FGNAMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK-VLFPGATNNDMLRLHMELKGPF 793 (887)
Q Consensus 720 FG~a~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~-~PF~~~~~~~~l~~i~~~~g~~ 793 (887)
||+|....... .....||+.|+|||++.+..|+.++|||||||+||+|+++. +||.+.+..+.+..+.....
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-- 231 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-- 231 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--
T ss_pred CCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--
T ss_conf 510300357876526742677773434888870499997355634489899999679886556899999999863578--
Q ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 76653016666634433335566767824699999998615988745422489999956589999999980313989996
Q 002732 794 PKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRM 873 (887)
Q Consensus 794 p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~Rp 873 (887)
+..+..++..+.+||.+||..+|.+||
T Consensus 232 -----------------------------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RP 258 (283)
T d1mqba_ 232 -----------------------------------------------------LPTPMDCPSAIYQLMMQCWQQERARRP 258 (283)
T ss_dssp -----------------------------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHCCCCHHHCC
T ss_conf -----------------------------------------------------998504579999999997767976893
Q ss_pred CHHHHHH
Q ss_conf 9998984
Q 002732 874 TVAQALT 880 (887)
Q Consensus 874 Ta~eiL~ 880 (887)
|+.+||+
T Consensus 259 t~~eil~ 265 (283)
T d1mqba_ 259 KFADIVS 265 (283)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
T ss_conf 9999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.14 Aligned_cols=259 Identities=22% Similarity=0.337 Sum_probs=207.0
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCC-CCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 2434858899885137851899999767899-99817999996056--02037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~-~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++..++|.+++.||.|+||.||+|.+...+. .....||||++... ......+..|+.++.++. +|++|+.++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~-----~h~~iv~~~ 83 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-----HHLNVVNLL 83 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-----CCCEEEEEE
T ss_conf 616799798449841678399999986777555783999999860017178999999999988614-----998499741
Q ss_pred CEEEE-CCEEEEEEECC-HHHHHHHHHHHCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 01112-68389997621-1239999998166-------------789999999999999999997421156231578899
Q 002732 640 SSFKY-RNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 640 ~~~~~-~~~l~lV~E~~-~gsL~~lL~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~ 704 (887)
+++.. ...+++||||+ +|+|.++|..... ...|++..+..|+.||+.||.|||+++|||+||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379717867731
Q ss_pred CCCCCCCCCEEEEEECCCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCH
Q ss_conf 7312589990999822742005889----86676557765552446089999435699999999999909-999999991
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFAGKN----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATN 779 (887)
Q Consensus 705 NILi~~~~~~iKL~DFG~a~~~~~~----~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG-~~PF~~~~~ 779 (887)
||||+. ++.+||+|||+|...... ......||+.|+|||++.+..|+.++|||||||+||+|++| .+||.+...
T Consensus 164 NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 164 NILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GEEECG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CEEECC-CCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf 065779-9828984575200113566522247516672102036864688996632213678999998688999989998
Q ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 89999999850999766530166666344333355667678246999999986159887454224899999565899999
Q 002732 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 780 ~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~d 859 (887)
...+..++.....+ ..+..++..+.+
T Consensus 243 ~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~l~~ 268 (299)
T d1ywna1 243 DEEFCRRLKEGTRM------------------------------------------------------RAPDYTTPEMYQ 268 (299)
T ss_dssp SHHHHHHHHHTCCC------------------------------------------------------CCCTTCCHHHHH
T ss_pred HHHHHHHHHCCCCC------------------------------------------------------CCCCCCCHHHHH
T ss_conf 99999999638988------------------------------------------------------888657899999
Q ss_pred HHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 9998031398999699989847
Q 002732 860 LLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~eiL~H 881 (887)
||.+||..||.+|||+.|||+|
T Consensus 269 li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 269 TMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999767796679199999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=340.40 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=205.9
Q ss_pred ECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 34858899885137851899999767899998179999960560203777999999999609999999525686401112
Q 002732 565 LDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 565 l~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
+.++|.+++.||.|+||+||+|.+..++ +.||||++.... ....+..|+.++..+. +|++|+.+..++..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~-~~~~~~~E~~i~~~l~-----~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAG----EEVAIKLECVKT-KHPQLHIESKIYKMMQ-----GGVGIPTIRWCGAE 74 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTT----EEEEEEEEESCT-TSCCHHHHHHHHHHST-----TSTTCCCEEEEEEE
T ss_pred ECCEEEEEEEEEECCCCEEEEEEECCCC----CEEEEEEECHHC-CCHHHHHHHHHHHHCC-----CCCCCCEEEEEEEC
T ss_conf 8888999689850788099999998899----899999972100-5888999999999703-----89960179999951
Q ss_pred CCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC--CCCEEEEEECCC
Q ss_conf 683899976211239999998166789999999999999999997421156231578899731258--999099982274
Q 002732 645 RNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE--AKNVLKLCDFGN 722 (887)
Q Consensus 645 ~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~--~~~~iKL~DFG~ 722 (887)
.+.+++|||+++++|...+.... ..+++..+..++.||+.||.|||++||||+||||+|||++. ....++|+|||+
T Consensus 75 ~~~~~ivme~~~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 75 GDYNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred CCEEEEEEEECCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCC
T ss_conf 98778999873871333244306--8876899999999999999999979944266787660643357776156504675
Q ss_pred CEECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHC--
Q ss_conf 20058898---------6676557765552446089999435699999999999909999999991899999998509--
Q 002732 723 AMFAGKNE---------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNNDMLRLHMELKG-- 791 (887)
Q Consensus 723 a~~~~~~~---------~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~g-- 791 (887)
|....... ....+||+.|+|||++.+..|+.++|||||||+||+|++|..||...........+.....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred CEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 13425544554100013577678735329999918998983218861778999984987665530577999999852356
Q ss_pred -CCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
Q ss_conf -9976653016666634433335566767824699999998615988745422489999956589999999980313989
Q 002732 792 -PFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPE 870 (887)
Q Consensus 792 -~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~ 870 (887)
.+|..- ..+.++..+.+||.+||..+|.
T Consensus 233 ~~~~~~~---------------------------------------------------~~~~~p~~~~~li~~cl~~~p~ 261 (299)
T d1ckia_ 233 MSTPIEV---------------------------------------------------LCKGYPSEFATYLNFCRSLRFD 261 (299)
T ss_dssp HHSCHHH---------------------------------------------------HTTTSCHHHHHHHHHHHHSCTT
T ss_pred CCCCHHH---------------------------------------------------HCCCCCHHHHHHHHHHCCCCHH
T ss_conf 7898357---------------------------------------------------5347889999999998439955
Q ss_pred CCCCHH---HHHHCCCCC
Q ss_conf 996999---898479877
Q 002732 871 KRMTVA---QALTHPFIS 885 (887)
Q Consensus 871 ~RpTa~---eiL~HPwl~ 885 (887)
+||++. ++|+|+|..
T Consensus 262 ~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 262 DKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp CCCCHHHHHHHHHHHHHH
T ss_pred HCCCHHHHHHHHHHHHHH
T ss_conf 791999999999999997
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=344.30 Aligned_cols=256 Identities=19% Similarity=0.260 Sum_probs=210.3
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCC-CCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 243485889988513785189999976789-9998179999960560--2037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAG-NGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~-~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
|+..++|++++.||.|+||+||+|...... ......||||++.... .....+.+|+.+|..| .|+||+.++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~ 82 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF------DNPNIVKLL 82 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC------CCTTBCCEE
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHC------CCCCCCCCE
T ss_conf 38988938867982078839999998887657788299999988210857999999999999966------899765524
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEE
Q ss_conf 0111268389997621-1239999998166---------------------78999999999999999999742115623
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR---------------------NIGLKLTAVRAYAKQLFIALKHLKNCGVL 697 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~---------------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIi 697 (887)
++|...+.+++|||++ +|+|.++|..... ...|++..+..|+.||+.||.|||+++||
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEE
T ss_conf 66605980389998158992999998527554210000111001210346788989999999999999985541357868
Q ss_pred CCCCCCCCCCCCCCCCEEEEEECCCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCC-C
Q ss_conf 15788997312589990999822742005889----866765577655524460899994356999999999999099-9
Q 002732 698 HCDIKPDNMLVNEAKNVLKLCDFGNAMFAGKN----EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK-V 772 (887)
Q Consensus 698 HrDLKP~NILi~~~~~~iKL~DFG~a~~~~~~----~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~-~ 772 (887)
|+||||+||||+. ++.+||+|||+|...... ......+++.|+|||++.+..|+.++||||||||||+|++|. +
T Consensus 163 HrDlKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEECCCCEEECC-CCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 5488401168989-992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHH
Q ss_conf 99999918999999985099976653016666634433335566767824699999998615988745422489999956
Q 002732 773 LFPGATNNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPK 852 (887)
Q Consensus 773 PF~~~~~~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 852 (887)
||.+.+..+.+..+..... +..+..
T Consensus 242 p~~~~~~~e~~~~v~~~~~-------------------------------------------------------~~~p~~ 266 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNI-------------------------------------------------------LACPEN 266 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCC-------------------------------------------------------CCCCTT
T ss_pred CCCCCCHHHHHHHHHCCCC-------------------------------------------------------CCCCCC
T ss_conf 9999899999999973997-------------------------------------------------------888732
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 5899999999803139899969998984
Q 002732 853 MLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 853 ~s~~~~dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
++..+.+||..||..+|.+|||+.||++
T Consensus 267 ~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 267 CPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 5299999999974889657939999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.39 Aligned_cols=258 Identities=22% Similarity=0.333 Sum_probs=211.2
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCC-CCCCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 24348588998851378518999997678-99998179999960560--2037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKA-GNGEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~-~~~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++-.++|.+++.||.|+||.||+|..... .......||||+++... .....+..|+.++..|. +||||++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~-----~HpnIv~~~ 93 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG-----NHMNIVNLL 93 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----CCCCEEEEE
T ss_conf 377899698549820688299999980664477886999999874248779999999999987626-----999887899
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCC
Q ss_conf 0111268389997621-1239999998166---------------78999999999999999999742115623157889
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFGR---------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKP 703 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~---------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP 703 (887)
++|.....+||||||+ +|+|.++|..... ...+++..+..|+.||+.||.|||+++|||+||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCCCCCCCCCEEEEEECCCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 973125899909998227420058898----667655776555244608999943569999999999990-999999999
Q 002732 704 DNMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGAT 778 (887)
Q Consensus 704 ~NILi~~~~~~iKL~DFG~a~~~~~~~----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~ 778 (887)
+|||++. .+.++|+|||++....... ....++|+.|+|||++.+..++.++|||||||+||+|++ |.+||.+..
T Consensus 174 ~NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 174 RNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCCCC-CCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 2100002-575210234010233678861586201359687677886179999740010258999999858998877899
Q ss_pred HHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 18999999985099976653016666634433335566767824699999998615988745422489999956589999
Q 002732 779 NNDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFK 858 (887)
Q Consensus 779 ~~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~ 858 (887)
....+..++.....+ ..+..++..+.
T Consensus 253 ~~~~~~~~i~~~~~~------------------------------------------------------~~~~~~~~~l~ 278 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRM------------------------------------------------------LSPEHAPAEMY 278 (311)
T ss_dssp SSHHHHHHHHHTCCC------------------------------------------------------CCCTTSCHHHH
T ss_pred HHHHHHHHHHCCCCC------------------------------------------------------CCCCCCCHHHH
T ss_conf 899999998668988------------------------------------------------------98543659999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 9999803139899969998984
Q 002732 859 DLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 859 dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
+||.+||.+||.+|||+.+||+
T Consensus 279 ~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 279 DIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999975779657929999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.92 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=210.3
Q ss_pred EECCCEEEEEEECCCCCEEEEEEEECCCCC---CCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHHCCCCCCCCCEEEE
Q ss_conf 434858899885137851899999767899---9981799999605602--03777999999999609999999525686
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGN---GEPEEVAIKIIRNNET--MNKAGQTEVQILKKLAGADPENKRHCIRF 638 (887)
Q Consensus 564 il~~rY~i~~~LG~G~fG~Vy~a~d~~~~~---~~~~~vAIKii~~~~~--~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l 638 (887)
+..++|.+++.||.|+||.||+|....++. .....||||+++.... ....+..|+.++..+. .||||+++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~-----~HpnIv~~ 84 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINL 84 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHC-----CCCEEEEC
T ss_conf 2589969700985167828999998578755566754999999881128688999999999999813-----99969734
Q ss_pred CCEEEECCEEEEEEECC-HHHHHHHHHHHCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCC
Q ss_conf 40111268389997621-1239999998166-------------789999999999999999997421156231578899
Q 002732 639 ASSFKYRNHLCLVFESL-HMNLREVLKKFGR-------------NIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPD 704 (887)
Q Consensus 639 ~~~~~~~~~l~lV~E~~-~gsL~~lL~~~~~-------------~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~ 704 (887)
+++|.....+++||||+ +|+|.++|..... ...|++..+..|+.||+.||.|||+.+|||+||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCC
T ss_conf 65220188689999736999099999860677643222334574346799999999999999998766379786302210
Q ss_pred CCCCCCCCCEEEEEECCCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCH
Q ss_conf 73125899909998227420058898----667655776555244608999943569999999999990-9999999991
Q 002732 705 NMLVNEAKNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATN 779 (887)
Q Consensus 705 NILi~~~~~~iKL~DFG~a~~~~~~~----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~ 779 (887)
|||++. ++.+||+|||++....... .....+++.|+|||++.+..|+.++||||||||||+|++ |.+||.+.+.
T Consensus 165 NiLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 165 NVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GEEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CEEECC-CCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH
T ss_conf 224547-8976762211101135555543146678884663266751798882555477588888740179898999999
Q ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 89999999850999766530166666344333355667678246999999986159887454224899999565899999
Q 002732 780 NDMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 780 ~~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~d 859 (887)
...+..+..... +..+..++..+.+
T Consensus 244 ~~~~~~i~~~~~-------------------------------------------------------~~~p~~~~~~l~~ 268 (299)
T d1fgka_ 244 EELFKLLKEGHR-------------------------------------------------------MDKPSNCTNELYM 268 (299)
T ss_dssp HHHHHHHHTTCC-------------------------------------------------------CCCCSSCCHHHHH
T ss_pred HHHHHHHHCCCC-------------------------------------------------------CCCCCCCHHHHHH
T ss_conf 999999972888-------------------------------------------------------8987435299999
Q ss_pred HHHHHCCCCCCCCCCHHHHHH
Q ss_conf 999803139899969998984
Q 002732 860 LLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~eiL~ 880 (887)
||.+||+.||..||||.|||+
T Consensus 269 li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 269 MMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHH
T ss_conf 999976679767939999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.14 Aligned_cols=252 Identities=23% Similarity=0.250 Sum_probs=207.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE
Q ss_conf 85889988513785189999976789999817999996056--0203777999999999609999999525686401112
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY 644 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~ 644 (887)
++|.+.++||+|+||+||+|.+..++. ...||||.+... ......+..|+.+|..|. .||||++++++|..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----~HpnIv~~~~~~~~ 82 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGL--RMDAAIKRMKEYASKDDHRDFAGELEVLCKLG-----HHPNIINLLGACEH 82 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTE--EEEEEEEEEECC------CHHHHHHHHHTTCC-----CCTTBCCEEEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCE--EEEEEEEEECCCCCHHHHHHHHHHHHHHHHCC-----CCCCEEEEEEEEEC
T ss_conf 996887798207882899999989996--99999999782338579999999999998622-----89988367888841
Q ss_pred CCEEEEEEECC-HHHHHHHHHHH-------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC
Q ss_conf 68389997621-12399999981-------------66789999999999999999997421156231578899731258
Q 002732 645 RNHLCLVFESL-HMNLREVLKKF-------------GRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE 710 (887)
Q Consensus 645 ~~~l~lV~E~~-~gsL~~lL~~~-------------~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~ 710 (887)
.+.+||||||+ +|+|.++|... .....|++..+..++.||+.||.|||+.+|||+||||+|||++.
T Consensus 83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162 (309)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
T ss_conf 87369999802898699998640355555123101234578999999999999999987663089545550520489868
Q ss_pred CCCEEEEEECCCCEECCCCC-CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHH
Q ss_conf 99909998227420058898-66765577655524460899994356999999999999099-99999991899999998
Q 002732 711 AKNVLKLCDFGNAMFAGKNE-ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGK-VLFPGATNNDMLRLHME 788 (887)
Q Consensus 711 ~~~~iKL~DFG~a~~~~~~~-~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~-~PF~~~~~~~~l~~i~~ 788 (887)
.+.+||+|||+|....... .....+|..|+|||++.+..|+.++||||||||||+|++|. +||.+.+..+.+..+..
T Consensus 163 -~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 163 -NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp -GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred -CCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf -8763874344322444223455301377555538752699996221531388999998368999999999999999982
Q ss_pred HHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 50999766530166666344333355667678246999999986159887454224899999565899999999803139
Q 002732 789 LKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLD 868 (887)
Q Consensus 789 ~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~D 868 (887)
.. .+..+..++..+.+||.+||..|
T Consensus 242 ~~-------------------------------------------------------~~~~~~~~~~~~~~li~~cl~~d 266 (309)
T d1fvra_ 242 GY-------------------------------------------------------RLEKPLNCDDEVYDLMRQCWREK 266 (309)
T ss_dssp TC-------------------------------------------------------CCCCCTTBCHHHHHHHHHHTCSS
T ss_pred CC-------------------------------------------------------CCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 68-------------------------------------------------------88887667899999999976789
Q ss_pred CCCCCCHHHHHHC
Q ss_conf 8999699989847
Q 002732 869 PEKRMTVAQALTH 881 (887)
Q Consensus 869 P~~RpTa~eiL~H 881 (887)
|.+|||+.+||+|
T Consensus 267 P~~RPs~~eil~~ 279 (309)
T d1fvra_ 267 PYERPSFAQILVS 279 (309)
T ss_dssp GGGSCCHHHHHHH
T ss_pred HHHCCCHHHHHHH
T ss_conf 6689499999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=331.72 Aligned_cols=255 Identities=20% Similarity=0.213 Sum_probs=205.6
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEE
Q ss_conf 24348588998851378518999997678999981799999605602037779999999996099999995256864011
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSF 642 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~ 642 (887)
.++.++|.+++.||.|+||+||+|.+..++ ..||||++.... ....+..|+.++..|. ++++++.+++++
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~-~~~~~~~e~~~~~~l~-----~~~~i~~~~~~~ 70 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNN----QQVAIKFEPRRS-DAPQLRDEYRTYKLLA-----GCTGIPNVYYFG 70 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTT----EEEEEEEEECCT-TSCCHHHHHHHHHHTT-----TCTTCCCEEEEE
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCC----CEEEEEEECCCC-CCHHHHHHHHHHHHHC-----CCCCCCEEEEEE
T ss_conf 978980699799841788299999998899----799999975025-8299999999999964-----899987799996
Q ss_pred EECCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCC----CCCEEEEE
Q ss_conf 12683899976211239999998166789999999999999999997421156231578899731258----99909998
Q 002732 643 KYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNE----AKNVLKLC 718 (887)
Q Consensus 643 ~~~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~----~~~~iKL~ 718 (887)
....+.|+|||+++++|.+++...+. .+++..+..++.||+.||.|||++||||+||||+||||+. ..+.+||+
T Consensus 71 ~~~~~~~~vme~~~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 71 QEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred ECCCCCEEEEEECCCCHHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEEC
T ss_conf 01881179999648887999975203--1106899999999999999999779662667713152347543447956872
Q ss_pred ECCCCEECCCC---------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH
Q ss_conf 22742005889---------8667655776555244608999943569999999999990999999999189---99999
Q 002732 719 DFGNAMFAGKN---------EITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGATNND---MLRLH 786 (887)
Q Consensus 719 DFG~a~~~~~~---------~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~~~~---~l~~i 786 (887)
|||+|...... ....++||+.|+|||++.+..|+.++|||||||+||+|++|..||.+..... .+..+
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 36605771467665411102467627751026798964888886999898319999998698767885302199999999
Q ss_pred HHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 98509997665301666663443333556676782469999999861598874542248999995658999999998031
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
.......|..- ..+.++.+|.+||..|+.
T Consensus 229 ~~~~~~~~~~~---------------------------------------------------l~~~~p~~l~~ii~~~~~ 257 (293)
T d1csna_ 229 GEKKQSTPLRE---------------------------------------------------LCAGFPEEFYKYMHYARN 257 (293)
T ss_dssp HHHHHHSCHHH---------------------------------------------------HTTTSCHHHHHHHHHHHH
T ss_pred HHCCCCCCHHH---------------------------------------------------HCCCCCHHHHHHHHHHHC
T ss_conf 70567999589---------------------------------------------------657998999999999843
Q ss_pred CCCCCCCCHHHHHH
Q ss_conf 39899969998984
Q 002732 867 LDPEKRMTVAQALT 880 (887)
Q Consensus 867 ~DP~~RpTa~eiL~ 880 (887)
.+|.+||+.+.+.+
T Consensus 258 ~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 258 LAFDATPDYDYLQG 271 (293)
T ss_dssp CCTTCCCCHHHHHH
T ss_pred CCCCCCCCHHHHHH
T ss_conf 99300859999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.93 Aligned_cols=261 Identities=19% Similarity=0.252 Sum_probs=213.6
Q ss_pred CEECCCEEEEEEECCCCCEEEEEEEECCCCC-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
Q ss_conf 2434858899885137851899999767899-998179999960560--2037779999999996099999995256864
Q 002732 563 EILDGRYEVTAAHGKGVFSTVVRAKDLKAGN-GEPEEVAIKIIRNNE--TMNKAGQTEVQILKKLAGADPENKRHCIRFA 639 (887)
Q Consensus 563 eil~~rY~i~~~LG~G~fG~Vy~a~d~~~~~-~~~~~vAIKii~~~~--~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~ 639 (887)
++..++|.+++.||.|+||+||+|.+..... .....||||++.... .....+..|+.++.++ +||||++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~ 89 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF------NCHHVVRLL 89 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC------CCTTBCCEE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEE
T ss_conf 42689918835982078818999998786447789689999987012868999999999999976------999884125
Q ss_pred CEEEECCEEEEEEECC-HHHHHHHHHHHC-------CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCC
Q ss_conf 0111268389997621-123999999816-------67899999999999999999974211562315788997312589
Q 002732 640 SSFKYRNHLCLVFESL-HMNLREVLKKFG-------RNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEA 711 (887)
Q Consensus 640 ~~~~~~~~l~lV~E~~-~gsL~~lL~~~~-------~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~ 711 (887)
++|...+.++|||||+ +|+|.+++.... ....+++..+..|+.||+.||.|||+++|||+||||+||||+.
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~- 168 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE- 168 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-
T ss_pred EEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECC-
T ss_conf 4784288106777604899889998750332113444688799999999999999999876479654328677540359-
Q ss_pred CCEEEEEECCCCEECCCCC----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHH
Q ss_conf 9909998227420058898----6676557765552446089999435699999999999909-9999999918999999
Q 002732 712 KNVLKLCDFGNAMFAGKNE----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTG-KVLFPGATNNDMLRLH 786 (887)
Q Consensus 712 ~~~iKL~DFG~a~~~~~~~----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG-~~PF~~~~~~~~l~~i 786 (887)
++.+||+|||+|....... .....+++.|+|||++.+..|+.++|||||||+||+|++| .+||.+.+..+.+..+
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i 248 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 96499942454202357763031340231632378888736998833344437899999996899999998999999999
Q ss_pred HHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 98509997665301666663443333556676782469999999861598874542248999995658999999998031
Q 002732 787 MELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFV 866 (887)
Q Consensus 787 ~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~ 866 (887)
..... +..++.++..+.+||.+||+
T Consensus 249 ~~~~~-------------------------------------------------------~~~p~~~~~~l~~li~~cl~ 273 (308)
T d1p4oa_ 249 MEGGL-------------------------------------------------------LDKPDNCPDMLFELMRMCWQ 273 (308)
T ss_dssp HTTCC-------------------------------------------------------CCCCTTCCHHHHHHHHHHTC
T ss_pred HHCCC-------------------------------------------------------CCCCCCCHHHHHHHHHHHCC
T ss_conf 80888-------------------------------------------------------88863353999999999757
Q ss_pred CCCCCCCCHHHHHH------CCCCC
Q ss_conf 39899969998984------79877
Q 002732 867 LDPEKRMTVAQALT------HPFIS 885 (887)
Q Consensus 867 ~DP~~RpTa~eiL~------HPwl~ 885 (887)
.+|.+|||+.+||+ +|+|.
T Consensus 274 ~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 274 YNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp SSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred CCHHHCCCHHHHHHHHHHHCCCCCC
T ss_conf 7965893999999997876177875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.38 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=205.9
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC----CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCE
Q ss_conf 485889988513785189999976789999817999996056----0203777999999999609999999525686401
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN----ETMNKAGQTEVQILKKLAGADPENKRHCIRFASS 641 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~----~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~ 641 (887)
..+|.+++.||+|+||+||+|...... .....||||++.+. ......+.+|+.+|..| +||||++++++
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~~~g~ 79 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPS-GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL------DHRNLIRLYGV 79 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTT-SCEEEEEEEC--------CHHHHHHHHHHHHHHHC------CCTTBCCEEEE
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCC-CCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEE
T ss_conf 489199789803888399999998899-90799999999835557989999999999999868------99998789877
Q ss_pred EEECCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEEC
Q ss_conf 11268389997621-12399999981667899999999999999999974211562315788997312589990999822
Q 002732 642 FKYRNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDF 720 (887)
Q Consensus 642 ~~~~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DF 720 (887)
|.. ..++|||||+ +++|.+++..... .|++..+..++.||+.||.|||+++|+|+||||.||||+. ++.+||+||
T Consensus 80 ~~~-~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~-~~~vkl~Df 155 (273)
T d1u46a_ 80 VLT-PPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDF 155 (273)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred EEE-CCHHEEEEEECCCCHHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCC-CCCEEECCC
T ss_conf 740-100114654238612544421268--9999999999999999998752178752056688815655-654332561
Q ss_pred CCCEECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 7420058898-----667655776555244608999943569999999999990-9999999991899999998509997
Q 002732 721 GNAMFAGKNE-----ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFP 794 (887)
Q Consensus 721 G~a~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p 794 (887)
|++....... .....++..|+|||++.+..|+.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL- 234 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred HHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-
T ss_conf 1555303588752654763257310799998379999421566148999999968999999969999999998479999-
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 66530166666344333355667678246999999986159887454224899999565899999999803139899969
Q 002732 795 KKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMT 874 (887)
Q Consensus 795 ~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpT 874 (887)
..++.++..+.+||.+||..||.+|||
T Consensus 235 -----------------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt 261 (273)
T d1u46a_ 235 -----------------------------------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPT 261 (273)
T ss_dssp -----------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred -----------------------------------------------------CCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf -----------------------------------------------------985445399999999976889667929
Q ss_pred HHHHHH
Q ss_conf 998984
Q 002732 875 VAQALT 880 (887)
Q Consensus 875 a~eiL~ 880 (887)
+.+|+.
T Consensus 262 ~~ei~~ 267 (273)
T d1u46a_ 262 FVALRD 267 (273)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.64 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=206.1
Q ss_pred EECCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 43485889988513785189999976789999817999996056020377799999999960999999952568640111
Q 002732 564 ILDGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 564 il~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
+-.++|.+++.||.|+||.||+|.... ..||||++++.. ..+.+.+|+.+|.+| +||||++++++|.
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~i~~~~-~~~~~~~E~~~l~~l------~HpnIv~~~g~~~ 70 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDA-TAQAFLAEASVMTQL------RHSNLVQLLGVIV 70 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCCC---HHHHHTHHHHTTC------CCTTBCCEEEEEC
T ss_pred CCHHHEEEEEEEECCCCEEEEEEEECC------EEEEEEEECCHH-HHHHHHHHHHHHHHC------CCCCEEEEEEEEE
T ss_conf 578994885798207980899999999------099999988577-799999999999867------8989854987887
Q ss_pred E-CCEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECC
Q ss_conf 2-68389997621-123999999816678999999999999999999742115623157889973125899909998227
Q 002732 644 Y-RNHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFG 721 (887)
Q Consensus 644 ~-~~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG 721 (887)
. .+.+||||||+ +|+|.++|..... ..+++..+..|+.||+.||.|||+.+|||+||+|+|||++. ++.+||+|||
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~-~~~~kl~dfg 148 (262)
T d1byga_ 71 EEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFG 148 (262)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCC
T ss_pred ECCCCEEEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECC-CCCEEECCCC
T ss_conf 238928999963699989999874578-88899999999999985232113376553666567601468-9977632456
Q ss_pred CCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCHHHHHC
Q ss_conf 420058898667655776555244608999943569999999999990-9999999991899999998509997665301
Q 002732 722 NAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYT-GKVLFPGATNNDMLRLHMELKGPFPKKMLRK 800 (887)
Q Consensus 722 ~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~g~~p~~~l~~ 800 (887)
++...... .....++..|+|||++.+..|+.++|||||||+||||++ |.+||...+..+.+..+....
T Consensus 149 ~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------- 217 (262)
T d1byga_ 149 LTKEASST-QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------- 217 (262)
T ss_dssp C-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------
T ss_pred CCEECCCC-CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC----------
T ss_conf 00344787-7655666467781787279888588777579999999978999999999999999998089----------
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 66666344333355667678246999999986159887454224899999565899999999803139899969998984
Q 002732 801 GAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQALT 880 (887)
Q Consensus 801 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~eiL~ 880 (887)
.+..++.++..+.+||.+||..||.+|||+.+|++
T Consensus 218 ---------------------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 218 ---------------------------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp ---------------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------------------------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ---------------------------------------------99997657999999999975669768939999999
Q ss_pred C
Q ss_conf 7
Q 002732 881 H 881 (887)
Q Consensus 881 H 881 (887)
+
T Consensus 253 ~ 253 (262)
T d1byga_ 253 Q 253 (262)
T ss_dssp H
T ss_pred H
T ss_conf 9
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.42 Aligned_cols=248 Identities=18% Similarity=0.198 Sum_probs=197.5
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECC--CCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEE-C
Q ss_conf 88998851378518999997678999981799999605--60203777999999999609999999525686401112-6
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRN--NETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKY-R 645 (887)
Q Consensus 569 Y~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~--~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~-~ 645 (887)
+.+.++||.|+||+||+|.+..++ .....||||++.. +......+..|+.+|.+| .||||+++++++.. .
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~~~g~~~~~~ 101 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDND-GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF------SHPNVLSLLGICLRSE 101 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC------CCTTBCCCCEEEEETT
T ss_pred ECCCEEEEECCCEEEEEEEEECCC-CEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHC------CCCCEEEEEEEEEECC
T ss_conf 526669813688099999997799-879999999988436978999999999999867------8999867867898069
Q ss_pred CEEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCCCCCCEEEEEECCCCE
Q ss_conf 8389997621-123999999816678999999999999999999742115623157889973125899909998227420
Q 002732 646 NHLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAM 724 (887)
Q Consensus 646 ~~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~ 724 (887)
..+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+|+|+||||+||||+. ++.+||+|||++.
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~ 178 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLAR 178 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSSGGGC
T ss_pred CCEEEEEEEEECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECC-CCCEEEECCCCHH
T ss_conf 94389998740674144210134--54048999999999887652003367625776687576779-9988991065232
Q ss_pred ECCCCC------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHHHHCCCCHHH
Q ss_conf 058898------667655776555244608999943569999999999990999999999-1899999998509997665
Q 002732 725 FAGKNE------ITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCLYELYTGKVLFPGAT-NNDMLRLHMELKGPFPKKM 797 (887)
Q Consensus 725 ~~~~~~------~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL~eLltG~~PF~~~~-~~~~l~~i~~~~g~~p~~~ 797 (887)
...... .....+|+.|+|||++.+..++.++|||||||+||||++|..||.... ..+....+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~------ 252 (311)
T d1r0pa_ 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------ 252 (311)
T ss_dssp CTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC------
T ss_pred HCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC------
T ss_conf 25566555310025655564556768874379997457466199999999789999888999999999980898------
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 30166666344333355667678246999999986159887454224899999565899999999803139899969998
Q 002732 798 LRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFNIKPKDIGSIVTASPGEDPKMLANFKDLLDKIFVLDPEKRMTVAQ 877 (887)
Q Consensus 798 l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~s~~~~dLL~kmL~~DP~~RpTa~e 877 (887)
+..++.++..+.+||..||..||.+|||+.|
T Consensus 253 -------------------------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 253 -------------------------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp -------------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -------------------------------------------------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -------------------------------------------------8996447599999999976889768939999
Q ss_pred HHHC
Q ss_conf 9847
Q 002732 878 ALTH 881 (887)
Q Consensus 878 iL~H 881 (887)
+++|
T Consensus 284 i~~~ 287 (311)
T d1r0pa_ 284 LVSR 287 (311)
T ss_dssp HHHH
T ss_pred HHHH
T ss_conf 9999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.24 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=189.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEEC
Q ss_conf 48588998851378518999997678999981799999605602037779999999996099999995256864011126
Q 002732 566 DGRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 566 ~~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
+..|.+.+.||+|+||+||+|... + ..||||++............|+..+..+ +||||+++++++...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g----~~vAvK~~~~~~~~~~~~e~ei~~~~~~------~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--G----EEVAVKIFSSREERSWFREAEIYQTVML------RHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--T----EEEEEEEECGGGHHHHHHHHHHHTSTTC------CCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC--C----EEEEEEEECCCCHHHHHHHHHHHHHHHC------CCCCCCCEEEEEEEC
T ss_conf 868999889820788199999999--9----8999999872004679999999999627------998683268899837
Q ss_pred C----EEEEEEECC-HHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC--------CCEECCCCCCCCCCCCCCC
Q ss_conf 8----389997621-12399999981667899999999999999999974211--------5623157889973125899
Q 002732 646 N----HLCLVFESL-HMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKN--------CGVLHCDIKPDNMLVNEAK 712 (887)
Q Consensus 646 ~----~l~lV~E~~-~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs--------~gIiHrDLKP~NILi~~~~ 712 (887)
+ .+||||||+ +|+|..+|... .+++..+..++.|++.||.|||. +||||+||||+||||+. +
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~ 144 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-N 144 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-T
T ss_pred CCCCEEEEEEEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECC-C
T ss_conf 98604899999646698989998658----999899999999999999998876652046898661531731357868-8
Q ss_pred CEEEEEECCCCEECCCCC------CCCCCCCCCCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 909998227420058898------66765577655524460899------994356999999999999099999999918
Q 002732 713 NVLKLCDFGNAMFAGKNE------ITPYLVSRFYRAPEIILGLP------YDHPLDIWSVGCCLYELYTGKVLFPGATNN 780 (887)
Q Consensus 713 ~~iKL~DFG~a~~~~~~~------~~~~~gt~~Y~APE~l~~~~------~t~~sDIwSLGviL~eLltG~~PF~~~~~~ 780 (887)
+.+||+|||++....... .....||+.|+|||++.+.. ++.++|||||||+||+|++|..||......
T Consensus 145 ~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 145 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred CCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 77688763866234677762001355250354767822105654546777675012201599999996289988766311
Q ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 99999998509997665301666663443333556676782469999999861-59887454224899999565899999
Q 002732 781 DMLRLHMELKGPFPKKMLRKGAFTDQHFDQDLNFHATEEDPVTKKAIKKIIFN-IKPKDIGSIVTASPGEDPKMLANFKD 859 (887)
Q Consensus 781 ~~l~~i~~~~g~~p~~~l~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~~~~~~~~~s~~~~d 859 (887)
... + +......+. ...+...+.. .....+... .........+.+
T Consensus 225 ~~~-----------------------~------~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~l~~ 269 (303)
T d1vjya_ 225 QLP-----------------------Y------YDLVPSDPS-VEEMRKVVCEQKLRPNIPNR-----WQSCEALRVMAK 269 (303)
T ss_dssp CCT-----------------------T------TTTSCSSCC-HHHHHHHHTTSCCCCCCCGG-----GGGCHHHHHHHH
T ss_pred CCC-----------------------H------HHCCCCCCH-HHHHHHHHHCCCCCCCCCCC-----CCCHHHHHHHHH
T ss_conf 241-----------------------0------122556430-99999987502468887765-----577689999999
Q ss_pred HHHHHCCCCCCCCCCHHHHHHC
Q ss_conf 9998031398999699989847
Q 002732 860 LLDKIFVLDPEKRMTVAQALTH 881 (887)
Q Consensus 860 LL~kmL~~DP~~RpTa~eiL~H 881 (887)
|+.+||+.||.+|||+.||+++
T Consensus 270 li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 270 IMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999760698589599999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.3e-24 Score=172.18 Aligned_cols=169 Identities=16% Similarity=0.155 Sum_probs=115.9
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCH-------------------HHHHHHHHHHHHHHHHCCCC
Q ss_conf 88998851378518999997678999981799999605602-------------------03777999999999609999
Q 002732 569 YEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNET-------------------MNKAGQTEVQILKKLAGADP 629 (887)
Q Consensus 569 Y~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~-------------------~~~~~~~Ei~iL~~L~~~~~ 629 (887)
+.+..+||.|+||+||+|.+. ++ ..||||++..... .......|+.++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----- 71 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL----- 71 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-----
T ss_pred CHHCCEEEECCCEEEEEEECC-CC----CEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHC-----
T ss_conf 022778024856599999979-99----99999998604434666556563000888999999778999999981-----
Q ss_pred CCCCCEEEECCEEEECCEEEEEEECCHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCCCCCC
Q ss_conf 99952568640111268389997621123999999816678999999999999999999742115623157889973125
Q 002732 630 ENKRHCIRFASSFKYRNHLCLVFESLHMNLREVLKKFGRNIGLKLTAVRAYAKQLFIALKHLKNCGVLHCDIKPDNMLVN 709 (887)
Q Consensus 630 ~~h~~Iv~l~~~~~~~~~l~lV~E~~~gsL~~lL~~~~~~~~ls~~~~~~i~~qIl~aL~yLHs~gIiHrDLKP~NILi~ 709 (887)
.+.+++.++++. ..+||||++.+... ..++...+..++.||+.+|.|||.+||+|+||||+|||++
T Consensus 72 -~~~~v~~~~~~~----~~~lvme~~~~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~ 137 (191)
T d1zara2 72 -QGLAVPKVYAWE----GNAVLMELIDAKEL---------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS 137 (191)
T ss_dssp -TTSSSCCEEEEE----TTEEEEECCCCEEG---------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred -CCCCCCEEEEEC----CCEEEEEEECCCCC---------CCHHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEE
T ss_conf -699914499862----88899995045654---------2001578999999999999998268889836890361142
Q ss_pred CCCCEEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHH
Q ss_conf 8999099982274200588986676557765552446089999435699999999
Q 002732 710 EAKNVLKLCDFGNAMFAGKNEITPYLVSRFYRAPEIILGLPYDHPLDIWSVGCCL 764 (887)
Q Consensus 710 ~~~~~iKL~DFG~a~~~~~~~~~~~~gt~~Y~APE~l~~~~~t~~sDIwSLGviL 764 (887)
. ..++|+|||+|.....+....+...-.....+. ....|+..+|+||+.--+
T Consensus 138 ~--~~~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 138 E--EGIWIIDFPQSVEVGEEGWREILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp T--TEEEECCCTTCEETTSTTHHHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred C--CCEEEEECCCCCCCCCCCCHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHH
T ss_conf 8--989998778843089987099998779999999-757899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=2.7e-07 Score=60.88 Aligned_cols=147 Identities=15% Similarity=0.127 Sum_probs=84.8
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEEC
Q ss_conf 858899885137851899999767899998179999960560-2037779999999996099999995256864011126
Q 002732 567 GRYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNE-TMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYR 645 (887)
Q Consensus 567 ~rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~-~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~ 645 (887)
..|.++...+-++.+.||.+.... ..++||+..... .....+..|..++..|.. +-.+++++.++...
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~------~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-----~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGEN------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-----KLPVPKVLHFERHD 82 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSS------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-----TSCCCCEEEEEEET
T ss_pred HCEEEEECCCCCCCCCEEEEEECC------CEEEEEECCCCCCCCHHHHHHHHHHHHHHHC-----CCCCCCEEEEEECC
T ss_conf 352799767899877189999089------8699998488765325569999999998760-----69987289997508
Q ss_pred CEEEEEEECCHH-HHHHH-----------------HHHHCC--CC--CCC--HHH----HHHH-----------------
Q ss_conf 838999762112-39999-----------------998166--78--999--999----9999-----------------
Q 002732 646 NHLCLVFESLHM-NLREV-----------------LKKFGR--NI--GLK--LTA----VRAY----------------- 680 (887)
Q Consensus 646 ~~l~lV~E~~~g-sL~~l-----------------L~~~~~--~~--~ls--~~~----~~~i----------------- 680 (887)
+..++||+++.| .+... +..... .. ++. ... ...+
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred CCEEEEEEECCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 96499998604334354334402699999989999999855684214357644656555778998776555543033232
Q ss_pred ----HHHHHHHHHHH---HCCCEECCCCCCCCCCCCCCCCEEEEEECCCCEE
Q ss_conf ----99999999742---1156231578899731258999099982274200
Q 002732 681 ----AKQLFIALKHL---KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 681 ----~~qIl~aL~yL---Hs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~ 725 (887)
+..++..+.-+ ....++|+|+.|.|||++. ++.+-|+||+.+.+
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECC-CCEEEEEECHHCCC
T ss_conf 0057999999998449867817898600476423649-96599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=8e-06 Score=51.43 Aligned_cols=77 Identities=18% Similarity=0.112 Sum_probs=48.8
Q ss_pred EEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCC--------CHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEE
Q ss_conf 988513785189999976789999817999996056--------020377799999999960999999952568640111
Q 002732 572 TAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNN--------ETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFK 643 (887)
Q Consensus 572 ~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~--------~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~ 643 (887)
.+.||.|....||.+.+...+ ..|+||..... +........|..+|..+....+ ..+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~----~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p---~~vP~v~~~-- 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHD----RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVP---HLVPRVFYS-- 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC--------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCG---GGSCCEEEE--
T ss_pred EEEECCCCEEEEEEEEECCCC----EEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCCEEEEE--
T ss_conf 998079852768999957998----48999617713034677788877899999999998650579---885528998--
Q ss_pred ECCEEEEEEECCHH
Q ss_conf 26838999762112
Q 002732 644 YRNHLCLVFESLHM 657 (887)
Q Consensus 644 ~~~~l~lV~E~~~g 657 (887)
+....++|||++.+
T Consensus 102 d~~~~~lvmE~L~~ 115 (392)
T d2pula1 102 DTEMAVTVMEDLSH 115 (392)
T ss_dssp ETTTTEEEECCCTT
T ss_pred CCCCCEEEEECCCC
T ss_conf 59887798713577
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=2e-05 Score=48.87 Aligned_cols=140 Identities=14% Similarity=0.100 Sum_probs=79.7
Q ss_pred EECCCC-CEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 851378-5189999976789999817999996056020377799999999960999999952568640111268389997
Q 002732 574 AHGKGV-FSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNHLCLVF 652 (887)
Q Consensus 574 ~LG~G~-fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~l~lV~ 652 (887)
.+..|. .+.||.+.... + ..+++|+..... ...+..|..+|..|.... ..+++++.++...+..++||
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~----~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g----vpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-R----PVLFVKTDLSGA--LNELQDEAARLSWLATTG----VPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-S----CCEEEEEECSCT--TSCHHHHHHHHHHHHTTT----CCBCCEEEEEECSSCEEEEE
T ss_pred ECCCCCCCCEEEEEEECC-C----CEEEEEECCCCC--HHHHHHHHHHHHHHHHCC----CCCCCEEEECCCCCCEEEEE
T ss_conf 767865477589999389-8----789999589667--768999999999998659----99886132224566159998
Q ss_pred ECCHH-H--------------HHHHHHHHCC----CCCC--CHHHHHHHHH--------------------HHHHHHHHH
Q ss_conf 62112-3--------------9999998166----7899--9999999999--------------------999999742
Q 002732 653 ESLHM-N--------------LREVLKKFGR----NIGL--KLTAVRAYAK--------------------QLFIALKHL 691 (887)
Q Consensus 653 E~~~g-s--------------L~~lL~~~~~----~~~l--s~~~~~~i~~--------------------qIl~aL~yL 691 (887)
+++.| . +..+|..... ..++ .......... .+...+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EEEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHH
T ss_conf 74413554322126899999999999987368854488755412468899999987541101134011213799999999
Q ss_pred -------HCCCEECCCCCCCCCCCCCCCCEEEEEECCCCEE
Q ss_conf -------1156231578899731258999099982274200
Q 002732 692 -------KNCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 692 -------Hs~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~ 725 (887)
....+||+|+.|.|||++. +..+-|+||+.+.+
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~-~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV 205 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred HHHCCCCCCCEEEECCCCCCCEEEEC-CCEEEEEECHHCCC
T ss_conf 87187657956786788876357737-96589998533265
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.02 E-value=0.0001 Score=44.30 Aligned_cols=140 Identities=17% Similarity=0.135 Sum_probs=77.9
Q ss_pred CCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEE--CCEEEECCEEEEEEECC
Q ss_conf 7851899999767899998179999960560203777999999999609999999525686--40111268389997621
Q 002732 578 GVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRF--ASSFKYRNHLCLVFESL 655 (887)
Q Consensus 578 G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l--~~~~~~~~~l~lV~E~~ 655 (887)
+.--.||.+... ++ ..|++|+..........+..|..++..|...... .+..+.. -..+......+.|++++
T Consensus 33 s~EN~vy~v~~~-dg----~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gip-v~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 33 SYENRVYQFQDE-DR----RRFVVKFYRPERWTADQILEEHQFALQLVNDEVP-VAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp CSSSEEEEECCT-TC----CCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS-BCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred CCCCEEEEEECC-CC----CEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCEECCCCEEEEEEEEEEEEEEEC
T ss_conf 612026999838-99----9799998478778899999999999999855998-78752068980566534799998652
Q ss_pred HHH------------HHHHHH---HHCC------CCC-------------------CCHH---HHHHHHHHHHHHHHHHH
Q ss_conf 123------------999999---8166------789-------------------9999---99999999999997421
Q 002732 656 HMN------------LREVLK---KFGR------NIG-------------------LKLT---AVRAYAKQLFIALKHLK 692 (887)
Q Consensus 656 ~gs------------L~~lL~---~~~~------~~~-------------------ls~~---~~~~i~~qIl~aL~yLH 692 (887)
.|. +..+|. .... ... ++.. ....++..++..+.-+-
T Consensus 107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 186 (325)
T d1zyla1 107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 186 (325)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 77688999999999989999998863035786556778978876656899987476998898999999999999999845
Q ss_pred ----CCCEECCCCCCCCCCCCCCCCEEEEEECCCCEEC
Q ss_conf ----1562315788997312589990999822742005
Q 002732 693 ----NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMFA 726 (887)
Q Consensus 693 ----s~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~~ 726 (887)
..++||+|+.|.|||++ ++. .|+||+.++..
T Consensus 187 ~~~~p~~liHgDlh~~NvL~~--~~~-~~IDFdd~~~g 221 (325)
T d1zyla1 187 REDFTVLRLHGDCHAGNILWR--DGP-MFVDLDDARNG 221 (325)
T ss_dssp CSCSCCEECCSSCSGGGEEES--SSE-EECCCTTCCEE
T ss_pred CCCCCCEEECCCCCCCCEEEE--CCC-EEEECHHCCCC
T ss_conf 456871202478880428783--893-58865201468
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.94 E-value=0.00015 Score=43.20 Aligned_cols=149 Identities=13% Similarity=0.054 Sum_probs=77.2
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEE-CCE--EEE
Q ss_conf 58899885137851899999767899998179999960560203777999999999609999999525686-401--112
Q 002732 568 RYEVTAAHGKGVFSTVVRAKDLKAGNGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRF-ASS--FKY 644 (887)
Q Consensus 568 rY~i~~~LG~G~fG~Vy~a~d~~~~~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l-~~~--~~~ 644 (887)
...-+..|..|.--+.|++.... + .+++|++... ........++.++..|..... ..|..+.. -+. ...
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~~-g-----~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~-pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTTK-D-----PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGL-SCPLPLPRKDGELLGEL 90 (316)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-----CEEEEEECC----CCHHHHHHHHHHHHHHTTC-CCCCBCCBTTCCSCEEE
T ss_pred CCEEEECCCCCCCCCEEEEEECC-C-----CEEEEECCCC-CCHHHHHHHHHHHHHHHHCCC-CCCCCCEECCCCCCEEE
T ss_conf 85685237888526738999789-7-----2899980789-998899999999875430255-54556410489762134
Q ss_pred CCEEEEEEECCHH---------------HHHHHHHHHCC------CCCC------------------CHHHHHHHHHHHH
Q ss_conf 6838999762112---------------39999998166------7899------------------9999999999999
Q 002732 645 RNHLCLVFESLHM---------------NLREVLKKFGR------NIGL------------------KLTAVRAYAKQLF 685 (887)
Q Consensus 645 ~~~l~lV~E~~~g---------------sL~~lL~~~~~------~~~l------------------s~~~~~~i~~qIl 685 (887)
....+.++.++.+ .+...+..... .... ........+..+.
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 170 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 170 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred ECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_conf 12550245311465533320467888889987645444320245310111012002456777765311412799999998
Q ss_pred HHHHHHH----CCCEECCCCCCCCCCCCCCCCEEEEEECCCCEE
Q ss_conf 9997421----156231578899731258999099982274200
Q 002732 686 IALKHLK----NCGVLHCDIKPDNMLVNEAKNVLKLCDFGNAMF 725 (887)
Q Consensus 686 ~aL~yLH----s~gIiHrDLKP~NILi~~~~~~iKL~DFG~a~~ 725 (887)
..+.... ..||||+|+.+.|||++. +..+-|+||+.++.
T Consensus 171 ~~~~~~~~~~L~~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 171 DYLAAHWPKDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHCCC-CCCEEEECCCCCCC
T ss_conf 76420485545450333786365640204-54126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.72 E-value=0.00018 Score=42.71 Aligned_cols=77 Identities=13% Similarity=0.063 Sum_probs=48.2
Q ss_pred EEEEECCCCCEEEEEEEECCCC---CCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCEEEECCE
Q ss_conf 9988513785189999976789---9998179999960560203777999999999609999999525686401112683
Q 002732 571 VTAAHGKGVFSTVVRAKDLKAG---NGEPEEVAIKIIRNNETMNKAGQTEVQILKKLAGADPENKRHCIRFASSFKYRNH 647 (887)
Q Consensus 571 i~~~LG~G~fG~Vy~a~d~~~~---~~~~~~vAIKii~~~~~~~~~~~~Ei~iL~~L~~~~~~~h~~Iv~l~~~~~~~~~ 647 (887)
-+..|+.|-.-.+|++...... ...+..|++++.-.. ........|..+++.|.... ..++++.+|..
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~g-----l~Pkll~~~~~--- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERH-----LGPKLYGIFSG--- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTT-----SSSCEEEEETT---
T ss_pred EEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CHHHHHHHHHHHHHHHHHCC-----CCCEEEEECCC---
T ss_conf 9999178533434899968877544578981799965996-11658999999999997579-----99808998189---
Q ss_pred EEEEEECCHH
Q ss_conf 8999762112
Q 002732 648 LCLVFESLHM 657 (887)
Q Consensus 648 l~lV~E~~~g 657 (887)
.+|++|+.|
T Consensus 117 -g~I~efi~g 125 (395)
T d1nw1a_ 117 -GRLEEYIPS 125 (395)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEECC
T ss_conf -569997345
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.15 E-value=0.014 Score=30.55 Aligned_cols=41 Identities=32% Similarity=0.419 Sum_probs=35.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 87999998799999999999999887787430234577778
Q 002732 402 QEEEDLDRIMEESRKRRQAILEKYKNQHLQQQKDSNLVDVE 442 (887)
Q Consensus 402 ~~~~~~~k~~e~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~ 442 (887)
.|+++..+|...+.++++||+++|.....+|+.+++++++.
T Consensus 59 YEDEdGDRITVRSDEEl~AMisyy~~~~~eq~~~g~~~~pL 99 (105)
T d2npta1 59 YEDEDGDRITVRSDEEMKAMLSYYYSTVMEQQVNGQLIEPL 99 (105)
T ss_dssp EECTTSCEEEECSHHHHHHHHHHHHHHHHHHHTTTCCCCCE
T ss_pred ECCCCCCEEEECCHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 02565887687267999999999999999998347998873
|